Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,Reactome_2022__Interferon Signaling R-HSA-913531,-0.714268061224069,-1.981403965376481,0.0,0.07476807722018666,0.07,14/74,3.61%,RSAD2;GBP1;VCAM1;GBP4;XAF1;GBP2;EIF2AK2;ISG15;HERC5;IFI27;MX1;STAT1;OAS3;IRF1
prerank,Reactome_2022__Interferon Alpha/Beta Signaling R-HSA-909733,-0.8357690455217378,-1.9481172776706563,0.0,0.05981446177614933,0.1,9/27,3.61%,RSAD2;XAF1;GBP2;ISG15;IFI27;MX1;STAT1;OAS3;IRF1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.8464145258101511,-1.8443067400370325,0.05263157894736842,0.14205934671835466,0.45,9/23,3.61%,RSAD2;XAF1;GBP2;ISG15;IFI27;MX1;STAT1;OAS3;IRF1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.8464145258101511,-1.8443067400370325,0.05263157894736842,0.14205934671835466,0.45,9/23,3.61%,RSAD2;XAF1;GBP2;ISG15;IFI27;MX1;STAT1;OAS3;IRF1
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.8976396311603846,-1.8187091727016451,0.0,0.14953615444037333,0.54,7/20,4.22%,RSAD2;EIF2AK2;IFIH1;ISG15;MX1;OAS3;FAM111A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Chorionic Villus,-0.7729559201083701,-1.775211421455578,0.0,0.24175011634527027,0.72,8/25,7.01%,SAMD9L;GBP4;XAF1;GBP2;CD74;SP100;APOL3;GIMAP8
prerank,CellMarker_Augmented_2021__Macrophage:Lymph Node,-0.8814947731966251,-1.7613193120928554,0.0,0.15701296216239202,0.79,2/8,0.72%,SAMD9L;GBP2
prerank,CellMarker_Augmented_2021__Macrophage:Eye,-0.8814947731966251,-1.7613193120928554,0.0,0.15701296216239202,0.79,2/8,0.72%,SAMD9L;GBP2
prerank,CellMarker_Augmented_2021__Macrophage:Visceral Adipose Tissue,-0.8814947731966251,-1.7613193120928554,0.0,0.15701296216239202,0.79,2/8,0.72%,SAMD9L;GBP2
prerank,CellMarker_Augmented_2021__Monocyte:Kidney,-0.8814947731966251,-1.7613193120928554,0.0,0.15701296216239202,0.79,2/8,0.72%,SAMD9L;GBP2
prerank,CellMarker_Augmented_2021__Macrophage:Artery,-0.8814947731966251,-1.7613193120928554,0.0,0.15701296216239202,0.79,2/8,0.72%,SAMD9L;GBP2
prerank,CellMarker_Augmented_2021__Macrophage:Retinal Pigment Epithelium,-0.8814947731966251,-1.7613193120928554,0.0,0.15701296216239202,0.79,2/8,0.72%,SAMD9L;GBP2
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.8322450560855181,-1.747253283428145,0.0,0.18576991493938688,0.83,7/25,4.22%,RSAD2;EIF2AK2;IFIH1;ISG15;MX1;OAS3;FAM111A
prerank,CellMarker_Augmented_2021__Hair Follicle cell:Hair Follicle,-0.7310900422269199,-1.7403925622783678,0.0,0.19119265460590593,0.85,13/46,7.25%,SAMD9L;GBP1;GBP4;XAF1;GBP2;CPQ;IRF1;DDX60L;TNFSF10;SP100;APOL3;GIMAP8;SP140L
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.8796664915421746,-1.7401649911898818,0.03571428571428571,0.17844647763217888,0.85,5/11,8.53%,PRIMPOL;FAM111A;ATR;THOC1;SAMHD1
prerank,Reactome_2022__Post NMDA Receptor Activation Events R-HSA-438064,0.8589660315978619,1.734321236648209,0.0,0.0443511550671103,0.04,5/21,4.91%,ERBB4;GRIA2;LRRC7;PRKAG2;GRIN2B
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.8674988642559726,-1.7203350955293855,0.0,0.21822932538641984,0.93,3/10,3.61%,XAF1;STAT1;IRF1
prerank,Reactome_2022__Transcriptional Regulation By VENTX R-HSA-8853884,-0.8719412208050892,-1.7099343630922128,0.0,0.23046160272575186,0.95,2/15,3.69%,ANAPC16;TNRC6C
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.9339035906951286,1.7062135661818214,0.0,0.09424620451760937,0.12,3/13,1.67%,NRCAM;RTN4;MAP2
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.9328741918203158,-1.7057397922584516,0.0,0.23136566117579987,0.97,1/10,0.05%,RSAD2
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.9698665869196597,-1.6971302232830068,0.0,0.23851016633239547,0.98,1/5,0.19%,DDX60
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.9698665869196597,-1.6971302232830068,0.0,0.23851016633239547,0.98,1/5,0.19%,DDX60
prerank,Reactome_2022__TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.8202048157155838,-1.694989196878662,0.0,0.2339172701602983,0.98,2/10,7.22%,IFIH1;TRIM25
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.8740918709981099,-1.6940767539340635,0.0,0.22736292572865857,0.98,2/11,3.98%,DDX60;BMP6
prerank,KEGG_2021_Human__Spinocerebellar ataxia,0.7961506202528096,1.6908621008354556,0.0,0.0887023101342206,0.16,8/45,8.23%,PIK3R3;GRIA2;PSMC6;ITPR1;MAP3K5;GRIN2B;PIK3R1;RB1CC1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.8051684167538403,-1.6903631929243215,0.04,0.22495438885377902,0.98,5/13,8.55%,PRIMPOL;FAM111A;ATR;THOC1;MSH3
prerank,KEGG_2021_Human__Prion disease,0.7734098074759209,1.6871049907201658,0.0,0.07207062698405423,0.17,12/60,6.93%,PIK3R3;LAMC1;PSMC6;ITPR1;HSPA5;NCAM2;GRIN2B;CACNA1C;NDUFA12;PIK3R1;PRNP;TUBB4B
prerank,Reactome_2022__Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,0.8329685068923822,1.6802958571486055,0.0,0.08426719462750956,0.21,5/26,4.91%,ERBB4;GRIA2;LRRC7;PRKAG2;GRIN2B
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.6981631517944434,-1.678749389602047,0.0,0.24766925579186835,0.98,5/32,3.61%,RSAD2;VCAM1;IL15;HERC5;IRF1
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.7946102581363097,-1.6769559239678955,0.04,0.24494022097333157,0.98,7/16,7.28%,GBP1;GBP4;GBP2;CD74;STAT1;SP100;GCH1
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Germ,-0.813542491307148,-1.6677119726225127,0.0,0.2703153561037518,0.98,6/23,7.01%,SAMD9L;GBP4;XAF1;TNFSF10;APOL3;GIMAP8
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.840968445482801,-1.6628857823238592,0.04,0.2769188045192099,0.98,6/16,5.55%,SAMD9L;GBP2;IFIH1;IRF1;DDX60L;SP100
prerank,KEGG_2021_Human__Breast cancer,0.7769848455460825,1.6519843671852872,0.0,0.13674939479025675,0.38,13/46,13.89%,PIK3R3;WNT2B;FGFR1;PIK3R1;ESR2;CDK6;GRB2;JAG2;JUN;CDKN1A;FOS;SHC2;KRAS
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),0.8128932891405869,1.6511383271257654,0.0,0.11879773678690259,0.38,3/22,1.43%,MTHFD1L;LDHA;SCP2
prerank,KEGG_2021_Human__MicroRNAs in cancer,0.7358453430348009,1.6496601699080207,0.0,0.10949191407192854,0.38,11/64,8.82%,PIK3R3;DDIT4;ZEB2;TIMP3;PRKCE;ZFPM2;PIK3R1;RASSF1;CDK6;GRB2;CDKN1B
prerank,CellMarker_Augmented_2021__DCLK1+ Progenitor cell:Large Intestine,-0.8360720410321412,-1.6435228136920683,0.0,0.3458023571433633,1.0,4/13,3.21%,GBP1;VCAM1;COL8A1;MX1
prerank,KEGG_2021_Human__PPAR signaling pathway,0.879001721153448,1.6434057542773173,0.0,0.12319765296419527,0.45,6/15,7.30%,ANGPTL4;SCP2;PCK1;PLIN2;ACOX1;ACSL5
prerank,CellMarker_Augmented_2021__SLC16A7+ cell:Lung,-0.5318873077942483,-1.6357283788170964,0.0,0.36791050411450477,1.0,25/238,6.29%,RSAD2;IFI44L;GBP4;NEK3;SLC22A5;XAF1;ALS2;ZNF33B;OCLN;LEPR;ATM;ZNF875;DCP1A;BTBD9;NKD1;ATRN;FAM111A;ATR;TSTD3;YEATS2;ZMAT3;SLC25A29;RC3H1;LENG8;ITIH5
prerank,CellMarker_Augmented_2021__Granulosa cell:Fetal Gonad,0.7671082631389075,1.6326447715166548,0.0,0.1541202638582083,0.56,15/43,12.83%,LDHA;TSC22D3;RPS11;GAPDH;PGK1;SCARB2;SRGN;MT2A;RPS27A;ATP2B1;GGT5;ATP1A1;RPL8;RPL34;TMEM132C
prerank,CellMarker_Augmented_2021__Neuronal Progenitor cell:Undefined,0.8322787575609988,1.630010645222681,0.0,0.15522904273488605,0.6,12/24,6.88%,ERBB4;GRIA2;ATRNL1;MAP2;CNTN1;CADM2;MAP1B;GPM6B;NPAS3;CTNND2;SNAP25;LRP1B
prerank,Reactome_2022__Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,0.748682408003117,1.6274269722361572,0.0,0.14876116595426578,0.6,6/43,4.91%,ERBB4;GRIA2;LRRC7;GRIK1;PRKAG2;GRIN2B
prerank,KEGG_2021_Human__Pyruvate metabolism,0.9291830748604581,1.6200428387734913,0.0,0.16802264515809093,0.66,3/9,1.86%,PKM;LDHA;PCK1
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.8889628830369053,-1.6198562070206903,0.04878048780487805,0.42642726707913137,1.0,3/5,5.23%,SLC22A5;SLC25A26;SLC25A29
prerank,CellMarker_Augmented_2021__M1 macrophage:Lung,-0.9215140630267199,-1.6185417943059777,0.0,0.42328379200460514,1.0,12/19,5.68%,RSAD2;SAMD9L;GBP1;EPSTI1;GBP2;IFIH1;TAP1;MX1;IRF1;PARP9;TNFSF10;APOL3
prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,0.8426621768620983,1.6167741635461934,0.0,0.1671088164135763,0.68,7/18,4.91%,ADM;GRIA2;GRIK1;GRIK2;GRM7;S1PR1;GRIN2B
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,0.7200022774130383,1.6165805733508454,0.0,0.15670741457045637,0.68,24/105,12.32%,PIK3R3;LAMC1;DDIT4;ERBB4;PPP2R3A;PCK1;PKN3;PPP2R2B;LAMA5;FGFR1;PIK3R1;JAK1;HSP90AA1;CDK6;GRB2;COL4A2;ITGA1;CDKN1B;HSP90B1;VWF;PHLPP1;MAGI2;CDKN1A;FLT1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.7811001091846297,-1.6105636112387762,0.037037037037037035,0.44930941404505925,1.0,3/11,2.15%,RSAD2;CD74;IL15
prerank,KEGG_2021_Human__ErbB signaling pathway,0.7744294306624835,1.6093070874471158,0.0,0.1753256598746704,0.74,13/40,13.94%,PIK3R3;ERBB4;NRG2;PIK3R1;GRB2;CDKN1B;NRG3;JUN;CDKN1A;SHC2;MAPK10;KRAS;PAK2
prerank,KEGG_2021_Human__Small cell lung cancer,0.8038209167788278,1.606659072834034,0.0,0.17740462026844117,0.8,7/35,8.82%,PIK3R3;LAMC1;LAMA5;PIK3R1;CDK6;COL4A2;CDKN1B
prerank,Reactome_2022__Bile Acid And Bile Salt Metabolism R-HSA-194068,-0.8935098442906848,-1.606369282414405,0.03125,0.45903068014575216,1.0,1/7,0.35%,SLCO1A2
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.9250714733773421,1.6057860973142968,0.0,0.17186072588505238,0.81,5/10,4.75%,PKM;LDHA;PCK1;GAPDH;PGK1
prerank,KEGG_2021_Human__Non-small cell lung cancer,0.8044765680604098,1.6035996396036505,0.0,0.1674839671613244,0.82,5/31,8.31%,PIK3R3;PIK3R1;RASSF1;CDK6;GRB2
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.8876022747800862,-1.6033502383635911,0.030303030303030304,0.4624625482178017,1.0,3/7,8.34%,ARID5B;PKD2;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.7252551783324701,-1.6027180367583775,0.03333333333333333,0.4518128094876994,1.0,3/12,6.11%,ATM;ATR;PARN
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.9268105824782072,-1.6026491147753625,0.029411764705882353,0.43947014277198615,1.0,3/10,2.15%,RSAD2;IFIH1;IL15
prerank,CellMarker_Augmented_2021__Muscle cell:Embryoid Body,0.8443339441777022,1.6017049129002758,0.0,0.16465366318664698,0.82,8/24,9.85%,CCDC3;ADAMTS9;NES;ANK2;PTPRD;CTNNA3;COL4A2;GJA1
prerank,KEGG_2021_Human__HIF-1 signaling pathway,0.7916653080034076,1.6016769120771608,0.0,0.1568130125587114,0.82,12/41,12.32%,PIK3R3;SERPINE1;LDHA;GAPDH;PGK1;PIK3R1;CDKN1B;SLC2A1;HIF1A;IFNGR1;CDKN1A;FLT1
prerank,CellMarker_Augmented_2021__Lymphocyte:Blood,-0.810734606470225,-1.6011905718412005,0.0,0.4352714549521137,1.0,3/19,1.46%,GBP1;GBP2;CPQ
prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,0.7598574306916541,1.6010332694293392,0.0,0.1517011099454568,0.82,9/44,8.63%,PIK3R3;WNT2B;TBX3;FGFR1;PIK3R1;JAK1;SMAD5;GRB2;KLF4
prerank,Reactome_2022__PI3K/AKT Signaling In Cancer R-HSA-2219528,0.8113851038865297,1.6009832971829685,0.0,0.14558748728551424,0.82,9/35,8.95%,PIK3R3;ERBB4;NRG2;FGFR1;PIK3R1;ESR2;GRB2;CDKN1B;NRG3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.9566717587621362,-1.6000410837165495,0.0,0.4309002345058127,1.0,1/6,0.24%,CEMIP
prerank,KEGG_2021_Human__Hepatocellular carcinoma,0.7421344368750388,1.598298397766972,0.0,0.150147139550113,0.84,13/57,14.71%,PIK3R3;WNT2B;PHF10;PBRM1;PIK3R1;NFE2L2;CDK6;GRB2;CDKN1A;SHC2;SMARCC1;KRAS;TXNRD1
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.7592614343498455,1.597899909273649,0.0,0.14547178862012178,0.84,7/49,8.31%,PIK3R3;PKM;PDK4;PCK1;PIK3R1;INSIG1;GRB2
prerank,Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315,0.7123562606802974,1.5959639766982587,0.012658227848101266,0.14499416079632213,0.84,18/60,17.29%,ERBB4;GRIA2;LRRC7;SYN3;GRIK1;PRKAG2;GLUL;GRIN2B;SNAP25;DNAJC5;PPFIA2;SLC38A2;SH2D3C;ADCY2;NCALD;SYT1;PRKX;SLC1A2
prerank,KEGG_2021_Human__Colorectal cancer,0.7587253939580924,1.5936025358868458,0.0,0.14496257165453644,0.85,9/39,14.74%,PIK3R3;PIK3R1;GRB2;JUN;CDKN1A;FOS;MAPK10;KRAS;RAC1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.8753609641598933,-1.5931630945414061,0.05128205128205128,0.45301786274692596,1.0,2/7,5.87%,GBP1;ZDHHC2
prerank,KEGG_2021_Human__GnRH secretion,0.8444940121659426,1.5918524363466284,0.0,0.1453292313359775,0.86,5/19,6.40%,PIK3R3;ITPR1;CACNA1C;PIK3R1;ESR2
prerank,KEGG_2021_Human__mTOR signaling pathway,0.7577518981630859,1.5894560842907761,0.0,0.1510233297543842,0.87,3/49,1.62%,PIK3R3;DDIT4;WNT2B
prerank,KEGG_2021_Human__Amoebiasis,0.7943325934584946,1.5870234343230085,0.0,0.15412026385820826,0.9,6/31,8.39%,PIK3R3;LAMC1;LAMA5;PIK3R1;SERPINB6;COL4A2
prerank,CellMarker_Augmented_2021__Muller Glia Precursor cell:Retina,-0.623138622956028,-1.5847643251054613,0.041666666666666664,0.4209767826093119,1.0,15/47,7.25%,SAMD9L;GBP1;DDX60;GBP2;IFIH1;TAP1;PARP14;OAS3;IRF1;PARP9;DDX60L;SP100;SP110;IFI44;SP140L
prerank,CellMarker_Augmented_2021__Prostate Stem cell:Prostate,-0.623138622956028,-1.5847643251054613,0.041666666666666664,0.4209767826093119,1.0,15/47,7.25%,SAMD9L;GBP1;DDX60;GBP2;IFIH1;TAP1;PARP14;OAS3;IRF1;PARP9;DDX60L;SP100;SP110;IFI44;SP140L
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Oral Cavity,-0.623138622956028,-1.5847643251054613,0.041666666666666664,0.4209767826093119,1.0,15/47,7.25%,SAMD9L;GBP1;DDX60;GBP2;IFIH1;TAP1;PARP14;OAS3;IRF1;PARP9;DDX60L;SP100;SP110;IFI44;SP140L
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Amniotic Fluid,-0.623138622956028,-1.5847643251054613,0.041666666666666664,0.4209767826093119,1.0,15/47,7.25%,SAMD9L;GBP1;DDX60;GBP2;IFIH1;TAP1;PARP14;OAS3;IRF1;PARP9;DDX60L;SP100;SP110;IFI44;SP140L
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Myometrium,-0.623138622956028,-1.5847643251054613,0.041666666666666664,0.4209767826093119,1.0,15/47,7.25%,SAMD9L;GBP1;DDX60;GBP2;IFIH1;TAP1;PARP14;OAS3;IRF1;PARP9;DDX60L;SP100;SP110;IFI44;SP140L
prerank,CellMarker_Augmented_2021__Serous Acinar cell:Salivary Gland,-0.623138622956028,-1.5847643251054613,0.041666666666666664,0.4209767826093119,1.0,15/47,7.25%,SAMD9L;GBP1;DDX60;GBP2;IFIH1;TAP1;PARP14;OAS3;IRF1;PARP9;DDX60L;SP100;SP110;IFI44;SP140L
prerank,CellMarker_Augmented_2021__Myometrial Stem cell:Myometrium,-0.623138622956028,-1.5847643251054613,0.041666666666666664,0.4209767826093119,1.0,15/47,7.25%,SAMD9L;GBP1;DDX60;GBP2;IFIH1;TAP1;PARP14;OAS3;IRF1;PARP9;DDX60L;SP100;SP110;IFI44;SP140L
prerank,KEGG_2021_Human__Insulin signaling pathway,0.7300747141826389,1.5835844901536698,0.0136986301369863,0.1641708078693841,0.93,5/47,8.31%,PIK3R3;PCK1;PRKAG2;PIK3R1;GRB2
prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,0.76436276542733,1.5835202432948687,0.0,0.1590404701234658,0.93,4/32,7.36%,PIK3R3;PIK3R1;CPEB4;HSP90AA1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord Blood,-0.67790875247195,-1.5804213788109764,0.0,0.43095047061592695,1.0,9/34,7.07%,SAMD9L;GBP1;GBP2;CPQ;CD74;SP100;APOL3;GIMAP8;IFI44
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.8649073375623837,1.5773717620222794,0.0,0.17807660746642773,0.94,3/17,6.14%,PIK3R3;TTC7A;PIK3R1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.7520718885372959,1.5743021900485161,0.0,0.18686185186363383,0.95,12/48,8.29%,NRCAM;DDIT4;WNT2B;SPOCK1;BHLHE40;IL1RAPL1;MAP1B;ELP3;PTPRD;FGFR1;NAV1;CDK6
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.8324887351123037,1.5739747703196654,0.0,0.1824733237046824,0.95,7/15,8.61%,SERPINE1;SPOCK1;TIMP3;GAPDH;VSIR;SERPINB6;PICALM
prerank,"Reactome_2022__Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",0.8118893054787687,1.5736181780524874,0.0,0.1789445909304936,0.95,4/17,4.99%,HSPA5;CANX;CALR;SEC24D
prerank,"Reactome_2022__PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",0.8306095963816447,1.5729503793072745,0.0,0.17470759056841423,0.95,8/31,8.95%,PIK3R3;ERBB4;NRG2;FGFR1;PIK3R1;ESR2;GRB2;NRG3
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,-0.9302120992755523,-1.5718781473220933,0.0,0.46730048262616675,1.0,1/6,1.99%,ANAPC16
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.9209046047788798,1.5714925988328179,0.0,0.17711283635352598,0.96,1/10,0.03%,PIK3R3
prerank,KEGG_2021_Human__Central carbon metabolism in cancer,0.8476111645043756,1.5713965401135408,0.0,0.17257148157523047,0.96,7/21,9.83%,PIK3R3;PKM;LDHA;FGFR1;PIK3R1;SLC2A1;HIF1A
prerank,KEGG_2021_Human__Chagas disease,0.7641827147747122,1.570354222624806,0.029411764705882353,0.17629584139176344,0.97,9/33,13.39%,PIK3R3;SERPINE1;PPP2R2B;CALR;PIK3R1;JUN;IFNGR1;FOS;MAPK10
prerank,Reactome_2022__Negative Regulation Of PI3K/AKT Network R-HSA-199418,0.8116213761447192,1.5682606111130712,0.0,0.1792976573749642,0.97,9/34,11.02%,PIK3R3;ERBB4;NRG2;FGFR1;PIK3R1;ESR2;GRB2;NRG3;PHLPP1
prerank,KEGG_2021_Human__AMPK signaling pathway,0.7834481404547227,1.5672290013214716,0.0,0.17793261020971632,0.97,6/42,6.14%,PIK3R3;PPP2R3A;PCK1;PRKAG2;PPP2R2B;PIK3R1
prerank,Reactome_2022__RAC2 GTPase Cycle R-HSA-9013404,0.7718120185079879,1.5659698051040136,0.0,0.17766247582115696,0.98,6/41,7.14%,PIK3R3;DOCK3;VAPB;LBR;PIK3R1;ARHGAP21
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.8047806308623262,1.5652748068145044,0.014925373134328358,0.17715262506919624,0.98,7/21,7.20%,NRCAM;DDIT4;SPOCK1;MAP1B;ELP3;FGFR1;NAV1
prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,0.7637686925210005,1.564228374666104,0.0,0.17912938740993994,0.98,5/32,6.14%,PIK3R3;PRKAG2;MAP3K5;NDUFA12;PIK3R1
prerank,CellMarker_Augmented_2021__Neuron:Spinal Cord,0.7258748482816012,1.563050583014277,0.0,0.18102020356195564,0.98,15/51,8.50%,NRCAM;GRIA2;ATRNL1;MAP2;CNTN1;CADM2;ANK2;MAP1B;NPAS3;CTNND2;NFASC;SNAP25;LRP1B;TTLL7;PPFIA2
prerank,Reactome_2022__GPVI-mediated Activation Cascade R-HSA-114604,0.8990092402743868,1.5627350423025632,0.0,0.17882008266420005,0.98,1/13,0.03%,PIK3R3
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.8350098993838826,1.5622760622193799,0.030303030303030304,0.17717362466913333,0.98,1/15,0.32%,NRCAM
prerank,KEGG_2021_Human__Acute myeloid leukemia,0.8177128646152617,1.562100995728709,0.0,0.17378411781398323,0.98,4/25,8.31%,PIK3R3;DUSP6;PIK3R1;GRB2
prerank,CellMarker_Augmented_2021__Theca Interna cell:Ovarian Follicle,-0.6948737915917002,-1.5615986021473491,0.0,0.5134583262161799,1.0,3/24,6.40%,VCAM1;ITIH5;PODN
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.9145252122612278,-1.561279016866096,0.08108108108108109,0.5039368404640583,1.0,3/6,4.65%,TAP1;DISP1;ABCG2
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.9414156120985339,-1.5605449722411573,0.05263157894736842,0.4974276196237125,1.0,3/5,5.55%,ISG15;MX1;SP100
prerank,CellMarker_Augmented_2021__Interstitial cell:Dorsolateral Prefrontal Cortex,-0.7182359387249605,-1.559046760643912,0.0,0.49720771351424137,1.0,11/30,8.63%,SAMD9L;GBP2;CPQ;IFIH1;PARP9;TNFSF10;SP100;APOL3;SP110;SP140L;PPP2R5A
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.8805994390697833,-1.55845538217397,0.0,0.4817002604611656,1.0,1/5,0.13%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.8805994390697833,-1.55845538217397,0.0,0.4817002604611656,1.0,1/5,0.13%,GBP1
prerank,Reactome_2022__Long-term Potentiation R-HSA-9620244,0.9197614026835524,1.5584053048912485,0.0,0.1851660724051855,0.99,4/7,4.91%,ERBB4;GRIA2;LRRC7;GRIN2B
prerank,KEGG_2021_Human__Glioma,0.7693597671745602,1.5564618462987476,0.0,0.1908838928868767,0.99,7/31,13.89%,PIK3R3;PIK3R1;CDK6;GRB2;CDKN1A;SHC2;KRAS
prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,0.7620144159911861,1.553367317944391,0.04411764705882353,0.2032050518219044,0.99,7/25,14.74%,PIK3R3;PIK3R1;JUN;FOS;TAB2;MAPK10;RAC1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.830284286801546,1.5530283179807651,0.0,0.20062621561018293,1.0,1/18,0.08%,CCDC3
prerank,KEGG_2021_Human__Insulin resistance,0.768102514351297,1.5523371953492378,0.0,0.19916953895878237,1.0,7/36,9.30%,PIK3R3;PCK1;PRKAG2;PRKCE;PIK3R1;OGT;SLC2A1
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.6699392965240244,-1.5521964585617296,0.038461538461538464,0.5061119118013727,1.0,7/32,3.61%,GBP1;VCAM1;GBP4;GBP2;STAT1;OAS3;IRF1
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.7018752357080636,-1.5516732140226963,0.034482758620689655,0.4911082124778577,1.0,10/37,3.61%,RSAD2;IFI44L;EIF2AK2;IFIH1;ISG15;IFI27;MX1;STAT1;OAS3;IRF1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.7018752357080636,-1.5516732140226963,0.034482758620689655,0.4911082124778577,1.0,10/37,3.61%,RSAD2;IFI44L;EIF2AK2;IFIH1;ISG15;IFI27;MX1;STAT1;OAS3;IRF1
prerank,Reactome_2022__Extra-nuclear Estrogen Signaling R-HSA-9009391,0.8123365086663122,1.551643141845642,0.013333333333333334,0.19998339012078828,1.0,5/25,8.82%,PIK3R3;PIK3R1;ESR2;HSP90AA1;CDKN1B
prerank,KEGG_2021_Human__Sphingolipid signaling pathway,0.7358953358087679,1.5496401498292218,0.0,0.2047280997294288,1.0,7/48,6.14%,PIK3R3;PPP2R3A;PPP2R2B;MAP3K5;S1PR1;PRKCE;PIK3R1
prerank,Reactome_2022__G Alpha (Q) Signaling Events R-HSA-416476,0.7651266383027441,1.5473389517430671,0.0,0.21125155439860432,1.0,7/39,8.31%,PIK3R3;ITPR1;MGLL;ANXA1;PRKCE;PIK3R1;GRB2
prerank,KEGG_2021_Human__Type II diabetes mellitus,0.8838667824730531,1.5469590547182204,0.0,0.21009448025325095,1.0,5/15,6.14%,PIK3R3;PKM;PRKCE;CACNA1C;PIK3R1
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.8522867440225586,1.5463940273482186,0.02857142857142857,0.21029212932244246,1.0,6/15,8.63%,PKM;ADAMTS9;KLF2;GLUL;JAK1;KLF4
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.6546766585425841,1.5462077872634112,0.0,0.20715685345929435,1.0,34/142,18.57%,PIK3R3;CEP57;DDIT4;ERBB4;PDK4;NEDD9;FES;GRIN2B;FGFR1;PIK3R1;HSP90AA1;GRB2;COL4A2;ANKS1B;FLT1;BCAR1;SHC2;GIGYF2;ARPC2;KIF16B;PAK2;RASA1;GRB10;RAC1;FOXC1;SHOC2;CRK;PLAT;SPRED1;SDCBP;PXN;NAMPT;KALRN;STAT3
prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,0.8494826173102108,1.5461561200317224,0.0,0.20394260649712198,1.0,3/16,6.14%,PIK3R3;MGLL;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.9527928923588859,-1.5457901122384463,0.0,0.5120324184803129,1.0,1/6,0.05%,RSAD2
prerank,KEGG_2021_Human__B cell receptor signaling pathway,0.7778839089462799,1.545636157340042,0.0,0.20154738613158593,1.0,8/30,14.74%,PIK3R3;CD81;PIK3R1;GRB2;JUN;FOS;KRAS;RAC1
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.9074017723057981,1.5452996337699467,0.0,0.20098817097873,1.0,5/9,5.52%,PNP;BCL6;PCK1;ZBTB1;VSIR
prerank,CellMarker_Augmented_2021__Exhausted CD8+ T cell:Liver,-0.574802033582455,-1.5450027634537535,0.0,0.5070289439965541,1.0,14/98,3.40%,SAMD9L;GBP1;VCAM1;DDX60;GBP4;EPSTI1;GBP2;FAM3C;ATP10D;ARID5B;GMDS;PARP14;MX1;OAS3
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.8118428031894523,1.5446473880752105,0.0,0.20027318459991994,1.0,6/27,4.38%,DDIT4;PBX3;WNT2B;SPOCK1;IL1RAPL1;PTPRD
prerank,CellMarker_Augmented_2021__Somatic Stem cell:Endometrium,0.7559711793279043,1.5440305471661655,0.0,0.18469088145803791,1.0,7/45,4.38%,CCDC3;ADAMTS9;KHDRBS3;RAPGEF5;NES;ANK2;PTPRD
prerank,CellMarker_Augmented_2021__Ovarian Somatic cell:Ovary,0.7559711793279043,1.5440305471661655,0.0,0.18469088145803791,1.0,7/45,4.38%,CCDC3;ADAMTS9;KHDRBS3;RAPGEF5;NES;ANK2;PTPRD
prerank,CellMarker_Augmented_2021__Stem cell:Gastric Gland,0.7559711793279043,1.5440305471661655,0.0,0.18469088145803791,1.0,7/45,4.38%,CCDC3;ADAMTS9;KHDRBS3;RAPGEF5;NES;ANK2;PTPRD
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Gastrointestinal Tract,0.7559711793279043,1.5440305471661655,0.0,0.18469088145803791,1.0,7/45,4.38%,CCDC3;ADAMTS9;KHDRBS3;RAPGEF5;NES;ANK2;PTPRD
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Gland,0.7559711793279043,1.5440305471661655,0.0,0.18469088145803791,1.0,7/45,4.38%,CCDC3;ADAMTS9;KHDRBS3;RAPGEF5;NES;ANK2;PTPRD
prerank,CellMarker_Augmented_2021__Corneal Limbal Stem cell:Limbal Epithelium,0.7559711793279043,1.5440305471661655,0.0,0.18469088145803791,1.0,7/45,4.38%,CCDC3;ADAMTS9;KHDRBS3;RAPGEF5;NES;ANK2;PTPRD
prerank,"Reactome_2022__Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",0.8452744399574258,1.5432323947910944,0.014285714285714285,0.1859937524117196,1.0,4/21,8.31%,PIK3R3;PIK3R1;JAK1;GRB2
prerank,CellMarker_Augmented_2021__Extravillous Trophoblast cell:Placenta,-0.731512942326222,-1.5388301510906197,0.030303030303030304,0.5294826001809553,1.0,5/17,6.16%,GBP1;VCAM1;EPSTI1;DSE;OPTN
prerank,Reactome_2022__Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,0.8588485667381905,1.538256451413854,0.0,0.2029681332585117,1.0,8/22,8.95%,PIK3R3;ERBB4;NRG2;FGFR1;PIK3R1;ESR2;GRB2;NRG3
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.8382959386649422,-1.5376063876622388,0.0,0.5258279529091817,1.0,9/22,4.22%,RSAD2;EIF2AK2;UBP1;IFIH1;ISG15;MX1;STAT1;OAS3;FAM111A
prerank,KEGG_2021_Human__Proteoglycans in cancer,0.7027700890954235,1.537363836871676,0.0,0.20595947353082733,1.0,11/78,9.83%,PIK3R3;ERBB4;ITPR1;WNT2B;ANK2;TIMP3;FGFR1;PIK3R1;GRB2;ANK3;HIF1A
prerank,KEGG_2021_Human__Alzheimer disease,0.6932979743189667,1.5339181237288706,0.0,0.21726072583550654,1.0,14/82,8.23%,PIK3R3;RTN4;PSMC6;ITPR1;WNT2B;MAP3K5;GAPDH;GRIN2B;CACNA1C;NDUFA12;PIK3R1;TUBB4B;BACE2;RB1CC1
prerank,Reactome_2022__RET Signaling R-HSA-8853659,0.8555881405242094,1.532843140200551,0.0,0.21850335729729675,1.0,4/17,8.31%,PIK3R3;DOK5;PIK3R1;GRB2
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.6888124958179334,1.5303553536529848,0.0,0.22642431797419466,1.0,13/54,11.58%,GRIA2;DTNA;SYN3;GRIK1;GRIK2;KCNMB4;GRM7;GRIN2B;MBP;SNAP25;DNAJC5;SLC12A6;NRXN1
prerank,CellMarker_Augmented_2021__Brush Cell (Tuft cell):Lung,0.8044509141302789,1.5292034184328416,0.0,0.2257360072005486,1.0,5/21,7.46%,MAFF;RAPGEF5;ANXA1;NAV1;ALPL
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Lung,0.8044509141302789,1.5292034184328416,0.0,0.2257360072005486,1.0,5/21,7.46%,MAFF;RAPGEF5;ANXA1;NAV1;ALPL
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Eye,0.7933852193418267,1.528931065562625,0.014705882352941176,0.22400140344021532,1.0,8/21,4.91%,GRIA2;MAP2;CNTN1;IL1RAPL1;MAP1B;GPM6B;NPAS3;GRIN2B
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.833859945849186,1.5274575315534562,0.0,0.22785405915727916,1.0,2/15,2.82%,PBX3;NES
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.7386330400700098,1.5274115045835606,0.0125,0.2254517049244774,1.0,13/40,13.39%,CCDC3;ADM;MAP2;DOK5;NES;ANK2;MAP1B;PTPRD;NFASC;GJA1;BOC;SHC2;MAPK10
prerank,KEGG_2021_Human__cAMP signaling pathway,0.7104828778335864,1.5231251990640196,0.0,0.23973962784752,1.0,17/63,15.30%,PIK3R3;GRIA2;GRIN2B;ACOX1;CACNA1C;RAPGEF3;PIK3R1;ATP2B1;JUN;PDE10A;RAP1A;ATP1A1;ATP1B3;FOS;MAPK10;RAC1;ADCY2
prerank,Reactome_2022__Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,0.8330166550847187,1.5226511708166022,0.013513513513513514,0.23832066457748427,1.0,1/26,0.03%,PIK3R3
prerank,Reactome_2022__SHC1 Events In ERBB2 Signaling R-HSA-1250196,0.8840788869053477,1.5214059921118275,0.0,0.2419513905893249,1.0,5/9,8.95%,ERBB4;PRKCE;NRG2;GRB2;NRG3
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.8378883618935691,-1.5213981504672718,0.0,0.605621425483512,1.0,1/10,0.05%,RSAD2
prerank,Reactome_2022__Costimulation By CD28 Family R-HSA-388841,0.8485275542324671,1.520852792306533,0.0,0.24119201682084399,1.0,3/20,8.31%,PIK3R3;PIK3R1;GRB2
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.7698102183725797,1.5193922816215348,0.012987012987012988,0.24380242509274877,1.0,6/43,6.14%,PIK3R3;TTC7A;INPP5F;ARF1;MTMR12;PIK3R1
prerank,KEGG_2021_Human__Longevity regulating pathway,0.7492420662765892,1.5192525685608411,0.024390243902439025,0.24189221930280275,1.0,4/35,8.23%,PIK3R3;PRKAG2;PIK3R1;RB1CC1
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.7227080550298501,1.5191088105645902,0.0,0.2395214368823201,1.0,15/65,12.64%,RFTN1;LRRC7;EHD4;ANK2;KCNIP4;TTC7A;CD81;DPP10;PACS1;ANK3;RAP1A;ATP1B3;MAGI2;NRXN1;MAP7
prerank,KEGG_2021_Human__African trypanosomiasis,-0.9383485483487239,-1.519089631937485,0.0,0.6081136947241849,1.0,2/6,2.58%,VCAM1;PLCB4
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.8556019336230505,-1.5177439776039456,0.05405405405405406,0.6070233269313905,1.0,6/8,12.35%,ISG15;OAS3;SAMHD1;STAT2;NLRC5;PTPN2
prerank,CellMarker_Augmented_2021__Epithelial cell:Undefined,-0.9127135454371134,-1.5175320973646156,0.02702702702702703,0.5986047290059253,1.0,1/7,0.16%,VCAM1
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.899365395259577,-1.5173228437152395,0.046511627906976744,0.5904412401085045,1.0,3/5,9.75%,PKD2;OFD1;RFX3
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.7475563359742519,1.5166683395149743,0.013157894736842105,0.24866546492683192,1.0,4/33,8.31%,PIK3R3;PDK4;PIK3R1;GRB2
prerank,KEGG_2021_Human__Pyrimidine metabolism,0.8965811981365197,1.516449190891359,0.01694915254237288,0.24725768949913993,1.0,2/10,4.44%,PNP;UPP1
prerank,KEGG_2021_Human__Chemical carcinogenesis,0.7157805026822603,1.515185332451286,0.0125,0.24953616916879642,1.0,15/55,16.41%,PIK3R3;BCL6;CACNA1C;PIK3R1;ESR2;HSP90AA1;GRB2;KLF4;HSP90B1;JUN;FOS;KRAS;ADCY2;ATF2;KPNA4
prerank,Reactome_2022__ESR-mediated Signaling R-HSA-8939211,0.7202651828331335,1.5129228832365762,0.0,0.2576705693844615,1.0,14/63,12.91%,PIK3R3;ERBB4;PIK3R1;ESR2;CBFB;HSP90AA1;KDM1A;JUND;CDKN1B;JUN;RAD21;FKBP5;FOS;AGO2
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.7176254438301541,-1.512775213785918,0.037037037037037035,0.6068489610796644,1.0,3/14,6.11%,ATM;ATR;PARN
prerank,KEGG_2021_Human__Estrogen signaling pathway,0.708667453618497,1.5104467772256096,0.013333333333333334,0.26515314212164864,1.0,14/45,15.91%,PIK3R3;ITPR1;PIK3R1;ESR2;HSP90AA1;GRB2;HSP90B1;JUN;FKBP5;FOS;SHC2;KRAS;ADCY2;ATF2
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.958336929628513,1.5097312885188587,0.01639344262295082,0.26598897520301523,1.0,1/5,0.08%,CCDC3
prerank,KEGG_2021_Human__T cell receptor signaling pathway,0.742621138710437,1.5095489399997604,0.0,0.2637726590833402,1.0,8/40,13.94%,PIK3R3;PIK3R1;GRB2;JUN;FOS;MAPK10;KRAS;PAK2
prerank,Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934,0.6397653672875847,1.5089849134193105,0.0,0.26495195240612246,1.0,31/174,14.45%,PIK3R3;LAMC1;DOCK3;ERBB4;ITPR1;FES;LAMA5;PRKCE;GRIN2B;DUSP6;NRG2;FGFR1;PIK3R1;HSP90AA1;JUND;RPS27A;GRB2;COL4A2;NRG3;CTNNA1;HIF1A;RAP1A;REST;FOS;FLT1;BCAR1;SHC2;TAB2;ITGB1;GRB10;ERBIN
prerank,Reactome_2022__PI Metabolism R-HSA-1483255,0.7932589244578407,1.5071133422719536,0.014285714285714285,0.27376550614878653,1.0,4/35,6.14%,PIK3R3;INPP5F;MTMR12;PIK3R1
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.9176884385908365,1.5048914355785568,0.030303030303030304,0.2844357240783554,1.0,2/7,1.91%,PDK4;PRKAG2
prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,0.7362719182465727,1.5046882451558612,0.0273972602739726,0.2825706167533315,1.0,3/26,8.31%,PIK3R3;PIK3R1;GRB2
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.9167354154002063,1.504629713596158,0.0,0.28007754424880155,1.0,1/7,0.85%,AKAP12
prerank,KEGG_2021_Human__Aldosterone-regulated sodium reabsorption,0.8276768056228017,1.504037972148876,0.038461538461538464,0.27982944125263404,1.0,6/13,13.89%,PIK3R3;PIK3R1;ATP1A1;ATP1B3;NEDD4L;KRAS
prerank,Reactome_2022__Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.9435855771670599,-1.503812740498393,0.0,0.6378042065478533,1.0,1/5,1.99%,ANAPC16
prerank,Reactome_2022__Phosphorylation Of APC/C R-HSA-176412,-0.9435855771670599,-1.503812740498393,0.0,0.6378042065478533,1.0,1/5,1.99%,ANAPC16
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.9466935796248326,1.5032654760496873,0.0,0.2817602792498772,1.0,2/7,2.44%,KLF2;KCNMB4
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.9782892173786697,1.5030195952178325,0.0,0.2802088753390488,1.0,2/6,1.67%,RTN4;MAP2
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.9844216223227397,1.5028149969812663,0.0,0.2786873061188133,1.0,1/5,0.11%,CEP57
prerank,Reactome_2022__Signaling By Nuclear Receptors R-HSA-9006931,0.6900308913051086,1.502418549522837,0.0125,0.27782830709896955,1.0,16/76,12.91%,PIK3R3;ERBB4;PDK4;PCK1;PIK3R1;ESR2;CBFB;HSP90AA1;KDM1A;JUND;CDKN1B;JUN;RAD21;FKBP5;FOS;AGO2
prerank,KEGG_2021_Human__Neurotrophin signaling pathway,0.7282377841717194,1.50225314529985,0.0,0.2761487013612528,1.0,11/50,15.72%,PIK3R3;MAP3K5;PIK3R1;GRB2;JUN;RAP1A;SHC2;MAPK10;KRAS;RAC1;CRK
prerank,KEGG_2021_Human__Diabetic cardiomyopathy,0.7619548202753247,1.5015810318051281,0.0,0.2775055917516855,1.0,5/36,6.14%,PIK3R3;PDK4;GAPDH;NDUFA12;PIK3R1
prerank,CellMarker_Augmented_2021__Liver Stem cell:Fetal Liver,0.7300755691832796,1.500839008738568,0.012658227848101266,0.2790426839639023,1.0,6/37,9.85%,LAMC1;PLS3;NES;MYO1B;COL4A2;GJA1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Periosteum,0.717307958414892,1.5003138103815743,0.02564102564102564,0.27943262148933945,1.0,12/39,16.04%,SERPINE1;PLS3;SPOCK1;EPS8;PLSCR4;MYO1B;COL4A2;GJA1;WWTR1;ALCAM;NAV2;PLAT
prerank,Reactome_2022__Glucose Metabolism R-HSA-70326,0.8026924870034241,1.500085615733255,0.02564102564102564,0.2781019018867212,1.0,3/22,4.75%,PKM;PCK1;PGK1
prerank,KEGG_2021_Human__Melanoma,0.7837502350819396,1.4991707478063985,0.04285714285714286,0.2815898786805945,1.0,4/22,8.29%,PIK3R3;FGFR1;PIK3R1;CDK6
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.8329712721336202,1.498835774156972,0.0,0.2803626588170901,1.0,2/17,1.62%,DIXDC1;WNT2B
prerank,CellMarker_Augmented_2021__Cardiovascular Progenitor cell:Heart,0.759028121774083,1.4978473855849366,0.014285714285714285,0.28249330849161625,1.0,9/30,12.96%,CCDC3;ADAMTS9;NES;PTPRD;COL4A2;GJA1;FOXF1;FLT1;SHC2
prerank,Reactome_2022__Neuronal System R-HSA-112316,0.6434555874653838,1.4978081189477932,0.0,0.2802098196235631,1.0,26/83,17.29%,ERBB4;GRIA2;LRRC7;SYN3;GRIK1;PRKAG2;KCNMB4;IL1RAPL1;GLUL;PTPRD;GRIN2B;LRRTM4;SNAP25;DNAJC5;PPFIA2;NRXN3;SLC38A2;NRXN1;DLGAP2;SH2D3C;ADCY2;NCALD;SYT1;PRKX;RTN3;SLC1A2
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.8542536977523835,-1.4972179031417066,0.030303030303030304,0.6681061757318109,1.0,2/8,7.30%,CEMIP;PKD2
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.9453997785760687,1.49585142940869,0.0,0.2876075990547609,1.0,1/7,0.74%,MTFR1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.8194002384058208,-1.4953963797038927,0.027777777777777776,0.6683844874880631,1.0,1/7,0.82%,EIF2AK2
prerank,KEGG_2021_Human__Chronic myeloid leukemia,0.7650647327453524,1.4930121221437904,0.0,0.3022378282806094,1.0,9/36,13.89%,PIK3R3;BCR;PIK3R1;CDK6;GRB2;CDKN1B;CDKN1A;SHC2;KRAS
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.6993887140021482,1.491303235874659,0.028169014084507043,0.30969994606691553,1.0,11/43,11.58%,GRIA2;DTNA;GRIK1;GRIK2;KCNMB4;GRM7;GRIN2B;MBP;SNAP25;SLC12A6;NRXN1
prerank,CellMarker_Augmented_2021__T cell:Skin,-0.8782467472044291,-1.4908086960176072,0.07692307692307693,0.686620175805381,1.0,3/7,3.61%,GBP2;TAP1;IRF1
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.8076765557824186,1.4902267879376254,0.045454545454545456,0.31243133601301215,1.0,4/15,4.75%,ERBB4;PCK1;ANXA1;PGK1
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.6829337969848164,-1.48959146659259,0.03571428571428571,0.6843839616236812,1.0,8/26,7.22%,GBP1;VCAM1;GBP2;STAT1;OAS3;IRF1;SP100;TRIM25
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.758857066334371,1.488321315342954,0.0,0.3191233321530521,1.0,5/26,9.03%,PKM;PCK1;PIK3R1;INSIG1;OGT
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex3:Brain,0.7057500340340633,1.4872991812086727,0.025974025974025976,0.32274705135295056,1.0,15/36,12.83%,PCDH9;GRIA2;CADM2;PPP2R2B;GPM6B;LSAMP;NPAS3;CTNND2;PPFIA2;LRRC4C;NEGR1;MAGI2;NRXN1;ANKS1B;TMEM132C
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.8420763775292465,1.486662427446892,0.0,0.3247530858633035,1.0,5/10,7.44%,SERPINE1;SPOCK1;TIMP3;GAPDH;SERPINB6
prerank,KEGG_2021_Human__Peroxisome,0.861926581322095,1.4864583754977219,0.013513513513513514,0.32390884561307604,1.0,3/15,7.30%,SCP2;ACOX1;ACSL5
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.9427028253957861,1.4862960799586975,0.01694915254237288,0.32235717585363094,1.0,3/8,1.91%,PDK4;PCK1;PRKAG2
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.6718512254534968,1.4861508569630173,0.0,0.3212776212825147,1.0,14/71,9.59%,NRCAM;DDIT4;PBX3;GRIK1;TBX3;SPOCK1;NES;ELP3;GRIN2B;ROBO2;MBP;SEMA6B;SLC2A1;CNTNAP2
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.8835959342737602,1.486025592082676,0.030303030303030304,0.31941701879332846,1.0,1/8,0.88%,PSMC6
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.7453913962283378,-1.4859048957297945,0.0967741935483871,0.6970607631649566,1.0,1/9,1.20%,UBP1
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.7597912578372226,1.4854946571831948,0.013333333333333334,0.31987390608917843,1.0,12/28,17.29%,GRIA2;PDK4;SLC8A1;GLUL;ENPP2;VWF;GAS7;NRXN1;TMEM132C;TNS1;PLXDC2;SLC1A2
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.9222006326096605,-1.485363591103239,0.030303030303030304,0.6894613627397481,1.0,2/6,0.72%,GBP4;GBP2
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.8728114796299176,-1.484591866197285,0.08333333333333333,0.6838327694177864,1.0,1/5,1.06%,CTNNA2
prerank,Reactome_2022__L1CAM Interactions R-HSA-373760,0.7302414299795065,1.4838980848016925,0.0,0.32538731286440964,1.0,8/43,8.79%,LAMC1;NRCAM;CNTN1;ANK2;NFASC;FGFR1;ITGA1;ANK3
prerank,Reactome_2022__CD28 Co-Stimulation R-HSA-389356,0.8764383703430864,1.483881090214734,0.0,0.3229318478323968,1.0,3/15,8.31%,PIK3R3;PIK3R1;GRB2
prerank,Reactome_2022__Interferon Gamma Signaling R-HSA-877300,-0.6704072188484882,-1.4838244241448417,0.047619047619047616,0.679418488713826,1.0,7/33,3.61%,GBP1;VCAM1;GBP4;GBP2;STAT1;OAS3;IRF1
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.8326058004324813,1.4819367541114488,0.015384615384615385,0.3309146259852222,1.0,5/11,7.44%,SERPINE1;SPOCK1;TIMP3;GAPDH;SERPINB6
prerank,CellMarker_Augmented_2021__Endothelial cell:Cornea,-0.89169374674553,-1.481209646631689,0.024390243902439025,0.6831693414721416,1.0,1/7,0.16%,VCAM1
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.8144932567311096,1.4811079572632468,0.0,0.33416889529411187,1.0,3/17,4.01%,ERBB4;NES;MAP1B
prerank,KEGG_2021_Human__Parkinson disease,0.686497065186169,1.4810536867476911,0.011904761904761904,0.33221046495879375,1.0,15/54,16.02%,PSMC6;ITPR1;HSPA5;MAP3K5;NDUFA12;NFE2L2;TUBB4B;PINK1;RPS27A;DUSP1;UBE2J1;MAPK10;TUBA1B;TUBB6;PSMA7
prerank,KEGG_2021_Human__Focal adhesion,0.663379443906391,1.480311532217228,0.0,0.3339776373993003,1.0,23/84,17.66%,PIK3R3;LAMC1;LAMA5;PIK3R1;GRB2;COL4A2;ITGA1;VWF;JUN;RAP1A;FLT1;BCAR1;SHC2;MAPK10;ITGB1;PAK2;RAC1;CRK;PARVB;ACTN1;PPP1CB;PXN;MYL12B
prerank,KEGG_2021_Human__Axon guidance,0.6785445870232873,1.4791562832124434,0.011363636363636364,0.3378857734718009,1.0,19/68,18.30%,PIK3R3;FES;ROBO2;PIK3R1;SEMA6B;SRGAP1;SSH1;LRRC4C;UNC5C;BOC;ITGB1;KRAS;PAK2;RASA1;RAC1;SEMA3F;PLXNA2;MYL12B;CFL1
prerank,KEGG_2021_Human__VEGF signaling pathway,0.7426382652849687,1.4786731623951794,0.05555555555555555,0.3379293233098479,1.0,1/25,0.03%,PIK3R3
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Undefined,-0.7540695560562904,-1.4783772368539319,0.07142857142857142,0.6920306083974747,1.0,6/15,10.36%,GBP4;XAF1;APOL3;GIMAP8;TNFRSF1B;CFLAR
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.8227850621822154,-1.4783620562454323,0.09090909090909091,0.6834736858890315,1.0,1/5,2.95%,ATM
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.7570120063039343,1.4780764070318968,0.02531645569620253,0.338793545651537,1.0,2/26,0.88%,ST18;PSMC6
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.9743807140709184,1.477812242299183,0.0,0.3386667245381915,1.0,1/5,0.03%,PIK3R3
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.7216041851072642,1.4778062968415917,0.0,0.33619470465105145,1.0,13/49,14.08%,NFKBIZ;AFF3;TRIM5;SLC8A1;ARF1;SCARB2;YBX3;AFF4;CDK6;HIF1A;REST;KIF16B;RASA1
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.8248351927991915,1.477440950322838,0.0,0.33616890000143024,1.0,8/16,11.37%,MAFF;SERPINE1;NFKBIZ;BHLHE40;TINAGL1;KLF4;FOSL2;ANXA2
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.7089357606739973,1.477409922283094,0.0,0.3338301869709651,1.0,7/42,8.39%,LAMC1;PLS3;TBX3;NES;PLOD2;MYO1B;COL4A2
prerank,CellMarker_Augmented_2021__Morula Cell (Blastomere):Embryo,0.7587804956488946,1.476531642715869,0.0,0.33580160265097797,1.0,10/29,12.38%,AKAP12;PSMC6;LDHA;GLUD1;RPS27A;RPL23;KLF4;GJA1;ATP1B3;RPL34
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.8812402107847188,-1.4764906308791608,0.05263157894736842,0.6864817164031213,1.0,2/5,1.86%,CD74;IFIH1
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.7344919575949624,1.4760582659470711,0.0,0.3369586869903682,1.0,9/40,13.52%,ERBB4;NEDD9;FES;PTPRD;FGFR1;FLT1;BCAR1;SHC2;ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.8380809365622912,-1.4757523090410003,0.06818181818181818,0.6811189473595055,1.0,1/6,0.05%,RSAD2
prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,0.700219055003219,1.4748237073684134,0.013333333333333334,0.3403638819322778,1.0,4/34,6.14%,PIK3R3;PRKCE;ASAP2;PIK3R1
prerank,Reactome_2022__Axon Guidance R-HSA-422475,0.6180785018022575,1.47457822534508,0.0,0.3389141587383551,1.0,43/208,17.10%,PIK3R3;LAMC1;NRCAM;PSMC6;DOK5;CNTN1;FES;ANK2;RPS11;MYO9B;GRIN2B;ROBO2;CACNA1C;NFASC;FGFR1;PIK3R1;RPS9;PRNP;HSP90AA1;SRGAP1;RPS27A;RPL23;GRB2;COL4A2;ITGA1;ANK3;UNC5C;MYL6;MYH10;RPL8;RPL34;RPL37;RPLP2;ARPC2;ITGB1;GRB10;RPL13A;ALCAM;RPS12;PSMA7;PLXNA2;SDCBP;DAG1
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.7871897509469008,-1.4743727433519038,0.041666666666666664,0.6817407330149069,1.0,2/10,5.55%,EPSTI1;SP100
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.7895000831571714,1.4740174736237868,0.014705882352941176,0.33964052951566587,1.0,7/18,16.49%,IL1RAPL1;PTPRD;CNTNAP2;NRXN1;CLDN5;RAC1;LIMS1
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.8066349962150606,-1.4739334559683182,0.034482758620689655,0.6759390219167829,1.0,6/13,12.35%,ISG15;OAS3;SAMHD1;STAT2;NLRC5;PTPN2
prerank,Reactome_2022__Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,-0.90569394517001,-1.4738350594552245,0.02857142857142857,0.6681627230171034,1.0,2/6,6.72%,ANAPC16;CDC14A
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.7950642415618109,1.4737783879733313,0.0273972602739726,0.3381393236323479,1.0,4/17,7.38%,MAP2;GPC5;HSP90AA1;KDM1A
prerank,KEGG_2021_Human__Autophagy,0.7037302543726867,1.4734813407653922,0.012987012987012988,0.3371143447652442,1.0,9/52,9.83%,PIK3R3;DDIT4;ITPR1;ATG12;PIK3R1;RB1CC1;LAMP2;ATG4C;HIF1A
prerank,Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604,0.6775019156526491,1.4734729018378667,0.011363636363636364,0.3348210499028956,1.0,18/93,12.91%,PIK3R3;ERBB4;PSMC6;NRG2;FGFR1;PIK3R1;ESR2;KDM1A;RPS27A;GRB2;CDKN1B;NRG3;JUN;PHLPP1;REST;CDKN1A;CNOT6L;AGO2
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.7136576770064812,1.4727544882710204,0.013888888888888888,0.33690396002837,1.0,12/37,7.17%,SERPINE1;GRIA2;AKAP12;MAP2;CNTN1;ANK2;MAP1B;LSAMP;PTPRD;NFASC;SNAP25;TTLL7
prerank,CellMarker_Augmented_2021__Mesothelial cell:Lung,0.7627081224309995,1.4726228275856452,0.0,0.3310916526450337,1.0,10/37,11.21%,AKAP12;KHDRBS3;SPOCK1;NES;ANK2;MAP1B;PTPRD;COL4A2;GJA1;MYH10
prerank,CellMarker_Augmented_2021__Interstitial cell:Bladder,0.7627081224309995,1.4726228275856452,0.0,0.3310916526450337,1.0,10/37,11.21%,AKAP12;KHDRBS3;SPOCK1;NES;ANK2;MAP1B;PTPRD;COL4A2;GJA1;MYH10
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Germ,0.7627081224309995,1.4726228275856452,0.0,0.3310916526450337,1.0,10/37,11.21%,AKAP12;KHDRBS3;SPOCK1;NES;ANK2;MAP1B;PTPRD;COL4A2;GJA1;MYH10
prerank,KEGG_2021_Human__Osteoclast differentiation,0.7144307349468714,1.472276642605343,0.012987012987012988,0.33066412157764963,1.0,13/44,14.74%,PIK3R3;JUNB;PIK3R1;JAK1;JUND;GRB2;FOSL2;JUN;IFNGR1;FOS;TAB2;MAPK10;RAC1
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.8458539954274754,-1.4717700561273483,0.037037037037037035,0.6742167893517996,1.0,2/6,3.61%,STAT1;IRF1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.9327410969565612,1.4710029523931303,0.01639344262295082,0.3361121849693751,1.0,1/6,0.56%,ADM
prerank,Reactome_2022__Regulation Of Signaling By CBL R-HSA-912631,0.8739860586660375,1.4697589100311301,0.014925373134328358,0.3411295011492997,1.0,3/11,8.31%,PIK3R3;PIK3R1;GRB2
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.8665930436131972,1.469484712099244,0.027777777777777776,0.33993014335307764,1.0,4/12,7.38%,CALR;UFL1;CBFB;KDM1A
prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,0.7360517385343468,1.4691867675106807,0.02531645569620253,0.3400965977501968,1.0,4/42,6.14%,PIK3R3;ITPR1;INPP5F;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.8428976388283965,1.4681921475852295,0.014084507042253521,0.3442158117788146,1.0,7/15,11.90%,DDIT4;MAP3K5;GRIN2B;PRNP;PICALM;REST;FOS
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.7461072471926566,1.467693576754774,0.014705882352941176,0.34470391406589523,1.0,2/25,0.64%,LAMC1;RTN4
prerank,KEGG_2021_Human__Prolactin signaling pathway,0.739189239709761,1.4671655276073288,0.02631578947368421,0.34469773505774565,1.0,8/27,13.89%,PIK3R3;PIK3R1;ESR2;GRB2;FOS;SHC2;MAPK10;KRAS
prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,0.7204865095935338,1.4671433469951223,0.013157894736842105,0.34261267289342706,1.0,7/36,14.74%,PIK3R3;PIK3R1;GRB2;IFNGR1;SHC2;KRAS;RAC1
prerank,KEGG_2021_Human__Prostate cancer,0.6971952102914162,1.4671233914763704,0.012987012987012988,0.3406912486288737,1.0,7/44,9.56%,PIK3R3;FGFR1;PIK3R1;HSP90AA1;GRB2;CDKN1B;HSP90B1
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.931315842743779,1.467029236522028,0.015151515151515152,0.3388619887920727,1.0,1/5,0.77%,ADAMTS9
prerank,KEGG_2021_Human__Endometrial cancer,0.7262998270843473,1.4670030112879424,0.025,0.33691912737330876,1.0,6/29,11.87%,PIK3R3;PIK3R1;CTNNA3;GRB2;CTNNA1;CDKN1A
prerank,CellMarker_Augmented_2021__Oligodendrocyte:Brain,0.7199564377940454,1.466843414093508,0.05194805194805195,0.33608169487592277,1.0,6/43,5.44%,ZEB2;RTN4;GRIA2;MAP2;GRIK2;MBP
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.8610310639261103,1.4666106904164293,0.0,0.3353216117952733,1.0,1/10,0.03%,PIK3R3
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.8416062387688359,1.4649268101204747,0.02666666666666667,0.34225198578896565,1.0,6/11,11.58%,GRIA2;ATRNL1;CTNND2;HS6ST3;SNAP25;NRXN1
prerank,KEGG_2021_Human__Cholinergic synapse,0.7385112534967835,1.464634221244316,0.05063291139240506,0.3432566941571262,1.0,4/33,6.14%,PIK3R3;ITPR1;CACNA1C;PIK3R1
prerank,KEGG_2021_Human__Relaxin signaling pathway,0.6883195183885098,1.464125036189799,0.041666666666666664,0.343919447998083,1.0,11/46,15.91%,PIK3R3;PIK3R1;GRB2;COL4A2;JUN;FOS;SHC2;MAPK10;KRAS;ADCY2;ATF2
prerank,"Reactome_2022__Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",0.8747333644522464,1.4638499252816077,0.0,0.3436558435525499,1.0,3/7,4.91%,GRIA2;LRRC7;GRIN2B
prerank,Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945,-0.808931961435868,-1.4637011892699732,0.0,0.7093513900866905,1.0,2/9,5.82%,ARNT2;MIA3
prerank,KEGG_2021_Human__Type I diabetes mellitus,-0.8233827294428729,-1.4635475616437323,0.05128205128205128,0.702140216076844,1.0,5/8,15.86%,ICA1;HLA-F;HLA-C;HLA-A;HSPD1
prerank,Reactome_2022__Interleukin Receptor SHC Signaling R-HSA-912526,0.8971274702211367,1.4632231073925333,0.043478260869565216,0.34548245351541657,1.0,4/11,8.31%,PIK3R3;PIK3R1;JAK1;GRB2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Cartilage,-0.7620458967068457,-1.4630308631817548,0.13513513513513514,0.6966032542806606,1.0,1/11,0.16%,VCAM1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.8535643395140691,-1.4629662042254672,0.07142857142857142,0.689029369404698,1.0,2/7,10.25%,CAPRIN1;CPEB3
prerank,CellMarker_Augmented_2021__Cartilage Progenitor cell:Cartilage,0.7123432608912271,1.4625821696244607,0.012987012987012988,0.3469634952691626,1.0,8/39,12.88%,PLS3;AKAP12;NES;MAP1B;COL4A2;GJA1;MYH10;BCAR1
prerank,Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925,0.6635626198766937,1.4616218082137924,0.0,0.35049016002889344,1.0,20/109,12.91%,PIK3R3;ERBB4;PSMC6;ITPR1;PRKCE;NRG2;FGFR1;PIK3R1;ESR2;KDM1A;RPS27A;GRB2;CDKN1B;NRG3;JUN;PHLPP1;REST;CDKN1A;CNOT6L;AGO2
prerank,Reactome_2022__Pyruvate Metabolism R-HSA-70268,0.9385553729176664,1.4612239507938547,0.0,0.35025876075398527,1.0,2/6,1.41%,PDK4;LDHA
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Dorsolateral Prefrontal Cortex,0.7550013398868994,1.4611488962538521,0.0273972602739726,0.3488192856858646,1.0,9/26,7.33%,GRIA2;GRIK2;ANK2;IL1RAPL1;MAP1B;GRIN2B;SNAP25;TTLL7;NAV3
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.7058262199841783,1.4604989034702973,0.0273972602739726,0.3505008426160774,1.0,18/50,14.10%,ADM;CANX;CALR;CD9;HSPH1;CD81;INPP5F;SGIP1;SCARB2;LRP1B;HSP90AA1;GRB2;PICALM;HSP90B1;PIKFYVE;ITGB1;HIP1R;AP1G1
prerank,Reactome_2022__Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,0.7984324416672819,1.4603738431939288,0.014705882352941176,0.3488873533546262,1.0,5/14,9.00%,CNTN5;MDGA2;LSAMP;ALPL;NEGR1
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,0.6620941130923674,1.4596527532513794,0.0,0.3496098819626308,1.0,25/82,20.82%,PIK3R3;FGFR1;PIK3R1;ARHGEF4;SSH1;ITGA1;GNA13;PIKFYVE;MYH10;BCAR1;ARPC2;ITGB1;KRAS;PAK2;RAC1;CRK;ACTN1;PPP1CB;PXN;MYL12B;CFL1;DIAPH2;LIMK2;GSN;ACTB
prerank,KEGG_2021_Human__Glucagon signaling pathway,0.7021645187021057,1.4595367509431525,0.06329113924050633,0.3482686909834462,1.0,5/37,1.91%,PKM;ITPR1;LDHA;PCK1;PRKAG2
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.7697436777827675,-1.4591672331631906,0.0,0.7021626240919948,1.0,3/12,7.30%,SLC22A5;SLC25A29;PKD2
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.9712637486987115,1.4588334656817017,0.0,0.34985380421653484,1.0,2/5,0.64%,NRCAM;RTN4
prerank,Reactome_2022__Nervous System Development R-HSA-9675108,0.6109672334832705,1.4568862282123072,0.0,0.35924435604359345,1.0,45/217,17.10%,PIK3R3;LAMC1;NRCAM;PSMC6;DOK5;CNTN1;FES;ANK2;RPS11;MYO9B;GRIN2B;ROBO2;CACNA1C;NFASC;FGFR1;PIK3R1;RPS9;PRNP;HSP90AA1;SRGAP1;RPS27A;RPL23;GRB2;COL4A2;ITGA1;ANK3;UNC5C;MYL6;MYH10;RPL8;RPL34;RPL37;RPLP2;ARPC2;PRX;ITGB1;GRB10;WWTR1;RPL13A;ALCAM;RPS12;PSMA7;PLXNA2;SDCBP;DAG1
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.8291538755035333,-1.4560625890520262,0.05555555555555555,0.7112719693816019,1.0,1/7,2.84%,HERC5
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreatic Islet,-0.6151433573702424,-1.4558880722710963,0.16,0.7042670499449842,1.0,4/31,5.34%,RSAD2;STARD3;SRBD1;PLAAT3
prerank,KEGG_2021_Human__Biosynthesis of unsaturated fatty acids,0.9285659915392819,1.454863066799471,0.0,0.36883743737440766,1.0,2/6,4.94%,SCP2;ACOX1
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.8584940863141762,-1.4548400927536784,0.045454545454545456,0.703376709423522,1.0,1/7,0.16%,VCAM1
prerank,Reactome_2022__Signaling By ERBB2 R-HSA-1227986,0.7532748710173754,1.4535439417588722,0.04225352112676056,0.37454794141839853,1.0,8/26,8.95%,ERBB4;PRKCE;NRG2;PIK3R1;HSP90AA1;RPS27A;GRB2;NRG3
prerank,CellMarker_Augmented_2021__Periodontal Ligament Stem cell:Periodontal Ligament,-0.710525538058612,-1.4534150359522968,0.038461538461538464,0.7036856615007253,1.0,6/15,14.42%,GBP4;CD74;GIMAP8;TNFRSF1B;RCSD1;GIMAP4
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.8591607370011469,-1.453201415878955,0.030303030303030304,0.6971344366644697,1.0,5/6,13.78%,PLA1A;PLA2G4A;PLAAT3;OSBPL8;MBOAT2
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.6503686216620612,1.45270931835308,0.0,0.37904484439869135,1.0,16/65,13.86%,RTN4;ANK2;CALR;GAPDH;PIK3R1;SMAD7;PINK1;HSP90AA1;RAB21;RPL23;LAMP2;CCNH;ATP1B3;CDKN1A;HIP1R;NAA16
prerank,KEGG_2021_Human__Cellular senescence,0.6873288409051033,1.452320142636732,0.01282051282051282,0.379756765262132,1.0,3/58,1.35%,PIK3R3;SERPINE1;ITPR1
prerank,Reactome_2022__Interaction Between L1 And Ankyrins R-HSA-445095,0.9024501044076318,1.4517681662610054,0.030303030303030304,0.3807007256571414,1.0,4/8,8.79%,NRCAM;ANK2;NFASC;ANK3
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.9055229201377302,-1.4493594507477692,0.0392156862745098,0.7019043983935892,1.0,2/5,1.83%,PLA2G4A;CD74
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.9055229201377302,-1.4493594507477692,0.0392156862745098,0.7019043983935892,1.0,2/5,1.83%,PLA2G4A;CD74
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Embryonic Prefrontal Cortex,0.722637810004803,1.449250819537025,0.02857142857142857,0.39439145419892707,1.0,13/30,18.43%,CNTN1;CADM2;CD9;GPM6B;LSAMP;DUSP6;LRRC4C;TRIB2;PON2;ALCAM;PLAT;SYT1;PDE4B
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.7231141869727986,1.4486950193456825,0.038461538461538464,0.3960771602249958,1.0,5/39,6.14%,PIK3R3;INPP5F;ARF1;MTMR12;PIK3R1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.7447387917785969,1.4482327336094507,0.0,0.39638844841229837,1.0,5/34,8.39%,LAMC1;PLS3;NES;GAPDH;COL4A2
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.8124402136370387,1.4470993297730617,0.045454545454545456,0.4016830142123071,1.0,6/18,12.93%,MTHFD1L;SLC52A3;SLC2A1;SLC2A3;MTHFD2L;BTD
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.7557554149260278,-1.4470001314996457,0.12,0.7087107440749816,1.0,4/10,9.30%,IL15;STAT1;PKD2;STAT2
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.7557746121580888,1.4463580180498066,0.012987012987012988,0.40458757642141546,1.0,9/32,11.87%,RTN4;BCL6;MAP2;HYAL2;ESR2;CDKN1B;GJA1;ADAM15;CDKN1A
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.906910441374277,1.4460101231484257,0.034482758620689655,0.4046172131122498,1.0,1/5,0.50%,B3GNT2
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Salivary Gland,0.7395069317720907,1.4458224982605108,0.0136986301369863,0.4041268009891118,1.0,11/34,14.85%,LAMC1;SERPINE1;PLS3;MYO1B;COL4A2;GJA1;ANXA2;ITGB1;WWTR1;CTTNBP2NL;TUBB6
prerank,Reactome_2022__GPCR Downstream Signaling R-HSA-388396,0.6269884468642043,1.445377441449769,0.011235955056179775,0.40513516260785215,1.0,14/102,10.86%,PIK3R3;ADM;ITPR1;GRM7;MGLL;ANXA1;PDE7A;PRKCE;PIK3R1;ARHGEF4;GRB2;PDE10A;RGS7;GNA13
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.8900058680774703,1.4448628126593064,0.043478260869565216,0.4064760500480521,1.0,1/7,0.69%,SERPINE1
prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,0.9397037288873724,1.4443802305096447,0.0,0.40734830115484383,1.0,5/6,4.75%,PKM;LDHA;PCK1;GAPDH;PGK1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Cartilage,0.6929571717319697,1.4441873654012765,0.0,0.40617511910950505,1.0,13/50,16.04%,LAMC1;PLS3;MAP1B;PLOD2;MYO1B;COL4A2;GJA1;BCAR1;WWTR1;CTTNBP2NL;ALCAM;NAV2;PLAT
prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",0.6726968538283108,1.443672092269941,0.023529411764705882,0.407040042443327,1.0,14/53,15.91%,PIK3R3;ITPR1;JUNB;CACNA1C;PIK3R1;GRB2;FOS;BCAR1;SHC2;MAPK10;KRAS;ADCY2;CRK;ATF2
prerank,CellMarker_Augmented_2021__Circulating Precursor cell:Peripheral Blood,-0.6274949929286319,-1.4430931043856672,0.08333333333333333,0.7232316109508656,1.0,5/26,8.92%,GBP4;CD74;MMRN1;GIMAP8;PROM1
prerank,CellMarker_Augmented_2021__Leydig Precursor cell:Fetal Gonad,0.6682641275290752,1.4424415389759422,0.0,0.4128241352963853,1.0,22/75,16.63%,PCDH9;TSC22D3;TIMP3;LSAMP;PLIN2;CHSY1;PDE5A;RPS18;INSIG1;DLC1;RPS27A;RPL23;PPFIA2;NEGR1;CFH;RPL8;RPL34;EEF1A1;RPL13A;RPS12;ADD3;SYT1
prerank,KEGG_2021_Human__Purine metabolism,0.7248398004026892,1.4410690062831508,0.02702702702702703,0.4184386614999979,1.0,9/26,18.43%,PKM;PNP;PDE7A;PDE5A;PDE10A;ADCY2;ADSS2;ADK;PDE4B
prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,0.7272874531753986,1.4409422739428728,0.029850746268656716,0.41723349129384013,1.0,7/35,11.90%,PIK3R3;PIK3R1;JAK1;JUN;HIF1A;IFNGR1;FOS
prerank,CellMarker_Augmented_2021__Epithelial cell:Kidney,-0.8308670376230896,-1.4407484354641866,0.07407407407407407,0.728137433205699,1.0,1/7,2.76%,OCLN
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.8480459735870853,1.440338826589729,0.029850746268656716,0.4186881429842875,1.0,3/9,4.91%,GRIA2;LRRC7;GRIN2B
prerank,Reactome_2022__Class B/2 (Secretin Family Receptors) R-HSA-373080,0.8405201227808341,1.4402003800845016,0.04054054054054054,0.4174387800561557,1.0,2/12,1.62%,ADM;WNT2B
prerank,Reactome_2022__ECM Proteoglycans R-HSA-3000178,0.836890660982825,1.439279272495352,0.046875,0.4210628748920607,1.0,3/15,4.17%,LAMC1;SERPINE1;LAMA5
prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,0.6206301144433448,1.4386653058976506,0.012345679012345678,0.4226947707805353,1.0,14/72,15.72%,PIK3R3;ITPR1;TRIM5;CALR;PIK3R1;JUN;FOS;TAB2;MAPK10;KRAS;PAK2;AP1G1;RAC1;CRK
prerank,Reactome_2022__GRB2 Events In ERBB2 Signaling R-HSA-1963640,0.8871873141232628,1.4385442784423546,0.03225806451612903,0.4219309276567408,1.0,4/6,8.95%,ERBB4;NRG2;GRB2;NRG3
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.6893330360922019,1.4381844783929068,0.04878048780487805,0.42225098483189355,1.0,6/53,6.14%,PIK3R3;CHPT1;INPP5F;ARF1;MTMR12;PIK3R1
prerank,Reactome_2022__Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,0.8084474035423198,1.4371636049933656,0.08450704225352113,0.4273887273918757,1.0,5/10,8.95%,ERBB4;NRG2;HSP90AA1;GRB2;NRG3
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.8215517336019362,1.434881664520314,0.057971014492753624,0.4398333899744316,1.0,2/12,11.47%,RTN4;REST
prerank,KEGG_2021_Human__NF-kappa B signaling pathway,-0.6896939072637271,-1.4348762090029548,0.1,0.7505395516249915,1.0,3/23,7.22%,VCAM1;ATM;TRIM25
prerank,Reactome_2022__GPCR Ligand Binding R-HSA-500792,0.7560429608723773,1.4345056396880764,0.014285714285714285,0.44032845341748267,1.0,5/24,3.90%,ADM;WNT2B;GRM7;S1PR1;ANXA1
prerank,"Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002",0.6330088827976177,1.4337736783683677,0.0,0.4430891587180829,1.0,19/91,11.18%,PIK3R3;SERPINE1;ITPR1;HSPA5;CD9;MGLL;TIMP3;PRKCE;SYTL4;RAPGEF3;PIK3R1;SRGN;GRB2;LAMP2;VWF;RAP1A;PECAM1;GNA13;PIKFYVE
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.7217464129254799,1.4336153527500042,0.012987012987012988,0.4417248927655559,1.0,4/30,7.25%,PKM;PCK1;PIK3R1;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.7517367478744336,1.433319083169318,0.046875,0.4416287186163672,1.0,7/22,11.90%,DDIT4;MAP3K5;GRIN2B;PRNP;PICALM;CDKN1B;FOS
prerank,Reactome_2022__Generation Of Second Messenger Molecules R-HSA-202433,-0.7718629433961262,-1.4329268264315822,0.12121212121212122,0.7540687244303875,1.0,1/8,2.55%,EVL
prerank,Reactome_2022__Glycolysis R-HSA-70171,0.7947710492537055,1.4328636283861478,0.02564102564102564,0.442990997207874,1.0,2/18,4.75%,PKM;PGK1
prerank,Reactome_2022__Non-integrin membrane-ECM Interactions R-HSA-3000171,0.7537390540058004,1.4323501967667935,0.1,0.4451177256793746,1.0,7/17,17.10%,LAMC1;LAMA5;NRXN1;ITGB1;DMD;ACTN1;DAG1
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.8997071881303675,1.4319545950867107,0.031746031746031744,0.445213397319027,1.0,1/7,7.38%,KDM1A
prerank,Reactome_2022__Signaling By GPCR R-HSA-372790,0.6204997698056647,1.4310801185837443,0.0,0.4487474509220813,1.0,27/109,18.43%,PIK3R3;ADM;ITPR1;WNT2B;GRM7;S1PR1;MGLL;ANXA1;PDE7A;PRKCE;PIK3R1;ARHGEF4;GRB2;PDE10A;RGS7;GNA13;ITGB1;CD55;ECT2;DGKI;ADCY2;GRK5;PRKX;ARHGEF2;FZD4;KALRN;PDE4B
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.9393453360929365,1.4307689918598518,0.0,0.4485189391464219,1.0,1/5,0.32%,NRCAM
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),0.7193404799288847,1.430467496690174,0.039473684210526314,0.44859769230723945,1.0,7/27,16.68%,CEP57;HYAL2;FGFR1;GRB2;KIF16B;SHOC2;SPRED1
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.7768759601139879,1.4298827855611334,0.03278688524590164,0.4504477472968954,1.0,7/18,11.58%,RFTN1;IL1RAPL1;PTPRD;PICALM;ANK3;ANXA2;NRXN1
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.8157959721866948,1.4295977236605688,0.0,0.45016422393116956,1.0,6/16,8.98%,GRIA2;CADM2;ANK2;MAP1B;CTNND2;LRRC4C
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.7910465873346618,-1.4290258408020475,0.16666666666666666,0.7690328096387854,1.0,1/6,0.16%,VCAM1
prerank,Reactome_2022__CD28 Dependent PI3K/Akt Signaling R-HSA-389357,0.9087424258214891,1.4289487691234213,0.014705882352941176,0.45128805410481576,1.0,1/9,0.03%,PIK3R3
prerank,Reactome_2022__Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,0.9231278870342476,1.4283314913306588,0.015151515151515152,0.45280131963786263,1.0,1/5,0.80%,GRIA2
prerank,CellMarker_Augmented_2021__Tumor-propagating cell:Undefined,0.6665331281533347,1.4266448127090032,0.011904761904761904,0.45265411333844596,1.0,14/52,18.25%,PLS3;AKAP12;NES;ARHGAP23;MAP1B;PLOD2;COL4A2;GJA1;BCAR1;WWTR1;NAV2;PLAT;AFAP1L1;FZD4
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone,0.6665331281533347,1.4266448127090032,0.011904761904761904,0.45265411333844596,1.0,14/52,18.25%,PLS3;AKAP12;NES;ARHGAP23;MAP1B;PLOD2;COL4A2;GJA1;BCAR1;WWTR1;NAV2;PLAT;AFAP1L1;FZD4
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Molar,0.6665331281533347,1.4266448127090032,0.011904761904761904,0.45265411333844596,1.0,14/52,18.25%,PLS3;AKAP12;NES;ARHGAP23;MAP1B;PLOD2;COL4A2;GJA1;BCAR1;WWTR1;NAV2;PLAT;AFAP1L1;FZD4
prerank,CellMarker_Augmented_2021__Progenitor cell:Fetal Liver,0.6665331281533347,1.4266448127090032,0.011904761904761904,0.45265411333844596,1.0,14/52,18.25%,PLS3;AKAP12;NES;ARHGAP23;MAP1B;PLOD2;COL4A2;GJA1;BCAR1;WWTR1;NAV2;PLAT;AFAP1L1;FZD4
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone Marrow,0.6665331281533347,1.4266448127090032,0.011904761904761904,0.45265411333844596,1.0,14/52,18.25%,PLS3;AKAP12;NES;ARHGAP23;MAP1B;PLOD2;COL4A2;GJA1;BCAR1;WWTR1;NAV2;PLAT;AFAP1L1;FZD4
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Adipose Tissue,0.6665331281533347,1.4266448127090032,0.011904761904761904,0.45265411333844596,1.0,14/52,18.25%,PLS3;AKAP12;NES;ARHGAP23;MAP1B;PLOD2;COL4A2;GJA1;BCAR1;WWTR1;NAV2;PLAT;AFAP1L1;FZD4
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.761977619456714,1.4260622933505915,0.015873015873015872,0.4546477577294386,1.0,6/15,13.47%,GPM6B;PICALM;CTNNA1;OTUD7B;COMMD1;NEDD4L
prerank,KEGG_2021_Human__Pancreatic cancer,0.7314563060223247,1.425669139824782,0.013333333333333334,0.45556349498281773,1.0,8/32,14.74%,PIK3R3;PIK3R1;JAK1;CDK6;CDKN1A;MAPK10;KRAS;RAC1
prerank,Reactome_2022__Signaling By SCF-KIT R-HSA-1433557,0.8092492295457689,1.425326306308553,0.014492753623188406,0.45594331383385356,1.0,4/20,8.31%,PIK3R3;FES;PIK3R1;GRB2
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.7723935164718564,1.4252471677255734,0.0,0.45421700189419856,1.0,8/15,8.50%,GRIA2;MAP2;CADM2;ANK2;CTNND2;HS6ST3;SNAP25;PPFIA2
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.737654420479411,1.4244775049296798,0.06578947368421052,0.4573593898605119,1.0,9/24,12.96%,CCDC3;CNTN1;ANK2;GPM6B;PTPRD;NFASC;NRXN1;TMEM132C;SHC2
prerank,CellMarker_Augmented_2021__B cell:Undefined,0.7895016154613004,1.4241568576260106,0.07462686567164178,0.4576792807619855,1.0,4/13,10.46%,CD9;CD81;BCR;PECAM1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.8869912259480824,-1.4240802543307474,0.0625,0.787343456974861,1.0,1/5,0.37%,RNF213
prerank,Reactome_2022__Signaling By NTRK2 (TRKB) R-HSA-9006115,0.8422169604458943,1.4240628383880665,0.014084507042253521,0.45676971511137743,1.0,4/13,8.31%,DOCK3;GRIN2B;PIK3R1;GRB2
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.6964101376044265,1.4239042068423684,0.0641025641025641,0.45596182195583207,1.0,14/39,13.39%,ERBB4;GRIA2;MAP2;CNTN1;ANK2;PTPRD;NFASC;SNAP25;PPFIA2;PPP1R9A;UNC5C;NRXN1;SHC2;MAPK10
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tendon,-0.7623317234039897,-1.423799941973374,0.10526315789473684,0.7666497103114326,1.0,1/10,0.16%,VCAM1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone,-0.7623317234039897,-1.423799941973374,0.10526315789473684,0.7666497103114326,1.0,1/10,0.16%,VCAM1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Muscle,-0.7623317234039897,-1.423799941973374,0.10526315789473684,0.7666497103114326,1.0,1/10,0.16%,VCAM1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),-0.8607261642786003,-1.4236097690603247,0.02631578947368421,0.7602335778269073,1.0,3/5,13.65%,RFX3;FOXO1;CLOCK
prerank,CellMarker_Augmented_2021__Plasma cell:Salivary Gland,0.7332492874854398,1.4233499713111792,0.057971014492753624,0.4574063745687103,1.0,4/23,7.62%,LAMC1;PLS3;LAMA5;MYO1B
prerank,KEGG_2021_Human__Homologous recombination,-0.8335562102292992,-1.422055182329138,0.125,0.7609351131636272,1.0,3/7,7.92%,BABAM2;ATM;RAD51B
prerank,CellMarker_Augmented_2021__LGR5+ Stem cell:Small Intestine,0.7329198684270898,1.4217651516221799,0.0273972602739726,0.4656405408568986,1.0,5/35,9.85%,LAMC1;PLS3;TIMP3;COL4A2;GJA1
prerank,Reactome_2022__Regulation Of Insulin Secretion R-HSA-422356,0.7303771893346596,1.4202540300279205,0.03076923076923077,0.4739449792527185,1.0,6/27,10.07%,ITPR1;CACNA1C;RAPGEF3;SNAP25;SLC2A1;RAP1A
prerank,CellMarker_Augmented_2021__Progenitor cell:Skin,-0.8895189145747925,-1.4201169644018723,0.1111111111111111,0.7639815602084299,1.0,2/5,8.92%,OCLN;PROM1
prerank,CellMarker_Augmented_2021__Bipolar cell:Eye,0.6707366171192756,1.4199388004812248,0.014285714285714285,0.47391057154001814,1.0,11/45,15.03%,PCDH9;SPOCK1;MAP1B;CCDC88A;SNAP25;ARHGAP21;NAV3;NEGR1;RGS7;MPRIP;DGKI
prerank,Reactome_2022__Hemostasis R-HSA-109582,0.597163581897303,1.419747686725791,0.01098901098901099,0.4731403306122016,1.0,34/187,11.37%,PIK3R3;MAFF;DOCK3;SERPINE1;ITPR1;HSPA5;MAFK;KCNMB4;ZNF160;SLC8A1;CD9;MGLL;TIMP3;PRKCE;SYTL4;ZFPM2;PDE5A;RAPGEF3;PIK3R1;KDM1A;SERPINB6;SRGN;GRB2;ATP2B1;ITGA1;LAMP2;VWF;PDE10A;RAP1A;PECAM1;GNA13;PIKFYVE;ATP1B3;ANXA2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.8504641508419499,1.4193555387509331,0.05128205128205128,0.47379679188945006,1.0,4/8,11.08%,PKM;YBX3;CPEB4;CNBP
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.8806810210998617,1.418091658439518,0.014492753623188406,0.47992330143607626,1.0,3/6,10.62%,ANXA1;KLF4;OTUD7B
prerank,Reactome_2022__ERBB2 Regulates Cell Motility R-HSA-6785631,0.8708437759072392,1.4177999088375641,0.08620689655172414,0.4800012817355391,1.0,3/6,8.95%,ERBB4;NRG2;NRG3
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.896757114378146,1.4177664945594632,0.03571428571428571,0.4783136305145804,1.0,1/6,0.88%,PSMC6
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.6537954808024743,-1.416881081483501,0.06666666666666667,0.7737160848053246,1.0,4/20,5.23%,SLCO1A2;SLC38A3;ABCG2;SLC25A29
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.7161888581190353,1.4163070089991892,0.029411764705882353,0.4857443070713899,1.0,13/37,8.98%,GRIA2;ATRNL1;CADM2;NES;ANK2;GPM6B;LSAMP;NPAS3;ROBO2;CTNND2;SNAP25;PPFIA2;LRRC4C
prerank,Reactome_2022__Integration Of Energy Metabolism R-HSA-163685,0.7019435305966847,1.416275300199208,0.041666666666666664,0.48386751059552824,1.0,7/34,10.07%,ITPR1;PRKAG2;CACNA1C;RAPGEF3;SNAP25;SLC2A1;RAP1A
prerank,CellMarker_Augmented_2021__Fibroblast:Heart,0.7006085408568881,1.4156358955155608,0.05714285714285714,0.4858508085829512,1.0,5/34,10.89%,LAMC1;ADM;SCARB2;MYO1B;TBC1D9
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.7979720192036444,-1.4152402914976876,0.0975609756097561,0.7698488512373256,1.0,3/7,12.91%,HLA-F;HLA-C;HLA-A
prerank,Reactome_2022__Endosomal/Vacuolar Pathway R-HSA-1236977,-0.7979720192036444,-1.4152402914976876,0.0975609756097561,0.7698488512373256,1.0,3/7,12.91%,HLA-F;HLA-C;HLA-A
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Germ,-0.8875394670228283,-1.4152035026028602,0.05,0.7633495605584449,1.0,3/7,8.92%,VCAM1;ABCG2;PROM1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.8751130244278574,1.4151709889200423,0.07042253521126761,0.4861260641241397,1.0,5/9,9.83%,ATF3;HSPA5;KLF2;NFE2L2;HIF1A
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.7747547307425801,1.4150749130406586,0.028169014084507043,0.48515728527911967,1.0,3/14,4.91%,GRIA2;LRRC7;GRIN2B
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.7444527205743539,1.413430747766696,0.11842105263157894,0.49400295529431715,1.0,5/17,7.38%,MAP2;FES;PINK1;HSP90AA1;KDM1A
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.6924961428929848,-1.4129889911672224,0.16666666666666666,0.7688865458272472,1.0,5/11,11.61%,PARP14;PARP9;ZC3HAV1;PARP12;PARP11
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.7759989782256226,1.4129173622610465,0.06153846153846154,0.49525456491606495,1.0,7/15,15.30%,DTNA;CADM2;ANO5;LRP1B;CTNNA3;PIAS2;ADCY2
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.8169471906922958,-1.4127925191348418,0.10256410256410256,0.7629539093434262,1.0,3/7,12.91%,TAP1;HLA-F;HLA-A
prerank,Reactome_2022__MET Promotes Cell Motility R-HSA-8875878,0.7656526854575261,1.4118500959301856,0.07042253521126761,0.4995202227815446,1.0,6/17,15.72%,LAMC1;LAMA5;GRB2;RAP1A;ITGB1;CRK
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.7173670000062627,1.411253482525814,0.03076923076923077,0.5010021719539616,1.0,11/24,11.58%,GRIA2;SPOCK1;CADM2;LSAMP;NFASC;SNAP25;PPFIA2;LRRC4C;NEGR1;PDE10A;NRXN1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.7393832636929561,1.4109881277782936,0.041666666666666664,0.5009071631108928,1.0,6/22,16.68%,CEP57;FGFR1;GRB2;KIF16B;SHOC2;SPRED1
prerank,Reactome_2022__FCERI Mediated MAPK Activation R-HSA-2871796,0.7650702216626393,1.4102720725953035,0.058823529411764705,0.5029784802679217,1.0,4/15,13.39%,GRB2;JUN;FOS;MAPK10
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Ovary,0.8877927741853898,1.4101379526385238,0.043478260869565216,0.5018410853508045,1.0,1/6,0.61%,ZEB2
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.8468011552123229,1.409919802237957,0.047619047619047616,0.5015290500321484,1.0,2/8,4.01%,MAP2;MAP1B
prerank,Reactome_2022__Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,0.8547768435336838,1.4095134362311033,0.046875,0.5019900041669261,1.0,2/7,4.91%,LRRC7;GRIN2B
prerank,CellMarker_Augmented_2021__Proximal Tubular cell:Kidney,-0.7741560549633637,-1.4092767980201055,0.08823529411764706,0.7722655297963009,1.0,3/9,7.01%,GBP4;MMRN1;GIMAP8
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.8000474246982886,-1.409109422017282,0.10344827586206896,0.7665926976163845,1.0,1/8,0.19%,DDX60
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.8140034992660615,1.4088645284907002,0.029411764705882353,0.5054325863994147,1.0,3/16,1.91%,PSMC6;PDK4;PRKAG2
prerank,Reactome_2022__Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,0.7931432785444654,1.4087733875998227,0.05970149253731343,0.5041757742686448,1.0,6/12,9.56%,CALR;HSPH1;HSP90AA1;DLC1;COL4A2;HSP90B1
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.7120751493699436,1.4086481817735181,0.0,0.5031824749503259,1.0,12/50,11.21%,ADAMTS9;AKAP12;DIXDC1;NES;ANK2;MAP1B;NFASC;NAV1;COL4A2;GJA1;PDE10A;MYH10
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.8241614412459562,1.4085080951913709,0.013157894736842105,0.5018594580977956,1.0,3/14,5.15%,AFF3;TBX3;CACNA1C
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.6423443250219867,-1.4082788043747656,0.14285714285714285,0.7655004972726779,1.0,4/24,8.50%,RNF213;UBE3D;NFX1;MDM2
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.6955711712718163,1.4081749170994924,0.025974025974025976,0.5026044248940427,1.0,11/49,12.64%,EHD4;ANK2;KCNIP4;TTC7A;CD81;DPP10;PACS1;ANK3;RAP1A;ATP1B3;MAP7
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.7498795374080673,-1.4078951514442306,0.09090909090909091,0.7606570500665272,1.0,1/6,1.41%,STARD3
prerank,CellMarker_Augmented_2021__Cancer cell:Esophagus,0.6901358931617553,1.4078898215389863,0.012658227848101266,0.5024232736281703,1.0,18/43,22.20%,ANGPTL4;SERPINE1;MGLL;TINAGL1;PLSCR4;DLC1;EMP1;CFH;TNS1;PLAT;AFAP1L1;TGM2;NPAS2;RBMS2;GSN;FNDC3B;EPAS1;CAV2
prerank,CellMarker_Augmented_2021__Basophil:Lung,-0.7536682649099018,-1.4078495841745775,0.09090909090909091,0.7545447268319166,1.0,4/11,7.84%,GBP1;TNFSF10;GIMAP8;SMAD1
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.8790736402274895,1.4076283672570198,0.07352941176470588,0.5021184341526417,1.0,1/5,2.44%,KCNMB4
prerank,KEGG_2021_Human__Yersinia infection,0.6560706849285803,1.4073362004297485,0.041666666666666664,0.5023557330026529,1.0,11/59,15.72%,PIK3R3;PIK3R1;JUN;FOS;BCAR1;ARPC2;TAB2;MAPK10;ITGB1;RAC1;CRK
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.8212551642067941,-1.4067626850106891,0.15789473684210525,0.7534555423936699,1.0,3/6,13.68%,MSH3;XPC;MCM9
prerank,CellMarker_Augmented_2021__Endothelial Stem cell:Blood Vessel,-0.784759693695424,-1.4063268338156676,0.15384615384615385,0.7487058184218209,1.0,1/9,0.16%,VCAM1
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.6660507379042246,1.4062055643774938,0.04054054054054054,0.5081351553491126,1.0,12/48,8.98%,GRIA2;ATRNL1;MAP2;CNTN1;CADM2;ANK2;MAP1B;LSAMP;NFASC;SNAP25;PPFIA2;LRRC4C
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.936806985007763,1.4049349960217001,0.015384615384615385,0.5141601378319087,1.0,4/5,4.75%,PKM;LDHA;GAPDH;PGK1
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.8320754592595159,-1.4048118362139301,0.027777777777777776,0.749355577131599,1.0,1/6,1.17%,MLLT3
prerank,Reactome_2022__G Alpha (S) Signaling Events R-HSA-418555,0.7149330439229504,1.404684694482869,0.01282051282051282,0.5140627399352655,1.0,6/25,16.97%,ADM;PDE7A;PDE10A;ITGB1;ADCY2;GRK5
prerank,KEGG_2021_Human__Renal cell carcinoma,0.713306368711215,1.4044314595639078,0.015151515151515152,0.5137205747441301,1.0,12/33,15.72%,PIK3R3;PIK3R1;GRB2;SLC2A1;JUN;HIF1A;RAP1A;CDKN1A;KRAS;PAK2;RAC1;CRK
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.9489960371657209,1.4043250375314393,0.016666666666666666,0.512891758322042,1.0,3/6,3.80%,RIMKLB;GLUD1;GLUL
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.7816970487311214,1.4042392963907533,0.03896103896103896,0.5116628677064611,1.0,4/15,10.39%,PRKAG2;HSPA5;CPEB4;SIK2
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.8589983629555451,1.4039074833897798,0.08333333333333333,0.5117783377132701,1.0,1/8,0.98%,BCL6
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.86581463669736,1.4038827025417155,0.015151515151515152,0.5099576448080101,1.0,3/9,5.13%,RTN4;CD81;SCARB2
prerank,Reactome_2022__Signaling By ERBB4 R-HSA-1236394,0.7125302799778643,1.4028245040111667,0.029850746268656716,0.5139752517469287,1.0,7/25,13.31%,ERBB4;NRG2;PIK3R1;RPS27A;GRB2;NRG3;TAB2
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.9158035165782225,1.4022850992445215,0.014285714285714285,0.5157222760691779,1.0,4/6,4.75%,PKM;LDHA;GAPDH;PGK1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.6450532504249852,-1.401996737040775,0.125,0.7580652273713371,1.0,2/19,0.72%,GBP1;GBP2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.7611088118054885,-1.4016713440874333,0.16666666666666666,0.7536268948784327,1.0,2/7,0.77%,GBP1;HOMER2
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.8676235775563982,1.4015838311412068,0.07936507936507936,0.51925151782258,1.0,2/6,6.91%,ARF1;PRNP
prerank,Reactome_2022__Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,0.7237315940511819,1.4004535560223714,0.013888888888888888,0.5253386369463541,1.0,14/26,22.42%,ERBB4;KHDRBS3;NRG2;RPS27A;CDKN1B;NRG3;HIF1A;BCAR1;CRK;STAT3;PTPN1;SOCS3;EPAS1;UBC
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.7343063140373383,1.3998741811343751,0.0273972602739726,0.5274619513338474,1.0,10/35,11.87%,RTN4;BCL6;HYAL2;ESR2;MT1M;MT2A;CDKN1B;GJA1;ADAM15;CDKN1A
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.7125930444111424,1.3995547124897587,0.05714285714285714,0.527439403720697,1.0,13/27,16.12%,GRIA2;CNTN1;CADM2;LSAMP;ROBO2;CTNND2;NFASC;SNAP25;LRRC4C;NRXN1;MAPK10;ERO1B;ADGRB3
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Muscle,0.6850533322082853,1.3994121333170086,0.05555555555555555,0.5263554192228773,1.0,6/32,9.27%,SERPINE1;ARHGAP23;TIMP3;PLSCR4;COL4A2;EMP1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.6521640199682293,-1.3993839764146685,0.10714285714285714,0.7583702707419403,1.0,2/14,3.69%,FAXDC2;TNRC6C
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Parotid Gland,0.7195010162551746,1.3982677776358678,0.07462686567164178,0.5322922197365375,1.0,8/25,10.78%,DOK5;ANK2;TIMP3;PTPRD;NFASC;COL4A2;GJA1;BOC
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Bone Marrow,-0.6740800410056272,-1.3982471496600999,0.16129032258064516,0.7577078089143414,1.0,2/17,4.65%,VCAM1;ABCG2
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.9523100319072725,1.3980743696356084,0.014285714285714285,0.5317453626884174,1.0,1/5,0.03%,PIK3R3
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.6948042626063777,1.39803051602208,0.02564102564102564,0.5300352075739568,1.0,12/52,12.64%,EHD4;ANK2;KCNIP4;TTC7A;CD81;DPP10;PACS1;CCDC88A;ANK3;RAP1A;ATP1B3;MAP7
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.6915519878737562,-1.3979085313975643,0.06060606060606061,0.7537772461905896,1.0,6/13,12.35%,ISG15;OAS3;SAMHD1;STAT2;NLRC5;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.7084999258217675,1.3978706484785548,0.02666666666666667,0.5289185389690435,1.0,10/35,13.68%,PKM;ANGPTL4;SERPINE1;RAPGEF3;JAK1;KLF4;HIF1A;FLT1;AGO2;ITGB1
prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,0.7113720571236027,1.3975149751038807,0.06944444444444445,0.5296254223127309,1.0,2/36,1.35%,PIK3R3;ITPR1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.8039620352402266,1.3970554796428027,0.04411764705882353,0.5302888974777581,1.0,6/14,11.85%,RTN4;SLC2A13;PRNP;TMED10;PICALM;IFNGR1
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.8714231473347148,1.3965921946548419,0.058823529411764705,0.5319452984476508,1.0,4/8,8.79%,ANK2;KCNIP4;DPP10;ANK3
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.7642861145793101,1.3963886811856503,0.0625,0.5312197831917504,1.0,2/19,6.96%,CCDC3;PLCL1
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Eye,0.6783702856440599,1.396314909322508,0.06666666666666667,0.5284546447508339,1.0,7/40,9.85%,LAMC1;AKAP12;NES;ANK2;MAP1B;COL4A2;GJA1
prerank,CellMarker_Augmented_2021__Neural Stem cell:Spinal Cord,0.6783702856440599,1.396314909322508,0.06666666666666667,0.5284546447508339,1.0,7/40,9.85%,LAMC1;AKAP12;NES;ANK2;MAP1B;COL4A2;GJA1
prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,0.7404077207876294,1.3962003042829187,0.03896103896103896,0.5272943640828625,1.0,4/27,6.14%,PIK3R3;ITPR1;PRKCE;PIK3R1
prerank,Reactome_2022__Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,0.9055139419673734,1.396162261191819,0.07272727272727272,0.5258025543755542,1.0,3/5,8.50%,IL1RAPL1;PTPRD;PPFIA2
prerank,KEGG_2021_Human__Gastric cancer,0.7037993610634328,1.3961564336260097,0.05263157894736842,0.5240577585599313,1.0,10/41,13.89%,PIK3R3;WNT2B;PIK3R1;CTNNA3;GRB2;CDKN1B;CTNNA1;CDKN1A;SHC2;KRAS
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.6086199030104442,1.3958047253575965,0.04819277108433735,0.5251341578427527,1.0,29/91,23.03%,ERBB4;PSMC6;LRRC7;MAP3K5;GRIN2B;DUSP6;MBP;NRG2;FGFR1;PIK3R1;JAK1;RPS27A;GRB2;PEBP1;SHC2;KRAS;RASA1;SHOC2;PSMA7;SPRED1;PPP1CB;BCL2L1;TAOK1;ZFP36;YWHAB;SETX;YWHAE;UBC;MEF2C
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.6795743010981083,1.3956587378284968,0.06493506493506493,0.5242620122958165,1.0,4/28,6.35%,CCDC3;PCK1;PRKAG2;SIN3B
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.8739043780874542,1.3954120006375406,0.06153846153846154,0.5240282449372328,1.0,2/6,1.86%,MTHFD1L;PCK1
prerank,Reactome_2022__PI3K Events In ERBB2 Signaling R-HSA-1963642,0.8525046205831749,1.3952912012444683,0.045454545454545456,0.5230914660339949,1.0,5/8,8.95%,ERBB4;NRG2;PIK3R1;GRB2;NRG3
prerank,PanglaoDB_Augmented_2021__T Cells,0.7550602976663741,1.3946502574750697,0.05405405405405406,0.5256720654329248,1.0,3/16,3.75%,MAFF;JUNB;CD81
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.6781952643075262,1.3945430422549177,0.05714285714285714,0.5247360497765666,1.0,8/29,14.45%,ERBB4;NRG2;PIK3R1;HSP90AA1;GRB2;BCAR1;KIF16B;ERBIN
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Skin,0.6572433097113688,1.3944757926116393,0.05194805194805195,0.5233656585113058,1.0,6/43,9.27%,LAMC1;SERPINE1;RRBP1;PLSCR4;COL4A2;EMP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.8402959148280617,1.3944399840749604,0.05333333333333334,0.5220774994574775,1.0,2/9,3.90%,PNP;ANXA1
prerank,CellMarker_Augmented_2021__Preadipocyte Progenitor cell:Adipose Tissue,-0.561561156928107,-1.3941065539523292,0.029411764705882353,0.767029152490144,1.0,3/33,6.40%,VCAM1;ITIH5;PODN
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.7134572327536484,1.3936906661279826,0.04054054054054054,0.524955735921808,1.0,7/26,12.43%,SLC8A1;IPO7;PKIG;HYAL2;DUSP1;CDKN1B;STK38
prerank,Reactome_2022__Muscle Contraction R-HSA-397014,0.695640641399964,1.3936898289262112,0.05747126436781609,0.5232345695745234,1.0,22/48,22.87%,CLIC2;ITPR1;SLC8A1;KCNIP4;ANXA1;CACNA1C;PDE5A;TPM4;ATP2B1;ITGA1;MYL6;ATP1B3;ANXA2;DYSF;WWTR1;DMD;MYL12B;RYR3;ATP2B4;AHCYL1;CALD1;ATP1B1
prerank,CellMarker_Augmented_2021__Megakaryocyte-erythroid progenitor:Germ,-0.7124695875976782,-1.393590445752671,0.034482758620689655,0.757968409894569,1.0,6/13,14.42%,GBP4;CD74;GIMAP8;TNFRSF1B;RCSD1;GIMAP4
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Germ,-0.7124695875976782,-1.393590445752671,0.034482758620689655,0.757968409894569,1.0,6/13,14.42%,GBP4;CD74;GIMAP8;TNFRSF1B;RCSD1;GIMAP4
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood,-0.6097546636891016,-1.3935094183411099,0.038461538461538464,0.7526467116590284,1.0,5/35,1.83%,SAMD9L;GBP1;GBP4;XAF1;CD74
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.7052859676609377,1.3933239238098538,0.04,0.523408852078765,1.0,12/34,13.39%,GRIA2;CADM2;LSAMP;PTPRD;SGIP1;ROBO2;CACNA1C;NFASC;CPEB4;MAGI2;NRXN1;MAPK10
prerank,Reactome_2022__Acyl Chain Remodelling Of PS R-HSA-1482801,-0.8862833586308653,-1.3924585941819705,0.09090909090909091,0.7521114730741741,1.0,3/5,5.34%,PLA1A;PLA2G4A;PLAAT3
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.8387122457750668,1.3921313060823537,0.04918032786885246,0.5297579336517703,1.0,1/8,1.91%,PRKAG2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.8971108137609273,1.3920744828085787,0.037037037037037035,0.5281819376174045,1.0,1/6,0.53%,DDIT4
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Corneal Epithelium,0.7725333651184958,1.391931035241051,0.05714285714285714,0.5224054322808666,1.0,2/14,2.82%,CCDC3;NES
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Liver,0.7725333651184958,1.391931035241051,0.05714285714285714,0.5224054322808666,1.0,2/14,2.82%,CCDC3;NES
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Corneal Epithelium,0.7725333651184958,1.391931035241051,0.05714285714285714,0.5224054322808666,1.0,2/14,2.82%,CCDC3;NES
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Laryngeal Squamous Epithelium,0.7725333651184958,1.391931035241051,0.05714285714285714,0.5224054322808666,1.0,2/14,2.82%,CCDC3;NES
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.7950382252992272,1.3915132718497898,0.1076923076923077,0.5230389812826547,1.0,5/8,20.03%,TSG101;HYAL2;ZFYVE28;DUSP22;SH3BP5
prerank,Reactome_2022__Interleukin-7 Signaling R-HSA-1266695,0.9077315565304327,1.3910776195886676,0.046153846153846156,0.5241275435199986,1.0,3/8,7.09%,PIK3R3;PIK3R1;JAK1
prerank,CellMarker_Augmented_2021__Stem cell:Esophagus,0.6799379975476282,1.3904624087297959,0.04225352112676056,0.5261595761453688,1.0,10/40,10.78%,CCDC3;MAP2;CNTN1;NES;ANK2;MAP1B;PTPRD;NFASC;GJA1;BOC
prerank,Reactome_2022__Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,0.7671490348131373,1.3902514784709805,0.04225352112676056,0.5254068006130614,1.0,3/16,10.07%,ITPR1;RAPGEF3;RAP1A
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.8740638953515403,1.390162438064226,0.01639344262295082,0.5240991384271142,1.0,3/6,8.61%,PRNP;TMED10;PICALM
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Intestine,0.6554321898679228,1.3900829134479262,0.05555555555555555,0.5197400984426989,1.0,13/50,14.98%,LAMC1;PLS3;PLOD2;SCARB2;EPS8;MYO1B;CTNNA1;HIF1A;MYO1E;TBC1D9;REEP3;CTTNBP2NL;ALCAM
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gastrointestinal Tract,0.6554321898679228,1.3900829134479262,0.05555555555555555,0.5197400984426989,1.0,13/50,14.98%,LAMC1;PLS3;PLOD2;SCARB2;EPS8;MYO1B;CTNNA1;HIF1A;MYO1E;TBC1D9;REEP3;CTTNBP2NL;ALCAM
prerank,CellMarker_Augmented_2021__Mucous Acinar cell:Salivary Gland,0.6554321898679228,1.3900829134479262,0.05555555555555555,0.5197400984426989,1.0,13/50,14.98%,LAMC1;PLS3;PLOD2;SCARB2;EPS8;MYO1B;CTNNA1;HIF1A;MYO1E;TBC1D9;REEP3;CTTNBP2NL;ALCAM
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.7163549610167395,1.389533150743229,0.029411764705882353,0.5209533650484093,1.0,4/18,4.99%,BCAP31;CANX;CALR;SEC24D
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.9017866429095924,1.3887803462221935,0.037037037037037035,0.5240529727999624,1.0,1/5,0.24%,LAMC1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.8346925318996271,-1.3882339444714935,0.125,0.7618703343020481,1.0,2/8,3.27%,IFIH1;STAT1
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.8346925318996271,-1.3882339444714935,0.125,0.7618703343020481,1.0,2/8,3.27%,IFIH1;STAT1
prerank,KEGG_2021_Human__Rap1 signaling pathway,0.5955304645191423,1.3872589700221458,0.022988505747126436,0.5310810526650647,1.0,16/76,15.72%,PIK3R3;RAPGEF5;GRIN2B;RAPGEF3;FGFR1;PIK3R1;RAP1A;MAGI2;FLT1;BCAR1;DOCK4;ITGB1;KRAS;RAC1;ADCY2;CRK
prerank,Reactome_2022__Signaling By ERBB2 KD Mutants R-HSA-9664565,0.7908875931971964,1.3872327056231875,0.07246376811594203,0.529681464605504,1.0,6/13,8.95%,ERBB4;NRG2;PIK3R1;HSP90AA1;GRB2;NRG3
prerank,CellMarker_Augmented_2021__Podocyte:Renal Glomerulus,0.7994907476744689,1.3871276411398115,0.05970149253731343,0.5270781058857426,1.0,5/10,12.11%,EHD4;TUBB4B;SLC2A1;ANXA2;RPL8
prerank,CellMarker_Augmented_2021__Glomerular Epithelial cell:Renal Glomerulus,0.7994907476744689,1.3871276411398115,0.05970149253731343,0.5270781058857426,1.0,5/10,12.11%,EHD4;TUBB4B;SLC2A1;ANXA2;RPL8
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.8531725024983867,-1.3869607493528509,0.16666666666666666,0.7627427471781073,1.0,2/5,2.15%,RSAD2;IL15
prerank,Reactome_2022__Repression Of WNT Target Genes R-HSA-4641265,-0.8166455392386784,-1.3869175134686094,0.08571428571428572,0.7574705492191861,1.0,3/6,10.41%,TCF7L1;CTBP2;TLE4
prerank,Reactome_2022__NS1 Mediated Effects On Host Pathways R-HSA-168276,-0.6372868942396971,-1.3858706361695114,0.08,0.756759753007175,1.0,3/17,6.61%,EIF2AK2;ISG15;NUP214
prerank,Reactome_2022__tRNA Processing In Nucleus R-HSA-6784531,-0.7532131868375285,-1.3851420938298453,0.14285714285714285,0.7547333638829198,1.0,2/11,6.61%,RPP38;NUP214
prerank,Reactome_2022__Antigen processing-Cross Presentation R-HSA-1236975,0.6988184146857416,1.3850862619158744,0.09210526315789473,0.5374356328850904,1.0,4/30,8.07%,PSMC6;SEC22B;CALR;RPS27A
prerank,Reactome_2022__Role Of Phospholipids In Phagocytosis R-HSA-2029485,0.8502260625101637,1.3846447295970332,0.028985507246376812,0.538738077976019,1.0,3/10,6.14%,ITPR1;PRKCE;PIK3R1
prerank,CellMarker_Augmented_2021__Interneuron:Embryonic Prefrontal Cortex,0.8957465966395087,1.3845284954867298,0.04225352112676056,0.5380779193020389,1.0,4/7,8.55%,ERBB4;PLS3;LDHA;NRXN3
prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,0.7147720188716967,1.3840594991714061,0.0410958904109589,0.5394041238237793,1.0,1/31,0.03%,PIK3R3
prerank,KEGG_2021_Human__FoxO signaling pathway,0.6773172781658844,1.3833765756298921,0.04411764705882353,0.5420287312242535,1.0,10/53,8.82%,PIK3R3;BCL6;PCK1;PRKAG2;KLF2;S1PR1;ATG12;PIK3R1;GRB2;CDKN1B
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),-0.8360217791032396,-1.3826354647888945,0.07894736842105263,0.7612127411072104,1.0,3/6,15.96%,ATG10;SENP6;UBA2
prerank,CellMarker_Augmented_2021__Stem cell:Periodontal Ligament,0.8488470642133636,1.3822473780246625,0.041666666666666664,0.5477100475155188,1.0,5/8,14.98%,NES;KLF4;PECAM1;ITGB1;ALCAM
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.8938819065441381,1.382162654638961,0.03333333333333333,0.5465647225425042,1.0,3/6,8.45%,ADM;KCNMB4;ATP2B1
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.7623197472992896,1.3814549688989026,0.08450704225352113,0.5493103015684687,1.0,1/14,0.03%,PIK3R3
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.798468857166585,1.3814391898966019,0.07042253521126761,0.5477367650788122,1.0,3/10,12.01%,ADAMTS9;SMAD7;FOXF1
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.8830833085900878,1.3808561169222462,0.04411764705882353,0.5498025257240511,1.0,1/6,1.62%,WNT2B
prerank,Reactome_2022__Interleukin-2 Family Signaling R-HSA-451927,0.7851322258237808,1.3806683316695312,0.05333333333333334,0.5493226149855145,1.0,4/16,8.31%,PIK3R3;PIK3R1;JAK1;GRB2
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.7440884827336409,-1.380665327971671,0.06060606060606061,0.7657192243983453,1.0,5/9,13.78%,PLA1A;PLA2G4A;PLAAT3;OSBPL8;MBOAT2
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.8033709017049947,1.3803737717355578,0.0625,0.550157708306588,1.0,4/12,7.62%,PLS3;NEDD9;EPS8;MYO1B
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.9063807959375009,1.380308992299771,0.04838709677419355,0.5487310682602577,1.0,1/6,1.91%,PRKAG2
prerank,Reactome_2022__Signaling By ERBB2 In Cancer R-HSA-1227990,0.7868684321151844,1.3802787294168892,0.07462686567164178,0.5472475979273368,1.0,6/14,8.95%,ERBB4;NRG2;PIK3R1;HSP90AA1;GRB2;NRG3
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.7929960081394958,1.379755608642035,0.09090909090909091,0.54837406906658,1.0,5/13,9.56%,PLS3;NEDD9;EPS8;MYO1B;HSP90B1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.7826206906783699,1.3793273975296407,0.058823529411764705,0.5492345891753769,1.0,2/9,6.32%,SERPINE1;NFE2L2
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.653935219604405,1.3792678709936779,0.05128205128205128,0.5479889072140334,1.0,12/57,12.88%,RTN4;CHPT1;BCL6;SPOCK1;HYAL2;ESR2;CDKN1B;NRG3;GJA1;ADAM15;CDKN1A;BCAR1
prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,0.6438258812295735,1.3791149401874223,0.075,0.5478785856328059,1.0,6/49,11.24%,PIK3R3;PIK3R1;SLC2A1;HIF1A;ATP1A1;ATP1B3
prerank,CellMarker_Augmented_2021__Mast cell:Kidney,0.6709812443608825,1.378480976351861,0.1,0.5508542013407758,1.0,5/22,7.84%,NFKBIZ;CD9;TIMP3;BACE2;DLC1
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.8817762255984632,1.378414723455149,0.03076923076923077,0.5497748672914338,1.0,2/7,7.07%,MAFF;CBFB
prerank,CellMarker_Augmented_2021__Epithelial cell:Mammary Epithelium,0.9084204818315835,1.3772557405928634,0.041666666666666664,0.5558592892993162,1.0,1/5,4.17%,LAMA5
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.743922851115029,1.3771890628746046,0.06060606060606061,0.5548036373445343,1.0,5/15,8.31%,ERBB4;NRG2;PIK3R1;HSP90AA1;GRB2
prerank,CellMarker_Augmented_2021__T cell:Undefined,0.7933778189122068,1.3770858511433783,0.06349206349206349,0.553722264802769,1.0,3/11,10.46%,CD9;CD81;PECAM1
prerank,KEGG_2021_Human__Carbohydrate digestion and absorption,0.796623118069058,1.3765836405303054,0.0641025641025641,0.555276461440221,1.0,4/11,11.24%,PIK3R3;PIK3R1;ATP1A1;ATP1B3
prerank,CellMarker_Augmented_2021__Monocyte:Fetal Kidney,0.5745935970980227,1.3765195654913653,0.010638297872340425,0.5539471903538791,1.0,76/219,21.59%,PKM;ADM;ZEB2;RTN4;PNP;CHPT1;BCL6;SPOPL;KLF6;NFKBIZ;BNIP3L;TSC22D3;GLUL;ANXA1;LBR;PGK1;OGFRL1;CHSY1;DUSP6;JAK1;SERPINB6;JUND;SRGN;GRB2;DUSP1;ATP2B1;PICALM;KLF4;BRI3;LAMP2;AHNAK;HIF1A;GAS7;PECAM1;SLC2A3;ANXA2;ACAP2;IFNGR1;CDKN1A;PELI1;DENND3;ARPC2;CD55;TMEM59;S100A6;LRRFIP1;SLC16A6;RAC1;CCNL1;NCOR2;PSAP;LIMS1;ACTN1;PLXDC2;SDCBP;RTN3;ESYT2;BTG2;VMP1;LGALS3;MIDN;NAMPT;TMBIM6;NACC2;SULF2;CHMP4B;WIPF1;IFNGR2;SOCS3;SH3KBP1;BTG1;TNFRSF10B;PNRC1;MCL1;ATP13A3;ZFP36
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),-0.6893891453327136,-1.3765022514882785,0.08695652173913043,0.7818456297094243,1.0,3/14,3.37%,PLA1A;PLA2G4A;GPCPD1
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.8702026318412744,1.3764498880166602,0.05970149253731343,0.552877467143409,1.0,3/6,8.63%,PKM;JAK1;KLF4
prerank,Reactome_2022__SHC1 Events In ERBB4 Signaling R-HSA-1250347,0.9114361567254945,1.3757936636808576,0.01639344262295082,0.5551432823343537,1.0,4/5,8.95%,ERBB4;NRG2;GRB2;NRG3
prerank,Reactome_2022__Cardiac Conduction R-HSA-5576891,0.6947303012949363,1.3757206363836594,0.08641975308641975,0.5540449025297416,1.0,7/29,11.24%,CLIC2;ITPR1;SLC8A1;KCNIP4;CACNA1C;ATP2B1;ATP1B3
prerank,Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001,0.6224231023242779,1.3748849389904931,0.07058823529411765,0.5578250911961902,1.0,21/76,17.24%,ERBB4;PSMC6;LRRC7;GRIN2B;DUSP6;NRG2;FGFR1;PIK3R1;JAK1;RPS27A;GRB2;NRG3;VWF;RAP1A;PEBP1;SHC2;DUSP16;SHOC2;PSMA7;SPRED1;PPP1CB
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,-0.6148222237181827,-1.3748737147867205,0.10714285714285714,0.7821772161055253,1.0,7/27,9.72%,IL32;IL15;LEPR;BMP6;TNFSF10;ACVR1;TNFRSF1B
prerank,CellMarker_Augmented_2021__Megakaryocyte Erythroid cell:Undefined,0.8092562245120738,1.3742219964400857,0.06557377049180328,0.5605562422035472,1.0,3/10,10.46%,CD9;CD81;PECAM1
prerank,CellMarker_Augmented_2021__Endothelial cell:Undefined,-0.7352752694898076,-1.3741404790352463,0.07317073170731707,0.7798412876089058,1.0,1/11,0.16%,VCAM1
prerank,Reactome_2022__FOXO-mediated Transcription R-HSA-9614085,0.7229104715970506,1.37380921617419,0.04054054054054054,0.5616881228212114,1.0,6/26,11.87%,BCL6;PCK1;PINK1;KLF4;CDKN1B;CDKN1A
prerank,Reactome_2022__Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,0.8632525697223604,1.372752309898966,0.058823529411764705,0.5673664872027888,1.0,2/6,4.91%,LRRC7;GRIN2B
prerank,CellMarker_Augmented_2021__Stem cell:Fetal Liver,0.678721190048002,1.3719733968877235,0.1111111111111111,0.5705115155986501,1.0,8/27,9.85%,DOK5;NES;ANK2;MAP1B;PTPRD;FGFR1;COL4A2;GJA1
prerank,CellMarker_Augmented_2021__Ionocyte cell:Lung,0.6076746711666817,1.371864406189523,0.05813953488372093,0.5696043484799569,1.0,14/87,11.00%,MTHFD1L;ADM;KHDRBS3;PPP2R3A;PRKAG2;ANK2;CD9;SCARB2;DUSP6;BCR;CDKN1B;YTHDC1;TBC1D9;ATP1A1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.8621522842673617,-1.3718558976822177,0.037037037037037035,0.784657909711442,1.0,2/5,7.30%,TTN;PKD2
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.6798692612582291,1.3718482483194203,0.1111111111111111,0.5681493534843535,1.0,6/27,8.29%,ERBB4;FES;CD9;INPP5F;NRG2;CDK6
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.9127515483557171,1.3716472670186846,0.015625,0.567743791660191,1.0,2/5,1.91%,PDK4;PRKAG2
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.777327148351005,1.370962840703251,0.045454545454545456,0.5699062336378402,1.0,2/12,4.94%,SCP2;ACOX1
prerank,KEGG_2021_Human__Ras signaling pathway,0.6029398620312341,1.370668793137608,0.08333333333333333,0.569894066037477,1.0,17/76,15.27%,PIK3R3;RAPGEF5;GRIN2B;FGFR1;PIK3R1;REL;RASSF1;GRB2;RAP1A;FLT1;SHC2;MAPK10;KRAS;PAK2;RASA1;RAC1;SHOC2
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Adipose Tissue,0.6532724719529853,1.3701322072669335,0.04819277108433735,0.5716742378136636,1.0,15/47,22.20%,LAMC1;SERPINE1;PLOD2;MYO1B;SLC38A2;ANXA2;ANO6;ITGB1;REEP3;TRAM1;FNDC3B;VEGFC;EXT1;SERPINH1;CAV2
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.8142034832767212,1.3698219034910843,0.06557377049180328,0.5719602511386903,1.0,2/8,12.54%,TSG101;ZFYVE28
prerank,Reactome_2022__NF-kB Activation Thru FADD/RIP-1 Pathway Mediated By Caspase-8 And -10 R-HSA-933543,-0.89752030711374,-1.3694649980824418,0.03125,0.7896115182104849,1.0,3/6,7.22%,IFIH1;CASP10;TRIM25
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.7944071832364153,1.3693672503224037,0.02857142857142857,0.5732114884797573,1.0,7/13,14.98%,GRIA2;CTNND2;NFASC;SNAP25;ENPP2;NRXN1;ALCAM
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.8762817373105867,-1.3690329062961806,0.10526315789473684,0.786419668587091,1.0,1/5,0.16%,VCAM1
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.7283169528139265,1.3688294718844773,0.05555555555555555,0.5752694318589245,1.0,4/19,6.06%,SERPINE1;NFKBIZ;CD81;HYAL2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Adipose Tissue,-0.7318064364461543,-1.3687188204457688,0.08571428571428572,0.7824728508016602,1.0,1/11,0.16%,VCAM1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Endometrium,-0.572578239874147,-1.3683808793089924,0.15,0.7786773393143415,1.0,6/37,4.78%,SAMD9L;GBP1;DDX60;CD74;PARP14;DDX60L
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.7845623572119697,1.367234395512328,0.031746031746031744,0.5843475017548062,1.0,4/10,16.04%,TIMP3;PRNP;TMEM59;PLAT
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.9034133131837742,1.3668588997024538,0.03278688524590164,0.5854951808791898,1.0,1/5,1.67%,MAP2
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.8936179444236713,1.3667616972067558,0.08450704225352113,0.5844549787684697,1.0,1/5,1.25%,ATF3
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.7847690925485296,1.365931716441347,0.07352941176470588,0.5878912517094648,1.0,2/12,4.94%,SCP2;ACOX1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.7313980838662192,-1.365930060430671,0.15625,0.786491307022082,1.0,4/12,3.61%,IFIH1;ISG15;OAS3;IRF1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.6646629375740934,1.365902147069068,0.1,0.5865529435551076,1.0,2/33,0.88%,ST18;PSMC6
prerank,KEGG_2021_Human__ECM-receptor interaction,0.728547627761639,1.3658236635106473,0.10810810810810811,0.585458964081079,1.0,5/21,9.67%,LAMC1;LAMA5;COL4A2;ITGA1;VWF
prerank,Reactome_2022__ER-Phagosome Pathway R-HSA-1236974,0.7017427310114013,1.365802535489391,0.08571428571428572,0.583986442486997,1.0,4/27,8.07%,PSMC6;SEC22B;CALR;RPS27A
prerank,Reactome_2022__Nicotinamide Salvaging R-HSA-197264,-0.8462363061870177,-1.365781325074206,0.08571428571428572,0.777248148193486,1.0,3/5,4.25%,RNLS;PARP14;PARP9
prerank,Reactome_2022__Nicotinate Metabolism R-HSA-196807,-0.8462363061870177,-1.365781325074206,0.08571428571428572,0.777248148193486,1.0,3/5,4.25%,RNLS;PARP14;PARP9
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.7459009506615921,1.3654501970786324,0.11428571428571428,0.5847923910477821,1.0,3/10,9.91%,UFL1;CBFB;ZNF366
prerank,PanglaoDB_Augmented_2021__Podocytes,0.6078768776257313,1.3649752326704756,0.023255813953488372,0.586035222723634,1.0,21/88,18.91%,LAMC1;ADM;PLS3;EHD4;PLOD2;PLSCR4;MYO1B;SRGAP1;COL4A2;GJA1;MYO1E;TRIB2;MAGI2;BCAR1;WWTR1;FOXC1;NAV2;CADPS2;FZD4;PODXL;NFIB
prerank,Reactome_2022__Downregulation Of ERBB2 Signaling R-HSA-8863795,0.7564976815782112,1.3642960892604958,0.05970149253731343,0.5882981256785478,1.0,5/14,8.95%,ERBB4;NRG2;HSP90AA1;RPS27A;NRG3
prerank,CellMarker_Augmented_2021__Progenitor cell:Undefined,0.7821129243958483,1.3642899122683718,0.05714285714285714,0.5867458878799237,1.0,9/13,20.98%,HSPA5;CALR;GAPDH;HYAL2;HSP90B1;TXNRD1;ALCAM;NPM1;TNFRSF10B
prerank,CellMarker_Augmented_2021__Gonadal Mitotic Phase Fetal Germ cell:Fetal Gonad,0.6153331959756793,1.364226244695967,0.05555555555555555,0.5856103172348051,1.0,19/49,16.36%,DDIT4;PNP;WNT2B;HSPA5;CALR;CD9;CD81;UPP1;MBP;ALPL;RPL23;COL4A2;PEBP1;NSMAF;SLC25A16;EEF1A1;RPL13A;DMD;PLXNA2
prerank,Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996,0.6192869798715682,1.3633337471352593,0.07142857142857142,0.5896317275687151,1.0,21/79,17.24%,ERBB4;PSMC6;LRRC7;GRIN2B;DUSP6;NRG2;FGFR1;PIK3R1;JAK1;RPS27A;GRB2;NRG3;VWF;RAP1A;PEBP1;SHC2;DUSP16;SHOC2;PSMA7;SPRED1;PPP1CB
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.8141473803176498,1.3631134454629927,0.04285714285714286,0.589307265266715,1.0,2/14,2.71%,RTN4;SPOCK1
prerank,Reactome_2022__NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.7747149106437651,1.3626372662121695,0.08823529411764706,0.5907504375322798,1.0,5/17,8.39%,CACNA1C;FGFR1;PRNP;GRB2;COL4A2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.8510393628871139,1.3624650469185875,0.0625,0.5902226306815115,1.0,2/6,8.26%,SMAD7;RPL23
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.875685404816672,-1.3612631221702152,0.08333333333333333,0.7940369800783825,1.0,3/5,10.36%,PGM5;TTN;CFLAR
prerank,CellMarker_Augmented_2021__Platelet:Undefined,0.8353533174926513,1.3611915864138076,0.07017543859649122,0.5973870191929019,1.0,4/8,10.68%,CD9;LAMP2;PECAM1;LRRC32
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.850616145646122,1.3610968121888434,0.08064516129032258,0.5962989818899889,1.0,2/6,9.30%,PRKAG2;SLC2A1
prerank,Reactome_2022__N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,0.7138592614538855,1.360836763803624,0.09722222222222222,0.5961906884957999,1.0,4/17,8.07%,CANX;CALR;EDEM3;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.7686500873591615,1.360517614404358,0.09375,0.5969688333453184,1.0,3/15,6.91%,DOCK3;NEDD9;PRNP
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.8470575430071571,-1.3601561819738637,0.08571428571428572,0.7944587487191117,1.0,1/6,0.85%,MVB12B
prerank,Reactome_2022__Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,0.6663669321347714,1.3597679087957824,0.04285714285714286,0.6004792955005223,1.0,9/28,20.61%,CEP57;TUBB4B;HSP90AA1;CEP70;ALMS1;CSNK1D;DYNC1H1;PAFAH1B1;CEP290
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.8813207802511923,1.359710969757089,0.11864406779661017,0.5994797793237742,1.0,1/5,1.43%,SCP2
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.8767912819840431,1.3595523382504004,0.10344827586206896,0.5987973084380442,1.0,3/6,3.80%,RIMKLB;GLUD1;GLUL
prerank,KEGG_2021_Human__Platelet activation,0.6254216184214196,1.3592588690935283,0.09411764705882353,0.599362867265349,1.0,6/46,10.86%,PIK3R3;ITPR1;PIK3R1;VWF;RAP1A;GNA13
prerank,KEGG_2021_Human__Apoptosis,0.6756063661268594,1.3591796876710323,0.05194805194805195,0.5983173953614556,1.0,9/42,14.26%,PIK3R3;ITPR1;MAP3K5;PIK3R1;JUN;FOS;MAPK10;KRAS;TUBA1B
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.7016669079311952,1.3584284507518403,0.039473684210526314,0.6013577618204822,1.0,6/27,9.83%,PSMC6;ATF3;KLF2;NFE2L2;RPS27A;HIF1A
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.6568898499493655,1.3581856039404157,0.02666666666666667,0.6012107843211192,1.0,11/38,17.05%,ERBB4;FES;INPP5F;NRG2;ENPP2;CDK6;PRAG1;RAC1;CRK;PLXNA2;PRKX
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.7834292116691173,-1.3577295521992805,0.1891891891891892,0.8009708858384201,1.0,3/6,14.71%,RC3H1;ZC3HAV1;PNPT1
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.7105479699641687,1.3574740929036606,0.1111111111111111,0.6041724899230468,1.0,8/23,12.30%,DDIT4;MAP3K5;GRIN2B;PRNP;PICALM;REST;FOS;BTBD10
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.670065239352007,-1.3570574519160332,0.19444444444444445,0.7993086027380842,1.0,2/12,5.87%,GBP1;ZDHHC2
prerank,CellMarker_Augmented_2021__Chondrocyte:Cartilage,0.7030137524853077,1.355687221952341,0.07042253521126761,0.6153024542087575,1.0,7/29,10.78%,NES;ANK2;MAP1B;FGFR1;COL4A2;GJA1;BOC
prerank,Reactome_2022__MET Activates PTK2 Signaling R-HSA-8874081,0.8505587965628139,1.3549423102373757,0.06153846153846154,0.6180745768334857,1.0,2/9,4.17%,LAMC1;LAMA5
prerank,Reactome_2022__MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,0.8089384267797409,1.3549360464488545,0.07352941176470588,0.6166088845765103,1.0,4/10,11.31%,GRIA2;GRIN2B;FKBP5;SLC2A3
prerank,CellMarker_Augmented_2021__Trophoblast cell:Placenta,0.6986113847393062,1.354873387102505,0.02564102564102564,0.6154554349719062,1.0,15/31,22.20%,SERPINE1;ANXA1;ARHGAP23;COL4A2;EMP1;ANXA2;ITGB1;WWTR1;TUBB6;PLAT;AFAP1L1;VEGFC;EXT1;SERPINH1;CAV2
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Blood,-0.7453893607496536,-1.3547894892274848,0.12903225806451613,0.8061785634357738,1.0,2/14,4.65%,VCAM1;ABCG2
prerank,CellMarker_Augmented_2021__Stromal cell:Undefined,-0.7862131660700362,-1.354740439627178,0.14705882352941177,0.8013268676073506,1.0,1/7,0.16%,VCAM1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.884178049637754,1.3543368484671658,0.09859154929577464,0.6173216259528084,1.0,3/5,11.08%,PKM;YBX3;CNBP
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.8656798095049154,1.3540547537538201,0.10294117647058823,0.6175236385556795,1.0,3/7,9.83%,NFE2L2;PINK1;HIF1A
prerank,KEGG_2021_Human__Phospholipase D signaling pathway,0.6252689348872239,1.3538196697310634,0.06493506493506493,0.6174495173797081,1.0,13/57,15.80%,PIK3R3;GRM7;ARF1;RAPGEF3;PIK3R1;GRB2;GNA13;SHC2;KRAS;DGKI;PLPP1;ADCY2;AGPAT4
prerank,Reactome_2022__Laminin Interactions R-HSA-3000157,0.802892259899524,1.3535257364654047,0.1044776119402985,0.6176227683355509,1.0,3/12,8.71%,LAMC1;LAMA5;ITGA1
prerank,Reactome_2022__Developmental Biology R-HSA-1266738,0.55617689913947,1.3533949823476392,0.02040816326530612,0.61697384604469,1.0,55/302,15.64%,PIK3R3;LAMC1;NRCAM;ANGPTL4;PSMC6;PCK1;DOK5;CNTN1;FES;KAZN;ANK2;RPS11;MYO9B;GRIN2B;ROBO2;CACNA1C;ZFPM2;NFASC;FGFR1;PIK3R1;RPS9;PRNP;CBFB;HSP90AA1;SRGAP1;RPS27A;RPL23;GRB2;COL4A2;KLF4;ITGA1;ANK3;CTNNA1;JUN;UNC5C;MYL6;BOC;MYH10;CCNC;CDKN1A;RPL8;RPL34;RPL37;RPLP2;ARPC2;ACVR2A;PRX;ITGB1;PIAS2;GRB10;WWTR1;RPL13A;ALCAM;RPS12;NCOR2
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.8054646394920144,-1.3532980791601235,0.17073170731707318,0.7975261570153245,1.0,4/5,19.36%,HIBCH;ACAT1;HIBADH;AUH
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.8054646394920144,-1.3532980791601235,0.17073170731707318,0.7975261570153245,1.0,4/5,19.36%,HIBCH;ACAT1;HIBADH;AUH
prerank,KEGG_2021_Human__Human cytomegalovirus infection,0.6052439264454768,1.3529663557211495,0.075,0.6176389919936986,1.0,15/84,15.91%,PIK3R3;ITPR1;CALR;PIK3R1;JAK1;CDK6;GRB2;GNA13;CDKN1A;BCAR1;KRAS;RAC1;ADCY2;CRK;ATF2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.8740261772802509,1.3527074504782952,0.014492753623188406,0.6175380731334499,1.0,2/7,4.01%,MAP2;MAP1B
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.703318445664938,1.3524418464173662,0.0958904109589041,0.6173561211149171,1.0,12/29,11.58%,GRIA2;CNTN1;ANK2;MAP1B;GPM6B;LSAMP;PTPRD;ROBO2;NFASC;SNAP25;MAGI2;NRXN1
prerank,CellMarker_Augmented_2021__Astrocyte:Brain,0.6600835055870942,1.3517333535995129,0.06578947368421052,0.6203739807797995,1.0,19/50,17.61%,DTNA;ATF3;DOK5;SPOCK1;JUNB;GLUL;TIMP3;GRAMD2B;JUND;MT2A;JUN;HIF1A;FOS;PON2;TNS1;PSAP;SLC1A2;NHSL1;BTG2
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.6819589646522115,-1.351456647813207,0.13513513513513514,0.8003395161581699,1.0,5/11,14.42%,GBP2;GIMAP8;TNFRSF1B;HLA-F;GIMAP4
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.8566723329949026,1.3513992361869323,0.09722222222222222,0.6205646069054757,1.0,2/8,5.13%,PDK4;SCARB2
prerank,Reactome_2022__Nuclear Signaling By ERBB4 R-HSA-1251985,0.7641295353314117,1.3509270632632542,0.08064516129032258,0.6221841175868399,1.0,4/13,13.31%,ERBB4;NRG2;NRG3;TAB2
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.8589159585763084,-1.3508522883016563,0.11363636363636363,0.7985139466533961,1.0,1/6,0.16%,VCAM1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.8648866473433168,1.350831578021156,0.058823529411764705,0.6212122041347737,1.0,2/6,4.36%,SERPINE1;INPP5F
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.809716107237779,1.3500455020757,0.11428571428571428,0.6247552842413583,1.0,2/8,4.33%,B3GNT2;GPC5
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,0.6154422601133104,1.3500416287366055,0.08333333333333333,0.6232462135064758,1.0,15/73,14.74%,PIK3R3;ITPR1;PIK3R1;CLEC2B;JAK1;RPS27A;CDK6;JUN;HIF1A;IFNGR1;CDKN1A;FOS;MAPK10;KRAS;RAC1
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Undefined,-0.7396892891660435,-1.350018317255451,0.15151515151515152,0.7973449010705483,1.0,3/12,6.40%,VCAM1;LIMS2;PODN
prerank,CellMarker_Augmented_2021__Luteinizing Granulosa cell:Ovarian Follicle,0.7797363009305064,1.3499930900541226,0.1111111111111111,0.6219581559079883,1.0,6/13,16.18%,ERBB4;CTNNA3;MAGI2;NRXN1;MTUS2;DMD
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.8610633299901342,1.349825257283854,0.04918032786885246,0.6216624644142311,1.0,2/6,2.52%,TSG101;TRIM5
prerank,Reactome_2022__VEGFR2 Mediated Cell Proliferation R-HSA-5218921,0.8334558172766342,1.3497130017600123,0.046875,0.6208895815180412,1.0,1/7,1.35%,ITPR1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex7:Brain,0.6670350735244539,1.3497019048917687,0.05263157894736842,0.6194307255545214,1.0,11/34,11.58%,DOK5;ANK2;MAP1B;LSAMP;PTPRD;ROBO2;CACNA1C;NFASC;BOC;MAGI2;NRXN1
prerank,Reactome_2022__Resolution Of D-Loop Structures R-HSA-5693537,-0.819279313274421,-1.349641246312041,0.16129032258064516,0.789452398576977,1.0,2/5,7.92%,ATM;RAD51B
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,-0.819279313274421,-1.349641246312041,0.16129032258064516,0.789452398576977,1.0,2/5,7.92%,ATM;RAD51B
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.7969831823672391,-1.3495066687936426,0.14705882352941177,0.7852428300434366,1.0,1/8,0.16%,VCAM1
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.7138339640621278,1.3487680347313746,0.12698412698412698,0.6238799712781578,1.0,6/16,6.67%,RTN4;GRIA2;MAP2;CADM2;GRIN2B;SNAP25
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.8049154807545058,1.3485475221946681,0.08955223880597014,0.6236881181312386,1.0,4/10,11.58%,IL1RAPL1;PTPRD;ROBO2;NRXN1
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Peripheral Blood,0.7998401626344812,1.3484101932407435,0.08695652173913043,0.6230757877539759,1.0,2/9,8.71%,CD81;ITGA1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.6665612865850878,1.3480573350299077,0.04878048780487805,0.6241741941790713,1.0,8/42,8.63%,SERPINE1;BCL6;NFKBIZ;MGLL;ANXA1;UFL1;HYAL2;KLF4
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.822928979135371,1.3477527604138777,0.10144927536231885,0.6240616429301195,1.0,4/8,17.21%,GRB2;ERBIN;SHOC2;TGM2
prerank,KEGG_2021_Human__Chemokine signaling pathway,0.6302127091866875,1.3476342018004097,0.0625,0.6234527641243967,1.0,13/58,18.57%,PIK3R3;PIK3R1;GRB2;RAP1A;BCAR1;SHC2;KRAS;RAC1;ADCY2;CRK;GRK5;PXN;STAT3
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood,-0.5500491086029111,-1.3476067457525471,0.043478260869565216,0.7890907842007393,1.0,7/42,8.92%,VCAM1;CD74;MMRN1;CLIC5;ITIH5;GIMAP8;PROM1
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.6839157580807744,1.3469548152015494,0.12987012987012986,0.6259513314853985,1.0,8/29,15.25%,LAMC1;PLS3;TBX3;TIMP3;COL4A2;BOC;WWTR1;FOXC1
prerank,Reactome_2022__PI3K Events In ERBB4 Signaling R-HSA-1250342,0.9092271378354834,1.3468308228425847,0.03125,0.6250805986453762,1.0,4/5,8.95%,ERBB4;NRG2;PIK3R1;NRG3
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.6670475405969568,1.3461658056308368,0.056338028169014086,0.6277973513217364,1.0,11/31,18.65%,SPNS2;VAPB;ENPP2;KDSR;SAMD8;NSMAF;SERINC1;PLPP1;PSAP;ESYT2;ST6GALNAC3
prerank,CellMarker_Augmented_2021__AXL+SIGLEC6+ Dendritic cell:Blood,0.699509122903321,1.3461329635555395,0.08955223880597014,0.6265377834684944,1.0,8/20,13.84%,BHLHE40;MGLL;NDRG1;KLF4;MYO1E;TBC1D9;CDKN1A;SLC20A1
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.7459905768736506,1.3460656624836886,0.1,0.6255166986796057,1.0,6/15,10.07%,ITPR1;CACNA1C;RAPGEF3;SNAP25;SLC2A1;RAP1A
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.8912666106146867,1.3460535841486412,0.09836065573770492,0.6241393653484911,1.0,1/5,0.69%,SERPINE1
prerank,Reactome_2022__RHOC GTPase Cycle R-HSA-9013106,0.6545852592692305,1.3459878339250175,0.09210526315789473,0.6232829379152832,1.0,7/40,7.84%,PKN3;VAPB;LBR;MYO9B;PIK3R1;ARHGAP21;DLC1
prerank,CellMarker_Augmented_2021__Myotube:Muscle,-0.7554919354323342,-1.3446383407281524,0.15789473684210525,0.79702770316719,1.0,3/5,13.36%,TTN;ZNF106;RCSD1
prerank,Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149,0.6255939097903656,1.3444975314555303,0.043010752688172046,0.6316959655739113,1.0,10/81,8.10%,PIK3R3;DOCK3;ARHGAP23;LBR;MYO9B;PIK3R1;ARHGAP21;SRGAP1;DLC1;ARHGEF4
prerank,Reactome_2022__NCAM1 Interactions R-HSA-419037,0.8529686192219947,1.344206975248337,0.13846153846153847,0.632644132267914,1.0,3/6,8.39%,CACNA1C;PRNP;COL4A2
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.8103812662125105,-1.3441099253950828,0.1282051282051282,0.7942468553828602,1.0,2/5,9.00%,ATG10;UGCG
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.6621181625889658,1.3440416054201465,0.07352941176470588,0.6323360824113174,1.0,8/38,8.31%,RTN4;ERBB4;NRG2;FGFR1;PIK3R1;PINK1;HSP90AA1;GRB2
prerank,CellMarker_Augmented_2021__Mitotic Fetal Germ cell:Fetal Gonad,0.5723033793492139,1.344013405413257,0.010526315789473684,0.6311628171102215,1.0,59/173,22.12%,PKM;DDIT4;PNP;AKAP12;LDHA;SCP2;WNT2B;FES;GLUD1;CD9;CD81;UPP1;SYTL4;MBP;RPS18;ALPL;SRGAP1;TPM4;RPL23;COL4A2;KLF4;CRIP2;OGT;SLC2A1;RAD21;MYL6;NSMAF;SLC25A16;RPL8;RPL34;RPL37;EEF1A1;RPL13A;TUBB6;MGAT5;DMD;PSAP;ACTN1;SDCBP;RSU1;ZMIZ1;PODXL;CARHSP1;STAT3;ST6GALNAC3;ESAM;TEC;NPM1;GSN;DPYSL2;ELK3;PMM2;ACTB;MCL1;SERPINH1;ANXA3;GPRC5B;YWHAB;CALD1
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.7367860865885988,1.343920464676026,0.1111111111111111,0.6304272557991194,1.0,6/19,18.65%,ADAMTS9;MGAT4A;HIF1A;GOLPH3;FUT8;ST6GALNAC3
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.8340610116599594,-1.3438814190360164,0.06976744186046512,0.7724901796431105,1.0,3/5,12.91%,HLA-F;HLA-C;HLA-A
prerank,KEGG_2021_Human__Graft-versus-host disease,-0.8340610116599594,-1.3438814190360164,0.06976744186046512,0.7724901796431105,1.0,3/5,12.91%,HLA-F;HLA-C;HLA-A
prerank,KEGG_2021_Human__Autoimmune thyroid disease,-0.8340610116599594,-1.3438814190360164,0.06976744186046512,0.7724901796431105,1.0,3/5,12.91%,HLA-F;HLA-C;HLA-A
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.8340610116599594,-1.3438814190360164,0.06976744186046512,0.7724901796431105,1.0,3/5,12.91%,HLA-F;HLA-C;HLA-A
prerank,KEGG_2021_Human__Allograft rejection,-0.8340610116599594,-1.3438814190360164,0.06976744186046512,0.7724901796431105,1.0,3/5,12.91%,HLA-F;HLA-C;HLA-A
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.804302973539141,1.3438138176666918,0.07246376811594203,0.6282320863587193,1.0,3/13,8.23%,ATG12;PINK1;RB1CC1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.804302973539141,1.3438138176666918,0.07246376811594203,0.6282320863587193,1.0,3/13,8.23%,ATG12;PINK1;RB1CC1
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.5699091480568109,1.3435167385085718,0.03488372093023256,0.6284932475455426,1.0,31/120,21.70%,PKM;PNP;LRRC7;NFASC;SNAP25;TUBB4B;DNAJC5;HSP90AA1;SERPINB6;BRI3;LAMP2;RAP1A;PECAM1;SLC2A3;ANXA2;ANO6;EEF1A1;CD55;RAC1;PSAP;SDCBP;LGALS3;DYNC1H1;KMT2E;CAB39;GSN;HSPA8;CEP290;DNAJC13;ANXA3;B4GALT1
prerank,KEGG_2021_Human__Pathways in cancer,0.5615893710903709,1.3429600848555758,0.022222222222222223,0.6305675870706257,1.0,34/164,15.72%,PIK3R3;LAMC1;WNT2B;LAMA5;BCR;FGFR1;PIK3R1;NFE2L2;ESR2;JAK1;HSP90AA1;CTNNA3;RASSF1;CDK6;GRB2;COL4A2;CDKN1B;SLC2A1;JAG2;CTNNA1;HSP90B1;JUN;HIF1A;GNA13;IFNGR1;CDKN1A;FOS;MAPK10;ITGB1;KRAS;TXNRD1;RAC1;ADCY2;CRK
prerank,Reactome_2022__Degradation Of Extracellular Matrix R-HSA-1474228,0.7302304895114526,1.342703618919413,0.09333333333333334,0.6307468407985238,1.0,3/19,4.17%,LAMC1;ADAMTS9;LAMA5
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.7308441379644359,1.342639093707779,0.10606060606060606,0.6298466071408402,1.0,9/20,17.29%,SYN3;GLUL;SNAP25;DNAJC5;PPFIA2;SLC38A2;NRXN1;SYT1;SLC1A2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.682166026693755,1.3426015783802658,0.0945945945945946,0.6285750047152415,1.0,3/27,3.43%,PSMC6;SEC22B;CALR
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.6980447143067479,1.3425633257688065,0.11392405063291139,0.6272591852340521,1.0,5/23,9.16%,LAMC1;ATRNL1;LAMA5;PIK3R1;MICALL2
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.6942772220436285,1.3421363051825201,0.05970149253731343,0.6283661683356487,1.0,5/18,13.47%,SPOPL;KLF2;SSH1;KLF4;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.742361315925099,1.342024564868425,0.16417910447761194,0.6278025330211526,1.0,4/15,14.08%,SERPINE1;DLC1;ADAM15;RASA1
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.6536055900605915,1.3419923036317956,0.043478260869565216,0.6265468824609279,1.0,15/47,17.10%,RTN4;ERBB4;HYAL2;NRG2;FGFR1;PIK3R1;PINK1;HSP90AA1;GRB2;PHLPP1;MAGI2;ITGB1;RAC1;MTDH;DAG1
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.7192207643210584,1.3418080867685147,0.07792207792207792,0.6262620690949549,1.0,7/25,11.24%,ITPR1;SLC8A1;ANK2;SMAD7;ATP2B1;ATP1A1;ATP1B3
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.7425098473787594,1.3417957983026725,0.08,0.6249413592891762,1.0,4/17,17.21%,BHLHE40;SPEN;REST;TGM2
prerank,Reactome_2022__Signaling By NTRK3 (TRKC) R-HSA-9034015,0.9056052646640113,1.3414834374897993,0.06666666666666667,0.6258687165887049,1.0,2/5,8.31%,PIK3R1;GRB2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.6838766966260315,1.3414594788805698,0.0945945945945946,0.6246776602551029,1.0,3/26,3.43%,PSMC6;SEC22B;CALR
prerank,CellMarker_Augmented_2021__Mucosal-associated Invariant T cell:Liver,0.7420186686432956,1.3411910804824207,0.11594202898550725,0.6250618264740252,1.0,5/18,11.85%,PNP;SLC4A10;PRNP;DUSP1;IFNGR1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.7170683559898411,1.3411482927144587,0.07792207792207792,0.6239757153012379,1.0,6/18,16.12%,ADM;S1PR1;GNA13;ADGRG1;ADCY2;ADGRB3
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.6589282817221102,1.3411163838726867,0.06944444444444445,0.6229676560858203,1.0,5/35,7.36%,DDIT4;RAPGEF3;SMAD7;PINK1;HSP90AA1
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.8172697861796187,1.340677640812212,0.11267605633802817,0.6248639111158475,1.0,3/10,10.17%,SUN2;MYO1B;MYO1E
prerank,CellMarker_Augmented_2021__Medullary Thymus Epithelial cell:Thymus,0.7736814935903638,1.3401237609743653,0.09859154929577464,0.6255744979487812,1.0,2/13,7.30%,B3GNT2;ACSL5
prerank,CellMarker_Augmented_2021__Cortical Thymus Epithelial cell:Thymus,0.7736814935903638,1.3401237609743653,0.09859154929577464,0.6255744979487812,1.0,2/13,7.30%,B3GNT2;ACSL5
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.8902935626420826,1.339888774735941,0.05970149253731343,0.62320604035877,1.0,2/6,7.84%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.8902935626420826,1.339888774735941,0.05970149253731343,0.62320604035877,1.0,2/6,7.84%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.8902935626420826,1.339888774735941,0.05970149253731343,0.62320604035877,1.0,2/6,7.84%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.836340933429114,1.3398768742582758,0.078125,0.621902286643314,1.0,1/8,0.72%,ERBB4
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.6888356164137133,1.3392031189045723,0.12857142857142856,0.6246840991568257,1.0,5/18,11.37%,SERPINE1;SGIP1;RAB21;MAGI2;ANXA2
prerank,Reactome_2022__Post-translational Protein Phosphorylation R-HSA-8957275,0.6672319918114307,1.3391747903169353,0.09876543209876543,0.6221348718600306,1.0,3/29,9.56%,LAMC1;MGAT4A;HSP90B1
prerank,Reactome_2022__Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,0.6672319918114307,1.3391747903169353,0.09876543209876543,0.6221348718600306,1.0,3/29,9.56%,LAMC1;MGAT4A;HSP90B1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.8180505545781431,1.3391275367258664,0.07017543859649122,0.6209638603535949,1.0,1/6,0.66%,PNP
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.6738153425439467,1.3387264293059835,0.14285714285714285,0.6222248155364815,1.0,5/36,8.23%,PRKAG2;BNIP3L;GAPDH;PINK1;RB1CC1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Brown Adipose Tissue,0.6517132885235871,1.3386460574405183,0.04054054054054054,0.6212248245882982,1.0,9/54,8.84%,ERBB4;ADAMTS9;DTNA;ANK2;MAP1B;PTPRD;LRP1B;CTNNA3;PPP1R9A
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.853169616473695,1.3385305156406737,0.03076923076923077,0.6207977116578479,1.0,3/5,12.40%,SERPINE1;DUSP1;ANO6
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.7780953752665576,1.3383356679215186,0.09333333333333334,0.6208216055769278,1.0,2/13,3.64%,ERBB4;CCDC60
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.8477922039596859,1.3382657692314646,0.08333333333333333,0.6199489383024422,1.0,3/7,11.87%,IPO7;CDKN1B;CDKN1A
prerank,Reactome_2022__RHOG GTPase Cycle R-HSA-9013408,0.6907798656429872,1.3381898648554567,0.038461538461538464,0.6190564356686834,1.0,8/31,14.45%,DOCK3;VAPB;LBR;PIK3R1;ARHGAP21;DOCK4;ITGB1;ERBIN
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Peripheral Blood,0.6260978130570294,1.3379109185142897,0.0975609756097561,0.6197885992005499,1.0,15/41,22.34%,SERPINE1;PLSCR4;MSRB3;EMP1;VWF;LRRC32;CFH;ITGB1;TNS1;AFAP1L1;TGM2;GSN;EPAS1;CDH5;SPARC
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.8549061464562107,1.3372557074376352,0.16393442622950818,0.6222757729447728,1.0,3/5,8.63%,KLF2;NFE2L2;KLF4
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.7379822787639723,-1.3370350859776208,0.06896551724137931,0.7968080455391984,1.0,4/10,14.82%,TENT2;PARN;LARP1;CIRBP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.7564526788004143,1.3367344880454557,0.03389830508474576,0.6234892864761382,1.0,2/11,3.43%,SERPINE1;CALR
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),0.5703498561878511,1.3362822248442676,0.03488372093023256,0.6240841105871949,1.0,30/118,21.70%,PKM;PNP;LRRC7;NFASC;SNAP25;TUBB4B;DNAJC5;HSP90AA1;SERPINB6;BRI3;LAMP2;RAP1A;PECAM1;SLC2A3;ANXA2;ANO6;EEF1A1;CD55;RAC1;PSAP;SDCBP;LGALS3;DYNC1H1;CAB39;GSN;HSPA8;CEP290;DNAJC13;ANXA3;B4GALT1
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),0.5703498561878511,1.3362822248442676,0.03488372093023256,0.6240841105871949,1.0,30/118,21.70%,PKM;PNP;LRRC7;NFASC;SNAP25;TUBB4B;DNAJC5;HSP90AA1;SERPINB6;BRI3;LAMP2;RAP1A;PECAM1;SLC2A3;ANXA2;ANO6;EEF1A1;CD55;RAC1;PSAP;SDCBP;LGALS3;DYNC1H1;CAB39;GSN;HSPA8;CEP290;DNAJC13;ANXA3;B4GALT1
prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,0.626616769711506,1.3359690093249537,0.05333333333333334,0.6245888556882881,1.0,16/61,9.93%,HSPA5;BCAP31;CANX;RRBP1;MAP3K5;CALR;HSPH1;EDEM3;SEC24D;NFE2L2;ERO1A;DNAJC5;HSP90AA1;UBE2J1;HSP90B1;NPLOC4
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.784758456090524,1.335920428636792,0.14492753623188406,0.6235837351825975,1.0,4/9,14.74%,PDK4;PRKAG2;NOS1AP;RAC1
prerank,Reactome_2022__RHOA GTPase Cycle R-HSA-8980692,0.6320567171803408,1.3357328869276666,0.03571428571428571,0.6232078016032415,1.0,17/67,18.80%,BCAP31;PKN3;ARHGAP23;VAPB;LBR;MYO9B;PIK3R1;ARHGAP21;SRGAP1;DLC1;ARHGEF4;ECT2;ERBIN;PCDH7;ARHGEF2;KALRN;FAM13A
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.7627911137601137,-1.3353939911959973,0.1935483870967742,0.7995983808783559,1.0,4/10,9.93%,COL8A1;RTF1;LAMA3;FN1
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.7335017999365276,-1.335369345025901,0.16666666666666666,0.795298430319751,1.0,1/8,1.01%,CARMIL1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.6925823458591746,1.33530346665408,0.1044776119402985,0.6243580053692314,1.0,5/21,11.87%,MAP2;NES;KDM1A;ADAM15;CDKN1A
prerank,"KEGG_2021_Human__Alanine, aspartate and glutamate metabolism",0.8688675134000434,1.3352920701056987,0.12962962962962962,0.6230830153139248,1.0,3/6,3.80%,RIMKLB;GLUD1;GLUL
prerank,CellMarker_Augmented_2021__Hepatocyte:Fetal Liver,0.6514081677000971,1.3352059645545562,0.0641025641025641,0.6222733898964734,1.0,7/32,16.10%,PLS3;LAMA5;PLOD2;MYO1B;BCAR1;WWTR1;SEMA3F
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.7814032918730242,1.335068096163462,0.13432835820895522,0.6219032825688846,1.0,4/11,11.87%,TBX3;CALR;SMC6;CDKN1A
prerank,Reactome_2022__NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,0.8044324852891553,1.3349142252130353,0.07352941176470588,0.6213514353746036,1.0,4/9,9.61%,CNTN1;RPS27A;JAG2;MIB1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Amniotic Membrane,0.653657076783086,1.3347771805340973,0.029850746268656716,0.6196385656495451,1.0,7/30,16.04%,SERPINE1;TIMP3;PLSCR4;COL4A2;EMP1;ALCAM;PLAT
prerank,CellMarker_Augmented_2021__Dental Pulp cell:Dental Pulp,0.653657076783086,1.3347771805340973,0.029850746268656716,0.6196385656495451,1.0,7/30,16.04%,SERPINE1;TIMP3;PLSCR4;COL4A2;EMP1;ALCAM;PLAT
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.7033605347438093,1.3347069402742886,0.017241379310344827,0.6187760227997555,1.0,6/18,16.12%,GRIA2;DPP10;SNAP25;MTUS2;BTBD10;ADGRB3
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.8495721150856479,1.334692674599689,0.08064516129032258,0.616335939179035,1.0,1/6,7.30%,ACSL5
prerank,Reactome_2022__Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,0.8495721150856479,1.334692674599689,0.08064516129032258,0.616335939179035,1.0,1/6,7.30%,ACSL5
prerank,KEGG_2021_Human__Viral carcinogenesis,0.6286524156191423,1.334627960925283,0.07228915662650602,0.6155985579595591,1.0,17/64,17.50%,PIK3R3;PKM;PIK3R1;REL;JAK1;CDK6;GRB2;CDKN1B;JUN;CDKN1A;KRAS;RAC1;ATF2;SND1;ACTN1;HDAC7;PXN
prerank,CellMarker_Augmented_2021__Oligodendrocyte Precursor cell:Brain,0.6269514815848408,1.3346070861949293,0.08860759493670886,0.6145254495118495,1.0,18/39,17.29%,GRIA2;CADM2;ANK2;GPM6B;LSAMP;NPAS3;PTPRD;GRIN2B;ROBO2;NFASC;PPFIA2;LRRC4C;MAGI2;NRXN1;MAPK10;ADCY2;ADGRB3;SLC1A2
prerank,Reactome_2022__Gluconeogenesis R-HSA-70263,0.8715340648345054,1.3345653577531207,0.0967741935483871,0.6137271371659628,1.0,2/5,4.75%,PCK1;PGK1
prerank,CellMarker_Augmented_2021__Liver Progenitor cell:Fetal Liver,0.6599237968646078,1.3332282691303348,0.125,0.6196117252022761,1.0,9/32,17.10%,NES;LAMA5;MYO1B;COL4A2;GJA1;BOC;BCAR1;SEMA3F;DAG1
prerank,CellMarker_Augmented_2021__Mesoderm cell:Germ,-0.8258478160906912,-1.33291291168657,0.09090909090909091,0.8017214769037905,1.0,1/6,0.16%,VCAM1
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.6884027343787833,1.3328868381203471,0.08196721311475409,0.6200857090278625,1.0,7/21,14.74%,SERPINE1;ARF1;SGIP1;RAB21;PICALM;HIP1R;RAC1
prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,0.6334478168914035,1.3328510160263198,0.04819277108433735,0.6189674080653832,1.0,10/42,15.72%,PIK3R3;PIK3R1;CTNNA3;CTNNA1;BCAR1;SHC2;ARPC2;ITGB1;RAC1;CRK
prerank,CellMarker_Augmented_2021__CD4+ Cytotoxic T cell:Liver,0.7182083502435164,1.3327260253151982,0.10810810810810811,0.6184795399403934,1.0,12/24,17.50%,ZEB2;SUN2;GLUL;MBP;RASSF1;SLC2A1;AHNAK;DSTN;ADGRG1;AGPAT4;TMEM181;PXN
prerank,KEGG_2021_Human__Human papillomavirus infection,0.6004416816528978,1.3324162525297978,0.056179775280898875,0.6189752501695047,1.0,16/112,9.67%,PIK3R3;PKM;LAMC1;PPP2R3A;WNT2B;BCAP31;PPP2R2B;LAMA5;PIK3R1;JAK1;CDK6;GRB2;COL4A2;ITGA1;CDKN1B;VWF
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.8197312616927599,1.3318872235805874,0.10909090909090909,0.6205822013983763,1.0,2/8,4.20%,HSPA5;VAPB
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.8275750347806657,-1.3315997609220203,0.17777777777777778,0.802827392692999,1.0,3/5,13.65%,ATM;ATR;CLOCK
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.7864551118008171,1.3310684121819039,0.0967741935483871,0.6244047136978289,1.0,3/13,16.04%,SPOPL;OGT;PLAT
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.6683985895130278,1.3310160269844906,0.057971014492753624,0.6232889577356346,1.0,9/26,20.61%,CEP57;TUBB4B;HSP90AA1;CEP70;ALMS1;CSNK1D;DYNC1H1;PAFAH1B1;CEP290
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.5866947759131014,1.3306964982366056,0.033707865168539325,0.6242137368602027,1.0,26/106,15.75%,NRCAM;ZEB2;ERBB4;GRIK1;RAPGEF5;TBX3;SPOCK1;NES;GPM6B;ELP3;LSAMP;ROBO2;MBP;NFASC;NAV1;NAV3;SEMA6B;SLC2A1;NRXN1;BTD;TRAK1;PRX;ECT2;WWTR1;FEZ2;NAV2
prerank,Reactome_2022__Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,0.6345592886421499,1.3306591652340205,0.05405405405405406,0.6230365448869758,1.0,11/48,15.51%,ATF3;RPS11;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12
prerank,Reactome_2022__cGMP Effects R-HSA-418457,0.8330423786941364,1.3305341826403585,0.12727272727272726,0.6211141671675223,1.0,4/6,9.96%,ITPR1;KCNMB4;PDE5A;PDE10A
prerank,Reactome_2022__Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,0.8330423786941364,1.3305341826403585,0.12727272727272726,0.6211141671675223,1.0,4/6,9.96%,ITPR1;KCNMB4;PDE5A;PDE10A
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.8137365287452755,-1.3305028906537035,0.16666666666666666,0.8037568301170067,1.0,4/6,11.61%,PARP14;PARP9;PARP12;PARP11
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.6998750002236565,1.330465658440285,0.07894736842105263,0.6201696663493057,1.0,6/22,9.54%,GRIA2;LRRC7;ANK2;GRIN2B;ANK3;AHNAK
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperones R-HSA-381033,0.862645368114266,1.329491086171479,0.06060606060606061,0.6248604436233781,1.0,3/6,9.56%,HSPA5;CALR;HSP90B1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.8098465327831482,1.328789148524196,0.18032786885245902,0.6273895150716274,1.0,2/7,3.96%,GRIK2;SLC4A10
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.5741825598584787,1.3286854899813656,0.1038961038961039,0.6266783288813341,1.0,25/72,23.56%,CEP57;NES;EPS8;TUBB4B;HSP90AA1;CDK6;CDKN1B;CCNH;CDKN1A;CEP70;CRLF3;ENSA;PPP1CB;ALMS1;CSNK1D;DYNC1H1;CHMP4B;PAFAH1B1;CEP290;DNM2;ARPP19;YWHAE;PLCB1;MAX;CCNY
prerank,Reactome_2022__RHO GTPases Activate CIT R-HSA-5625900,0.7644453573896619,1.3285266564904095,0.14492753623188406,0.6262531223105865,1.0,5/11,17.66%,CDKN1B;MYL6;MYH10;PPP1CB;MYL12B
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.6049021429431393,1.3280786912777152,0.04878048780487805,0.627220992003006,1.0,13/72,13.68%,LAMC1;PLS3;NES;CD9;SMAD5;MYO1B;COL4A2;KLF4;CTNNA1;GJA1;PECAM1;ANO6;ITGB1
prerank,Reactome_2022__Protein Localization R-HSA-9609507,0.6552403313379838,1.3279723351395443,0.0684931506849315,0.6266445001654333,1.0,4/29,10.70%,ACOX1;PRNP;RPS27A;HSPA9
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.6171162826868895,1.3276639377583221,0.08571428571428572,0.6271963637957267,1.0,18/47,22.39%,CEP57;NES;TUBB4B;HSP90AA1;CCNH;CDKN1A;CEP70;ENSA;PPP1CB;ALMS1;CSNK1D;DYNC1H1;PAFAH1B1;CEP290;DNM2;ARPP19;YWHAE;PLCB1
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.8996860384500526,1.327632599825755,0.07936507936507936,0.6261682814080177,1.0,2/5,2.42%,ADAMTS9;KLF2
prerank,Reactome_2022__ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,0.7027176835361287,1.327415328615747,0.12987012987012986,0.6261580632942658,1.0,1/18,0.56%,ADM
prerank,CellMarker_Augmented_2021__Stromal cell:Amniotic Membrane,0.6730755803493796,1.326935034955577,0.0684931506849315,0.6275903738865365,1.0,16/42,24.94%,ZEB2;RFTN1;S1PR1;ANXA1;CHST11;SRGN;SLC2A3;KCTD12;AGPAT4;WIPF1;SOCS3;SPARC;ETS1;FYN;MSN;ZEB1
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.8964668782558303,1.3260786709341261,0.017241379310344827,0.631746104153606,1.0,1/5,4.94%,ACOX1
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.6968225324901522,1.325912878740785,0.056338028169014086,0.6314677997079282,1.0,5/22,15.19%,SPNS2;VAPB;KDSR;SAMD8;PLPP1
prerank,"Reactome_2022__FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",0.8182853024903851,1.3255539686627604,0.030303030303030304,0.6324748696539455,1.0,1/8,1.86%,PCK1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestinal Crypt,0.695605408391981,1.3253076638474977,0.08955223880597014,0.6325380535775539,1.0,11/23,17.85%,CD9;ANXA1;ATP8B1;BACE2;EMP1;HIF1A;MYO1E;ANXA2;S100A6;ALCAM;LGALS3
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Bone Marrow,0.845001547791782,1.3245961850464805,0.1111111111111111,0.6353729416777658,1.0,2/6,10.46%,ALPL;PECAM1
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.6974572387506348,1.3244947115689802,0.056338028169014086,0.6346641777405775,1.0,5/22,15.19%,SPNS2;VAPB;KDSR;SAMD8;PLPP1
prerank,Reactome_2022__Ion Homeostasis R-HSA-5578775,0.7260560342607173,1.3241634360237071,0.07894736842105263,0.6355724434473536,1.0,5/19,11.24%,CLIC2;ITPR1;SLC8A1;ATP2B1;ATP1B3
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.7813932638243073,1.3231042685918255,0.0967741935483871,0.6404205029958259,1.0,6/14,15.64%,PDK4;ARF1;PINK1;SSH1;KIF16B;NCOR2
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.7154596558019688,1.3229844925359975,0.10810810810810811,0.6397696438235114,1.0,9/25,16.97%,ADM;AKAP12;S1PR1;GNA13;ADGRG1;ADCY2;ADGRB3;PSAP;GRK5
prerank,CellMarker_Augmented_2021__Megakaryocyte:Undefined,0.8528265020870138,1.3228263296295553,0.0625,0.6396492540559855,1.0,2/5,10.46%,CD9;PECAM1
prerank,KEGG_2021_Human__Lipid and atherosclerosis,0.581625265986722,1.3227901683790773,0.058823529411764705,0.6385596675132948,1.0,17/69,14.74%,PIK3R3;ITPR1;HSPA5;MAP3K5;PIK3R1;NFE2L2;ERO1A;HSP90AA1;HSP90B1;MIB1;JUN;RAP1A;FOS;TAB2;MAPK10;KRAS;RAC1
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.6162459505582578,1.3226583817746096,0.08823529411764706,0.6381474783399064,1.0,18/48,22.39%,CEP57;NES;TUBB4B;HSP90AA1;CCNH;CDKN1A;CEP70;ENSA;PPP1CB;ALMS1;CSNK1D;DYNC1H1;PAFAH1B1;CEP290;DNM2;ARPP19;YWHAE;PLCB1
prerank,PanglaoDB_Augmented_2021__Pericytes,0.6352829498846319,1.3223827462052433,0.07692307692307693,0.6384298372870678,1.0,10/35,15.25%,ADM;TIMP3;PDE5A;PLSCR4;ALPL;MYO1B;COL4A2;PECAM1;TNS1;FOXC1
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.7721814185884083,1.3220731059639177,0.171875,0.639088406971295,1.0,1/8,0.69%,SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.8689655967435244,1.3218016246502717,0.06896551724137931,0.6396608100622475,1.0,2/6,8.82%,IPO7;CDKN1B
prerank,Reactome_2022__Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.7834791097413885,1.3217549976934828,0.09090909090909091,0.6387067472658992,1.0,3/9,11.18%,INPP5F;MTMR12;PIKFYVE
prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,0.6563842051540878,1.321658142267925,0.08333333333333333,0.6379230048374587,1.0,5/31,5.79%,GRIA2;ITPR1;MGLL;CACNA1C;NDUFA12
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Fetal Liver,-0.6230348979995599,-1.3214162843989772,0.12,0.8389141691596138,1.0,4/20,10.70%,VCAM1;PODN;FN1;LDB2
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.7816309846462834,1.3209481166445207,0.11428571428571428,0.6405330279884583,1.0,2/8,8.23%,UFL1;RB1CC1
prerank,CellMarker_Augmented_2021__Nucleus Pulposus cell:Intervertebral Disc,0.6652432233613151,1.3208253460057189,0.09722222222222222,0.6399564374173251,1.0,8/35,16.04%,CCDC3;TBX3;COL4A2;PDE10A;BOC;FOXF1;PCDH7;PLAT
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.9154341278354529,1.3206257259789702,0.04838709677419355,0.637454939658704,1.0,3/6,4.75%,PKM;GAPDH;PGK1
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.9154341278354529,1.3206257259789702,0.04838709677419355,0.637454939658704,1.0,3/6,4.75%,PKM;GAPDH;PGK1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.9154341278354529,1.3206257259789702,0.04838709677419355,0.637454939658704,1.0,3/6,4.75%,PKM;GAPDH;PGK1
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.7657725129567544,1.320494571184172,0.041666666666666664,0.6369914037240916,1.0,4/17,8.61%,CANX;INPP5F;SGIP1;PICALM
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.845005762589974,1.3204198735493553,0.1,0.6362827353343177,1.0,3/7,5.15%,SLC8A1;GRIN2B;CACNA1C
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.8890426399666743,1.3201907833768387,0.03333333333333333,0.6367881352297647,1.0,3/7,4.75%,PCK1;GAPDH;PGK1
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.7825302022688818,1.3200997272723547,0.15384615384615385,0.6360004824595965,1.0,2/8,3.43%,SERPINE1;CALR
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.834037804898904,1.320079834604373,0.1,0.6349088785345182,1.0,1/6,2.39%,FES
prerank,"Reactome_2022__Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.8012924705333382,1.3200545885282688,0.06153846153846154,0.6339233927525043,1.0,1/9,0.80%,GRIA2
prerank,CellMarker_Augmented_2021__Epithelial cell:Corneal Epithelium,-0.5608414088302264,-1.320003607359939,0.10526315789473684,0.8403688070601525,1.0,11/46,7.25%,SAMD9L;GBP1;EPSTI1;GBP2;IRF1;DDX60L;SP100;APOL3;SP110;SAT1;SP140L
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.8924215529026394,1.3194359172280858,0.08823529411764706,0.6364676099635356,1.0,2/5,2.55%,ERBB4;TBX3
prerank,Reactome_2022__Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,0.8625434198092354,1.3193704436262572,0.028985507246376812,0.6356456371177955,1.0,2/6,4.91%,LRRC7;GRIN2B
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Umbilical Cord Blood,0.6880964553602367,1.3193619963000431,0.14285714285714285,0.6345220655800955,1.0,4/21,8.90%,LDHA;CALR;ANXA1;UBE2J1
prerank,Reactome_2022__Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,-0.617670095538028,-1.319004246524955,0.12903225806451613,0.8405952638392771,1.0,3/14,9.22%,TBL1X;TBL1XR1;CHD9
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Embryonic Prefrontal Cortex,0.6839820925191019,1.318910631025088,0.09859154929577464,0.6360985361796107,1.0,6/28,6.93%,ZEB2;LDHA;APOLD1;PLIN2;SNAP25;TUBB4B
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.8181202134183593,1.3186213177611452,0.12,0.6365159613395178,1.0,5/9,13.63%,PPM1D;DUSP6;DUSP1;PPM1A;DUSP16
prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,-0.7436137801184721,-1.3184189992447952,0.12,0.8384878079225129,1.0,1/9,0.74%,RPP38
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.7046327928236289,1.318394641250338,0.13432835820895522,0.6368510804786836,1.0,4/16,11.63%,EHD4;RAB11FIP3;MICALL2;ACAP2
prerank,KEGG_2021_Human__Pathways of neurodegeneration,0.5716133548812231,1.3183240495511526,0.03571428571428571,0.6361770002058181,1.0,16/108,8.90%,GRIA2;PSMC6;ITPR1;WNT2B;HSPA5;MAP3K5;VAPB;GRIN2B;CACNA1C;NDUFA12;PRNP;TUBB4B;PINK1;RPS27A;RB1CC1;UBE2J1
prerank,KEGG_2021_Human__Apelin signaling pathway,0.655307593219444,1.3183140620705478,0.06493506493506493,0.6350425370271628,1.0,6/45,4.78%,SERPINE1;ITPR1;PRKAG2;KLF2;SLC8A1;PRKCE
prerank,"KEGG_2021_Human__Valine, leucine and isoleucine degradation",-0.8060913204613495,-1.318247908111862,0.10810810810810811,0.8346836256944477,1.0,6/7,19.36%,HIBCH;ACAT1;HADHB;HIBADH;PCCA;AUH
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.8517300076282461,1.3177803355531104,0.12857142857142856,0.6367243045617434,1.0,2/6,8.23%,ATG12;RB1CC1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.839388973777192,1.317029927497174,0.11290322580645161,0.6390215475333962,1.0,2/5,14.32%,HIF1A;GRB10
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.6825374240088597,1.3170022259769103,0.12162162162162163,0.6379281212134809,1.0,14/29,22.66%,ANGPTL4;SERPINE1;RAPGEF3;HIF1A;FLT1;AGO2;ITGB1;MTDH;GATA2;BTG1;VEGFC;ANXA3;CDH5;ETS1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.8330829462699539,-1.3165641648005175,0.16666666666666666,0.838714883242828,1.0,3/5,12.91%,HLA-F;SERPINB9;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.8098111018761516,1.3160836335141133,0.1206896551724138,0.641553442644195,1.0,2/8,5.29%,ERBB4;ZFPM2
prerank,Reactome_2022__Effects Of PIP2 Hydrolysis R-HSA-114508,0.8213553771416087,1.315980574980128,0.140625,0.6409380053313511,1.0,3/10,4.78%,ITPR1;MGLL;PRKCE
prerank,CellMarker_Augmented_2021__Neural cell:Embryoid Body,0.7168982030095594,1.3158067794013588,0.09722222222222222,0.6405238404822298,1.0,6/14,13.39%,ANK2;GPM6B;PTPRD;CTNND2;NRXN1;MAPK10
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.8539651502684957,-1.3156309771664108,0.07692307692307693,0.8392222170100742,1.0,1/5,0.37%,RNF213
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Breast,0.7670737426356375,1.3154946865077966,0.10144927536231885,0.6400173168830269,1.0,7/10,21.51%,ANXA1;KLF4;FOSL2;ANXA2;S100A6;LGALS3;ANXA3
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Jejunum,0.7670737426356375,1.3154946865077966,0.10144927536231885,0.6400173168830269,1.0,7/10,21.51%,ANXA1;KLF4;FOSL2;ANXA2;S100A6;LGALS3;ANXA3
prerank,CellMarker_Augmented_2021__Small Intestinal Stem cell:Small Intestinal Crypt,0.6368178085286907,1.3152501295757113,0.06329113924050633,0.6355032972958367,1.0,13/47,10.78%,ATRNL1;MAP2;CNTN1;ANK2;MAP1B;GPM6B;LSAMP;NPAS3;PTPRD;NFASC;PPFIA2;GJA1;BOC
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestine,0.6368178085286907,1.3152501295757113,0.06329113924050633,0.6355032972958367,1.0,13/47,10.78%,ATRNL1;MAP2;CNTN1;ANK2;MAP1B;GPM6B;LSAMP;NPAS3;PTPRD;NFASC;PPFIA2;GJA1;BOC
prerank,CellMarker_Augmented_2021__Esophageal Mucosal cell:Esophagus,0.6368178085286907,1.3152501295757113,0.06329113924050633,0.6355032972958367,1.0,13/47,10.78%,ATRNL1;MAP2;CNTN1;ANK2;MAP1B;GPM6B;LSAMP;NPAS3;PTPRD;NFASC;PPFIA2;GJA1;BOC
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Esophagus,0.6368178085286907,1.3152501295757113,0.06329113924050633,0.6355032972958367,1.0,13/47,10.78%,ATRNL1;MAP2;CNTN1;ANK2;MAP1B;GPM6B;LSAMP;NPAS3;PTPRD;NFASC;PPFIA2;GJA1;BOC
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Colon,0.6368178085286907,1.3152501295757113,0.06329113924050633,0.6355032972958367,1.0,13/47,10.78%,ATRNL1;MAP2;CNTN1;ANK2;MAP1B;GPM6B;LSAMP;NPAS3;PTPRD;NFASC;PPFIA2;GJA1;BOC
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.8522431085559112,1.3150438592451927,0.1267605633802817,0.635536352587773,1.0,4/8,5.15%,CLIC2;SLC8A1;ANK2;CACNA1C
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Liver,0.7513853263548717,1.314721972612007,0.11688311688311688,0.6365095982511253,1.0,4/14,8.71%,AKAP12;GPM6B;ZBTB1;ITGA1
prerank,Reactome_2022__Signaling By KIT In Disease R-HSA-9669938,0.8413156209642028,1.314372376681362,0.05714285714285714,0.6371274176549915,1.0,3/11,8.31%,PIK3R3;PIK3R1;GRB2
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.6553421433144458,1.3141736411380516,0.10294117647058823,0.6372940842763865,1.0,12/34,16.63%,SYN3;GRIK1;GRIK2;KCNMB4;GRM7;BCR;NRG3;LRRC4C;ITGB1;DLGAP2;DGKI;SYT1
prerank,Reactome_2022__Neurotransmitter Release Cycle R-HSA-112310,0.7429214877339245,1.313733319173263,0.0821917808219178,0.6386488383872904,1.0,9/17,20.58%,SYN3;SNAP25;DNAJC5;PPFIA2;SLC38A2;SH2D3C;SYT1;SLC1A2;HSPA8
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Lung,0.6217441914970406,1.3134811810154563,0.0875,0.6389095123593148,1.0,18/50,22.20%,SERPINE1;MGLL;TIMP3;COL4A2;KLF4;FOSL2;EMP1;TBC1D9;CFH;TNS1;PLXNA2;TGM2;RBMS2;GSN;FNDC3B;VEGFC;EPAS1;CAV2
prerank,Reactome_2022__N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,0.7323611185071243,1.3132726418117617,0.171875,0.6390721823177177,1.0,4/8,21.70%,MGAT4A;MGAT5;FUT8;B4GALT1
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.8659419940132211,1.3132238593464798,0.01639344262295082,0.6382844554413496,1.0,3/8,4.75%,PCK1;GAPDH;PGK1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.6424170305265482,1.3124893923038023,0.04,0.641408262220552,1.0,12/40,11.13%,GRIA2;ATRNL1;MAP2;CADM2;ANK2;MAP1B;GPM6B;INSYN2A;SNAP25;PPFIA2;CNTNAP2;PREPL
prerank,Reactome_2022__Stimuli-sensing Channels R-HSA-2672351,0.6752449312635296,1.3123904914544768,0.06493506493506493,0.6408896440838787,1.0,7/23,13.47%,CLIC2;TSC22D3;ANO5;ANO2;RPS27A;ANO6;NEDD4L
prerank,KEGG_2021_Human__Hepatitis B,0.6216945522348917,1.312313659662162,0.10843373493975904,0.6401414325055915,1.0,10/54,13.89%,PIK3R3;PIK3R1;JAK1;GRB2;JUN;CDKN1A;FOS;TAB2;MAPK10;KRAS
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.8166902571592354,1.3119999999025609,0.08064516129032258,0.641205284412085,1.0,4/8,8.63%,KLF2;SMAD7;NFE2L2;KLF4
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.7368208739151384,-1.311619039582719,0.08,0.843633137967773,1.0,1/8,0.13%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.7368208739151384,-1.311619039582719,0.08,0.843633137967773,1.0,1/8,0.13%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.7368208739151384,-1.311619039582719,0.08,0.843633137967773,1.0,1/8,0.13%,GBP1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.7479384819715884,1.311414774865788,0.11594202898550725,0.6431878298315635,1.0,1/13,0.53%,DDIT4
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.8319445097793845,-1.311309914884062,0.125,0.8401530003493204,1.0,4/6,13.65%,ATM;ATR;STK33;CLOCK
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.8445551766742588,1.311251916394232,0.10344827586206896,0.6430917484730994,1.0,3/7,8.61%,RTN4;PRNP;PICALM
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.5578282603474582,1.3111375875914069,0.10714285714285714,0.6428427998479385,1.0,22/101,14.40%,LAMC1;ERBB4;TBX3;NES;CALR;CD81;ZFPM2;UFL1;FGFR1;RPS9;KDM1A;RPL23;CDK6;GJA1;CNBP;CDKN1A;FLT1;CNOT6L;CLDN5;KRAS;S100A6;WWTR1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.8075482416965268,1.3109555924086576,0.13333333333333333,0.642460891526024,1.0,4/8,11.55%,ARF1;PRNP;MT2A;COMMD1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.8330379540313149,1.3092434282358718,0.15789473684210525,0.6510115975922263,1.0,2/7,5.29%,ERBB4;ZFPM2
prerank,Reactome_2022__Sphingolipid De Novo Biosynthesis R-HSA-1660661,0.70650455414854,1.309163930390948,0.08571428571428572,0.6503502493668146,1.0,5/18,15.19%,SPNS2;VAPB;KDSR;SAMD8;PLPP1
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.6567786985181358,1.3090687511113859,0.1323529411764706,0.6498052809510968,1.0,7/25,11.87%,STARD4;INPP5F;GRB2;KLF4;MAGI2;ANXA2;CDKN1A
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Lung,0.8294688926503966,1.308413615527122,0.0967741935483871,0.6509195378075937,1.0,3/9,6.16%,SLC52A3;CD9;TINAGL1
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Liver,0.8294688926503966,1.308413615527122,0.0967741935483871,0.6509195378075937,1.0,3/9,6.16%,SLC52A3;CD9;TINAGL1
prerank,Reactome_2022__Dopamine Neurotransmitter Release Cycle R-HSA-212676,0.7768691908661891,1.3081457419986977,0.15714285714285714,0.6513602871950819,1.0,3/10,8.50%,SYN3;SNAP25;PPFIA2
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.7894322575965729,1.308085318617029,0.171875,0.6484944570912066,1.0,3/6,13.78%,CD81;CFH;CD55
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.7894322575965729,1.308085318617029,0.171875,0.6484944570912066,1.0,3/6,13.78%,CD81;CFH;CD55
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.7894322575965729,1.308085318617029,0.171875,0.6484944570912066,1.0,3/6,13.78%,CD81;CFH;CD55
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.7313852186705279,-1.3076547354056731,0.21212121212121213,0.8526258620320566,1.0,3/5,20.35%,BICD1;CCDC68;NIN
prerank,CellMarker_Augmented_2021__Chromaffin cell:Adrenal Gland,0.6924964964699264,1.3071310460223091,0.125,0.6508082501148432,1.0,11/21,12.83%,GRIA2;CADM2;GPM6B;LSAMP;NPAS3;CACNA1C;CTNND2;TRIM9;LRRC4C;NRXN1;TMEM132C
prerank,CellMarker_Augmented_2021__Natural Killer cell:Breast,0.6924964964699264,1.3071310460223091,0.125,0.6508082501148432,1.0,11/21,12.83%,GRIA2;CADM2;GPM6B;LSAMP;NPAS3;CACNA1C;CTNND2;TRIM9;LRRC4C;NRXN1;TMEM132C
prerank,CellMarker_Augmented_2021__Definitive Zone cell:Adrenal Gland,0.6924964964699264,1.3071310460223091,0.125,0.6508082501148432,1.0,11/21,12.83%,GRIA2;CADM2;GPM6B;LSAMP;NPAS3;CACNA1C;CTNND2;TRIM9;LRRC4C;NRXN1;TMEM132C
prerank,Reactome_2022__Nonhomologous End-Joining (NHEJ) R-HSA-5693571,-0.729548356291456,-1.3069775231056968,0.16666666666666666,0.8518959690656962,1.0,3/9,8.13%,BABAM2;ATM;HERC2
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.7032789069129122,1.3067559390522665,0.109375,0.6518049180604828,1.0,6/13,6.37%,GRIA2;GRIK1;GRIK2;GRM7;GRIN2B;CPEB4
prerank,Reactome_2022__Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,-0.6717208422442996,-1.3065132908494363,0.16216216216216217,0.8494950569471107,1.0,1/12,0.16%,VCAM1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.8321245372072008,1.306354872506011,0.06153846153846154,0.6525555681780763,1.0,1/5,1.91%,PRKAG2
prerank,CellMarker_Augmented_2021__Myofibroblast:Undefined,-0.6721848913771046,-1.3061741248961767,0.12903225806451613,0.8298884590957039,1.0,3/16,6.40%,VCAM1;LIMS2;PODN
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Undefined,-0.6721848913771046,-1.3061741248961767,0.12903225806451613,0.8298884590957039,1.0,3/16,6.40%,VCAM1;LIMS2;PODN
prerank,CellMarker_Augmented_2021__Fibroblast:Corneal Endothelium,-0.6721848913771046,-1.3061741248961767,0.12903225806451613,0.8298884590957039,1.0,3/16,6.40%,VCAM1;LIMS2;PODN
prerank,CellMarker_Augmented_2021__Peritubular Myoid cell:Testis,-0.6721848913771046,-1.3061741248961767,0.12903225806451613,0.8298884590957039,1.0,3/16,6.40%,VCAM1;LIMS2;PODN
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Blood Vessel,-0.6721848913771046,-1.3061741248961767,0.12903225806451613,0.8298884590957039,1.0,3/16,6.40%,VCAM1;LIMS2;PODN
prerank,KEGG_2021_Human__Huntington disease,0.6077825163170784,1.3059503305012503,0.08333333333333333,0.6535645842494506,1.0,15/60,17.29%,GRIA2;PSMC6;ITPR1;MAP3K5;GRIN2B;NDUFA12;TUBB4B;RB1CC1;REST;MAPK10;TUBA1B;TUBB6;PSMA7;TGM2;SLC1A2
prerank,Reactome_2022__O-linked Glycosylation Of Mucins R-HSA-913709,0.7578294637329323,1.3054227649593055,0.171875,0.6554817943098005,1.0,1/12,0.50%,B3GNT2
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.6291497329617819,-1.305185833479612,0.16,0.8305178795378954,1.0,7/14,13.73%,CTNNA2;SRGAP2;SRGAP2C;SEMA6A;NTNG1;RAPGEF2;ULK4
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Ligament,-0.7462474208468912,-1.3050982626197145,0.14285714285714285,0.8266844794123596,1.0,2/9,1.83%,VCAM1;CD74
prerank,Reactome_2022__SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,0.7397938989979702,1.3050484312347397,0.13846153846153847,0.6566311086254961,1.0,5/14,14.40%,SERPINE1;SMAD7;RPS27A;CCNC;WWTR1
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.8718346756873456,1.304721482448794,0.125,0.6572945013081355,1.0,2/5,4.78%,ADM;PRKCE
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.6913498184413001,1.3042632009430726,0.08620689655172414,0.6588812039289612,1.0,5/18,13.28%,PSMC6;UFL1;PINK1;COMMD1;TMF1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.6375885045864907,1.3041853593427983,0.10810810810810811,0.6580972226041383,1.0,13/41,23.48%,RTN4;CALR;PRKCE;ENPP2;HIF1A;BCAR1;RAC1;ATOH8;ANXA3;SPARC;ETS1;SCARB1;ADAM9
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.6429045329333553,1.3039794559142226,0.17142857142857143,0.6582013973915533,1.0,8/38,10.78%,ADAMTS9;NES;ANK2;MAP1B;TIMP3;COL4A2;GJA1;BOC
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.8318279500405636,1.303514253617889,0.06382978723404255,0.6598523593996236,1.0,1/5,6.11%,FGFR1
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.8751569785221466,1.3033410805323038,0.04838709677419355,0.6594200344182046,1.0,2/5,3.43%,KLF2;CALR
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.7301761382460219,1.3032982732995249,0.12987012987012986,0.6585852811207157,1.0,6/19,14.16%,ANK2;SYTL4;PLSCR4;ANK3;ANO6;DYSF
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.7836111657386591,1.3030549429654363,0.13636363636363635,0.6589628642946356,1.0,3/9,13.71%,SGIP1;PICALM;HIP1R
prerank,Reactome_2022__KEAP1-NFE2L2 Pathway R-HSA-9755511,0.649507110635125,1.3029432963605088,0.12658227848101267,0.6583877739005352,1.0,7/32,16.02%,PSMC6;MAFK;NFE2L2;RPS27A;NPLOC4;TXNRD1;PSMA7
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.850657394178436,1.3029366944264145,0.11666666666666667,0.6573213818327694,1.0,2/6,6.91%,RTN4;PRNP
prerank,KEGG_2021_Human__Epstein-Barr virus infection,0.5866852261749064,1.3017824046604114,0.13414634146341464,0.6633342575703413,1.0,13/59,15.64%,PIK3R3;PSMC6;CALR;PIK3R1;JAK1;CDK6;CDKN1B;JUN;CDKN1A;TAB2;MAPK10;RAC1;NCOR2
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Skin,0.8176247696961649,1.3016679737559442,0.15254237288135594,0.6629733007445626,1.0,2/5,13.68%,NES;ITGB1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.8092124927496548,-1.301634423467369,0.21428571428571427,0.8385019954134464,1.0,2/5,12.91%,TAP1;HLA-A
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.7540506800772259,1.3016176538065494,0.14666666666666667,0.6622136399200665,1.0,1/9,1.06%,PDK4
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.6785102415058064,-1.3016036923132206,0.21212121212121213,0.8345576307084446,1.0,2/8,9.54%,CLCN3;ATP6V1H
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.6636595100149569,1.301490877929871,0.11538461538461539,0.6616923761096738,1.0,10/30,16.68%,SERPINE1;ADAMTS9;KLF2;PGK1;COL4A2;KLF4;CLDN5;FOXC1;ATF2;SPRED1
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.7849176491403883,1.3013461146377907,0.15873015873015872,0.6612634022853182,1.0,5/11,12.88%,DDIT4;GRB2;RAP1A;MAGI2;BCAR1
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.6326951192620992,1.3013312268176351,0.1111111111111111,0.6602389324060605,1.0,16/38,25.95%,FES;INPP5F;RAB21;PICALM;STXBP5L;HIP1R;SYT1;ABL2;RIMS2;PTPN1;DNAJC13;RUFY2;RAB8B;SCARB1;FGR;MAP2K1
prerank,Reactome_2022__Platelet Calcium Homeostasis R-HSA-418360,0.8143130876123286,1.3012599722442268,0.11688311688311688,0.6595609070322217,1.0,3/9,8.45%,ITPR1;SLC8A1;ATP2B1
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.7889518862439884,1.300818295341073,0.16417910447761194,0.6603093716800467,1.0,5/9,17.21%,IL1RAPL1;PTPRD;SPEN;NRXN1;TGM2
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.7075577688535493,1.3006068939884765,0.1,0.6604074185926448,1.0,7/16,13.78%,PCK1;TMEM45B;TTC7A;PLIN2;ACSL5;SLC26A2;CD55
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.8345300254967352,1.300584958355742,0.09859154929577464,0.6583957675961758,1.0,2/6,6.19%,GRIN2B;INSYN2A
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.8345300254967352,1.300584958355742,0.09859154929577464,0.6583957675961758,1.0,2/6,6.19%,GRIN2B;INSYN2A
prerank,PanglaoDB_Augmented_2021__Sebocytes,0.8366808241161701,1.3004268102332839,0.11267605633802817,0.6583531313960306,1.0,3/7,8.63%,ANGPTL4;TMEM45B;KLF4
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.6900392627214533,1.3003346019550808,0.09876543209876543,0.6578277774147522,1.0,6/21,9.83%,BNIP3L;PGK1;NDRG1;CPEB4;PINK1;HIF1A
prerank,Reactome_2022__Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,0.7580748825664945,1.3002794088970016,0.08955223880597014,0.6569827302131203,1.0,4/13,9.61%,CNTN1;RPS27A;JAG2;MIB1
prerank,Reactome_2022__Phospholipid Metabolism R-HSA-1483257,0.5991625137236762,1.2998801763922507,0.09523809523809523,0.6584934357632856,1.0,6/64,6.14%,PIK3R3;CHPT1;MGLL;INPP5F;MTMR12;PIK3R1
prerank,KEGG_2021_Human__ABC transporters,-0.7628809024564158,-1.2998038258064486,0.21621621621621623,0.8377654166972568,1.0,2/8,4.65%,TAP1;ABCG2
prerank,Reactome_2022__Potassium Channels R-HSA-1296071,0.8333512585463656,1.2993993019102135,0.16393442622950818,0.6600348863639055,1.0,1/6,2.44%,KCNMB4
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.8005950962551523,-1.2993791963603536,0.23809523809523808,0.8360299107915172,1.0,1/5,1.83%,CD74
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.6223954060033949,1.2992389482496427,0.05194805194805195,0.6603098050676627,1.0,14/39,22.28%,CEP57;PSMC6;TUBB4B;HSP90AA1;CEP70;BRD4;PSMA7;ALMS1;CSNK1D;DYNC1H1;PAFAH1B1;CEP290;AVEN;YWHAE
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.6943744723428518,1.298731342919574,0.10294117647058823,0.6619321191456079,1.0,6/25,8.61%,MAP2;TRIM5;UFL1;HSP90AA1;KDM1A;PICALM
prerank,Reactome_2022__Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,0.6425379671268175,1.298604651742873,0.07352941176470588,0.6615832044994824,1.0,13/31,22.42%,CEP57;TUBB4B;HSP90AA1;RPS27A;CEP70;PPP1CB;ALMS1;CSNK1D;DYNC1H1;PAFAH1B1;CEP290;YWHAE;UBC
prerank,Reactome_2022__CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,0.7798617385513145,1.2984994070220996,0.12903225806451613,0.6610762479560544,1.0,2/10,4.91%,LRRC7;GRIN2B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.821172916698039,1.2983860398362177,0.12857142857142856,0.6602884144903627,1.0,4/10,5.15%,CLIC2;SLC8A1;ANK2;CACNA1C
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.7431357131027568,-1.2983717697848547,0.18421052631578946,0.8367554334286083,1.0,1/6,0.35%,SLCO1A2
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.7210719568541187,-1.2980163563739997,0.2,0.8338608191030292,1.0,2/10,3.61%,HABP4;IRF1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.8664243674767278,1.2978564561755923,0.12903225806451613,0.662693689822315,1.0,2/5,12.54%,TSG101;ZFYVE28
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.8627804098879829,1.2978280917408909,0.07692307692307693,0.6617297934001111,1.0,1/5,4.70%,GAPDH
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.8355826982092904,1.2976191514226354,0.058823529411764705,0.6616826843134332,1.0,4/10,5.15%,CLIC2;SLC8A1;ANK2;CACNA1C
prerank,Reactome_2022__Neutrophil Degranulation R-HSA-6798695,0.5498214940785295,1.297470627608529,0.06818181818181818,0.6611971250669514,1.0,29/117,21.70%,PKM;LRRC7;NFASC;TINAGL1;SNAP25;TUBB4B;DNAJC5;HSP90AA1;SERPINB6;DLC1;LAMP2;RAP1A;PECAM1;PIKFYVE;SLC2A3;ANXA2;ANO6;EEF1A1;CD55;SDCBP;LGALS3;EGFL7;DYNC1H1;CAB39;GSN;HSPA8;CEP290;DNAJC13;B4GALT1
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),0.8399789064658683,1.2971384946953322,0.13333333333333333,0.662149432798935,1.0,1/7,1.43%,SCP2
prerank,CellMarker_Augmented_2021__Stem cell:Molar,0.708575289669345,1.297077533126696,0.11666666666666667,0.6613498738240706,1.0,5/17,13.68%,SERPINE1;TIMP3;COL4A2;EMP1;ITGB1
prerank,Reactome_2022__Potential Therapeutics For SARS R-HSA-9679191,0.6321920387235264,1.2968502299699693,0.15584415584415584,0.6614957317174829,1.0,17/42,26.08%,S1PR1;NFE2L2;JAK1;HSP90AA1;KDM1A;GRB2;ATP1B3;REST;IFNGR1;ITGB1;BRD4;IFNGR2;SH3KBP1;ATP1B1;NCK1;TUBB;CRBN
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.7364051010050829,1.296718034809959,0.09859154929577464,0.6612227238149998,1.0,11/18,22.92%,ITPR1;SLC8A1;ANK2;ATP2B1;ATP1A1;ATP1B3;RYR3;ATP2B4;AHCYL1;ATP1B1;TMEM65
prerank,Reactome_2022__VEGFA-VEGFR2 Pathway R-HSA-4420097,0.631695209445955,1.2966605355363818,0.1,0.6605676353205793,1.0,16/43,28.47%,ITPR1;PIK3R1;HSP90AA1;CTNNA1;BCAR1;SHC2;CRK;ABI1;AHCYL1;CDH5;NCK1;FYN;MTOR;CDC42;PIK3CB;CALM1
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.887381753414689,1.296200241868735,0.11764705882352941,0.6619305619890663,1.0,1/5,0.40%,ANGPTL4
prerank,KEGG_2021_Human__Cardiac muscle contraction,0.7757963880207893,1.2961855860864069,0.12857142857142856,0.660981435826069,1.0,5/14,11.24%,SLC8A1;CACNA1C;TPM4;ATP1A1;ATP1B3
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.7265961422040496,1.2961556013517619,0.1076923076923077,0.6600872496921756,1.0,8/21,8.71%,ADM;PCK1;LSAMP;PTPRD;SGIP1;NFASC;ENPP2;ITGA1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.8077435453886055,1.29590046670008,0.18181818181818182,0.6607526413449868,1.0,3/7,13.57%,KCNMB4;ANK2;NOS1AP
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.7737386768716046,1.2953912070748095,0.11594202898550725,0.6625385555624942,1.0,3/8,18.88%,NUDCD3;CCDC14;CSNK1D
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.8717286460465441,1.2952605363583323,0.11666666666666667,0.6623531171394921,1.0,1/5,1.01%,RFTN1
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Undefined,0.7838012849679042,1.2946849850450954,0.14705882352941177,0.664440906968137,1.0,4/8,18.38%,CD9;KLF4;PECAM1;PODXL
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,0.5878049275685536,1.2945669202597856,0.07407407407407407,0.6639952386132567,1.0,14/71,15.91%,PIK3R3;CANX;CALR;CRTC3;PIK3R1;JAK1;SLC2A1;JUN;CDKN1A;FOS;MAPK10;KRAS;ADCY2;ATF2
prerank,Reactome_2022__PINK1-PRKN Mediated Mitophagy R-HSA-5205685,0.7750557859765794,1.294557992099555,0.11594202898550725,0.6619769775627267,1.0,3/9,8.07%,ATG12;PINK1;RPS27A
prerank,Reactome_2022__Mitophagy R-HSA-5205647,0.7750557859765794,1.294557992099555,0.11594202898550725,0.6619769775627267,1.0,3/9,8.07%,ATG12;PINK1;RPS27A
prerank,Reactome_2022__Calnexin/calreticulin Cycle R-HSA-901042,0.7404921047853193,1.2943715658935406,0.13636363636363635,0.6618965013352731,1.0,4/13,8.07%,CANX;CALR;EDEM3;RPS27A
prerank,KEGG_2021_Human__Circadian rhythm,0.7165210710440605,1.2930524661468823,0.109375,0.6680350020932769,1.0,5/14,18.88%,PRKAG2;BHLHE40;NPAS2;CRY1;CSNK1D
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone,-0.5981848712314083,-1.2927733069868153,0.10714285714285714,0.8454816694187933,1.0,4/24,5.68%,SAMD9L;LIMS2;PLXND1;APOL3
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Whartons Jelly,-0.5981848712314083,-1.2927733069868153,0.10714285714285714,0.8454816694187933,1.0,4/24,5.68%,SAMD9L;LIMS2;PLXND1;APOL3
prerank,Reactome_2022__Dissolution Of Fibrin Clot R-HSA-75205,0.8326105418308647,1.292113326271414,0.15254237288135594,0.6719370574032852,1.0,4/5,16.04%,SERPINE1;SERPINB6;ANXA2;PLAT
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.8396956811438553,1.292049580189444,0.23880597014925373,0.6712795985637551,1.0,3/6,7.54%,RTN4;MAP2;SEMA6B
prerank,CellMarker_Augmented_2021__Effector CD8+ Memory T (Tem) cell:Peripheral Blood,0.6862825287254034,1.2919838646960888,0.1232876712328767,0.6706071506581394,1.0,12/24,17.58%,ZEB2;GLUL;MBP;RASSF1;WDR37;SLC2A1;AHNAK;DSTN;ADGRG1;AGTPBP1;PXN;TPST2
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.7506840202707233,1.2918971214363357,0.1746031746031746,0.6700386409277334,1.0,4/11,11.10%,SLC8A1;CACNA1C;ATP2B1;MICU2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.8487556963272438,1.2918875794034272,0.125,0.6690480246228493,1.0,1/6,1.43%,SCP2
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.7112514345197555,1.2916946401151002,0.18840579710144928,0.6691438200945813,1.0,4/12,7.30%,SCP2;MGLL;ACOX1;ACSL5
prerank,Reactome_2022__Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,0.6796392713692124,1.2914501561415463,0.1323529411764706,0.668372581916985,1.0,9/21,20.61%,CEP57;TUBB4B;HSP90AA1;CEP70;ALMS1;CSNK1D;DYNC1H1;PAFAH1B1;CEP290
prerank,Reactome_2022__AURKA Activation By TPX2 R-HSA-8854518,0.6796392713692124,1.2914501561415463,0.1323529411764706,0.668372581916985,1.0,9/21,20.61%,CEP57;TUBB4B;HSP90AA1;CEP70;ALMS1;CSNK1D;DYNC1H1;PAFAH1B1;CEP290
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.8485069812424394,1.2912156676710815,0.18333333333333332,0.6687722805104384,1.0,1/5,2.92%,ANK2
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.8661700835069075,1.291147388039895,0.09523809523809523,0.668262206735769,1.0,3/5,9.56%,HSPA5;CALR;HSP90B1
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.6825815790221742,1.2909245985548463,0.07462686567164178,0.668778459116134,1.0,10/22,20.61%,CEP57;TUBB4B;HSP90AA1;CEP70;ALMS1;CSNK1D;DYNC1H1;NPM1;PAFAH1B1;CEP290
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.8424014892577151,1.2903932041806119,0.10344827586206896,0.6707021876714593,1.0,1/6,1.94%,DOK5
prerank,Reactome_2022__FRS-mediated FGFR1 Signaling R-HSA-5654693,0.8557623058540571,1.2903479891818002,0.14754098360655737,0.6698565316291576,1.0,2/5,8.31%,FGFR1;GRB2
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.8689842967351752,1.2901613828985992,0.09090909090909091,0.6697158204440041,1.0,3/6,8.02%,ARF1;PRNP;MT2A
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.6441105783930938,1.289873295664761,0.15789473684210525,0.6702434721700576,1.0,10/31,17.98%,MYO9B;EPS8;BCR;DLC1;GRB2;OGT;DENND3;ERBIN;SHOC2;ARHGEF2
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperone Genes R-HSA-381183,0.8626893457615701,1.2898255306839503,0.0967741935483871,0.6694189942817337,1.0,3/5,9.56%,HSPA5;CALR;HSP90B1
prerank,Reactome_2022__NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,-0.675500934956297,-1.2898016692223935,0.21212121212121213,0.8532730472949039,1.0,5/10,17.34%,STAT1;PLXND1;MAML3;MAML2;PBX1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.7659222278896377,1.2897787645903234,0.16071428571428573,0.6677275849833908,1.0,1/8,0.61%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.7659222278896377,1.2897787645903234,0.16071428571428573,0.6677275849833908,1.0,1/8,0.61%,ZEB2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Placenta,-0.8081674472845264,-1.2897143883272368,0.20833333333333334,0.849618094383755,1.0,1/5,0.16%,VCAM1
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.7890535802607515,1.289658507493035,0.125,0.6672591443479918,1.0,5/10,8.98%,GRIK1;GRIK2;BCR;NRG3;LRRC4C
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.6625722488932843,1.2895056478810198,0.09722222222222222,0.6675379195209273,1.0,5/32,6.75%,ST18;GRIA2;GPM6B;MBP;ENPP2
prerank,KEGG_2021_Human__Cysteine and methionine metabolism,0.7907869964623314,1.2893639685640823,0.16417910447761194,0.6671870028677682,1.0,1/7,1.41%,LDHA
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.6212834837767568,1.289021900258287,0.09210526315789473,0.6680764528179096,1.0,6/40,9.59%,PBX3;MAP2;GPM6B;PPP1R9A;MICALL2;CNTNAP2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.8412400843207969,1.2889696460699844,0.11290322580645161,0.666371162332619,1.0,2/5,13.25%,CCNH;TAF1D
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.8412400843207969,1.2889696460699844,0.11290322580645161,0.666371162332619,1.0,2/5,13.25%,CCNH;TAF1D
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.7912942559201368,1.2882866066822785,0.171875,0.6692813029489301,1.0,2/7,7.36%,MAP2;HSP90AA1
prerank,Reactome_2022__Mitotic G2-G2/M Phases R-HSA-453274,0.6028076875095612,1.2879864155679444,0.0958904109589041,0.6685805409931769,1.0,17/54,22.42%,CEP57;PSMC6;TUBB4B;HSP90AA1;RPS27A;CCNH;CDKN1A;CEP70;PSMA7;PPP1CB;ALMS1;CSNK1D;DYNC1H1;PAFAH1B1;CEP290;YWHAE;UBC
prerank,Reactome_2022__G2/M Transition R-HSA-69275,0.6028076875095612,1.2879864155679444,0.0958904109589041,0.6685805409931769,1.0,17/54,22.42%,CEP57;PSMC6;TUBB4B;HSP90AA1;RPS27A;CCNH;CDKN1A;CEP70;PSMA7;PPP1CB;ALMS1;CSNK1D;DYNC1H1;PAFAH1B1;CEP290;YWHAE;UBC
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.6947129851958262,-1.2867182169691807,0.1794871794871795,0.8572125114940561,1.0,1/14,0.16%,VCAM1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.6502953583764571,1.2866801148645715,0.1111111111111111,0.6749302438388536,1.0,9/32,17.50%,LAMC1;ATRNL1;LAMA5;PIK3R1;MICALL2;RAC1;PARVB;ACTN1;PXN
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.746229963047917,-1.2866459502729644,0.17647058823529413,0.8534689075059635,1.0,5/6,22.52%,GIMAP8;GIMAP4;RORA;CYLD;GIMAP7
prerank,Reactome_2022__Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,0.7462548906381964,1.2866020481007958,0.14102564102564102,0.6742945522592523,1.0,2/10,1.41%,PDK4;LDHA
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Uterus,0.6564964118888975,1.2865905289894555,0.11428571428571428,0.6733668005697204,1.0,4/19,3.51%,EHD4;BHLHE40;RRBP1;JUNB
prerank,Reactome_2022__E2F Mediated Regulation Of DNA Replication R-HSA-113510,0.8215033105335829,1.28638917810052,0.208955223880597,0.6736810010120328,1.0,1/6,5.87%,POLA1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Skin,0.7086215299752009,1.2862257233210308,0.14084507042253522,0.6735221114761937,1.0,7/15,13.39%,ERBB4;GPM6B;PTPRD;CTNND2;PPP1R9A;NRXN1;MAPK10
prerank,Reactome_2022__Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,0.6743386359613561,1.2860789230021688,0.11940298507462686,0.6724589664512847,1.0,9/22,20.61%,CEP57;TUBB4B;HSP90AA1;CEP70;ALMS1;CSNK1D;DYNC1H1;PAFAH1B1;CEP290
prerank,Reactome_2022__Centrosome Maturation R-HSA-380287,0.6743386359613561,1.2860789230021688,0.11940298507462686,0.6724589664512847,1.0,9/22,20.61%,CEP57;TUBB4B;HSP90AA1;CEP70;ALMS1;CSNK1D;DYNC1H1;PAFAH1B1;CEP290
prerank,Reactome_2022__Hedgehog On State R-HSA-5632684,0.6784366395319493,1.2860552889828454,0.17105263157894737,0.6715568903948266,1.0,4/25,10.78%,PSMC6;SPOPL;RPS27A;BOC
prerank,KEGG_2021_Human__Shigellosis,0.5690245827886946,1.2854231013152198,0.11494252873563218,0.6739918780435787,1.0,20/99,17.98%,PIK3R3;ITPR1;ARF1;PRKCE;ATG12;PIK3R1;RPS27A;JUN;BCAR1;ARPC2;TAB2;MAPK10;ITGB1;RAC1;CRK;ACTN1;MALT1;PXN;MYL12B;ARHGEF2
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.7958327486339984,1.285236575700448,0.125,0.6739468341229221,1.0,4/9,8.61%,GRIN2B;MBP;VSIR;PICALM
prerank,Reactome_2022__Signaling By VEGF R-HSA-194138,0.6299501366220166,1.2847542293641523,0.11842105263157894,0.6754351672338305,1.0,18/47,28.47%,ITPR1;PIK3R1;HSP90AA1;CTNNA1;FLT1;BCAR1;SHC2;CRK;ABI1;AHCYL1;VEGFC;CDH5;NCK1;FYN;MTOR;CDC42;PIK3CB;CALM1
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.6862560033416155,1.2846400086501824,0.140625,0.6750174890937191,1.0,5/18,13.47%,SERPINE1;SGIP1;RAB21;ANO6;NEDD4L
prerank,Reactome_2022__Viral mRNA Translation R-HSA-192823,0.6067022431993305,1.2845236839282996,0.07894736842105263,0.6746010233720116,1.0,11/48,15.51%,PBRM1;RPS11;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12
prerank,CellMarker_Augmented_2021__Activated B cell:Peripheral Blood,-0.7357747620919837,-1.2845214733914094,0.2727272727272727,0.8569944702858249,1.0,4/8,12.32%,TAP1;IRF1;NLRC5;HLA-C
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),0.6608970301688976,1.2840341508529876,0.09876543209876543,0.6763551147734321,1.0,6/27,11.55%,POLA1;RPS27A;RFC3;USP45;CCNH;COMMD1
prerank,CellMarker_Augmented_2021__Specialist Antigen Presenting cell:Undefined,-0.7729071900310163,-1.2840015236967333,0.17391304347826086,0.855457060471334,1.0,1/5,0.16%,VCAM1
prerank,CellMarker_Augmented_2021__Brown Adipogenic Precursor cell:Adipose Tissue,0.7000681651311963,1.2839142838807645,0.1044776119402985,0.6751053351147489,1.0,5/25,10.78%,DOK5;ANK2;MAP1B;NFASC;BOC
prerank,CellMarker_Augmented_2021__Beige Adipogenic Precursor cell:Adipose Tissue,0.7000681651311963,1.2839142838807645,0.1044776119402985,0.6751053351147489,1.0,5/25,10.78%,DOK5;ANK2;MAP1B;NFASC;BOC
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.9046728146790624,-1.2832011291105858,0.08333333333333333,0.8546197009966109,1.0,2/5,2.97%,RNF213;ZNRF3
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Endometrium,-0.6421851084043388,-1.283195941638896,0.21739130434782608,0.8468504309875508,1.0,7/12,6.69%,GBP4;IL32;IRF1;CASP10;PARP9;TNFSF10;SAT1
prerank,CellMarker_Augmented_2021__Trophoblast cell:Endometrium,-0.6421851084043388,-1.283195941638896,0.21739130434782608,0.8468504309875508,1.0,7/12,6.69%,GBP4;IL32;IRF1;CASP10;PARP9;TNFSF10;SAT1
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Intestine,0.6601775607053921,1.2827968383554982,0.09859154929577464,0.6800510443623579,1.0,10/33,16.68%,ANGPTL4;SERPINE1;MYO1B;EMP1;DSTN;BCAR1;WWTR1;NAV2;PLAT;SPRED1
prerank,Reactome_2022__ROS And RNS Production In Phagocytes R-HSA-1222556,-0.7365016183451969,-1.2825714759659956,0.23684210526315788,0.8454882433527987,1.0,1/5,9.54%,ATP6V1H
prerank,Reactome_2022__Serotonin Neurotransmitter Release Cycle R-HSA-181429,0.8076699798960858,1.2818854518975045,0.2,0.6838162060617392,1.0,3/8,8.50%,SYN3;SNAP25;PPFIA2
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.8122442531496029,1.2818505583889126,0.11594202898550725,0.6830077880334986,1.0,3/8,14.16%,CRTC3;IFNGR1;DYSF
prerank,PanglaoDB_Augmented_2021__Keratinocytes,0.8505603121788425,1.2818118757836838,0.09375,0.6822813467005029,1.0,2/5,6.72%,LAMA5;REL
prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,0.5950683542029337,1.2813368413631858,0.0641025641025641,0.6837681844510767,1.0,20/83,17.29%,ERBB4;GRIA2;PSMC6;HSPA5;MAP3K5;VAPB;GRIN2B;NDUFA12;NRG2;TUBB4B;PINK1;RB1CC1;NRG3;TUBA1B;RAC1;TUBB6;SRSF7;PSMA7;TPR;SLC1A2
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.8329165924759862,1.281025468059478,0.21621621621621623,0.68436119720675,1.0,3/5,10.57%,SLC8A1;ANK3;SLC12A6
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.889640584118742,1.280954852613304,0.03571428571428571,0.6837152492337824,1.0,3/6,4.75%,PCK1;GAPDH;PGK1
prerank,Reactome_2022__Peptide Ligand-Binding Receptors R-HSA-375276,0.8169208467228312,1.2806779969068414,0.10344827586206896,0.6840532081172235,1.0,1/7,3.90%,ANXA1
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.6954102783009236,-1.2806385101320477,0.18421052631578946,0.850065886953834,1.0,1/13,0.16%,VCAM1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.8393633570286669,1.2801201185366415,0.061224489795918366,0.6862249866571257,1.0,2/6,3.67%,PNP;HSPH1
prerank,CellMarker_Augmented_2021__Decidual cell:Placenta,0.6699985567723585,1.2799818682113617,0.1267605633802817,0.6858318573091394,1.0,5/24,7.62%,ANGPTL4;SERPINE1;PLOD2;EPS8;MYO1B
prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,0.6031047387465175,1.2799683481161375,0.24,0.684903594875272,1.0,13/49,13.52%,PIK3R3;KLF2;MAP3K5;PIK3R1;NFE2L2;HSP90AA1;DUSP1;HSP90B1;JUN;PECAM1;FOS;MAPK10;ACVR2A
prerank,Reactome_2022__RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,0.7351633459814348,1.2798798562485738,0.10606060606060606,0.6843559623494591,1.0,1/15,1.57%,ELL2
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone Marrow,-0.7825043049349131,-1.2796518133667312,0.2857142857142857,0.8500761568791986,1.0,2/5,5.52%,CD74;TNFSF10
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.6763435717288827,1.2790879783906457,0.19696969696969696,0.687647359219597,1.0,10/17,21.91%,MGAT4A;MCFD2;UBE2J1;TMEM165;MGAT5;FUT8;MGAT1;PMM2;B4GALT1;UGGT2
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.8237246654141512,1.2789145527392791,0.17543859649122806,0.6873643781240144,1.0,1/5,0.69%,SERPINE1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tooth,0.7917332371113175,1.2787991107925718,0.15,0.6871606118884388,1.0,2/6,14.98%,CD81;ALCAM
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.6234943776317811,1.2787909501474883,0.136986301369863,0.6852378566909634,1.0,13/45,21.22%,PSMC6;PIK3R1;GRB2;JUN;FOS;TAB2;MAPK10;PAK2;RAC1;PSMA7;MALT1;TEC;PPP3CB
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.6234943776317811,1.2787909501474883,0.136986301369863,0.6852378566909634,1.0,13/45,21.22%,PSMC6;PIK3R1;GRB2;JUN;FOS;TAB2;MAPK10;PAK2;RAC1;PSMA7;MALT1;TEC;PPP3CB
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.7729401145084402,-1.278463883360089,0.18181818181818182,0.8507205286209365,1.0,3/5,6.51%,PARP14;PARP9;ZC3HAV1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.8260880573242719,1.2782790390873107,0.1,0.6871461880661692,1.0,1/5,6.11%,FGFR1
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.6596344649517202,-1.278241032989056,0.25806451612903225,0.8475376931114937,1.0,1/8,5.87%,ZDHHC2
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.630640744598155,1.2781521833962861,0.16666666666666666,0.6869282804328909,1.0,9/32,20.29%,NEDD9;S1PR1;ANXA1;GRB2;MICALL2;BCAR1;PARVB;PTPN1;GSN
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.8354902279784333,1.2777055823190626,0.13636363636363635,0.6883616950250973,1.0,4/6,13.57%,KCNMB4;ANK2;ANK3;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.7840732588196953,1.2775070463049627,0.16417910447761194,0.6882982028139443,1.0,3/7,14.24%,CD81;HSP90AA1;PTTG1IP
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.8124481742838108,1.27721703360583,0.14285714285714285,0.6888715822048364,1.0,3/8,9.24%,PURA;POLA1;NOC3L
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.8260331887777016,1.2770924008462594,0.1694915254237288,0.6885284213215724,1.0,1/5,0.66%,PNP
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.8289580993300508,1.2768054154991781,0.16129032258064516,0.6872267071018602,1.0,1/6,5.79%,NDUFA12
prerank,Reactome_2022__Complex I Biogenesis R-HSA-6799198,0.8289580993300508,1.2768054154991781,0.16129032258064516,0.6872267071018602,1.0,1/6,5.79%,NDUFA12
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.8289580993300508,1.2768054154991781,0.16129032258064516,0.6872267071018602,1.0,1/6,5.79%,NDUFA12
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.7612335198673276,1.276568321548237,0.09230769230769231,0.6873657979159622,1.0,4/11,19.50%,PLS3;GJA1;TGM2;SULF2
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.8819134472122199,1.2765607622329647,0.04918032786885246,0.6864573223164961,1.0,2/5,11.47%,CALR;REST
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.7627131970543949,1.276260168913714,0.18840579710144928,0.687242985018756,1.0,4/11,14.74%,PRKCE;HYAL2;ITGB1;RAC1
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.763609250085904,1.2761632042075566,0.136986301369863,0.686920763902993,1.0,1/8,1.06%,PDK4
prerank,KEGG_2021_Human__Thermogenesis,0.6068718171955628,1.2755615092367758,0.17073170731707318,0.6889151410528107,1.0,12/51,15.91%,PRKAG2;MAP3K5;MGLL;NDUFA12;FGFR1;ACSL5;KDM1A;GRB2;SMARCC1;KRAS;ADCY2;ATF2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.7202073422462694,1.2755200561633373,0.22077922077922077,0.6881014324310541,1.0,3/17,5.15%,BCAP31;SLC8A1;CACNA1C
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Tooth,-0.6210787008158671,-1.275475328979946,0.18181818181818182,0.8548704050308069,1.0,2/15,7.01%,GBP4;GIMAP8
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreas,0.5997134141596767,1.2750687670432312,0.2054794520547945,0.6893698847603669,1.0,10/42,19.20%,EDEM3;UFL1;ZNF800;CBFB;RAD21;MTDH;ATF2;TRAM1;ARFGEF2;NR1D2
prerank,Reactome_2022__Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.7945230699455668,1.2746611541972943,0.11764705882352941,0.6896848635797094,1.0,2/8,5.82%,GPC5;HS6ST3
prerank,Reactome_2022__HS-GAG Biosynthesis R-HSA-2022928,0.7945230699455668,1.2746611541972943,0.11764705882352941,0.6896848635797094,1.0,2/8,5.82%,GPC5;HS6ST3
prerank,CellMarker_Augmented_2021__Gonadal Endothelial cell:Fetal Gonad,0.5431568353392582,1.2745330099254824,0.021505376344086023,0.6893771743827657,1.0,73/227,23.13%,LAMC1;ANGPTL4;ADM;PNP;ADAMTS9;PLS3;AKAP12;DIXDC1;PDK4;NEDD9;KLF6;RAPGEF5;TIMP3;LBR;BAZ1A;DUSP6;ASAP2;HYAL2;TMEM184B;REL;NAV1;NAV3;MYO1B;SSH1;KLF4;CRIP2;GGT5;RFC3;LRRC32;FKBP5;ADAM15;ANXA2;PELI1;DENND3;DOCK4;LRRFIP1;GRB10;WWTR1;SH2D3C;TUBB6;FOXC1;ADD3;PLAT;PLXNA2;FRMD4A;LIMS1;HDAC7;PXN;TPST2;MIDN;ARHGEF2;FZD4;PDE4B;NFIB;EGFL7;HBP1;WIPF1;SOCS3;ELK3;RASIP1;ACTB;EDIL3;PGS1;CDC37;TFPI;MTSS1;ETS1;NARF;FAM171A1;TAGLN2;MEF2C;PREX1;ABCG1
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.9175860051046747,1.2743518297668106,0.04477611940298507,0.6893288923016369,1.0,2/5,6.14%,PIK3R3;PIK3R1
prerank,CellMarker_Augmented_2021__Progenitor cell:Prostate,-0.7984510111250955,-1.2742630871020857,0.23809523809523808,0.8558803905579518,1.0,2/5,7.68%,ABCG2;LAMA3
prerank,CellMarker_Augmented_2021__Granulosa cell:Undefined,0.6497543043330135,1.2742121737782954,0.10294117647058823,0.6890225337206821,1.0,15/40,22.34%,AKAP12;NES;MAP1B;TIMP3;NAV1;DLC1;COL4A2;GJA1;NAV2;PLAT;AFAP1L1;FZD4;EDIL3;CALD1;SPARC
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreas,0.6490758094329941,1.2739538435310604,0.17567567567567569,0.6896877636462057,1.0,13/29,21.86%,GPM6B;LSAMP;PTPRD;ROBO2;PPP1R9A;CNTNAP2;MAGI2;NRXN1;SULT1C4;ADCY2;KALRN;GRIA4;PLP1
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.7920527165268915,1.2738558405605989,0.08771929824561403,0.6892605738298454,1.0,2/8,7.38%,NES;KDM1A
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.6886862485267112,-1.2736178208547797,0.1891891891891892,0.854192489224308,1.0,1/10,0.05%,RSAD2
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Adipose Tissue,-0.6794589754822915,-1.273597314929782,0.23255813953488372,0.8505929902796084,1.0,1/9,0.16%,VCAM1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.8592131878391986,1.2733618735308088,0.10526315789473684,0.6910581579948616,1.0,1/7,0.72%,ERBB4
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.7794466349739239,1.273046699664774,0.1506849315068493,0.691974697314097,1.0,3/10,2.92%,HSPA5;BCAP31;ANK2
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.8631965408654598,1.273038944246363,0.11864406779661017,0.691048320567774,1.0,3/5,12.91%,CALR;GJA1;AGO2
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.6371569845754053,1.273013671835907,0.15294117647058825,0.690260045523073,1.0,3/32,8.07%,DIXDC1;WNT2B;RPS27A
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Lung,0.5891126199522727,1.2729815078765898,0.10843373493975904,0.6894889541131836,1.0,14/50,18.91%,SERPINE1;PLS3;PLOD2;EPS8;TINAGL1;PLSCR4;EMP1;DSTN;BCAR1;PON2;WWTR1;AFAP1L1;NPAS2;NFIB
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.6973326103751325,1.2729780333866132,0.16216216216216217,0.6885546872376914,1.0,9/20,22.28%,BCAP31;SLC8A1;CACNA1C;ATP2B1;CD55;ABL2;ATP2B4;CAV2;YWHAE
prerank,Reactome_2022__Signaling By B Cell Receptor (BCR) R-HSA-983705,0.6268763346205136,1.2725433874846894,0.1728395061728395,0.6899185262012628,1.0,14/43,23.82%,PSMC6;ITPR1;PIK3R1;REL;RPS27A;GRB2;PSMA7;MALT1;SH3KBP1;AHCYL1;PPP3CB;UBC;NCK1;FYN
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.6983840626190047,1.2724987679785897,0.1095890410958904,0.6892259398418941,1.0,1/15,0.32%,NRCAM
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.8780876803596682,1.2724786712426464,0.05555555555555555,0.688400553312239,1.0,3/5,11.58%,IL1RAPL1;PTPRD;NRXN1
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.7749079419341063,1.2722168668693072,0.14492753623188406,0.6888326129139432,1.0,1/8,1.54%,SUN2
prerank,Reactome_2022__Mitotic G1 Phase And G1/S Transition R-HSA-453279,0.6500402637599684,1.2721569974242914,0.16049382716049382,0.6881592075251428,1.0,7/34,11.87%,PSMC6;POLA1;RPS27A;CDK6;CDKN1B;CCNH;CDKN1A
prerank,Reactome_2022__Chaperone Mediated Autophagy R-HSA-9613829,0.7295955121239434,1.2720726659854575,0.20967741935483872,0.6876962535523538,1.0,7/11,22.42%,PLIN2;HSP90AA1;RPS27A;LAMP2;EEF1A1;HSPA8;UBC
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.6450768125944998,1.2720698103790595,0.125,0.6867731713328203,1.0,11/40,15.27%,RAPGEF5;BCR;CCDC88A;RASSF1;GRB2;JUN;CDKN1A;SHC2;KRAS;RAC1;SHOC2
prerank,KEGG_2021_Human__Complement and coagulation cascades,0.7691487937333881,1.272010485593545,0.12698412698412698,0.6860011937407762,1.0,5/10,16.04%,SERPINE1;VWF;CFH;CD55;PLAT
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Breast,0.6218496733497758,1.2719667910001917,0.1323529411764706,0.6844041379022558,1.0,5/28,9.27%,SERPINE1;TIMP3;PLSCR4;COL4A2;EMP1
prerank,CellMarker_Augmented_2021__Stem cell:Placenta,0.6218496733497758,1.2719667910001917,0.1323529411764706,0.6844041379022558,1.0,5/28,9.27%,SERPINE1;TIMP3;PLSCR4;COL4A2;EMP1
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.7826991773846576,1.2716903349540343,0.1724137931034483,0.6848671021444562,1.0,1/6,5.15%,CACNA1C
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.6963288488816677,1.2716071110828242,0.14705882352941177,0.6842052692203107,1.0,3/15,9.19%,TSG101;RPL23;LAMP2
prerank,CellMarker_Augmented_2021__Colony-forming cell:Prostate,0.5894046375332527,1.271316819807143,0.07407407407407407,0.6845934451753787,1.0,7/59,9.27%,PLS3;CD9;ASAP2;TINAGL1;MYO1B;BACE2;EMP1
prerank,CellMarker_Augmented_2021__Fibroblast:Embryonic Stem Cell,0.6330393717638323,1.2712834150884278,0.19444444444444445,0.6784615020853264,1.0,9/30,10.78%,DOK5;SPOCK1;NES;ANK2;MAP1B;NFASC;COL4A2;GJA1;BOC
prerank,CellMarker_Augmented_2021__Fibroblast:Synovium,0.6330393717638323,1.2712834150884278,0.19444444444444445,0.6784615020853264,1.0,9/30,10.78%,DOK5;SPOCK1;NES;ANK2;MAP1B;NFASC;COL4A2;GJA1;BOC
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Pancreas,0.6330393717638323,1.2712834150884278,0.19444444444444445,0.6784615020853264,1.0,9/30,10.78%,DOK5;SPOCK1;NES;ANK2;MAP1B;NFASC;COL4A2;GJA1;BOC
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Blood Vessel,0.6330393717638323,1.2712834150884278,0.19444444444444445,0.6784615020853264,1.0,9/30,10.78%,DOK5;SPOCK1;NES;ANK2;MAP1B;NFASC;COL4A2;GJA1;BOC
prerank,CellMarker_Augmented_2021__Testis Somatic cell:Testis,0.6330393717638323,1.2712834150884278,0.19444444444444445,0.6784615020853264,1.0,9/30,10.78%,DOK5;SPOCK1;NES;ANK2;MAP1B;NFASC;COL4A2;GJA1;BOC
prerank,CellMarker_Augmented_2021__Spermatogonial Stem cell:Embryo,0.6330393717638323,1.2712834150884278,0.19444444444444445,0.6784615020853264,1.0,9/30,10.78%,DOK5;SPOCK1;NES;ANK2;MAP1B;NFASC;COL4A2;GJA1;BOC
prerank,CellMarker_Augmented_2021__Retinal Ganglion cell:Embryonic Stem Cell,0.6330393717638323,1.2712834150884278,0.19444444444444445,0.6784615020853264,1.0,9/30,10.78%,DOK5;SPOCK1;NES;ANK2;MAP1B;NFASC;COL4A2;GJA1;BOC
prerank,Reactome_2022__Signaling By Erythropoietin R-HSA-9006335,0.7145578800892047,1.2712090868885335,0.18840579710144928,0.6778451733428804,1.0,2/12,8.31%,PIK3R1;GRB2
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.8223936036030921,1.2710595352438985,0.11864406779661017,0.6777702667607709,1.0,2/6,11.37%,RFTN1;ANXA2
prerank,Reactome_2022__Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.6282717503917641,1.2710587435612648,0.07692307692307693,0.6768942056858772,1.0,5/43,7.38%,MAFF;DOCK3;MAFK;ZFPM2;KDM1A
prerank,GO_Biological_Process_2021__cardiac atrium development (GO:0003230),0.8641754979928291,1.27100867165407,0.11475409836065574,0.6762387075422849,1.0,1/5,2.92%,ANK2
prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,-0.5432578273767721,-1.2704374808727426,0.11538461538461539,0.8579149243121506,1.0,7/52,5.42%,GBP1;GBP4;GBP2;PLCB4;STAT1;OAS3;NOD1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.7351742857764515,1.2703293181249353,0.11290322580645161,0.6780821394635455,1.0,1/14,1.57%,ELL2
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.7351742857764515,1.2703293181249353,0.11290322580645161,0.6780821394635455,1.0,1/14,1.57%,ELL2
prerank,CellMarker_Augmented_2021__Platelet:Blood,0.6991767232460185,1.2702270240440166,0.13043478260869565,0.6777465235598511,1.0,5/15,13.68%,CD9;LAMP2;PECAM1;LRRC32;ITGB1
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.7065191427243288,1.270166000069992,0.2054794520547945,0.6771946601369739,1.0,4/10,16.52%,PCK1;ADAM15;ADCY2;GOLPH3
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,0.8157320432015793,1.2700117989239708,0.14925373134328357,0.6770634611222875,1.0,2/7,7.04%,BCL6;PINK1
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.6667160644348249,1.2700069260221154,0.17105263157894737,0.6761963052989078,1.0,6/20,20.56%,ADM;SMAD7;FLT1;RASA1;EGFL7;RASIP1
prerank,Reactome_2022__Cellular Response To Starvation R-HSA-9711097,0.5870648246352073,1.2695398771762239,0.1125,0.6775374277498636,1.0,11/61,15.51%,ATF3;RPS11;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12
prerank,Reactome_2022__Cilium Assembly R-HSA-5617833,0.5847859723998644,1.2693897469855568,0.14285714285714285,0.6776222906324924,1.0,4/46,7.36%,CEP57;RAB11FIP3;TUBB4B;HSP90AA1
prerank,Reactome_2022__TP53 Regulates Metabolic Genes R-HSA-5628897,0.6520337063651381,1.269213728181975,0.175,0.6775918849860688,1.0,2/26,1.91%,DDIT4;PRKAG2
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.6862461426546527,1.2691333436245429,0.15714285714285714,0.6770301485455027,1.0,5/19,15.19%,MTHFD1L;NSMAF;MTHFD2L;BTD;PLPP1
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.7611808373211741,1.2689696321052026,0.16666666666666666,0.677072306802331,1.0,2/7,5.15%,NES;CACNA1C
prerank,Reactome_2022__Signaling By NTRKs R-HSA-166520,0.6112864951244728,1.2688667678058263,0.14864864864864866,0.6767132474855373,1.0,13/52,18.57%,DOCK3;GRIN2B;DUSP6;PIK3R1;JUND;GRB2;RAP1A;REST;FOS;SHC2;CRK;TF;STAT3
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.7901230545710839,1.26861969172391,0.14516129032258066,0.6770990696326223,1.0,4/6,19.10%,FGFR1;GNA13;FLT1;ABL2
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.6534509110420537,1.2685455444869607,0.13580246913580246,0.6766980360754974,1.0,11/30,20.29%,SLC2A1;VWF;HIF1A;LRRC32;ITGB1;DYSF;TNS1;KCTD12;PSAP;EGFL7;GSN
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.8193024993102926,1.2685299594066946,0.1076923076923077,0.675898474824221,1.0,3/8,7.68%,ANK2;CACNA1C;CTNNA3
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.8567920341533651,1.2684438258620128,0.09836065573770492,0.67540025378709,1.0,1/6,6.32%,NFE2L2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.7781931610476394,1.2683781337827258,0.1111111111111111,0.6748890785180045,1.0,2/9,6.27%,DDIT4;SMAD7
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.6598982698964379,1.2680248083787096,0.17142857142857143,0.6757865102212895,1.0,14/26,22.87%,SLC8A1;ANK2;CALR;VAPB;ATP2B1;ATP1A1;ATP1B3;TMEM165;NEDD4L;SLC30A1;ATP2B4;ATP13A3;CDH5;ATP1B1
prerank,Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,0.5400153565534216,1.2677181022818884,0.06593406593406594,0.6762841302102646,1.0,38/177,17.37%,PIK3R3;ERBB4;PSMC6;RRBP1;WDR48;DUSP6;NRG2;FGFR1;PIK3R1;ESR2;HSP90AA1;TPM4;RPS27A;GRB2;CDKN1B;NRG3;JAG2;MIB1;VWF;RAP1A;PEBP1;CCNC;CDKN1A;TRAK1;DUSP16;LRRFIP1;TENT4A;ERBIN;MPRIP;SHOC2;NCOR2;PSMA7;SND1;TNKS;SPRED1;TPR;PPP1CB;HDAC7
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.7512406746453206,1.2673603556152975,0.15492957746478872,0.6774752366565209,1.0,4/14,14.08%,CPEB4;PRNP;PINK1;RASA1
prerank,CellMarker_Augmented_2021__Cancer cell:Lung,0.8361157057011951,1.2668356502885787,0.2,0.6781512234129484,1.0,2/5,16.10%,LAMA5;SEMA3F
prerank,CellMarker_Augmented_2021__Epithelial cell:Blood,0.8361157057011951,1.2668356502885787,0.2,0.6781512234129484,1.0,2/5,16.10%,LAMA5;SEMA3F
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.6390976719773378,1.26645876639434,0.1891891891891892,0.6793636485407234,1.0,8/22,18.03%,SMAD7;PINK1;KDM1A;COMMD1;PTTG1IP;NDFIP1;MALT1;CRY1
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.6336917060358066,-1.2664446122392847,0.18181818181818182,0.8693488251328978,1.0,2/13,7.22%,UBE3D;TRIM25
prerank,CellMarker_Augmented_2021__Limbal Mesenchymal cell:Sclerocorneal Tissue,-0.5150780013862396,-1.265804801750816,0.15384615384615385,0.867760882427046,1.0,4/39,6.75%,VCAM1;LIMS2;PODN;ZNF521
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.7395753484587173,1.2657497697940365,0.15492957746478872,0.6817720497434608,1.0,2/10,6.27%,ROBO2;SMAD7
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR1 R-HSA-5654687,0.7869017765769639,1.2655643443883398,0.18181818181818182,0.6818637874644232,1.0,3/9,8.31%,FGFR1;PIK3R1;GRB2
prerank,Reactome_2022__Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,0.6159956459094422,1.2654249068390169,0.14473684210526316,0.6815753808044911,1.0,15/54,22.42%,PSMC6;ITPR1;PIK3R1;RPS27A;GRB2;JUN;FOS;TAB2;MAPK10;PSMA7;MALT1;TEC;AHCYL1;PPP3CB;UBC
prerank,Reactome_2022__Complement Cascade R-HSA-166658,0.7807088027588931,1.2654114143634845,0.125,0.6807536925731803,1.0,5/9,16.02%,CD81;PIKFYVE;CFH;CD55;PSMA7
prerank,Reactome_2022__Scavenging By Class A Receptors R-HSA-3000480,0.8494478890563792,1.2650376288084262,0.09230769230769231,0.6822358533725205,1.0,3/6,9.56%,CALR;COL4A2;HSP90B1
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.8791716998826735,1.2649302166743328,0.11666666666666667,0.6817378086880245,1.0,1/5,8.29%,CDK6
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.6070321021832977,1.2646672544421822,0.08108108108108109,0.6820670059563175,1.0,10/51,17.18%,LAMC1;TIMP3;EPS8;COL4A2;EMP1;WWTR1;ZC3H7A;NAV2;PLAT;AFAP1L1
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.8104494090207588,-1.2646081782429839,0.2564102564102564,0.8687216251093964,1.0,1/6,4.36%,EZH1
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.6205754961011131,1.2641688760915661,0.13414634146341464,0.6836118138528238,1.0,13/50,20.19%,TBX3;CALR;ZFPM2;SMAD7;CDK6;TRIB2;REST;WWTR1;SPRED1;HDAC7;GATA2;NOTCH4;SMAD6
prerank,KEGG_2021_Human__Dopaminergic synapse,0.6124071843227815,1.2640841706691857,0.13924050632911392,0.6831278824710229,1.0,6/47,5.15%,GRIA2;PPP2R3A;ITPR1;PPP2R2B;GRIN2B;CACNA1C
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.7646024062473952,1.264048192435473,0.171875,0.682394124252696,1.0,1/12,0.69%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.7624154519508654,-1.2636057431746979,0.1276595744680851,0.8685558303745018,1.0,1/7,0.05%,RSAD2
prerank,Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057,0.5640209510597917,1.2635337665881439,0.10714285714285714,0.6840302047363649,1.0,23/102,17.24%,ERBB4;PSMC6;LRRC7;GRIN2B;DUSP6;NRG2;FGFR1;PIK3R1;JAK1;RPS27A;GRB2;NRG3;VWF;JUN;RAP1A;PEBP1;AGO2;SHC2;DUSP16;SHOC2;PSMA7;SPRED1;PPP1CB
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.5917356913173428,1.2633678628000968,0.21052631578947367,0.684006662855901,1.0,11/36,22.90%,CALR;FGFR1;HIF1A;BCAR1;RAC1;ATOH8;GATA2;ANXA3;SPARC;ETS1;SCARB1
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.7656358906842498,1.263355893269161,0.15492957746478872,0.6832189840100086,1.0,2/10,5.60%,ANXA1;BCR
prerank,Reactome_2022__Signaling To RAS R-HSA-167044,0.771498004960314,1.2631961021791933,0.22580645161290322,0.6830716226121308,1.0,2/6,12.96%,GRB2;SHC2
prerank,KEGG_2021_Human__Toxoplasmosis,0.6174671551565721,1.2629467595288848,0.1917808219178082,0.6831602451290418,1.0,11/31,20.58%,LAMC1;LAMA5;JAK1;IFNGR1;TAB2;MAPK10;ITGB1;STAT3;IFNGR2;BCL2L1;HSPA8
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.8228431597733579,1.262793569894655,0.17391304347826086,0.6829717977079136,1.0,3/6,17.16%,RTN4;REEP3;RTN3
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.656659907252439,1.262704114480471,0.11688311688311688,0.6825626174620645,1.0,10/35,9.77%,ATF3;ITPR1;HSPA5;BCAP31;MAP3K5;UFL1;PIK3R1;ERO1A;HSP90B1;JUN
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.726236627630762,1.2624262737855854,0.15584415584415584,0.6829967416686001,1.0,4/14,3.90%,SLC8A1;ANK2;MGLL;ANXA1
prerank,CellMarker_Augmented_2021__Basal cell:Lung,0.7687862430091692,1.2619914160806203,0.109375,0.6842986052332131,1.0,3/9,16.04%,ATP1B3;TUBB6;PLAT
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.8215832817893203,1.2619347902438631,0.14285714285714285,0.6837928861200903,1.0,3/6,16.04%,PGK1;VSIR;PLAT
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.7631096647341574,1.261319485698284,0.17567567567567569,0.6863561351623245,1.0,2/12,7.09%,ST18;JAK1
prerank,KEGG_2021_Human__DNA replication,0.8560308609486693,1.261302131793489,0.18571428571428572,0.685601808503347,1.0,2/5,10.23%,POLA1;RFC3
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Uterus,0.574726846227134,1.2612368742072548,0.14666666666666667,0.6851100766957144,1.0,20/62,22.20%,TIMP3;SYTL4;TINAGL1;ATP8B1;PLSCR4;DLC1;EMP1;VWF;CFH;WWTR1;PLAT;AFAP1L1;NPAS2;FZD4;TM4SF18;NFIB;RBMS2;EPAS1;CDH5;CAV2
prerank,Reactome_2022__EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,0.7318712058758371,1.2611387089189117,0.18840579710144928,0.6848251437695613,1.0,1/11,0.24%,LAMC1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.7720367302216038,1.260387582632088,0.22033898305084745,0.6850153187917638,1.0,1/6,0.50%,B3GNT2
prerank,Reactome_2022__Keratan Sulfate Biosynthesis R-HSA-2022854,0.7720367302216038,1.260387582632088,0.22033898305084745,0.6850153187917638,1.0,1/6,0.50%,B3GNT2
prerank,Reactome_2022__Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.7720367302216038,1.260387582632088,0.22033898305084745,0.6850153187917638,1.0,1/6,0.50%,B3GNT2
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.7720367302216038,1.260387582632088,0.22033898305084745,0.6850153187917638,1.0,1/6,0.50%,B3GNT2
prerank,Reactome_2022__Nuclear Events Mediated By NFE2L2 R-HSA-9759194,0.6599816984331154,1.2603256366962103,0.1282051282051282,0.6844734465977558,1.0,6/25,16.02%,PSMC6;MAFK;NFE2L2;RPS27A;TXNRD1;PSMA7
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.5611904691108882,1.2599089443589297,0.08045977011494253,0.6861504619048184,1.0,29/73,27.33%,SERPINE1;PDK4;FES;RAPGEF3;CPEB4;INSIG1;SSH1;HSP90B1;JUN;RAP1A;FOS;TGM2;PXN;FZD4;PDE4B;RYR3;ABL2;ATP2B4;ACTB;ZFP36;SETX;MEF2C;ADAM9;MTOR;SLC38A9;EGFR;CAPN2;VCP;AKAP6
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.7311281259005317,1.2597422755558358,0.12121212121212122,0.6859754020857833,1.0,7/11,20.58%,SYN3;SNAP25;DNAJC5;NRXN1;SYT1;RIMS2;HSPA8
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.6511065556477191,1.2597411429095637,0.1794871794871795,0.6851357749106477,1.0,2/22,9.14%,KHDRBS3;YTHDC1
prerank,CellMarker_Augmented_2021__Progenitor cell:Corneal Epithelium,0.6347670174829477,1.2596373150778608,0.15384615384615385,0.6848132812654483,1.0,7/26,14.34%,SERPINE1;ATP8B1;EMP1;ANXA2;ANO6;ITGB1;REEP3
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.6204096585850907,1.2591835018471125,0.13333333333333333,0.6860890831779658,1.0,15/38,22.44%,ANGPTL4;TBX3;TIMP3;LAMA5;EPS8;PLSCR4;SHC2;CD55;TNS1;FZD4;TF;DIAPH2;GSN;EPAS1;COL18A1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.8524669388734325,1.2589132583657243,0.1746031746031746,0.6867938622465446,1.0,3/5,8.02%,MT1M;PRNP;MT2A
prerank,Reactome_2022__Mitotic Prometaphase R-HSA-68877,0.6100557332687768,1.2587915009657837,0.11538461538461539,0.6864840326480767,1.0,20/49,25.87%,CEP57;TUBB4B;HSP90AA1;RAD21;WAPL;AHCTF1;CEP70;ALMS1;RPS27;CSNK1D;DYNC1H1;PAFAH1B1;CEP290;TAOK1;YWHAE;SPC25;XPO1;SMC3;TUBB;CDK5RAP2
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.6634443867017128,1.2587786631617002,0.17391304347826086,0.6857298266869485,1.0,4/22,13.31%,RFTN1;RPS27A;HSP90B1;TAB2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.5694275609470634,1.2585290228278723,0.15294117647058825,0.6860417734894868,1.0,8/53,8.79%,SEC22B;BCAP31;ANK2;VAPB;SEC24D;MCFD2;TMED10;ANK3
prerank,KEGG_2021_Human__Legionellosis,0.7002326415597931,1.258476146716485,0.16176470588235295,0.6854514074995749,1.0,2/12,4.54%,SEC22B;ARF1
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.8348472014860309,1.258380827408395,0.171875,0.6850506291153776,1.0,2/5,10.23%,POLA1;RFC3
prerank,KEGG_2021_Human__Glycosaminoglycan biosynthesis,0.6917888653422846,1.2582794652681253,0.16176470588235295,0.6845837037734741,1.0,4/15,7.01%,B3GNT2;CHSY1;HS6ST3;CHST11
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.7876246971835421,1.25823301119176,0.13333333333333333,0.684104500392776,1.0,2/6,15.99%,POLA1;BRD4
prerank,Reactome_2022__Signaling By FLT3 Fusion Proteins R-HSA-9703465,0.7234683115822088,1.2578196801934383,0.1323529411764706,0.6851798162194545,1.0,3/12,11.87%,PIK3R1;GRB2;CDKN1A
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.5623067177864033,1.2578150757918247,0.1111111111111111,0.6843934272569463,1.0,16/60,16.18%,RRBP1;RPS11;RPS18;RPS9;RPS27A;RPL23;GGT5;RPL8;RPL34;RPL37;RPLP2;AGO2;EEF1A1;RPL13A;RPS12;DMD
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.7691686824683955,-1.2578148371754898,0.20588235294117646,0.8872266388775002,1.0,2/7,9.35%,IRF1;OTUD4
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.6104879911577155,1.2576630433931986,0.07692307692307693,0.6845039715779313,1.0,13/36,13.39%,GRIA2;MAP2;CADM2;ANK2;MAP1B;LSAMP;PTPRD;NFASC;SNAP25;PPFIA2;MAGI2;NRXN1;MAPK10
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.7245884428368726,1.2576094491333616,0.15151515151515152,0.6838670583061586,1.0,4/9,23.61%,CBFB;FOXC1;ZFP36;PRKCH
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.5777799386876545,-1.2572624905913667,0.23333333333333334,0.8857482639499911,1.0,2/16,5.42%,EIF2AK2;NOD1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.7486496592577994,1.2569671514417282,0.19444444444444445,0.6863767700049426,1.0,3/11,7.68%,ANK2;CACNA1C;CTNNA3
prerank,KEGG_2021_Human__JAK-STAT signaling pathway,0.6009951156019403,1.2566700681178928,0.09876543209876543,0.6869370980502486,1.0,6/41,11.87%,PIK3R3;PIK3R1;JAK1;GRB2;IFNGR1;CDKN1A
prerank,Reactome_2022__RHOD GTPase Cycle R-HSA-9013405,0.6557297406897022,1.2566010403270376,0.189873417721519,0.6865388632091055,1.0,6/23,8.42%,AKAP12;VAPB;LBR;PIK3R1;ARHGAP21;SLC4A7
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.8218936691799723,1.256512478886777,0.23880597014925373,0.6861681398017538,1.0,2/5,6.32%,BCAP31;NFE2L2
prerank,Reactome_2022__Collagen Chain Trimerization R-HSA-8948216,-0.7541842498864013,-1.2563538339112474,0.4,0.8858597503556295,1.0,1/5,0.21%,COL8A1
prerank,Reactome_2022__Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,0.6665677997193954,1.2557935899030526,0.2112676056338028,0.6889283489252326,1.0,7/21,15.64%,SERPINE1;SMAD7;RPS27A;PPM1A;NEDD4L;WWTR1;NCOR2
prerank,KEGG_2021_Human__Choline metabolism in cancer,0.5971296135700516,1.2557652075596055,0.15714285714285714,0.6882112329888035,1.0,12/40,15.19%,PIK3R3;CHPT1;PIK3R1;GRB2;JUN;HIF1A;FOS;MAPK10;KRAS;RAC1;DGKI;PLPP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.7752884528550179,1.2556660331945626,0.19480519480519481,0.687866303588583,1.0,3/10,6.27%,SLC8A1;ANK2;SMAD7
prerank,Reactome_2022__Signaling By Interleukins R-HSA-449147,0.5388298737440654,1.2552636856590764,0.08139534883720931,0.6887908826274698,1.0,26/138,13.68%,PIK3R3;PSMC6;BCL6;CANX;S1PR1;IL1RAPL1;ANXA1;LAMA5;DUSP6;PIK3R1;SNAP25;JAK1;HSP90AA1;RPS27A;GRB2;HSP90B1;JUN;HIF1A;HSPA9;ANXA2;CDKN1A;FOS;PELI1;TAB2;MAPK10;ITGB1
prerank,Reactome_2022__RHO GTPases Activate ROCKs R-HSA-5627117,0.7162378005871924,1.2551244611593537,0.23529411764705882,0.6886440806566105,1.0,5/12,19.60%,MYL6;MYH10;PPP1CB;MYL12B;LIMK2
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.7579123218208804,-1.2549939768953553,0.2571428571428571,0.8877923790934771,1.0,2/8,9.88%,PLA2G4A;GNA14
prerank,KEGG_2021_Human__IL-17 signaling pathway,0.6368753149012707,1.2548851992728773,0.13432835820895522,0.6889327015552463,1.0,7/21,13.39%,HSP90AA1;JUND;HSP90B1;JUN;FOS;TAB2;MAPK10
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.6670033384417444,-1.2547300203360705,0.23684210526315788,0.8849537106295566,1.0,1/6,4.59%,MTERF1
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.748409551197431,-1.2546374640445492,0.3055555555555556,0.8814844770604925,1.0,1/5,3.05%,IFI27
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.7278530730721632,-1.254118804480918,0.21052631578947367,0.8799675279142634,1.0,1/7,0.35%,SLCO1A2
prerank,Reactome_2022__COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,0.6535241641035808,1.254117656754615,0.19736842105263158,0.6921176838397418,1.0,1/16,1.04%,SEC22B
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.8056630887622405,1.2540530785536501,0.2028985507246377,0.6915334163592699,1.0,3/6,17.00%,RTN4;AHCTF1;TPR
prerank,CellMarker_Augmented_2021__Epithelial cell:Embryoid Body,0.6052931692893245,1.2539645253595728,0.15492957746478872,0.6911870028275694,1.0,11/44,16.18%,PLS3;PPP2R3A;ANK2;TIMP3;COL4A2;GJA1;BOC;CTTNBP2NL;PCDH7;NAV2;DMD
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.7744777131654902,1.2537576491325606,0.1896551724137931,0.6912219368713718,1.0,3/8,11.85%,SLC2A13;PICALM;IFNGR1
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Undefined,0.7809410060973081,1.253697453462129,0.22727272727272727,0.6906801184638433,1.0,2/6,10.68%,REL;LRRC32
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.8573942122271823,1.2535485620245752,0.17142857142857143,0.6898095188312319,1.0,3/5,14.21%,LBR;INSIG1;LSS
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.8573942122271823,1.2535485620245752,0.17142857142857143,0.6898095188312319,1.0,3/5,14.21%,LBR;INSIG1;LSS
prerank,Reactome_2022__Integration Of Provirus R-HSA-162592,0.7955732592054788,1.2533764297948855,0.23880597014925373,0.6888517049364591,1.0,1/5,4.67%,SGIP1
prerank,Reactome_2022__Early Phase Of HIV Life Cycle R-HSA-162594,0.7955732592054788,1.2533764297948855,0.23880597014925373,0.6888517049364591,1.0,1/5,4.67%,SGIP1
prerank,KEGG_2021_Human__Tight junction,0.5843445988474277,1.2529992354755495,0.1282051282051282,0.6896839137257393,1.0,23/60,20.82%,PRKAG2;PPP2R2B;MAP3K5;PRKCE;YBX3;MICALL2;JUN;RAP1A;MYL6;MYH10;CLDN5;ARPC2;MAPK10;NEDD4L;ITGB1;TUBA1B;RAC1;ACTN1;MYL12B;ARHGEF2;NEDD4;AFDN;ACTB
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.5435225575658756,1.2529886461696105,0.08421052631578947,0.688939494746993,1.0,40/147,20.19%,ST18;RTN4;ERBB4;BCL6;BNIP3L;PPM1D;PBRM1;CD9;HYAL2;ESR2;DLC1;CDK6;DUSP1;KLF4;ITGA1;CDKN1B;GJA1;ADAM15;MAGI2;REST;CDKN1A;ADGRG1;RASA1;DYSF;CTTNBP2NL;PLPP1;CRLF3;PLXNA2;ACTN1;BTG2;NPAS2;TMBIM6;PODXL;NACC2;ABI1;RERG;NOTCH4;CHMP4B;NPM1;SMAD6
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.7758061379771105,1.2529050836626845,0.13432835820895522,0.688417797042564,1.0,5/9,20.66%,RTN4;ANO6;AHCTF1;TPR;AFDN
prerank,Reactome_2022__Downregulation Of ERBB4 Signaling R-HSA-1253288,0.7985510491834502,1.2527525513324478,0.18181818181818182,0.6882348884521223,1.0,2/7,8.07%,ERBB4;RPS27A
prerank,Reactome_2022__Signaling By NOTCH2 R-HSA-1980145,0.7001184934971627,1.2527303238907708,0.136986301369863,0.6875336807581833,1.0,4/14,9.61%,CNTN1;RPS27A;JAG2;MIB1
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.6010700891355947,-1.25206677642868,0.14814814814814814,0.8843333364766128,1.0,3/16,4.62%,MGMT;BABAM2;SLF2
prerank,KEGG_2021_Human__Coronavirus disease,0.5492595355734454,1.2518065751730894,0.06578947368421052,0.6909402200904783,1.0,17/87,13.39%,PIK3R3;RPS11;PIK3R1;RPS18;RPS9;JAK1;RPS27A;RPL23;VWF;JUN;FOS;RPL8;RPL34;RPL37;RPLP2;TAB2;MAPK10
prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,0.6105031840282183,1.251748204483411,0.16455696202531644,0.690276305803832,1.0,21/49,23.88%,ITPR1;KCNMB4;SLC8A1;PRKCE;CACNA1C;PDE5A;ATP2B1;GNA13;ATP1A1;ATP1B3;ADCY2;ATF2;PPP1CB;ATP2B4;PPP3CB;ADCY9;PLCB1;ATP1B1;MEF2C;PPP3CC;CREB3L2
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.832214467438902,1.250785644340996,0.13793103448275862,0.6940206243820393,1.0,3/8,13.71%,RTN4;CCDC88A;HIP1R
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.7482207728300748,-1.2506184281850792,0.17073170731707318,0.8852171117797409,1.0,3/5,12.83%,MRPS31;GSPT1;PTCD3
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.7441942921783531,1.2504370235922944,0.1791044776119403,0.6946067251532034,1.0,4/10,19.28%,MAP2;HSP90AA1;RASA1;ESAM
prerank,CellMarker_Augmented_2021__Neutrophil:Kidney,0.7065089466225632,1.2499359514734758,0.23943661971830985,0.6961842067772739,1.0,6/14,18.01%,ADM;ALPL;FOS;PELI1;SDCBP;NAMPT
prerank,CellMarker_Augmented_2021__T Helper cell:Eye,-0.7508554702046093,-1.2498044572138594,0.21212121212121213,0.880981572731571,1.0,4/7,14.42%,CD74;GIMAP8;TNFRSF1B;GIMAP4
prerank,CellMarker_Augmented_2021__T Helper cell:Salivary Gland,-0.7508554702046093,-1.2498044572138594,0.21212121212121213,0.880981572731571,1.0,4/7,14.42%,CD74;GIMAP8;TNFRSF1B;GIMAP4
prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,0.5408703305031971,1.249757510961355,0.15294117647058825,0.6961354208660805,1.0,26/71,20.98%,ARF1;GAPDH;SEC24D;TUBB4B;MYO1B;TMED10;JUN;MYO1E;GNA13;MYH10;FOS;CLDN5;ARPC2;TAB2;MAPK10;ITGB1;PAK2;TUBA1B;RAC1;TUBB6;ARHGEF2;TMBIM6;ABI1;WIPF1;ACTB;TNFRSF10B
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.7578687865576229,1.2490577351514178,0.2028985507246377,0.6984921037149915,1.0,4/11,14.08%,CPEB4;PINK1;HIF1A;RASA1
prerank,Reactome_2022__Signal Transduction R-HSA-162582,0.5060769726489567,1.2489821117441227,0.01,0.69810670965426,1.0,163/689,21.33%,PIK3R3;LAMC1;DOCK3;ADM;RTN4;SERPINE1;ERBB4;AKAP12;PSMC6;PDK4;SPOPL;KHDRBS3;ITPR1;LRRC7;WNT2B;PCK1;PRKAG2;CNTN1;BCAP31;FES;GRM7;PKN3;S1PR1;MGLL;ANXA1;ARHGAP23;LAMA5;VAPB;GPC5;LBR;PDE7A;MYO9B;PRKCE;GRIN2B;PDE5A;DUSP6;RAPGEF3;NRG2;FGFR1;PIK3R1;CCDC88A;SMAD7;ESR2;CBFB;JAK1;ARHGAP21;SMAD5;HSP90AA1;KDM1A;JUND;SRGAP1;DLC1;TPM4;RPS27A;ARHGEF4;GRB2;COL4A2;SLC4A7;PICALM;CDKN1B;NRG3;JAG2;CTNNA1;MIB1;VWF;JUN;HIF1A;GJA1;PDE10A;RAD21;RAP1A;PEBP1;MYL6;OTUD7B;RGS7;BOC;GNA13;FKBP5;PHLPP1;MYH10;NSMAF;CCNC;REST;CDKN1A;FOS;PPM1A;FLT1;STK38;PRAG1;CNOT6L;BCAR1;AGO2;SHC2;TRAK1;AHCTF1;ARPC2;TAB2;NEDD4L;DOCK4;ACVR2A;DUSP16;ITGB1;CD55;TMEM59;ECT2;TUBA1B;GRB10;WWTR1;ERBIN;DGKI;PCDH7;SHOC2;ADCY2;ADD3;NCOR2;CRK;PSMA7;PLAT;TNKS;SPRED1;ACTN1;GRK5;PRKX;PPP1CB;HDAC7;MYL12B;ARHGEF2;TRA2B;RALGAPA1;FZD4;KALRN;PDE4B;TF;STAT3;FAM13A;RPS27;DIAPH2;ABL2;ABI1;DYNC1H1;PTPN1;USP34;NOTCH4;LIMK2;TEC;PLEKHG1;WIPF1;SOCS3;CDK8;CAB39;SMAD6;SH3KBP1;NEDD4;BCL2L1;PAFAH1B1;GRM5;TNFRSF10B;AHCYL1;DNM2;VEGFC;PPP3CB;EPAS1;TAOK1
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Undefined,-0.5163708834764339,-1.2489251945856281,0.16666666666666666,0.8803181254493849,1.0,8/35,5.79%,SAMD9L;XAF1;GBP2;CPQ;PARP14;DDX60L;SP100;BMP2K
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.6867044072108328,-1.2489080855913322,0.2777777777777778,0.8769357073153069,1.0,3/11,5.55%,ATM;ATR;SP100
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.8153783528778296,1.248899258844637,0.14925373134328357,0.6978120393313627,1.0,3/6,18.03%,BHLHE40;PPP1CB;CRY1
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.5327245255173875,1.2486056667770005,0.03260869565217391,0.6981717812255193,1.0,47/180,20.19%,ST18;ERBB4;BCL6;FES;TBX3;PPM1D;PBRM1;CALR;JUNB;CD81;UFL1;FGFR1;CCDC88A;RPS9;JUND;DLC1;RPL23;CDK6;KLF4;ITGA1;CDKN1B;JAG2;JUN;CNBP;MAGI2;REST;CDKN1A;FLT1;CNOT6L;CLDN5;ADGRG1;KRAS;WWTR1;PLPP1;LIMS1;SDCBP;GRK5;BTG2;ARHGEF2;NAMPT;STAT3;DUSP22;NACC2;ABI1;RERG;NPM1;SMAD6
prerank,KEGG_2021_Human__Amphetamine addiction,0.6577020699813627,1.248439135169383,0.189873417721519,0.6980953749651045,1.0,11/21,23.88%,GRIA2;GRIN2B;CACNA1C;JUN;FOS;ATF2;PPP1CB;GRIA4;PPP3CB;PPP3CC;CREB3L2
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.6722627819370962,1.2482199131920617,0.2289156626506024,0.6984028054700002,1.0,7/15,23.82%,MAP3K5;ANXA1;NFE2L2;ECT2;SETX;ADAM9;FYN
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.7551201974357474,1.2474891721164614,0.18333333333333332,0.7010727083952232,1.0,3/9,11.85%,SLC2A13;PICALM;IFNGR1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Oral Cavity,0.6943318492497561,1.2473515891893339,0.1780821917808219,0.7008528759152192,1.0,8/17,21.30%,PDK4;BACE2;KLF4;ANXA2;S100A6;LGALS3;GSN;EPAS1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.7958221024147007,1.246991985696969,0.24285714285714285,0.7019207518609675,1.0,2/6,14.16%,SYTL4;DYSF
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),0.8238195700728842,1.2466302527209068,0.12962962962962962,0.7027570365900758,1.0,2/5,11.37%,RFTN1;ANXA2
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.6161606040406971,1.2463535917233086,0.14864864864864866,0.7032353733204134,1.0,3/30,7.04%,ZEB2;SCARB2;PINK1
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.8010205180486987,1.24555122609439,0.203125,0.7061130633193197,1.0,3/5,15.06%,ACOX1;ENPP2;LPIN2
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.7517711307076613,1.2453199537158255,0.125,0.7062693091808251,1.0,4/12,13.04%,SPOCK1;ANXA1;CDK6;TRAK1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.7388934139099099,1.245236082666932,0.18181818181818182,0.7058676405309463,1.0,2/8,8.63%,KLF2;KLF4
prerank,Reactome_2022__FCERI Mediated Ca+2 Mobilization R-HSA-2871809,0.6973658773859099,1.2448053270948085,0.2361111111111111,0.7067452755371684,1.0,5/16,21.22%,ITPR1;GRB2;TEC;AHCYL1;PPP3CB
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.6953118493747767,1.2448043511428462,0.18309859154929578,0.705939408632337,1.0,5/19,16.36%,RTN4;ROBO2;LRRC4C;PAK2;PLXNA2
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.6520482585428853,1.2446980646150365,0.17142857142857143,0.7057162866216756,1.0,7/28,8.45%,SLC8A1;ANK2;CALR;VAPB;MT1M;MT2A;ATP2B1
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Corneal Endothelium,0.6207740912120426,1.244684178186753,0.21333333333333335,0.7050017226111476,1.0,9/41,16.57%,ADAMTS9;NES;TIMP3;PTPRD;COL4A2;GJA1;FLT1;NAV2;CADPS2
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.7807540393666886,1.2445825963030464,0.234375,0.7047297742084129,1.0,4/7,19.76%,SEC22B;PINK1;FEZ2;CHMP4B
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.8087517415138283,1.2445428482163217,0.14705882352941177,0.7041312212527489,1.0,2/6,6.27%,DDIT4;SMAD7
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.6956881867813276,1.2444773986285107,0.19736842105263158,0.7037351645852705,1.0,8/15,22.28%,KCNMB4;KCNIP4;DPP10;NEDD4L;NOS1AP;CAB39;NEDD4;YWHAE
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.808347433481667,1.2444301591211684,0.23636363636363636,0.7032144354666792,1.0,3/6,15.96%,ERBB4;CRLF3;MGAT5
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.5795581474473303,-1.2443169744819134,0.23684210526315788,0.8906445714672397,1.0,6/20,6.16%,GBP4;GBP2;ISG15;OAS3;NOD1;OPTN
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.8579696913934953,1.2440263792190214,0.13846153846153847,0.7043505271347981,1.0,2/5,7.36%,MTHFD1L;HSP90AA1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.7003194333076026,1.2438786405969002,0.17567567567567569,0.7041810795768366,1.0,3/14,3.96%,ST18;GRIA2;SLC4A10
prerank,Reactome_2022__DAP12 Signaling R-HSA-2424491,0.7224346281124366,1.243732248600211,0.1774193548387097,0.7041872165988421,1.0,2/13,8.31%,PIK3R1;GRB2
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.6660452828259302,1.2436761262656675,0.16666666666666666,0.7037933293654014,1.0,1/20,0.53%,DDIT4
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.7535011360988153,1.2434981440531827,0.19718309859154928,0.7040621004417648,1.0,3/11,11.47%,NFE2L2;PINK1;REST
prerank,Reactome_2022__Glutathione Conjugation R-HSA-156590,0.8348178305751748,1.243314812383738,0.15517241379310345,0.704218017028754,1.0,2/5,9.43%,PRNP;GGT5
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.5516812794713964,1.2432233323749664,0.08045977011494253,0.7039500047941202,1.0,8/85,11.55%,LAMC1;PSMC6;FEM1C;MGAT4A;DCAF10;HSP90B1;HIF1A;COMMD1
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.7278754199532521,1.2431020142854021,0.12121212121212122,0.7038319246466587,1.0,6/10,20.58%,SYN3;SNAP25;DNAJC5;NRXN1;SYT1;HSPA8
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.8471178517524195,1.2427631826174395,0.13559322033898305,0.704497215410186,1.0,3/5,8.29%,CD9;ANXA1;CDK6
prerank,Reactome_2022__IRE1alpha Activates Chaperones R-HSA-381070,0.7679751999938352,1.2427199909141204,0.21666666666666667,0.7039069661435098,1.0,1/7,1.99%,HSPA5
prerank,Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387,0.5855112739600709,1.2421286594784162,0.16666666666666666,0.7058853441399839,1.0,11/58,9.30%,PKM;B3GNT2;PCK1;GPC5;PGK1;CHSY1;HS6ST3;HYAL2;CHST11;RPS27A;SLC2A1
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.6247033871461303,1.2421088728816398,0.10126582278481013,0.7051461997946511,1.0,7/39,9.83%,PSMC6;BNIP3L;PGK1;NDRG1;PINK1;RPS27A;HIF1A
prerank,Reactome_2022__FLT3 Signaling R-HSA-9607240,0.6934866167959596,1.2417671040583107,0.18309859154929578,0.7057823041566877,1.0,8/17,23.82%,PIK3R1;RPS27A;GRB2;CDKN1B;GRB10;ABL2;UBC;FYN
prerank,Reactome_2022__Smooth Muscle Contraction R-HSA-445355,0.723822397556245,1.2416756507686544,0.19230769230769232,0.7054157517753207,1.0,8/17,17.66%,ANXA1;PDE5A;TPM4;ITGA1;MYL6;ANXA2;DYSF;MYL12B
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.7743249257046938,1.241291210770604,0.140625,0.7063711665463009,1.0,3/9,11.47%,PCK1;ANXA1;REST
prerank,CellMarker_Augmented_2021__Endothelial cell:Heart,0.5911505319133561,1.241266724175411,0.1625,0.7057457717603408,1.0,17/44,22.52%,PDK4;RAPGEF3;ANO2;GGT5;VWF;ZNF366;PECAM1;LRRC32;FLT1;CLDN5;DYSF;TNS1;ESAM;NOTCH4;GSN;CDH5;SCARF1
prerank,Reactome_2022__Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,0.782676694658367,1.2411788736879559,0.22058823529411764,0.7054913596994643,1.0,4/8,16.63%,SNAP25;PPFIA2;SH2D3C;SYT1
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.6425582576080345,1.2409253882002915,0.2028985507246377,0.7060743266177916,1.0,5/23,7.99%,SEC22B;VAPB;SEC24D;MCFD2;TMED10
prerank,KEGG_2021_Human__Ribosome,0.5676385029233982,1.2408436270060785,0.14102564102564102,0.7056111427833329,1.0,11/52,15.51%,RPS11;RPS18;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.7626208489816043,1.2406049790364349,0.15942028985507245,0.705922551484839,1.0,4/14,6.80%,ITPR1;SLC8A1;GRIN2B;ERO1A
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.6113083937214734,1.2405504864161432,0.15492957746478872,0.7054850907923443,1.0,6/28,8.71%,TIMP3;SEC24D;PLSCR4;MSRB3;COL4A2;ITGA1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone Marrow,0.816055490725956,1.2405493502660445,0.16666666666666666,0.7047178009558521,1.0,2/5,13.68%,NES;ITGB1
prerank,Reactome_2022__SLC Transporter Disorders R-HSA-5619102,-0.5357883284780051,-1.2402105999539526,0.18181818181818182,0.9020813557625896,1.0,2/25,1.12%,SLC22A5;SLC4A4
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.6133618074874436,1.2399513481285738,0.15384615384615385,0.7064732694699438,1.0,11/44,19.68%,PSMC6;RFTN1;NFKBIZ;PIK3R1;BCAR1;TAB2;PAK2;PSMA7;MALT1;PDE4B;TEC
prerank,Reactome_2022__RAF-independent MAPK1/3 Activation R-HSA-112409,0.715072246980361,1.2399451949613367,0.2153846153846154,0.7056943573757102,1.0,3/10,13.63%,DUSP6;JAK1;DUSP16
prerank,Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291,0.5553901154470897,1.2398104992599912,0.12790697674418605,0.7054300322334514,1.0,18/90,16.02%,PSMC6;RIMKLB;GLUD1;GLUL;RPS11;TINAGL1;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;SERINC1;RPL13A;TXNRD1;RPS12;PSMA7
prerank,CellMarker_Augmented_2021__CD14+ Endothelial Progenitor cell:Blood,0.5982000738187854,1.239598626416649,0.2073170731707317,0.7054590355627955,1.0,13/33,22.15%,PDK4;VWF;PECAM1;LRRC32;FLT1;CLDN5;DYSF;TNS1;KCTD12;PLXDC2;NOTCH4;GSN;CDH5
prerank,Reactome_2022__Sphingolipid Metabolism R-HSA-428157,0.6350768068696968,1.239143240316625,0.17142857142857143,0.7067185978578384,1.0,8/25,18.96%,SPNS2;VAPB;KDSR;SAMD8;PLPP1;ESYT2;ARSG;EGFL7
prerank,Reactome_2022__G1/S Transition R-HSA-69206,0.6454398975417897,1.2389171075645964,0.17333333333333334,0.7071234243260268,1.0,7/28,16.02%,PSMC6;POLA1;RPS27A;CDKN1B;CCNH;CDKN1A;PSMA7
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.7742119560501135,1.2388093656871169,0.14035087719298245,0.706785745566463,1.0,2/8,12.54%,TSG101;ZFYVE28
prerank,KEGG_2021_Human__Circadian entrainment,0.6054019853769801,1.238577210879989,0.19480519480519481,0.7071167456017428,1.0,11/31,22.39%,GRIA2;ITPR1;GRIN2B;CACNA1C;FOS;NOS1AP;ADCY2;RYR3;GRIA4;ADCY9;PLCB1
prerank,CellMarker_Augmented_2021__Fibroblast:Pancreas,0.5946383233475744,1.2385496312147528,0.16,0.7064886676144337,1.0,8/37,10.78%,DOK5;NES;ANK2;MAP1B;NAV1;COL4A2;GJA1;BOC
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.6015227535843706,1.2382311065147107,0.14285714285714285,0.7070495070644132,1.0,3/29,10.76%,PSMC6;SMAD7;TRIB2
prerank,Reactome_2022__Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,-0.742895620129131,-1.2381585813254048,0.28125,0.9058601163688936,1.0,2/10,2.12%,COL8A1;TLL1
prerank,Reactome_2022__Constitutive Signaling By EGFRvIII R-HSA-5637810,0.7155482182324676,1.2379537818482418,0.19117647058823528,0.7076333311198877,1.0,3/10,8.31%,PIK3R1;HSP90AA1;GRB2
prerank,Reactome_2022__Metabolism R-HSA-1430728,0.5004155166860681,1.237053812806922,0.05102040816326531,0.7113233646245999,1.0,52/430,8.26%,PIK3R3;MTHFD1L;PKM;ANGPTL4;B3GNT2;PSMC6;CHPT1;PDK4;SPNS2;ITPR1;LDHA;RIMKLB;PCK1;SLC52A3;PRKAG2;PPA1;GLUD1;STARD4;MGLL;GLUL;RPS11;VAPB;GPC5;INPP5F;UPP1;LBR;PLIN2;PGK1;ACOX1;SEC24D;CACNA1C;CHSY1;MTMR12;RAPGEF3;NDUFA12;HS6ST3;DHRS7B;HYAL2;PIK3R1;TINAGL1;SIN3B;SNAP25;RPS9;ENPP2;PRNP;CHST11;INSIG1;ACSL5;HSP90AA1;KDSR;RPS27A;RPL23
prerank,Reactome_2022__Glutamate Neurotransmitter Release Cycle R-HSA-210500,0.7637936171534682,1.2369160134479613,0.17647058823529413,0.7112128036415366,1.0,5/10,17.29%,SNAP25;PPFIA2;SLC38A2;SYT1;SLC1A2
prerank,Reactome_2022__Unfolded Protein Response (UPR) R-HSA-381119,0.673884240966313,1.2365636865841283,0.2,0.7121762734769822,1.0,5/20,12.72%,ATF3;HSPA5;CALR;HSP90B1;DCP2
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.7812709008444066,1.2365176849344859,0.2631578947368421,0.7115708960522625,1.0,2/6,7.04%,SMAD7;PINK1
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.7394947379697003,1.2363772629229584,0.16417910447761194,0.7114243098631422,1.0,3/10,10.70%,HSPA5;ERO1A;HSPA9
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.6514991207302341,1.2363293103366424,0.28,0.7108210612003133,1.0,8/27,13.55%,LAMC1;GRIA2;ANK2;NFASC;NDRG1;TMEM132C;SHC2;PRX
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.6411989297791175,1.2360334004526108,0.24,0.711624614035901,1.0,3/21,9.43%,ADM;CD81;GGT5
prerank,KEGG_2021_Human__Long-term potentiation,0.6135587613618924,1.23596114418062,0.14864864864864866,0.7111904511261975,1.0,6/30,10.07%,GRIA2;ITPR1;GRIN2B;CACNA1C;RAPGEF3;RAP1A
prerank,Reactome_2022__IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,0.7782627936928203,1.2357132124283305,0.2727272727272727,0.7113086196857816,1.0,1/6,7.09%,JAK1
prerank,Reactome_2022__Signaling By TGFB Family Members R-HSA-9006936,0.5889970100141098,1.235638003630485,0.189873417721519,0.7108996834474637,1.0,14/47,20.19%,SERPINE1;SMAD7;SMAD5;RPS27A;CCNC;PPM1A;NEDD4L;ACVR2A;ITGB1;WWTR1;NCOR2;PPP1CB;CDK8;SMAD6
prerank,Reactome_2022__Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,0.6063611571812628,1.2354734080269056,0.16883116883116883,0.7110059497867596,1.0,17/42,26.29%,ITPR1;MYO9B;PRKCE;PIK3R1;HSP90AA1;GRB2;MYO1E;ARPC2;CRK;ABI1;WIPF1;AHCYL1;NCK1;FYN;FGR;WASL;CDC42
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.6944538035168343,-1.2353048153876154,0.3170731707317073,0.9127960917363268,1.0,2/7,10.07%,HABP4;LARP1
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.7454055033230649,1.2352106024642229,0.20967741935483872,0.7106687775339117,1.0,4/8,11.90%,MT1M;MT2A;JUN;FOS
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.7454055033230649,1.2352106024642229,0.20967741935483872,0.7106687775339117,1.0,4/8,11.90%,MT1M;MT2A;JUN;FOS
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.7632494309811999,1.2352066345397186,0.18181818181818182,0.7099046175580687,1.0,5/10,13.57%,KCNMB4;ANK2;ATP1B3;ANO6;NOS1AP
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.8316612453331653,1.2350305250425437,0.17307692307692307,0.7099757675001915,1.0,1/5,2.44%,KCNMB4
prerank,Reactome_2022__Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,0.5622747992882953,1.2343926078904048,0.0975609756097561,0.7122357702676394,1.0,15/67,18.86%,PSMC6;RPS11;ROBO2;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12;PSMA7;DAG1;RPS27
prerank,KEGG_2021_Human__MAPK signaling pathway,0.5239646520509509,1.2342890964332558,0.060240963855421686,0.7119834006499586,1.0,22/96,15.91%,ERBB4;MAP3K5;CACNA1C;DUSP6;FGFR1;JUND;GRB2;DUSP1;JUN;RAP1A;FOS;PPM1A;FLT1;TAB2;MAPK10;DUSP16;KRAS;PAK2;RASA1;RAC1;CRK;ATF2
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.7981241264660972,1.2340961155850554,0.16071428571428573,0.7122064232056251,1.0,1/5,2.52%,TRIM5
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.5373046116562846,1.2340223256371328,0.14130434782608695,0.711871614619955,1.0,20/112,13.89%,PIK3R3;KLF2;ANK2;INPP5F;PPHLN1;VSIR;NFE2L2;RPL23;KLF4;ANK3;SLC38A2;HIF1A;GJA1;MAGI2;ANXA2;IFNGR1;AGO2;CLDN5;NOS1AP;KRAS
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.8261611087128843,1.2337548811300865,0.2,0.7124022741936289,1.0,3/6,12.88%,DDIT4;GRB2;BCAR1
prerank,CellMarker_Augmented_2021__Neuron:Adipose Tissue,0.7178309747579131,1.2332567337009746,0.15942028985507245,0.7139967968087785,1.0,4/13,6.67%,GRIA2;MAP2;MAP1B;SNAP25
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.7279629883614717,1.233250556971774,0.17105263157894737,0.7132592475344978,1.0,7/13,13.84%,ANO5;SLC20A2;ANO2;SLC12A6;ANO6;SLC26A2;SLC20A1
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.5888314333934069,1.2328169715934805,0.1111111111111111,0.7145306430833275,1.0,19/45,16.12%,ZEB2;GRIA2;CADM2;GPM6B;LSAMP;NPAS3;GRIN2B;UFL1;NFASC;PPFIA2;NRXN3;LRRC4C;GJA1;MAGI2;NRXN1;MAPK10;ITGB1;ADCY2;ADGRB3
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.602318789591037,1.2326082930924935,0.16901408450704225,0.7145961904988499,1.0,12/30,17.29%,GRIA2;CADM2;LSAMP;SGIP1;SNAP25;PPFIA2;CNTNAP2;MAGI2;NRXN1;ADGRB3;FRMD3;SLC1A2
prerank,CellMarker_Augmented_2021__Circulating Stem Like cell:Peripheral Blood,-0.5807970987089197,-1.2324937981416926,0.16,0.9197956991678599,1.0,8/17,7.25%,SLFN12L;IL15;PARP14;IRF1;DDX60L;SP100;SP110;SP140L
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.6989939027572919,1.2322271091227657,0.16176470588235295,0.7153803606773294,1.0,5/11,20.56%,ADM;RASA1;SPRED1;EGFL7;RASIP1
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.7274401300123381,1.232179941195141,0.21621621621621623,0.7148563430708094,1.0,4/11,14.18%,MAP3K5;ANXA1;NFE2L2;ECT2
prerank,Reactome_2022__Selective Autophagy R-HSA-9663891,0.659647064722365,1.2319526136009211,0.2222222222222222,0.7149801265431714,1.0,6/20,8.07%,PRKAG2;PLIN2;ATG12;PINK1;HSP90AA1;RPS27A
prerank,Reactome_2022__Signaling By MET R-HSA-6806834,0.6314082921474427,1.2318979016027887,0.20270270270270271,0.714375424347647,1.0,11/33,20.27%,LAMC1;LAMA5;PIK3R1;RPS27A;GRB2;RAP1A;ITGB1;CRK;STAT3;PTPN1;SH3KBP1
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.6983383117961028,1.2315068622850671,0.2054794520547945,0.7153207724395362,1.0,4/11,17.45%,SERPINE1;NFE2L2;ANO6;GATA2
prerank,CellMarker_Augmented_2021__Side-population cell:Undefined,0.6967259193555244,1.2311717963437827,0.14492753623188406,0.7160648698916587,1.0,8/19,13.92%,CD9;ANXA1;BACE2;KLF4;EMP1;ANXA2;ITGB1;S100A6
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.841950263900415,-1.2309678774396393,0.23684210526315788,0.9220411103833297,1.0,2/5,14.58%,PDGFB;STX3
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.7791286876851848,1.2307885973291626,0.20588235294117646,0.7169127708326902,1.0,2/7,2.63%,AKAP12;GRM7
prerank,Reactome_2022__Cargo Concentration In ER R-HSA-5694530,0.8019806355829586,1.2307156357411309,0.203125,0.7164138452863151,1.0,3/7,7.52%,SEC22B;SEC24D;MCFD2
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.6199317706980206,-1.2305448908445382,0.37037037037037035,0.9200594573205334,1.0,6/14,14.16%,CD74;PARP14;PARP9;NLRC5;GAS6;HSPA1A
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.8056368169474544,1.2303632826767046,0.203125,0.7169324492170766,1.0,2/6,7.22%,SNAP25;DNAJC5
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.6800942663272536,1.230184720901156,0.19718309859154928,0.716878064876855,1.0,4/20,13.09%,ADAMTS9;HSP90AA1;LAMP2;DENND3
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.7737596474030821,1.2300350169482368,0.1917808219178082,0.7169170675806027,1.0,2/9,5.60%,ANXA1;BCR
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.7185230873169572,1.2299469984622224,0.1917808219178082,0.7167696389548588,1.0,2/14,7.09%,ST18;JAK1
prerank,CellMarker_Augmented_2021__Neural Crest cell:Germ,0.6471251641661292,1.2298664447646128,0.20270270270270271,0.7164596351082508,1.0,7/29,10.76%,ZEB2;PPP2R2B;S1PR1;MYO9B;BACH2;GAS7;TRIB2
prerank,KEGG_2021_Human__Various types of N-glycan biosynthesis,0.7171057465777135,1.2297451193879163,0.15873015873015872,0.7162432605256132,1.0,4/10,21.70%,MGAT4A;FUT8;MGAT1;B4GALT1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.6240917729328849,1.2293960092542089,0.15584415584415584,0.7169445488348503,1.0,16/38,23.93%,SERPINE1;PDK4;FES;INSIG1;ADAM15;ATP1A1;ADCY2;FZD4;PDE4B;ABL2;ZFP36;SETX;TFPI;MEF2C;ADAM9;MSN
prerank,CellMarker_Augmented_2021__Stem cell:Submandibular Gland,0.5712999727684284,1.2293045344972156,0.12987012987012986,0.7164961575786802,1.0,14/46,22.15%,PDK4;TIMP3;PLSCR4;DLC1;GGT5;VWF;CFH;FLT1;CLDN5;TM4SF18;ESAM;NOTCH4;EPAS1;CDH5
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.639387892066429,1.22921849181232,0.2191780821917808,0.7160834613578421,1.0,4/22,14.45%,UFL1;KLF4;COMMD1;ERBIN
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.683396496442171,-1.2291579961864012,0.22727272727272727,0.9214359194986613,1.0,2/6,4.38%,ATM;ATR
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.6935200082825463,1.2289897876447973,0.15492957746478872,0.7164702252803747,1.0,5/17,19.76%,SEC22B;PINK1;PIKFYVE;FEZ2;CHMP4B
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.699924325968344,1.2288511643879447,0.18571428571428572,0.7164168333103292,1.0,1/12,0.58%,PBX3
prerank,"Reactome_2022__Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",0.70033638962321,1.2287307771099623,0.18181818181818182,0.7162365049939351,1.0,2/18,8.07%,ANGPTL4;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.5546903125420544,1.228637450453723,0.1891891891891892,0.715998863163284,1.0,13/69,14.74%,PIK3R3;ERBB4;FGFR1;PINK1;HSP90AA1;RB1CC1;HIF1A;PECAM1;BTBD10;FLT1;ACVR2A;KRAS;RAC1
prerank,KEGG_2021_Human__Oxidative phosphorylation,0.7191799690193825,1.2285110089549813,0.15492957746478872,0.7157386638545952,1.0,2/14,5.79%,PPA1;NDUFA12
prerank,Reactome_2022__Signaling By EGFR In Cancer R-HSA-1643713,0.6902606319542282,1.2283046443023733,0.21212121212121213,0.7152658921572583,1.0,4/13,8.31%,PIK3R1;HSP90AA1;RPS27A;GRB2
prerank,Reactome_2022__Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,0.6902606319542282,1.2283046443023733,0.21212121212121213,0.7152658921572583,1.0,4/13,8.31%,PIK3R1;HSP90AA1;RPS27A;GRB2
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.8334122513918744,1.2279754364180566,0.19672131147540983,0.7162137046511019,1.0,2/5,12.11%,LAMA5;RPL8
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.7371419095121607,1.2276680919066114,0.2328767123287671,0.716929993956205,1.0,6/9,24.14%,ANK2;ANK3;ATP1B3;DMD;ATP1B1;WNK1
prerank,Reactome_2022__Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,0.8219762617734585,1.2275571287389817,0.20588235294117646,0.7158610894186964,1.0,1/5,4.33%,GPC5
prerank,Reactome_2022__Retinoid Metabolism And Transport R-HSA-975634,0.8219762617734585,1.2275571287389817,0.20588235294117646,0.7158610894186964,1.0,1/5,4.33%,GPC5
prerank,Reactome_2022__PI-3K cascade:FGFR1 R-HSA-5654689,0.7888896399377947,1.2274547354310594,0.208955223880597,0.7155914694496759,1.0,3/7,8.31%,FGFR1;PIK3R1;GRB2
prerank,Reactome_2022__Elastic Fibre Formation R-HSA-1566948,0.8185513150150365,1.227280160025316,0.21311475409836064,0.7158253566411464,1.0,2/5,16.31%,ITGB1;MFAP3
prerank,"Reactome_2022__Cell Cycle, Mitotic R-HSA-69278",0.5302599569930548,1.2272633955364398,0.06818181818181818,0.7150995712983305,1.0,41/132,23.67%,CEP57;PSMC6;LBR;POLA1;TUBB4B;HSP90AA1;RPS27A;CDK6;CDKN1B;RAD21;RFC3;CCNH;CDKN1A;WAPL;AHCTF1;TUBA1B;TUBB6;CEP70;LPIN2;ENSA;PSMA7;MCPH1;TPR;PPP1CB;RAB2A;ALMS1;RPS27;CSNK1D;DYNC1H1;CHMP4B;PAFAH1B1;CEP290;TAOK1;ARPP19;YWHAE;UBC;TMPO;SPC25;MAX;H3-3B;XPO1
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.7807403083222522,1.2271256492570868,0.2222222222222222,0.7149570460355467,1.0,1/7,3.40%,MAP3K5
prerank,CellMarker_Augmented_2021__Purkinje cell:Undefined,0.7180467123984281,1.2270825183690586,0.25806451612903225,0.71445015880975,1.0,4/8,14.53%,PDE5A;MBP;ATP2B1;MPRIP
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Oral Mucosa,-0.5334527136392506,-1.227049979698682,0.13793103448275862,0.9250505116386611,1.0,3/31,6.40%,VCAM1;LIMS2;PODN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.7362670867175588,1.2270236906593122,0.22388059701492538,0.7139329286534452,1.0,4/11,13.57%,ANK2;CACNA1C;CTNNA3;NOS1AP
prerank,CellMarker_Augmented_2021__Paneth cell:Large Intestine,-0.5066310515474588,-1.2269362383085007,0.15,0.9219165754982473,1.0,3/43,3.59%,RSAD2;CD74;LMO2
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.6795022101954322,1.226868469799385,0.24050632911392406,0.7139853640342188,1.0,4/11,16.52%,CTNNA1;ADAM15;ADCY2;GOLPH3
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.6712277072584799,-1.2268035687253118,0.2608695652173913,0.9190387724355735,1.0,3/8,9.30%,STAT1;PKD2;STAT2
prerank,Reactome_2022__Platelet Homeostasis R-HSA-418346,0.6322345207203972,1.2267424771948388,0.15384615384615385,0.7138672853757883,1.0,7/29,10.46%,ITPR1;KCNMB4;SLC8A1;PDE5A;ATP2B1;PDE10A;PECAM1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.8356774686662942,1.2263987896623971,0.19230769230769232,0.7145325164228076,1.0,2/6,5.29%,ERBB4;ZFPM2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.7680645436662357,1.226270018260368,0.21739130434782608,0.7143120849075542,1.0,3/8,6.80%,ITPR1;MAP3K5;ERO1A
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.668794330128165,1.226075412966888,0.20270270270270271,0.714443198146949,1.0,7/14,21.67%,YBX3;HSP90AA1;OGT;PELI1;SDCBP;ARHGEF2;CDC37
prerank,Reactome_2022__Peroxisomal Protein Import R-HSA-9033241,0.6902264960763917,1.2259728153489586,0.20270270270270271,0.7141327950716672,1.0,2/15,8.07%,ACOX1;RPS27A
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.737948900784331,1.2258932490784888,0.20833333333333334,0.7136534867717665,1.0,3/9,6.27%,ROBO2;ZFPM2;SMAD7
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.7744604414179295,1.225760494451535,0.31746031746031744,0.7134574303412845,1.0,2/6,15.11%,FGFR1;ANKRD11
prerank,CellMarker_Augmented_2021__Pericyte:Skeletal Muscle,0.5759502913005989,1.2256432150389385,0.16216216216216217,0.7133407295916047,1.0,13/58,13.12%,ZEB2;S1PR1;SGIP1;CACNA1C;ENPP2;PLCL1;VWF;GAS7;PECAM1;LRRC32;FLT1;TMEM132C;CLDN5
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.6972430251728909,1.2255556651009727,0.2463768115942029,0.7123538441908479,1.0,6/9,21.91%,MCFD2;UBE2J1;MGAT5;FUT8;MGAT1;UGGT2
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.6972430251728909,1.2255556651009727,0.2463768115942029,0.7123538441908479,1.0,6/9,21.91%,MCFD2;UBE2J1;MGAT5;FUT8;MGAT1;UGGT2
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.6467595545637885,1.2255055639560875,0.22972972972972974,0.7118000541171267,1.0,2/22,8.29%,LAMC1;CDK6
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.6117805802579376,1.2254269918834568,0.1917808219178082,0.7114158936398077,1.0,5/29,8.39%,WNT2B;TIMP3;PLSCR4;TPM4;COL4A2
prerank,Reactome_2022__Peptide Chain Elongation R-HSA-156902,0.5810629542333238,1.225383844262187,0.13333333333333333,0.7102575144000604,1.0,11/48,15.51%,RPS11;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;EEF1A1;RPL13A;RPS12
prerank,Reactome_2022__Eukaryotic Translation Elongation R-HSA-156842,0.5810629542333238,1.225383844262187,0.13333333333333333,0.7102575144000604,1.0,11/48,15.51%,RPS11;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;EEF1A1;RPL13A;RPS12
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.6221517417689232,1.2250637952005803,0.25,0.7110408539761696,1.0,8/25,18.03%,WDR48;SMAD7;PINK1;COMMD1;PTTG1IP;NDFIP1;MALT1;CRY1
prerank,Reactome_2022__S Phase R-HSA-69242,0.5881284925975283,1.2249467415290727,0.1728395061728395,0.7107708950424612,1.0,9/42,12.19%,PSMC6;POLA1;RPS27A;CDKN1B;RAD21;RFC3;CCNH;CDKN1A;WAPL
prerank,Reactome_2022__Activation Of AP-1 Family Of Transcription Factors R-HSA-450341,0.7518931693355955,1.2248866965975662,0.1935483870967742,0.7104120627294516,1.0,3/6,13.39%,JUN;FOS;MAPK10
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.7891061781467321,1.224771482104192,0.208955223880597,0.7102884380989478,1.0,1/6,1.91%,PRKAG2
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Eye,0.669143742048793,1.2247020214030815,0.2463768115942029,0.709919658434633,1.0,6/20,12.83%,DOK5;GPM6B;PTPRD;CTNND2;LRRC4C;TMEM132C
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.6101857003347455,1.2246822910181112,0.2,0.7092507453659219,1.0,7/28,14.74%,ADM;MGLL;ANXA1;REL;GGT5;FOS;RAC1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.8174734834824968,1.2245979806922982,0.20588235294117646,0.7089839389455457,1.0,4/6,11.00%,SLC8A1;CACNA1C;GJA1;ATP1A1
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.5636135790313619,1.223779773451161,0.1125,0.7119539230406889,1.0,6/78,7.36%,CEP57;EHD4;RAB11FIP3;NUDCD3;TUBB4B;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.8249577771685934,1.223628491141554,0.13846153846153847,0.7119182528921245,1.0,2/6,7.07%,CD81;CBFB
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.7000960083674574,1.2235028075453105,0.18840579710144928,0.7116939730651437,1.0,4/14,15.80%,SCP2;ACSL5;LSS;AGPAT4
prerank,Reactome_2022__Regulation Of Complement Cascade R-HSA-977606,0.768635477270669,1.2234822171087611,0.2037037037037037,0.7110598936134459,1.0,4/8,16.02%,CD81;CFH;CD55;PSMA7
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.8172254136320335,1.2221038697727145,0.13114754098360656,0.7159986672172852,1.0,1/6,2.55%,TBX3
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.772651914964984,1.2220280170808315,0.25675675675675674,0.7156160674126805,1.0,1/9,1.06%,PDK4
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.715566999344555,-1.2220126703999112,0.2564102564102564,0.9347741731532295,1.0,2/5,8.79%,HABP4;HIPK2
prerank,CellMarker_Augmented_2021__Sertoli cell:Seminal Plasma,-0.6528279891091551,-1.2217431362699058,0.23529411764705882,0.932070353407958,1.0,1/7,1.27%,SLC38A3
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.5119649477647684,1.2213950389163915,0.044444444444444446,0.7176441387454302,1.0,49/279,16.49%,PIK3R3;CCDC3;BCL6;NFKBIZ;AFF3;TRIM5;BHLHE40;SLC8A1;ANK2;CALR;ZNF280D;VSIR;YBX3;AFF4;NFE2L2;ESR2;REL;PINK1;RPL23;CDK6;PICALM;KLF4;ANK3;YTHDC1;PTBP2;SLC38A2;AHNAK;HIF1A;GJA1;CREM;LARP4;CNBP;REST;IFNGR1;AGO2;CLDN5;SBNO1;PRX;NOS1AP;ZBTB38;KRAS;WWTR1;ZC3H7A;NDFIP1;FOXC1;ATF2;HNRNPH3;ATOH8;LIMS1
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.7184255564730331,1.2212193032778835,0.14925373134328357,0.7176030142195617,1.0,1/12,2.74%,BHLHE40
prerank,CellMarker_Augmented_2021__Stem cell:Ovarian Cortex,-0.7161367783434959,-1.221090968219842,0.23684210526315788,0.9309341783235273,1.0,1/6,0.35%,SLCO1A2
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.6666441066256543,1.2210592296407186,0.25675675675675674,0.717473710528437,1.0,1/16,0.69%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.7307709472543371,1.2209710962337827,0.1935483870967742,0.7164120914700922,1.0,4/10,13.57%,KLF2;HSP90AA1;KLF4;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.7307709472543371,1.2209710962337827,0.1935483870967742,0.7164120914700922,1.0,4/10,13.57%,KLF2;HSP90AA1;KLF4;NOS1AP
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.804600592619823,1.2209112259587755,0.14925373134328357,0.7159543603690662,1.0,3/6,11.58%,LRRC7;MAGI2;NRXN1
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.7084568747999065,1.2207567127945111,0.23529411764705882,0.7160909365580382,1.0,2/11,22.18%,YTHDC1;SETX
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.7885174381208712,1.2207477608913844,0.2602739726027397,0.715436825674153,1.0,2/8,13.94%,JAK1;PAK2
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.7584819822428037,-1.2206950365978173,0.2631578947368421,0.925446850855033,1.0,2/5,3.90%,CLYBL;DISP1
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.7584819822428037,-1.2206950365978173,0.2631578947368421,0.925446850855033,1.0,2/5,3.90%,CLYBL;DISP1
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.5626227198611558,-1.2206916991233216,0.15384615384615385,0.9219696916007413,1.0,3/17,7.09%,GBP1;GCNT2;EFNA5
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.5913081865393093,1.2204094164956374,0.1780821917808219,0.7161987711430691,1.0,9/37,16.60%,ERBB4;FGFR1;PINK1;HSP90AA1;KLF4;RFC3;FLT1;SERINC1;TNKS
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.7662598561017684,1.2203448256191596,0.22727272727272727,0.7158526231768245,1.0,5/9,13.47%,ANK2;CACNA1C;GJA1;ATP1A1;NEDD4L
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.773788335437283,-1.2199192991631325,0.3170731707317073,0.9213684263027985,1.0,2/6,1.83%,EIF2AK2;CD74
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.6240294936366242,1.219912480211046,0.2222222222222222,0.7171599287147419,1.0,8/20,19.39%,IL1RAPL1;ANXA1;SYTL4;RAB21;STXBP5L;CADPS2;SYT1;RIMS2
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.7953901435163834,1.2198912522502845,0.22058823529411764,0.7165292133228807,1.0,3/5,18.27%,ZBTB1;CBFB;ZMIZ1
prerank,KEGG_2021_Human__Phagosome,0.5785178389693756,1.2197397702587398,0.23170731707317074,0.7164677850705822,1.0,10/41,14.85%,SEC22B;CANX;CALR;TUBB4B;LAMP2;PIKFYVE;ITGB1;TUBA1B;RAC1;TUBB6
prerank,Reactome_2022__Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,0.7299348058560978,1.2196364311988184,0.22950819672131148,0.7161118219361986,1.0,4/7,15.88%,WDR48;RPS27A;RFC3;UBE2B
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Death Genes With Uncertain Roles In P53-Dependent Apoptosis R-HSA-6803205,0.7988934425061099,1.2194578528069253,0.20588235294117646,0.7161163395840887,1.0,2/6,6.29%,BCL6;NDRG1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.574261721661552,1.2191733230351647,0.1728395061728395,0.7166545434935471,1.0,27/61,24.38%,ANGPTL4;SERPINE1;GLUL;PGK1;RAPGEF3;COL4A2;KLF4;HIF1A;FLT1;AGO2;CLDN5;ITGB1;FOXC1;MTDH;ATF2;SPRED1;GATA2;ATP2B4;BTG1;VEGFC;ANXA3;CDH5;SPARC;ETS1;ADAMTS1;EMP2;PPARG
prerank,Reactome_2022__Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,0.7154970291813887,1.2190767020390942,0.2112676056338028,0.7163429692561678,1.0,7/15,23.82%,ITPR1;PIK3R1;GRB2;SH3KBP1;AHCYL1;NCK1;FYN
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.6076713778973621,1.218999857252485,0.16176470588235295,0.7159015613749388,1.0,16/34,22.87%,SLC8A1;ANK2;CALR;VAPB;ATP2B1;MICU2;TMEM165;PDZD8;HERPUD1;SLC30A1;ATP2B4;ATP13A3;CDH5;CAV2;YWHAE;ATP1B1
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.5784564375627878,-1.2184526868840408,0.2903225806451613,0.9249317101531814,1.0,7/28,5.82%,SLC22A5;SLCO1A2;TAP1;DISP1;ABCG2;CHKA;MIA3
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.8141969256905919,1.2182763154077785,0.203125,0.7182736893471456,1.0,1/5,1.67%,MAP2
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.8423352936267235,1.217985453102772,0.2,0.7187859776568638,1.0,1/5,3.45%,STARD4
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.5553775567657352,1.2178268501348373,0.14102564102564102,0.7187986932785162,1.0,19/54,27.57%,RPS11;RPS18;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12;TRAM1;RPS27;RPL10;RPL37A;RPL21;RPLP1;SEC62;RPS15
prerank,KEGG_2021_Human__Hematopoietic cell lineage,0.7205979068162789,1.2175781401881356,0.11764705882352941,0.7193094683259775,1.0,3/12,13.78%,CD9;ITGA1;CD55
prerank,Reactome_2022__Uptake And Actions Of Bacterial Toxins R-HSA-5339562,0.7236086120909333,1.2173259707265756,0.23809523809523808,0.7197543426098336,1.0,5/11,16.63%,CD9;SNAP25;HSP90AA1;TXNRD1;SYT1
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex R-HSA-170834,0.6034588290741301,1.2171920751570342,0.21052631578947367,0.7196796227325073,1.0,10/38,17.24%,SERPINE1;SMAD7;RPS27A;CCNC;PPM1A;NEDD4L;ITGB1;WWTR1;NCOR2;PPP1CB
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.649784895119042,1.216730645881589,0.203125,0.7194347838595124,1.0,4/20,7.99%,SEC22B;SEC24D;MCFD2;TMED10
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.649784895119042,1.216730645881589,0.203125,0.7194347838595124,1.0,4/20,7.99%,SEC22B;SEC24D;MCFD2;TMED10
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.649784895119042,1.216730645881589,0.203125,0.7194347838595124,1.0,4/20,7.99%,SEC22B;SEC24D;MCFD2;TMED10
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.795002338384383,-1.2165320332050016,0.1794871794871795,0.9282442785373588,1.0,2/7,11.69%,PLAAT3;MFF
prerank,Reactome_2022__Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,0.7670054165111806,1.2164377000228392,0.25396825396825395,0.7201034386066205,1.0,5/7,14.85%,TUBB4B;TTLL7;TUBA1B;AGTPBP1;TUBB6
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.7149794686687176,1.2164165555618904,0.16,0.7194802679788425,1.0,3/11,6.27%,ROBO2;ZFPM2;SMAD7
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.6631313457223141,1.2161454911374276,0.2191780821917808,0.7200293990146636,1.0,7/25,17.16%,RTN4;VAPB;PRNP;TOR1AIP2;REEP3;TRAM1;RTN3
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.7453763319703122,1.2161134727502299,0.2153846153846154,0.7187975402462615,1.0,1/8,7.30%,ACSL5
prerank,Reactome_2022__Fatty acyl-CoA Biosynthesis R-HSA-75105,0.7453763319703122,1.2161134727502299,0.2153846153846154,0.7187975402462615,1.0,1/8,7.30%,ACSL5
prerank,Reactome_2022__Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,0.6455156602238111,1.2160359211075444,0.2,0.7182958809781994,1.0,8/25,15.64%,SERPINE1;SMAD7;RPS27A;CCNC;PPM1A;NEDD4L;WWTR1;NCOR2
prerank,CellMarker_Augmented_2021__Type II pneumocyte:Lung,0.7209503838279004,1.2158720597620076,0.21621621621621623,0.7182768026107562,1.0,4/10,18.57%,BHLHE40;ADGRG1;VWA2;STAT3
prerank,Reactome_2022__Regulation Of Cytoskeletal Remodeling And Cell Spreading By IPP Complex Components R-HSA-446388,0.8120483315590264,1.2156382260411909,0.22535211267605634,0.7186854481655945,1.0,4/5,17.74%,PARVB;LIMS1;ACTN1;RSU1
prerank,Reactome_2022__MAPK1 (ERK2) Activation R-HSA-112411,0.7741632452243757,1.215637231955842,0.17647058823529413,0.7179930729746835,1.0,1/6,7.09%,JAK1
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.5976221571626131,1.214853861624147,0.19736842105263158,0.7205035095069825,1.0,15/48,24.14%,PSMC6;RFTN1;NFKBIZ;PIK3R1;BCAR1;TAB2;PAK2;PSMA7;MALT1;PDE4B;TEC;MEF2C;NCK1;FYN;WNK1
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.5937150082202735,1.2142498195797053,0.22535211267605634,0.7224973741797911,1.0,11/34,23.98%,ADAMTS9;CALR;GLUL;BCAR1;RAC1;ATOH8;ANXA3;SPARC;ETS1;SCARB1;EMP2
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.7612377365041755,1.2142212393782457,0.18055555555555555,0.7219204945469907,1.0,1/7,0.58%,PBX3
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6616325364978846,1.2140942581054488,0.2835820895522388,0.7218129205427928,1.0,4/17,17.45%,ANXA1;KLF4;HDAC7;GATA2
prerank,Reactome_2022__GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,0.5616631742560158,1.2139413809574204,0.1875,0.7217161834866056,1.0,17/54,25.58%,RPS11;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12;RPS27;EIF3A;EIF5;RPL37A;RPL21;EIF3H;RPLP1
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5617740396648924,1.21393090925755,0.15789473684210525,0.7210886073842244,1.0,11/51,15.51%,RPS11;RPS18;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12
prerank,Reactome_2022__Respiratory Electron Transport R-HSA-611105,0.7370255229151139,1.213903366564867,0.29508196721311475,0.7205258943295038,1.0,1/11,5.79%,NDUFA12
prerank,Reactome_2022__RHOB GTPase Cycle R-HSA-9013026,0.5898576384474994,1.213603526033849,0.1728395061728395,0.7213210803075338,1.0,9/39,17.98%,PKN3;MYO9B;PIK3R1;ARHGAP21;DLC1;ECT2;ERBIN;PCDH7;ARHGEF2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.6469105272426906,-1.2135933922904316,0.2222222222222222,0.9358563993847618,1.0,1/8,2.18%,ISG15
prerank,Reactome_2022__SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,0.5737792770855699,1.2135178191615552,0.14864864864864866,0.7210133814682754,1.0,12/49,18.86%,RPS11;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12;TRAM1;RPS27
prerank,KEGG_2021_Human__N-Glycan biosynthesis,0.6949730558109755,1.2133542168099727,0.15625,0.7210130884228291,1.0,5/12,21.70%,MGAT4A;MGAT5;FUT8;MGAT1;B4GALT1
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.7416955574108448,1.2133322761386056,0.23333333333333334,0.7204103136103519,1.0,2/8,16.79%,RAD21;NAA50
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.7039334096736901,1.2132922374812298,0.24615384615384617,0.7199037251298042,1.0,4/15,9.83%,PRKAG2;SCARB2;OGT;HIF1A
prerank,Reactome_2022__Cytokine Signaling In Immune System R-HSA-1280215,-0.3690658159882018,-1.213180438432,0.0,0.9339616842946885,1.0,16/211,3.61%,RSAD2;GBP1;VCAM1;GBP4;XAF1;GBP2;EIF2AK2;IL32;IL15;ISG15;HERC5;IFI27;MX1;STAT1;OAS3;IRF1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.6184255565428226,1.2130176400407946,0.18055555555555555,0.7205269240660084,1.0,18/35,31.45%,PIK3R1;HSP90AA1;FLT1;BCAR1;SHC2;PAK2;RAC1;CRK;PXN;ABI1;VEGFC;NCK1;FYN;CDC42;PIK3CB;DAB2IP;DOCK1;PTK2
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.6410544683247796,1.2130017173244618,0.16883116883116883,0.7199157906033672,1.0,6/28,12.91%,PKM;YBX3;RPS9;LARP4;CNBP;AGO2
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.6519577669102007,1.2129615810556214,0.18055555555555555,0.7194216447412576,1.0,7/21,17.50%,TINAGL1;SMIM3;COL4A2;EMP1;WWTR1;SEMA3F;PXN
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.7298008868573452,1.2125132605277473,0.22857142857142856,0.7206115923273536,1.0,2/10,13.68%,HIF1A;ITGB1
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.6804809048561301,1.2124425052732508,0.15625,0.7203174090022763,1.0,5/18,8.61%,ADM;CD9;CD81;GRB2;PICALM
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.6816368159856172,1.2122304394989216,0.26229508196721313,0.7204122754414233,1.0,7/14,21.83%,NEDD9;HYAL2;PRNP;PTPN1;SH3BP5;GRM5;GPRC5B
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.592358463928155,1.2119458614793304,0.21794871794871795,0.7210524354311797,1.0,8/39,14.45%,BHLHE40;UFL1;SMAD7;PRNP;KDM1A;KLF4;COMMD1;ERBIN
prerank,Reactome_2022__Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,0.6823110341379999,1.2119303024011896,0.22727272727272727,0.720465230954308,1.0,3/23,5.79%,PDK4;LDHA;NDUFA12
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.7372475806468972,1.2117170419016035,0.15789473684210525,0.7199112963063207,1.0,6/9,25.26%,EPS8;TRIOBP;ADD3;GSN;CAPZA2;ADD1
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.7372475806468972,1.2117170419016035,0.15789473684210525,0.7199112963063207,1.0,6/9,25.26%,EPS8;TRIOBP;ADD3;GSN;CAPZA2;ADD1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.6779299726061119,1.2115121930325148,0.15625,0.7200688003638473,1.0,2/15,4.94%,SCP2;ACOX1
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.7893758777476553,1.2112712532549053,0.2033898305084746,0.7203826149895348,1.0,1/6,5.66%,CRTC3
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.6178323423423654,1.211111929157093,0.1643835616438356,0.7204142114346442,1.0,8/38,11.58%,NRCAM;PTPRD;CTNND2;PPFIA2;ANK3;LRRC4C;REST;NRXN1
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Bone Marrow,0.6242522996766124,1.2110839159292632,0.18055555555555555,0.7198517598040051,1.0,8/26,22.12%,SERPINE1;PLSCR4;COL4A2;GJA1;PLAT;EDIL3;VEGFC;CALD1
prerank,Reactome_2022__GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,0.6603702314351588,1.2109914992524813,0.21052631578947367,0.7195402300829095,1.0,3/17,8.07%,PSMC6;NFE2L2;RPS27A
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Subcutaneous Adipose Tissue,0.6285284191650383,1.2107046841060958,0.17721518987341772,0.7201445994902552,1.0,7/26,15.48%,ADM;BCL6;KLF4;FOSL2;DYSF;TNS1;KCTD12
prerank,CellMarker_Augmented_2021__Epithelial Hair Follicle Stem cell:Hair Follicle,0.8275900518916564,1.2105851182910012,0.21428571428571427,0.7199684694633716,1.0,2/5,14.58%,TINAGL1;VWA2
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.5551910155946014,1.2104641695316356,0.16470588235294117,0.7198238147420629,1.0,16/90,13.68%,PIK3R3;RTN4;NEDD9;SUN2;HSPA5;ELP3;PRKCE;VSIR;ENPP2;SEMA6B;HIF1A;PECAM1;FLT1;BCAR1;AGO2;ITGB1
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.8196412444140873,1.2104413305896653,0.208955223880597,0.7192541740245003,1.0,3/5,17.00%,RTN4;AHCTF1;TPR
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.7504721027315164,1.2104402576075586,0.22388059701492538,0.7185819738618606,1.0,3/5,24.75%,HIF1A;EPAS1;DCUN1D4
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.780812851251656,1.2104139275205035,0.24324324324324326,0.7180145564144339,1.0,3/6,7.07%,BCL6;VSIR;CBFB
prerank,Reactome_2022__Formation Of A Pool Of Free 40S Subunits R-HSA-72689,0.5670348772760483,1.2102380403953863,0.17721518987341772,0.7180584396872821,1.0,16/50,25.58%,RPS11;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12;RPS27;EIF3A;RPL37A;RPL21;EIF3H;RPLP1
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.7262883531896519,1.2102024329234933,0.2459016393442623,0.7175339015726945,1.0,6/8,24.38%,CD9;CD81;ITGB1;SREBF2;LDLR;PPARG
prerank,Reactome_2022__Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,0.6710404076176627,1.210076483599244,0.23684210526315788,0.7174129694526448,1.0,6/15,23.67%,SMAD7;RPS27A;NEDD4L;PPP1CB;UBC;XPO1
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.7511430308855735,-1.2098741235967139,0.2926829268292683,0.943185448192429,1.0,1/5,1.01%,CARMIL1
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.8285181588650885,1.2095628693113618,0.15151515151515152,0.7188393956388802,1.0,1/6,0.77%,ADAMTS9
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.746455726718374,1.2094674085730726,0.2112676056338028,0.7186659518332729,1.0,1/8,11.47%,REST
prerank,CellMarker_Augmented_2021__Granulosa cell:Ovary,0.7812603373837104,1.2093614834262987,0.22058823529411764,0.7185237153200625,1.0,4/10,14.85%,MTHFD1L;COL4A2;BCAR1;TUBB6
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.8263284929505383,1.2093545275008686,0.16129032258064516,0.7178983233346702,1.0,2/5,7.68%,CACNA1C;CTNNA3
prerank,Reactome_2022__Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,0.8522158527013208,1.2090237694291157,0.20967741935483872,0.7185996927347135,1.0,3/5,11.87%,CDK6;CDKN1B;CDKN1A
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.5607845645220275,1.2088670881601795,0.21333333333333335,0.7185708438558297,1.0,11/46,10.78%,DOK5;NES;ANK2;GLUL;TIMP3;PTPRD;NFASC;PLSCR4;COL4A2;GJA1;BOC
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.6873498635635809,1.2088497159333806,0.22535211267605634,0.7179471438662008,1.0,11/15,29.19%,HSPA5;GLUD1;MBP;CCDC14;ACTB;PLP1;YWHAE;CDC42;ZNF148;CALM1;YWHAQ
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Germ,0.6565314254911111,1.2087798571192097,0.21794871794871795,0.7176012790860752,1.0,7/13,14.61%,GRIA2;CNTN5;GRM7;GRIN2B;RALYL;NRXN1;DLGAP2
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.6739091388838655,1.2086811097912482,0.21428571428571427,0.7173277192467875,1.0,2/13,5.15%,PBX3;CACNA1C
prerank,Reactome_2022__ISG15 Antiviral Mechanism R-HSA-1169408,-0.49236735892004235,-1.2080814113772684,0.2,0.9464369450041638,1.0,7/35,7.22%,EIF2AK2;ISG15;HERC5;MX1;STAT1;NUP214;TRIM25
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.6080077715934669,-1.2078838411233255,0.20588235294117646,0.9435346509495984,1.0,1/12,0.56%,PRIMPOL
prerank,Reactome_2022__DAG And IP3 Signaling R-HSA-1489509,0.6754216457458783,1.2078320925794301,0.23943661971830985,0.7201743832945346,1.0,6/17,21.89%,ITPR1;PRKCE;ADCY2;PRKX;AHCYL1;ADCY9
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.7755381384119664,1.207342444559854,0.21428571428571427,0.7216873092152988,1.0,1/5,4.91%,GRIN2B
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.7461069714130567,1.2071053183362441,0.28125,0.7218701813685467,1.0,1/9,0.72%,ERBB4
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.595827627250273,1.2068160179803966,0.24324324324324326,0.7224607313565365,1.0,12/32,21.70%,B3GNT2;MGAT4A;PLOD2;OGT;TMEM165;TRAK1;MGAT5;FUT8;EOGT;MGAT1;PMM2;B4GALT1
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.5454230000226624,1.2064543634987204,0.15384615384615385,0.7233151613150782,1.0,15/67,15.51%,PPA1;RRBP1;RPS11;RPS18;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;AGO2;EEF1A1;RPL13A;RPS12
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.752370712549319,1.2061138180368778,0.21875,0.7239440263399319,1.0,1/8,7.30%,ACSL5
prerank,PanglaoDB_Augmented_2021__Tuft Cells,0.7244397517228417,1.2061055122861075,0.265625,0.7232900297916997,1.0,1/8,1.97%,KLF6
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Retina,0.7483730096598594,1.2061035291001965,0.25,0.7226270691777751,1.0,3/10,12.88%,NES;MAP1B;BCAR1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.645344309818969,-1.206030890315179,0.3235294117647059,0.9463776221038647,1.0,1/10,3.27%,STAT1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.6475768112593692,1.2060033659691598,0.28378378378378377,0.7224019298442528,1.0,2/13,6.00%,MBP;NFASC
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Mammary Gland,0.5792842200830682,1.205964494744102,0.2702702702702703,0.7219438821274105,1.0,12/37,23.93%,ANXA1;DUSP6;S100A6;DYSF;TRIOBP;ACTN1;HDAC7;PXN;BCL2L1;SPARC;ETS1;MSN
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.5390105164984059,1.2058484957132352,0.2261904761904762,0.72186167013251,1.0,25/90,22.42%,SUN2;ANK2;VAPB;SGIP1;SCARB2;CCDC88A;RPS27A;GRB2;PICALM;ANK3;TOR1AIP2;ARPC2;HIP1R;DYSF;REEP3;SYT1;FZD4;TF;CHMP4B;SH3KBP1;HSPA8;ACTB;DNM2;SYNJ2;UBC
prerank,Reactome_2022__Metabolism Of Vitamins And Cofactors R-HSA-196854,0.6071580099811039,1.2058102016681604,0.24,0.721374574916896,1.0,9/36,12.14%,MTHFD1L;SLC52A3;GPC5;ENPP2;HSP90AA1;SLC2A1;SLC2A3;SLC25A16;MTHFD2L
prerank,KEGG_2021_Human__Vascular smooth muscle contraction,0.587685942178825,1.2057677805436635,0.22784810126582278,0.7209794179214757,1.0,8/40,11.21%,ADM;ITPR1;KCNMB4;PRKCE;CACNA1C;MYL6;GNA13;MYH10
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Fetal Liver,0.5866005615965497,1.2053793571581441,0.17567567567567569,0.7220505505205619,1.0,7/44,12.32%,ADAMTS9;DOK5;PTPRD;PLSCR4;VWF;GJA1;FLT1
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.6608738389428745,1.205344105063099,0.19117647058823528,0.7214636324612239,1.0,5/16,14.74%,KLF2;HSP90AA1;KLF4;NOS1AP;RAC1
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.7584165214023509,1.2053270897676114,0.26865671641791045,0.7208475155573166,1.0,4/9,11.87%,RTN4;MAP2;CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.6435319204480138,1.205141730106557,0.17105263157894737,0.7210187438876062,1.0,12/30,20.16%,PRKAG2;SLC8A1;HYAL2;CDKN1B;TRIB2;CDKN1A;PAK2;WWTR1;SPRED1;PTPN1;SH3BP5;NPM1
prerank,CellMarker_Augmented_2021__Epiblast cell:Embryo,0.6699813244635684,1.2049726043197766,0.208955223880597,0.7209580361613139,1.0,3/16,7.44%,PBX3;UPP1;SERPINB6
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.6602920143408394,1.2048101311872632,0.208955223880597,0.7210785458699169,1.0,5/27,9.83%,RTN4;GLUL;PRKCE;ENPP2;HIF1A
prerank,Reactome_2022__Cap-dependent Translation Initiation R-HSA-72737,0.5609863249404659,1.2040936667227264,0.16666666666666666,0.7232897346755939,1.0,17/55,25.58%,RPS11;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12;RPS27;EIF3A;EIF5;RPL37A;RPL21;EIF3H;RPLP1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.7540104934084453,1.2038036331920654,0.2564102564102564,0.723809645500809,1.0,4/7,19.42%,PIK3R1;PXN;STAT3;PTPN1
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.6639740352088652,1.2037936179511317,0.24050632911392406,0.7232148193352885,1.0,8/20,22.15%,CADM2;SMAD7;CTNNA1;PAK2;AFDN;ACTB;TBCD;CDH5
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.6343774834019343,1.203738031821207,0.1917808219178082,0.722701269808525,1.0,7/23,17.50%,MAP3K5;ANXA1;NFE2L2;JUN;FOS;ECT2;PXN
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.6965418496033398,-1.2036001472466635,0.2571428571428571,0.9516557273919745,1.0,1/5,8.55%,MSH3
prerank,CellMarker_Augmented_2021__Megakaryocyte:Umbilical Cord Blood,0.6401004239645763,1.203525290354006,0.17105263157894737,0.7229398533048527,1.0,8/22,14.16%,ZEB2;TM6SF1;FES;VWF;PECAM1;LRRC32;CLDN5;DYSF
prerank,Reactome_2022__RND1 GTPase Cycle R-HSA-9696273,-0.5752737519056561,-1.2032238207637367,0.22580645161290322,0.9493098851709229,1.0,2/18,0.77%,EPSTI1;HOMER2
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.6949728444025799,1.2032014917514542,0.23880597014925373,0.7236083084166846,1.0,4/15,9.83%,PRKAG2;PINK1;OGT;HIF1A
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.7823779643453812,1.203138041759081,0.24,0.7232357653842707,1.0,2/8,8.37%,PPP2R2B;DUSP1
prerank,Reactome_2022__Signaling By Hedgehog R-HSA-5358351,0.5954707212188944,1.203070771056069,0.2077922077922078,0.7228738825994528,1.0,7/43,16.02%,PSMC6;SPOPL;GPC5;RPS27A;BOC;ADCY2;PSMA7
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.6595501298858817,1.2029907433652012,0.1917808219178082,0.7225425912924659,1.0,10/20,22.15%,LAMC1;MBP;GJA1;PECAM1;CLDN5;ITGB1;DMD;ESAM;ACTB;CDH5
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.6221092344578448,1.2027858292619522,0.21875,0.7226107371556992,1.0,7/21,12.43%,TSG101;HYAL2;FGFR1;DUSP1;TRIB2;FLT1;STK38
prerank,Reactome_2022__TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,0.6784533604017373,1.2027623224586617,0.2465753424657534,0.7220312257309119,1.0,7/19,23.67%,SMAD7;RPS27A;NEDD4L;ITGB1;PPP1CB;UBC;XPO1
prerank,Reactome_2022__Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,0.5989547727989726,1.2027423569075886,0.22784810126582278,0.7214726609851042,1.0,2/33,1.35%,ADM;ITPR1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.7005089237436253,1.2020378578698547,0.25,0.7239779133421297,1.0,5/12,14.74%,PINK1;GRB2;PIKFYVE;CDKN1A;RAC1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.6568354786495183,1.201642708212669,0.16901408450704225,0.7247896759186299,1.0,8/23,19.68%,ERBB4;FES;FGFR1;FLT1;TPST2;ABL2;ABI1;TEC
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.6965676556932985,1.2012741903762172,0.288135593220339,0.7255404266260578,1.0,1/9,1.86%,PCK1
prerank,Reactome_2022__Constitutive Signaling By Overexpressed ERBB2 R-HSA-9634285,0.7663143412322295,1.201160652592649,0.265625,0.725446845002009,1.0,4/6,21.67%,HSP90AA1;GRB2;ERBIN;CDC37
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.7109041262535035,1.200873696283468,0.21666666666666667,0.725977676117509,1.0,4/12,16.87%,TSG101;SYTL4;CADPS2;SDCBP
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Blood,0.6955360753331377,1.2006319994356776,0.2361111111111111,0.7262501642239312,1.0,3/11,9.77%,JUNB;CD9;JUN
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.5080798777849282,-1.2002549947347751,0.21428571428571427,0.9571126580675418,1.0,7/30,10.33%,RNF213;ALS2;CLYBL;DISP1;PKD2;SAMHD1;RBMX
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Placenta,0.6446009556293197,1.200230387908298,0.23880597014925373,0.7274618092943418,1.0,7/22,16.10%,ARHGAP23;TIMP3;COL4A2;GJA1;BOC;PCDH7;SEMA3F
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.7194684126731978,1.2002072505427561,0.19298245614035087,0.7268925049278889,1.0,4/9,13.47%,GPM6B;PICALM;COMMD1;NEDD4L
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.772487245894013,1.2001341992605676,0.3103448275862069,0.7266302887720353,1.0,2/5,8.07%,PGK1;RPS27A
prerank,KEGG_2021_Human__Glycerolipid metabolism,0.6901371885685872,1.1999933806971437,0.2857142857142857,0.726516507904272,1.0,5/11,15.80%,MGLL;DGKI;LPIN2;PLPP1;AGPAT4
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.8032408475377788,1.199978032949125,0.22580645161290322,0.7252949994722638,1.0,1/6,5.79%,NDUFA12
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.8032408475377788,1.199978032949125,0.22580645161290322,0.7252949994722638,1.0,1/6,5.79%,NDUFA12
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.7194675307560171,-1.1996000061864331,0.3,0.9563565862774129,1.0,1/6,1.86%,IFIH1
prerank,CellMarker_Augmented_2021__Induced Pluripotent Stem cell:Undefined,0.7055911816546194,1.1995580532083758,0.2318840579710145,0.7264026582131815,1.0,7/12,18.57%,TBX3;VSIR;ALPL;KLF4;ITGB1;PODXL;STAT3
prerank,CellMarker_Augmented_2021__Dopaminergic neuron:Midbrain,0.7372012079331434,1.1993197552687824,0.25,0.7260684776940947,1.0,4/9,17.10%,LAMA5;CTNNA1;SEMA3F;DAG1
prerank,CellMarker_Augmented_2021__Epithelial cell:Uterus,0.7372012079331434,1.1993197552687824,0.25,0.7260684776940947,1.0,4/9,17.10%,LAMA5;CTNNA1;SEMA3F;DAG1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.7460924680901456,1.1985041198109199,0.25806451612903225,0.7287326514433954,1.0,2/7,17.85%,MGAT5;LGALS3
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.6227287596271853,1.198425903659484,0.2714285714285714,0.7285000736155982,1.0,4/25,4.01%,NRCAM;RTN4;GRM7;MAP1B
prerank,Reactome_2022__Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,0.6556939641167013,1.198334001733683,0.20270270270270271,0.7282091375042805,1.0,5/17,16.02%,PSMC6;HSP90AA1;RPS27A;CDKN1A;PSMA7
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.714198751413877,1.1982285973942648,0.23880597014925373,0.7279872185099885,1.0,3/14,7.54%,ERBB4;PKN3;SEMA6B
prerank,Reactome_2022__Leishmania Infection R-HSA-9658195,0.551019651587614,1.1982213325585966,0.14102564102564102,0.7273550320640069,1.0,18/66,24.30%,ADM;ITPR1;MYO9B;GRB2;GGT5;JUN;MYO1E;ARPC2;ADCY2;CRK;PRKX;ABI1;WIPF1;AHCYL1;ADCY9;NCK1;FYN;FGR
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.7425267629601068,1.198059482222286,0.3333333333333333,0.7273589431006089,1.0,3/7,13.57%,ANK2;PRNP;NOS1AP
prerank,Reactome_2022__Activation Of NF-kappaB In B Cells R-HSA-1169091,0.6280983102926221,1.1977825116801015,0.23684210526315788,0.7279289491428447,1.0,5/23,17.13%,PSMC6;REL;RPS27A;PSMA7;MALT1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.7098485145494227,1.197568451291779,0.26153846153846155,0.7282736612943853,1.0,4/8,22.18%,JUN;BCLAF1;MED4;SETX
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.6772648793991793,-1.1975230543618545,0.3235294117647059,0.9600705224924474,1.0,1/6,0.13%,GBP1
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.6279201245388766,1.1973124837874567,0.2535211267605634,0.7286859701920282,1.0,8/24,11.47%,ITPR1;GLUD1;CACNA1C;RAPGEF3;SNAP25;SLC2A1;RAP1A;REST
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.6126551656933082,1.1971459536178566,0.26582278481012656,0.7287471069971344,1.0,7/24,22.23%,PICALM;NEDD4L;HIP1R;LGALS3;ABL2;PTPN1;RUFY2
prerank,GO_Biological_Process_2021__limb development (GO:0060173),-0.739202560517859,-1.1970159798359996,0.2,0.958371318117676,1.0,1/7,2.97%,ZNRF3
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.763282536375106,1.196488026472234,0.22857142857142856,0.7310451465590376,1.0,2/10,9.03%,PDK4;OGT
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.6534347564601496,1.1963462290577915,0.25675675675675674,0.7310263677111101,1.0,5/22,9.93%,PSMC6;HSPA5;UBE2J1;HSP90B1;NPLOC4
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.6970546429329608,1.196346177455599,0.2807017543859649,0.730386239543237,1.0,4/8,24.38%,FGFR1;FLT1;MEF2C;PPARG
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.7616371749640466,1.1962715340962193,0.28125,0.7300576507427066,1.0,3/8,11.37%,SCARB2;PIKFYVE;ANXA2
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.6429137827689972,1.196233749576397,0.25,0.7295164096910676,1.0,2/17,2.87%,ZEB2;PKN3
prerank,Reactome_2022__CLEC7A (Dectin-1) Signaling R-HSA-5607764,0.6191561297700594,1.1961264554182311,0.28378378378378377,0.7292569401296818,1.0,9/34,22.42%,PSMC6;ITPR1;RPS27A;TAB2;PSMA7;MALT1;AHCYL1;PPP3CB;UBC
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.678232586461763,1.1958208996313218,0.2318840579710145,0.7298686921460733,1.0,5/12,25.44%,EPS8;PICALM;RAC1;MSN;MTOR
prerank,Reactome_2022__M Phase R-HSA-68886,0.5315028664752182,1.1957340636712985,0.11627906976744186,0.7295030333782648,1.0,33/101,23.67%,CEP57;PSMC6;LBR;TUBB4B;HSP90AA1;RPS27A;RAD21;WAPL;AHCTF1;TUBA1B;TUBB6;CEP70;LPIN2;ENSA;PSMA7;MCPH1;TPR;RAB2A;ALMS1;RPS27;CSNK1D;DYNC1H1;CHMP4B;PAFAH1B1;CEP290;TAOK1;ARPP19;YWHAE;UBC;TMPO;SPC25;H3-3B;XPO1
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.6713740749520762,1.195732918373172,0.2638888888888889,0.7288675777742768,1.0,2/13,7.84%,ROBO2;DLC1
prerank,CellMarker_Augmented_2021__Osteogenic Precursor-Like cell:Dermis,0.5881543017333158,1.1955039803643328,0.16216216216216217,0.7290920735292541,1.0,15/48,13.47%,ERBB4;MAP2;CNTN1;MAP1B;NPAS3;LRP1B;TTLL7;SRGAP1;PPP1R9A;LRRC4C;PDE10A;UNC5C;ANKS1B;MAPK10;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.6885947064403142,1.1953408057479935,0.2459016393442623,0.7291329893032933,1.0,1/12,1.67%,MAP2
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.5105836199751792,1.195249820962184,0.12087912087912088,0.7289426376907551,1.0,28/125,19.10%,LAMC1;RRBP1;RPS11;MGAT4A;PLOD2;RPS18;RPS9;ERO1A;MSRB3;RPS27A;RPL23;HSP90B1;MSRA;RPL8;RPL34;STK38;RPL37;RPLP2;AGO2;DENND3;EEF1A1;RPL13A;RPS12;PLAT;TF;CSNK1G3;RPS27;ABL2
prerank,Reactome_2022__Influenza Viral RNA Transcription And Replication R-HSA-168273,0.5622262532560178,1.1952055093602119,0.18181818181818182,0.7284831216839072,1.0,14/62,18.86%,PBRM1;RPS11;RPS9;HSP90AA1;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12;TPR;RPS27
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.7801401159728292,1.195169515687511,0.29310344827586204,0.7279763204109533,1.0,3/5,18.57%,BACH2;CD55;STAT3
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.7905288304841609,1.195108244359869,0.24615384615384617,0.727595303242431,1.0,2/6,6.32%,SERPINE1;NFE2L2
prerank,Reactome_2022__Negative Regulation Of FGFR1 Signaling R-HSA-5654726,0.7093020925176822,1.1948768752853138,0.2698412698412698,0.7278389339563136,1.0,3/11,8.31%,FGFR1;RPS27A;GRB2
prerank,Reactome_2022__Sema3A PAK Dependent Axon Repulsion R-HSA-399954,0.7376287656378353,1.1945912570075703,0.21212121212121213,0.7283507055214435,1.0,3/9,16.36%,FES;HSP90AA1;PLXNA2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.7167770328287826,1.1943473441906334,0.2638888888888889,0.7285836789730326,1.0,3/10,18.57%,TMED10;MALT1;STAT3
prerank,Reactome_2022__Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,0.766210671594518,1.1939934139175565,0.25757575757575757,0.7293620220384412,1.0,3/8,16.63%,SNAP25;PPFIA2;SYT1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.7382960062354964,1.19392489183842,0.3389830508474576,0.728981453001252,1.0,1/6,5.42%,DUSP6
prerank,Reactome_2022__Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,0.7301300565741395,1.1934056741255064,0.24285714285714285,0.7303411759413284,1.0,4/9,20.40%,PIK3R1;GRB2;CDKN1A;BCL2L1
prerank,Reactome_2022__Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.5980337079388005,-1.1930699625964065,0.32,0.9689942807736192,1.0,2/10,5.23%,SLC38A3;SLC25A29
prerank,KEGG_2021_Human__Cocaine addiction,0.6845307068625945,1.1928600477055646,0.22972972972972974,0.7316317051111656,1.0,3/13,9.77%,GRIA2;GRIN2B;JUN
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Breast,0.7915252073506368,1.1925473990031317,0.23636363636363636,0.7321566541091595,1.0,2/5,7.38%,NES;KDM1A
prerank,CellMarker_Augmented_2021__Stromal cell:Bone Marrow,0.8045918612763281,1.1924884641030626,0.3114754098360656,0.7318131261718371,1.0,3/5,14.98%,ITGA1;ITGB1;ALCAM
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.788407085404041,-1.1924248703494233,0.3235294117647059,0.9680204332197907,1.0,1/5,7.30%,PKD2
prerank,CellMarker_Augmented_2021__Natural Regulatory T (Treg) cell:Peripheral Blood,-0.6744458449265897,-1.1922397748570115,0.25,0.9650384661916152,1.0,4/7,22.52%,GIMAP8;GIMAP4;CYLD;GIMAP7
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.7041346348685774,1.1921369895222589,0.3150684931506849,0.7325561059452428,1.0,2/10,14.74%,EPS8;RAC1
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),0.7045913048531598,1.1921127227208614,0.28169014084507044,0.7313756514840454,1.0,1/11,0.88%,PSMC6
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.7045913048531598,1.1921127227208614,0.28169014084507044,0.7313756514840454,1.0,1/11,0.88%,PSMC6
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.6534186659649455,-1.1914837324219232,0.21875,0.9645081961404081,1.0,4/8,15.17%,EVL;SRGAP2C;KANK1;ODF2L
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.5752996766911156,1.1914441208100701,0.22535211267605634,0.7333617408237024,1.0,11/32,18.03%,SPOPL;UFL1;SMAD7;PINK1;HSP90AA1;OGT;COMMD1;PTTG1IP;NDFIP1;MALT1;CRY1
prerank,Reactome_2022__Regulation Of BACH1 Activity R-HSA-9708530,0.7746484153481692,1.191371145934402,0.23529411764705882,0.7330566235953178,1.0,2/6,8.07%,MAFK;RPS27A
prerank,Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241,0.5429957373412556,1.191370318753077,0.19753086419753085,0.7324295435066991,1.0,7/70,7.36%,CEP57;PRKAG2;GLUD1;RAB11FIP3;CRTC3;TUBB4B;HSP90AA1
prerank,CellMarker_Augmented_2021__Microglial cell:Embryonic Prefrontal Cortex,0.5079583947977798,1.1912494503670752,0.1839080459770115,0.7325142910400337,1.0,35/131,19.18%,TM6SF1;PDK4;KLF6;FES;KLF2;PPA1;JUNB;TSC22D3;CD81;GLUL;MGAT4A;SERPINB6;SRGN;DUSP1;TACC1;BRI3;LAMP2;JUN;IFNGR1;FOS;DOCK4;LPIN2;KCTD12;PSAP;FRMD4A;LIMS1;SYT1;SPRED1;PLXDC2;BTG2;VMP1;HERPUD1;NFIB;EGFL7;MGAT1
prerank,CellMarker_Augmented_2021__Mitotic Arrest Phase Fetal Germ cell:Fetal Gonad,0.4803431395276381,1.190582633954196,0.0851063829787234,0.7342653761719048,1.0,41/280,14.93%,PIK3R3;ANGPTL4;MAP2;PRKAG2;KLF6;AFF3;BNIP3L;TBX3;OXR1;RRBP1;GLUL;MGAT4A;BAZ1A;EPS8;DUSP6;YBX3;CCDC88A;NDRG1;ZNF800;ARHGAP21;CDK6;PPP1R9A;PTBP2;CNTNAP2;VWF;RGS7;PHLPP1;SETD3;ANXA2;NRXN1;PELI1;CNOT6L;TOM1L2;SBNO1;NEDD4L;ACVR2A;ZBTB38;CD55;GRB10;MPRIP;RALY
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.7147564978722952,1.1903397392013182,0.3142857142857143,0.7346511509345953,1.0,1/7,2.55%,TBX3
prerank,CellMarker_Augmented_2021__Neural Crest cell:Undefined,0.794069944041409,1.189900598610391,0.30158730158730157,0.7357546583458363,1.0,2/6,13.68%,NES;ITGB1
prerank,Reactome_2022__Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,-0.5871565959422065,-1.189488933113619,0.3125,0.9684045607279389,1.0,3/13,10.41%,H2AC6;TCF7L1;TLE4
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.6706666004645935,1.1889955502281986,0.3,0.7386129542543501,1.0,1/14,0.50%,B3GNT2
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),0.5450379606839918,1.1888600165135776,0.18421052631578946,0.7386071509389058,1.0,19/55,27.57%,RPS11;RPS18;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12;RPS27;CHMP4B;RPL10;RPL37A;RPL21;RPLP1;SEC62;RPS15
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.6108154110554054,-1.1884769396010735,0.19444444444444445,0.9693090937303359,1.0,3/11,6.11%,UBE3D;CREB5;PARN
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.4729950117043784,-1.1883534088587988,0.11538461538461539,0.9663381840443986,1.0,5/50,3.56%,RNF213;MLLT3;ANKRD6;ZNRF3;NKD1
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.7917131125968941,1.1883072842590316,0.2631578947368421,0.7403267531939983,1.0,2/5,6.32%,BCAP31;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.49537326063667647,1.188298940747666,0.06382978723404255,0.7397071788826752,1.0,59/264,20.16%,MAFF;ST18;ZEB2;SERPINE1;ATF3;KLF6;KLF2;TBX3;PHF10;JUNB;CD81;ZFPM2;CRTC3;HYAL2;PIK3R1;SMAD7;NFE2L2;REL;SMAD5;KDM1A;JUND;RPS27A;KLF4;OGT;FOSL2;JUN;HIF1A;CNBP;SETD3;CCNC;REST;FOS;FOXF1;AGO2;TMF1;ACVR2A;ZBTB38;WWTR1;LPIN2;FOXC1;CRLF3;ATF2;BRD4;ATOH8;TNKS;GATA2;NPAS2;ARHGEF2;NAMPT;ZMIZ1;STAT3;NFIB;NR1D2;NFIC;RLF;NOTCH4;BCLAF1;CDK8;NPM1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.6218865395020963,1.188273277013102,0.19444444444444445,0.7392298422454815,1.0,4/24,9.83%,PSMC6;NFE2L2;RPS27A;HIF1A
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.7726947571859522,1.187707227971096,0.24561403508771928,0.7408034747553887,1.0,3/7,11.10%,SLC8A1;CACNA1C;MICU2
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5670506081375026,-1.1876872955367053,0.2,0.9617563155204983,1.0,5/29,4.65%,SLC22A5;SLC4A4;SLC38A3;LEPR;ABCG2
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.5670506081375026,-1.1876872955367053,0.2,0.9617563155204983,1.0,5/29,4.65%,SLC22A5;SLC4A4;SLC38A3;LEPR;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.5609103510255813,1.187651118763188,0.20253164556962025,0.7402602430809357,1.0,7/65,7.54%,PIK3R3;NEDD9;SUN2;HSPA5;ELP3;VSIR;SEMA6B
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.745269428324585,1.187646712890513,0.2727272727272727,0.7396522120347483,1.0,2/8,14.50%,AGO2;ZC3H7A
prerank,KEGG_2021_Human__RNA transport,-0.4946755450182594,-1.1876257489196689,0.21052631578947367,0.9586612807591756,1.0,4/39,6.61%,RPP38;GEMIN5;THOC1;NUP214
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.7747468308552978,1.1876110924035128,0.3,0.7391765372532201,1.0,2/5,5.58%,HSPA5;UFL1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.7227924134240903,1.1874626644104473,0.24615384615384617,0.7385085387980121,1.0,1/9,0.24%,LAMC1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.7227924134240903,1.1874626644104473,0.24615384615384617,0.7385085387980121,1.0,1/9,0.24%,LAMC1
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.6765177655389364,1.1871022674655072,0.20833333333333334,0.739148490650094,1.0,6/11,22.15%,MAP2;SSH1;HIP1R;ARFGEF1;TBCD;CDH5
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.7191653676606298,1.1869009558975738,0.25757575757575757,0.7393012208161922,1.0,3/9,9.83%,NFE2L2;SMAD5;HIF1A
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.6028610177887466,-1.1865018675061045,0.23333333333333334,0.9589908276834701,1.0,1/14,1.51%,RHOBTB1
prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,0.586236281595372,1.1859040700085275,0.2602739726027397,0.7428818473740976,1.0,7/39,9.77%,PIK3R3;SERPINE1;PRKCE;PIK3R1;COL4A2;CDKN1B;JUN
prerank,Reactome_2022__Cellular Responses To Stimuli R-HSA-8953897,0.4890166060533001,1.1858482902268244,0.11458333333333333,0.742461855375356,1.0,69/226,25.58%,PSMC6;ATF3;HSPA5;MAFK;MAP3K5;CALR;HSPH1;RPS11;CRTC3;NFE2L2;SIN3B;MT1M;RPS9;ERO1A;HSP90AA1;MT2A;RPS27A;RPL23;CDK6;CDKN1B;HSP90B1;JUN;HIF1A;NPLOC4;HSPA9;FKBP5;CDKN1A;FOS;RPL8;RPL34;RPL37;DCP2;RPLP2;EEF1A1;MAPK10;GRB10;RPL13A;TXNRD1;RPS12;NCOR2;PSMA7;TPR;NPAS2;HERPUD1;STAT3;RPS27;DYNC1H1;HSPA8;EPAS1;SERPINH1;YWHAE;UBC;ETS1;MEF2C;H3-3B;XPO1;CREB3L2;RPL37A;CAPZA2;RPL21;MT1E;ATF6;RPS6KA3;TERF2IP;ADD1;CREBBP;PSMB9;MTOR;RPLP1
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.6373178046620045,1.1857287698492722,0.2535211267605634,0.7422570518758855,1.0,5/18,10.62%,SERPINE1;ANXA1;HYAL2;KLF4;OTUD7B
prerank,Reactome_2022__Hedgehog Ligand Biogenesis R-HSA-5358346,0.6429578115912091,1.1856158139957063,0.24,0.7420525925839773,1.0,3/18,8.07%,PSMC6;GPC5;RPS27A
prerank,"Reactome_2022__Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",0.7751794088892177,1.1855996696585207,0.3181818181818182,0.7415319486577393,1.0,1/6,5.15%,CACNA1C
prerank,Reactome_2022__L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,0.5607083011033689,1.185584859116428,0.19736842105263158,0.7409842727864947,1.0,16/53,25.58%,RPS11;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12;RPS27;EIF3A;RPL37A;RPL21;EIF3H;RPLP1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.8123197545075314,1.1852836213292537,0.23376623376623376,0.7414691534155474,1.0,2/5,8.79%,SLC8A1;ANK3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.6373807624847063,-1.18521364735729,0.29411764705882354,0.9603715430708376,1.0,1/7,2.95%,ATM
prerank,"Reactome_2022__GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",0.7568925300586516,1.1851486234718365,0.2413793103448276,0.7413496152580855,1.0,4/6,20.58%,SNAP25;DNAJC5;SYT1;HSPA8
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.7573012719569696,1.1850561358370588,0.29577464788732394,0.7412117201958381,1.0,3/6,21.59%,CDK6;HSPA9;ZFP36
prerank,Reactome_2022__Extension Of Telomeres R-HSA-180786,0.7109312405753234,1.1847479642790573,0.29850746268656714,0.7417322773012878,1.0,2/10,10.23%,POLA1;RFC3
prerank,KEGG_2021_Human__Calcium signaling pathway,0.5441957112013579,1.1847212301919456,0.25316455696202533,0.7411959847545875,1.0,16/44,23.16%,ERBB4;ITPR1;SLC8A1;CACNA1C;FGFR1;ATP2B1;FLT1;ADCY2;RYR3;ATP2B4;GRM5;VEGFC;PPP3CB;ADCY9;PLCB1;PPP3CC
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.7285878036916078,1.1846907807759033,0.3076923076923077,0.7406420770222109,1.0,3/8,23.98%,MYO1B;SEMA3F;EMP2
prerank,Reactome_2022__TRAIL Signaling R-HSA-75158,-0.7160388708588864,-1.1845545296773892,0.3333333333333333,0.9593102784432512,1.0,3/6,10.36%,CASP10;TNFSF10;CFLAR
prerank,Reactome_2022__Cyclin D Associated Events In G1 R-HSA-69231,0.7054294891502537,1.18425861299494,0.30985915492957744,0.7418831141073652,1.0,5/16,11.87%,RPS27A;CDK6;CDKN1B;CCNH;CDKN1A
prerank,CellMarker_Augmented_2021__Decidual cell:Blood,-0.5089654772961656,-1.184006222503405,0.2,0.9580521130220779,1.0,11/46,6.69%,SAMD9L;GBP1;GBP2;IFIH1;TAP1;OAS3;PARP9;TNFSF10;SP100;APOL3;SAT1
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.6943964200653832,1.1839797867162811,0.25675675675675674,0.7421241818083677,1.0,3/13,11.29%,ITGA1;HSP90B1;MAGI2
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.7543297635976287,1.1834073152713478,0.2608695652173913,0.7437588997744672,1.0,3/6,17.45%,FES;RASSF1;GATA2
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.7535763448637224,1.1833926043505254,0.31666666666666665,0.7432139275701075,1.0,4/7,24.38%,CDK6;HDAC7;SMAD6;PPARG
prerank,Reactome_2022__Integrin Cell Surface Interactions R-HSA-216083,-0.5978926713417538,-1.1832646543725696,0.2857142857142857,0.9573365642437779,1.0,1/19,0.16%,VCAM1
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.6926956979857459,1.1831442563233123,0.17647058823529413,0.7434993717692547,1.0,5/10,21.30%,PINK1;HSP90AA1;HIF1A;ZMIZ1;EPAS1
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.6519111800569833,1.1827838726041877,0.22388059701492538,0.7442263798989726,1.0,7/18,8.98%,GRIA2;MAP2;ANK2;CTNND2;NFASC;SNAP25;LRRC4C
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.5769755576843837,1.1826226981480354,0.1518987341772152,0.7441976596509848,1.0,7/50,10.28%,ZEB2;KLF2;STARD4;HSP90AA1;KLF4;HIF1A;LARP4
prerank,KEGG_2021_Human__Mineral absorption,0.6713200256017877,1.1825732937033129,0.23943661971830985,0.7438104266986785,1.0,11/18,24.65%,SLC8A1;MT1M;MT2A;ATP2B1;ATP1A1;ATP1B3;TF;SLC30A1;ATP2B4;ATP1B1;MT1E
prerank,KEGG_2021_Human__Measles,0.5712566517134344,1.1824131816665382,0.20253164556962025,0.7439290784589464,1.0,9/41,13.39%,PIK3R3;PIK3R1;JAK1;CDK6;CDKN1B;JUN;FOS;TAB2;MAPK10
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.5928959695865184,-1.182256756642633,0.2222222222222222,0.9583746792972605,1.0,4/16,3.61%,IFIH1;ISG15;OAS3;IRF1
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.747017113412108,1.1818432075876661,0.2542372881355932,0.7457455808966428,1.0,2/6,18.88%,CCDC14;CSNK1D
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.6140000062305636,1.1815596222268456,0.24285714285714285,0.7461559090694985,1.0,7/20,11.58%,GRIA2;LSAMP;GRIN2B;SNAP25;PPFIA2;MAGI2;NRXN1
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.6337166514656903,1.1815057214413658,0.2676056338028169,0.7457775012999668,1.0,5/22,14.18%,NRCAM;CALR;FGFR1;REST;ECT2
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6753113225989407,1.181446914533966,0.26153846153846155,0.7454638097458822,1.0,7/13,23.03%,GRIK1;GRM7;NRXN1;DGKI;SYT1;GRM5;MEF2C
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.5686213413757173,-1.1813544463597676,0.25,0.9584964385801363,1.0,3/10,5.34%,PLA2G4A;PLPPR4;PLAAT3
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.7985725454839776,1.1808441746928493,0.23809523809523808,0.7470809356941891,1.0,2/5,6.06%,GPC5;HYAL2
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.5906678538637415,-1.1808180761323148,0.1875,0.9573586560964575,1.0,3/14,9.08%,SLCO1A2;ABCG2;SLC16A2
prerank,CellMarker_Augmented_2021__Naive Regulatory T (Treg) cell:Peripheral Blood,-0.6334799137694147,-1.179884192716619,0.34285714285714286,0.9538556205899734,1.0,4/8,14.42%,GIMAP8;TNFRSF1B;RCSD1;GIMAP4
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Blood,-0.6334799137694147,-1.179884192716619,0.34285714285714286,0.9538556205899734,1.0,4/8,14.42%,GIMAP8;TNFRSF1B;RCSD1;GIMAP4
prerank,Reactome_2022__Polymerase Switching On C-strand Of Telomere R-HSA-174411,0.7729643659782459,1.179559402836079,0.25,0.7514193533165298,1.0,2/5,10.23%,POLA1;RFC3
prerank,Reactome_2022__CLEC7A (Dectin-1) Induces NFAT Activation R-HSA-5607763,0.749684637947062,1.1794012994434995,0.27692307692307694,0.7513940542362364,1.0,1/9,1.35%,ITPR1
prerank,Reactome_2022__Eukaryotic Translation Termination R-HSA-72764,0.5580369866724025,1.1793938835529076,0.18666666666666668,0.7507938744200203,1.0,10/47,15.51%,RPS11;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.706668551083235,-1.1793834265804837,0.3783783783783784,0.9525702264775849,1.0,3/7,8.07%,PLXND1;SP100;WARS1
prerank,Reactome_2022__Selenoamino Acid Metabolism R-HSA-2408522,0.5493932185351583,1.1792185501912553,0.23076923076923078,0.7507326583347845,1.0,11/53,15.51%,RPS11;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;TXNRD1;RPS12
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.6599976505873499,1.1790487227888382,0.22388059701492538,0.7507444288907196,1.0,5/16,15.06%,ACOX1;ACSL5;GGT5;PON2;LPIN2
prerank,Reactome_2022__Estrogen-dependent Gene Expression R-HSA-9018519,0.6035075268869615,1.1780204978829283,0.19718309859154928,0.7543155605851587,1.0,9/39,12.91%,ERBB4;CBFB;HSP90AA1;KDM1A;JUND;JUN;RAD21;FOS;AGO2
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.6091482727829113,1.1780197374662664,0.18840579710144928,0.7536967619300438,1.0,12/28,25.66%,MAP2;NAV3;SSH1;HIP1R;ARHGEF2;HSPA8;ARFGEF1;TBCD;TAOK1;CDH5;LDLR;HDGFL3
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.5295428145819391,1.1773338443612344,0.16455696202531644,0.7558145714848552,1.0,16/59,18.30%,RTN4;RAPGEF3;FGFR1;ENPP2;PINK1;ZDHHC6;GJA1;REST;NRXN1;SPIRE1;AGO2;DAG1;RIF1;DDHD1;FZD4;CFL1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.725231123225417,1.1773189526336136,0.2835820895522388,0.7552863678126055,1.0,4/10,19.28%,FES;RAPGEF3;ABL2;ESAM
prerank,Reactome_2022__Downstream TCR Signaling R-HSA-202424,0.6144081456976416,1.1772734801332736,0.20833333333333334,0.7548497633997764,1.0,6/29,17.13%,PSMC6;PIK3R1;RPS27A;TAB2;PSMA7;MALT1
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.6809345570666115,1.1768219768357022,0.3103448275862069,0.7559460367550677,1.0,1/9,1.86%,PCK1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.7231364690365929,1.176816689969513,0.2535211267605634,0.7553556097367223,1.0,2/9,5.60%,ANXA1;BCR
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.7459194959861393,1.1766020901497343,0.2608695652173913,0.7554721446594752,1.0,7/9,22.87%,SLC8A1;ANK2;CACNA1C;ATP1A1;DMD;YWHAE;ATP1B1
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.6396423756209708,1.1765450237798418,0.24050632911392406,0.7551182080604352,1.0,8/20,13.39%,GRIA2;CNTN1;PTPRD;NFASC;SNAP25;NRXN1;SHC2;MAPK10
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.7499270681434901,1.1762718046681246,0.3389830508474576,0.755596206620109,1.0,1/7,5.15%,CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.6537441159321989,1.1762571017162138,0.18840579710144928,0.7550711917023955,1.0,9/15,24.38%,KLF4;JUN;HIF1A;FOS;ATOH8;GATA2;STAT3;ETS1;PPARG
prerank,KEGG_2021_Human__Bile secretion,-0.5969450189685969,-1.1758271317443059,0.27586206896551724,0.9621980861133392,1.0,3/15,4.65%,SLCO1A2;SLC4A4;ABCG2
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.7920522856009786,1.1756571947774053,0.20588235294117646,0.7554377998849733,1.0,4/6,13.47%,SLC8A1;ATP1A1;ATP1B3;NEDD4L
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.7920522856009786,1.1756571947774053,0.20588235294117646,0.7554377998849733,1.0,4/6,13.47%,SLC8A1;ATP1A1;ATP1B3;NEDD4L
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.7920522856009786,1.1756571947774053,0.20588235294117646,0.7554377998849733,1.0,4/6,13.47%,SLC8A1;ATP1A1;ATP1B3;NEDD4L
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.7389949959442235,1.1756067103625443,0.25,0.7550046164234883,1.0,1/8,2.74%,BHLHE40
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.6346351774016971,1.1751631391691806,0.21212121212121213,0.7561368357295154,1.0,11/23,22.87%,SLC8A1;ANK2;CALR;VAPB;ATP2B1;TMEM165;SLC30A1;ATP2B4;ATP13A3;CDH5;ATP1B1
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),0.5423847341244445,1.175016410678941,0.22077922077922077,0.7559643598898417,1.0,10/51,15.51%,RPS11;RPS18;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPL13A;RPS12
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,0.5574358987626843,1.1749252376315218,0.17567567567567569,0.7557831853966557,1.0,10/48,15.51%,RPS11;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.7023677144682496,1.1747113304264405,0.21428571428571427,0.7559790735872813,1.0,3/12,10.70%,HSPA5;ERO1A;HSPA9
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.6653938805738701,-1.1744216720749936,0.3783783783783784,0.9606587505805567,1.0,1/8,1.12%,SLC4A4
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.6653938805738701,-1.1744216720749936,0.3783783783783784,0.9606587505805567,1.0,1/8,1.12%,SLC4A4
prerank,KEGG_2021_Human__Mitophagy,0.613246753446664,1.173939416113938,0.22535211267605634,0.758532032650406,1.0,8/30,13.89%,BNIP3L;PINK1;RPS27A;JUN;HIF1A;TBC1D15;MAPK10;KRAS
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.6559429482314971,1.17381769581098,0.22388059701492538,0.7582865296671972,1.0,7/22,13.68%,ADM;CD9;CD81;GRB2;PICALM;KIF16B;ITGB1
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.5064307611625026,-1.1733344892713327,0.20689655172413793,0.961138713713051,1.0,8/25,11.45%,RNF213;ALS2;ZNHIT6;HOMER1;PKD2;HGSNAT;RBMX;MCU
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Deciduous Tooth,0.5495502667846134,1.1733126055584515,0.25925925925925924,0.7595985458537912,1.0,10/46,13.12%,ZEB2;S1PR1;GGT5;VWF;ZNF366;PECAM1;LRRC32;CFH;FLT1;CLDN5
prerank,PanglaoDB_Augmented_2021__Interneurons,0.550720867301616,1.172824954465484,0.175,0.7609978635365905,1.0,17/62,17.80%,GRIA2;MAP2;OXR1;CADM2;CTNND2;TRIM9;ATG12;SNAP25;ARHGAP21;SRGAP1;PPFIA2;NRXN1;NCALD;ADGRB3;SYT1;GATA2;LPGAT1
prerank,Reactome_2022__Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,0.7330290714804187,1.1727852134737986,0.3181818181818182,0.7605097339469035,1.0,5/9,21.70%,GPC5;CHSY1;SLC26A2;EXT1;B4GALT1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),-0.6760808694033471,-1.1727340450841688,0.3,0.9597769702704094,1.0,2/6,13.78%,TAPT1;MBOAT2
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7680428052160206,1.1726755551867356,0.3225806451612903,0.7604330492384169,1.0,1/5,3.75%,CD81
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.7730470859119416,1.1725651953683132,0.29850746268656714,0.7602494457078995,1.0,1/6,5.26%,WDR48
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.7317027312661457,1.1725612687128695,0.2753623188405797,0.7596561387399137,1.0,4/8,12.40%,ANO5;ANO2;SLC12A6;ANO6
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.6949497961310857,-1.1721066613217543,0.3235294117647059,0.9583996930995431,1.0,1/5,6.83%,ACVR1
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.7395500799393072,1.1717121563518884,0.3225806451612903,0.7623233275972907,1.0,3/8,17.85%,PICALM;RAC1;LGALS3
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.7809437580835399,1.1715099374967506,0.24615384615384617,0.7625034960344061,1.0,2/5,11.87%,LBR;CDKN1A
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.8234245730595522,1.1713998720987864,0.3064516129032258,0.7610093611144977,1.0,2/5,7.01%,CHSY1;CHST11
prerank,Reactome_2022__Chondroitin Sulfate Biosynthesis R-HSA-2022870,0.8234245730595522,1.1713998720987864,0.3064516129032258,0.7610093611144977,1.0,2/5,7.01%,CHSY1;CHST11
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.8234245730595522,1.1713998720987864,0.3064516129032258,0.7610093611144977,1.0,2/5,7.01%,CHSY1;CHST11
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.5557134342061718,1.1712246809090556,0.20253164556962025,0.7609948591035053,1.0,16/57,19.36%,MYO9B;EPS8;RAPGEF3;RASSF1;GRB2;JUN;RAP1A;GNA13;CDKN1A;SHC2;ADGRG1;KRAS;RAC1;SHOC2;CFL1;RERG
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.7487447565844135,1.1709399441432307,0.25675675675675674,0.7613703584592278,1.0,1/7,5.50%,RAPGEF3
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.7712743738282412,1.1709329242430997,0.23076923076923078,0.7608242275989309,1.0,1/7,1.86%,PCK1
prerank,CellMarker_Augmented_2021__Fibroblast:Undefined,0.7313553697249832,1.170783626675132,0.296875,0.7607922100747821,1.0,2/8,13.68%,CD81;ITGB1
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Undefined,-0.5184729051353244,-1.1705205255046505,0.23333333333333334,0.960416653152463,1.0,5/25,7.01%,GBP4;XAF1;CD74;APOL3;GIMAP8
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.5438448565769749,1.170422060711114,0.24691358024691357,0.761724014728167,1.0,11/86,9.99%,LAMC1;RTN4;PLS3;NEDD9;GPM6B;EPS8;MYO1B;PICALM;ANK3;SLC2A1;RAD21
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.7038027871117387,1.1702742020375518,0.273972602739726,0.7616383219174193,1.0,1/9,3.82%,TRMT9B
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.6843449736713771,1.169906363261958,0.2857142857142857,0.7624973462911195,1.0,3/12,6.91%,ARF1;CTNND2;PRNP
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.7512037949388981,-1.1698300915841664,0.38235294117647056,0.9597259522402856,1.0,2/5,9.19%,PLA2G4A;PDGFB
prerank,CellMarker_Augmented_2021__Endometrial Stromal Stem cell:Endometrium Stroma,0.5490297117233698,1.16955025417429,0.2602739726027397,0.7631609455243136,1.0,8/33,14.42%,PLSCR4;DLC1;MSRB3;COL4A2;GJA1;LRRC32;ITGB1;TNS1
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.3991245548238066,-1.1694084024979958,0.09090909090909091,0.9579024728131875,1.0,14/165,3.61%,RSAD2;GBP1;VCAM1;XAF1;GBP2;IL32;IL15;ISG15;LEPR;IFI27;MX1;STAT1;OAS3;IRF1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.5211928852961707,-1.1692783449133908,0.21428571428571427,0.9521510283940492,1.0,2/17,3.40%,IFIH1;OAS3
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.5211928852961707,-1.1692783449133908,0.21428571428571427,0.9521510283940492,1.0,2/17,3.40%,IFIH1;OAS3
prerank,Reactome_2022__FLT3 Signaling In Disease R-HSA-9682385,0.6305196882784508,1.1691094564928446,0.19444444444444445,0.7640967182498,1.0,6/18,22.42%,PIK3R1;RPS27A;GRB2;CDKN1A;BCL2L1;UBC
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.7001283324098986,1.1690159939431788,0.31666666666666665,0.7637011743357036,1.0,2/8,10.62%,CTNNA1;OTUD7B
prerank,Reactome_2022__Cellular Response To Chemical Stress R-HSA-9711123,0.5531457961515892,1.1689800609502752,0.2564102564102564,0.7632886586043809,1.0,10/46,16.02%,PSMC6;MAFK;NFE2L2;SIN3B;ERO1A;RPS27A;NPLOC4;TXNRD1;NCOR2;PSMA7
prerank,CellMarker_Augmented_2021__Oviduct-derived Stem cell:Oviduct,-0.7175569958811165,-1.1688377364747122,0.2777777777777778,0.9509445000805922,1.0,2/8,4.65%,VCAM1;ABCG2
prerank,Reactome_2022__Triglyceride Catabolism R-HSA-163560,0.7427810907407554,1.1684827926128982,0.3142857142857143,0.7645298536737061,1.0,2/5,17.24%,MGLL;PPP1CB
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.5947984099105321,1.1684740295214093,0.2571428571428571,0.7639591890947786,1.0,5/30,11.29%,LRRC7;FES;SCARB2;RAP1A;MAGI2
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.7192108247376447,1.1684572814010423,0.34545454545454546,0.7633806492509191,1.0,3/8,12.19%,PPHLN1;RAD21;WAPL
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.6844705728136232,1.1684275704612592,0.30985915492957744,0.7628819726812597,1.0,4/14,12.59%,SPOCK1;GRIN2B;PRNP;PRAG1
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.7129464851387124,1.1681708641490822,0.2835820895522388,0.7633657701788084,1.0,3/10,2.71%,MAP2;MDGA2;SPOCK1
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.7242561973438323,1.1680695119257576,0.265625,0.763113120716322,1.0,4/9,20.58%,SCARB2;LAMP2;NEDD4;HSPA8
prerank,CellMarker_Augmented_2021__Endothelial cell:Liver,-0.4403937505675858,-1.1680526830251157,0.1875,0.9504623081514401,1.0,2/40,1.33%,GBP4;ATP10D
prerank,KEGG_2021_Human__Fatty acid degradation,0.7486891861225834,1.1678637029702077,0.288135593220339,0.7631934162199466,1.0,2/8,7.30%,ACOX1;ACSL5
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.6663225241383904,1.1677138669146794,0.2463768115942029,0.7630812101905456,1.0,4/13,20.19%,HSPA5;PPM1A;RPL13A;SMAD6
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.7044575406863476,1.167556595002287,0.32727272727272727,0.7630652926469551,1.0,1/8,1.86%,PCK1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.7249648115715124,1.167473609500257,0.3333333333333333,0.7627438311886008,1.0,3/6,16.10%,SEMA6B;UNC5C;SEMA3F
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.5895424809035495,1.1673738557264732,0.31343283582089554,0.762588625363201,1.0,6/23,11.37%,MT1L;CD9;TINAGL1;BACE2;EMP1;ANXA2
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.7454373547074397,1.166823940611988,0.3125,0.7641421593254896,1.0,3/8,14.58%,TMEM45B;MAP7;VWA2
prerank,Reactome_2022__SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,0.6501613412827135,1.1666393125575856,0.25,0.7641602982438837,1.0,5/16,16.02%,PSMC6;RPS27A;CDKN1B;CDKN1A;PSMA7
prerank,Reactome_2022__RHOF GTPase Cycle R-HSA-9035034,0.6467456157672444,1.1665996897066817,0.25,0.7637258458799314,1.0,8/19,19.07%,AKAP12;MYO9B;PIK3R1;ARHGAP21;SLC4A7;ADD3;ACTN1;DIAPH2
prerank,Reactome_2022__MTOR Signaling R-HSA-165159,0.6978084707217691,1.1662842062958911,0.2876712328767123,0.7644573798685095,1.0,6/11,26.14%,PRKAG2;PPM1A;CAB39;YWHAB;MTOR;SLC38A9
prerank,Reactome_2022__Sensory Processing Of Sound R-HSA-9659379,0.5998348363635536,1.1662627518165534,0.24324324324324326,0.7639104122766068,1.0,10/19,24.22%,EPS8;SNAP25;DNAJC5;ATP2B1;MYO1E;TRIOBP;GSN;ATP2B4;MSN;CAPZA2
prerank,KEGG_2021_Human__Fatty acid biosynthesis,0.778499796466007,1.1662528104164678,0.2542372881355932,0.7633903493843783,1.0,1/6,7.30%,ACSL5
prerank,KEGG_2021_Human__Drug metabolism,0.7264571150750241,1.1658566210078893,0.27419354838709675,0.764380705405455,1.0,1/9,4.44%,UPP1
prerank,Reactome_2022__Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.520623447081571,-1.1655824339185614,0.3076923076923077,0.956174174794209,1.0,8/36,7.22%,EIF2AK2;ISG15;HERC5;MX1;STAT1;OAS3;NUP214;TRIM25
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.6580509014873077,1.16524911355672,0.3194444444444444,0.7661323942642441,1.0,7/17,23.48%,SERPINE1;PRKCE;MTDH;PDE4B;ZFP36;MEF2C;ADAM9
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.7189661519079535,1.1652343282775346,0.24615384615384617,0.7655944896760435,1.0,3/9,16.87%,PICALM;RAC1;SDCBP
prerank,Reactome_2022__Platelet Aggregation (Plug Formation) R-HSA-76009,0.688906416684549,1.1646740700600011,0.18055555555555555,0.7666228615432118,1.0,7/12,19.42%,RAPGEF3;GRB2;VWF;RAP1A;BCAR1;CRK;PTPN1
prerank,Reactome_2022__Integrin Signaling R-HSA-354192,0.688906416684549,1.1646740700600011,0.18055555555555555,0.7666228615432118,1.0,7/12,19.42%,RAPGEF3;GRB2;VWF;RAP1A;BCAR1;CRK;PTPN1
prerank,Reactome_2022__Cellular Responses To Stress R-HSA-2262752,0.4795051238164472,1.1644335915793087,0.11458333333333333,0.7670537454104785,1.0,66/223,25.58%,PSMC6;ATF3;HSPA5;MAFK;MAP3K5;CALR;HSPH1;RPS11;CRTC3;NFE2L2;SIN3B;RPS9;ERO1A;HSP90AA1;RPS27A;RPL23;CDK6;CDKN1B;HSP90B1;JUN;HIF1A;NPLOC4;HSPA9;FKBP5;CDKN1A;FOS;RPL8;RPL34;RPL37;DCP2;RPLP2;EEF1A1;MAPK10;GRB10;RPL13A;TXNRD1;RPS12;NCOR2;PSMA7;TPR;NPAS2;HERPUD1;STAT3;RPS27;DYNC1H1;HSPA8;EPAS1;SERPINH1;YWHAE;UBC;ETS1;MEF2C;H3-3B;XPO1;CREB3L2;RPL37A;CAPZA2;RPL21;ATF6;RPS6KA3;TERF2IP;ADD1;CREBBP;PSMB9;MTOR;RPLP1
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.6048623330035736,1.1641712498301047,0.28205128205128205,0.7676221237111829,1.0,6/36,13.71%,ST18;BCAP31;MAP3K5;DLC1;REST;HIP1R
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.7406393451103213,1.1640279082892089,0.2698412698412698,0.7677236713893136,1.0,1/6,1.49%,TSG101
prerank,Reactome_2022__N-Glycan Antennae Elongation R-HSA-975577,0.725409015815291,1.164004000293315,0.2982456140350877,0.7672646363573379,1.0,3/6,21.70%,MGAT4A;MGAT5;B4GALT1
prerank,Reactome_2022__Cyclin E Associated Events During G1/S Transition R-HSA-69202,0.6320328141948411,1.1639358975984633,0.2608695652173913,0.7663573131869876,1.0,6/23,16.02%,PSMC6;RPS27A;CDKN1B;CCNH;CDKN1A;PSMA7
prerank,Reactome_2022__Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,0.6320328141948411,1.1639358975984633,0.2608695652173913,0.7663573131869876,1.0,6/23,16.02%,PSMC6;RPS27A;CDKN1B;CCNH;CDKN1A;PSMA7
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.8015696011299094,1.1638193061865636,0.29310344827586204,0.7662100732356186,1.0,2/5,9.85%,KDM1A;GJA1
prerank,Reactome_2022__DAP12 Interactions R-HSA-2172127,0.6459124266330961,1.1637037652328144,0.30303030303030304,0.7661232278588779,1.0,2/15,8.31%,PIK3R1;GRB2
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.5823966587854242,-1.1636996240770112,0.25925925925925924,0.9592862986837603,1.0,4/17,5.52%,GBP1;MGMT;MX1;TNFSF10
prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,-0.5647354288292837,-1.1636977852125951,0.2857142857142857,0.956250582548685,1.0,4/20,7.22%,IFIH1;ISG15;CASP10;TRIM25
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.726234466769257,1.1636163533265047,0.2903225806451613,0.765899100584759,1.0,3/8,10.57%,GLUL;SNAP25;SLC12A6
prerank,Reactome_2022__O-linked Glycosylation R-HSA-5173105,0.6148280779708253,1.163569938784132,0.2987012987012987,0.7654865189001752,1.0,2/21,0.77%,B3GNT2;ADAMTS9
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.6386744524160723,-1.163440741982186,0.34375,0.9540831203892023,1.0,3/7,17.10%,ARHGAP12;SPRY3;CD2AP
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.805574726508655,1.1634268644000847,0.27419354838709675,0.7655033375262702,1.0,2/5,8.79%,SLC8A1;ANK3
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.5418747131450748,1.1632544657839665,0.21794871794871795,0.7656143849307134,1.0,12/63,13.94%,LRRC7;FES;SPOCK1;IL1RAPL1;SCARB2;CCDC88A;PPFIA2;LRRC4C;RAP1A;MAGI2;PRAG1;PAK2
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Undefined,-0.554619211046474,-1.1632509585734694,0.2571428571428571,0.9518117301973575,1.0,1/21,0.16%,VCAM1
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.6003927846003578,1.1631809579787562,0.23684210526315788,0.7652714748838453,1.0,7/27,12.78%,SLC8A1;GRIN2B;CACNA1C;ATP2B1;MICU2;ANO6;TMEM165
prerank,Reactome_2022__RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,0.6315887525036075,1.1630192581062067,0.2777777777777778,0.7652798651143937,1.0,3/16,13.73%,PBRM1;CBFB;SMARCC1
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.6817459300209976,-1.1629636518470228,0.34285714285714286,0.949648333771255,1.0,2/5,7.30%,STAT1;PKD2
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6451708360847963,1.162779068001457,0.34375,0.7654250231474148,1.0,5/12,18.03%,CALR;ZNF366;PIAS2;NCOR2;CRY1
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.6736774119898755,1.1627404866049127,0.28125,0.7649890872265014,1.0,5/12,24.38%,ACOX1;NR1D2;PNPLA8;ABCG1;PPARG
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.7311820606990611,1.1626760501138802,0.23728813559322035,0.7646221075657699,1.0,4/6,26.40%,FGFR1;FLT1;ABL2;EGFR
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.6083343543052443,1.1625322121284762,0.2898550724637681,0.7645030354693138,1.0,3/20,6.06%,SERPINE1;NFKBIZ;HYAL2
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.5035402576891191,1.1623970353439543,0.2087912087912088,0.7644523265199192,1.0,29/140,17.10%,PIK3R3;SERPINE1;ERBB4;NEDD9;SUN2;HSPA5;ANXA1;ELP3;VSIR;SMAD7;ENPP2;NAV3;SEMA6B;SRGAP1;DLC1;PECAM1;ADAM15;MAGI2;FLT1;BCAR1;CLDN5;ITGB1;RAC1;MGAT5;SEMA3F;PLXNA2;SDCBP;PRKX;DAG1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.5486802343355509,1.1621672204644047,0.23529411764705882,0.7646912383354779,1.0,9/37,17.50%,NFE2L2;ERO1A;PINK1;MSRA;JUN;HIF1A;FOS;TXNRD1;PXN
prerank,KEGG_2021_Human__Nucleotide excision repair,0.6853975865887867,1.162107425329396,0.34328358208955223,0.764300085536783,1.0,2/8,11.05%,RFC3;CCNH
prerank,Reactome_2022__C-type Lectin Receptors (CLRs) R-HSA-5621481,0.5844102002096409,1.1620220588471923,0.3246753246753247,0.7640965965866051,1.0,12/43,25.37%,PSMC6;ITPR1;RPS27A;TAB2;PSMA7;MALT1;AHCYL1;PPP3CB;UBC;FYN;CREBBP;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.5450826172165687,1.1618825190269078,0.25925925925925924,0.7639953761752026,1.0,10/62,11.85%,ADM;CALR;RAB11FIP3;CHSY1;SMAD7;PLCL1;SRGN;ATP2B1;GJA1;IFNGR1
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD Domain Mutants R-HSA-2691232,0.7040428090652078,1.1617305624697511,0.3050847457627119,0.764013169150904,1.0,3/9,9.61%,RPS27A;JAG2;MIB1
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.7544112511218886,1.16152473953766,0.25,0.764302403331338,1.0,3/5,21.38%,HS6ST3;SULF2;EXT1
prerank,Reactome_2022__RORA Activates Gene Expression R-HSA-1368082,-0.6426612000336086,-1.1614287472415732,0.358974358974359,0.9516107028199258,1.0,3/10,9.22%,TBL1X;TBL1XR1;CHD9
prerank,Reactome_2022__Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,0.7038033603722699,1.1610534733986773,0.3188405797101449,0.7642956684274925,1.0,1/11,0.88%,PSMC6
prerank,Reactome_2022__Metabolism Of Polyamines R-HSA-351202,0.7038033603722699,1.1610534733986773,0.3188405797101449,0.7642956684274925,1.0,1/11,0.88%,PSMC6
prerank,Reactome_2022__Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,0.7038033603722699,1.1610534733986773,0.3188405797101449,0.7642956684274925,1.0,1/11,0.88%,PSMC6
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.590375076926237,1.1610328765341225,0.25675675675675674,0.7638395442193111,1.0,6/29,18.88%,BCAP31;SMAD7;NFE2L2;TRIB2;HERPUD1;CSNK1D
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.6438586398209767,-1.1607752000688798,0.2903225806451613,0.9510219915577016,1.0,3/9,9.19%,PPP2R5A;PDGFC;PDGFB
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.6854632796162707,1.1606849977900318,0.20833333333333334,0.7648123442108261,1.0,6/10,27.22%,ITGB1;RAC1;PARVB;GSN;CDC42;RHOJ
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.7304397784946897,1.160587983542996,0.3142857142857143,0.7645591922060229,1.0,2/5,22.15%,AFDN;CDH5
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.742919264293016,1.1605320637543655,0.2753623188405797,0.764146099803534,1.0,2/7,21.14%,PRNP;MCL1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.6758233751382604,1.1597994496976578,0.25396825396825395,0.7660945336668267,1.0,6/11,20.61%,ROBO2;HYAL2;FOXC1;PRKX;SULF2;CEP290
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.74576990093399,1.1597552982952675,0.3142857142857143,0.7656977531343055,1.0,1/7,3.45%,STARD4
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.5308001774089186,-1.1595691941458586,0.3181818181818182,0.9522248691685202,1.0,3/13,11.21%,SLC38A3;SLC25A29;SLC38A6
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.7071405590388014,1.1595285479446467,0.3382352941176471,0.7659750930743793,1.0,4/11,11.24%,SLC8A1;SLC12A6;ATP1A1;ATP1B3
prerank,Reactome_2022__Neddylation R-HSA-8951664,0.5459805663117321,1.159325227793629,0.2,0.7661089981973699,1.0,8/60,11.55%,PSMC6;FEM1C;NFE2L2;DCAF10;RPS27A;HIF1A;NPLOC4;COMMD1
prerank,Reactome_2022__Triglyceride Metabolism R-HSA-8979227,0.757562427787702,1.1593061346055893,0.31343283582089554,0.7655870160314637,1.0,3/6,17.24%,MGLL;LPIN2;PPP1CB
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.5033126605366228,-1.1592747584711345,0.2222222222222222,0.9503647610996855,1.0,3/24,3.82%,GBP1;CARMIL1;LIMS2
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.744542708347252,1.1589871940414664,0.29577464788732394,0.7660570058646575,1.0,3/8,10.07%,TMEM45B;ACSL5;RAP1A
prerank,KEGG_2021_Human__Vitamin digestion and absorption,0.7485016317822787,1.1583510354736497,0.3125,0.7678188802477509,1.0,4/6,24.46%,SLC52A3;BTD;SCARB1;LMBRD1
prerank,CellMarker_Augmented_2021__Endothelial cell:White Adipose Tissue,0.5360361651836227,1.1583490047019562,0.20987654320987653,0.7672548535437311,1.0,16/49,22.34%,PLSCR4;COL4A2;GGT5;VWF;LRRC32;CFH;CLDN5;DYSF;TNS1;AFAP1L1;TM4SF18;NOTCH4;GSN;EPAS1;CDH5;SPARC
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.6488144658406368,1.1580226654710852,0.31343283582089554,0.7679236560174318,1.0,8/19,26.40%,DPP10;PRKCE;PIK3R1;ITGB1;LGALS3;ATP2B4;PRKCH;EGFR
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6334862965944439,1.1580223115854855,0.22972972972972974,0.7673436532560893,1.0,11/20,24.38%,KLF4;JUN;HIF1A;REST;FOS;ATOH8;GATA2;STAT3;NFIB;ETS1;PPARG
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.5419598984877779,1.1579365810283146,0.189873417721519,0.7671076198116983,1.0,9/42,16.52%,CHPT1;SPNS2;VAPB;KDSR;SAMD8;LPIN2;PLPP1;DMD;GOLPH3
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.6469854214794358,1.1578728675769079,0.25757575757575757,0.7667130675741851,1.0,2/13,5.23%,PPM1D;PPHLN1
prerank,Reactome_2022__Signal Attenuation R-HSA-74749,0.7588551682536437,1.1572160130349973,0.2777777777777778,0.7687004361377318,1.0,2/5,14.32%,GRB2;GRB10
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6936045322463006,1.1570650939831977,0.23943661971830985,0.7686726451907964,1.0,8/12,22.87%,ANK2;ATP1B3;NEDD4L;ITGB1;CAB39;NEDD4;YWHAE;ATP1B1
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.5617495901818615,1.1569779265046392,0.20987654320987653,0.7683612355559927,1.0,16/46,23.93%,FES;RAPGEF3;INSIG1;SSH1;CTNNA1;HSP90B1;RAP1A;ATP1A1;ADCY2;GOLPH3;TGM2;RYR3;ACTB;TFPI;MEF2C;MSN
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.5811201981090912,1.156821344781043,0.28125,0.7684171082708191,1.0,7/25,11.58%,GRIA2;CADM2;PDE5A;CTNND2;SNAP25;CNTNAP2;NRXN1
prerank,Reactome_2022__EPHA-mediated Growth Cone Collapse R-HSA-3928663,0.6844043352194282,1.1562550750828906,0.35384615384615387,0.7701889635104588,1.0,4/9,23.82%,MYL6;MYH10;MYL12B;FYN
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.5332045754091966,1.1561890282301566,0.25316455696202533,0.7698854410373307,1.0,7/65,8.23%,PIK3R3;ERBB4;RAPGEF3;PINK1;HSP90AA1;DLC1;RB1CC1
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.593321105093191,1.1561714460318846,0.31343283582089554,0.7693993796985439,1.0,12/27,24.99%,PCK1;ANXA1;ALPL;GGT5;PELI1;TAB2;ERBIN;STAT3;SMAD6;ABCG1;PPARG;RPS6KA3
prerank,Reactome_2022__Synaptic Adhesion-Like Molecules R-HSA-8849932,0.7608480324994227,1.1560073450889088,0.35,0.7694459949742634,1.0,4/6,20.93%,PTPRD;GRIN2B;RTN3;GRIA4
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.6641297944299918,1.1557835533782088,0.3142857142857143,0.7696503441496213,1.0,2/10,3.93%,KCNIP4;DPP10
prerank,Reactome_2022__PERK Regulates Gene Expression R-HSA-381042,0.729407361715042,1.1557592599232178,0.31343283582089554,0.7692070464521055,1.0,2/9,1.99%,ATF3;HSPA5
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.7093257757758842,1.155657655926499,0.3582089552238806,0.7690297890208064,1.0,2/8,7.54%,ERBB4;SEMA6B
prerank,Reactome_2022__Loss Of MECP2 Binding Ability To NCoR/SMRT Complex R-HSA-9022537,-0.6612133553066056,-1.1556476185175246,0.35555555555555557,0.9592236622874998,1.0,2/5,6.77%,TBL1X;TBL1XR1
prerank,CellMarker_Augmented_2021__Secretory cell:Lung,-0.549562627978295,-1.1556080978901817,0.2903225806451613,0.9563412215517415,1.0,3/17,4.41%,SLC4A4;CD74;PLK2
prerank,Reactome_2022__Signaling By FGFR1 R-HSA-5654736,0.6384164133678434,1.1555519169423512,0.3382352941176471,0.7689356649247319,1.0,4/18,8.31%,FGFR1;PIK3R1;RPS27A;GRB2
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.6232842241300517,1.1551705879111898,0.2647058823529412,0.7696945882455134,1.0,3/17,10.07%,PINK1;HSP90AA1;RAP1A
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.6721585191601982,1.1551378469187674,0.2537313432835821,0.7692194829298088,1.0,5/13,12.40%,SLC4A10;ANO5;ANO2;SLC12A6;ANO6
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.5606616698297149,1.1550621010076065,0.2891566265060241,0.7689517936691384,1.0,14/60,19.42%,PPP2R3A;PPM1D;PPP2R2B;PTPRD;DUSP6;DUSP1;SSH1;PPM1A;DUSP16;CTTNBP2NL;PPP1CB;DUSP22;MTMR6;PTPN1
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.7839225110394359,1.154840957290642,0.265625,0.7691554451970131,1.0,1/5,12.91%,AGO2
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.5505756969968357,1.1547006497189924,0.2564102564102564,0.7690863459189613,1.0,9/48,11.47%,BCL6;FES;PLEKHB2;FGFR1;SMAD7;CBFB;CDK6;KLF4;REST
prerank,KEGG_2021_Human__Olfactory transduction,0.7208749783524552,1.1545648964520685,0.3116883116883117,0.7690420989957134,1.0,3/8,15.86%,SLC8A1;ANO2;NCALD
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.6035116222736121,1.1545551355184864,0.32894736842105265,0.7684785641925691,1.0,6/30,12.78%,ITPR1;SLC8A1;ANK2;CACNA1C;ANO6;TMEM165
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation R-HSA-933541,-0.7418509690922408,-1.1545234781334037,0.4,0.9571231283904386,1.0,2/7,7.22%,IFIH1;TRIM25
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.750554216330044,1.1542866694959242,0.35294117647058826,0.7689373272175726,1.0,2/5,21.14%,BCL2L1;MCL1
prerank,CellMarker_Augmented_2021__Basal cell:Airway Epithelium,0.6365872765197774,1.1542532341281013,0.2608695652173913,0.7684899474880136,1.0,10/20,28.87%,HYAL2;ADAM15;BCAR1;PTTG1IP;DAG1;HDLBP;SERPINH1;TM4SF1;SH3GL1;CD63
prerank,Reactome_2022__Selenocysteine Synthesis R-HSA-2408557,0.543451718293512,1.1540724756178387,0.28,0.768520302556624,1.0,10/48,15.51%,RPS11;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12
prerank,CellMarker_Augmented_2021__FOXP3+ Natural Regulatory T (Treg) cell:Blood,-0.6726096810400035,-1.153695241155462,0.391304347826087,0.9569170641412943,1.0,3/5,22.52%,TNFRSF1B;GIMAP4;GIMAP7
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.6148631374920355,1.1535246395281438,0.25333333333333335,0.770186246397993,1.0,3/16,13.31%,REL;RPS27A;TAB2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.6944124402403397,1.152991718931394,0.23333333333333334,0.7717511640520406,1.0,5/12,23.03%,KCNMB4;PREPL;SLC30A1;RIMS2;MEF2C
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Tonsil,0.5731736078516764,1.1528693689449605,0.3055555555555556,0.7716887597141341,1.0,8/32,12.48%,CD9;ASAP2;BACE2;KLF4;EMP1;CTNNA1;MYO1E;DSTN
prerank,CellMarker_Augmented_2021__Neural Stem cell:Inferior Colliculus,0.5597223155206335,1.1527597947557395,0.28205128205128205,0.7714706281736439,1.0,11/37,21.86%,NES;ANK2;MAP1B;PTPRD;PPP1R9A;GJA1;NAV2;STOX2;PODXL;GPRC5B;PLP1
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.6222980078558393,1.1527393566060955,0.28378378378378377,0.7709741902362658,1.0,3/24,7.68%,ADM;ZFPM2;CTNNA3
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.4821237464305977,1.152605331197408,0.16304347826086957,0.7708961201740577,1.0,53/209,22.42%,ANGPTL4;RTN4;BCL6;HSPA5;BNIP3L;TBX3;MAP3K5;CALR;ANXA1;DUSP6;PIK3R1;NDRG1;PINK1;HSP90AA1;RPS27A;ARHGEF4;HSP90B1;JUN;HSPA9;GNA13;PHLPP1;REST;ANO6;BCAR1;ITGB1;HIP1R;NAA16;PAK2;RASA1;ECT2;MTDH;GOLPH3;ACTN1;GRK5;MALT1;TGM2;ARHGEF2;TMBIM6;CFL1;KALRN;BCLAF1;NPM1;SMAD6;BCL2L1;TNFRSF10B;DNM2;MCL1;TNFAIP8;AVEN;RPL10;BCL2L14;SETX;UBC
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.7375318077530315,1.1525567085658048,0.2037037037037037,0.7704335704573005,1.0,2/8,13.71%,CCDC88A;HIP1R
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.6882076619020047,1.1517951773909134,0.34782608695652173,0.7726618818052214,1.0,5/7,29.14%,CACNA1C;ATP1A1;GSN;CAMK2D;FGF12
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.699034999269157,1.151703632126346,0.3888888888888889,0.7718750269844268,1.0,1/8,5.52%,VSIR
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.699034999269157,1.151703632126346,0.3888888888888889,0.7718750269844268,1.0,1/8,5.52%,VSIR
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.5187379674903195,-1.1513925597342467,0.23809523809523808,0.9613852612077356,1.0,4/19,8.92%,PLA2G4A;OCLN;NKD1;PROM1
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.561576584144308,1.1511923372268313,0.2716049382716049,0.7731346220225238,1.0,12/50,17.21%,RTN4;BCL6;BNIP3L;CALR;NDRG1;PINK1;HSP90AA1;PHLPP1;BCAR1;ACTN1;MALT1;TGM2
prerank,Reactome_2022__FCGR3A-mediated IL10 Synthesis R-HSA-9664323,0.6542612740848742,1.1510249383372584,0.23943661971830985,0.7731205301211402,1.0,7/18,24.30%,ITPR1;ADCY2;PRKX;AHCYL1;ADCY9;FYN;FGR
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.6694286103274532,1.151003344111966,0.28169014084507044,0.7726176511938904,1.0,3/12,9.43%,ANXA1;ALPL;GGT5
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,0.669804711940216,1.1509004104313791,0.3142857142857143,0.772473706527722,1.0,6/12,24.38%,CD9;VWF;PECAM1;GATA2;FGR;PPARG
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.7844275080252235,1.1507642416197996,0.3125,0.7723869169684497,1.0,3/6,11.47%,PINK1;HIF1A;REST
prerank,CellMarker_Augmented_2021__T Helper cell:Lung,0.6963812520285787,1.150365915813326,0.34782608695652173,0.7727335863615755,1.0,1/7,4.62%,MYO9B
prerank,CellMarker_Augmented_2021__Platelet:Liver,0.6963812520285787,1.150365915813326,0.34782608695652173,0.7727335863615755,1.0,1/7,4.62%,MYO9B
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.6030007008266982,1.1503577556484208,0.26506024096385544,0.7721922465225849,1.0,3/25,11.47%,KHDRBS3;YTHDC1;REST
prerank,Reactome_2022__RHO GTPase Cycle R-HSA-9012999,0.4897916616494209,1.1503537501187524,0.14893617021276595,0.7716354766193254,1.0,44/192,19.79%,PIK3R3;DOCK3;AKAP12;BCAP31;PKN3;ARHGAP23;VAPB;LBR;MYO9B;PDE5A;PIK3R1;CCDC88A;ARHGAP21;HSP90AA1;SRGAP1;DLC1;TPM4;ARHGEF4;GRB2;SLC4A7;PICALM;GJA1;GNA13;STK38;PRAG1;DOCK4;ITGB1;TMEM59;ECT2;TUBA1B;ERBIN;PCDH7;ADD3;ACTN1;ARHGEF2;TRA2B;RALGAPA1;KALRN;FAM13A;DIAPH2;ABL2;ABI1;PLEKHG1;WIPF1
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.4963368222377554,-1.1500456342272092,0.25,0.9627355791120875,1.0,4/36,3.98%,RSAD2;TTN;DISP1;BMP6
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.7432198854532925,1.1498687633736435,0.2857142857142857,0.7729599059366059,1.0,1/6,2.52%,TRIM5
prerank,Reactome_2022__VEGFR2 Mediated Vascular Permeability R-HSA-5218920,0.6712996155782125,1.1495668485911357,0.35135135135135137,0.7736911596230543,1.0,5/13,28.47%,HSP90AA1;CTNNA1;CDH5;MTOR;CALM1
prerank,Reactome_2022__Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,0.6146909220341596,1.1494530593058856,0.2857142857142857,0.7735958315857187,1.0,7/26,12.14%,MTHFD1L;SLC52A3;ENPP2;SLC2A1;SLC2A3;SLC25A16;MTHFD2L
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.6746435029818536,-1.1492306010923365,0.3611111111111111,0.9629222066236162,1.0,1/7,0.24%,CEMIP
prerank,Reactome_2022__Fanconi Anemia Pathway R-HSA-6783310,0.7560134281497265,1.1491583305806452,0.3125,0.7742932051933273,1.0,2/6,8.07%,WDR48;RPS27A
prerank,CellMarker_Augmented_2021__Fibroblast:Peripheral Blood,0.6490753406185417,1.1490540206227688,0.31746031746031744,0.7741086810437977,1.0,4/16,10.78%,TIMP3;COL4A2;GJA1;BOC
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.7043691956662772,-1.1481716957738937,0.2857142857142857,0.9637175971365692,1.0,2/5,18.11%,ARHGAP35;CXCL12
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.7371907662448223,-1.1481586760889706,0.4,0.9608373537949593,1.0,2/5,16.79%,ACVR1;MDM4
prerank,"Reactome_2022__Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",0.6131055972375056,1.1478505658353286,0.29577464788732394,0.7778168613617741,1.0,6/22,19.47%,RPS11;RPS9;RPS27A;RPS12;RPS27;EIF3A
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.6096284528684321,1.1476951397360977,0.22535211267605634,0.7777026687195454,1.0,5/23,13.41%,B3GNT2;CHSY1;CHST11;GGT5;SLC26A2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.7076259095306501,1.1472487863710024,0.38028169014084506,0.7786127506654368,1.0,2/10,6.37%,KLF2;CPEB4
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.6954281478379839,1.1471960282887634,0.2727272727272727,0.77828863795638,1.0,4/11,19.76%,SEC22B;PINK1;FEZ2;CHMP4B
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.5173578492605209,1.1471819939363537,0.30434782608695654,0.7777556405105636,1.0,28/89,23.08%,ST18;ERBB4;TBX3;PPM1D;PBRM1;DLC1;CDK6;KLF4;ITGA1;CDKN1B;MAGI2;REST;CDKN1A;ADGRG1;PLPP1;GATA2;BTG2;NACC2;ABI1;RERG;NPM1;SMAD6;BTG1;MORC3;COL18A1;MTSS1;ETS1;ADAMTS1
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.5801740291834965,1.1470488654714575,0.2857142857142857,0.777625731187556,1.0,6/34,12.88%,PLS3;GAPDH;MYO1B;PEBP1;FKBP5;BCAR1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.5791545651075218,1.1469901438454384,0.3108108108108108,0.777335201156289,1.0,6/33,10.78%,PBX3;TIMP3;COL4A2;EMP1;GJA1;BOC
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.6964670805293529,1.146897734495299,0.3384615384615385,0.7771415077375321,1.0,2/6,3.90%,IL1RAPL1;ANXA1
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.7203088414234095,1.146758198263122,0.31343283582089554,0.7770765558155933,1.0,4/9,18.43%,ANXA1;PIKFYVE;LGALS3;PDE4B
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.6669685939568457,-1.146586905340085,0.41025641025641024,0.9631385707018401,1.0,2/5,8.58%,PARN;ST3GAL1
prerank,Reactome_2022__Innate Immune System R-HSA-168249,0.48011823868132825,1.1465263970222597,0.16129032258064516,0.7775011010127699,1.0,59/267,21.25%,PKM;PSMC6;ITPR1;LRRC7;CD81;MYO9B;PRKCE;DUSP6;ATG12;NFASC;PIK3R1;TINAGL1;SNAP25;TUBB4B;DNAJC5;HSP90AA1;SERPINB6;DLC1;RPS27A;GRB2;LAMP2;HSP90B1;JUN;RAP1A;MYO1E;PECAM1;PIKFYVE;SLC2A3;ANXA2;CFH;FOS;PELI1;ANO6;EEF1A1;ARPC2;TAB2;MAPK10;CD55;LRRFIP1;CRK;ALPK1;PSMA7;SDCBP;MALT1;LGALS3;EGFL7;ABI1;DYNC1H1;TEC;WIPF1;CAB39;GSN;BCL2L1;HSPA8;CEP290;AHCYL1;DNM2;PPP3CB;DNAJC13
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.7801046983288452,1.1463872161791127,0.2903225806451613,0.7769062974409359,1.0,3/5,17.98%,YBX3;PELI1;ARHGEF2
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.7801046983288452,1.1463872161791127,0.2903225806451613,0.7769062974409359,1.0,3/5,17.98%,YBX3;PELI1;ARHGEF2
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.6383603654043247,1.1462468303177396,0.2898550724637681,0.7769377704166043,1.0,1/15,0.08%,CCDC3
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.6824462316575122,1.1462397424579671,0.40298507462686567,0.7764332081878531,1.0,2/10,9.16%,PINK1;MICALL2
prerank,Reactome_2022__Signaling By FGFR3 R-HSA-5654741,0.6424446240756487,1.1460786134376535,0.3088235294117647,0.7759534939839383,1.0,3/15,8.31%,PIK3R1;RPS27A;GRB2
prerank,Reactome_2022__Signaling By FGFR4 R-HSA-5654743,0.6424446240756487,1.1460786134376535,0.3088235294117647,0.7759534939839383,1.0,3/15,8.31%,PIK3R1;RPS27A;GRB2
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5891544596171255,1.1460189739176228,0.23809523809523808,0.7755944163922793,1.0,5/24,17.45%,ANXA1;FGFR1;HIF1A;HDAC7;GATA2
prerank,KEGG_2021_Human__Leishmaniasis,0.621115074115101,1.1454002270487915,0.3055555555555556,0.7772061315924025,1.0,7/15,13.68%,JAK1;JUN;IFNGR1;FOS;EEF1A1;TAB2;ITGB1
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.6530015578770263,-1.145288088009241,0.41935483870967744,0.9645529674441327,1.0,2/8,14.21%,YEATS2;KAT6B
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.6620061839927109,-1.145180153077063,0.38095238095238093,0.9619861684610406,1.0,2/6,12.91%,HLA-F;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.7166162704397627,1.1450367306500897,0.34545454545454546,0.7781778420968086,1.0,2/7,4.38%,IL1RAPL1;PTPRD
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.6665803334433138,-1.1450298272305595,0.3235294117647059,0.9596126672748007,1.0,7/10,19.18%,PDGFB;ZSWIM5;PTPN2;USP14;STX3;MYCBP2;ZSWIM6
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.7341547382156951,1.1449237737747164,0.3188405797101449,0.7780648667583335,1.0,2/5,17.53%,KDM1A;RIF1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.6795148174271102,1.1449209738386514,0.2753623188405797,0.7775142730196462,1.0,7/10,28.58%,HYAL2;PHLPP1;MAGI2;DAG1;RACK1;PIK3CB;PLEKHA1
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.537752462324389,1.144731589697377,0.2727272727272727,0.777640553909835,1.0,6/37,15.70%,BNIP3L;TRIM5;UFL1;PINK1;TMEM59;MTDH
prerank,CellMarker_Augmented_2021__Mast Cell progenitor:Bone Marrow,0.604767357369325,1.1444407776879981,0.2777777777777778,0.7763593555175654,1.0,10/23,23.67%,CANX;IPO7;LARP4;HSPA9;ECT2;NUDCD1;NAA50;NPM1;ATP13A3;XPO1
prerank,CellMarker_Augmented_2021__Erythroblast:Blood,0.604767357369325,1.1444407776879981,0.2777777777777778,0.7763593555175654,1.0,10/23,23.67%,CANX;IPO7;LARP4;HSPA9;ECT2;NUDCD1;NAA50;NPM1;ATP13A3;XPO1
prerank,CellMarker_Augmented_2021__Megakaryocyte Progenitor cell:Subcutaneous Adipose Tissue,0.604767357369325,1.1444407776879981,0.2777777777777778,0.7763593555175654,1.0,10/23,23.67%,CANX;IPO7;LARP4;HSPA9;ECT2;NUDCD1;NAA50;NPM1;ATP13A3;XPO1
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Peripheral Blood,0.604767357369325,1.1444407776879981,0.2777777777777778,0.7763593555175654,1.0,10/23,23.67%,CANX;IPO7;LARP4;HSPA9;ECT2;NUDCD1;NAA50;NPM1;ATP13A3;XPO1
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.6663404084885214,-1.1443109095454336,0.2857142857142857,0.9589837892478779,1.0,1/9,0.82%,EIF2AK2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.7539662397264191,1.1442074291054987,0.2876712328767123,0.7769219136738186,1.0,1/6,1.30%,CLIC2
prerank,CellMarker_Augmented_2021__Anterior Foregut Endoderm cell:Lung,-0.5319685232625618,-1.144131592309375,0.25,0.9540097876575736,1.0,4/19,5.55%,XAF1;CPQ;DDX60L;SP100
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Embryonic Stem Cell,-0.5319685232625618,-1.144131592309375,0.25,0.9540097876575736,1.0,4/19,5.55%,XAF1;CPQ;DDX60L;SP100
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.7361793628582691,1.1438585556295584,0.3787878787878788,0.7776103857614687,1.0,2/8,10.17%,MYO1B;MYO1E
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.7233069744395088,1.143750817558516,0.3114754098360656,0.777403570857812,1.0,2/8,15.67%,AGO2;TUT7
prerank,Reactome_2022__Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,0.6287635907515221,1.1436533000629467,0.25316455696202533,0.7772998621480035,1.0,2/15,8.07%,PSMC6;RPS27A
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.6090064165873853,1.1431203087304103,0.3717948717948718,0.7786425345941037,1.0,5/26,18.25%,PSMC6;MAGI2;RAC1;PSMA7;FZD4
prerank,KEGG_2021_Human__Proteasome,0.6875476404591202,1.1431120068987597,0.2835820895522388,0.7781195350360359,1.0,1/13,0.88%,PSMC6
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.5510401791342592,1.142926956937341,0.2894736842105263,0.7783390964339777,1.0,5/51,8.07%,CEP57;PSMC6;TUBB4B;HSP90AA1;RPS27A
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.6779826087697516,1.1427032153925125,0.36363636363636365,0.7786608641841045,1.0,2/10,5.29%,ROBO2;ZFPM2
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.5353418724770005,1.1426665638950062,0.25925925925925924,0.7782098907582224,1.0,19/63,21.14%,DDIT4;ITPR1;HYAL2;PINK1;DUSP1;PDE10A;PEBP1;OTUD7B;PHLPP1;MAGI2;PPM1A;UBE2B;SPRED1;DAG1;HDAC7;HERPUD1;BCL2L1;ATP2B4;MCL1
prerank,Reactome_2022__Metabolism Of Lipids R-HSA-556833,0.4799763121635336,1.1426592907269133,0.21505376344086022,0.7776808094198291,1.0,20/175,7.89%,PIK3R3;ANGPTL4;CHPT1;SPNS2;PRKAG2;STARD4;MGLL;VAPB;INPP5F;LBR;PLIN2;ACOX1;SEC24D;MTMR12;DHRS7B;PIK3R1;SIN3B;INSIG1;ACSL5;KDSR
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.6377215733146979,1.1425239092647812,0.25,0.7776954580939158,1.0,2/16,8.07%,MAP3K5;RPS27A
prerank,Reactome_2022__FCERI Mediated NF-kB Activation R-HSA-2871837,0.6086563237283992,1.1425122625314426,0.25675675675675674,0.7772146741512258,1.0,5/24,17.13%,PSMC6;RPS27A;TAB2;PSMA7;MALT1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.7476165898500038,1.1425104985313397,0.23809523809523808,0.776679564940299,1.0,3/7,18.03%,BHLHE40;PPP1CB;CRY1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In1:Brain,0.6417173112607304,1.1423877927108341,0.2903225806451613,0.7765299882137873,1.0,7/14,12.83%,GRIA2;GPM6B;LSAMP;CTNND2;CNTNAP2;NRXN1;TMEM132C
prerank,Reactome_2022__P75 NTR Receptor-Mediated Signaling R-HSA-193704,0.5521547586760769,1.1418976212338932,0.2375,0.7776282937005597,1.0,11/40,24.78%,RTN4;RPS27A;ARHGEF4;GNA13;ECT2;ARHGEF2;KALRN;YWHAE;UBC;PREX1;FGD4
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.7151835899543809,1.141780244926003,0.3442622950819672,0.777470416150799,1.0,2/8,7.54%,ERBB4;SEMA6B
prerank,Reactome_2022__GRB2:SOS Provides Linkage To MAPK Signaling For Integrins R-HSA-354194,0.7261594286987632,1.1412480342609914,0.30158730158730157,0.7787702378700984,1.0,3/7,10.07%,GRB2;VWF;RAP1A
prerank,Reactome_2022__NGF-stimulated Transcription R-HSA-9031628,0.6936386129233583,1.1412270898934789,0.3389830508474576,0.7783298839187318,1.0,5/10,21.09%,JUND;REST;FOS;TF;DNM2
prerank,Reactome_2022__Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,0.6090026042797321,1.1410463292284487,0.29333333333333333,0.7784535394939076,1.0,4/16,11.05%,RPS27A;RFC3;USP45;CCNH
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.7104661114144468,1.1404092183826813,0.34375,0.7801956188797834,1.0,4/6,24.81%,ADGRB3;MYEF2;MEF2C;SORT1
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.6697294942259021,-1.1403187337169913,0.375,0.962573022377062,1.0,1/8,2.95%,ATM
prerank,Reactome_2022__Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,0.5934639631087082,1.1401332679265335,0.28169014084507044,0.7806381513353866,1.0,9/18,24.22%,EPS8;SNAP25;DNAJC5;ATP2B1;MYO1E;TRIOBP;ATP2B4;MSN;CAPZA2
prerank,Reactome_2022__Signaling By NTRK1 (TRKA) R-HSA-187037,0.5658836770906429,1.1400537604276126,0.3088235294117647,0.7804085465382758,1.0,16/44,25.95%,DUSP6;PIK3R1;JUND;GRB2;RAP1A;REST;FOS;SHC2;CRK;TF;STAT3;DNM2;YWHAB;MEF2C;RPS6KA3;MAP2K1
prerank,Reactome_2022__Vif-mediated Degradation Of APOBEC3G R-HSA-180585,0.6289916162475064,1.140031952572129,0.3,0.7799217722691666,1.0,2/15,8.07%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.6570668749546544,1.1399073765772838,0.29850746268656714,0.779794359344509,1.0,1/14,0.77%,ADAMTS9
prerank,Reactome_2022__Signaling By FGFR4 In Disease R-HSA-5655291,0.7390933190011053,1.139892903563171,0.30158730158730157,0.7787536471272888,1.0,2/7,8.31%,PIK3R1;GRB2
prerank,Reactome_2022__Signaling By FGFR3 In Disease R-HSA-5655332,0.7390933190011053,1.139892903563171,0.30158730158730157,0.7787536471272888,1.0,2/7,8.31%,PIK3R1;GRB2
prerank,PanglaoDB_Augmented_2021__Platelets,0.567776928519359,1.1398582311423682,0.2987012987012987,0.7783160860013993,1.0,8/35,11.31%,SERPINE1;CD9;ERO1A;SRGN;VWF;PECAM1;LRRC32;SLC2A3
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),0.7077339326781018,1.139777495213443,0.31343283582089554,0.7780890756601907,1.0,3/8,10.23%,RPS27A;NPLOC4;RFC3
prerank,Reactome_2022__Establishment Of Sister Chromatid Cohesion R-HSA-2468052,0.7348828524958366,1.139734503021302,0.3114754098360656,0.777621513510231,1.0,2/7,12.19%,RAD21;WAPL
prerank,CellMarker_Augmented_2021__M1 macrophage:Brain,0.7531755419738404,1.1394060883071795,0.2833333333333333,0.7782882316713705,1.0,4/5,24.12%,JUNB;MGAT1;TAGLN2;GUK1
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.5752653480740172,1.1392513742308972,0.27848101265822783,0.7782944911330708,1.0,5/38,5.58%,BCL6;TRIM5;MGLL;ANXA1;UFL1
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.5596854481385881,-1.1392170337997436,0.37142857142857144,0.9633241855334022,1.0,3/19,8.50%,VCAM1;NOD1;MDM2
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.6684430872578673,1.1386798072797275,0.3181818181818182,0.7795568409872848,1.0,5/9,24.14%,DUSP1;FOXC1;LRCH1;OXSR1;WNK1
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR2 R-HSA-5654696,0.7273164172203941,1.1385281118044464,0.2727272727272727,0.7784509785400965,1.0,2/8,8.31%,PIK3R1;GRB2
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR4 R-HSA-5654716,0.7273164172203941,1.1385281118044464,0.2727272727272727,0.7784509785400965,1.0,2/8,8.31%,PIK3R1;GRB2
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR3 R-HSA-5654708,0.7273164172203941,1.1385281118044464,0.2727272727272727,0.7784509785400965,1.0,2/8,8.31%,PIK3R1;GRB2
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.4971700579910481,-1.1384344961081736,0.3181818181818182,0.9631746134765392,1.0,10/42,10.52%,GBP1;GBP2;ISG15;DCP1A;OPTN;BICD1;MDM2;COG3;CNTLN;CEP68
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.6931048586965075,1.1384063731039589,0.328125,0.7783179254202214,1.0,2/8,17.90%,MGAT4A;FUT8
prerank,Reactome_2022__Signaling By ERBB2 ECD Mutants R-HSA-9665348,0.6773162580306127,1.1383039269104913,0.31343283582089554,0.778069157509223,1.0,4/10,14.45%,PIK3R1;HSP90AA1;GRB2;ERBIN
prerank,KEGG_2021_Human__Long-term depression,0.5575525389408842,1.1382345411397792,0.2597402597402597,0.7777280804552028,1.0,2/22,1.35%,GRIA2;ITPR1
prerank,PanglaoDB_Augmented_2021__Ductal Cells,0.6967383866960567,1.1381099772873593,0.3698630136986301,0.7777578426599949,1.0,2/8,6.48%,TINAGL1;ATP8B1
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Endometrium,-0.5540209227128289,-1.1380887661707701,0.2903225806451613,0.961587227525975,1.0,3/22,2.52%,ZMAT1;CD74;MMRN1
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.6725836492810845,1.1379332544108598,0.32432432432432434,0.7778878007824217,1.0,3/12,15.64%,KDM1A;PIAS2;NCOR2
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.7455436293765383,1.1378138998002474,0.3728813559322034,0.7778942950156802,1.0,2/5,15.64%,PIAS2;NCOR2
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.6609977011662216,1.1377547373604027,0.4050632911392405,0.7775696865368288,1.0,3/12,4.78%,SERPINE1;ANXA1;PRKCE
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Undefined,0.5643420534216951,1.1376143553532692,0.2318840579710145,0.7774994474169374,1.0,12/33,18.57%,HSPA5;NES;CD9;KLF4;GJA1;PECAM1;FLT1;ITGB1;CD55;ALCAM;PODXL;STAT3
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.760147712654663,1.1375883821463788,0.3770491803278688,0.7770140903253636,1.0,2/5,13.20%,SPIRE1;ARPC2
prerank,Reactome_2022__Uptake And Function Of Diphtheria Toxin R-HSA-5336415,0.7880153396755886,1.1374435824443963,0.2833333333333333,0.7769520174308486,1.0,3/5,14.71%,CD9;HSP90AA1;TXNRD1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.5464296462683229,-1.1372155085311457,0.25,0.9613783696521212,1.0,3/17,6.11%,ATM;ATR;PARN
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.758620466265852,1.1372044995228505,0.3181818181818182,0.7774198486711651,1.0,3/6,16.18%,ANK2;SMAD7;DMD
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.6676375227696422,1.136928776408264,0.3333333333333333,0.7779100520248516,1.0,5/10,24.14%,DUSP1;FOXC1;LRCH1;OXSR1;WNK1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.6623823375358711,-1.1366880339375043,0.2571428571428571,0.9603905339166877,1.0,2/5,10.25%,RC3H1;CPEB3
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.7114678904846975,1.1360553833304856,0.3333333333333333,0.7797619630164613,1.0,1/8,2.55%,TBX3
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.7114678904846975,1.1360553833304856,0.3333333333333333,0.7797619630164613,1.0,1/8,2.55%,TBX3
prerank,Reactome_2022__ER Quality Control Compartment (ERQC) R-HSA-901032,0.6821665160524019,1.13585770408575,0.3230769230769231,0.779989184641918,1.0,7/10,27.14%,EDEM3;RPS27A;AMFR;UGGT2;UBC;SEL1L;UGGT1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.7595744680851063,1.1358195976625465,0.3230769230769231,0.7796115824193234,1.0,5/5,24.14%,ANK3;ATP1B3;DMD;ATP1B1;WNK1
prerank,Reactome_2022__Degradation Of AXIN R-HSA-4641257,0.6224539581816313,1.1357069512871294,0.2972972972972973,0.7794715503044635,1.0,4/17,16.60%,PSMC6;RPS27A;PSMA7;TNKS
prerank,CellMarker_Augmented_2021__Proerythroblast:Germ,0.7229637624176707,1.1354721656238995,0.3442622950819672,0.7796450119205944,1.0,2/7,7.76%,FES;SRGN
prerank,KEGG_2021_Human__Adipocytokine signaling pathway,0.6021429394292539,1.1354219302236732,0.29411764705882354,0.7793142442103894,1.0,7/23,19.84%,PCK1;PRKAG2;ACSL5;SLC2A1;MAPK10;STAT3;SOCS3
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.7095225019754513,1.1353006821511231,0.3333333333333333,0.779113658155006,1.0,2/10,6.27%,ZFPM2;SMAD7
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.5412112020079077,1.1351722322651345,0.2625,0.779065862297316,1.0,8/55,11.87%,PDK4;PRKAG2;HSPA5;MAP3K5;CPEB4;LAMP2;SIK2;CDKN1A
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.6767533539683678,1.1351501285620824,0.3333333333333333,0.778568524209025,1.0,2/11,4.36%,MAP2;INPP5F
prerank,Reactome_2022__Orc1 Removal From Chromatin R-HSA-68949,0.6128326133622355,1.13512814351197,0.24324324324324326,0.7780947149960614,1.0,2/17,8.07%,PSMC6;RPS27A
prerank,CellMarker_Augmented_2021__Natural Killer cell:Lymph Node,0.6635609281296847,1.134773821257839,0.32857142857142857,0.7789761384659479,1.0,4/14,14.66%,ZEB2;BACH2;GAS7;SH2D3C
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.45819189417987766,1.1346513121317583,0.1111111111111111,0.7788068913619283,1.0,109/490,21.30%,MAFF;ST18;PBX3;ZEB2;ERBB4;BCL6;ATF3;KLF6;MAFK;KLF2;TBX3;BHLHE40;ZNF160;PHF10;MAP3K5;CALR;JUNB;ELP3;NPAS3;BAZ1A;ZBTB1;ZFPM2;ZNF280D;PURA;POLA1;SMAD7;NFE2L2;ESR2;ATP8B1;ZNF586;REL;BACH2;CBFB;SMAD5;KDM1A;JUND;ARID5A;ELP4;PICALM;KLF4;CDKN1B;OGT;FOSL2;JUN;HIF1A;ZNF366;RAD21;CREM;SPEN;CCNH;CNBP;SETD3;CCNC;REST;CDKN1A;FOS;PPM1A;FOXF1;TRAK1;SBNO1;ZBTB10;SMARCC1;ZBTB38;NAA16;LRRFIP1;PIAS2;WWTR1;BRWD3;FOXC1;CRLF3;CCNL1;NCOR2;MTDH;CRK;ATF2;BRD4;NR2C1;ATOH8;LIMS1;GATA2;NPAS2;CRY1;FZD4;ZMIZ1;STAT3;ZNF43;NFIB;MBD2;NACC2;NR1D2;HBP1;NFIC;RLF;NOTCH4;BCLAF1;KMT2E;CREBZF;NPM1;SMAD6;RCOR3;ELK3;HSPA8;CEP290;ATP2B4;BTG1;DENND4A;DNM2;PPP3CB;EPAS1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.6430274042434633,1.1343372070748605,0.36764705882352944,0.7794130335303003,1.0,1/13,0.53%,DDIT4
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.6124216428098532,1.1340846339172979,0.3333333333333333,0.7797145703322286,1.0,7/21,17.21%,IL1RAPL1;PTPRD;ROBO2;KDM1A;SPEN;PLXNA2;TGM2
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.5182502785418628,-1.1334584970982122,0.2413793103448276,0.9682898185431632,1.0,7/17,22.50%,BICD1;EFNA5;CLASP1;CYLD;PHLDB1;PHLDB2;MARK2
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.7450657078420504,1.1333367144350397,0.3,0.7812113168866105,1.0,2/5,18.57%,JAK1;STAT3
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.7450657078420504,1.1333367144350397,0.3,0.7812113168866105,1.0,2/5,18.57%,JAK1;STAT3
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.5834608797995052,1.1333320704632417,0.30985915492957744,0.7806849166623318,1.0,4/23,16.79%,SRGN;OGT;NAA16;NAA50
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.6384260775296164,1.13332463357672,0.35135135135135137,0.7802046773212833,1.0,4/9,12.40%,ANK2;ATP2B1;ANK3;ANO6
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.6551024743204104,1.1331309273419479,0.31343283582089554,0.7803684123992507,1.0,4/14,17.00%,PRKAG2;OGT;HIF1A;TPR
prerank,KEGG_2021_Human__Glutamatergic synapse,0.5508140292103713,1.1330773968157855,0.28,0.7800024935319041,1.0,8/41,5.15%,GRIA2;ITPR1;GRIK1;GRIK2;GRM7;GLUL;GRIN2B;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.6875299461407538,1.1327398375877087,0.34285714285714286,0.7807178872967209,1.0,2/8,8.79%,ANK2;ANK3
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.6603430014944978,1.1327155280497447,0.359375,0.7802993579671602,1.0,2/12,9.16%,PINK1;MICALL2
prerank,Reactome_2022__TRAF3-dependent IRF Activation Pathway R-HSA-918233,-0.7503234190099778,-1.132687093703468,0.3333333333333333,0.9681280915216736,1.0,2/7,7.22%,IFIH1;TRIM25
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.7524186373702284,1.132548634620699,0.30303030303030304,0.7802663387027899,1.0,1/5,11.16%,SETD3
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.6549117068972066,1.1324062049259698,0.23880597014925373,0.7801730226550148,1.0,3/17,16.55%,ADAMTS9;DENND3;SND1
prerank,Reactome_2022__Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,0.7298580399004784,1.1323301616611097,0.359375,0.7798687810780931,1.0,2/6,10.23%,POLA1;RFC3
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.5578901586557403,1.132295819150305,0.35526315789473684,0.7794820957557362,1.0,5/24,9.03%,INPP5F;FGFR1;PIK3R1;PLCL1;OGT
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.5076252376434798,1.132229832010904,0.24705882352941178,0.7791636816279115,1.0,28/95,24.78%,BCL6;BNIP3L;MAP3K5;DUSP6;PRNP;DLC1;RPS27A;ARHGEF4;JUN;GNA13;REST;ANO6;ITGB1;HIP1R;ECT2;TGM2;ARHGEF2;KALRN;BCLAF1;BTG1;TNFRSF10B;DNM2;TNFAIP8;UBC;PREX1;ATF6;RACK1;FGD4
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.614107883426365,-1.1319769294082758,0.3333333333333333,0.9676665028505711,1.0,2/10,9.19%,SLC4A4;PDGFB
prerank,Reactome_2022__Translesion Synthesis By POLH R-HSA-110320,0.711897274529752,1.1319040642852387,0.3125,0.7796355352400915,1.0,3/6,10.23%,RPS27A;NPLOC4;RFC3
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.5908116709533133,1.1317889052614816,0.2916666666666667,0.7794677917320003,1.0,8/20,26.40%,HYAL2;JUN;HIF1A;FOS;PXN;ADAM9;FYN;EGFR
prerank,Reactome_2022__Post-chaperonin Tubulin Folding Pathway R-HSA-389977,0.7423539799264842,1.1315034606075225,0.3389830508474576,0.7799087517314461,1.0,5/6,25.82%,TUBB4B;TUBA1B;TUBB6;TBCD;TUBB
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.7074057791678064,1.1311540823140307,0.34328358208955223,0.7806644072002259,1.0,1/8,0.98%,BCL6
prerank,CellMarker_Augmented_2021__Germ cell:Gonad,-0.6074519314677003,-1.130801336052913,0.29411764705882354,0.9682787352781597,1.0,2/7,6.06%,MIPOL1;ABHD18
prerank,CellMarker_Augmented_2021__Endometrial Progenitor cell:Endometrium,0.6954260207097589,1.1307470319839337,0.3125,0.7815540740944888,1.0,4/11,17.72%,NUDCD3;TMEM184B;LSS;FAM219A
prerank,Reactome_2022__Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,0.7123913327370655,1.1306250134403324,0.3333333333333333,0.781437964769322,1.0,5/9,26.14%,PRKAG2;PPM1A;CAB39;MTOR;SLC38A9
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreatic Islet,0.6000011154096032,1.1303057527032332,0.2602739726027397,0.7819213522819881,1.0,12/27,30.12%,BCAP31;SMIM3;MYL6;PTTG1IP;RSU1;SERF2;TAGLN2;CLIC1;DHRSX;ANXA5;CD63;MYL12A
prerank,Reactome_2022__MET Activates PI3K/AKT Signaling R-HSA-8851907,0.764516845796473,1.1300044675355532,0.38095238095238093,0.7825089006776449,1.0,2/6,8.31%,PIK3R1;GRB2
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.5844229417014232,1.1296060661490732,0.2911392405063291,0.7833649951588705,1.0,6/30,11.87%,TSG101;SLC8A1;CDKN1B;TRIB2;CCNH;CDKN1A
prerank,Reactome_2022__Signaling By FGFR R-HSA-190236,0.5686997247687222,1.1295069653501308,0.3116883116883117,0.7830909694157225,1.0,4/27,8.31%,FGFR1;PIK3R1;RPS27A;GRB2
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.6192737820434115,1.1290532575064065,0.3333333333333333,0.7841173636839665,1.0,8/19,23.03%,CPEB4;PINK1;REST;BTBD10;RASA1;INPP5A;CHMP4B;MEF2C
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.5097152797860502,1.1289518082806436,0.23863636363636365,0.7839253321222298,1.0,8/86,8.23%,PIK3R3;ERBB4;ATF3;CCDC88A;PRNP;PINK1;HSP90AA1;RB1CC1
prerank,Reactome_2022__CRMPs In Sema3A Signaling R-HSA-399956,0.7451315373695594,1.1289224260380857,0.36363636363636365,0.7834947910198381,1.0,4/6,23.82%,FES;PLXNA2;DPYSL2;FYN
prerank,Reactome_2022__Regulation Of KIT Signaling R-HSA-1433559,0.7202197298862016,1.1285887268279557,0.36666666666666664,0.7841534753661041,1.0,2/6,23.82%,GRB2;FYN
prerank,Reactome_2022__Formation Of Incision Complex In GG-NER R-HSA-5696395,0.6402895008159157,1.1285580765067635,0.2857142857142857,0.7837382625678081,1.0,3/11,11.05%,RPS27A;USP45;CCNH
prerank,Reactome_2022__Translation Initiation Complex Formation R-HSA-72649,0.6057324124247331,1.1285417136625366,0.2676056338028169,0.7827309137137578,1.0,6/24,19.47%,RPS11;RPS9;RPS27A;RPS12;RPS27;EIF3A
prerank,"Reactome_2022__mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",0.6057324124247331,1.1285417136625366,0.2676056338028169,0.7827309137137578,1.0,6/24,19.47%,RPS11;RPS9;RPS27A;RPS12;RPS27;EIF3A
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.4623397050773214,-1.1283779813604222,0.23809523809523808,0.9733949161757218,1.0,5/46,2.84%,GBP1;HOMER2;IFIH1;ISG15;HERC5
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.736888315448737,1.1283283320009672,0.3442622950819672,0.7828975357403148,1.0,4/6,26.29%,CTNND2;DIP2A;WASL;CDC42
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.7236870634822524,1.1282977370355216,0.2641509433962264,0.7824545519204048,1.0,1/6,9.56%,HSP90B1
prerank,Reactome_2022__Regulation Of RUNX3 Expression And Activity R-HSA-8941858,0.6195010463402234,1.1274021107786505,0.3026315789473684,0.7846634278174268,1.0,3/18,8.07%,PSMC6;CBFB;RPS27A
prerank,Reactome_2022__Metabolism Of Non-Coding RNA R-HSA-194441,-0.6154444498518539,-1.1273635871345526,0.37037037037037035,0.9741790528520791,1.0,2/11,6.61%,GEMIN5;NUP214
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6992021563203616,1.127202979149751,0.4126984126984127,0.7847690493819239,1.0,3/9,17.45%,ANXA1;HDAC7;GATA2
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.6854928716789734,1.127011879741708,0.3484848484848485,0.7849190291333585,1.0,1/11,0.53%,DDIT4
prerank,Reactome_2022__Cholesterol Biosynthesis R-HSA-191273,0.7364329634004216,1.1267128044566468,0.359375,0.7853652733173923,1.0,1/6,4.46%,LBR
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.6089449120306687,1.1262998175075745,0.30864197530864196,0.7863367950659372,1.0,4/25,5.58%,BCL6;MGLL;ANXA1;UFL1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.6952218697571089,1.1262662091213214,0.3333333333333333,0.7859377000151824,1.0,3/8,8.63%,KLF2;NFE2L2;KLF4
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.6387903033108908,1.1258911728368566,0.2777777777777778,0.7868039885996647,1.0,1/16,0.88%,PSMC6
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.584897456239396,1.1258430170736702,0.3142857142857143,0.7864198979316441,1.0,5/28,15.25%,NES;MAP1B;BOC;BCAR1;FOXC1
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.6016504604400417,1.125827008134225,0.2753623188405797,0.785910741155896,1.0,8/19,23.03%,KCNMB4;ANXA1;RAB21;STXBP5L;SYT1;RIMS2;RAB8B;MEF2C
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.6142336736043837,1.125719813995938,0.373134328358209,0.7857935092258139,1.0,5/13,21.22%,MAP1B;HSP90AA1;ALCAM;SEMA3F;PPP3CB
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.7191489361702127,1.1255827793310553,0.27941176470588236,0.7857797127625284,1.0,5/5,28.18%,COMMD1;NEDD4L;NEDD4;WNK1;CAMK2D
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.7173677994669619,1.1255330450224776,0.375,0.7853383470468848,1.0,4/7,24.65%,MT1M;MT2A;SLC30A1;MT1E
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.5682584158207308,1.1252757206053,0.3026315789473684,0.7858405824565428,1.0,7/38,16.87%,ZEB2;SMAD7;RPS27A;PPM1A;STRAP;SPRED1;SDCBP
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.6487830187403808,-1.124865700575396,0.37142857142857144,0.9794193297223884,1.0,1/10,0.16%,VCAM1
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.6945661766097043,-1.1248506523897406,0.40625,0.9767083129899343,1.0,1/6,4.94%,BCOR
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.6649787565946341,1.1248134555309515,0.4411764705882353,0.7869385060596201,1.0,3/7,29.38%,REST;WDR43;CNOT2
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.4589968535475074,1.124665771965792,0.1958762886597938,0.7868062660454063,1.0,81/334,22.66%,MAFF;ST18;ZEB2;SERPINE1;ERBB4;ATF3;KLF6;KLF2;TBX3;PHF10;MAP3K5;JUNB;CD81;NPAS3;ZFPM2;CRTC3;HYAL2;PIK3R1;SMAD7;NFE2L2;ESR2;REL;SMAD5;KDM1A;JUND;RPS27A;PICALM;KLF4;OGT;FOSL2;JUN;HIF1A;CNBP;SETD3;CCNC;REST;FOS;PPM1A;FOXF1;AGO2;TMF1;ACVR2A;SMARCC1;ZBTB38;NAA16;WWTR1;LPIN2;FOXC1;CRLF3;ATF2;BRD4;ATOH8;TNKS;GATA2;NPAS2;ARHGEF2;NAMPT;FZD4;ZMIZ1;STAT3;NFIB;NR1D2;NFIC;RLF;NOTCH4;BCLAF1;KMT2E;CDK8;NPM1;ELK3;CEP290;DNM2;PPP3CB;EPAS1;TFCP2;MED4;SETX;PLCB1;UBC;SREBF2;ETS1
prerank,Reactome_2022__Degradation Of GLI2 By Proteasome R-HSA-5610783,0.5981449052553621,1.1246224021255737,0.3125,0.7864315641284899,1.0,2/20,8.07%,PSMC6;RPS27A
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.5418750381604828,1.1245993655090518,0.3333333333333333,0.7860059244265942,1.0,13/34,10.78%,GRIA2;MAP2;DOK5;ANK2;MAP1B;GPM6B;NPAS3;PTPRD;NFASC;PPFIA2;LRRC4C;GJA1;BOC
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.7046237831189351,1.1245897406712113,0.3333333333333333,0.7855147623276807,1.0,3/6,26.64%,UFL1;MBD2;CHD1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.6301073231982769,1.124490965689685,0.4027777777777778,0.7853471244047671,1.0,4/10,19.39%,PDE7A;RAPGEF3;ADCY2;RIMS2
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.7052033635255601,1.1243152605580151,0.4032258064516129,0.7854217036148889,1.0,3/7,10.49%,GLUL;ZDHHC6;ZDHHC14
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.5838098411980888,1.1240691559978648,0.323943661971831,0.7856720645645894,1.0,12/29,24.99%,SERPINE1;GGT5;PELI1;TAB2;ERBIN;PDE4B;SMAD6;ZFP36;SCARB1;MEF2C;ADAM9;RPS6KA3
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.738965057302993,1.123891874447448,0.3880597014925373,0.7856218310219931,1.0,2/5,14.21%,SCP2;LSS
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.6973179620917681,1.1238090769633822,0.3380281690140845,0.7855057957422247,1.0,1/7,1.99%,HSPA5
prerank,Reactome_2022__GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,0.5882274391244388,1.123644726686301,0.2962962962962963,0.7856312704227881,1.0,2/21,8.07%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.3939257368140624,-1.1231093123562563,0.125,0.9791027558463823,1.0,14/132,8.50%,RNF213;ATG10;MSL2;IFIH1;ANAPC16;ISG15;HERC5;ZNRF3;NFX1;NUP214;RTF1;HECW2;HERC2;MDM2
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.7170686556717726,1.1230319686822474,0.391304347826087,0.7868383151680332,1.0,1/5,3.90%,ANXA1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.7333527154407607,1.1228882333113424,0.3424657534246575,0.786853183590172,1.0,1/9,2.55%,TBX3
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.7856635094529495,1.1227411731065933,0.30434782608695654,0.7868096372348398,1.0,1/5,3.82%,TRMT9B
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.6980709987898923,-1.1226921607531701,0.325,0.9747363010859786,1.0,2/5,9.59%,MX1;DNM3
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.6980709987898923,-1.1226921607531701,0.325,0.9747363010859786,1.0,2/5,9.59%,MX1;DNM3
prerank,CellMarker_Augmented_2021__Plasmablast:Blood,-0.6007656939969419,-1.122500749568409,0.3333333333333333,0.9726342504713416,1.0,3/6,22.52%,RCSD1;GIMAP4;GIMAP7
prerank,Reactome_2022__Cohesin Loading Onto Chromatin R-HSA-2470946,0.6966085165513742,1.1224601186813319,0.30303030303030304,0.7866789774929664,1.0,2/8,12.19%,RAD21;WAPL
prerank,Reactome_2022__Mitotic Telophase/Cytokinesis R-HSA-68884,0.6966085165513742,1.1224601186813319,0.30303030303030304,0.7866789774929664,1.0,2/8,12.19%,RAD21;WAPL
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.6062294289160681,-1.1222743628767702,0.375,0.9706692527828537,1.0,2/11,1.81%,CPQ;PLA2G4A
prerank,Reactome_2022__Gap Junction Trafficking And Regulation R-HSA-157858,0.7079788002989993,1.122224842282253,0.375,0.7871018722192618,1.0,2/6,21.09%,GJA1;DNM2
prerank,Reactome_2022__Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,0.6290194727346204,1.1220706624001549,0.2972972972972973,0.7870437164872116,1.0,2/14,8.07%,PSMC6;RPS27A
prerank,KEGG_2021_Human__TNF signaling pathway,0.5220215610164378,1.121454352676919,0.3246753246753247,0.7887608473500158,1.0,4/44,6.14%,PIK3R3;MAP3K5;JUNB;PIK3R1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.7316971435363689,1.1214113515016444,0.3484848484848485,0.7878433394375443,1.0,2/9,6.80%,ITPR1;ERO1A
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.7316971435363689,1.1214113515016444,0.3484848484848485,0.7878433394375443,1.0,2/9,6.80%,ITPR1;ERO1A
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5645829690812028,1.1213879302768999,0.3037974683544304,0.7863918098336564,1.0,19/35,31.45%,PRKCE;PIK3R1;HSP90AA1;GRB2;ARPC2;RAC1;CRK;ABI1;WIPF1;ACTB;NCK1;FYN;FGR;WASL;CDC42;PIK3CB;ACTR2;DOCK1;PTK2
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.5645829690812028,1.1213879302768999,0.3037974683544304,0.7863918098336564,1.0,19/35,31.45%,PRKCE;PIK3R1;HSP90AA1;GRB2;ARPC2;RAC1;CRK;ABI1;WIPF1;ACTB;NCK1;FYN;FGR;WASL;CDC42;PIK3CB;ACTR2;DOCK1;PTK2
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5645829690812028,1.1213879302768999,0.3037974683544304,0.7863918098336564,1.0,19/35,31.45%,PRKCE;PIK3R1;HSP90AA1;GRB2;ARPC2;RAC1;CRK;ABI1;WIPF1;ACTB;NCK1;FYN;FGR;WASL;CDC42;PIK3CB;ACTR2;DOCK1;PTK2
prerank,KEGG_2021_Human__mRNA surveillance pathway,0.5795534168900864,1.121208629320444,0.30864197530864196,0.7863633719496957,1.0,2/30,3.29%,PPP2R3A;PPP2R2B
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.7145575266775952,1.1211896116805296,0.3466666666666667,0.7858714712275212,1.0,6/7,28.47%,ANK2;AHNAK;DMD;YWHAE;CAMK2D;CALM1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.6542297408084427,1.1211387765464063,0.3333333333333333,0.7855032494939101,1.0,3/13,16.49%,PIK3R1;RAC1;LIMS1
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.6545347611076173,1.1209665357504859,0.3424657534246575,0.7855839379670883,1.0,4/8,29.93%,HSP90AA1;PTTG1IP;MSN;DAB2IP
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5843008631082254,1.1209562444148926,0.35135135135135137,0.7851151914186095,1.0,5/27,13.04%,B3GNT2;PLOD2;OGT;TMTC1;TRAK1
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.6802976401259213,1.1205580210616857,0.3384615384615385,0.7858316793006509,1.0,4/8,23.69%,PTBP2;NCOR2;TMBIM6;PTBP3
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.6050179666448653,1.1201196451507671,0.35714285714285715,0.7868143229174623,1.0,5/15,14.66%,MAP3K5;RPS27A;TAB2;MAPK10;SH2D3C
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.7618631769675082,1.12007807165646,0.3384615384615385,0.7858920865045234,1.0,3/5,11.24%,SLC12A6;ATP1A1;ATP1B3
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.7618631769675082,1.12007807165646,0.3384615384615385,0.7858920865045234,1.0,3/5,11.24%,SLC12A6;ATP1A1;ATP1B3
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.7144088529670662,1.1199388049076087,0.38333333333333336,0.7858497305482764,1.0,2/7,11.87%,CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.6088252776663614,-1.1197621224878676,0.38461538461538464,0.9764211042657415,1.0,5/13,20.82%,STAT1;PDGFB;IGFBP3;CDH13;IL6R
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.6700390934356862,1.1196351327453882,0.36507936507936506,0.7863402194495971,1.0,1/11,0.69%,SERPINE1
prerank,Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989,0.5013149380588797,1.11932603241625,0.23595505617977527,0.7870027563409243,1.0,14/99,12.91%,DDIT4;BCL6;PRKAG2;BNIP3L;NDRG1;RPS27A;CDKN1B;JUN;RFC3;CCNH;CDKN1A;FOS;CNOT6L;AGO2
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.45871686141983015,1.1191820103750194,0.10101010101010101,0.7868734762166042,1.0,114/514,20.64%,MAFF;ST18;PBX3;ZEB2;SERPINE1;BCL6;ATF3;KLF6;MAFK;KLF2;TBX3;BHLHE40;ZNF160;PHF10;PPM1D;CALR;JUNB;CD81;ELP3;NPAS3;BAZ1A;ZBTB1;ZFPM2;CRTC3;PURA;HYAL2;PIK3R1;SMAD7;NFE2L2;SIN3B;ESR2;ZNF586;REL;BACH2;CBFB;SMAD5;KDM1A;JUND;ARID5A;RPS27A;RPL23;ELP4;KLF4;OGT;FOSL2;JUN;HIF1A;ZNF366;RAD21;CREM;SPEN;OTUD7B;CCNH;CNBP;SETD3;CCNC;REST;CDKN1A;FOS;PPM1A;FOXF1;AGO2;TRAK1;TMF1;NEDD4L;ACVR2A;ZBTB10;SMARCC1;ZBTB38;LRRFIP1;PIAS2;WWTR1;LPIN2;BRWD3;FOXC1;CRLF3;CCNL1;NCOR2;MTDH;CRK;ATF2;BRD4;NR2C1;ATOH8;TNKS;MCPH1;SDCBP;TPR;GATA2;RIF1;NPAS2;ARHGEF2;NAMPT;CRY1;ZMIZ1;STAT3;DUSP22;ZNF43;NFIB;MBD2;NACC2;NR1D2;HBP1;NFIC;RLF;NOTCH4;BCLAF1;CREBZF;CDK8;NPM1;SMAD6;RCOR3;ELK3;ATP2B4
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.6823563114633584,1.1188571238655522,0.359375,0.7875276228815434,1.0,4/13,19.76%,SUN2;REEP3;TPR;CHMP4B
prerank,Reactome_2022__PI3K Cascade R-HSA-109704,0.6868843374809088,1.118810263960803,0.36363636363636365,0.7871540091274549,1.0,3/11,8.31%,FGFR1;PIK3R1;GRB2
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.6591516306783533,1.1187803298406291,0.32432432432432434,0.7867521727665321,1.0,7/12,30.46%,ANXA1;ANXA2;KATNBL1;UVRAG;RAB3GAP2;ATL3;CALCOCO2
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.7364210416744321,1.118413369630011,0.328125,0.7873692689266986,1.0,2/5,12.88%,NEDD9;BCAR1
prerank,Reactome_2022__Signaling By FGFR2 In Disease R-HSA-5655253,0.669139678121517,1.1184008876169125,0.36764705882352944,0.7868818055119434,1.0,2/10,8.31%,PIK3R1;GRB2
prerank,CellMarker_Augmented_2021__Myogenic Endothelial cell:Skeletal Muscle,0.5385534078529617,1.1183560659679153,0.3333333333333333,0.7865668755966922,1.0,8/48,13.12%,ZEB2;S1PR1;VWF;ZNF366;PECAM1;LRRC32;FLT1;CLDN5
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.5855429444272465,1.1183014360841486,0.358974358974359,0.7862022460936184,1.0,4/24,18.25%,PSMC6;RAC1;PSMA7;FZD4
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.5481487622171568,-1.117938829303451,0.25,0.9794202737637675,1.0,5/27,3.61%,IFIH1;ISG15;STAT1;OAS3;IRF1
prerank,Reactome_2022__Signaling By ROBO Receptors R-HSA-376176,0.49549378506337866,1.1179075650679533,0.3068181818181818,0.7869039454842583,1.0,18/92,19.10%,PSMC6;RPS11;MYO9B;ROBO2;RPS9;SRGAP1;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12;PSMA7;DAG1;RPS27;ABL2
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6080076339466662,1.1176897193112298,0.35294117647058826,0.7871400680414863,1.0,1/15,1.38%,LRRC7
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.5605686441176261,1.1176516971420383,0.33766233766233766,0.7867543414570749,1.0,9/29,21.67%,BCAP31;ZDHHC6;LAMP2;ZDHHC14;PIKFYVE;TRAK1;SDCBP;VPS37A;CDC37
prerank,Reactome_2022__NIK To Noncanonical NF-kB Signaling R-HSA-5676590,0.6139960696433224,1.1175089561227551,0.33783783783783783,0.7862412375515153,1.0,2/17,8.07%,PSMC6;RPS27A
prerank,Reactome_2022__Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,0.6139960696433224,1.1175089561227551,0.33783783783783783,0.7862412375515153,1.0,2/17,8.07%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.7462029564719139,1.117500408678002,0.39344262295081966,0.7857712682307966,1.0,1/6,1.54%,SUN2
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.6622154118885607,1.1171611904815864,0.38461538461538464,0.7863921547069663,1.0,6/14,22.15%,MAP2;NAV3;ARHGEF2;TBCD;TAOK1;CDH5
prerank,Reactome_2022__PI-3K cascade:FGFR2 R-HSA-5654695,0.729997617778247,1.1171422330364105,0.35714285714285715,0.7849215647573061,1.0,2/6,8.31%,PIK3R1;GRB2
prerank,Reactome_2022__PI-3K cascade:FGFR3 R-HSA-5654710,0.729997617778247,1.1171422330364105,0.35714285714285715,0.7849215647573061,1.0,2/6,8.31%,PIK3R1;GRB2
prerank,Reactome_2022__PI-3K cascade:FGFR4 R-HSA-5654720,0.729997617778247,1.1171422330364105,0.35714285714285715,0.7849215647573061,1.0,2/6,8.31%,PIK3R1;GRB2
prerank,KEGG_2021_Human__Thyroid hormone synthesis,0.620934212333096,1.1169749297325873,0.3116883116883117,0.7849372615619328,1.0,8/21,15.91%,ITPR1;HSPA5;CANX;HSP90B1;ATP1A1;ATP1B3;ADCY2;ATF2
prerank,CellMarker_Augmented_2021__Stem cell:Salivary Gland,-0.4295723000134978,-1.1168683275003688,0.22727272727272727,0.9798760391590725,1.0,7/54,7.25%,SAMD9L;DDX60;PARP14;FAM111A;SP100;ZC3HAV1;SP140L
prerank,Reactome_2022__Asparagine N-linked Glycosylation R-HSA-446203,0.4992489432725581,1.1166970143508292,0.3108108108108108,0.7854998695398026,1.0,22/79,22.42%,SEC22B;CANX;ANK2;CALR;MGAT4A;EDEM3;SEC24D;MCFD2;RPS27A;ANK3;CD55;MGAT5;AMFR;FUT8;ST6GALNAC3;CSNK1D;EGFL7;DYNC1H1;PMM2;B4GALT1;UGGT2;UBC
prerank,Reactome_2022__MET Activates RAP1 And RAC1 R-HSA-8875555,0.667012855518708,1.1166247490715373,0.3333333333333333,0.7853377146046332,1.0,3/10,15.72%,GRB2;RAP1A;CRK
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.6308240723777356,-1.116597640747749,0.3939393939393939,0.9780160200359889,1.0,3/10,9.93%,COL8A1;LAMA3;FN1
prerank,CellMarker_Augmented_2021__Stem cell:Dental Pulp,0.7656480534817061,1.1162625693703656,0.359375,0.7860837882504095,1.0,2/5,14.98%,ITGB1;ALCAM
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.7090806007296281,-1.1160034056045085,0.4,0.977154917741839,1.0,3/7,11.37%,ATM;LDB2;NLRC5
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Brain,0.6607306107648035,1.115462362463949,0.36231884057971014,0.7883460349452898,1.0,3/10,11.31%,NES;BOC;SLC2A3
prerank,Reactome_2022__TRP Channels R-HSA-3295583,-0.7442806953818928,-1.1154099177126302,0.36585365853658536,0.9768531451539608,1.0,4/5,23.35%,TRPM6;TRPM7;TRPC4AP;TRPM3
prerank,Reactome_2022__Adherens Junctions Interactions R-HSA-418990,0.6518111896111596,1.11523616286202,0.3582089552238806,0.7885791237611361,1.0,4/12,22.15%,CADM2;CTNNA1;AFDN;CDH5
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.5838175982848823,1.115079974365913,0.3835616438356164,0.7886349067680418,1.0,3/20,15.30%,ADM;GGT5;ADCY2
prerank,CellMarker_Augmented_2021__Cancer cell:Brain,0.6076983704015876,1.1148861118000857,0.3582089552238806,0.7886552395453064,1.0,8/18,14.56%,CANX;IPO7;POLA1;NOC3L;HSP90B1;RFC3;HSPA9;NUDCD1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.7479363516474912,1.1145913335974797,0.2807017543859649,0.7890078971991551,1.0,2/5,13.78%,CD81;CD55
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.7222177817267187,1.1144240134356274,0.37333333333333335,0.7889996991854362,1.0,4/9,22.15%,JAK1;PAK2;ACTB;CDH5
prerank,KEGG_2021_Human__Morphine addiction,0.5973078937761399,1.1143759978198646,0.2894736842105263,0.7886454596089503,1.0,6/20,21.89%,PDE7A;PDE10A;ADCY2;GRK5;PDE4B;ADCY9
prerank,Reactome_2022__Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,0.6622802794924757,1.1143637433713884,0.3968253968253968,0.787176611907111,1.0,3/13,8.31%,FGFR1;PIK3R1;GRB2
prerank,Reactome_2022__IGF1R Signaling Cascade R-HSA-2428924,0.6622802794924757,1.1143637433713884,0.3968253968253968,0.787176611907111,1.0,3/13,8.31%,FGFR1;PIK3R1;GRB2
prerank,Reactome_2022__IRS-related Events Triggered By IGF1R R-HSA-2428928,0.6622802794924757,1.1143637433713884,0.3968253968253968,0.787176611907111,1.0,3/13,8.31%,FGFR1;PIK3R1;GRB2
prerank,CellMarker_Augmented_2021__Neural Stem cell:Brain,0.6582708206406349,1.1139591314459962,0.38571428571428573,0.7881980768129031,1.0,4/10,13.68%,NES;CD81;ADGRG1;ITGB1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.6207091215610052,1.1139180066305159,0.38961038961038963,0.7878032315777849,1.0,3/21,5.15%,ITPR1;SLC8A1;CACNA1C
prerank,Reactome_2022__IRS-mediated Signaling R-HSA-112399,0.6868623166891923,1.1138449140327242,0.35384615384615387,0.7875073830007918,1.0,3/12,8.31%,FGFR1;PIK3R1;GRB2
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.7590847552965443,1.1134864597934742,0.3770491803278688,0.7883017049729454,1.0,2/5,14.82%,ATG12;AGTPBP1
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,0.6815232798126194,1.1130689418079869,0.4090909090909091,0.7892285233599434,1.0,4/9,20.69%,KLF4;CDKN1B;CDKN1A;BTG1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.542722599364886,1.113059596480502,0.3108108108108108,0.7887778495144764,1.0,7/29,13.31%,ERBB4;PRKAG2;FGFR1;RAP1A;CDKN1A;FLT1;TAB2
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.5077273254133878,1.1129525955229793,0.25,0.7887066958848935,1.0,25/90,24.78%,BCL6;BNIP3L;MAP3K5;DUSP6;RPS27A;ARHGEF4;JUN;GNA13;REST;ANO6;ITGB1;HIP1R;ECT2;TGM2;ARHGEF2;KALRN;BCLAF1;TNFRSF10B;DNM2;TNFAIP8;UBC;PREX1;ATF6;RACK1;FGD4
prerank,CellMarker_Augmented_2021__Meiotic Prophase Fetal Germ cell:Fetal Gonad,0.45535058439227255,1.112873034644379,0.24210526315789474,0.7885093955819754,1.0,34/319,14.21%,PIK3R3;PBX3;RTN4;SPOPL;BCAP31;OXR1;NUFIP2;BAZ1A;MTMR12;UFL1;CCDC88A;REL;ZNF800;ZFR;DCAF10;ARHGAP21;TACC1;WDR37;PTBP2;SLC38A2;TBC1D15;BOC;PHLPP1;SUGP2;BTBD10;MAP7;GIGYF2;TMF1;MAPK10;ACVR2A;CD55;ACBD3;RASA1;LSS
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.6299313556805367,1.1128274120204253,0.40540540540540543,0.7881581529577784,1.0,3/11,18.57%,ANXA1;GGT5;STAT3
prerank,Reactome_2022__Vpu Mediated Degradation Of CD4 R-HSA-180534,0.6272336308392956,1.1127797135020732,0.32,0.7877653283706298,1.0,2/15,8.07%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.7017067723969503,1.1126028342696164,0.3472222222222222,0.787799991639509,1.0,2/8,8.82%,SMAD7;CDKN1B
prerank,CellMarker_Augmented_2021__CD1C-CD141- Dendritic cell:Blood,-0.3910024663638725,-1.1125337230662995,0.1,0.9833128796714029,1.0,10/105,5.52%,GBP1;DDX60;GBP4;GBP2;PSTPIP2;ISG15;EVL;IRF1;DDX60L;TNFSF10
prerank,CellMarker_Augmented_2021__Thecal cell:Ovary,-0.5863407504252625,-1.1124441268288525,0.2857142857142857,0.9780968357877826,1.0,2/15,1.46%,GBP2;CPQ
prerank,CellMarker_Augmented_2021__Zymogenic Chief cell:Gastric Epithelium,-0.5863407504252625,-1.1124441268288525,0.2857142857142857,0.9780968357877826,1.0,2/15,1.46%,GBP2;CPQ
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.5078258817377,-1.1123280011374497,0.34615384615384615,0.9758453121971646,1.0,3/14,11.21%,SLC38A3;SLC16A2;SLC38A6
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.7179534141715425,1.1122449703637496,0.38181818181818183,0.7885901198044601,1.0,4/8,17.21%,BCAP31;MICU2;PDZD8;TGM2
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.688508659805907,1.112016890660953,0.42857142857142855,0.7889318250580596,1.0,2/7,11.47%,ANXA1;REST
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.7235398829565325,1.111943023743378,0.40625,0.7886163560491611,1.0,3/6,25.13%,FGFR1;STOX2;USP22
prerank,Reactome_2022__MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,0.6103524184220203,1.1117110653708941,0.3582089552238806,0.7889645966566743,1.0,4/14,13.39%,DUSP6;JUN;FOS;MAPK10
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.5483577286280855,1.1117013360663555,0.3108108108108108,0.788495991595888,1.0,6/38,9.85%,PLS3;TBX3;HYAL2;FGFR1;ALPL;GJA1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.7107796704020968,1.1114856980280596,0.36923076923076925,0.7885649317836321,1.0,3/8,16.18%,KCNMB4;ANK3;DMD
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.7230561773444564,1.1109658856602067,0.34375,0.7897767126234039,1.0,1/6,2.52%,TRIM5
prerank,Reactome_2022__Cell Cycle R-HSA-1640170,0.4716605735704718,1.1107333164247615,0.2826086956521739,0.7902069256845584,1.0,51/165,26.06%,CEP57;PSMC6;SUN2;LBR;POLA1;TUBB4B;HSP90AA1;RPS27A;CDK6;CDKN1B;RAD21;RFC3;CCNH;CDKN1A;WAPL;AHCTF1;TUBA1B;TUBB6;CEP70;LPIN2;ENSA;PSMA7;MCPH1;TPR;PPP1CB;RAB2A;ALMS1;RPS27;CSNK1D;DYNC1H1;CHMP4B;NPM1;PAFAH1B1;CEP290;TAOK1;ARPP19;YWHAB;YWHAE;UBC;TMPO;SPC25;MAX;H3-3B;XPO1;NSD2;TERF2IP;PSMB9;SMC3;TUBB;CDK5RAP2;SMARCA5
prerank,Reactome_2022__MAPK3 (ERK1) Activation R-HSA-110056,0.7029604956170465,1.110621291038201,0.417910447761194,0.7900380111499405,1.0,1/6,7.09%,JAK1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.5695494097271694,-1.110577226559031,0.375,0.9782055457883339,1.0,1/9,0.24%,CEMIP
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Adipose Tissue,0.5067051517052708,1.1105525313614144,0.2839506172839506,0.7897301894972135,1.0,12/53,14.42%,ZEB2;S1PR1;GGT5;VWF;ZNF366;PECAM1;LRRC32;CFH;FLT1;CLDN5;DYSF;TNS1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.607899001382022,1.1105388404425551,0.36231884057971014,0.7892698188102774,1.0,10/22,26.40%,DPP10;PRKCE;PIK3R1;CNST;ITGB1;LGALS3;ATP2B4;PRKCH;RACK1;EGFR
prerank,Reactome_2022__Degradation Of DVL R-HSA-4641258,0.6167442345197675,1.1104349775367706,0.3611111111111111,0.7890531782913931,1.0,2/15,8.07%,PSMC6;RPS27A
prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,0.5597439744080939,1.110092381846301,0.3048780487804878,0.7896838411604767,1.0,13/46,17.24%,PPP2R3A;SLC8A1;PPP2R2B;CACNA1C;RAPGEF3;TPM4;ATP2B1;CREM;ATP1A1;ATP1B3;ADCY2;ATF2;PPP1CB
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.6881229570280435,1.1099832979142652,0.3333333333333333,0.7895019053991154,1.0,3/12,4.78%,SERPINE1;ANXA1;PRKCE
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.6294369889045113,1.1095712687563948,0.36619718309859156,0.7903256564687142,1.0,5/17,19.76%,ANK3;MYH10;RASA1;ECT2;CHMP4B
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.6526958616473707,1.1094882116611862,0.4,0.7900465288407776,1.0,7/12,27.14%,EDEM3;RPS27A;AMFR;UGGT2;UBC;SEL1L;UGGT1
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.6925238430853317,1.1093146575237882,0.40298507462686567,0.7900793991827103,1.0,4/8,24.65%,MT1M;MT2A;SLC30A1;MT1E
prerank,CellMarker_Augmented_2021__Villous Stromal cell:Placenta,0.6109381666827637,1.1089624916037157,0.39705882352941174,0.7908320349997124,1.0,4/16,9.27%,TIMP3;PLSCR4;COL4A2;EMP1
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.6826195284376265,1.1088322039798664,0.36764705882352944,0.7907675377249404,1.0,3/13,13.94%,PIK3R1;DLC1;PAK2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Blood,0.7330636306990987,1.1087265613248884,0.36923076923076925,0.7905717817269644,1.0,1/5,2.82%,NES
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.6125588205939457,1.108708333948518,0.37333333333333335,0.7901621129939267,1.0,5/21,20.98%,PSMC6;REL;PSMA7;MALT1;TNFRSF10B
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.5460060510551882,1.10843623285947,0.2948717948717949,0.7905607198668535,1.0,16/32,22.66%,GRIA2;CADM2;S1PR1;GPM6B;NFASC;SNAP25;GJA1;NRXN1;TMEM132C;ADGRB3;SLC1A2;SOCS3;GRM5;GPRC5B;PLP1;ETS1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.5007716541989822,-1.1081999864113468,0.2692307692307692,0.9828971016188864,1.0,3/20,4.38%,BABAM2;ATM;ATR
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.4920302646985603,1.1080428924221346,0.3176470588235294,0.7914901061556457,1.0,26/113,18.17%,CCDC3;PPM1D;CALR;GAPDH;PPHLN1;REL;PINK1;SRGN;ATP2B1;PICALM;KLF4;PTBP2;HIF1A;REST;DCP2;AGO2;GIGYF2;CLDN5;RPL13A;NDFIP1;NCOR2;ATOH8;DIP2A;GATA2;BTG2;TMBIM6
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.7541362562787695,1.1077629389422927,0.4166666666666667,0.7919149729465823,1.0,3/5,18.57%,PIK3R1;PXN;STAT3
prerank,KEGG_2021_Human__Gap junction,0.5159946249607333,1.1076318365131617,0.3194444444444444,0.7919051719774882,1.0,15/34,26.40%,ITPR1;TUBB4B;GRB2;GJA1;KRAS;TUBA1B;TUBB6;ADCY2;CSNK1D;GRM5;ADCY9;PLCB1;TUBB;MAP2K1;EGFR
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.7208470402490688,1.1075663281691295,0.3380281690140845,0.7911560561948163,1.0,4/6,22.87%,SLC8A1;ATP1A1;GSN;ATP1B1
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.7208470402490688,1.1075663281691295,0.3380281690140845,0.7911560561948163,1.0,4/6,22.87%,SLC8A1;ATP1A1;GSN;ATP1B1
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.6085310363905256,1.1075509444170748,0.36764705882352944,0.7907340474054074,1.0,7/19,26.16%,MYO1B;PPFIA2;MYO1E;TRAK1;PAFAH1B1;TANC2;WASL
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.6576432163715534,1.1075029480107281,0.4117647058823529,0.7903400579418797,1.0,1/8,1.27%,NEDD9
prerank,Reactome_2022__Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,0.7220382481874497,1.1074485470111297,0.3333333333333333,0.7900427332997035,1.0,2/6,8.07%,NRG2;RPS27A
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.5188996651508405,1.107301514744998,0.34615384615384615,0.7900135315127527,1.0,10/47,13.71%,CHPT1;SPOCK1;PINK1;HSP90AA1;PICALM;NRG3;RAP1A;STK38L;BCAR1;HIP1R
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.4951649456515485,1.107267647361794,0.3253012048192771,0.7897167769050527,1.0,18/82,17.10%,NRCAM;DOK5;MAP1B;LAMA5;ROBO2;PIK3R1;HSP90AA1;SEMA6B;GRB2;NRXN3;ANK3;UNC5C;NRXN1;S100A6;GRB10;FEZ2;SEMA3F;DAG1
prerank,Reactome_2022__RHOH GTPase Cycle R-HSA-9013407,0.624203395161365,1.1071850956821883,0.3384615384615385,0.7895232445241415,1.0,4/15,18.22%,SLC4A7;TMEM59;TUBA1B;RALGAPA1
prerank,Reactome_2022__RHO GTPases Activate PAKs R-HSA-5627123,0.6376142564725973,1.1071505648850686,0.32857142857142857,0.7891517792364474,1.0,6/13,28.47%,MYL6;MYH10;PPP1CB;MYL12B;CDC42;CALM1
prerank,Reactome_2022__PCP/CE Pathway R-HSA-4086400,0.5585047329324044,1.1071334871960774,0.32098765432098764,0.7887191359571996,1.0,4/29,18.25%,PSMC6;RPS27A;PSMA7;FZD4
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.6232804446746076,1.106921298320811,0.36363636363636365,0.788841416243796,1.0,3/16,9.83%,PCK1;PIK3R1;HIF1A
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.5298300967962618,1.106513941931771,0.32051282051282054,0.789544953461054,1.0,5/48,5.10%,DDIT4;PBX3;NES;GRIN2B;ROBO2
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.5418891168040731,1.1060860882372685,0.3291139240506329,0.7904321918017824,1.0,9/47,15.25%,ERBB4;CACNA1C;ZFPM2;DLC1;CDKN1B;CDKN1A;FOXF1;TAB2;FOXC1
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.657629493627798,1.1059545407055964,0.3968253968253968,0.7903755673412187,1.0,3/13,10.46%,RAPGEF3;RAP1A;PECAM1
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.7196246103721551,1.1056245284391781,0.29310344827586204,0.7910563778780276,1.0,2/5,11.16%,ATP2B1;SETD3
prerank,CellMarker_Augmented_2021__Endothelial cell:Lung,0.7395798397943232,1.1054677985124985,0.4153846153846154,0.7910813180501078,1.0,3/6,12.32%,VWF;PECAM1;FLT1
prerank,Reactome_2022__Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.6903097950477347,1.1052494325597884,0.3157894736842105,0.7910857703706231,1.0,3/10,7.01%,GPC5;CHSY1;CHST11
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.6128629315553589,1.1050432445339653,0.4,0.7913014780981017,1.0,4/15,9.03%,SPOPL;UFL1;SMAD7;OGT
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.65916915949904,1.1047291214125496,0.38571428571428573,0.7917621053465562,1.0,5/8,29.24%,OGT;SETD3;WDR82;TET2;KMT2A
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.5873468484177118,1.1043446796447571,0.33783783783783783,0.7915362337651626,1.0,6/29,17.13%,PSMC6;TAB2;KRAS;PAK2;PSMA7;MALT1
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.5873468484177118,1.1043446796447571,0.33783783783783783,0.7915362337651626,1.0,6/29,17.13%,PSMC6;TAB2;KRAS;PAK2;PSMA7;MALT1
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.5873468484177118,1.1043446796447571,0.33783783783783783,0.7915362337651626,1.0,6/29,17.13%,PSMC6;TAB2;KRAS;PAK2;PSMA7;MALT1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.5706553340936876,1.103970884950673,0.3116883116883117,0.7923760515199153,1.0,9/25,22.18%,PPM1D;CBFB;JUN;CCNC;CDKN1A;BCLAF1;CDK8;MED4;SETX
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.5809229527856818,1.10380682285991,0.3382352941176471,0.7924000613827373,1.0,5/27,9.83%,PDK4;PCK1;PIK3R1;BACE2;HIF1A
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.7578659669020243,1.1037218294218034,0.4426229508196721,0.7921729719774465,1.0,2/5,16.10%,UNC5C;SEMA3F
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.46254728206923396,1.1034382301370707,0.2553191489361702,0.7927056908416908,1.0,47/199,19.55%,ZEB2;BCL6;ATF3;MAFK;KLF2;TBX3;BHLHE40;CALR;ZBTB1;ZFPM2;PURA;SMAD7;SIN3B;ESR2;CBFB;KDM1A;ARID5A;RPS27A;RPL23;KLF4;JUN;ZNF366;CREM;SPEN;OTUD7B;CNBP;REST;PPM1A;NEDD4L;LRRFIP1;FOXC1;NCOR2;MTDH;NR2C1;MCPH1;SDCBP;TPR;RIF1;CRY1;STAT3;DUSP22;NFIB;MBD2;NACC2;NR1D2;NFIC;NOTCH4
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.7398084657432438,1.103402445735536,0.37037037037037035,0.7923634768277913,1.0,2/5,22.39%,AGO2;PLCB1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.6460657563182253,1.1029291267140477,0.4383561643835616,0.7935117930256933,1.0,2/12,5.31%,INPP5F;MTMR12
prerank,Reactome_2022__Disease R-HSA-1643685,0.4434668897252076,1.1026736162260913,0.2727272727272727,0.7939141059288815,1.0,100/514,17.37%,PIK3R3;ADM;ERBB4;ADAMTS9;PSMC6;ITPR1;TSG101;CANX;ZNF160;RRBP1;PBRM1;CALR;S1PR1;CD9;RPS11;MGAT4A;GPC5;MYO9B;SGIP1;PGK1;PACS1;SEC24D;CHSY1;WDR48;DUSP6;POLA1;NRG2;FGFR1;PIK3R1;NFE2L2;ESR2;SLC20A2;SNAP25;RPS9;PRNP;JAK1;HSP90AA1;KDM1A;TPM4;RPS27A;RPL23;CDK6;GRB2;CDKN1B;NRG3;SLC2A1;JAG2;GGT5;MIB1;VWF;JUN;GJA1;RAP1A;MYO1E;RFC3;PEBP1;SLC12A6;CCNH;CNBP;ATP1B3;CCNC;REST;IFNGR1;CDKN1A;RPL8;RPL34;RPL37;RPLP2;TRAK1;ARPC2;TAB2;SLC26A2;NEDD4L;DUSP16;ITGB1;LRRFIP1;AP1G1;TENT4A;ERBIN;MPRIP;RPL13A;TXNRD1;SHOC2;ADCY2;RPS12;NCOR2;CRK;MGAT5;BRD4;PSMA7;KPNA4;SND1;TNKS;SYT1;SPRED1;TPR;PRKX;DAG1;PPP1CB;HDAC7
prerank,Reactome_2022__Early SARS-CoV-2 Infection Events R-HSA-9772572,0.6771010896998728,1.1024647819287288,0.3880597014925373,0.7939979742330184,1.0,5/10,27.54%,GPC5;CHMP4B;UVRAG;VCP;PIK3C3
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.6184666061338064,1.1024344581300516,0.375,0.7935814375948688,1.0,5/12,21.67%,HSP90AA1;OGT;PELI1;SDCBP;CDC37
prerank,Reactome_2022__Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,0.6265685122287374,1.1023933133331978,0.3013698630136986,0.7927228759292652,1.0,2/15,8.07%,PSMC6;RPS27A
prerank,Reactome_2022__Regulation Of Apoptosis R-HSA-169911,0.6265685122287374,1.1023933133331978,0.3013698630136986,0.7927228759292652,1.0,2/15,8.07%,PSMC6;RPS27A
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.5898105203219864,1.1023714892354763,0.34328358208955223,0.7923416184463512,1.0,8/16,33.33%,TAF1D;ZMIZ1;ACTB;SMARCA5;ATAD2B;ARID1A;DEK;EP300
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.5378476275535766,1.102046930198747,0.3076923076923077,0.7928578295893176,1.0,9/31,26.06%,PSMC6;RPS27A;CCNH;PSMA7;NPM1;UBC;NAP1L4;PSMB9;SMARCA5
prerank,CellMarker_Augmented_2021__Ciliated Epithelial cell:Esophagus,0.5417237329348478,1.101882092793231,0.34177215189873417,0.792975735589715,1.0,7/50,7.17%,ERBB4;DTNA;TMEM45B;CCDC60;CSMD1;CHST11;TTLL7
prerank,Reactome_2022__Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,0.6726964589300242,1.1017460970358273,0.3235294117647059,0.7928846760592676,1.0,1/9,1.70%,GRIK1
prerank,Reactome_2022__Adaptive Immune System R-HSA-1280218,0.4599768635816572,1.1014326755617263,0.26595744680851063,0.7933188318553954,1.0,17/215,8.90%,PIK3R3;PSMC6;SEC22B;ITPR1;HSPA5;CANX;CALR;CD81;SEC24D;RAPGEF3;UFL1;TRIM9;PIK3R1;REL;RPS27A;GRB2;UBE2J1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.590000842240477,1.1011274081701994,0.288135593220339,0.7939072053882001,1.0,3/19,7.81%,PDK4;PCK1;BACE2
prerank,Reactome_2022__Signaling By Leptin R-HSA-2586552,0.7429090066831874,1.1008318161432638,0.3333333333333333,0.7944612455729761,1.0,2/5,19.84%,STAT3;SOCS3
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.6825446924268511,1.1007371382716022,0.4383561643835616,0.7942552686601669,1.0,2/8,7.04%,BCAP31;PINK1
prerank,Reactome_2022__Transport To Golgi And Subsequent Modification R-HSA-948021,0.504266311523886,1.100613997950708,0.32894736842105265,0.7941771414992623,1.0,11/53,19.31%,SEC22B;ANK2;MGAT4A;SEC24D;MCFD2;ANK3;CD55;MGAT5;FUT8;CSNK1D;DYNC1H1
prerank,Reactome_2022__SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,0.6140181985710423,1.100331247411215,0.3561643835616438,0.7944951013792547,1.0,2/16,8.07%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.751427078582946,1.1002032973086908,0.3225806451612903,0.7943968006280914,1.0,1/5,7.38%,KDM1A
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),0.6066866791241252,1.0998435850504156,0.352112676056338,0.795210311167003,1.0,2/17,8.07%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.7137679164990979,1.099761709081243,0.3787878787878788,0.7951116970573592,1.0,1/6,12.91%,AGO2
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.7161001230304032,1.099739439032685,0.3088235294117647,0.7947319900129415,1.0,4/8,23.03%,RFTN1;BCAR1;TEC;MEF2C
prerank,Reactome_2022__NOTCH2 Intracellular Domain Regulates Transcription R-HSA-2197563,-0.6344885447170849,-1.0996998549376766,0.3793103448275862,1.0,1.0,4/5,22.44%,MAML3;MAML2;CREB1;RBPJ
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.5924387380307544,-1.0994666192846845,0.4117647058823529,1.0,1.0,1/7,1.46%,CPQ
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.7316489361702128,1.0994609529417052,0.40625,0.7951356448875351,1.0,5/5,26.93%,HSP90B1;NPLOC4;HERPUD1;SEL1L;VCP
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.5930637104602747,-1.099343723462584,0.34146341463414637,1.0,1.0,1/7,12.35%,PTPN2
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood Vessel,-0.5161753538728243,-1.099314106004706,0.2962962962962963,0.999053446791874,1.0,2/27,0.64%,VCAM1;THSD1
prerank,KEGG_2021_Human__Antigen processing and presentation,0.5663044304206784,1.099163024822249,0.390625,0.7955923124282234,1.0,4/19,7.36%,HSPA5;CANX;CALR;HSP90AA1
prerank,CellMarker_Augmented_2021__Stem cell:Liver,0.6662775220669773,1.098960462958221,0.43103448275862066,0.7956674746676534,1.0,1/7,2.82%,NES
prerank,Reactome_2022__CD28 Dependent Vav1 Pathway R-HSA-389359,0.7128907943345546,1.098812453826052,0.3582089552238806,0.7957024700052283,1.0,3/6,26.29%,GRB2;FYN;CDC42
prerank,Reactome_2022__FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,0.6037008611814725,1.0987426490185412,0.37333333333333335,0.7954637330549565,1.0,2/16,8.07%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.5866537037218335,1.0983359811820328,0.38235294117647056,0.7959658035818286,1.0,5/21,19.10%,ITPR1;SCARB2;DEPP1;PSAP;ABL2
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.6890342098086761,1.098288522283147,0.47058823529411764,0.7956871913505728,1.0,2/7,16.33%,PRNP;TRAM1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.6149756530735121,1.098244867986503,0.34328358208955223,0.7953689339822146,1.0,9/23,21.14%,YBX3;NFE2L2;PINK1;PTTG1IP;ARHGEF2;HERPUD1;TMBIM6;BCL2L1;MCL1
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.566172697581595,1.0981851861962837,0.3380281690140845,0.7950776962353604,1.0,10/29,20.56%,MYO9B;EPS8;BCR;DLC1;PRAG1;ADGRG1;RAC1;ARHGEF2;ABL2;RASIP1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.6563827615859468,1.0981269468874897,0.4126984126984127,0.7948067741198349,1.0,4/7,25.87%,GJA1;ITGB1;PAFAH1B1;CDK5RAP2
prerank,CellMarker_Augmented_2021__FGFR1LowNME5- Epithelial cell:Esophagus,0.6750326246797987,1.0980432265816795,0.3384615384615385,0.7946492498766949,1.0,4/8,21.62%,GAS7;SLC2A3;SH3KBP1;PHTF2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.5111422454092253,1.0976272460744672,0.2894736842105263,0.7956086702146729,1.0,15/51,21.83%,NEDD9;PRKAG2;CCDC88A;PRNP;HSP90AA1;RAP1A;CDKN1A;TAB2;PAK2;ECT2;PTPN1;CAB39;GRM5;TAOK1;GPRC5B
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.6499916831926906,1.0974465661065607,0.3194444444444444,0.7957165891728885,1.0,4/10,19.39%,SNAP25;DNAJC5;SYT1;RIMS2
prerank,"Reactome_2022__Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",0.46312219560529555,1.0971916964354822,0.22105263157894736,0.7961297910325145,1.0,57/257,19.79%,PIK3R3;DOCK3;AKAP12;BCAP31;PKN3;ARHGAP23;VAPB;LBR;MYO9B;PDE5A;PIK3R1;CCDC88A;ARHGAP21;HSP90AA1;KDM1A;SRGAP1;DLC1;TPM4;ARHGEF4;GRB2;SLC4A7;PICALM;CDKN1B;CTNNA1;GJA1;MYL6;GNA13;MYH10;STK38;PRAG1;TRAK1;AHCTF1;ARPC2;DOCK4;ITGB1;TMEM59;ECT2;TUBA1B;ERBIN;PCDH7;ADD3;ACTN1;PPP1CB;MYL12B;ARHGEF2;TRA2B;RALGAPA1;KALRN;FAM13A;RPS27;DIAPH2;ABL2;ABI1;DYNC1H1;LIMK2;PLEKHG1;WIPF1
prerank,Reactome_2022__Reduction Of Cytosolic Ca++ Levels R-HSA-418359,0.760112362778664,1.0971062273235286,0.4057971014492754,0.7958524145345915,1.0,2/5,8.45%,SLC8A1;ATP2B1
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.7431449473113916,1.096910133123983,0.41333333333333333,0.7959798884360522,1.0,3/5,19.04%,SLC8A1;TGM2;RYR3
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.5096427772918178,-1.0968198359319514,0.3333333333333333,1.0,1.0,5/28,9.19%,CEMIP;TPD52L1;PKD2;PDGFC;PDGFB
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.6801445613455177,1.0966768807050156,0.4262295081967213,0.7962861521455821,1.0,3/8,22.15%,FOXF1;NOTCH4;CDH5
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.7148412990666151,1.0964907449823915,0.4067796610169492,0.7963602264081251,1.0,3/7,4.94%,SCP2;MGLL;ACOX1
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.6747313217268008,1.096394002721942,0.4166666666666667,0.7962621032638255,1.0,3/7,17.85%,ANXA1;FLT1;LGALS3
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.6698783214389026,1.0963826911113121,0.43283582089552236,0.7958068534207685,1.0,2/10,7.04%,CCDC88A;PINK1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.6288208695154898,1.0960900531090312,0.4032258064516129,0.7962645584670983,1.0,3/15,10.46%,RAPGEF3;RAP1A;PECAM1
prerank,Reactome_2022__Alpha-protein Kinase 1 Signaling Pathway R-HSA-9645460,0.7049275404861938,1.0955479239348034,0.4126984126984127,0.7975146468518788,1.0,4/6,22.42%,RPS27A;TAB2;ALPK1;UBC
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.6601046729901218,1.0955328987690258,0.35294117647058826,0.7970726720436488,1.0,3/8,12.40%,SLC4A10;ANO5;ANO6
prerank,KEGG_2021_Human__Vibrio cholerae infection,0.6039614730618261,1.0953054449137942,0.3835616438356164,0.7972054124570417,1.0,2/17,6.80%,ARF1;ERO1A
prerank,CellMarker_Augmented_2021__Mesothelial cell:Undefined,0.7181500337248257,1.09527677934571,0.3783783783783784,0.7968169150397372,1.0,3/6,25.15%,LAMA5;ANXA3;PLEC
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.6386470852754967,1.095201188602246,0.373134328358209,0.796587088208186,1.0,4/11,20.37%,HIF1A;GRB10;PTPN1;NEDD4
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.6636753576894013,1.094691266840111,0.352112676056338,0.7977344494371933,1.0,3/8,9.85%,ADAMTS9;SMAD5;GJA1
prerank,Reactome_2022__Post-translational Protein Modification R-HSA-597592,0.44183447761686007,1.0945492772057728,0.2755102040816326,0.7977216292259327,1.0,64/369,19.44%,LAMC1;B3GNT2;ADAMTS9;PSMC6;SEC22B;FEM1C;CNTN5;MDGA2;CANX;ANK2;CALR;MGAT4A;EDEM3;LSAMP;SEC24D;WDR48;SMAD7;NFE2L2;TUBB4B;DCAF10;TTLL7;ALPL;MCFD2;RAB21;RPS27A;ANK3;NEGR1;OGT;HSP90B1;SMC6;HIF1A;NPLOC4;RAD21;OTUD7B;COMMD1;EEF1A1;CD55;PIAS2;TUBA1B;AGTPBP1;TUBB6;UHRF2;RAB30;NCOR2;UBE2B;MGAT5;PSMA7;NR2C1;TNKS;AMFR;TPR;DAG1;RAB2A;HDAC7;TPST2;FUT8;PIGN;TF;ARSG;ST6GALNAC3;CSNK1D;EGFL7;DYNC1H1;USP34
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.6904501478044839,-1.0941336833237472,0.40625,1.0,1.0,2/5,21.73%,RPS8;RPS16
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.7128483259416017,1.09411745169102,0.39344262295081966,0.7985774225206882,1.0,3/6,11.63%,RAP1A;MAGI2;ACAP2
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.559844919032934,-1.0940627356902057,0.2916666666666667,1.0,1.0,4/13,16.15%,SHLD1;MSH3;SHLD2;POLR2A
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.48894561239479734,1.0939749669227672,0.345679012345679,0.7984852008872081,1.0,18/73,21.14%,ITPR1;PRKAG2;TRIM5;GAPDH;UFL1;PINK1;RB1CC1;DEPP1;EEF1A1;TAB2;TMEM59;MTDH;PSAP;STAT3;ABL2;NEDD4;RASIP1;MCL1
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.6343749581552195,1.0938029036162578,0.3770491803278688,0.7985639732971205,1.0,2/17,4.46%,PNP;LBR
prerank,Reactome_2022__Signaling By Rho GTPases R-HSA-194315,0.4621978342073403,1.09355738747888,0.23958333333333334,0.7988134358510591,1.0,56/252,19.79%,PIK3R3;DOCK3;AKAP12;BCAP31;PKN3;ARHGAP23;VAPB;LBR;MYO9B;PDE5A;PIK3R1;CCDC88A;ARHGAP21;HSP90AA1;KDM1A;SRGAP1;DLC1;TPM4;ARHGEF4;GRB2;SLC4A7;PICALM;CDKN1B;CTNNA1;GJA1;MYL6;GNA13;MYH10;STK38;PRAG1;AHCTF1;ARPC2;DOCK4;ITGB1;TMEM59;ECT2;TUBA1B;ERBIN;PCDH7;ADD3;ACTN1;PPP1CB;MYL12B;ARHGEF2;TRA2B;RALGAPA1;KALRN;FAM13A;RPS27;DIAPH2;ABL2;ABI1;DYNC1H1;LIMK2;PLEKHG1;WIPF1
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.5784337548392734,1.093334682599895,0.3783783783783784,0.7991085559516287,1.0,11/34,22.87%,LAMA5;SCARB2;CTNNA1;ATP1A1;BCAR1;CADPS2;DAG1;HDLBP;EPAS1;COL18A1;ATP1B1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.5792559340800765,1.0929977286572063,0.2972972972972973,0.7995279824109955,1.0,2/19,7.01%,B3GNT2;CHST11
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.5873027646127993,-1.0929605954428516,0.3793103448275862,1.0,1.0,5/11,17.34%,STAT1;PLXND1;MAML3;MAML2;PBX1
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.6379551725104665,1.0923820581004595,0.37681159420289856,0.8009763526808091,1.0,5/17,19.55%,TBX3;FGFR1;HIF1A;LIMS1;NOTCH4
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Liver,0.5266402029912345,1.0921710056362364,0.38961038961038963,0.8011779282660912,1.0,9/52,12.32%,S1PR1;SGIP1;CACNA1C;ENPP2;VWF;ZNF366;PECAM1;LRRC32;FLT1
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.7284765031971159,1.0920970278150222,0.4393939393939394,0.8009470187894845,1.0,1/5,11.85%,IFNGR1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.6948031402194565,1.092057217682971,0.39344262295081966,0.800086987648711,1.0,2/7,10.23%,RPS27A;RFC3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",0.6948031402194565,1.092057217682971,0.39344262295081966,0.800086987648711,1.0,2/7,10.23%,RPS27A;RFC3
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.7009541624002259,1.0916246909623446,0.35714285714285715,0.8008769972267413,1.0,5/9,23.03%,TBX3;BOC;BTG1;PLCB1;MEF2C
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.47788876870838587,1.0915001905791888,0.27848101265822783,0.8008624234002522,1.0,8/53,9.85%,AKAP12;TIMP3;PLSCR4;DLC1;COL4A2;OGT;MIB1;GJA1
prerank,Reactome_2022__Ribosomal Scanning And Start Codon Recognition R-HSA-72702,0.5896241835703411,1.0913242006481085,0.35294117647058826,0.8009196957599156,1.0,9/24,27.57%,RPS11;RPS9;RPS27A;RPS12;RPS27;EIF3A;EIF5;EIF3H;RPS15
prerank,CellMarker_Augmented_2021__Enterocyte Progenitor cell:Small Intestine,0.6187027303876992,1.0909955002690772,0.4626865671641791,0.8014467775642459,1.0,6/13,13.36%,PNP;ZNF586;SLC2A1;ATP1B3;COMMD1;PON2
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreas,0.5444370559512386,1.090570484991023,0.35714285714285715,0.8021428172181805,1.0,8/31,13.57%,MAP2;MAP1B;HS6ST3;SNAP25;TTLL7;STXBP5L;BCAR1;NOS1AP
prerank,Reactome_2022__Asymmetric Localization Of PCP Proteins R-HSA-4608870,0.601315295833186,1.0904364918543832,0.3783783783783784,0.8021079783176254,1.0,4/17,18.25%,PSMC6;RPS27A;PSMA7;FZD4
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.7028574988623466,1.0904297769382953,0.40625,0.8016627627928014,1.0,2/5,26.85%,AHCYL1;PAPOLA
prerank,CellMarker_Augmented_2021__Villous cytotrophoblast:Placenta,0.6074025725843801,1.0903142975145006,0.3582089552238806,0.8015240748681466,1.0,7/17,27.49%,POLA1;KDM1A;RFC3;NPM1;TMPO;TUBB;HNRNPU
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.7288722461131584,1.0902738905264295,0.42857142857142855,0.8011187660728412,1.0,3/5,14.74%,CFH;CD55;RAC1
prerank,Reactome_2022__Translation R-HSA-72766,0.4899708133348052,1.0900065391493712,0.32926829268292684,0.8014357770257486,1.0,15/73,19.47%,PPA1;RPS11;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;EEF1A1;RPL13A;RPS12;TRAM1;RPS27;EIF3A
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.6522418332972514,-1.0897711037383908,0.4117647058823529,1.0,1.0,2/5,4.65%,SLCO1A2;ABCG2
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.5350681648868312,1.0897470321258758,0.36363636363636365,0.8017264191762101,1.0,7/33,17.18%,TBX3;NES;TIMP3;COL4A2;BCAR1;WWTR1;AFAP1L1
prerank,Reactome_2022__Translesion Synthesis By POLK R-HSA-5655862,0.689480141704899,1.089672571090715,0.45161290322580644,0.8014646047774759,1.0,2/7,10.23%,RPS27A;RFC3
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.5348156051032297,1.0896247887823574,0.3902439024390244,0.8011836219141616,1.0,14/53,19.42%,PPP2R3A;PPM1D;PTPRD;DUSP6;ALPL;DUSP1;SSH1;PPM1A;DUSP16;CTTNBP2NL;PLPP1;PPP1CB;MTMR6;PTPN1
prerank,Reactome_2022__Gap Junction Degradation R-HSA-190873,0.7123687696715102,1.089468932015132,0.3939393939393939,0.8006680307013033,1.0,2/5,21.09%,GJA1;DNM2
prerank,Reactome_2022__Gap Junction Trafficking R-HSA-190828,0.7123687696715102,1.089468932015132,0.3939393939393939,0.8006680307013033,1.0,2/5,21.09%,GJA1;DNM2
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.6586179560662512,1.0892370319895186,0.43478260869565216,0.800932351040254,1.0,1/9,2.74%,BHLHE40
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.5228882515742925,1.0889954083277458,0.35443037974683544,0.8010862618875496,1.0,18/52,23.48%,HYAL2;SMAD7;SMAD5;RPS27A;JUN;LRRC32;FOS;CLDN5;ITGB1;LIMS1;PXN;ZMIZ1;DUSP22;SMAD6;CDH5;UBC;MEF2C;ADAM9
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.5173344039718206,1.0887945905920844,0.37333333333333335,0.8012529385000754,1.0,14/65,17.45%,CCDC3;REL;PINK1;PICALM;KLF4;HIF1A;REST;AGO2;CLDN5;NDFIP1;ATOH8;SDCBP;DIP2A;GATA2
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.6120525898881968,1.0881982271001165,0.3888888888888889,0.8025708946034188,1.0,9/19,26.29%,ARF1;JAK1;HSPA9;ANXA2;PAK2;CFL1;PLCB1;MSN;CDC42
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.5969249002919184,1.088175814005797,0.37681159420289856,0.8021611098828927,1.0,2/22,9.19%,PDK4;LAMP2
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.6482078381884859,-1.0877604071926972,0.4117647058823529,1.0,1.0,1/6,0.24%,CEMIP
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.6482078381884859,-1.0877604071926972,0.4117647058823529,1.0,1.0,1/6,0.24%,CEMIP
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.6577363584016518,1.0876544002263167,0.47761194029850745,0.8031216228243698,1.0,2/10,20.19%,ROBO2;SMAD6
prerank,Reactome_2022__Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,0.5902722909388458,1.0876450095515597,0.34177215189873417,0.801745814963168,1.0,2/16,8.07%,PSMC6;RPS27A
prerank,Reactome_2022__Hh Mutants Are Degraded By ERAD R-HSA-5362768,0.5902722909388458,1.0876450095515597,0.34177215189873417,0.801745814963168,1.0,2/16,8.07%,PSMC6;RPS27A
prerank,Reactome_2022__Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,0.5902722909388458,1.0876450095515597,0.34177215189873417,0.801745814963168,1.0,2/16,8.07%,PSMC6;RPS27A
prerank,KEGG_2021_Human__Renin secretion,0.5718906170381043,1.087617655565998,0.4230769230769231,0.8014086114517566,1.0,2/18,5.15%,ITPR1;CACNA1C
prerank,CellMarker_Augmented_2021__Oogenesis Phase Fetal Germ cell:Fetal Gonad,0.4562410395734658,1.0875838550003996,0.26881720430107525,0.8010589145234301,1.0,41/245,16.57%,SLCO4A1;B3GNT2;ERBB4;RFTN1;ITPR1;ELL2;GRIK2;MDGA2;TBX3;SLC8A1;GLUL;MAP1B;MGAT4A;BAZ1A;EPS8;ESR2;INSIG1;NRXN3;BRI3;ANK3;CDKN1B;MICALL2;CNTNAP2;UNC5C;MYO1E;PECAM1;CCNH;NRXN1;MAP7;AGO2;TRAK1;PON2;NEDD4L;HIP1R;DYSF;RALY;BBS9;NAV2;ADSS2;FRMD3;CADPS2
prerank,Reactome_2022__Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,0.598306143803921,1.0875207491754773,0.359375,0.8007933294695665,1.0,8/19,24.99%,DUSP6;JUND;REST;FOS;TF;DNM2;MEF2C;RPS6KA3
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.6699139544582873,1.0873709020715825,0.4,0.8007983296149555,1.0,1/5,6.75%,ENPP2
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.6799140537680949,1.087367982612588,0.4307692307692308,0.8003402608557627,1.0,1/6,2.82%,NES
prerank,Reactome_2022__Signaling By ALK R-HSA-201556,0.6716331488928584,1.0871859214061925,0.4153846153846154,0.8004483611104801,1.0,3/8,18.57%,PIK3R1;HIF1A;STAT3
prerank,Reactome_2022__Disorders Of Developmental Biology R-HSA-9675151,-0.6104285366577253,-1.0870054151137554,0.4117647058823529,1.0,1.0,2/7,6.77%,TBL1X;TBL1XR1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.6818313271991876,1.086456767597674,0.42424242424242425,0.802168754980465,1.0,3/6,13.52%,SMAD7;MAGI2;ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.701332979470459,1.086454602666071,0.373134328358209,0.8017042681507137,1.0,3/11,13.94%,PIK3R1;DLC1;PAK2
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.6424424734956469,1.086429282372171,0.40350877192982454,0.801330150543413,1.0,1/10,4.14%,TIMP3
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.5266569273023892,1.0861289633506825,0.358974358974359,0.8020658858521716,1.0,8/45,15.25%,ERBB4;CACNA1C;ZFPM2;CDKN1B;CDKN1A;FOXF1;TAB2;FOXC1
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.6079909586824164,1.08598226088356,0.32,0.8020188571723962,1.0,1/17,0.88%,PSMC6
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.662517838246422,1.085844925003277,0.3793103448275862,0.8019526665579352,1.0,4/8,25.95%,RAB21;DNAJC13;MSN;MAP2K1
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.4647286738382818,1.085828421218867,0.32941176470588235,0.8015344574671784,1.0,27/105,22.42%,ANGPTL4;HSPA5;BNIP3L;TBX3;ANXA1;PIK3R1;RPS27A;HSP90B1;HSPA9;NAA16;PAK2;RASA1;MTDH;GOLPH3;GRK5;MALT1;TMBIM6;CFL1;NPM1;SMAD6;BCL2L1;MCL1;TNFAIP8;AVEN;RPL10;SETX;UBC
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.6524704272863198,-1.085798874599467,0.3870967741935484,1.0,1.0,2/5,9.19%,PDGFC;PDGFB
prerank,Reactome_2022__NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,0.6326601476504342,1.0857574657640836,0.40298507462686567,0.8012766818082457,1.0,3/10,9.61%,RPS27A;JAG2;MIB1
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.6403328493788891,-1.085691900296921,0.46153846153846156,1.0,1.0,3/10,3.40%,EIF2AK2;CD74;OAS3
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.5301791678659409,1.0855913546837856,0.4,0.80133892056088,1.0,4/42,7.04%,MTFR1;BCAP31;BNIP3L;PINK1
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Foreskin,0.4781196469059564,1.085401467541341,0.3493975903614458,0.8015416820082482,1.0,18/71,26.24%,SPOPL;EDEM3;PICALM;ACAP2;IFNGR1;STK38;TMF1;TMEM59;TRAM1;VMP1;TMBIM6;HBP1;ARFGEF1;PTBP3;LMBRD1;UBXN4;SEL1L;STXBP3
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.4531029897396637,1.0853198285541346,0.3563218390804598,0.8013035085778502,1.0,30/135,21.59%,ERBB4;TBX3;CALR;CD81;UFL1;FGFR1;RPS9;RPL23;CDKN1B;SMC6;CNBP;FLT1;CNOT6L;CLDN5;ADGRG1;KRAS;WWTR1;RAC1;SDCBP;GRK5;TGM2;GATA2;NAMPT;DYNC1H1;CSPP1;BCLAF1;NPM1;SLFN11;VEGFC;ZFP36
prerank,Reactome_2022__ABC-family Proteins Mediated Transport R-HSA-382556,0.5646202339567965,1.085171009398416,0.35526315789473684,0.8011868920463753,1.0,8/22,26.93%,PSMC6;RPS27A;PSMA7;UBC;ABCG1;SEL1L;PSMB9;VCP
prerank,Reactome_2022__Degradation Of GLI1 By Proteasome R-HSA-5610780,0.5812367599217045,1.0850592648146842,0.37037037037037035,0.8010576504605446,1.0,2/20,8.07%,PSMC6;RPS27A
prerank,Reactome_2022__Regulation Of RAS By GAPs R-HSA-5658442,0.5730830558605947,1.084934338023855,0.40540540540540543,0.8011453400427655,1.0,4/21,16.68%,PSMC6;RPS27A;PSMA7;SPRED1
prerank,Reactome_2022__Generic Transcription Pathway R-HSA-212436,0.4519866382255803,1.0849342536314472,0.24742268041237114,0.8006849116864191,1.0,56/279,20.19%,DDIT4;SERPINE1;GRIA2;PSMC6;BCL6;PCK1;PRKAG2;BNIP3L;ZNF160;PPM1D;PBRM1;LBR;GRIN2B;SMAD7;NDRG1;SIN3B;ESR2;ZNF586;PINK1;CBFB;RPS27A;CDK6;KLF4;CDKN1B;JUN;RFC3;FKBP5;CCNH;SLC2A3;CCNC;CDKN1A;FOS;PPM1A;CNOT6L;AGO2;CLDN5;NEDD4L;SMARCC1;WWTR1;TXNRD1;NCOR2;PSMA7;NR2C1;HDAC7;GATA2;BTG2;LGALS3;ZNF43;NR1D2;PTPN1;NOTCH4;SOCS3;KMT2E;CDK8;NPM1;SMAD6
prerank,Reactome_2022__Striated Muscle Contraction R-HSA-390522,0.7308175438862738,1.084732605358265,0.45454545454545453,0.8007981891575985,1.0,2/6,16.18%,TPM4;DMD
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.650044830799906,1.0846537949412518,0.4153846153846154,0.800529437994479,1.0,6/9,27.14%,RPS27A;AMFR;UGGT2;UBC;SEL1L;UGGT1
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.6798639852535955,1.084506577578454,0.44285714285714284,0.8005408934911783,1.0,5/8,27.49%,ANXA1;REST;ZFP36;ADAM9;HNRNPU
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.5959099342913596,1.0844288076501793,0.3972602739726027,0.8002853134149431,1.0,9/20,26.29%,ARF1;JAK1;HSPA9;ANXA2;PAK2;CFL1;PLCB1;MSN;CDC42
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.6883688498745404,1.0840295050971342,0.36923076923076925,0.8010593797228742,1.0,6/10,23.88%,WNT2B;HYAL2;NFIB;SULF2;MEF2C;CREB3L2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.6111288255146831,1.0839867608007323,0.41333333333333333,0.8007656930838213,1.0,1/12,0.77%,ADAMTS9
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.725640827501373,1.0838845533757824,0.40625,0.8006119713710116,1.0,4/5,24.14%,ANK3;DMD;ATP1B1;WNK1
prerank,Reactome_2022__STAT5 Activation Downstream Of FLT3 ITD Mutants R-HSA-9702518,0.7060563610005178,1.0838056929035214,0.3787878787878788,0.8003949942553173,1.0,4/6,27.65%,GRB2;CDKN1A;BCL2L1;GAB2
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.639073443851226,1.0836949463925916,0.32857142857142857,0.8003177342963416,1.0,7/13,21.06%,BCL6;CDKN1B;TOM1L2;FOXC1;BTG2;BTG1;CHFR
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.7311656382436001,-1.083638415440543,0.42105263157894735,1.0,1.0,3/5,19.92%,PDGFB;PDCD4;NFATC3
prerank,Reactome_2022__G-protein Activation R-HSA-202040,-0.6754377688379081,-1.0833908853890262,0.4838709677419355,1.0,1.0,2/6,16.68%,GNA14;GNB4
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.6095887146823799,1.0832652586722975,0.4266666666666667,0.8012986544767772,1.0,3/16,7.33%,MAP2;FES;NAV3
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.5926895827236778,1.083227205853222,0.4126984126984127,0.8009170181608002,1.0,8/19,27.33%,RFTN1;SDCBP;PLCB1;CSNK2A1;RPS6KA3;CDC42;EGFR;AKAP6
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.6305567471437857,1.0831177798010116,0.3880597014925373,0.800744662839079,1.0,3/15,9.83%,PRKAG2;OGT;HIF1A
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.4922167307222165,1.0829386677671284,0.40229885057471265,0.8008824309401845,1.0,16/66,17.10%,DOK5;LAMA5;ROBO2;PIK3R1;SEMA6B;GRB2;NRXN3;UNC5C;NRXN1;GRB10;RAC1;ALCAM;FEZ2;SEMA3F;PLXNA2;DAG1
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.6257300869743022,1.0826730193825824,0.3835616438356164,0.8011717562785764,1.0,6/12,24.73%,BCAP31;NACC2;BCLAF1;BCL2L1;NCK1;RACK1
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.5608351768134111,1.0823774768857162,0.37662337662337664,0.8016123797820545,1.0,9/21,21.49%,HSPA5;HSPH1;HSP90AA1;HSPA9;HERPUD1;TMBIM6;PTPN1;HSPA8;SERPINH1
prerank,Reactome_2022__Platelet Degranulation R-HSA-114608,0.521449314731702,1.0823098102308424,0.36619718309859156,0.8013516218503848,1.0,10/43,11.18%,SERPINE1;HSPA5;CD9;TIMP3;SYTL4;SRGN;LAMP2;VWF;PECAM1;PIKFYVE
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.7534699451335667,1.0821654819615454,0.41379310344827586,0.8014824202188878,1.0,2/5,17.29%,GJA1;SLC1A2
prerank,Reactome_2022__Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,0.6044418632550357,1.082015790778272,0.4,0.8014995429363448,1.0,6/19,22.42%,PSMC6;RPS27A;HIF1A;PSMA7;EPAS1;UBC
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.5861623279329742,-1.0817627954306268,0.4117647058823529,1.0,1.0,1/9,0.56%,PRIMPOL
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.6736013971445911,1.0816349508810572,0.43283582089552236,0.8019957092586002,1.0,5/8,27.22%,RAC1;PARVB;GSN;CDC42;RHOJ
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.6598130872526979,1.0815446288388644,0.41935483870967744,0.8018424241174336,1.0,1/9,0.74%,MTFR1
prerank,CellMarker_Augmented_2021__CD141+CLEC9A+ Dendritic cell:Blood,0.565847725960107,1.0814988576781468,0.41025641025641024,0.8015382018041373,1.0,10/33,17.21%,BCL6;EHD4;PPA1;NAV1;ZNF366;KIF16B;CTTNBP2NL;NCALD;ACTN1;TGM2
prerank,Reactome_2022__Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,0.5163972780766918,1.0814830560097968,0.37681159420289856,0.8011273484100188,1.0,10/45,11.18%,SERPINE1;HSPA5;CD9;TIMP3;SYTL4;SRGN;LAMP2;VWF;PECAM1;PIKFYVE
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.679933593882283,1.0814052433172736,0.41935483870967744,0.8010062624521227,1.0,2/8,20.61%,CSNK1D;CEP290
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.5882479890249275,1.081307298886432,0.43661971830985913,0.8010173112652118,1.0,3/17,7.84%,LAMC1;BCR;DLC1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.685907566047205,1.0807924650683625,0.4375,0.8018701400200133,1.0,4/9,18.43%,PECAM1;PIKFYVE;LGALS3;PDE4B
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.5805735555424448,1.0804118792743216,0.32,0.8026466612308109,1.0,5/27,9.93%,PSMC6;HSPA5;UBE2J1;HSP90B1;NPLOC4
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.6243829463050422,1.0803462754835815,0.4166666666666667,0.8023304669419813,1.0,5/13,19.39%,GRIK2;INPP5F;ANXA2;SYT1;RIMS2
prerank,Reactome_2022__Platelet Adhesion To Exposed Collagen R-HSA-75892,0.7259909550412342,1.0800337800490625,0.4444444444444444,0.8027483810662123,1.0,6/6,27.52%,ITGA1;VWF;ITGB1;FYN;ITGA10;ITGA2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.6700081329974542,-1.0799986378559134,0.4,1.0,1.0,3/7,11.42%,SHLD1;PARP9;SHLD2
prerank,Reactome_2022__Abacavir ADME R-HSA-2161522,0.6969082071793887,1.0796880303372902,0.4444444444444444,0.803316250590191,1.0,1/5,1.86%,PCK1
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),-0.6413100255278728,-1.0796060898264157,0.38461538461538464,1.0,1.0,1/5,3.13%,GMDS
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.6490278202259865,1.0795521443274898,0.3561643835616438,0.8032194639851719,1.0,2/11,8.37%,PINK1;DUSP1
prerank,Reactome_2022__Nuclear Envelope (NE) Reassembly R-HSA-2995410,0.591210038849449,1.0792998223872057,0.36231884057971014,0.8034420849466778,1.0,8/21,25.82%,LBR;TUBB4B;AHCTF1;TUBA1B;TUBB6;CHMP4B;TMPO;TUBB
prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,0.5586381724809851,1.0792983988260212,0.34177215189873417,0.8029886751921932,1.0,15/31,24.25%,ITPR1;PRKCE;CACNA1C;ATP2B1;ATP1A1;ATP1B3;ADCY2;ATF2;ATP2B4;ADCY9;PLCB1;ATP1B1;SCARB1;CREB3L2;LDLR
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.7515957446808513,1.079288129059669,0.36666666666666664,0.8025670453380711,1.0,5/5,24.94%,APOLD1;ATOH8;NOTCH4;BTG1;ZEB1
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.647231708817148,-1.0790638964216432,0.475,1.0,1.0,1/5,4.20%,ARHGAP12
prerank,Reactome_2022__Insulin Receptor Signaling Cascade R-HSA-74751,0.6260579590846655,1.0788530443836328,0.38095238095238093,0.803389673220306,1.0,4/15,14.32%,FGFR1;PIK3R1;GRB2;GRB10
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.6552749385035936,1.0785104273373578,0.38461538461538464,0.8039115354030648,1.0,2/9,10.31%,SCP2;PITPNC1
prerank,Reactome_2022__Dual Incision In GG-NER R-HSA-5696400,0.694924272023944,1.0784460917129743,0.4067796610169492,0.8036461762406776,1.0,2/6,10.23%,RPS27A;RFC3
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.7241735248929514,1.078418526994816,0.36065573770491804,0.8033374384609338,1.0,3/5,6.91%,RFTN1;VSIR;PRNP
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.5542330263549706,-1.0782687210085993,0.37142857142857144,1.0,1.0,5/12,6.72%,CEMIP;HOMER2;TBL1X;CLIC5;CDC14A
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.5542330263549706,-1.0782687210085993,0.37142857142857144,1.0,1.0,5/12,6.72%,CEMIP;HOMER2;TBL1X;CLIC5;CDC14A
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.6971426480502836,1.0782623339760806,0.42028985507246375,0.8033408530512115,1.0,3/6,25.02%,RAPGEF3;TAOK1;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.7182596791849554,1.078251675096418,0.43478260869565216,0.8029204472562608,1.0,4/5,28.18%,COMMD1;NEDD4L;CAB39;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),-0.6416106132551485,-1.0781305502669583,0.36585365853658536,1.0,1.0,3/5,29.08%,RORA;THRAP3;NLGN1
prerank,Reactome_2022__Signaling By FGFR2 R-HSA-5654738,0.5483280720875773,1.0781210363756784,0.36486486486486486,0.8028742595161397,1.0,3/24,8.31%,PIK3R1;RPS27A;GRB2
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.6445136854579263,1.0776346944995672,0.4375,0.8039549567520247,1.0,5/14,19.76%,SEC22B;PINK1;FEZ2;LIMK2;CHMP4B
prerank,KEGG_2021_Human__Glycosphingolipid biosynthesis,0.6824508849380502,1.0772616264887278,0.4,0.804567783307786,1.0,1/6,0.50%,B3GNT2
prerank,Reactome_2022__Nucleotide Catabolism R-HSA-8956319,0.6617793190043275,1.0771529723291946,0.4444444444444444,0.8043715026325926,1.0,1/7,4.44%,UPP1
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.5499344132112436,-1.077016450519264,0.3333333333333333,1.0,1.0,4/13,10.81%,ALS2;CLCN3;TMCC1;EEA1
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.6888057722853878,1.076635551077525,0.5151515151515151,0.8054619735471263,1.0,1/6,0.90%,CHPT1
prerank,Reactome_2022__Paracetamol ADME R-HSA-9753281,-0.6064114771574565,-1.0763749362423352,0.3902439024390244,1.0,1.0,2/6,4.65%,SLC38A3;ABCG2
prerank,CellMarker_Augmented_2021__Stem cell:Amniotic Membrane,-0.42068155761158865,-1.0761343534202892,0.3333333333333333,1.0,1.0,4/46,1.81%,GBP1;THSD1;ATP10D;PLA2G4A
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.48019999058874685,1.0760052673031137,0.3333333333333333,0.8070978475258883,1.0,11/60,15.51%,RPS11;RPS18;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.5317065314686744,1.0758112367647497,0.37662337662337664,0.8071425985078684,1.0,6/30,12.01%,SLC8A1;TIMP3;PLSCR4;COL4A2;GJA1;FOXF1
prerank,Reactome_2022__Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,0.5744731029161135,1.0756300943954118,0.36486486486486486,0.8073300073743878,1.0,5/17,22.42%,PSMC6;RPS27A;PSMA7;NOTCH4;UBC
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.5747593114252523,-1.075347389131651,0.41025641025641024,1.0,1.0,5/12,20.82%,PDGFB;STX3;CDH13;PRKD1;IL6R
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.6224268226790483,1.0753399035198647,0.37681159420289856,0.8077156457838623,1.0,7/13,24.38%,CDKN1B;JUN;GJA1;CDKN1A;MEF2C;ADAMTS1;PPARG
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.5375806770622676,1.075256719125077,0.3484848484848485,0.8075058683194244,1.0,7/27,15.99%,POLA1;CDK6;CDKN1B;CCNH;CDKN1A;CRLF3;BRD4
prerank,Reactome_2022__Metabolism Of Proteins R-HSA-392499,0.43609340872129576,1.0752139864872352,0.2857142857142857,0.8071476621536045,1.0,86/482,19.47%,LAMC1;B3GNT2;ADAMTS9;PSMC6;SEC22B;FEM1C;CNTN5;MDGA2;CANX;ANK2;PPA1;CALR;RPS11;MGAT4A;EDEM3;LSAMP;SEC24D;WDR48;SMAD7;NFE2L2;RPS9;ERO1A;TUBB4B;DCAF10;TTLL7;ALPL;MCFD2;RAB21;MSRB3;RPS27A;RPL23;KLF4;ANK3;NEGR1;OGT;HSP90B1;MSRA;SMC6;HIF1A;NPLOC4;RAD21;OTUD7B;RGS7;COMMD1;RPL8;RPL34;RPL37;RPLP2;EEF1A1;CD55;PIAS2;TUBA1B;RPL13A;AGTPBP1;TUBB6;ERO1B;UHRF2;RAB30;RPS12;SLC30A7;NCOR2;UBE2B;MGAT5;PSMA7;TRAM1;NR2C1;TNKS;AMFR;TPR;DAG1;RAB2A;HDAC7;TPST2;FUT8;PIGN;TF;STAT3;ARSG;ARFGEF2;ST6GALNAC3;RPS27;CSNK1D;EGFL7;DYNC1H1;USP34;EIF3A
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.678414333704516,1.074889789448209,0.4098360655737705,0.8077246723563579,1.0,4/5,31.98%,CFL1;PLCB1;RACK1;NR2C2
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.630905255288908,1.0747424834424886,0.45714285714285713,0.8076884877442025,1.0,5/11,25.66%,MAP1B;NAV3;ARHGEF2;TAOK1;HDGFL3
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.7138895917838476,1.0744024860604304,0.4126984126984127,0.8082645526898472,1.0,2/5,16.63%,KCNMB4;SYT1
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.6015082705951355,-1.0741751044264762,0.375,1.0,1.0,1/12,0.16%,VCAM1
prerank,Reactome_2022__UCH Proteinases R-HSA-5689603,0.5455221595128075,1.0741667185034485,0.4444444444444444,0.8084938683039251,1.0,4/27,9.03%,PSMC6;SMAD7;RPS27A;OGT
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.7194760528204432,1.0741268132254704,0.4126984126984127,0.8081978799200062,1.0,2/5,13.73%,RPL23;SMARCC1
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.6755882160649549,1.0740886487321684,0.36363636363636365,0.8078898739410061,1.0,1/6,12.91%,AGO2
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.5230510263897381,1.0740050328218274,0.352112676056338,0.8076439124247917,1.0,14/42,29.22%,UFL1;SMAD7;OGT;TRIB2;COMMD1;SDCBP;HERPUD1;CSNK1D;XPO1;RACK1;EIF3H;VCP;TLK2;RNF19A
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),0.6747934800150016,1.0739633402150754,0.45454545454545453,0.8063594380638992,1.0,1/8,3.00%,PPA1
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),0.6747934800150016,1.0739633402150754,0.45454545454545453,0.8063594380638992,1.0,1/8,3.00%,PPA1
prerank,Reactome_2022__tRNA Aminoacylation R-HSA-379724,0.6747934800150016,1.0739633402150754,0.45454545454545453,0.8063594380638992,1.0,1/8,3.00%,PPA1
prerank,Reactome_2022__Role Of LAT2/NTAL/LAB On Calcium Mobilization R-HSA-2730905,0.7181565665969593,1.0738959454615022,0.38461538461538464,0.806139498444969,1.0,5/7,27.65%,PIK3R1;GRB2;FYN;PIK3CB;GAB2
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.675519921684072,1.073876901145005,0.4189189189189189,0.8057598237379711,1.0,1/7,1.30%,CLIC2
prerank,"Reactome_2022__TICAM1,TRAF6-dependent Induction Of TAK1 Complex R-HSA-9014325",0.6880108275454392,1.0736015280702047,0.36507936507936506,0.8046996464287395,1.0,3/5,22.42%,RPS27A;TAB2;UBC
prerank,Reactome_2022__TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,0.6880108275454392,1.0736015280702047,0.36507936507936506,0.8046996464287395,1.0,3/5,22.42%,RPS27A;TAB2;UBC
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex R-HSA-937042,0.6880108275454392,1.0736015280702047,0.36507936507936506,0.8046996464287395,1.0,3/5,22.42%,RPS27A;TAB2;UBC
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex Upon TLR7/8 Or 9 Stimulation R-HSA-975163,0.6880108275454392,1.0736015280702047,0.36507936507936506,0.8046996464287395,1.0,3/5,22.42%,RPS27A;TAB2;UBC
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.6327537590304871,-1.0729212354465425,0.40540540540540543,1.0,1.0,3/6,18.65%,MRPS31;PTCD3;LARS2
prerank,Reactome_2022__TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,0.5717253173294057,1.072895655674005,0.36,0.8063773859234137,1.0,2/21,8.07%,PSMC6;RPS27A
prerank,Reactome_2022__Signal Transduction By L1 R-HSA-445144,0.6324721349646553,1.072876847375732,0.41935483870967744,0.8060233701300388,1.0,4/10,26.40%,FGFR1;ITGB1;MAP2K1;EGFR
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6945368993073742,1.0727701335630677,0.39436619718309857,0.8058965274798136,1.0,5/9,23.88%,WNT2B;NFIB;SULF2;MEF2C;CREB3L2
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.5611651445016029,1.0727553721482017,0.37333333333333335,0.8055064134308749,1.0,5/20,14.45%,PIK3R1;GRB2;BCAR1;KIF16B;ERBIN
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.5884089350743155,1.0726851478183634,0.36363636363636365,0.8052514244956674,1.0,7/21,20.69%,IPO7;CDK6;DUSP1;CDKN1B;FOXC1;BTG2;BTG1
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),0.5998888764260497,1.0726692034656367,0.4375,0.8048559779645629,1.0,2/16,22.18%,YTHDC1;SETX
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.564520408696612,1.0725799048564526,0.43478260869565216,0.8047117119257364,1.0,2/24,7.99%,SEC22B;TMED10
prerank,Reactome_2022__Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.48992491891818973,-1.0723196303956224,0.3333333333333333,1.0,1.0,4/22,7.22%,IFIH1;ISG15;HERC5;TRIM25
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.7177432859430914,1.0721709817444163,0.453125,0.8054477822234555,1.0,2/5,6.27%,NFKBIZ;SMAD7
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Vein,-0.4460007430011275,-1.0720664394276354,0.2857142857142857,1.0,1.0,1/37,0.16%,VCAM1
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.5183637483889901,-1.0718983913647202,0.3870967741935484,1.0,1.0,3/11,7.99%,TPD52L1;DEPTOR;SGMS1
prerank,Reactome_2022__GAB1 Signalosome R-HSA-180292,0.7064661213975586,1.071896322524163,0.42424242424242425,0.805749304233,1.0,2/6,8.31%,PIK3R1;GRB2
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.5877943898799064,1.0717305371878563,0.3770491803278688,0.8057818473054537,1.0,4/17,12.54%,TSG101;GRB2;ITGA1;ZFYVE28
prerank,Reactome_2022__ABC Transporter Disorders R-HSA-5619084,0.5889572692043428,1.0715680795486267,0.32,0.8057716388052532,1.0,8/18,26.93%,PSMC6;RPS27A;PSMA7;UBC;LMBRD1;SEL1L;PSMB9;VCP
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.4774546039978618,1.071525024359268,0.3780487804878049,0.80545039795626,1.0,19/76,19.26%,TBX3;CALR;JUNB;JUND;RASSF1;RPL23;CDK6;DUSP1;CDKN1B;JUN;MAGI2;CDKN1A;UHRF2;CRLF3;SND1;SDCBP;GRK5;STAT3;HBP1
prerank,Reactome_2022__HDMs Demethylate Histones R-HSA-3214842,-0.5609280486327928,-1.071344951350153,0.46153846153846156,1.0,1.0,2/12,8.10%,ARID5B;KDM7A
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.624334348110488,1.0709671636922111,0.4626865671641791,0.8066229178162048,1.0,1/10,0.74%,MTFR1
prerank,Reactome_2022__AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,0.5725758063502868,1.0708025225015734,0.36,0.806667093741219,1.0,2/19,8.07%,PSMC6;RPS27A
prerank,Reactome_2022__ROBO Receptors Bind AKAP5 R-HSA-9010642,0.7058345277828975,1.0705268926097111,0.4918032786885246,0.8071496180678578,1.0,1/5,5.10%,ROBO2
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.49439745962147785,1.069852527988351,0.32894736842105265,0.808812200557011,1.0,17/56,23.03%,ANXA1;HYAL2;SMAD7;KLF4;RAP1A;MAGI2;ACAP2;FLT1;BCAR1;EEF1A1;ACVR2A;FOXC1;LIMS1;DUSP22;ZFP36;SETX;MEF2C
prerank,KEGG_2021_Human__Oxytocin signaling pathway,0.5056936483736335,1.0695038325852335,0.31645569620253167,0.8094694016355791,1.0,17/49,23.16%,ITPR1;PRKAG2;CACNA1C;JUN;MYL6;CDKN1A;FOS;KRAS;ADCY2;PPP1CB;RYR3;ACTB;PPP3CB;ADCY9;PLCB1;MEF2C;PPP3CC
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.5425785927193707,1.0693734771211847,0.3466666666666667,0.8094328953010059,1.0,4/27,8.79%,NRCAM;MAP2;MAP1B;ANK3
prerank,KEGG_2021_Human__Nicotinate and nicotinamide metabolism,0.6996004864648647,1.0693530407451368,0.45454545454545453,0.8090562009345037,1.0,1/5,0.66%,PNP
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.6668111241041575,1.0691054577277734,0.4411764705882353,0.8093903634543358,1.0,3/7,21.22%,SYT1;RIMS2;PPP3CB
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.5718758791839099,1.068981423858359,0.42028985507246375,0.8093782357252645,1.0,5/19,9.03%,INPP5F;FGFR1;PIK3R1;PLCL1;OGT
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.5801130474056175,1.0688433072349541,0.3380281690140845,0.8093479246751636,1.0,3/18,8.82%,TBX3;CALR;CDKN1B
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.7056567395488802,1.068561908092262,0.44776119402985076,0.8097056284436379,1.0,3/5,24.14%,GPM6B;NEDD4;WNK1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.6147631572874093,1.0685582947614372,0.4852941176470588,0.8092752841535231,1.0,4/15,9.03%,SPOPL;UFL1;SMAD7;OGT
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.6532958529276601,1.068481459242629,0.4142857142857143,0.8090028553175408,1.0,5/11,19.42%,DUSP6;DUSP1;DUSP16;DUSP22;PTPN1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.5166832761718589,1.0682884106512647,0.3974358974358974,0.8090938610796361,1.0,19/48,27.76%,ZEB2;PSMC6;GPC5;PPM1A;UBE2B;PSMA7;TNKS;CSNK1G3;CSNK1D;USP34;SULF2;GPRC5B;CSNK2A1;WNK1;PSMB9;EGFR;VCP;SPIN1;XIAP
prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,0.5952061840468045,1.0681738275696502,0.4266666666666667,0.8090032980067466,1.0,8/25,17.10%,PRKAG2;SLC8A1;CACNA1C;TPM4;ITGA1;ITGB1;DMD;DAG1
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.6912153634878216,1.0674721181494775,0.4838709677419355,0.810708402540116,1.0,4/7,25.02%,RAPGEF3;DIP2A;TAOK1;TERF2IP
prerank,Reactome_2022__Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,0.5254094726580878,1.067283781468455,0.4225352112676056,0.8107499909318338,1.0,11/32,24.25%,SGIP1;SCARB2;RPS27A;GRB2;PICALM;SYT1;FZD4;TF;SH3KBP1;UBC;LDLR
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.5495219255686081,1.0671382859045395,0.391304347826087,0.8106345174037694,1.0,5/22,5.68%,GRIA2;MAP2;GPM6B;NPAS3;CTNND2
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.5783900698456712,-1.0670148802711559,0.3870967741935484,1.0,1.0,2/15,2.87%,VCAM1;LEPR
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.6201274327148466,1.0666992132894066,0.43243243243243246,0.8113460759977001,1.0,4/18,11.47%,BCAP31;MAP3K5;GRIN2B;REST
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.5371311588530899,1.0663727884961438,0.45121951219512196,0.8118758844391872,1.0,7/33,10.23%,PSMC6;BAZ1A;PURA;POLA1;RPS27A;NOC3L;RFC3
prerank,CellMarker_Augmented_2021__Central Nervous System Stem cell:Fetal Brain,-0.5450053981071012,-1.0663157052591912,0.38095238095238093,1.0,1.0,8/23,12.67%,CD74;MMRN1;TNFSF10;CLIC5;PROM1;RALGAPA2;MYO15B;FGD5
prerank,CellMarker_Augmented_2021__Stem cell:Pancreas,-0.4273991134186312,-1.0659289972363015,0.47619047619047616,1.0,1.0,2/23,4.30%,SLCO1A2;MIPOL1
prerank,Reactome_2022__Ion Channel Transport R-HSA-983712,0.5160583628846774,1.0657899190845272,0.4268292682926829,0.813086421816924,1.0,10/45,13.47%,CLIC2;TSC22D3;ANO5;ATP8B1;ANO2;RPS27A;ATP2B1;ATP1B3;ANO6;NEDD4L
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.5768968925542908,1.065456208056407,0.4057971014492754,0.8136990721497334,1.0,8/14,33.94%,EEF1A1;FOXC1;DUSP22;ZFP36;EGFR;DAB2IP;GAREM1;IQGAP1
prerank,CellMarker_Augmented_2021__Stem cell:Endometrium,0.7207624987550244,1.0653796124252266,0.5,0.8134678790669998,1.0,3/5,22.15%,PECAM1;ALCAM;CDH5
prerank,Reactome_2022__Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,0.6220323827629051,1.0653774916269985,0.42857142857142855,0.8130322764121137,1.0,5/9,31.45%,CDKN1B;FOS;XPO1;EGFR;PTK2
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Peripheral Blood,-0.45018378196057035,-1.0650850663557379,0.42105263157894735,1.0,1.0,5/40,10.70%,VCAM1;ITIH5;PODN;PROM1;LDB2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.6350839961075998,1.0649832989060442,0.4305555555555556,0.8128701335409764,1.0,4/12,19.76%,LBR;AHCTF1;REEP3;CHMP4B
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.6350839961075998,1.0649832989060442,0.4305555555555556,0.8128701335409764,1.0,4/12,19.76%,LBR;AHCTF1;REEP3;CHMP4B
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.6350839961075998,1.0649832989060442,0.4305555555555556,0.8128701335409764,1.0,4/12,19.76%,LBR;AHCTF1;REEP3;CHMP4B
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.5970431644644655,1.0649776219495362,0.43283582089552236,0.81243579857631,1.0,5/15,21.22%,MAP1B;HSP90AA1;ALCAM;SEMA3F;PPP3CB
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.6654009652266616,-1.0649638615512986,0.4864864864864865,1.0,1.0,1/5,1.81%,PLA2G4A
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),0.5939489491770581,1.064753738435716,0.38571428571428573,0.8126082504743257,1.0,3/16,11.05%,RPS27A;RFC3;CCNH
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.49605535358279523,1.0647290792492705,0.3181818181818182,0.812288525108991,1.0,14/63,18.80%,ARHGAP23;MYO9B;BCR;ARHGAP21;SRGAP1;DLC1;ARHGEF4;GNA13;ECT2;RAC1;TGM2;ARHGEF2;KALRN;FAM13A
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Brain,0.6264899818281672,1.0646366541028822,0.46774193548387094,0.8121430481617021,1.0,5/10,11.58%,GRIA2;CADM2;SNAP25;RALYL;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6516025235776759,1.0644505416090677,0.4603174603174603,0.812243457859458,1.0,5/8,33.81%,PINK1;DCUN1D4;ARRDC3;CDC14B;RAB1A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.7072566678817858,1.064438589407116,0.4406779661016949,0.8118465756679442,1.0,2/6,10.23%,RPS27A;RFC3
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.465609993744952,1.0643108139906492,0.3132530120481928,0.8117374945699446,1.0,19/106,14.74%,PIK3R3;ERBB4;PRKAG2;CD81;RAPGEF3;ENPP2;PRNP;PINK1;HSP90AA1;RB1CC1;RAP1A;PECAM1;CDKN1A;TAB2;ACVR2A;KRAS;PAK2;SH2D3C;RAC1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.5950392277152081,-1.0642173115356397,0.38235294117647056,1.0,1.0,1/10,0.77%,HOMER2
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.5106134914727274,1.0636613653997256,0.345679012345679,0.8131364226092489,1.0,9/46,16.68%,DDIT4;PRKAG2;SMAD7;PRNP;TRIB2;PAK2;WWTR1;DMD;SPRED1
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5781780722904154,1.0634966638462653,0.37662337662337664,0.8131942165925462,1.0,7/25,22.42%,SMAD7;RPS27A;PPM1A;STRAP;SPRED1;SMAD6;UBC
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.5582599670397754,-1.063467495014402,0.42424242424242425,1.0,1.0,1/15,0.13%,GBP1
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.5365828311274209,-1.0633410396284173,0.4074074074074074,1.0,1.0,4/14,8.50%,CD74;ATM;ATR;MDM2
prerank,KEGG_2021_Human__Basal cell carcinoma,0.6392164428770697,1.0630334597597315,0.4142857142857143,0.8142202618924211,1.0,3/13,18.25%,WNT2B;CDKN1A;FZD4
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.5004395573842187,1.0626931896583407,0.3698630136986301,0.8147792276586708,1.0,9/48,17.00%,PRKAG2;CCDC88A;CDKN1B;OGT;HIF1A;CDKN1A;BTBD10;SDCBP;TPR
prerank,Reactome_2022__tRNA Processing R-HSA-72306,-0.50536165588101,-1.0625635757952332,0.4090909090909091,1.0,1.0,4/18,10.86%,RPP38;NUP214;TRMT11;CDKAL1
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.6331831131595582,1.0618748467506085,0.45714285714285713,0.8165795192902718,1.0,4/12,26.29%,PIK3R1;FSCN1;WASL;CDC42
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.6341244523827408,1.0618218959547412,0.43548387096774194,0.8162892153074296,1.0,2/10,7.38%,NES;KDM1A
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,0.707380741150073,1.0614577841000719,0.45614035087719296,0.8169296674599198,1.0,2/5,10.23%,RPS27A;RFC3
prerank,Reactome_2022__RHO GTPases Activate PKNs R-HSA-5625740,0.5699954760817694,1.0610253760353932,0.4305555555555556,0.8177244215498461,1.0,9/22,23.51%,PKN3;KDM1A;MYL6;MYH10;PPP1CB;MYL12B;YWHAB;YWHAE;H3-3B
prerank,Reactome_2022__Host Interactions Of HIV Factors R-HSA-162909,0.5375629311195058,1.0605718903595232,0.4155844155844156,0.8186970607310264,1.0,12/44,23.82%,PSMC6;SGIP1;PACS1;RPS27A;AP1G1;PSMA7;TPR;NPM1;UBC;KPNA1;XPO1;FYN
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.6383110906727368,1.0603731972363677,0.40298507462686567,0.8188230773111085,1.0,4/15,17.45%,ZFPM2;TRIB2;WWTR1;GATA2
prerank,Reactome_2022__Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.6679194605275987,1.0603616136225935,0.4383561643835616,0.8179742537001706,1.0,3/6,26.45%,JUN;YWHAE;CAPN2
prerank,Reactome_2022__Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.6679194605275987,1.0603616136225935,0.4383561643835616,0.8179742537001706,1.0,3/6,26.45%,JUN;YWHAE;CAPN2
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.684744329055344,1.0589553307889732,0.4406779661016949,0.8215427230702016,1.0,3/5,17.58%,PPA1;SULT1C4;TPST2
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.6931272193118186,1.0585367469207592,0.48,0.8223443335360036,1.0,5/7,27.73%,SMAD7;PAK2;ACTB;TBCD;PIP5K1C
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.6163480551567022,-1.0583648970074129,0.4444444444444444,1.0,1.0,1/8,0.13%,GBP1
prerank,CellMarker_Augmented_2021__Myofibroblast:Liver,-0.4375652515066911,-1.0583420200248959,0.3333333333333333,1.0,1.0,1/27,0.16%,VCAM1
prerank,KEGG_2021_Human__Ovarian steroidogenesis,-0.5719846391074314,-1.0579196625656444,0.4827586206896552,1.0,1.0,2/10,3.98%,PLA2G4A;BMP6
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.46853185284229143,-1.0578519102935824,0.3333333333333333,1.0,1.0,3/26,5.92%,PGM5;TTN;EPB41L5
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.6399144040756175,1.057523060758141,0.46774193548387094,0.8247842013551525,1.0,2/6,15.19%,ESR2;PLPP1
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.683525737391519,1.0573825912709964,0.4375,0.8247166138235421,1.0,2/5,5.92%,CHPT1;DHRS7B
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,0.4933309524587828,1.0572705073083897,0.3625,0.8246253687317371,1.0,14/50,17.66%,PIK3R3;RAPGEF3;PIK3R1;CTNNA3;CTNNA1;RAP1A;PECAM1;BCAR1;CLDN5;ITGB1;RAC1;ACTN1;PXN;MYL12B
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.5062755990421903,1.0572030652755455,0.38666666666666666,0.8244097059533445,1.0,10/41,17.10%,LAMC1;PLS3;NES;TIMP3;COL4A2;BOC;BCAR1;WWTR1;DMD;DAG1
prerank,Reactome_2022__Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,-0.570931398527368,-1.0570140973284563,0.4,1.0,1.0,1/10,2.58%,PLCB4
prerank,Reactome_2022__ER To Golgi Anterograde Transport R-HSA-199977,0.5045119603270252,1.0568498902514536,0.41333333333333333,0.8248817047583313,1.0,5/43,8.79%,SEC22B;ANK2;SEC24D;MCFD2;ANK3
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.6817981795182009,1.0568439660763962,0.45161290322580644,0.8244529087501984,1.0,1/7,8.29%,CDK6
prerank,CellMarker_Augmented_2021__Stem cell:Limbal Epithelium,0.5311435416012462,1.0565593551123644,0.4025974025974026,0.8239380183747483,1.0,14/35,27.36%,TIMP3;PLOD2;PLSCR4;MYO1B;DLC1;MAP7;PON2;TM4SF18;EPAS1;ATP1B1;PPARG;WASL;EGFR;TM4SF1
prerank,CellMarker_Augmented_2021__Corneal Epithelial Progenitor cell:Embryonic Stem Cell,0.5311435416012462,1.0565593551123644,0.4025974025974026,0.8239380183747483,1.0,14/35,27.36%,TIMP3;PLOD2;PLSCR4;MYO1B;DLC1;MAP7;PON2;TM4SF18;EPAS1;ATP1B1;PPARG;WASL;EGFR;TM4SF1
prerank,CellMarker_Augmented_2021__Stem cell:Lacrimal Gland,0.5311435416012462,1.0565593551123644,0.4025974025974026,0.8239380183747483,1.0,14/35,27.36%,TIMP3;PLOD2;PLSCR4;MYO1B;DLC1;MAP7;PON2;TM4SF18;EPAS1;ATP1B1;PPARG;WASL;EGFR;TM4SF1
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Abdominal Adipose Tissue,0.6991990514190142,1.0565126050185432,0.421875,0.8231546025961224,1.0,2/6,12.96%,NES;SHC2
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Abdominal Adipose Tissue,0.6991990514190142,1.0565126050185432,0.421875,0.8231546025961224,1.0,2/6,12.96%,NES;SHC2
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.5892731074585472,1.0564350429745428,0.47058823529411764,0.8229701618689526,1.0,4/16,20.37%,TRIM5;PELI1;UBE2B;NEDD4
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.5008520868068485,-1.0561560262182255,0.3684210526315789,1.0,1.0,2/27,0.72%,GBP1;GBP2
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.6699191440422962,1.0561438634319136,0.3442622950819672,0.8233465028417819,1.0,4/7,30.44%,ATP1A1;TFPI;ABHD2;UBE3A
prerank,Reactome_2022__tRNA Modification In Nucleus And Cytosol R-HSA-6782315,0.6712609653184813,1.0557314334493701,0.42424242424242425,0.8241942642504604,1.0,1/7,3.82%,TRMT9B
prerank,CellMarker_Augmented_2021__CD1C+ A Dendritic cell:Blood,0.7236618232225352,1.0555985223040973,0.5,0.824062616590504,1.0,2/6,11.31%,CLIC2;SLC2A3
prerank,CellMarker_Augmented_2021__Progenitor cell:Embryonic Stem Cell,0.6044340339177838,1.0555451726312242,0.4430379746835443,0.8211071367668291,1.0,3/15,14.58%,PTPRD;PPP1R9A;VWA2
prerank,CellMarker_Augmented_2021__Neural Stem cell:Bone Marrow,0.6044340339177838,1.0555451726312242,0.4430379746835443,0.8211071367668291,1.0,3/15,14.58%,PTPRD;PPP1R9A;VWA2
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Pancreas,0.6044340339177838,1.0555451726312242,0.4430379746835443,0.8211071367668291,1.0,3/15,14.58%,PTPRD;PPP1R9A;VWA2
prerank,CellMarker_Augmented_2021__Dermal Papilla cell:Hair Follicle,0.6044340339177838,1.0555451726312242,0.4430379746835443,0.8211071367668291,1.0,3/15,14.58%,PTPRD;PPP1R9A;VWA2
prerank,CellMarker_Augmented_2021__Early Hematopoietic cell:Blood,0.6044340339177838,1.0555451726312242,0.4430379746835443,0.8211071367668291,1.0,3/15,14.58%,PTPRD;PPP1R9A;VWA2
prerank,CellMarker_Augmented_2021__Ductal cell:Pancreas,0.6044340339177838,1.0555451726312242,0.4430379746835443,0.8211071367668291,1.0,3/15,14.58%,PTPRD;PPP1R9A;VWA2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Larynx,0.6044340339177838,1.0555451726312242,0.4430379746835443,0.8211071367668291,1.0,3/15,14.58%,PTPRD;PPP1R9A;VWA2
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.685665725792381,1.0553167336853426,0.47058823529411764,0.8213181212176384,1.0,3/6,26.24%,REST;SYT1;STXBP3
prerank,KEGG_2021_Human__Salivary secretion,0.5730425571813287,1.0547383868915503,0.4268292682926829,0.8223912659752279,1.0,10/21,22.87%,ITPR1;ATP2B1;ATP1A1;ATP1B3;ADCY2;RYR3;ATP2B4;ADCY9;PLCB1;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.6568075613705386,-1.0546092394294566,0.40540540540540543,1.0,1.0,2/5,11.42%,SHLD1;SHLD2
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,0.48113863023462444,1.0543529106540286,0.4050632911392405,0.8230469705995777,1.0,10/55,15.51%,RPS11;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12
prerank,Reactome_2022__Signaling By NODAL R-HSA-1181150,0.6957904750754029,1.0542447012037228,0.4576271186440678,0.8228873929576321,1.0,1/5,13.52%,ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.5461058467821129,1.054081156834206,0.425,0.8229622742200473,1.0,5/31,16.02%,PSMC6;CDK6;KLF4;CDKN1A;PSMA7
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.4428394372371346,1.0540350609144669,0.4065934065934066,0.822703388997652,1.0,33/129,22.42%,ANGPTL4;PDK4;HSPA5;BNIP3L;TBX3;ANXA1;PIK3R1;CPEB4;PINK1;RPS27A;KLF4;HSP90B1;HSPA9;ITGB1;NAA16;PAK2;RASA1;MTDH;GOLPH3;GRK5;MALT1;TMBIM6;CFL1;NPM1;SMAD6;BCL2L1;MCL1;TNFAIP8;AVEN;RPL10;SETX;YWHAE;UBC
prerank,Reactome_2022__Plasma Lipoprotein Clearance R-HSA-8964043,0.6387552313759817,1.0535827811185103,0.3466666666666667,0.823480417433391,1.0,5/11,24.25%,RPS27A;HDLBP;UBC;SCARB1;LDLR
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.5275803929290905,-1.0534301468076332,0.43478260869565216,1.0,1.0,1/9,1.27%,SLC38A3
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.674543254261221,1.0534083082913182,0.44285714285714284,0.8236367392941564,1.0,1/8,2.92%,ANK2
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.6649656685566524,1.0533527246007999,0.4838709677419355,0.8234422019194297,1.0,4/8,28.95%,WAPL;TERF2IP;YLPM1;SMG1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.5268813541904384,1.053156278366696,0.3950617283950617,0.8235399609161934,1.0,10/39,19.44%,ZEB2;PSMC6;GPC5;PPM1A;UBE2B;PSMA7;TNKS;CSNK1G3;CSNK1D;USP34
prerank,Reactome_2022__Translesion Synthesis By POLI R-HSA-5656121,0.6895677554161078,1.0531280040797795,0.4918032786885246,0.8227314335297911,1.0,2/6,10.23%,RPS27A;RFC3
prerank,Reactome_2022__Translesion Synthesis By REV1 R-HSA-110312,0.6895677554161078,1.0531280040797795,0.4918032786885246,0.8227314335297911,1.0,2/6,10.23%,RPS27A;RFC3
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),0.5983896482333402,1.0530390505350162,0.41935483870967744,0.8225902751946037,1.0,4/15,12.54%,TSG101;GRB2;ITGA1;ZFYVE28
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.7178951871570285,1.0527057608094053,0.46153846153846156,0.8227745218722868,1.0,1/5,5.23%,PPHLN1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.7178951871570285,1.0527057608094053,0.46153846153846156,0.8227745218722868,1.0,1/5,5.23%,PPHLN1
prerank,Reactome_2022__Aggrephagy R-HSA-9646399,0.6180268875231443,1.0524536741861035,0.46153846153846156,0.8231285538899563,1.0,6/10,28.98%,HSP90AA1;RPS27A;DYNC1H1;UBC;VCP;DYNC1I2
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.5811970628623985,1.0523672721840651,0.391304347826087,0.8229001780647318,1.0,5/13,26.40%,AGO2;STAT3;ZFP36;MAP2K1;EGFR
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.4985518035173306,1.05228287534612,0.3950617283950617,0.8227360322647354,1.0,12/46,22.15%,TIMP3;PLSCR4;ARID5A;COL4A2;VWF;TNS1;PARVB;PLXNA2;GSN;EPAS1;CALD1;CDH5
prerank,Reactome_2022__G Alpha (Z) Signaling Events R-HSA-418597,0.6131659924653318,1.0516987488232907,0.44285714285714284,0.8239384090928423,1.0,5/12,27.97%,PRKCE;ADCY2;ADCY9;PRKCH;GNAI3
prerank,Reactome_2022__Circadian Clock R-HSA-400253,0.5226762808294051,1.051450788567418,0.4117647058823529,0.824308522531376,1.0,11/35,18.88%,SERPINE1;BHLHE40;CRTC3;RPS27A;HIF1A;CREM;PPP1CB;NPAS2;NAMPT;CRY1;CSNK1D
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.5623365585150045,1.0514491430182906,0.37662337662337664,0.8238767213147541,1.0,9/20,23.08%,TIMP3;MSRB3;COL4A2;FOXF1;PLAT;VEGFC;SERPINH1;CALD1;ADAMTS1
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.5965191297445142,1.051380536422484,0.45714285714285713,0.823660161871328,1.0,7/15,24.14%,ANK3;ATP1A1;NEDD4L;SYT1;TF;NEDD4;WNK1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.6421248536789689,1.051186212995333,0.36923076923076925,0.8236759125637249,1.0,1/11,4.20%,VAPB
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Pluripotent Stem Cell,0.5351971833130386,1.0507360317259107,0.42105263157894735,0.8244165283682884,1.0,11/22,24.17%,SLC8A1;GAS7;CCDC149;DYSF;TNS1;KCTD12;PSAP;IFNGR2;GSN;SPARC;RNF130
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.5140188760386719,1.050636100100273,0.41025641025641024,0.8243391308703296,1.0,11/36,19.04%,MT1M;PRNP;MT2A;ANK3;CDKN1B;JUN;FOS;ECT2;SYT1;TF;RYR3
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.4044073921008862,-1.0504575415051678,0.2631578947368421,1.0,1.0,1/30,0.13%,GBP1
prerank,KEGG_2021_Human__Hedgehog signaling pathway,0.5749383026446716,1.050277890969024,0.4657534246575342,0.8249975243694331,1.0,4/17,18.88%,SPOPL;BOC;CSNK1G3;CSNK1D
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.4201183889116999,-1.0502239439758068,0.36666666666666664,1.0,1.0,7/42,9.93%,PKHD1L1;GBP2;COBLL1;LAMA3;PTPN21;ST3GAL1;FN1
prerank,Reactome_2022__Caspase-mediated Cleavage Of Cytoskeletal Proteins R-HSA-264870,0.6824441646977976,1.050169478778345,0.4657534246575342,0.8249025344081296,1.0,3/5,25.26%,GSN;PLEC;ADD1
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6625713049932576,1.0499696540989387,0.4461538461538462,0.8250449083922125,1.0,1/8,8.63%,KLF4
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.6407259109481993,-1.0497818371095045,0.5,1.0,1.0,1/5,1.89%,CWC27
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.6407259109481993,-1.0497818371095045,0.5,1.0,1.0,1/5,1.89%,CWC27
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Liver,-0.4080424511746584,-1.0497253114037688,0.36363636363636365,1.0,1.0,6/60,7.25%,SAMD9L;IFIH1;DDX60L;SP100;ZC3HAV1;SP140L
prerank,Reactome_2022__Ephrin Signaling R-HSA-3928664,0.6640108473599409,1.0496671794848929,0.4189189189189189,0.8255110337706466,1.0,4/7,30.12%,SDCBP;FYN;EFNB2;MYL12A
prerank,Reactome_2022__Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.5364318500959959,-1.0495156802774743,0.3939393939393939,1.0,1.0,3/11,8.58%,GMDS;ST3GAL6;ST3GAL1
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.5393291208610872,1.0492814467013956,0.45569620253164556,0.8261327577131821,1.0,14/41,25.07%,KHDRBS3;PIK3R1;YTHDC1;PTBP2;SLC38A2;AHNAK;PRX;HNRNPH3;TRA2B;TMBIM6;ZNF326;SETX;PTBP3;CWC22
prerank,CellMarker_Augmented_2021__Multilymphoid Progenitor cell:Umbilical Cord Blood,0.44597546470963,1.0489198842474545,0.4044943820224719,0.8266267199044124,1.0,23/156,9.00%,NRCAM;PCDH9;BCL6;NEDD9;SYN3;GRIK1;AFF3;MDGA2;CADM2;JUNB;TSC22D3;CSMD1;PDE7A;MYO9B;SGIP1;CACNA1C;PIK3R1;SIN3B;TTC13;SMIM3;JUND;DUSP1;NEGR1
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.5337012376414931,1.0486882157653925,0.4025974025974026,0.8269007217323511,1.0,10/35,22.12%,PLS3;NES;COL4A2;GJA1;WWTR1;CTTNBP2NL;PLAT;VEGFC;SERPINH1;CALD1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.6709891005566522,-1.0482033515617686,0.4594594594594595,1.0,1.0,2/6,11.45%,CD74;MCU
prerank,CellMarker_Augmented_2021__Glial cell:Brain,0.5592867811005166,1.0477580014331704,0.5,0.8276250562178938,1.0,3/16,4.91%,GRIA2;CADM2;GRIN2B
prerank,CellMarker_Augmented_2021__Schwann cell:Intervertebral Disc,0.5592867811005166,1.0477580014331704,0.5,0.8276250562178938,1.0,3/16,4.91%,GRIA2;CADM2;GRIN2B
prerank,CellMarker_Augmented_2021__Astrocyte:Spinal Cord,0.5592867811005166,1.0477580014331704,0.5,0.8276250562178938,1.0,3/16,4.91%,GRIA2;CADM2;GRIN2B
prerank,CellMarker_Augmented_2021__Glial cell:Sympathetic Ganglion,0.5592867811005166,1.0477580014331704,0.5,0.8276250562178938,1.0,3/16,4.91%,GRIA2;CADM2;GRIN2B
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.6765959472430331,1.0476619554677191,0.5,0.8274946354177144,1.0,2/7,22.47%,PINK1;SREBF2
prerank,KEGG_2021_Human__Salmonella infection,0.46390170993673874,1.047524334597376,0.3875,0.8275831122368174,1.0,33/89,27.62%,ARF1;GAPDH;TUBB4B;HSP90AA1;AHNAK;HSP90B1;JUN;ANXA2;FOS;ARPC2;TAB2;MAPK10;ACBD3;TUBA1B;RAC1;TUBB6;KPNA4;MYL12B;PODXL;ABI1;DYNC1H1;ACTB;TNFRSF10B;DNM2;KPNA3;KPNA1;TUBB;MAP2K1;WASL;CDC42;RHOJ;PIK3C3;PIK3CB
prerank,Reactome_2022__HCMV Early Events R-HSA-9609690,-0.45921761426773294,-1.0474299935845341,0.4444444444444444,1.0,1.0,4/27,6.77%,TBL1X;H2AC6;NUP214;TBL1XR1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.54540585205259,1.0474248105687864,0.484375,0.8274240790037097,1.0,7/25,26.40%,RAPGEF3;PINK1;HSP90AA1;SH2D3C;ATP2B4;TERF2IP;EGFR
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.5705678847714675,1.047274422416063,0.4166666666666667,0.827345723731806,1.0,7/22,18.38%,SERPINE1;SPOCK1;DUSP1;RASA1;PLXNA2;FZD4;PODXL
prerank,CellMarker_Augmented_2021__Hepatic Progenitor-Like cell:Pluripotent Stem Cell,0.6335762425100674,1.0469406432674495,0.5151515151515151,0.8278364964010403,1.0,4/12,20.29%,DUSP6;ALPL;TNS1;GSN
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.47080786568355326,-1.0468245042757012,0.38095238095238093,1.0,1.0,3/21,8.53%,IRF1;PARP9;SAMHD1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.6010115516194058,-1.0467957928984966,0.48148148148148145,1.0,1.0,1/5,3.98%,BMP6
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.5542430417393822,1.0466410389777807,0.3972602739726027,0.828148666481099,1.0,6/24,19.76%,ANK3;MYH10;SPIRE1;RASA1;ECT2;CHMP4B
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.6987193413233879,1.0460746854795757,0.5344827586206896,0.8288179493377245,1.0,1/5,6.93%,TUBB4B
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.6987193413233879,1.0460746854795757,0.5344827586206896,0.8288179493377245,1.0,1/5,6.93%,TUBB4B
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.5208110319376164,1.0460394550981482,0.4444444444444444,0.8284924254103909,1.0,7/29,24.30%,ADM;GGT5;ADCY2;LGALS3;ADCY9;FYN;FGR
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.5995183462156286,-1.0456327222597903,0.41025641025641024,1.0,1.0,3/7,21.49%,HLA-F;HLA-A;NECTIN2
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.565935613643348,1.045316300783222,0.47560975609756095,0.8301222205199373,1.0,9/27,17.66%,DTNA;SLC8A1;TPM4;ITGA1;MYL6;DYSF;DMD;PXN;MYL12B
prerank,CellMarker_Augmented_2021__CD1C+ B Dendritic cell:Blood,0.6825983527317175,1.045064740045986,0.5384615384615384,0.8303693713488572,1.0,3/7,11.31%,ANXA1;ADAM15;SLC2A3
prerank,CellMarker_Augmented_2021__Endoderm Progenitor cell:Adipose Tissue,-0.44638209242866494,-1.0450152657698497,0.3181818181818182,1.0,1.0,3/41,2.52%,GBP4;CD74;MMRN1
prerank,Reactome_2022__RNA Polymerase II Transcription R-HSA-73857,0.43569657421100527,1.0448789885139624,0.3673469387755102,0.8304673606025734,1.0,60/311,20.19%,DDIT4;SERPINE1;GRIA2;PSMC6;BCL6;ELL2;PCK1;PRKAG2;BNIP3L;ZNF160;PPM1D;PBRM1;LBR;GRIN2B;AFF4;SMAD7;NDRG1;SIN3B;ESR2;ZNF586;PINK1;CBFB;RPS27A;CDK6;KLF4;CDKN1B;JUN;RFC3;FKBP5;CCNH;SLC2A3;CCNC;CDKN1A;FOS;PPM1A;CNOT6L;AGO2;CLDN5;NEDD4L;SMARCC1;WWTR1;TXNRD1;SRSF7;NCOR2;PSMA7;NR2C1;HDAC7;GATA2;BTG2;LGALS3;CSTF3;ZNF43;NR1D2;PTPN1;NOTCH4;SOCS3;KMT2E;CDK8;NPM1;SMAD6
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.6387662592449941,1.0447286193062553,0.4090909090909091,0.8304679371626694,1.0,4/11,14.18%,NRCAM;FGFR1;REST;ECT2
prerank,Reactome_2022__COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.4948436694800997,-1.0444809131441821,0.375,1.0,1.0,4/17,14.05%,PLA2G4A;BICD1;AGPAT3;DCTN4
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.6428856590927534,1.0440977004969634,0.463768115942029,0.8315841575083182,1.0,4/9,24.38%,CDKN1B;CDKN1A;MEF2C;PPARG
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.47575189892028247,1.043877002126507,0.3670886075949367,0.8317499882840976,1.0,21/53,31.39%,GLUL;RPS9;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS27;NPM1;RPL10;XPO1;RPL37A;RPL21;RPLP1;RPS15;WDR43;MTREX;XRN2;RPL24;RPS7
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4467615014956563,-1.0436236828943797,0.3076923076923077,1.0,1.0,2/23,5.42%,EIF2AK2;NOD1
prerank,CellMarker_Augmented_2021__Macrophage:Subcutaneous Adipose Tissue,-0.623710632382952,-1.0432316710751026,0.5142857142857142,1.0,1.0,3/6,14.42%,GIMAP8;TNFRSF1B;GIMAP4
prerank,CellMarker_Augmented_2021__Monocyte:Subcutaneous Adipose Tissue,-0.623710632382952,-1.0432316710751026,0.5142857142857142,1.0,1.0,3/6,14.42%,GIMAP8;TNFRSF1B;GIMAP4
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Brain,-0.623710632382952,-1.0432316710751026,0.5142857142857142,1.0,1.0,3/6,14.42%,GIMAP8;TNFRSF1B;GIMAP4
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Peripheral Blood,-0.623710632382952,-1.0432316710751026,0.5142857142857142,1.0,1.0,3/6,14.42%,GIMAP8;TNFRSF1B;GIMAP4
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.6450636551968342,1.0432030689279757,0.5,0.8332930486636101,1.0,3/8,21.65%,CANX;SYT1;SYNJ2
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.6422930049462939,1.042860465104693,0.4931506849315068,0.8337148866221812,1.0,3/9,21.65%,CANX;SYT1;SYNJ2
prerank,Reactome_2022__Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,0.5352370191028184,1.0427905706222895,0.3835616438356164,0.8334625728040286,1.0,11/29,26.29%,MYO9B;HSP90AA1;GRB2;MYO1E;ARPC2;CRK;ABI1;WIPF1;NCK1;WASL;CDC42
prerank,Reactome_2022__Regulation Of PTEN Gene Transcription R-HSA-8943724,0.5734857474350408,1.0427870008202118,0.4189189189189189,0.8330393227865107,1.0,7/22,26.14%,KDM1A;JUN;REST;HDAC7;PPARG;MTOR;SLC38A9
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.6397766988349555,1.0424896450043972,0.43103448275862066,0.8334777510631383,1.0,3/6,24.14%,FOXC1;OXSR1;WNK1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.5293636477209205,1.0423882949006382,0.4788732394366197,0.8333057576150363,1.0,2/24,2.84%,WNT2B;ZNF160
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.6774746914780236,1.0423654044005803,0.463768115942029,0.8329288225386159,1.0,2/7,16.68%,SMAD7;SPRED1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.6703880424675174,1.0422066380703094,0.4925373134328358,0.8329964695854424,1.0,3/6,25.37%,GRIN2B;FYN;PSMB9
prerank,KEGG_2021_Human__Protein export,0.6535923760419955,1.042080937079173,0.484375,0.8329103663289851,1.0,1/7,1.99%,HSPA5
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.5875442045396283,1.0419643473684854,0.5128205128205128,0.8327674617994878,1.0,6/11,24.14%,ANK3;ATP1A1;NEDD4;ATP2B4;AHCYL1;WNK1
prerank,CellMarker_Augmented_2021__Endothelial cell:Bone Marrow,-0.6398369063773683,-1.0417737452970535,0.5,1.0,1.0,1/7,0.16%,VCAM1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.6469284954449235,1.041751455699435,0.44285714285714284,0.832840773568553,1.0,4/8,33.81%,RPL23;CDC14B;RPS7;RAB1A
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.5351719004415503,1.0416726396174087,0.425,0.8326923680718864,1.0,14/31,27.33%,RAPGEF3;CPEB4;SSH1;CTNNA1;HSP90B1;RAP1A;GOLPH3;RYR3;ACTB;MEF2C;MTOR;SLC38A9;CAPN2;AKAP6
prerank,Reactome_2022__Transcriptional Regulation By RUNX2 R-HSA-8878166,0.5093288432933343,1.0415652383395397,0.4823529411764706,0.8325497948496872,1.0,8/39,17.85%,PSMC6;PPM1D;CBFB;RPS27A;CDKN1A;WWTR1;PSMA7;LGALS3
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.6349610839259603,1.0414088477368508,0.42424242424242425,0.8325265911669383,1.0,2/5,16.79%,NAA16;NAA50
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.5175787889059391,1.0413541748047423,0.38028169014084506,0.8322083421369495,1.0,8/41,11.29%,LRRC7;FES;IL1RAPL1;PTPRD;ROBO2;SCARB2;RAP1A;MAGI2
prerank,Reactome_2022__Small Interfering RNA (siRNA) Biogenesis R-HSA-426486,0.6989827688575505,1.0411025786029677,0.4918032786885246,0.8323554819442679,1.0,1/5,12.91%,AGO2
prerank,CellMarker_Augmented_2021__Eosinophil:Sputum,0.5811127908950553,1.0406856939124403,0.4605263157894737,0.8329559595950053,1.0,3/18,16.10%,CD9;CTNNA1;SEMA3F
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.5195295409647176,1.0398034447442486,0.45,0.834949587517243,1.0,11/33,25.44%,CCDC88A;PINK1;PAK2;ECT2;ADCY2;MALT1;TNFRSF10B;TAOK1;ADCY9;EMP2;MTOR
prerank,Reactome_2022__Interleukin-1 Signaling R-HSA-9020702,0.480783347873123,1.0397374324914492,0.42857142857142855,0.834749670235912,1.0,6/39,16.02%,PSMC6;RPS27A;PELI1;TAB2;ALPK1;PSMA7
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.6787387615570157,1.0395654535633685,0.5076923076923077,0.8348046535819764,1.0,2/5,19.12%,RAP1A;SLC30A1
prerank,Reactome_2022__Nef Mediated Downregulation Of MHC Class I Complex Cell Surface Expression R-HSA-164940,0.7169869068341697,1.039473776428458,0.41509433962264153,0.8346446134893521,1.0,2/5,14.10%,PACS1;AP1G1
prerank,CellMarker_Augmented_2021__Mesoderm cell:Undefined,0.6280062065797523,1.0394306084501528,0.4189189189189189,0.8342981496592888,1.0,2/9,6.45%,HYAL2;TMEM184B
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.6244174290383755,1.0394026257833244,0.4925373134328358,0.833952039003364,1.0,1/10,3.40%,MAP3K5
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.6406646471872622,1.039289508129664,0.48484848484848486,0.8338435133446457,1.0,4/7,29.99%,PRNP;TRAM1;EGFR;VAPA
prerank,Reactome_2022__Dual Incision In TC-NER R-HSA-6782135,0.5940302178727884,1.0391586012173721,0.4393939393939394,0.8329433421943777,1.0,3/15,11.05%,RPS27A;RFC3;CCNH
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,0.5940302178727884,1.0391586012173721,0.4393939393939394,0.8329433421943777,1.0,3/15,11.05%,RPS27A;RFC3;CCNH
prerank,Reactome_2022__Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,0.5940302178727884,1.0391586012173721,0.4393939393939394,0.8329433421943777,1.0,3/15,11.05%,RPS27A;RFC3;CCNH
prerank,CellMarker_Augmented_2021__Inflammatory cell:Muscle,-0.46347964015419424,-1.0390878804704515,0.4230769230769231,1.0,1.0,8/35,12.70%,GBP4;MMRN1;APOL3;GIMAP8;TNFRSF1B;CFLAR;FGD5;RASGRP3
prerank,CellMarker_Augmented_2021__Endothelial cell:Lymph Node,-0.46347964015419424,-1.0390878804704515,0.4230769230769231,1.0,1.0,8/35,12.70%,GBP4;MMRN1;APOL3;GIMAP8;TNFRSF1B;CFLAR;FGD5;RASGRP3
prerank,CellMarker_Augmented_2021__Immature Endothelial cell:Subcutaneous Adipose Tissue,-0.46347964015419424,-1.0390878804704515,0.4230769230769231,1.0,1.0,8/35,12.70%,GBP4;MMRN1;APOL3;GIMAP8;TNFRSF1B;CFLAR;FGD5;RASGRP3
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Subcutaneous Adipose Tissue,-0.46347964015419424,-1.0390878804704515,0.4230769230769231,1.0,1.0,8/35,12.70%,GBP4;MMRN1;APOL3;GIMAP8;TNFRSF1B;CFLAR;FGD5;RASGRP3
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.6697320240217117,1.0390562617891457,0.44642857142857145,0.8328919190710493,1.0,3/6,29.75%,PLPP1;ACER3;SPTLC2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Undefined,-0.4549135008603685,-1.0387470074226217,0.375,1.0,1.0,1/31,0.16%,VCAM1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),0.6160404839061797,1.0386321542448924,0.49230769230769234,0.8336574838630814,1.0,5/12,20.66%,SMAD7;JAK1;ANK3;PODXL;AFDN
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Undefined,0.6498365043458084,1.0385257893669622,0.5254237288135594,0.8335550696811835,1.0,5/8,18.38%,CD9;ALPL;PECAM1;ITGB1;PODXL
prerank,Reactome_2022__Beta-catenin Independent WNT Signaling R-HSA-3858494,0.4931887973761482,1.0385236764870576,0.4418604651162791,0.8331375735995011,1.0,9/53,22.42%,PSMC6;ITPR1;RPS27A;AGO2;PSMA7;FZD4;PPP3CB;PLCB1;UBC
prerank,Reactome_2022__Syndecan Interactions R-HSA-3000170,0.6389119523795496,1.0381987510008739,0.46875,0.833704957287656,1.0,4/8,30.94%,ITGB1;ACTN1;ITGA2;CASK
prerank,Reactome_2022__Clathrin-mediated Endocytosis R-HSA-8856828,0.49234642472079204,1.0378904875008295,0.463768115942029,0.8341424454844254,1.0,22/54,30.41%,SGIP1;SCARB2;RPS27A;GRB2;PICALM;ARPC2;HIP1R;SYT1;FZD4;TF;SH3KBP1;HSPA8;DNM2;SYNJ2;UBC;LDLR;WASL;EGFR;PIP5K1C;SH3GL1;ACTR2;SNX9
prerank,CellMarker_Augmented_2021__Paneth cell:Undefined,0.6068663276595789,1.037867749362828,0.43548387096774194,0.8337646248380239,1.0,3/11,15.19%,SCP2;PEBP1;PLPP1
prerank,KEGG_2021_Human__Cushing syndrome,0.5067126322507159,1.0376529514995754,0.5,0.8338365401301407,1.0,19/45,28.18%,ITPR1;WNT2B;CACNA1C;CDK6;CDKN1B;RAP1A;CDKN1A;ADCY2;ATF2;FZD4;ADCY9;PLCB1;SCARB1;CREB3L2;LDLR;MAP2K1;EGFR;GNAI3;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.5116342179913024,1.0376034476513185,0.43243243243243246,0.8335378539593756,1.0,16/27,36.20%,NEDD4L;SYT1;SDCBP;RIMS2;CSNK2A1;RPS6KA3;CDC42;EGFR;CDKL5;AKAP6;ADAM17;RIMS1;MTPN;DDX3X;MAP3K13;EIF4G2
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.6891642325712283,1.03753184208041,0.5151515151515151,0.8332563037899475,1.0,3/5,23.27%,ADGRB3;SCARF1;ANKS1A
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.4796102909084306,1.0373413340849114,0.44047619047619047,0.833283499944501,1.0,21/65,22.20%,SUN2;VAPB;ATP8B1;ARHGAP21;SRGN;TMED10;ANK3;TOR1AIP2;NPLOC4;WASHC4;DYSF;REEP3;RAB30;GOLPH3;RAB2A;VMP1;ARFGEF2;CSNK1D;ARFGEF1;DNAJC13;CAV2
prerank,Reactome_2022__Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,0.5609627637752469,1.0371714839383708,0.4507042253521127,0.8332265852680076,1.0,7/29,22.42%,PSMC6;REL;RPS27A;PSMA7;MALT1;PPP3CB;UBC
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.6291623036906943,1.0371055297973917,0.4225352112676056,0.8329680300830498,1.0,5/10,16.18%,SLC8A1;ANK2;KDM1A;DYSF;DMD
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.5612521190410368,1.0370742852994799,0.48484848484848486,0.8326313375585137,1.0,8/22,23.24%,RFTN1;ZDHHC6;ZDHHC14;PIKFYVE;SDCBP;VPS37A;AFDN;RAB3GAP2
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.4245009138021909,1.0370061977771179,0.3402061855670103,0.8324237174856107,1.0,68/324,21.33%,LAMC1;B3GNT2;PSMC6;PDK4;PPP2R3A;FEM1C;PRKAG2;PKN3;PPM1D;MAP3K5;ANXA1;MGAT4A;PTPRD;PRKCE;PLOD2;DUSP6;UFL1;BCR;FGFR1;ERO1A;PINK1;JAK1;DCAF10;ZDHHC6;CDK6;DUSP1;SSH1;MACROD2;HSP90B1;MSRA;HIF1A;SIK2;TRIB2;SETD3;COMMD1;PPM1A;STK38L;STK38;PRAG1;MAPK10;ACVR2A;DUSP16;PAK2;CTTNBP2NL;TRIOBP;PSMA7;PLAT;TNKS;GRK5;TGM2;PPP1CB;RAB2A;TF;CSNK1G3;CSNK1D;MTMR6;ABL2;MGAT1;PTPN1;LIMK2;TEC;SOCS3;CDK8;PMM2;MORC3;PPP3CB;EPAS1;TAOK1
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.6848293163710977,1.0369692827238675,0.4262295081967213,0.8321212047947009,1.0,3/5,29.03%,ATP1A1;TFPI;ABHD2
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.6681909650504045,1.0369238008947923,0.463768115942029,0.8318078143669521,1.0,2/6,11.29%,ITGA1;MAGI2
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.6985185497353834,1.0368140374911836,0.48484848484848486,0.831662397953245,1.0,2/5,13.04%,HIF1A;TRAK1
prerank,KEGG_2021_Human__Lysosome,0.5336939871403142,1.0366430357581844,0.4788732394366197,0.8316958732641546,1.0,6/24,18.59%,SCARB2;HYAL2;LAMP2;AP1G1;PSAP;ARSG
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),-0.6375430686131782,-1.0366198802803168,0.4444444444444444,1.0,1.0,2/7,16.79%,ACVR1;MDM4
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.6029669384223071,1.036540869953042,0.4626865671641791,0.8315729915578984,1.0,2/9,19.39%,NRXN1;RIMS2
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.47261262116590574,1.0364508392550231,0.4027777777777778,0.8314279128754697,1.0,8/58,10.09%,MAP2;GRM7;GPM6B;CTNND2;PPP1R9A;MICALL2;CNTNAP2;GAS7
prerank,Reactome_2022__Protein Methylation R-HSA-8876725,0.6980579941473793,1.036052031149466,0.5081967213114754,0.831946685813067,1.0,6/6,30.31%,EEF1A1;HSPA8;CAMKMT;VCP;CALM1;EEF2
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,0.5945759683038012,1.0358861961984371,0.4647887323943662,0.8319130562198515,1.0,6/15,20.16%,KDM1A;ALPL;RFC3;SMARCC1;GATA2;NPM1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.542191056671039,1.0356050148675422,0.4714285714285714,0.8322137656141704,1.0,3/20,11.55%,UFL1;RPL23;COMMD1
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.6125813156035527,1.0351427655999175,0.5070422535211268,0.833054361543692,1.0,2/10,7.36%,BCAP31;HSP90AA1
prerank,Reactome_2022__Signaling By Insulin Receptor R-HSA-74752,0.5680689560031784,1.0350850426593698,0.4782608695652174,0.8328142786516203,1.0,4/20,14.32%,FGFR1;PIK3R1;GRB2;GRB10
prerank,Reactome_2022__Signaling To ERKs R-HSA-187687,0.5664197028316245,1.0350321546974335,0.5285714285714286,0.8325299297563624,1.0,6/15,25.95%,GRB2;RAP1A;SHC2;CRK;YWHAB;MAP2K1
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.6158959398047128,-1.0344539172278715,0.5,1.0,1.0,1/9,0.16%,VCAM1
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.42693856570293565,1.0343794012003644,0.3870967741935484,0.833825069681343,1.0,57/272,20.58%,ZEB2;BCL6;ATF3;MAFK;KLF2;TBX3;BHLHE40;PHF10;CALR;ZBTB1;ZFPM2;PURA;SMAD7;SIN3B;ESR2;ATP8B1;CBFB;KDM1A;ARID5A;RPS27A;RPL23;KLF4;CDKN1B;JUN;ZNF366;CREM;SPEN;OTUD7B;CNBP;REST;PPM1A;NEDD4L;ZBTB38;LRRFIP1;FOXC1;NCOR2;MTDH;NR2C1;ATOH8;LIMS1;MCPH1;SDCBP;TPR;RIF1;CRY1;STAT3;DUSP22;MBD2;NACC2;NR1D2;NFIC;NOTCH4;BCLAF1;CREBZF;RCOR3;ELK3;HSPA8
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.5706388369508718,-1.0343078421797318,0.4666666666666667,1.0,1.0,2/9,2.95%,BABAM2;ATM
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.6309981365020685,-1.0339754086074855,0.4722222222222222,1.0,1.0,1/6,1.09%,MSL2
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.6912124055047593,1.0339719248601735,0.4918032786885246,0.8344853232909035,1.0,2/6,19.39%,NRXN1;RIMS2
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.5794829311137183,1.033861268178383,0.47297297297297297,0.834306109660483,1.0,6/19,23.03%,FGFR1;HIF1A;FOXC1;LIMS1;NOTCH4;MEF2C
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.6174997695351572,1.0336111536637775,0.4838709677419355,0.8344102388715079,1.0,2/11,9.19%,TSG101;LAMP2
prerank,CellMarker_Augmented_2021__Lymphoid Stem cell:Peripheral Blood,0.6655970050023636,1.033482215286208,0.46774193548387094,0.8344088244163711,1.0,1/6,11.98%,STRAP
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Umbilical Cord Blood,0.6048141466803895,1.0333819935039976,0.4864864864864865,0.8343242113606384,1.0,4/14,14.58%,ATP8B1;PLSCR4;CFH;VWA2
prerank,Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,0.6162419182132259,1.0333324332830127,0.5081967213114754,0.834034558825776,1.0,2/10,3.90%,S1PR1;ANXA1
prerank,Reactome_2022__Attenuation Phase R-HSA-3371568,0.5992131758247488,1.033254001394995,0.5076923076923077,0.8337839836654449,1.0,5/11,25.31%,HSPH1;HSP90AA1;HSPA8;SERPINH1;CREBBP
prerank,CellMarker_Augmented_2021__White Blood cell:Blood,-0.5561851252888936,-1.0329518907631703,0.36363636363636365,1.0,1.0,3/7,14.42%,TNFRSF1B;RCSD1;GIMAP4
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Undefined,-0.5561851252888936,-1.0329518907631703,0.36363636363636365,1.0,1.0,3/7,14.42%,TNFRSF1B;RCSD1;GIMAP4
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.6570626322220932,1.0328807185103293,0.5151515151515151,0.834292413605698,1.0,1/7,1.01%,RFTN1
prerank,Reactome_2022__RAB Geranylgeranylation R-HSA-8873719,0.552051821830814,1.0324775740327414,0.4931506849315068,0.8349331900614387,1.0,8/14,33.84%,RAB21;RAB30;RAB2A;RAB8B;RAB14;RAB7A;RAB1A;RAB11A
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.6339212985456976,-1.0323275624493027,0.5208333333333334,1.0,1.0,2/6,1.83%,PLA2G4A;CD74
prerank,Reactome_2022__RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.5152489024691231,-1.0318123552526477,0.34615384615384615,1.0,1.0,4/16,8.23%,MLLT3;RTF1;MLLT1;TAF3
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.5498097363936052,1.0317444988571902,0.4,0.8366190316489208,1.0,8/20,20.82%,CALR;ANXA1;ANXA2;NEDD4L;HIP1R;GATA2;DYNC1H1;ACTB
prerank,Reactome_2022__HSF1-dependent Transactivation R-HSA-3371571,0.5822940376941989,1.0315416132988746,0.45454545454545453,0.8368819638118457,1.0,7/14,28.18%,HSPH1;HSP90AA1;HSPA8;SERPINH1;CREBBP;MTOR;CAMK2D
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.4224616772362682,1.0312466367064843,0.4659090909090909,0.837260707390412,1.0,39/179,21.33%,ERBB4;PDK4;PCK1;PRKAG2;FES;PKN3;MAP3K5;PRKCE;BCR;FGFR1;SMAD7;PINK1;JAK1;CDK6;SIK2;TRIB2;CCNH;STK38L;FLT1;STK38;PRAG1;MAPK10;ACVR2A;PAK2;TNKS;GRK5;PRKX;CRY1;CSNK1G3;CSNK1D;ABL2;ABI1;LIMK2;TEC;CDK8;CAB39;MORC3;PPP3CB;TAOK1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.5156939959720498,1.0312248806247213,0.391304347826087,0.8368766844831924,1.0,11/25,32.99%,FGFR1;HIF1A;GATA2;ATP2B4;ETS1;MEF2C;PPARG;MECP2;RGCC;ADAM17;ACVRL1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.5837258396658496,1.0309605728929254,0.5147058823529411,0.8371887917704093,1.0,6/10,32.19%,GJA1;ITGB1;PAFAH1B1;CDK5RAP2;NDEL1;KPNB1
prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,-0.5718158314965486,-1.030866137177179,0.3939393939393939,1.0,1.0,1/6,3.13%,GMDS
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.4721905806880107,1.030774066746894,0.3924050632911392,0.8372080782416911,1.0,12/56,10.97%,LAMC1;SERPINE1;ADAMTS9;GPM6B;LAMA5;PLOD2;P4HA1;COL4A2;ITGA1;VWF;PECAM1;ADAM15
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.5568299411456434,1.0305358333983181,0.4375,0.8373983512198522,1.0,6/19,16.68%,PRKAG2;CDKN1B;TRIB2;PAK2;WWTR1;SPRED1
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.39994572143921703,-1.0304654842144383,0.3076923076923077,1.0,1.0,14/47,13.55%,GBP1;CD74;GCNT2;TGFBR3;PDGFC;PDGFB;FN1;SEMA6A;MFHAS1;SPRY3;PTPRR;PTPN2;RAPGEF2;GAS6
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.5847926158155579,1.0303658630835841,0.38571428571428573,0.8373182700480738,1.0,2/12,6.06%,SERPINE1;HYAL2
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.5983605023516012,1.0302911325951434,0.4788732394366197,0.8370564111094166,1.0,4/15,12.88%,ANK2;CTNND2;FGFR1;BCAR1
prerank,"Reactome_2022__BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",0.5622925410631493,1.030256960264763,0.4262295081967213,0.8367287152371656,1.0,2/14,2.74%,SERPINE1;BHLHE40
prerank,CellMarker_Augmented_2021__B cell:Kidney,0.4252764426922232,1.0299184025587063,0.40860215053763443,0.837161084033018,1.0,21/178,9.72%,LAMC1;PCDH9;AKAP12;CHPT1;AFF3;KLF2;RAPGEF5;ANK2;RPS11;AFF4;PKIG;BACH2;ALPL;GRB2;ATP2B1;STEAP1B;UBE2J1;LRRC4C;MACROD2;NOC3L;SMC6
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,0.4713674975584815,1.0297950386593042,0.4523809523809524,0.8370372585841874,1.0,5/69,7.09%,PIK3R3;ZNF160;CALR;PIK3R1;JAK1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.5234586078161771,-1.0297523919598364,0.35135135135135137,1.0,1.0,3/14,5.55%,ATM;ATR;SP100
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.5527944894035984,1.0297207403329502,0.4675324675324675,0.8368200577592964,1.0,7/25,24.38%,ZFPM2;AAMDC;TRIB2;WWTR1;GATA2;ZFP36;PPARG
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.49287761526864476,1.0292964770830506,0.43478260869565216,0.8374221504038648,1.0,13/45,23.37%,RTN4;SGIP1;HSP90AA1;PICALM;AHCTF1;HIP1R;DMD;TPR;PXN;CHMP4B;TBCD;UVRAG;NCK1
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.6481679101607974,1.0289487414886065,0.4383561643835616,0.837776396329011,1.0,2/8,11.47%,ROBO2;REST
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.6029612647668601,1.0288406709833653,0.4827586206896552,0.8376140693785122,1.0,3/11,19.39%,RAP1A;PREPL;RIMS2
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.4868498933703923,1.0287056381815702,0.4430379746835443,0.8376220622823058,1.0,9/50,15.75%,NES;ANK2;MAP1B;NFASC;COL4A2;GJA1;BOC;PCDH7;NAV2
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.5281223840908603,1.0285825753059599,0.47297297297297297,0.8375587255276258,1.0,14/25,30.36%,RAB11FIP3;AHCTF1;ECT2;SND1;DYNC1H1;BCL2L1;CAV2;UVRAG;CSNK2A1;IHO1;CDC42;PIK3C3;CALM1;PRPF40A
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.6456632323533409,1.0285033307706266,0.42857142857142855,0.8373528784690748,1.0,3/6,26.40%,NCOR2;MAP2K1;EGFR
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.6230413586266224,1.0282273285613468,0.48484848484848486,0.8376514744459468,1.0,7/10,30.17%,HSP90AA1;NOS1AP;DNM2;WASL;EGFR;CALM1;ZDHHC21
prerank,Reactome_2022__Negative Regulation Of FLT3 R-HSA-9706369,0.675924186470868,1.0281438602151094,0.47761194029850745,0.837500566534069,1.0,3/5,22.42%,RPS27A;ABL2;UBC
prerank,Reactome_2022__Mitotic Metaphase And Anaphase R-HSA-2555396,0.47785754183925666,1.0281328436252806,0.4,0.8367066502455855,1.0,22/66,25.82%,PSMC6;LBR;TUBB4B;RPS27A;RAD21;WAPL;AHCTF1;TUBA1B;TUBB6;PSMA7;RPS27;DYNC1H1;CHMP4B;PAFAH1B1;TAOK1;UBC;TMPO;SPC25;XPO1;PSMB9;SMC3;TUBB
prerank,Reactome_2022__Mitotic Anaphase R-HSA-68882,0.47785754183925666,1.0281328436252806,0.4,0.8367066502455855,1.0,22/66,25.82%,PSMC6;LBR;TUBB4B;RPS27A;RAD21;WAPL;AHCTF1;TUBA1B;TUBB6;PSMA7;RPS27;DYNC1H1;CHMP4B;PAFAH1B1;TAOK1;UBC;TMPO;SPC25;XPO1;PSMB9;SMC3;TUBB
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.5093371981657393,-1.0280201188947564,0.41379310344827586,1.0,1.0,7/15,22.50%,BICD1;EFNA5;CLASP1;CYLD;PHLDB1;PHLDB2;MARK2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.6860752644578653,1.0279816340016614,0.5230769230769231,0.8366494226282175,1.0,1/5,3.90%,ANXA1
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.46490958804839366,-1.0279543364365977,0.35714285714285715,1.0,1.0,3/26,6.40%,VCAM1;SNED1;PODN
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.687367325087662,1.0278462619205893,0.4423076923076923,0.8365922514483419,1.0,3/6,13.44%,INPP5F;ANXA2;KIF16B
prerank,Reactome_2022__Oncogenic MAPK Signaling R-HSA-6802957,0.5252410790376851,1.0275795114739528,0.4691358024691358,0.8369559152006505,1.0,12/35,17.24%,DUSP6;VWF;RAP1A;PEBP1;TRAK1;DUSP16;TENT4A;MPRIP;SHOC2;SND1;SPRED1;PPP1CB
prerank,Reactome_2022__CHL1 Interactions R-HSA-447041,0.659202926764131,1.027531185293563,0.47058823529411764,0.8366801707691081,1.0,5/7,27.52%,ITGA1;ITGB1;HSPA8;ITGA10;ITGA2
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.5065712683239556,-1.0272983298546339,0.38461538461538464,1.0,1.0,6/13,12.32%,IFIH1;TAP1;IRF1;PARP12;HLA-F;HLA-C
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.5030178397609599,1.0272746536313615,0.4473684210526316,0.8369342476075018,1.0,9/32,24.38%,ADM;KLF4;GGT5;ADCY2;ADCY9;CDH5;FYN;FGR;PPARG
prerank,Reactome_2022__Diseases Of DNA Repair R-HSA-9675135,-0.5640607898471056,-1.0271407450107342,0.5384615384615384,1.0,1.0,3/8,8.55%,ATM;RAD51B;MSH3
prerank,Reactome_2022__HSF1 Activation R-HSA-3371511,0.6265322065417284,1.0268236490797866,0.5151515151515151,0.83770645032147,1.0,5/11,22.28%,HSPH1;HSP90AA1;EEF1A1;SERPINH1;YWHAE
prerank,Reactome_2022__Signaling By BMP R-HSA-201451,0.5961934077055617,1.026556960479088,0.48484848484848486,0.838014311446356,1.0,4/14,20.19%,SMAD7;SMAD5;ACVR2A;SMAD6
prerank,Reactome_2022__Synthesis Of DNA R-HSA-69239,0.5442725377986717,1.0262075083392044,0.4305555555555556,0.838550821246736,1.0,4/25,10.23%,PSMC6;POLA1;RPS27A;RFC3
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.6389284378302232,1.0261873865674858,0.49230769230769234,0.8381932424095964,1.0,4/9,25.44%,LPGAT1;SCARB1;LDLR;MTOR
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.5038658332759882,1.0261847633171608,0.4861111111111111,0.8377924478787143,1.0,13/42,27.94%,NES;KDM1A;CDKN1A;CLDN5;HIP1R;CRK;AMFR;TMBIM6;ACTB;RACK1;ADD1;MARK3;SPPL3
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.6900463064475036,1.0260505328047584,0.47540983606557374,0.8377894001171187,1.0,1/5,22.26%,RAB8B
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.4417780393850661,1.0260376754275475,0.43373493975903615,0.8373946375882586,1.0,24/126,20.85%,MTFR1;NEDD9;VAPB;ATP8B1;PINK1;ARHGAP21;TMED10;TOR1AIP2;NPLOC4;LARP4;PIKFYVE;AGTPBP1;BRWD3;RAB30;PDZD8;GOLPH3;RAB2A;VMP1;CFL1;CSNK1D;CHMP4B;SH3KBP1;DPYSL2;ARFGEF1
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.5637811507487956,-1.0259745931513529,0.45714285714285713,1.0,1.0,2/10,16.23%,COG3;TRAPPC10
prerank,Reactome_2022__p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,0.6758910247485848,1.0255216334390649,0.5806451612903226,0.8383434127496643,1.0,4/7,15.72%,VWF;RAP1A;BCAR1;CRK
prerank,Reactome_2022__Regulation Of RUNX2 Expression And Activity R-HSA-8939902,0.5522012071668088,1.0254230428445503,0.4177215189873418,0.8381987844343811,1.0,3/23,8.07%,PSMC6;CBFB;RPS27A
prerank,Reactome_2022__Transcriptional Regulation By MECP2 R-HSA-8986944,0.5189088438828776,1.0252925507067412,0.41025641025641024,0.8382118411415709,1.0,7/29,15.64%,GRIA2;LBR;GRIN2B;FKBP5;SLC2A3;AGO2;NCOR2
prerank,Reactome_2022__Rap1 Signaling R-HSA-392517,0.6222967786495786,1.025115681581138,0.417910447761194,0.838262894130814,1.0,2/9,10.07%,RAPGEF3;RAP1A
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.5512603836474269,-1.0250474119783686,0.4482758620689655,1.0,1.0,3/12,9.35%,BABAM2;USP25;OTUD4
prerank,Reactome_2022__FCGR3A-mediated Phagocytosis R-HSA-9664422,0.5262238320372352,1.0250329418246924,0.43037974683544306,0.8381239448132457,1.0,15/30,31.45%,MYO9B;GRB2;MYO1E;ARPC2;CRK;ABI1;WIPF1;NCK1;FYN;FGR;WASL;CDC42;ACTR2;DOCK1;PTK2
prerank,Reactome_2022__RIPK1-mediated Regulated Necrosis R-HSA-5213460,0.5353562849553618,1.0248585774855608,0.4533333333333333,0.83771632821503,1.0,8/19,22.42%,HSP90AA1;RPS27A;OGT;PELI1;SDCBP;TNFRSF10B;CDC37;UBC
prerank,Reactome_2022__Regulation Of Necroptotic Cell Death R-HSA-5675482,0.5353562849553618,1.0248585774855608,0.4533333333333333,0.83771632821503,1.0,8/19,22.42%,HSP90AA1;RPS27A;OGT;PELI1;SDCBP;TNFRSF10B;CDC37;UBC
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Small Intestine,-0.5550389936595549,-1.0247164652356155,0.375,1.0,1.0,3/7,11.79%,RHBDD1;APCDD1;TRIQK
prerank,Reactome_2022__Metabolism Of Steroids R-HSA-8957322,-0.43562527586496114,-1.0242582206326172,0.4166666666666667,1.0,1.0,3/30,2.66%,SLCO1A2;STARD3;TBL1X
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.4699570880642794,1.024188827389281,0.48717948717948717,0.8390898209697,1.0,11/49,9.83%,LAMC1;ZEB2;KLF6;KLF2;TIMP3;PLSCR4;P4HA1;COL4A2;KLF4;FOSL2;HIF1A
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.5836175632634634,1.0241736793784726,0.44,0.8387124086158311,1.0,6/16,19.60%,GLUL;CTNNA1;OTUD7B;WWTR1;TPR;LIMK2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.7390665522381618,1.023908651044989,0.5076923076923077,0.8388388630490807,1.0,2/5,11.47%,PINK1;REST
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.6686940124394852,1.0236896259422457,0.5,0.8389543714177133,1.0,1/7,10.23%,RFC3
prerank,Reactome_2022__DCC Mediated Attractive Signaling R-HSA-418885,0.619356020208368,1.0236110507823795,0.4745762711864407,0.8387452464484222,1.0,6/10,31.45%,NCK1;FYN;WASL;CDC42;DOCK1;PTK2
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.6297513899003132,1.0234102084543113,0.4166666666666667,0.8389579965516553,1.0,2/7,7.04%,HSPA5;PINK1
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Visceral Adipose Tissue,0.5168643661318626,1.0233917839465843,0.47297297297297297,0.8381785024105273,1.0,8/36,13.39%,DOK5;PTPRD;SGIP1;NFASC;NAV1;GJA1;TMEM132C;MAPK10
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Visceral Adipose Tissue,0.5168643661318626,1.0233917839465843,0.47297297297297297,0.8381785024105273,1.0,8/36,13.39%,DOK5;PTPRD;SGIP1;NFASC;NAV1;GJA1;TMEM132C;MAPK10
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.6270725855450769,1.0232129784269923,0.49295774647887325,0.8382184770771446,1.0,2/9,18.57%,MALT1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.6633847791378396,1.0230830562272135,0.4647887323943662,0.8381127338624791,1.0,7/7,33.78%,ITGA1;MAGI2;MEF2C;MTOR;CALM1;MTMR9;HSP90AB1
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.6651860637275095,1.022833805995745,0.49230769230769234,0.8384277391936492,1.0,3/6,28.18%,GSN;EMP2;CAMK2D
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.4149465952602801,-1.0227271421820638,0.45454545454545453,1.0,1.0,8/54,7.28%,XAF1;EIF2AK2;CD74;ISG15;MX1;STAT1;SP100;GCH1
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.47188757946766907,-1.0224180628489925,0.4418604651162791,1.0,1.0,4/18,13.73%,EIF2AK2;TGFBR3;FOXO1;ULK4
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.5252542980677377,-1.0222781777606997,0.35714285714285715,1.0,1.0,3/15,9.72%,CD74;PARP14;TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.4863193943782379,1.0222410915847617,0.43209876543209874,0.8396102719826651,1.0,13/58,14.74%,SERPINE1;CALR;HYAL2;SMAD7;NAV3;SRGAP1;DLC1;GJA1;ADAM15;MAGI2;CLDN5;ADGRG1;RAC1
prerank,Reactome_2022__Interleukin-1 Family Signaling R-HSA-446652,0.47420390113445565,1.021872554583797,0.5064935064935064,0.840037384221182,1.0,8/50,18.57%,PSMC6;IL1RAPL1;RPS27A;PELI1;TAB2;ALPK1;PSMA7;STAT3
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.6278315348540383,1.0218324510804784,0.4931506849315068,0.8393186975364052,1.0,6/13,24.25%,INSIG1;CNBP;RALY;SCARB1;ABCG1;LDLR
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.6278315348540383,1.0218324510804784,0.4931506849315068,0.8393186975364052,1.0,6/13,24.25%,INSIG1;CNBP;RALY;SCARB1;ABCG1;LDLR
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.6703870828856829,1.0212402095522641,0.4262295081967213,0.8406760367008723,1.0,3/7,16.10%,ROBO2;SEMA6B;SEMA3F
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.3806654601163384,-1.0209340641065978,0.3333333333333333,1.0,1.0,7/87,4.20%,COL8A1;CARMIL1;RHOBTB1;PGM5;TLL1;EVL;ARHGAP12
prerank,Reactome_2022__Insulin Receptor Recycling R-HSA-77387,-0.5855582193580835,-1.0206516223466078,0.47368421052631576,1.0,1.0,1/6,9.54%,ATP6V1H
prerank,Reactome_2022__Gene Expression (Transcription) R-HSA-74160,0.42554806406385814,1.0205941006165682,0.46938775510204084,0.8418277256948901,1.0,65/344,20.19%,DDIT4;SERPINE1;GRIA2;PSMC6;BCL6;ELL2;PCK1;PRKAG2;BNIP3L;ZNF160;PPM1D;PBRM1;LBR;GRIN2B;AFF4;SMAD7;NDRG1;SIN3B;ESR2;ZNF586;PINK1;CBFB;HSP90AA1;RPS27A;CDK6;KLF4;CDKN1B;JUN;MYO1E;RFC3;FKBP5;CCNH;SLC2A3;CCNC;CDKN1A;FOS;PPM1A;CNOT6L;AGO2;CLDN5;TAF1D;NEDD4L;SMARCC1;WWTR1;TXNRD1;SRSF7;NCOR2;PSMA7;NR2C1;TPR;HDAC7;GATA2;BTG2;LGALS3;CSTF3;ZNF43;NFIB;NR1D2;PTPN1;NOTCH4;SOCS3;KMT2E;CDK8;NPM1;SMAD6
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.5830441098124632,1.020417827250038,0.5217391304347826,0.8418227603201025,1.0,3/10,19.39%,PREPL;SYT1;RIMS2
prerank,KEGG_2021_Human__Cell adhesion molecules,0.5075699331503465,1.0194691684452446,0.5,0.8437570883927745,1.0,14/40,14.98%,NRCAM;CNTN1;NCAM2;VSIR;NFASC;NRXN3;LRRC4C;NEGR1;CNTNAP2;PECAM1;NRXN1;CLDN5;ITGB1;ALCAM
prerank,Reactome_2022__AKT Phosphorylates Targets In Cytosol R-HSA-198323,0.6786144763427078,1.019336280037635,0.48333333333333334,0.8437136077863571,1.0,2/5,11.87%,CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.6487471669183489,1.018933017300126,0.47540983606557374,0.8434440166727823,1.0,1/10,7.36%,HSP90AA1
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),0.6487471669183489,1.018933017300126,0.47540983606557374,0.8434440166727823,1.0,1/10,7.36%,HSP90AA1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),0.6487471669183489,1.018933017300126,0.47540983606557374,0.8434440166727823,1.0,1/10,7.36%,HSP90AA1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.692395691271731,1.0188765083409088,0.5,0.843213206142396,1.0,3/5,24.49%,UPP1;DPYSL2;TET2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.6287998729211687,1.018592608030161,0.45714285714285713,0.8435557555246215,1.0,2/8,18.57%,MALT1;STAT3
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.5719583385248428,1.0183627773347192,0.5,0.843742712935335,1.0,3/24,6.11%,ERBB4;FES;FGFR1
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.6593925885439564,1.0181215582617333,0.5217391304347826,0.8439187873864177,1.0,4/7,31.66%,SMC6;CSNK2A1;IHO1;ZNF207
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.6074724008410015,1.0179777936518166,0.484375,0.843902139915404,1.0,4/10,28.95%,PPP1R10;TERF2IP;YLPM1;SMG1
prerank,Reactome_2022__Spry Regulation Of FGF Signaling R-HSA-1295596,0.6448773195584021,1.0174792766853138,0.45901639344262296,0.8448584967117457,1.0,2/9,8.31%,RPS27A;GRB2
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.49411112556531744,1.0172969418523496,0.4875,0.8448895040284512,1.0,15/45,23.48%,SMAD7;SMAD5;RPS27A;JUN;LRRC32;FOS;CLDN5;ITGB1;PXN;ZMIZ1;DUSP22;SMAD6;CDH5;UBC;ADAM9
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.5047852466903169,1.0171444022160412,0.41975308641975306,0.8448136626987364,1.0,4/39,8.82%,SEC22B;KLF2;KLF4;CDKN1B
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.5362197153546703,-1.0161087425428275,0.5555555555555556,1.0,1.0,3/12,8.50%,ATM;ATR;MDM2
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Peripheral Blood,0.6078344112625496,1.0157591098805605,0.46153846153846156,0.8478982078074382,1.0,2/10,8.45%,B3GNT2;ATP2B1
prerank,Reactome_2022__Nucleotide Excision Repair R-HSA-5696398,0.5292544792517626,1.015345017562248,0.4605263157894737,0.8484826305710634,1.0,4/23,11.05%,RPS27A;RFC3;USP45;CCNH
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.6718826336196662,1.0151474916907468,0.5538461538461539,0.8485545008733428,1.0,2/6,23.24%,ANXA2;RAB3GAP2
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,0.5743229768325495,1.0148966065677338,0.475,0.8488128754382341,1.0,3/17,6.29%,BCL6;BNIP3L;NDRG1
prerank,CellMarker_Augmented_2021__Basal cell:Undefined,-0.4574128274076935,-1.0147882671293904,0.43333333333333335,1.0,1.0,3/33,2.63%,GBP1;GBP2;TAP1
prerank,Reactome_2022__Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,0.6612802164096407,1.0147575890007325,0.4642857142857143,0.848756643426302,1.0,5/7,25.82%,TUBB4B;TUBA1B;TUBB6;CHMP4B;TUBB
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.6990500582611,1.0143985317564377,0.5357142857142857,0.8492223690335666,1.0,1/5,2.34%,BCAP31
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.5879852853292534,1.014202244683837,0.4861111111111111,0.8493256841332196,1.0,4/12,20.61%,TPR;DYNC1H1;NEDD4;CEP290
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In2:Brain,0.5043948175546403,1.0141390445123366,0.48148148148148145,0.849146916970474,1.0,11/36,11.29%,ATRNL1;ANK2;IL1RAPL1;MAP1B;GRIN2B;LRRTM4;TTLL7;NAV3;CTNNA3;STXBP5L;MAGI2
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.5056475030111137,1.0141193997344184,0.4444444444444444,0.8487875132208005,1.0,5/25,14.42%,TIMP3;PLSCR4;COL4A2;GJA1;TNS1
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.5914051065622803,1.0139666330594426,0.4492753623188406,0.8487261128164955,1.0,7/19,29.93%,BCAR1;SHC2;CADPS2;EPAS1;ATP1B1;EFNB2;DAB2IP
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.5309881081378598,-1.0139444631369163,0.4117647058823529,1.0,1.0,2/14,2.12%,COL8A1;TLL1
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5463692260842459,1.0136612157591338,0.4657534246575342,0.8490526047843914,1.0,8/17,30.44%,ESR2;TMF1;PLPP1;ZMIZ1;NEDD4;ARID1A;UBR5;UBE3A
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.5993512150670139,1.0134825961343898,0.4461538461538462,0.8490654796444446,1.0,5/7,36.07%,RAC1;ALMS1;CDC42;AKAP13;ACTG1
prerank,Reactome_2022__Phase 0 - Rapid Depolarisation R-HSA-5576892,0.6546666737858702,1.0134606187815556,0.47619047619047616,0.8487121107636514,1.0,4/7,29.14%,CACNA1C;CAMK2D;CALM1;FGF12
prerank,Reactome_2022__Synthesis Of PC R-HSA-1483191,0.6930302448012795,1.0132884997963163,0.5483870967741935,0.8487516620295105,1.0,3/6,15.06%,CHPT1;SH2D3C;LPIN2
prerank,Reactome_2022__MAP Kinase Activation R-HSA-450294,0.5048458558979151,1.0132023519211601,0.5,0.8482211407487171,1.0,6/28,13.39%,DUSP6;RPS27A;JUN;FOS;TAB2;MAPK10
prerank,Reactome_2022__Interleukin-17 Signaling R-HSA-448424,0.5048458558979151,1.0132023519211601,0.5,0.8482211407487171,1.0,6/28,13.39%,DUSP6;RPS27A;JUN;FOS;TAB2;MAPK10
prerank,Reactome_2022__Macroautophagy R-HSA-1632852,0.5031424366516511,1.013166622722209,0.47297297297297297,0.8478847432872835,1.0,8/36,9.48%,PRKAG2;PLIN2;ATG12;PINK1;HSP90AA1;RPS27A;RB1CC1;ATG4C
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.5339740744378464,-1.0131490994384744,0.4634146341463415,1.0,1.0,2/12,2.87%,CD74;LEPR
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.47322475296943234,-1.0131122759352644,0.4375,1.0,1.0,2/13,3.27%,FAXDC2;STAT1
prerank,KEGG_2021_Human__Cholesterol metabolism,0.6694393321033624,1.0129116352401755,0.5072463768115942,0.8481999555742914,1.0,2/10,4.20%,ANGPTL4;VAPB
prerank,Reactome_2022__Influenza Infection R-HSA-168255,0.45937881314460915,1.0123014929796217,0.4819277108433735,0.8494251770466509,1.0,16/75,17.00%,CANX;PBRM1;CALR;RPS11;RPS9;HSP90AA1;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12;KPNA4;TPR
prerank,KEGG_2021_Human__Aminoacyl-tRNA biosynthesis,-0.6182283324981959,-1.0120995150466532,0.4722222222222222,1.0,1.0,3/6,24.28%,WARS1;LARS2;FARS2
prerank,CellMarker_Augmented_2021__Bile Duct cell:Liver,0.581704069647615,1.0117686850671253,0.4782608695652174,0.8504058905389453,1.0,5/10,27.52%,LAMA5;SEMA3F;EGFR;TM4SF1;ITGA2
prerank,CellMarker_Augmented_2021__Luminal cell:Prostate,0.515663768601266,1.011407026383032,0.44594594594594594,0.8508833606550696,1.0,5/25,17.10%,LAMA5;MYO1B;BCAR1;SEMA3F;DAG1
prerank,Reactome_2022__Nephrin Family Interactions R-HSA-373753,0.5807722431643874,1.0113216234549427,0.4722222222222222,0.8507314686151032,1.0,8/14,30.94%,PIK3R1;MAGI2;ACTN1;NCK1;FYN;WASL;PIK3CB;CASK
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.5229430210756094,1.0111905724720283,0.4444444444444444,0.850627263036776,1.0,4/23,9.85%,DLC1;MSRB3;COL4A2;GJA1
prerank,Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148,0.47155569710754713,1.0111454394682409,0.41379310344827586,0.8503436401218233,1.0,8/66,10.86%,LBR;MYO9B;PIK3R1;ARHGAP21;SRGAP1;DLC1;ARHGEF4;GNA13
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.5516031527482844,-1.0111236810472337,0.5517241379310345,1.0,1.0,3/9,15.86%,ISG15;HLA-A;HSPD1
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.48888008691149515,1.0108515754778884,0.4878048780487805,0.8507357926509339,1.0,7/56,10.97%,DDIT4;RTN4;GAPDH;PRKCE;DLC1;OGT;ADAM15
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.4755413450549169,1.0107248160619338,0.44047619047619047,0.8506739327447443,1.0,16/63,17.50%,DOK5;TRIM5;MGLL;PRNP;CBFB;OGT;SIK2;PRAG1;RIC8B;CD55;WWTR1;VWA2;CRK;AMFR;GRK5;PXN
prerank,Reactome_2022__SEMA3A-Plexin Repulsion Signaling By Inhibiting Integrin Adhesion R-HSA-399955,0.7056866740970558,1.0103317888124785,0.47058823529411764,0.8512026368241428,1.0,4/6,27.73%,FES;PLXNA2;FYN;PIP5K1C
prerank,CellMarker_Augmented_2021__Pancreatic Endoderm cell:Embryonic Stem Cell,0.4964487952577522,1.0097582474054585,0.4520547945205479,0.8522209354601722,1.0,7/34,14.77%,ARHGAP23;TIMP3;EPS8;MYO1B;EMP1;WWTR1;CTTNBP2NL
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.6507098205192261,1.0097553123836054,0.53125,0.8518266146250526,1.0,2/7,10.68%,HIF1A;LRRC32
prerank,Reactome_2022__eNOS Activation R-HSA-203615,0.6400283730398704,1.0097462631640093,0.5333333333333333,0.8514274034066964,1.0,1/5,7.36%,HSP90AA1
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.5860966149639191,1.0096915777656608,0.5079365079365079,0.8511811795147157,1.0,5/10,29.61%,PICALM;COMMD1;TF;XIAP;FTL
prerank,KEGG_2021_Human__Oocyte meiosis,0.49674133079903704,1.0093864283951222,0.39473684210526316,0.8515874121003746,1.0,19/40,32.72%,ITPR1;CPEB4;ADCY2;PPP1CB;PPP3CB;ADCY9;YWHAB;YWHAE;PPP3CC;RPS6KA3;SMC3;MAP2K1;CAMK2D;CALM1;YWHAQ;RPS6KA2;CUL1;PPP2R5C;YWHAZ
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.6785903204646542,1.0093467426369924,0.5,0.8512887721588076,1.0,2/5,11.24%,KCNMB4;ATP1B3
prerank,Reactome_2022__Collagen Formation R-HSA-1474290,-0.5519257766064675,-1.009062292369436,0.5,1.0,1.0,2/13,2.12%,COL8A1;TLL1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.610860211670492,1.0089279658271404,0.5645161290322581,0.8520098612696757,1.0,7/9,27.33%,ANO6;NEDD4L;NEDD4;AHCYL1;YWHAE;WNK1;AKAP6
prerank,Reactome_2022__Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,0.644725246329481,1.0088260360516257,0.4852941176470588,0.8518583709804931,1.0,3/7,21.30%,KLF4;STAT3;EPAS1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.5585308821796945,1.0087190606006917,0.5303030303030303,0.851728023747961,1.0,11/15,30.17%,HSP90AA1;HIF1A;NOS1AP;ATP2B4;DNM2;SCARB1;WASL;EGFR;PIK3CB;CALM1;ZDHHC21
prerank,Reactome_2022__Erythropoietin Activates Phosphoinositide-3-kinase (PI3K) R-HSA-9027276,0.632990530787246,1.0084359341319096,0.4305555555555556,0.8519388818937087,1.0,1/6,6.14%,PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.5934345377480702,-1.008115927403792,0.5357142857142857,1.0,1.0,1/8,0.24%,CEMIP
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6017775721574017,1.0081090638826904,0.43283582089552236,0.8522282145499627,1.0,2/7,20.64%,PKIG;ATP2B4
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.564890577911256,1.008032651330647,0.4626865671641791,0.8519930282738335,1.0,3/13,16.87%,ARF1;MAGI2;SDCBP
prerank,Reactome_2022__COPII-mediated Vesicle Transport R-HSA-204005,0.5624998857310131,1.0079072804429197,0.4603174603174603,0.8518104640488481,1.0,3/21,7.52%,SEC22B;SEC24D;MCFD2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.587210282212014,1.0069839042237123,0.40298507462686567,0.8537911600454635,1.0,2/8,11.05%,RPS27A;CCNH
prerank,CellMarker_Augmented_2021__Astrocyte:Embryonic Prefrontal Cortex,0.4470524747861591,1.0067645083502197,0.47058823529411764,0.8539691361517274,1.0,25/87,17.85%,DTNA;DOK5;GLUD1;S1PR1;CD9;MGLL;GLUL;GPM6B;TIMP3;SERPINB6;ALPL;P4HA1;MT2A;JUN;GJA1;TRIB2;ADGRG1;PON2;PTTG1IP;ALCAM;ADD3;SYT1;DAG1;SLC1A2;LGALS3
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.5999473677571467,1.0067248318263289,0.5915492957746479,0.8536760141262204,1.0,5/10,28.95%,NPAS2;CRY1;BCLAF1;MCL1;SMG1
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),0.5965880867236713,1.0064667211088782,0.4507042253521127,0.8538747970007738,1.0,2/8,10.54%,RPS27A;USP45
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Embryonic Stem Cell,-0.4905227963834474,-1.005212889175318,0.4,1.0,1.0,1/20,0.16%,VCAM1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.6738216031030364,1.005189541665498,0.5,0.8568074393563624,1.0,3/5,22.39%,PIK3R1;GIGYF2;PLCB1
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.5668134934895392,1.0051468578707001,0.5373134328358209,0.8564820432169398,1.0,3/14,8.07%,ANXA1;PURA;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.4424581155457426,1.0047004360645035,0.4666666666666667,0.8573216153710972,1.0,20/136,14.29%,PIK3R3;ANK2;GAPDH;VSIR;PIK3R1;NFE2L2;RPL23;KLF4;ANK3;SLC38A2;HIF1A;GJA1;LARP4;IFNGR1;AGO2;CLDN5;TAF1D;NOS1AP;KRAS;TENT4A
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.6263720217555755,1.0046052921475024,0.5625,0.8571633312169858,1.0,3/8,14.74%,PRAG1;ADGRG1;RAC1
prerank,Reactome_2022__Glycosaminoglycan Metabolism R-HSA-1630316,0.506840713636787,1.0041202296730876,0.46153846153846156,0.857949614749978,1.0,6/27,7.01%,B3GNT2;GPC5;CHSY1;HS6ST3;HYAL2;CHST11
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.6293587026477581,-1.0038829286599462,0.4594594594594595,1.0,1.0,2/6,11.42%,SHLD1;SHLD2
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.5596070745748051,1.0036676771716753,0.49295774647887325,0.8587090819561123,1.0,8/20,25.31%,FES;CBFB;CDK6;HSPA9;LGALS3;KMT2E;MEF2C;CREBBP
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.6622861115539922,1.0036633829248172,0.5087719298245614,0.8583105764115945,1.0,2/6,21.38%,HS6ST3;EXT1
prerank,"Reactome_2022__Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",-0.5714665256641878,-1.0036215013286351,0.5151515151515151,1.0,1.0,1/12,0.32%,SLC22A5
prerank,CellMarker_Augmented_2021__Basal Progenitor cell:Breast,0.6468605589786567,1.0033784301518702,0.46153846153846156,0.8587200615954318,1.0,2/5,27.52%,ANXA3;ITGA2
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.6345817542689154,1.0028799739373082,0.5147058823529411,0.8594416408871314,1.0,1/9,5.42%,DUSP6
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Undefined,0.4686766732657553,1.0024192317988083,0.44047619047619047,0.8601104872932671,1.0,14/45,16.84%,ADAMTS9;SLC8A1;PTPRD;SGIP1;CACNA1C;ENPP2;VWF;LRRC32;NRXN1;FLT1;TMEM132C;TNS1;KCTD12;PLXDC2
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.6677102482328525,1.0022956865650414,0.5555555555555556,0.8600086483731261,1.0,2/5,13.47%,SMAD7;NEDD4L
prerank,Reactome_2022__Semaphorin Interactions R-HSA-373755,0.5284379815628908,1.002294000450537,0.4342105263157895,0.8596156685087548,1.0,10/29,20.42%,FES;HSP90AA1;ITGA1;MYL6;MYH10;ITGB1;PLXNA2;MYL12B;LIMK2;DPYSL2
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Corpus,0.4962363892854884,1.0022893548797656,0.45588235294117646,0.8592282553337861,1.0,4/21,16.57%,LAMA5;VWA2;NAV2;CADPS2
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.4762717028047956,1.0019410221019978,0.4794520547945205,0.8597452704961037,1.0,11/44,20.85%,SEC22B;ATP8B1;ARHGAP21;TMED10;NPLOC4;RAB30;GOLPH3;RAB2A;VMP1;CSNK1D;ARFGEF1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.6737176665104867,-1.0018580930943703,0.6410256410256411,1.0,1.0,2/5,11.45%,CD74;MCU
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.6737176665104867,-1.0018580930943703,0.6410256410256411,1.0,1.0,2/5,11.45%,CD74;MCU
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.6737176665104867,-1.0018580930943703,0.6410256410256411,1.0,1.0,2/5,11.45%,CD74;MCU
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.4550115445550066,1.0018481384512643,0.5125,0.8595710866250227,1.0,9/70,9.83%,PNP;SERPINE1;RFTN1;ANXA1;GAPDH;MBP;HYAL2;TMED10;HIF1A
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.6473615267193067,1.001759279415329,0.5396825396825397,0.8593295839869819,1.0,4/6,35.17%,ADAM9;MTOR;MAPRE2;IQSEC1
prerank,KEGG_2021_Human__SNARE interactions in vesicular transport,0.6078706730287324,1.0016788351074677,0.5070422535211268,0.8590779304026346,1.0,1/11,1.04%,SEC22B
prerank,Reactome_2022__Regulation Of PTEN Stability And Activity R-HSA-8948751,0.5399315316640354,1.0015703775528326,0.5324675324675324,0.8590132102620537,1.0,6/22,22.42%,PSMC6;RPS27A;PSMA7;TNKS;NEDD4;UBC
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.5050749727451757,1.0013479179033484,0.4383561643835616,0.8591973649700404,1.0,10/28,31.69%,PPM1D;PPHLN1;TAF1D;CREBZF;ACTB;SMARCA5;MTF2;MECP2;DEK;AEBP2
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant R-HSA-2660826,0.6803059953440994,1.001335538013436,0.5517241379310345,0.8588373205518928,1.0,1/5,9.38%,JAG2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.5522646245198468,1.001296985926566,0.4852941176470588,0.8585708306814512,1.0,3/15,9.03%,PCK1;ANXA1;OGT
prerank,Reactome_2022__Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,0.6912656812689043,1.0012945613916011,0.5573770491803278,0.8581700039631125,1.0,1/5,11.87%,CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.6351651688844402,1.0011895664837276,0.5362318840579711,0.8580127272799932,1.0,2/6,17.37%,PPM1A;HDAC7
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.5923426719923612,1.0001179655900816,0.5,0.8600845324587432,1.0,7/15,24.73%,BCAP31;PINK1;HERPUD1;BCLAF1;BCL2L1;MCL1;RACK1
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.6861059712126969,1.0000416671804186,0.5283018867924528,0.8598748185435505,1.0,3/5,26.16%,DNM2;ASAP1;WASL
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Undefined,0.6331364250198587,0.9994936257921008,0.5757575757575758,0.8607296451287246,1.0,2/7,11.31%,SMAD5;SLC2A3
prerank,KEGG_2021_Human__Insulin secretion,0.5432971539172035,0.9990447527741045,0.4794520547945205,0.8614184172687624,1.0,13/24,23.88%,KCNMB4;CACNA1C;SNAP25;SLC2A1;ATP1A1;ATP1B3;ADCY2;ATF2;RIMS2;ADCY9;PLCB1;ATP1B1;CREB3L2
prerank,Reactome_2022__Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.5588381644838208,0.9987916159654389,0.5507246376811594,0.8616316521132587,1.0,6/12,23.93%,EPS8;MYO1E;TRIOBP;GSN;ATP2B4;MSN
prerank,CellMarker_Augmented_2021__Endothelial cell:Brain,-0.5825270533071484,-0.9987015153681906,0.5142857142857142,1.0,1.0,1/8,0.16%,VCAM1
prerank,Reactome_2022__Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,0.5868035444802031,0.9986410825589813,0.5211267605633803,0.8616176700310787,1.0,6/17,26.48%,RPS27A;UBE2B;UBC;UBE2Q2;UBE2R2;UBE2H
prerank,Reactome_2022__Negative Regulation Of MAPK Pathway R-HSA-5675221,0.5357600827089736,0.998526251583001,0.5064935064935064,0.8615108729565091,1.0,8/16,27.09%,DUSP6;RPS27A;PEBP1;DUSP16;YWHAB;UBC;MAP2K1;MARK3
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Periodontal Ligament,0.49341252748947007,0.9985217999057554,0.5384615384615384,0.8607359738849107,1.0,9/37,12.83%,GPM6B;PTPRD;SGIP1;ROBO2;CACNA1C;ENPP2;NRXN1;FLT1;TMEM132C
prerank,CellMarker_Augmented_2021__Retinal Progenitor cell:Retina,0.49341252748947007,0.9985217999057554,0.5384615384615384,0.8607359738849107,1.0,9/37,12.83%,GPM6B;PTPRD;SGIP1;ROBO2;CACNA1C;ENPP2;NRXN1;FLT1;TMEM132C
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.6244098821590498,0.9983091117251104,0.5147058823529411,0.8608305822210585,1.0,1/7,12.91%,AGO2
prerank,KEGG_2021_Human__Influenza A,-0.4269598158480459,-0.9982798874085029,0.3684210526315789,1.0,1.0,6/46,3.40%,RSAD2;EIF2AK2;IFIH1;MX1;STAT1;OAS3
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.5734154721417849,0.9981648299599225,0.4852941176470588,0.8607603816169974,1.0,9/13,38.65%,NEDD4L;SYT1;RIMS2;PLCB1;CDKL5;RIMS1;INSR;MAP3K13;SMURF1
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.5917084388937071,0.9977374408993777,0.53125,0.8613128087818406,1.0,4/9,25.87%,GJA1;ITGB1;PAFAH1B1;CDK5RAP2
prerank,PanglaoDB_Augmented_2021__B Cells,-0.4804134016043254,-0.9976693551486271,0.4230769230769231,1.0,1.0,2/15,2.50%,CD74;EBF1
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.5334244878040311,-0.9972064036927623,0.4666666666666667,1.0,1.0,1/11,1.27%,SLC38A3
prerank,Reactome_2022__Regulation Of PTEN Localization R-HSA-8948747,0.5973192396261828,0.9971107878304795,0.5303030303030303,0.8623378573345379,1.0,4/7,27.76%,RPS27A;NEDD4;UBC;XIAP
prerank,CellMarker_Augmented_2021__Endocrine cell:Undefined,0.6014597711031313,0.9970432542112038,0.4714285714285714,0.8616516921993201,1.0,3/10,14.58%,SLC52A3;TINAGL1;VWA2
prerank,CellMarker_Augmented_2021__Endocrine cell:Embryonic Stem Cell,0.6014597711031313,0.9970432542112038,0.4714285714285714,0.8616516921993201,1.0,3/10,14.58%,SLC52A3;TINAGL1;VWA2
prerank,KEGG_2021_Human__Serotonergic synapse,0.49447200451102585,0.9969663208294811,0.5256410256410257,0.8614272054581765,1.0,4/28,8.37%,ITPR1;CACNA1C;RAPGEF3;DUSP1
prerank,Reactome_2022__Meiotic Synapsis R-HSA-1221632,0.6043730073452618,0.9962562207557514,0.5606060606060606,0.8628352954769024,1.0,2/13,9.99%,SUN2;RAD21
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.48898002694718734,0.9961234854011174,0.42857142857142855,0.8627695254511568,1.0,6/34,9.19%,TSG101;PRKAG2;ATG12;PINK1;RB1CC1;LAMP2
prerank,Reactome_2022__Negative Regulation Of FGFR4 Signaling R-HSA-5654733,0.6174943320769958,0.9956846249631314,0.49206349206349204,0.8625469613519582,1.0,2/10,8.31%,RPS27A;GRB2
prerank,Reactome_2022__Negative Regulation Of FGFR3 Signaling R-HSA-5654732,0.6174943320769958,0.9956846249631314,0.49206349206349204,0.8625469613519582,1.0,2/10,8.31%,RPS27A;GRB2
prerank,Reactome_2022__Negative Regulation Of FGFR2 Signaling R-HSA-5654727,0.6174943320769958,0.9956846249631314,0.49206349206349204,0.8625469613519582,1.0,2/10,8.31%,RPS27A;GRB2
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.4263895367017856,0.9954295106546145,0.48863636363636365,0.8628143357530339,1.0,27/141,20.58%,BCL6;TBX3;BHLHE40;PHF10;CALR;ZFPM2;ATP8B1;KDM1A;ARID5A;KLF4;CDKN1B;JUN;SPEN;REST;ZBTB38;NCOR2;ATOH8;LIMS1;CRY1;MBD2;NACC2;NR1D2;BCLAF1;CREBZF;RCOR3;ELK3;HSPA8
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.6750904586306425,0.9952991337001986,0.515625,0.8626975370671706,1.0,1/5,6.75%,ENPP2
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.6069911599468972,-0.9951413113530491,0.5294117647058824,1.0,1.0,1/5,1.81%,PLA2G4A
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.6046496683204224,0.9950861629041216,0.5166666666666667,0.8628724954450256,1.0,1/8,3.59%,S1PR1
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.5882562626588691,-0.9950120087915958,0.5161290322580645,1.0,1.0,2/7,16.79%,ACVR1;MDM4
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.6027033676895294,0.9949471874964557,0.6142857142857143,0.8627813491491592,1.0,5/10,21.89%,SLC25A16;SLC26A2;ADCY2;ADSS2;ADCY9
prerank,Reactome_2022__trans-Golgi Network Vesicle Budding R-HSA-199992,-0.44012127518279787,-0.9947748702134748,0.34615384615384615,1.0,1.0,3/32,4.73%,HOMER2;SNX2;TPD52L1
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.45834887877392694,0.9947405014602326,0.48,0.8628538688436702,1.0,12/52,17.45%,MAFF;FES;PRNP;VWF;PECAM1;LRRC32;ADGRG1;DYSF;TNS1;NCOR2;PLXDC2;GATA2
prerank,Reactome_2022__Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,0.6078232000398432,0.9944892507206134,0.5423728813559322,0.8630540612016745,1.0,4/8,29.69%,GRB2;RPS6KA3;EGFR;RPS6KA2
prerank,Reactome_2022__EPHB-mediated Forward Signaling R-HSA-3928662,0.5248777622381022,0.9943524533729684,0.5217391304347826,0.8629169921855085,1.0,9/19,31.45%,GRIN2B;ARPC2;KALRN;LIMK2;FYN;WASL;CDC42;ACTR2;PTK2
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.6148974985088206,0.9943213616730593,0.5166666666666667,0.8625707495038707,1.0,1/6,12.40%,ANO6
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.3751634305244477,-0.9939916131633675,0.4117647058823529,1.0,1.0,11/76,8.55%,PRIMPOL;MGMT;BABAM2;ATM;ASCC3;FAM111A;PARP9;ATR;RAD51B;HERC2;MSH3
prerank,CellMarker_Augmented_2021__Naive T cell:Bone Marrow,-0.5619767523055197,-0.9938284180872868,0.5405405405405406,1.0,1.0,3/6,14.42%,TNFRSF1B;RCSD1;GIMAP4
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.5469731734159038,0.9938163922238424,0.5633802816901409,0.8632708433075307,1.0,4/11,19.39%,PDE7A;RAPGEF3;ADCY2;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.6080926153937893,0.9937761507946108,0.5070422535211268,0.8629400569278897,1.0,2/10,16.49%,RAC1;LIMS1
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.6711969275679017,0.9934440364420153,0.5555555555555556,0.8633436628035016,1.0,1/6,6.40%,ESR2
prerank,Reactome_2022__Cytosolic Sulfonation Of Small Molecules R-HSA-156584,0.6284077056140853,0.9934020649752954,0.609375,0.8626472827671956,1.0,3/6,17.58%,SULT1C4;SLC26A2;TPST2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.6284077056140853,0.9934020649752954,0.609375,0.8626472827671956,1.0,3/6,17.58%,SULT1C4;SLC26A2;TPST2
prerank,KEGG_2021_Human__Th17 cell differentiation,0.5266177495900506,0.9932260358176009,0.47692307692307695,0.8627806540936317,1.0,11/34,23.16%,JAK1;HSP90AA1;JUN;HIF1A;IFNGR1;FOS;MAPK10;STAT3;IFNGR2;PPP3CB;PPP3CC
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5175081103585538,0.9931580761666767,0.5373134328358209,0.8625119134167505,1.0,8/24,16.49%,NEDD9;CALR;IL1RAPL1;PTPRD;RAC1;TRIOBP;CRK;LIMS1
prerank,CellMarker_Augmented_2021__Neural Tube cell:Germ,0.6404189415949311,0.9930155364832722,0.45454545454545453,0.8625231570809364,1.0,1/5,3.75%,CD81
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.6586337765334292,0.9926067921751681,0.49230769230769234,0.8626472430863709,1.0,3/6,19.39%,NEDD4L;SYT1;RIMS2
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.6586337765334292,0.9926067921751681,0.49230769230769234,0.8626472430863709,1.0,3/6,19.39%,NEDD4L;SYT1;RIMS2
prerank,CellMarker_Augmented_2021__Myeloid cell:Bone Marrow,-0.5878297900676471,-0.992478268581839,0.4473684210526316,1.0,1.0,1/9,0.16%,VCAM1
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.6173868004456223,0.9921268927759626,0.4647887323943662,0.8634405987108966,1.0,4/8,25.44%,KIF16B;NEDD4;UVRAG;MTOR
prerank,Reactome_2022__Sensory Perception R-HSA-9709957,0.4872514691755533,0.9919817052178573,0.52,0.8634006282965027,1.0,7/37,10.17%,GPC5;EPS8;ANO2;SNAP25;DNAJC5;ATP2B1;MYO1E
prerank,CellMarker_Augmented_2021__Vascular Endothelial cell:Placenta,-0.43483190232635216,-0.9919254472372971,0.4166666666666667,1.0,1.0,5/42,7.01%,VCAM1;MMRN1;APOL3;PODN;GIMAP8
prerank,Reactome_2022__Miro GTPase Cycle R-HSA-9715370,0.6563629599583738,0.9917466140604775,0.5,0.8635180040572111,1.0,1/5,13.04%,TRAK1
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.4546748393631063,0.9916813588106363,0.5,0.86324978663503,1.0,11/55,10.46%,SERPINE1;CD9;TIMP3;SYTL4;SNAP25;DNAJC5;SRGN;TMED10;LAMP2;VWF;PECAM1
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.5205908502227757,0.9916321358265215,0.5142857142857142,0.862997024083057,1.0,3/25,8.63%,SERPINE1;INPP5F;KLF4
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.5987390310028876,0.9915927209105847,0.5147058823529411,0.8618755913857749,1.0,3/9,19.87%,PPM1D;FOS;KMT2E
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.5987390310028876,0.9915927209105847,0.5147058823529411,0.8618755913857749,1.0,3/9,19.87%,PPM1D;FOS;KMT2E
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.5987390310028876,0.9915927209105847,0.5147058823529411,0.8618755913857749,1.0,3/9,19.87%,PPM1D;FOS;KMT2E
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.62718286762989,0.9915803812252277,0.46296296296296297,0.861487281115296,1.0,1/6,4.17%,LAMA5
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.6347432827879755,0.991560176680565,0.5074626865671642,0.86116002471605,1.0,6/6,36.63%,UGGT2;VCP;UGGT1;DNAJB14;CUL3;ATXN3
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.5566584297977241,0.9915178268783177,0.5806451612903226,0.8608330667722526,1.0,3/13,10.49%,GLUL;ZDHHC6;ZDHHC14
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.5131526694852416,0.9913521589267532,0.5633802816901409,0.8607843596479904,1.0,8/20,22.26%,ZDHHC6;ZDHHC14;PIKFYVE;TRAM1;SDCBP;CHMP4B;VPS37A;RAB8B
prerank,Reactome_2022__DNA Repair R-HSA-73894,-0.37370375620871493,-0.9912935210454745,0.5,1.0,1.0,10/65,8.55%,ISG15;MGMT;BABAM2;ATM;ASCC3;H2AC6;TRIM25;RAD51B;HERC2;MSH3
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.5168420713993015,0.9911999661312844,0.5454545454545454,0.8607356969037958,1.0,4/26,11.87%,PPM1D;CBFB;CCNC;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.531767785764104,0.9911393578366217,0.5373134328358209,0.8604699678611116,1.0,1/24,0.69%,SERPINE1
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.6220691503583325,0.9909500922172896,0.5245901639344263,0.8605577557377537,1.0,4/8,25.71%,CCDC60;VWA2;ATP1B1;NEBL
prerank,Reactome_2022__RHOBTB2 GTPase Cycle R-HSA-9013418,0.536755002466173,0.9909172159493255,0.5135135135135135,0.8602419045438339,1.0,5/15,21.67%,HSP90AA1;STK38;ACTN1;TRA2B;CDC37
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.6066516698775535,0.9901870850546941,0.5238095238095238,0.8614995057362815,1.0,2/9,7.04%,CCDC88A;PINK1
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.6110682225913935,-0.9898750589142307,0.4888888888888889,1.0,1.0,3/5,29.83%,PRKD1;HSPB1;PRKD2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.5148445778723905,-0.9895695229548487,0.4230769230769231,1.0,1.0,4/17,4.62%,MGMT;SHLD1;PARP9;SLF2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.6541189153732287,0.989543244292045,0.5409836065573771,0.8625543674955218,1.0,2/5,14.10%,ZBTB1;AP1G1
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.6255607390384716,0.9894027348333032,0.5573770491803278,0.862479845153319,1.0,1/8,3.59%,S1PR1
prerank,Reactome_2022__EPH-Ephrin Signaling R-HSA-2682334,0.48126111730466753,0.9886946753659301,0.5061728395061729,0.8638052112406569,1.0,15/39,31.45%,GRIN2B;MYL6;MYH10;ARPC2;SDCBP;MYL12B;KALRN;LIMK2;FYN;WASL;CDC42;EFNB2;ACTR2;MYL12A;PTK2
prerank,Reactome_2022__Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,-0.5379554081770707,-0.9886852872764524,0.5135135135135135,1.0,1.0,1/6,4.14%,H2AC6
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.46929752540382774,0.9886837187032972,0.4794520547945205,0.8630515435047763,1.0,9/43,10.97%,LAMC1;SERPINE1;ADAMTS9;LAMA5;COL4A2;ITGA1;VWF;PECAM1;ADAM15
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.46929752540382774,0.9886837187032972,0.4794520547945205,0.8630515435047763,1.0,9/43,10.97%,LAMC1;SERPINE1;ADAMTS9;LAMA5;COL4A2;ITGA1;VWF;PECAM1;ADAM15
prerank,Reactome_2022__Infectious Disease R-HSA-5663205,0.4014358495469581,0.9884134689047357,0.5157894736842106,0.8633088102655062,1.0,58/317,17.05%,ADM;PSMC6;ITPR1;TSG101;CANX;PBRM1;CALR;S1PR1;CD9;RPS11;MGAT4A;GPC5;MYO9B;SGIP1;PGK1;PACS1;SEC24D;NFE2L2;SNAP25;RPS9;JAK1;HSP90AA1;KDM1A;RPS27A;RPL23;GRB2;GGT5;JUN;GJA1;MYO1E;CCNH;CNBP;ATP1B3;REST;IFNGR1;RPL8;RPL34;RPL37;RPLP2;ARPC2;TAB2;NEDD4L;DUSP16;ITGB1;AP1G1;RPL13A;TXNRD1;ADCY2;RPS12;NCOR2;CRK;MGAT5;BRD4;PSMA7;KPNA4;SYT1;TPR;PRKX
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.5853408421043864,0.9876973902417735,0.5416666666666666,0.8645710830189081,1.0,5/11,27.49%,AAMDC;ZFP36;PPARG;ASXL2;HNRNPU
prerank,Reactome_2022__RHOJ GTPase Cycle R-HSA-9013409,0.49240833557734554,0.9876495548898104,0.5,0.8642898688230993,1.0,10/31,27.22%,PIK3R1;ARHGAP21;SLC4A7;GJA1;TMPO;PREX1;WASL;CDC42;GIT2;RHOJ
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.5028971729980303,0.9870619075355466,0.5675675675675675,0.8652994717203403,1.0,5/26,14.10%,CANX;ARF1;SEC24D;PIKFYVE;AP1G1
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.557151044740283,0.9870164377646677,0.5211267605633803,0.8650081436549781,1.0,7/13,28.47%,DLC1;ITGA1;MAGI2;CDH5;MTOR;SPPL3;CALM1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Lung,0.6000512155453401,0.9866506323152676,0.547945205479452,0.8655900544590956,1.0,3/7,14.98%,NES;KLF4;ALCAM
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.6083550542383669,0.9866412914403395,0.4925373134328358,0.8652186212164943,1.0,2/10,2.90%,DTNA;SLC8A1
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.515705263291649,0.9864285233202147,0.4864864864864865,0.8653888805838824,1.0,8/28,17.61%,RTN4;CALR;GAPDH;PRNP;GIGYF2;RPL13A;RTN3;BTG2
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.6019313463011693,0.9862665218280366,0.5454545454545454,0.8654237080418996,1.0,5/15,20.32%,CDK6;KLF4;CDKN1A;NACC2;SLFN11
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.6003488800133363,0.9861124214412591,0.5625,0.8654134317267385,1.0,6/9,37.66%,TGM2;PDE4B;ATP2B4;RYR2;PRKN;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.585289324907728,0.9860578406166477,0.5555555555555556,0.8651578817786465,1.0,4/10,19.39%,GRIK2;ANK3;SYT1;RIMS2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.5822105312286432,-0.9857145492241621,0.5,1.0,1.0,3/11,11.42%,SHLD1;PARP9;SHLD2
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.5828253415570783,-0.9853573448526648,0.45714285714285713,1.0,1.0,2/6,14.71%,MFF;PNPT1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.611230219114553,0.9845820693079426,0.5492957746478874,0.8681748611416413,1.0,3/6,18.38%,MYO1E;MAGI2;PODXL
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.5375472565044062,0.9843044071038021,0.4864864864864865,0.8684934408185656,1.0,7/19,22.28%,RAPGEF3;HYAL2;PIK3R1;ECT2;TPR;NEDD4;YWHAE
prerank,Reactome_2022__NF-kB Is Activated And Signals Survival R-HSA-209560,0.5986469559657908,0.9839943940589926,0.578125,0.8688917172767857,1.0,2/7,22.42%,RPS27A;UBC
prerank,Reactome_2022__Transcriptional Regulation By RUNX3 R-HSA-8878159,0.5109096705660724,0.9839857177931698,0.5466666666666666,0.8685201352298232,1.0,6/38,16.02%,PSMC6;CBFB;RPS27A;CDKN1A;WWTR1;PSMA7
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.4655545069461781,0.9835537026455107,0.5142857142857142,0.8691577768292496,1.0,4/35,13.52%,IL1RAPL1;ROBO2;KLF4;ACVR2A
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.5298424666560855,0.983352650355101,0.4444444444444444,0.8690809523877716,1.0,5/17,19.39%,GRIK2;GRIN2B;NRXN1;SYT1;RIMS2
prerank,Reactome_2022__Transport Of Small Molecules R-HSA-382551,0.4252430813148507,0.9832027330017995,0.6593406593406593,0.869004197095206,1.0,30/157,16.02%,SLCO4A1;ANGPTL4;PSMC6;CLIC2;SLC8A1;LRRC8B;TSC22D3;SLC4A10;ANO5;SLC2A13;ATP8B1;SLC20A2;ANO2;RPS27A;SLC4A7;ATP2B1;SLC2A1;SLC38A2;SLC12A6;MICU2;ATP1B3;SLC2A3;ANO6;SLC26A2;NEDD4L;SLC20A1;ADCY2;ADD3;SLC30A7;PSMA7
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.4611124697646795,0.9831229262557367,0.5185185185185185,0.8688028168775013,1.0,28/71,27.30%,NRCAM;FES;AAMDC;FGFR1;CTNNA1;GJA1;RAP1A;BOC;REST;ACVR2A;ECT2;WWTR1;FOXC1;SDCBP;ARHGEF2;BTG1;ZFP36;GPRC5B;PLCB1;MEF2C;PRKCH;PPARG;ZEB1;RPS6KA3;MTOR;CDC42;SLC6A6;ASXL2
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.6643919110359947,0.9824140827685645,0.6129032258064516,0.8700773306505347,1.0,3/6,27.07%,GJA1;SLC1A2;SLC6A6
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.5755169550309208,0.9819844791440515,0.42424242424242425,0.8706679900017278,1.0,5/10,37.24%,RAC1;ALMS1;CDC42;ACTG1;PRKN
prerank,Reactome_2022__RNA Polymerase I Transcription Initiation R-HSA-73762,0.614716319040676,0.9818661276804406,0.5882352941176471,0.8705757165677677,1.0,2/9,13.25%,CCNH;TAF1D
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.6055060298613988,0.9815309394817684,0.547945205479452,0.8710411516604115,1.0,4/9,25.71%,KDM1A;DMD;MEF2C;NEBL
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.5906515518809563,-0.9813524040068349,0.5348837209302325,1.0,1.0,2/5,25.95%,GAS6;ROCK1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.562063126878847,0.9809761383055572,0.4857142857142857,0.8720436380621339,1.0,2/20,6.24%,RTN4;CCDC88A
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.6635689535123283,0.9809194735082694,0.49206349206349204,0.8717767699962331,1.0,1/5,5.10%,ROBO2
prerank,CellMarker_Augmented_2021__Effector Regulatory T (Treg) cell:Peripheral Blood,-0.5291844499541566,-0.9803486286494258,0.5,1.0,1.0,3/8,14.42%,TNFRSF1B;RCSD1;GIMAP4
prerank,CellMarker_Augmented_2021__Beta cell:Pancreatic Islet,0.53895057869243,0.9800959012473183,0.5352112676056338,0.873140990922097,1.0,8/18,32.16%,ROBO2;ALCAM;MTSS1;RNF130;TERF2IP;CDH18;RAPH1;APLP2
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.4866760073578869,0.979871099331928,0.5783132530120482,0.8733410383771955,1.0,11/39,24.38%,SMAD7;SMAD5;RPS27A;MAGI2;PPM1A;STRAP;ACVR2A;SPRED1;SMAD6;UBC;PPARG
prerank,Reactome_2022__Interleukin-12 Family Signaling R-HSA-447115,0.5340394489247968,0.9795358889990164,0.5609756097560976,0.8737396124701794,1.0,4/19,11.37%,CANX;JAK1;HSPA9;ANXA2
prerank,CellMarker_Augmented_2021__Basal cell:Epithelium,0.5683834109645086,0.9792283346963646,0.4714285714285714,0.874058382815535,1.0,3/10,16.10%,ADAM15;ANXA2;SEMA3F
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.5797510704614849,0.9791675370341325,0.5571428571428572,0.8738011365818231,1.0,8/12,29.93%,HYAL2;DUSP1;STK38;PTPN1;HIPK3;PIK3CB;DNAJA1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.5009037794770593,0.9791085085104652,0.5,0.8735441205460832,1.0,11/31,21.33%,GPM6B;EPS8;RAPGEF3;CCDC88A;DLC1;HIP1R;RAC1;CRK;ABL2;ESAM;TAOK1
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.526907024515545,0.9779706813495109,0.6,0.8756972920652293,1.0,6/24,13.39%,PTPRD;NFASC;SNAP25;DEPP1;SHC2;MAPK10
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Brain,0.495190154196503,0.9778879915072873,0.4857142857142857,0.8754545278144192,1.0,8/31,10.78%,NES;ANK2;TIMP3;NFASC;NAV1;COL4A2;GJA1;BOC
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.5816461130587457,0.9777539418620341,0.4794520547945205,0.875390336362584,1.0,5/11,22.84%,YBX3;SERPINB6;ARHGEF2;CAB39;OXSR1
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.6462862660322665,0.9773557543712167,0.5238095238095238,0.876034354904743,1.0,1/5,17.08%,DIP2A
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.5883100617202427,0.977348227145984,0.5666666666666667,0.8756482180448601,1.0,3/7,21.89%,ADCY2;CRY1;ADCY9
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.508421084809549,0.9766842467290511,0.4444444444444444,0.876771473352575,1.0,5/17,22.12%,TIMP3;COL4A2;TNS1;RBPMS;CALD1
prerank,Reactome_2022__PTEN Regulation R-HSA-6807070,0.4897159551698329,0.9765716049918503,0.5679012345679012,0.8766919725581747,1.0,16/52,26.14%,PSMC6;KDM1A;RPS27A;JUN;REST;CNOT6L;AGO2;PSMA7;TNKS;HDAC7;NEDD4;UBC;PPARG;PSMB9;MTOR;SLC38A9
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.6477820922759856,0.9765067125559509,0.5573770491803278,0.8763999813868761,1.0,2/6,19.76%,EPS8;CHMP4B
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.4901710829561467,0.9763749997001427,0.5466666666666666,0.8762663650920837,1.0,16/37,31.45%,GRIN2B;ANKS1B;ARPC2;RASA1;RAC1;CRK;SDCBP;KALRN;ACTB;ANKS1A;FYN;WASL;CDC42;EFNB2;ACTR2;PTK2
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.49990391530710365,0.9761637936191231,0.5652173913043478,0.8763600563767394,1.0,5/27,14.66%,MAP3K5;RPS27A;TAB2;MAPK10;SH2D3C
prerank,Reactome_2022__Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,0.657560600352424,0.9761382282145206,0.5217391304347826,0.8760587296365012,1.0,1/7,4.46%,LBR
prerank,CellMarker_Augmented_2021__Lymphoid-primed Multipotent Progenitor cell:Umbilical Cord Blood,-0.44950904179804063,-0.9760299301536463,0.46153846153846156,1.0,1.0,6/18,10.70%,RNF213;EBF1;FGD6;DENND11;PROM1;LDB2
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.6042704298963948,0.9754766452837783,0.5873015873015873,0.8772182787878727,1.0,1/6,7.36%,HSP90AA1
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.5756166001543229,-0.9751999279180936,0.5428571428571428,1.0,1.0,1/9,2.95%,ATM
prerank,Reactome_2022__FGFR1 Mutant Receptor Activation R-HSA-1839124,0.543528651874452,0.9750148957335524,0.5492957746478874,0.8777799891763071,1.0,5/13,18.57%,FGFR1;PIK3R1;GRB2;LRRFIP1;STAT3
prerank,Reactome_2022__Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,-0.5726405802600735,-0.9746777284261062,0.4642857142857143,1.0,1.0,2/9,2.12%,COL8A1;TLL1
prerank,Reactome_2022__Interleukin-12 Signaling R-HSA-9020591,0.560255205120217,0.974402472286295,0.6052631578947368,0.878740537923715,1.0,3/15,11.37%,JAK1;HSPA9;ANXA2
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.6515181295118129,0.9741427747265197,0.5303030303030303,0.8789364074016363,1.0,2/7,11.47%,JUN;REST
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.6495015444048982,0.9739606119930136,0.5645161290322581,0.8789104455897038,1.0,4/5,34.77%,MYEF2;MEF2C;SORT1;AKAP13
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.5070266795531202,0.9739123866774073,0.525,0.8786727950595886,1.0,7/15,22.66%,CDK6;HIF1A;HSPA9;ACVR2A;STAT3;ZFP36;ETS1
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.5475148486660605,0.9738322247810564,0.547945205479452,0.8784451981817564,1.0,6/12,24.99%,RPS27A;HSP90B1;TAB2;ALPK1;UBC;RPS6KA3
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.38274013881978214,-0.9738102376186194,0.5,1.0,1.0,8/53,10.33%,MLLT3;MTERF1;NFX1;IVNS1ABP;RTF1;MLLT1;TAF3;RBMX
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.45370988543746155,0.9732490509808193,0.5131578947368421,0.8794672701329024,1.0,16/59,22.15%,TAMALIN;PKN3;TIMP3;HYAL2;TMEM184B;PLSCR4;BACE2;COL4A2;TMTC1;WWTR1;AFAP1L1;FZD4;SMAD6;EPAS1;CALD1;CDH5
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.32914804724936814,-0.9732280402255875,0.35,1.0,1.0,8/128,3.61%,GBP1;VCAM1;GBP4;GBP2;IL32;LEPR;STAT1;IRF1
prerank,PanglaoDB_Augmented_2021__Neurons,0.4755207731559835,0.973035469376731,0.582089552238806,0.8795591264650582,1.0,9/61,11.58%,GRIA2;CADM2;SGIP1;SNAP25;RB1CC1;PPFIA2;PPP1R9A;CNTNAP2;NRXN1
prerank,Reactome_2022__p75NTR Recruits Signaling Complexes R-HSA-209543,0.600956365082161,0.9727270992456358,0.5692307692307692,0.8798966413635592,1.0,2/6,22.42%,RPS27A;UBC
prerank,Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,0.40961084686635296,0.9720075070469031,0.5054945054945055,0.8810346146312172,1.0,10/128,8.90%,PSMC6;SEC22B;HSPA5;CANX;CALR;SEC24D;UFL1;TRIM9;RPS27A;UBE2J1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.6318578744077976,0.971837228930263,0.5294117647058824,0.880983251836831,1.0,4/7,20.37%,PRKCE;COMMD1;NEDD4L;NEDD4
prerank,Reactome_2022__Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534,-0.6148459832965321,-0.9717159061182703,0.48484848484848486,1.0,1.0,2/6,10.36%,TNFSF10;CFLAR
prerank,Reactome_2022__CASP8 Activity Is Inhibited R-HSA-5218900,-0.6148459832965321,-0.9717159061182703,0.48484848484848486,1.0,1.0,2/6,10.36%,TNFSF10;CFLAR
prerank,Reactome_2022__Dimerization Of Procaspase-8 R-HSA-69416,-0.6148459832965321,-0.9717159061182703,0.48484848484848486,1.0,1.0,2/6,10.36%,TNFSF10;CFLAR
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.518587880951692,0.9716551252687149,0.5571428571428572,0.8810104668847899,1.0,9/20,27.38%,MYO9B;EPS8;GNA13;ADGRG1;CFL1;PHACTR4;CDC42;RHOJ;ARHGAP29
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.4532564349787508,0.9716249283932608,0.5774647887323944,0.8806697002568179,1.0,7/51,10.09%,NRCAM;MAP2;MAP1B;CTNND2;ANK3;CNTNAP2;GAS7
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.5906013821164262,0.9716181538092136,0.5285714285714286,0.8802900036081124,1.0,2/8,12.32%,CD81;FLT1
prerank,Reactome_2022__TCR Signaling R-HSA-202403,0.5028395392150726,0.9714992016948667,0.5277777777777778,0.8801459273193107,1.0,6/37,17.13%,PSMC6;PIK3R1;RPS27A;TAB2;PSMA7;MALT1
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.590885681755196,-0.9711909844624392,0.5833333333333334,1.0,1.0,2/6,6.61%,IFI27;NUP214
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.518390185322913,0.9706044595520824,0.5384615384615384,0.8817903313895245,1.0,5/23,21.12%,FGFR1;HIF1A;GATA2;EGFL7;VEGFC
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.6312646289539297,-0.9705094175182346,0.5365853658536586,1.0,1.0,1/5,0.16%,VCAM1
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.6323630981423596,0.9704941900036046,0.625,0.8816212325216425,1.0,2/6,9.30%,PRKAG2;SLC2A1
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.5869467644655137,0.9701595997779813,0.59375,0.8820837729246878,1.0,4/9,30.17%,CLDN5;CDH5;ADD1;ZDHHC21
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.4388905129132559,0.9700180175687851,0.5058823529411764,0.8820027697999668,1.0,5/69,6.32%,PSMC6;SPOPL;FEM1C;TRIM9;NFE2L2
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.5732143102135081,0.969636746811058,0.5873015873015873,0.882337569079933,1.0,3/6,23.03%,MYL6;CAV2;MEF2C
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.5521443168270691,-0.9695967650340925,0.5757575757575758,1.0,1.0,1/7,0.82%,EIF2AK2
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.4840285904407555,-0.9694897927534478,0.5625,1.0,1.0,1/12,1.27%,SLC38A3
prerank,CellMarker_Augmented_2021__Stem cell:Muscle,-0.5942700661191485,-0.9690817644450634,0.5277777777777778,1.0,1.0,1/7,0.16%,VCAM1
prerank,CellMarker_Augmented_2021__Acinar cell:Salivary Gland,0.46277542521947246,0.9689201829745315,0.47674418604651164,0.8834591692385988,1.0,15/45,19.28%,ADM;PDK4;YBX3;MSRB3;VWF;LRRC32;TBC1D9;CLDN5;KCTD12;PARVB;GRK5;GATA2;INPP5A;EGFL7;ESAM
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.5363809856392162,0.9688587208879103,0.5074626865671642,0.8832310678106857,1.0,6/11,36.55%,TRAK1;DYNC1H1;PAFAH1B1;NDEL1;RAB1A;TRAK2
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.5398813212274719,0.9687439660391512,0.5616438356164384,0.8830813191682898,1.0,6/15,22.26%,CANX;ANXA1;GOLPH3;RIMS2;MIA2;RAB8B
prerank,Reactome_2022__Cellular Response To Hypoxia R-HSA-1234174,0.535119550471307,0.968571353319364,0.5070422535211268,0.883058643183411,1.0,8/22,25.37%,PSMC6;RPS27A;HIF1A;PSMA7;EPAS1;UBC;CREBBP;PSMB9
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.5560775405016974,0.9683867342407873,0.5522388059701493,0.8830408673485042,1.0,5/12,25.98%,RAB21;HIF1A;DYNC1H1;PAFAH1B1;KIF1B
prerank,Reactome_2022__p75NTR Signals Via NF-kB R-HSA-193639,0.5670778096648924,0.9680727709230934,0.5797101449275363,0.8833304237810751,1.0,2/8,22.42%,RPS27A;UBC
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.5507896602533906,-0.9678152866508959,0.5666666666666667,1.0,1.0,4/15,7.22%,IFIH1;ISG15;HERC5;TRIM25
prerank,Reactome_2022__Interleukin-27 Signaling R-HSA-9020956,0.6357445953505038,0.9673917787918325,0.5416666666666666,0.8837396348972113,1.0,2/6,7.09%,CANX;JAK1
prerank,Reactome_2022__Interleukin-35 Signaling R-HSA-8984722,0.6357445953505038,0.9673917787918325,0.5416666666666666,0.8837396348972113,1.0,2/6,7.09%,CANX;JAK1
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.6357445953505038,0.9673917787918325,0.5416666666666666,0.8837396348972113,1.0,2/6,7.09%,CANX;JAK1
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.4614772562406295,-0.9671815332053595,0.5,1.0,1.0,4/22,9.93%,ATG10;WARS1;STAT2;FN1
prerank,Reactome_2022__Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,0.5953059714556594,0.966792043812856,0.532258064516129,0.8847685355982368,1.0,5/8,30.17%,HSP90AA1;DNM2;WASL;CALM1;ZDHHC21
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.5654725016046567,-0.9666228459547045,0.5625,1.0,1.0,3/6,14.48%,NNT;ATP6V1H;SLC25A27
prerank,Reactome_2022__Cellular Response To Heat Stress R-HSA-3371556,0.4671060081497105,0.9665060859070228,0.5679012345679012,0.885003157383377,1.0,13/36,28.18%,HSPA5;HSPH1;HSP90AA1;HSPA9;EEF1A1;TPR;HSPA8;SERPINH1;YWHAE;CREBBP;MTOR;VCP;CAMK2D
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.3623844602188018,-0.9663399878066452,0.45,1.0,1.0,8/52,7.28%,CD74;IFIH1;ISG15;IFI27;MX1;SP100;TRIM25;GCH1
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.5781540007535333,0.966253221458195,0.5571428571428572,0.8851499996856859,1.0,4/10,17.00%,HYAL2;PIK3R1;ECT2;TPR
prerank,Reactome_2022__Autophagy R-HSA-9612973,0.47750302176114046,0.9662405730510157,0.5833333333333334,0.884800680523602,1.0,10/44,9.48%,TSG101;PRKAG2;PLIN2;ATG12;PINK1;HSP90AA1;RPS27A;RB1CC1;LAMP2;ATG4C
prerank,Reactome_2022__VLDLR Internalisation And Degradation R-HSA-8866427,0.5993698927013641,0.9657928409917449,0.6027397260273972,0.8854432980326038,1.0,2/7,22.42%,RPS27A;UBC
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.546556849032821,-0.9657899659908136,0.5151515151515151,1.0,1.0,3/9,5.74%,CD74;ATM;RC3H1
prerank,Reactome_2022__Mitochondrial Protein Import R-HSA-1268020,0.5757737335873033,0.9657464182847418,0.6101694915254238,0.8851767561487899,1.0,1/9,10.70%,HSPA9
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.5684913142331803,-0.9656567697576287,0.5263157894736842,1.0,1.0,1/8,5.95%,TMEM106B
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.677367187138764,0.9656414072495083,0.6296296296296297,0.885022151288806,1.0,1/5,4.91%,GRIN2B
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.5670420981986103,0.9652612660266197,0.5671641791044776,0.8854259548867465,1.0,3/13,16.60%,HSP90AA1;KLF4;TNKS
prerank,PanglaoDB_Augmented_2021__Microfold Cells,0.47148985145580163,0.9651581432985908,0.5671641791044776,0.8852568190178703,1.0,13/30,21.70%,EHD4;BHLHE40;JUNB;NFE2L2;KLF4;FOSL2;SUSD6;LGALS3;NFIB;MGAT1;NFIC;ZFP36;B4GALT1
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.4158687609693964,0.9649854571400217,0.5180722891566265,0.8852672922724013,1.0,7/91,9.30%,LAMC1;SEC22B;SEC24D;MCFD2;TMED10;PICALM;SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.6010805995152946,0.9648165234720042,0.5625,0.8852244263826631,1.0,2/6,18.27%,ZBTB1;ZMIZ1
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.48486458745243327,0.9644266024963162,0.5432098765432098,0.8856952804846461,1.0,5/42,18.11%,KHDRBS3;YTHDC1;REST;SRSF7;TRA2B
prerank,Reactome_2022__SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.38589617952817684,-0.964414673012022,0.4444444444444444,1.0,1.0,11/42,12.91%,IFIH1;ISG15;STAT1;NOD1;NUP214;TRIM25;STAT2;LARP1;HLA-F;HLA-C;HLA-A
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.5792885533908607,0.9643986713485189,0.6086956521739131,0.8853955360186424,1.0,2/9,6.06%,GPC5;HYAL2
prerank,"Reactome_2022__Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",0.5941187408941201,0.9642655466950284,0.6031746031746031,0.8852800428461188,1.0,1/13,5.79%,NDUFA12
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.6288915101403374,0.9642343732903418,0.6,0.8849759015829974,1.0,3/8,18.43%,PIKFYVE;LGALS3;PDE4B
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.5664118510099101,0.964149393704927,0.6527777777777778,0.8848123162346941,1.0,4/10,7.25%,SCP2;PRKAG2;LBR;INSIG1
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.5753592687222359,0.9639195982961316,0.618421052631579,0.8849148257633509,1.0,6/12,27.76%,KLF4;PAK2;YWHAE;CSNK2A1;RPS6KA3;XIAP
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.6576870514681452,0.963859112075052,0.5614035087719298,0.8846257416088487,1.0,2/5,11.29%,RAP1A;MAGI2
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.6334388600318003,0.9638405525372088,0.6206896551724138,0.8842837652939435,1.0,3/9,18.09%,BCAP31;TGM2;HERPUD1
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.6125212946406969,0.9637884969343489,0.6031746031746031,0.8840145245121962,1.0,1/7,11.16%,SETD3
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.5467017278837378,0.9636813341480001,0.5507246376811594,0.8839048115976095,1.0,5/16,31.39%,GLUL;NPM1;XPO1;RPS15;RPS7
prerank,Reactome_2022__Metabolism Of Nucleotides R-HSA-15869,0.561924374596954,0.9632928954186735,0.5362318840579711,0.8843790159443845,1.0,4/14,17.32%,UPP1;TXNRD1;ADSS2;ADK
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.557229219496495,0.9630621548053996,0.5194805194805194,0.8845103836616967,1.0,5/18,21.83%,TMEM45B;ADGRG1;VWA2;LGALS3;GPRC5B
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.5518419639460269,0.9629710742824684,0.5466666666666666,0.8842848995945843,1.0,2/12,8.50%,IL1RAPL1;PPFIA2
prerank,Reactome_2022__CaM Pathway R-HSA-111997,0.5492243393944511,0.9626068815657922,0.5362318840579711,0.8846378534327948,1.0,5/11,28.47%,ADCY2;PRKX;ADCY9;CAMK2D;CALM1
prerank,KEGG_2021_Human__p53 signaling pathway,0.5193364128440618,0.962536356925575,0.6025641025641025,0.8844365928418759,1.0,4/22,11.87%,SERPINE1;PPM1D;CDK6;CDKN1A
prerank,Reactome_2022__DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.43953330594789275,-0.9624717999951276,0.6190476190476191,1.0,1.0,5/35,7.22%,IFIH1;ISG15;HERC5;CASP10;TRIM25
prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",0.4769543750843506,0.9624363355399084,0.5584415584415584,0.8843029100034177,1.0,15/36,26.40%,ITPR1;FGFR1;JUND;GNA13;CDKN1A;FOS;ADCY2;ATF2;PDE4B;ADCY9;PLCB1;MEF2C;CREB3L2;MAP2K1;EGFR
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.5215689321937408,0.9622222130533801,0.5142857142857142,0.8843618395418466,1.0,2/25,7.04%,BNIP3L;PINK1
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.6177104650715087,0.9621386870350251,0.5555555555555556,0.8841850122435514,1.0,1/8,3.82%,TRMT9B
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.5247204893271694,-0.9616465861303726,0.5666666666666667,1.0,1.0,3/10,12.48%,SHLD1;SHLD2;RNF169
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.5277397939687044,-0.9615072306288954,0.5172413793103449,1.0,1.0,2/11,2.95%,BABAM2;ATM
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.5215600480652529,0.9611239227474648,0.5333333333333333,0.8862874414630573,1.0,3/19,17.13%,BNIP3L;DENND3;MALT1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.4088349720979204,0.960953248118636,0.5568181818181818,0.8862829541943587,1.0,33/149,17.21%,RTN4;ERBB4;BCAP31;TRIM5;GAPDH;NRG2;FGFR1;PIK3R1;REL;PINK1;HSP90AA1;RPL23;GRB2;VWF;GJA1;PPM1A;FLT1;PELI1;RPL37;TAB2;NOS1AP;ITGB1;SLC20A1;ECT2;RAC1;NDFIP1;MTDH;ALPK1;BRD4;LIMS1;GOLPH3;MALT1;TGM2
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.5067531726576535,0.960861318477128,0.5333333333333333,0.8861055243688721,1.0,3/12,26.40%,PRNP;LDLR;EGFR
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.60663321477208,0.9608101963006631,0.578125,0.8858226045073448,1.0,1/6,7.36%,HSP90AA1
prerank,Reactome_2022__Collagen Degradation R-HSA-1442490,0.5978681441850695,0.9606260372718014,0.5737704918032787,0.8858519236542866,1.0,3/5,32.24%,COL18A1;ADAM9;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.6489330142568521,0.9605092228147967,0.5932203389830508,0.885770867301475,1.0,4/5,35.17%,ADAM9;MTOR;MAPRE2;IQSEC1
prerank,Reactome_2022__Basigin Interactions R-HSA-210991,0.5746538027136509,0.9604935909069047,0.5714285714285714,0.8854357059781042,1.0,8/10,40.88%,ATP1B3;ITGB1;ATP1B1;SLC7A5;SLC16A1;SLC7A11;SLC3A2;BSG
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.529296438776103,0.9600406440375012,0.5555555555555556,0.8861746194521413,1.0,4/24,11.47%,BCAP31;MAP3K5;KLF4;REST
prerank,Reactome_2022__Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,-0.6039671695989528,-0.9600101535307864,0.4642857142857143,1.0,1.0,2/7,10.36%,TNFSF10;CFLAR
prerank,KEGG_2021_Human__Endocrine and other factor-regulated calcium reabsorption,0.5258264877580627,0.9598759150994132,0.5694444444444444,0.8861701945139924,1.0,9/20,22.87%,SLC8A1;ATP2B1;ATP1A1;ATP1B3;ATP2B4;DNM2;ADCY9;PLCB1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.6495465148941115,0.9597571364600112,0.5806451612903226,0.8860795616501734,1.0,2/5,16.10%,SEMA6B;SEMA3F
prerank,Reactome_2022__Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.446762071731662,-0.9594899908197924,0.36,1.0,1.0,3/29,4.73%,HOMER2;SNX2;TPD52L1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.42364054062689327,-0.9591730514344488,0.5263157894736842,1.0,1.0,2/33,0.64%,VCAM1;THSD1
prerank,Reactome_2022__Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,0.6058074892997345,0.9591720635640976,0.578125,0.8870709760778138,1.0,2/8,14.10%,PACS1;AP1G1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.5697195517177138,0.9591096849866819,0.5373134328358209,0.8867934017907148,1.0,2/8,3.90%,PCK1;ANXA1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.5527246106554593,0.9590167163059341,0.6142857142857143,0.8866021671698694,1.0,1/16,4.20%,VAPB
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5481555423704789,0.9589640450999533,0.5285714285714286,0.8863298157142704,1.0,3/15,15.67%,AGO2;ZC3H7A;TUT7
prerank,Reactome_2022__Formation Of Early Elongation Complex R-HSA-113418,0.6164625910228538,0.9589628664340459,0.6153846153846154,0.8855756218091023,1.0,1/5,11.05%,CCNH
prerank,Reactome_2022__Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,0.6164625910228538,0.9589628664340459,0.6153846153846154,0.8855756218091023,1.0,1/5,11.05%,CCNH
prerank,Reactome_2022__Biological Oxidations R-HSA-211859,-0.41207478117594365,-0.9589303944251334,0.4838709677419355,1.0,1.0,3/24,5.82%,SLC38A3;ARNT2;MIA3
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreas,-0.5414216115273961,-0.9588841522629791,0.42857142857142855,1.0,1.0,3/5,19.58%,LDB2;UBA2;PLCE1
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.5284554790525386,0.9587949031504857,0.5151515151515151,0.8855953455966132,1.0,6/15,35.67%,RPS27;NPM1;RPL10;RPS15;RPL24;DDX3X
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.46940524570227354,0.9586820342435484,0.5822784810126582,0.8855243645050265,1.0,12/44,22.28%,ATF3;HSPH1;PINK1;HSP90AA1;SLC38A2;AMFR;TPR;NPAS2;NPM1;HSPA8;MCL1;YWHAE
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.596335362874223,0.9585868003922267,0.5671641791044776,0.8853627956232566,1.0,3/7,18.27%,TMF1;PLPP1;ZMIZ1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.6023610481014194,0.9585161874270747,0.5652173913043478,0.88512506266299,1.0,4/6,39.07%,TRAK1;MTM1;TRAK2;MEF2A
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.599799479252711,0.9582529137578625,0.5862068965517241,0.8853642232292057,1.0,1/7,4.14%,TIMP3
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6413851635212173,0.9576997319577435,0.6376811594202898,0.8861225460878351,1.0,3/6,21.14%,FGFR1;BCL2L1;MCL1
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.6140773002399974,0.9575286685788426,0.5714285714285714,0.8861705608829048,1.0,1/5,7.14%,ARHGAP21
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.517880536816894,0.9575085123039622,0.5540540540540541,0.8858471958783186,1.0,11/24,24.38%,PGK1;COL4A2;KLF4;CLDN5;FOXC1;ATF2;SPRED1;ATP2B4;SPARC;ADAMTS1;PPARG
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Prostate,0.5898599575817112,0.9573414537392152,0.6153846153846154,0.8857953547748976,1.0,3/9,13.68%,NES;ITGA1;ITGB1
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.6311627667012838,-0.9570194742671757,0.5,1.0,1.0,2/5,11.42%,SHLD1;SHLD2
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.6311627667012838,-0.9570194742671757,0.5,1.0,1.0,2/5,11.42%,SHLD1;SHLD2
prerank,Reactome_2022__Hedgehog Off State R-HSA-5610787,0.4917894072447558,0.9570009203162122,0.5263157894736842,0.8861906847681237,1.0,4/32,16.02%,PSMC6;RPS27A;ADCY2;PSMA7
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.5940421620045294,0.9569862233955637,0.6153846153846154,0.8858439539947957,1.0,4/8,7.25%,SCP2;PRKAG2;LBR;INSIG1
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.48297668579994196,0.956898011709527,0.5822784810126582,0.8857066343518942,1.0,6/27,14.18%,ERBB4;FGFR1;CDKN1B;FLT1;EEF1A1;ECT2
prerank,KEGG_2021_Human__Gastric acid secretion,0.5207632288427366,0.9567584000710901,0.5802469135802469,0.8855741829300949,1.0,11/20,28.47%,ITPR1;ATP1A1;ATP1B3;ADCY2;ACTB;ADCY9;PLCB1;ATP1B1;GNAI3;CAMK2D;CALM1
prerank,Reactome_2022__MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,0.5587965214175405,0.9565099043352747,0.578125,0.8857410015704589,1.0,5/11,31.37%,RPS27A;UBC;MAP2K1;MAP3K8;CUL1
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.4810596300300837,-0.9564731619283259,0.5333333333333333,1.0,1.0,2/16,6.61%,IFIH1;NUP214
prerank,KEGG_2021_Human__Hippo signaling pathway,0.45802207952911156,0.9563595366587442,0.5487804878048781,0.8856750996256971,1.0,7/56,9.46%,SERPINE1;WNT2B;PPP2R2B;SMAD7;CTNNA3;RASSF1;CTNNA1
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.6121557787124765,0.9559946048136075,0.5901639344262295,0.886154866278312,1.0,4/6,24.38%,SREBF2;SCARB1;ABCG1;PPARG
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,0.5865777129987358,0.955727275491063,0.6521739130434783,0.8864302982644271,1.0,1/11,3.59%,S1PR1
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.6295899968457894,0.955699219510253,0.5970149253731343,0.8860939835148061,1.0,4/6,29.24%,OGT;WDR82;TET2;KMT2A
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.6306414222367425,0.9556964609519711,0.6271186440677966,0.8857200492435464,1.0,3/5,32.19%,SREBF2;ABCG1;KPNB1
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.6510318716509274,0.955461952427034,0.671875,0.8858437508924293,1.0,3/6,30.23%,SCARB1;ABCG1;ABCA5
prerank,Reactome_2022__Cytoprotection By HMOX1 R-HSA-9707564,0.5125067525493936,0.9553054321432811,0.5507246376811594,0.8857779739102407,1.0,3/16,6.35%,MAFK;NFE2L2;SIN3B
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),0.42800514077058505,0.955239970260254,0.5609756097560976,0.8855229609072641,1.0,17/89,16.52%,RRBP1;RPS11;POLA1;RPS18;RPS9;RPS27A;RPL23;RFC3;RPL8;RPL34;RPL37;RPLP2;AGO2;EEF1A1;RPL13A;RPS12;GOLPH3
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.6658273152631822,0.9551460105149306,0.5964912280701754,0.8853769620543054,1.0,1/5,7.60%,RAB21
prerank,KEGG_2021_Human__Ether lipid metabolism,0.5422254221903852,0.9550485039995434,0.5737704918032787,0.8851648919667928,1.0,2/7,6.75%,CHPT1;ENPP2
prerank,Reactome_2022__Synthesis Of PIPs At Late Endosome Membrane R-HSA-1660517,0.5946732066883906,0.9547889441326675,0.5571428571428572,0.8853689129072648,1.0,4/6,32.64%,PIKFYVE;PIK3C3;MTMR9;MTM1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.5563384362231595,0.9545341501174388,0.5571428571428572,0.885501896407011,1.0,3/16,9.03%,WDR48;PINK1;OGT
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.6144906844899166,0.9541054926599191,0.5757575757575758,0.8860550448272191,1.0,2/6,27.49%,REST;HNRNPU
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.5845740857195956,0.9539122264570021,0.6060606060606061,0.886003534559054,1.0,3/14,11.87%,CDK6;KLF4;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.589651416531561,-0.9538535213154083,0.5806451612903226,1.0,1.0,1/5,2.95%,ATM
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.608014450533509,0.953757653290701,0.6129032258064516,0.8859143224655281,1.0,2/7,24.38%,FOXC1;PPARG
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.5048214614689592,0.9537251649592009,0.515625,0.8855846600092127,1.0,8/24,23.82%,BNIP3L;PINK1;BTBD10;NPAS2;INPP5A;CHMP4B;NCK1;FYN
prerank,Reactome_2022__Cristae Formation R-HSA-8949613,0.5990708294186444,0.9535356310457119,0.5909090909090909,0.8856276993545503,1.0,1/6,10.70%,HSPA9
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.5208131538632844,0.9534743135487506,0.5714285714285714,0.8854209559190422,1.0,3/19,9.03%,VSIR;SRGN;OGT
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.5362894468946587,0.9533131319287256,0.625,0.8854027957620142,1.0,5/17,17.85%,PPP2R3A;PGK1;HNRNPH3;DAG1;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.643483899944842,0.9529193486341625,0.6666666666666666,0.8857989717968292,1.0,2/6,17.00%,PPHLN1;TPR
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5638825527841999,0.9528551523360663,0.6268656716417911,0.8855783003441581,1.0,1/14,0.69%,SERPINE1
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.4205981642976414,-0.9528042658423731,0.5238095238095238,1.0,1.0,3/29,5.39%,PRIMPOL;ATR;RHBDD1
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.6130665019088579,0.9527504883916712,0.5660377358490566,0.8854895336129021,1.0,1/5,3.27%,GLUD1
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),-0.5108019163730262,-0.9526906538706812,0.5666666666666667,1.0,1.0,2/11,10.41%,TCF7L1;TLE4
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.5669246038531986,0.9523572590360653,0.6029411764705882,0.886101470045222,1.0,5/10,25.23%,CANX;GOLPH3;MIA2;RAB8B;SEL1L
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.5166981000039008,0.9518262259254772,0.5555555555555556,0.88697139906309,1.0,5/27,11.85%,SLC2A13;PICALM;LARP4;NSMAF;IFNGR1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.5641729710982142,0.9517763754361606,0.5882352941176471,0.8866989244672451,1.0,2/13,5.21%,S1PR1;CHSY1
prerank,Reactome_2022__Regulation Of Beta-Cell Development R-HSA-186712,-0.49238820822666185,-0.9515840253406526,0.4666666666666667,1.0,1.0,5/10,22.44%,FOXO1;MAML3;MAML2;MAP4K2;RBPJ
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Heart,0.4835675834542803,0.9513034979646062,0.4875,0.887295482430081,1.0,5/25,16.10%,PLS3;MYO1B;BCAR1;PCDH7;SEMA3F
prerank,Reactome_2022__PECAM1 Interactions R-HSA-210990,0.6178745180768355,0.9506066301954094,0.65625,0.8882623800189331,1.0,2/7,23.82%,PECAM1;FYN
prerank,Reactome_2022__Ca-dependent Events R-HSA-111996,-0.44899244812383554,-0.9506038233343292,0.5151515151515151,1.0,1.0,1/13,1.81%,PLA2G4A
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.5454807831719384,0.9505172308550762,0.5789473684210527,0.8881210880419208,1.0,4/10,20.85%,SSH1;HIP1R;GSN;ARFGEF1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.6323852480706771,0.950500517457232,0.6153846153846154,0.8874028522471146,1.0,2/6,19.50%,HIF1A;SULF2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.6323852480706771,0.950500517457232,0.6153846153846154,0.8874028522471146,1.0,2/6,19.50%,HIF1A;SULF2
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.5798513217635614,0.95044356926849,0.6176470588235294,0.8871121410660305,1.0,4/10,24.38%,CDKN1B;CDKN1A;MEF2C;PPARG
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.46507145179273324,0.950371363160597,0.5512820512820513,0.8868685187358251,1.0,5/35,16.95%,CLIC2;CLDN5;HIP1R;FOXC1;AMFR
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.6165416315039146,0.9500455262758382,0.6268656716417911,0.8871354775797072,1.0,1/7,1.54%,SUN2
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.5845308945650076,0.9495941326060315,0.5970149253731343,0.887355267166021,1.0,2/9,18.78%,DLC1;DUSP22
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.5845308945650076,0.9495941326060315,0.5970149253731343,0.887355267166021,1.0,2/9,18.78%,DLC1;DUSP22
prerank,KEGG_2021_Human__GnRH signaling pathway,0.4574282903904372,0.9491379247585724,0.5066666666666667,0.888047237040192,1.0,7/33,15.30%,ITPR1;CACNA1C;GRB2;JUN;MAPK10;KRAS;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.6252605852889391,0.9488171480124643,0.5818181818181818,0.8884160866088585,1.0,4/6,23.03%,BOC;BTG1;PLCB1;MEF2C
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.5425810214481851,-0.9488134171162145,0.5588235294117647,1.0,1.0,3/10,8.50%,ATM;ATR;MDM2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5332153171957192,0.9486449318705112,0.6086956521739131,0.888434189503844,1.0,8/16,35.33%,KLF4;ATP2B4;MEF2C;PPARG;MECP2;RGCC;ACVRL1;DLL4
prerank,Reactome_2022__RHO GTPases Activate IQGAPs R-HSA-5626467,0.6135535592931879,0.9484010382758904,0.5909090909090909,0.8886624500604616,1.0,4/7,33.94%,CTNNA1;CDC42;CALM1;IQGAP1
prerank,Reactome_2022__Signaling By NOTCH4 R-HSA-9013694,0.4865968566114189,0.9481955063925233,0.5616438356164384,0.8887971475448904,1.0,7/28,25.37%,PSMC6;RPS27A;PSMA7;NOTCH4;UBC;CREBBP;PSMB9
prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,0.4837107907718822,0.9481876191884239,0.5441176470588235,0.8884464075601636,1.0,9/28,23.16%,JAK1;JAG2;JUN;IFNGR1;FOS;MAPK10;IFNGR2;PPP3CB;PPP3CC
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.5818233802561715,0.9481760797696843,0.5352112676056338,0.8881052919159934,1.0,4/9,23.69%,PTBP2;SRSF7;TMBIM6;PTBP3
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.6113961639057062,0.9481759408182873,0.6231884057971014,0.8877318245939093,1.0,3/8,23.03%,REST;PDE4B;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5870915057057258,0.9480573357856181,0.6101694915254238,0.8875497596568954,1.0,2/8,11.87%,GRB2;CDKN1A
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.5530780952575927,-0.9478908434259452,0.4666666666666667,1.0,1.0,2/6,10.36%,PGM5;CFLAR
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.5903201721436703,0.9477180336005148,0.6060606060606061,0.8879921181756051,1.0,4/9,27.81%,BRD4;RNF168;HNRNPU;WDR43
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.5082589683101587,-0.9476377093897503,0.5151515151515151,1.0,1.0,3/16,2.15%,VCAM1;CD74;IL15
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.6242021276595746,0.9475279766391671,0.576271186440678,0.8880196518655536,1.0,5/5,37.66%,LGALS3;MSN;STK10;PTK2;MAPK1
prerank,Reactome_2022__Diseases Of Metabolism R-HSA-5668914,0.4753317317207265,0.9471765664851034,0.6533333333333333,0.8883636904122446,1.0,16/39,24.46%,ADAMTS9;GPC5;CHSY1;PRNP;RPS27A;SLC26A2;DAG1;EGFL7;NOTCH4;PMM2;EXT1;B4GALT1;UBC;ADAMTS1;GBE1;LMBRD1
prerank,KEGG_2021_Human__Propanoate metabolism,0.6068964651715607,0.9470711652613514,0.6724137931034483,0.8882002774051497,1.0,2/9,4.94%,LDHA;ACOX1
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Plasma,0.6011242516528964,0.9468869582697579,0.5671641791044776,0.8878366707485733,1.0,1/6,20.88%,DENND4A
prerank,CellMarker_Augmented_2021__Erythroblast:Fetal Liver,0.6011242516528964,0.9468869582697579,0.5671641791044776,0.8878366707485733,1.0,1/6,20.88%,DENND4A
prerank,CellMarker_Augmented_2021__Adipose Multilineage-Differentiating Stress-Enduring cell:Adipose Tissue,0.4656323785404265,0.9464203907007673,0.5151515151515151,0.8883335608695452,1.0,3/22,10.68%,TIMP3;COL4A2;LRRC32
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.6703430556994623,0.9461261277127251,0.640625,0.888565265510857,1.0,1/5,5.26%,WDR48
prerank,Reactome_2022__Programmed Cell Death R-HSA-5357801,0.42685035336754223,0.9458728333829699,0.6091954022988506,0.8886296235002064,1.0,23/71,25.37%,PSMC6;BCAP31;HSP90AA1;RPS27A;OGT;PELI1;PSMA7;SDCBP;STAT3;CHMP4B;GSN;BCL2L1;TNFRSF10B;CDC37;YWHAB;AVEN;YWHAE;UBC;PPP3CC;KPNA1;PLEC;ADD1;PSMB9
prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,0.5041627737207024,0.9453721374272753,0.5679012345679012,0.8893576169343739,1.0,9/28,17.10%,SLC8A1;CACNA1C;CTNNA3;ITGA1;CTNNA1;GJA1;ITGB1;DMD;DAG1
prerank,Reactome_2022__Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.4886610173866592,-0.9449996706542015,0.5483870967741935,1.0,1.0,3/12,8.21%,MLLT3;RTF1;MLLT1
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5393896423108158,0.9448928149463462,0.5352112676056338,0.8900061340522637,1.0,3/14,13.68%,ROBO2;PECAM1;ITGB1
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.4947153864435511,0.9445948821853686,0.5609756097560976,0.8902645753480519,1.0,7/38,20.82%,PBRM1;BAZ1A;ZBTB1;SMARCC1;MBD2;NPM1;ACTB
prerank,Reactome_2022__Mitochondrial Biogenesis R-HSA-1592230,0.5011304726698519,0.9445695033271038,0.5,0.8899341094298048,1.0,4/24,10.70%,PRKAG2;GLUD1;CRTC3;HSPA9
prerank,KEGG_2021_Human__Dilated cardiomyopathy,0.5291228290869635,0.9441086846399416,0.5949367088607594,0.8905445052129752,1.0,10/26,21.89%,SLC8A1;CACNA1C;TPM4;ITGA1;ITGB1;ADCY2;DMD;DAG1;ACTB;ADCY9
prerank,Reactome_2022__MET Receptor Recycling R-HSA-8875656,0.6349316284309554,0.9437848207299466,0.6271186440677966,0.8908487126710942,1.0,2/5,15.72%,GRB2;CRK
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.5254796074063011,0.9437525287955485,0.5492957746478874,0.8905461941403344,1.0,7/15,13.52%,SLC8A1;S1PR1;GPM6B;SRGN;ATP2B1;ANO6;ACVR2A
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.5986839556682024,0.9433628239403549,0.6166666666666667,0.8909889757049474,1.0,1/6,1.91%,PRKAG2
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.5450284643517787,0.9433392218538312,0.6197183098591549,0.8906959024606129,1.0,3/12,14.32%,PRKAG2;PIK3R1;GRB10
prerank,Reactome_2022__Reproduction R-HSA-1474165,0.5370271524769638,0.9430551153061519,0.6285714285714286,0.8908793214554221,1.0,3/17,9.99%,SUN2;CD9;RAD21
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.5753249948245968,0.9429535570897821,0.6515151515151515,0.8907159497059639,1.0,1/11,2.55%,TBX3
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreas,0.45483423560810876,0.9427263622030594,0.5555555555555556,0.8909130672345504,1.0,5/30,15.75%,MAP2;LAMA5;BCAR1;PCDH7;NAV2
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.3815271039765966,-0.9422391960034251,0.5416666666666666,1.0,1.0,4/42,3.56%,MLLT3;ANKRD6;ZNRF3;NKD1
prerank,Reactome_2022__HCMV Infection R-HSA-9609646,-0.39317791935898044,-0.9418680411097027,0.5925925925925926,1.0,1.0,5/35,6.77%,MVB12B;TBL1X;H2AC6;NUP214;TBL1XR1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.42181129176153365,-0.9418667573324252,0.5882352941176471,1.0,1.0,4/24,9.35%,BABAM2;TOX;PDGFB;OTUD4
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.5412909730171294,0.9418099534137769,0.59375,0.8924584730117174,1.0,3/13,17.13%,ZBTB1;CD55;MALT1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.41216878972207616,-0.940990443643098,0.5142857142857142,1.0,1.0,2/20,1.86%,CD74;IFIH1
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.6044796321393546,0.9409712678627572,0.6268656716417911,0.8938456458040283,1.0,3/7,23.27%,ADGRB3;SCARF1;ANKS1A
prerank,Reactome_2022__APC Truncation Mutants Have Impaired AXIN Binding R-HSA-5467337,-0.5446167975018357,-0.9409156402632637,0.6060606060606061,1.0,1.0,1/6,8.63%,PPP2R5A
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5402290507664375,0.9409047014807352,0.6307692307692307,0.8936213276994643,1.0,1/11,1.38%,LRRC7
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.602804788049824,0.9405662023469156,0.5633802816901409,0.8939875610085264,1.0,2/6,21.59%,STAT3;ZFP36
prerank,Reactome_2022__SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,0.5070501155537789,0.9402790250011017,0.6027397260273972,0.8942059599279188,1.0,5/18,18.86%,RPS11;RPS9;RPS27A;RPS12;RPS27
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.5789860407252944,0.9402448094346431,0.639344262295082,0.8938988207270905,1.0,4/9,29.93%,ARFGEF1;LRCH1;WNK1;DAB2IP
prerank,Reactome_2022__ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,0.6586609640744312,0.9401727287396,0.6166666666666667,0.8936472144484072,1.0,3/6,18.09%,ATF3;DCP2;HERPUD1
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,0.4331148072619907,0.939720085933349,0.5897435897435898,0.8942108248741577,1.0,8/56,12.32%,PBX3;BCL6;NFKBIZ;DUSP6;REL;CDKN1B;CDKN1A;FLT1
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.4817720951636986,0.93969416249761,0.5945945945945946,0.8938672449271784,1.0,8/30,23.08%,ANXA1;CDK6;KLF4;CDKN1A;KMT2E;SLFN11;PLCB1;ADAMTS1
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.6522580134508855,0.9395348017102055,0.6417910447761194,0.8937585879623565,1.0,1/5,7.28%,SMAD5
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.5257792779164931,0.9393588151746852,0.5846153846153846,0.8937603931478174,1.0,9/14,33.09%,GGT5;PELI1;TAB2;ERBIN;SMAD6;RPS6KA3;IFNAR1;ADAM17;CYRIB
prerank,Reactome_2022__p53-Dependent G1 DNA Damage Response R-HSA-69563,0.519610583794878,0.9392354945358429,0.5675675675675675,0.8932907117350302,1.0,5/20,16.02%,PSMC6;RPS27A;CDKN1B;CDKN1A;PSMA7
prerank,Reactome_2022__G1/S DNA Damage Checkpoints R-HSA-69615,0.519610583794878,0.9392354945358429,0.5675675675675675,0.8932907117350302,1.0,5/20,16.02%,PSMC6;RPS27A;CDKN1B;CDKN1A;PSMA7
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.6018384277106736,0.9392336845559887,0.546875,0.8929298521102574,1.0,1/5,11.37%,ANXA2
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.6052273865888917,0.9392285522026569,0.5789473684210527,0.8918215403368479,1.0,3/5,32.24%,OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.6052273865888917,0.9392285522026569,0.5789473684210527,0.8918215403368479,1.0,3/5,32.24%,OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.6052273865888917,0.9392285522026569,0.5789473684210527,0.8918215403368479,1.0,3/5,32.24%,OXSR1;WNK1;ADAM17
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex8:Brain,0.5062550767592273,0.9391521162780537,0.618421052631579,0.8915902798416728,1.0,6/18,16.49%,RRBP1;ATP8B1;CTNNA3;PECAM1;MGAT5;LIMS1
prerank,Reactome_2022__Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,0.5609530286297467,0.9389224122096441,0.6271186440677966,0.8917488186710807,1.0,7/9,33.33%,CDKN1A;NPM1;CREBBP;EGFR;YY1;DEK;EP300
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.5999680167759842,-0.9388742524275705,0.6388888888888888,1.0,1.0,2/5,9.38%,ALS2;AUTS2
prerank,Reactome_2022__Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.542206001441438,-0.9385895058300652,0.5,1.0,1.0,3/9,8.58%,GMDS;ST3GAL6;ST3GAL1
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Endometrium,-0.5827831676135975,-0.9385592390635025,0.6129032258064516,1.0,1.0,2/9,4.65%,VCAM1;ABCG2
prerank,Reactome_2022__Signaling By Hippo R-HSA-2028269,0.5868582551675384,0.9383893098062602,0.6438356164383562,0.8926128130345485,1.0,3/10,22.28%,WWTR1;YWHAB;YWHAE
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.5715898624729367,0.9378684811860892,0.6176470588235294,0.89330663962722,1.0,6/8,28.90%,ANK2;VMP1;ATP1B1;AKAP6;CALM1;RYR2
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.4207532874378679,0.9376444029533827,0.5974025974025974,0.8934505395868616,1.0,20/71,25.44%,PCK1;PKN3;PRKCE;PINK1;PIKFYVE;STK38L;STK38;PAK2;TNKS;PRKX;CSNK1G3;CSNK1D;CAB39;MORC3;PRKCH;CSNK2A1;WNK1;HIPK3;RPS6KA3;MTOR
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4710519472160298,0.9376063144868101,0.6388888888888888,0.8931412910166516,1.0,5/29,14.10%,CANX;ARF1;SEC24D;PIKFYVE;AP1G1
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.5101471619058792,0.9375695980870796,0.5714285714285714,0.8928734651345775,1.0,8/17,28.47%,DLC1;HSP90B1;ENSA;ARPP19;YWHAB;CDH5;SPPL3;CALM1
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.4634877958089163,0.9373699610070239,0.5492957746478874,0.8929442091578667,1.0,7/23,21.30%,KDM1A;OGT;GJA1;GRB10;ALMS1;DYNC1H1;EPAS1
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.41081452864533696,0.937224717404872,0.6022727272727273,0.8928549308831822,1.0,29/123,25.74%,RRBP1;RPS11;RPS18;RPS9;RPS27A;RPL23;YTHDC1;RPL8;RPL34;RPL37;RPLP2;AGO2;EEF1A1;RPL13A;SRSF7;RPS12;HNRNPH3;GOLPH3;TPR;RPS27;RBMS2;RBPMS;RPL10;SETX;RPL37A;THOC2;RPL21;RPLP1;SRSF11
prerank,Reactome_2022__Oxidative Stress Induced Senescence R-HSA-2559580,0.4786987869830327,0.937129912988821,0.581081081081081,0.8927063354690585,1.0,6/28,13.39%,MAP3K5;RPS27A;CDK6;JUN;FOS;MAPK10
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.48868744081927595,0.9371098210701084,0.5230769230769231,0.8924117301497831,1.0,7/19,21.30%,KDM1A;OGT;GJA1;GRB10;ALMS1;DYNC1H1;EPAS1
prerank,Reactome_2022__ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,-0.5451156690023384,-0.9370860723120799,0.5135135135135135,1.0,1.0,1/7,4.14%,H2AC6
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.6030613259681776,0.9370563535463049,0.6451612903225806,0.8921401911765237,1.0,4/8,30.23%,ABCG1;PRKCH;PPARG;ABCA5
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.6246331680989627,0.9367961279253462,0.5833333333333334,0.8923069117915592,1.0,2/6,8.63%,MBP;KLF4
prerank,Reactome_2022__Visual Phototransduction R-HSA-2187338,0.5378682809148719,0.9366533986673443,0.5405405405405406,0.8922728112848473,1.0,1/12,4.33%,GPC5
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.46167591199533226,0.9366030547491723,0.620253164556962,0.8920244600087992,1.0,13/36,25.37%,PSMC6;SIN3B;LSS;PLPP1;NCOR2;PSMA7;PSAP;NR1D2;SREBF2;LDLR;PPARG;CREBBP;PSMB9
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.5404520992562296,0.9362825906317568,0.5636363636363636,0.8922639386138024,1.0,3/11,26.40%,BTBD10;SDCBP;EGFR
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.4890109468636661,-0.9361137251821328,0.5714285714285714,1.0,1.0,2/16,0.77%,GBP1;HOMER2
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.5498526608365981,0.9358750463589356,0.6533333333333333,0.8927993199766653,1.0,3/13,5.02%,TBX3;ANXA1;ZBTB1
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone Marrow,0.4473094863364556,0.9357165166667334,0.5844155844155844,0.8928015013196354,1.0,8/44,13.39%,PTPRD;SGIP1;CACNA1C;NFASC;ENPP2;VWF;TMEM132C;MAPK10
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.48687993819664244,0.9355838837321143,0.6216216216216216,0.8926261670121169,1.0,5/20,24.38%,SMAD7;SMAD5;ACVR2A;SMAD6;PPARG
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.5341688649460149,0.9349938024225896,0.5942028985507246,0.8934655752419832,1.0,2/12,3.80%,GLUD1;GLUL
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.47354528476680013,0.9348778385343883,0.573170731707317,0.8933765225510609,1.0,4/30,14.08%,GPM6B;CDK6;ADAM15;RASA1
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.6336345414925398,0.9348217776737643,0.6612903225806451,0.8931102473687395,1.0,2/5,19.50%,CHST11;SULF2
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.42663924657526375,-0.9346037083411967,0.5862068965517241,1.0,1.0,5/33,5.82%,SLC22A5;SLC38A3;ABCG2;SLC25A29;MIA3
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.5784578893421091,0.9342420679091606,0.6428571428571429,0.8935004412772428,1.0,4/9,17.00%,HYAL2;PIK3R1;ECT2;TPR
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.5784578893421091,0.9342420679091606,0.6428571428571429,0.8935004412772428,1.0,4/9,17.00%,HYAL2;PIK3R1;ECT2;TPR
prerank,CellMarker_Augmented_2021__Basophil:Umbilical Cord Blood,-0.5132755226010768,-0.9333288890498109,0.5405405405405406,1.0,1.0,2/5,22.52%,RCSD1;GIMAP7
prerank,CellMarker_Augmented_2021__T cell:Eye,-0.5132755226010768,-0.9333288890498109,0.5405405405405406,1.0,1.0,2/5,22.52%,RCSD1;GIMAP7
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.4115714844112941,0.9330298534292119,0.6375,0.8954093199549161,1.0,24/70,29.69%,PCK1;PKN3;PRKCE;PINK1;STK38L;STK38;PAK2;TNKS;PRKX;CSNK1G3;CSNK1D;CAB39;MORC3;PRKCH;CSNK2A1;WNK1;HIPK3;RPS6KA3;MTOR;MARK3;CAMK2D;TLK2;SMG1;RPS6KA2
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.4277124155728722,-0.933008278540949,0.5,1.0,1.0,5/17,13.81%,SLC38A3;SLC25A29;SLC16A2;SLC38A6;SLC23A2
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.6069653522456513,0.932897312102739,0.6197183098591549,0.8953196538864833,1.0,5/8,22.28%,PRKCE;NEDD4L;CAB39;NEDD4;YWHAE
prerank,Reactome_2022__MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,0.4542954823320183,0.9328815722241264,0.6521739130434783,0.8939059583658002,1.0,8/39,15.94%,DUSP6;RPS27A;JUN;FOS;PELI1;TAB2;MAPK10;ALPK1
prerank,Reactome_2022__Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,0.4542954823320183,0.9328815722241264,0.6521739130434783,0.8939059583658002,1.0,8/39,15.94%,DUSP6;RPS27A;JUN;FOS;PELI1;TAB2;MAPK10;ALPK1
prerank,Reactome_2022__MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,0.4542954823320183,0.9328815722241264,0.6521739130434783,0.8939059583658002,1.0,8/39,15.94%,DUSP6;RPS27A;JUN;FOS;PELI1;TAB2;MAPK10;ALPK1
prerank,Reactome_2022__TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,0.4542954823320183,0.9328815722241264,0.6521739130434783,0.8939059583658002,1.0,8/39,15.94%,DUSP6;RPS27A;JUN;FOS;PELI1;TAB2;MAPK10;ALPK1
prerank,Reactome_2022__Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,0.5259671923349138,0.9323322085125609,0.5540540540540541,0.8946233094919824,1.0,2/15,8.07%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.5153621849504199,0.9320502388151892,0.5573770491803278,0.8948420524243722,1.0,3/15,12.32%,MAP3K5;FGFR1;FLT1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.48506274251571596,-0.9317132359129167,0.5428571428571428,1.0,1.0,1/11,2.95%,ATM
prerank,Reactome_2022__RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,0.5242594320863104,0.9316867034003069,0.6164383561643836,0.8952371162857575,1.0,9/19,31.45%,GRB2;ARPC2;ABI1;WIPF1;NCK1;WASL;CDC42;ACTR2;PTK2
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.4674073704172513,0.9312548251515779,0.6376811594202898,0.895753999881529,1.0,8/35,22.15%,TIMP3;PLSCR4;COL4A2;GJA1;FZD4;EPAS1;CALD1;CDH5
prerank,CellMarker_Augmented_2021__Endothelial cell:Skin,0.4641072272177118,0.9312279798882221,0.5789473684210527,0.8954339035878041,1.0,13/40,22.52%,GGT5;VWF;ZNF366;PECAM1;LRRC32;FLT1;CLDN5;DYSF;TNS1;ESAM;NOTCH4;CDH5;SCARF1
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.498851665831377,0.9312142120711381,0.5694444444444444,0.8950869477180442,1.0,7/20,23.98%,SPOCK1;RAC1;LIMS1;RSU1;FZD4;TBCD;EMP2
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.6246703078565423,0.9311971189880106,0.6349206349206349,0.8947538293698982,1.0,1/6,5.10%,ROBO2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.4854707806788287,0.931136339384729,0.5714285714285714,0.8945338926738358,1.0,1/22,0.61%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.5546366564653111,0.9307639773418241,0.6351351351351351,0.8948197671403432,1.0,3/10,14.74%,FES;NAV3;RAC1
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.6373375805660701,0.9306493347403583,0.7258064516129032,0.8946812118579658,1.0,1/5,16.10%,SEMA3F
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.5207340949823668,0.9305848755359697,0.5303030303030303,0.894425485950132,1.0,3/16,9.85%,TIMP3;COL4A2;GJA1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.5427746790012156,-0.9300350015789023,0.6,1.0,1.0,2/6,4.25%,STAT1;PARP9
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.5029621368355156,0.9300136830489488,0.625,0.8952476343680711,1.0,1/23,1.01%,RFTN1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.4230768875123728,-0.9299636668301544,0.48,1.0,1.0,3/28,4.73%,EIF2AK2;ANKRD6;TPD52L1
prerank,Reactome_2022__Transcriptional Regulation By RUNX1 R-HSA-8878171,0.4344352735013829,0.9293586493815408,0.6179775280898876,0.8962584180833146,1.0,15/65,19.87%,PSMC6;PBRM1;SIN3B;CBFB;RPS27A;CDK6;CCNH;AGO2;CLDN5;SMARCC1;PSMA7;GATA2;LGALS3;SOCS3;KMT2E
prerank,Reactome_2022__Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,0.5324365770091919,0.9289989725758719,0.6027397260273972,0.8962013765277027,1.0,3/12,10.36%,VWF;RAP1A;PEBP1
prerank,Reactome_2022__MAP2K And MAPK Activation R-HSA-5674135,0.5324365770091919,0.9289989725758719,0.6027397260273972,0.8962013765277027,1.0,3/12,10.36%,VWF;RAP1A;PEBP1
prerank,Reactome_2022__NRIF Signals Cell Death From Nucleus R-HSA-205043,0.5781569645782533,0.9289928023637073,0.6440677966101694,0.8958555177288962,1.0,2/6,22.42%,RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.47692769096873205,0.9289265192489001,0.6575342465753424,0.8956314373449843,1.0,10/26,30.81%,TSG101;SDCBP;TPR;LGALS3;CDH5;RACK1;VCP;RGCC;DAB2IP;RAB7A
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.6004801496478432,0.9286693864335693,0.6507936507936508,0.8958033705806442,1.0,3/7,35.09%,TRA2B;PRPF8;SRRM1
prerank,Reactome_2022__Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,0.5274387890890213,0.9286295502635151,0.5945945945945946,0.8955210416379115,1.0,8/15,28.47%,VWF;RAP1A;PEBP1;YWHAB;MAP2K1;MARK3;CAMK2D;CALM1
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.5426554158734799,0.9286052492303475,0.6,0.8951939971581775,1.0,4/12,25.66%,NAV3;ARHGEF2;TAOK1;HDGFL3
prerank,Reactome_2022__Protein-protein Interactions At Synapses R-HSA-6794362,0.4732255224399091,0.9281381376781673,0.5833333333333334,0.8957882050229122,1.0,10/30,17.16%,IL1RAPL1;PTPRD;GRIN2B;LRRTM4;PPFIA2;NRXN3;NRXN1;DLGAP2;SYT1;RTN3
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.43370793607617514,-0.9280589887723445,0.5416666666666666,1.0,1.0,5/30,7.22%,IFIH1;ISG15;HERC5;IRF1;TRIM25
prerank,Reactome_2022__Tie2 Signaling R-HSA-210993,0.5847095744586642,0.9278459578535857,0.6417910447761194,0.8960316490401224,1.0,2/9,8.31%,PIK3R1;GRB2
prerank,CellMarker_Augmented_2021__Muscle Satellite cell:Muscle,0.5333491462137163,0.9277307003163547,0.6027397260273972,0.8959247552387727,1.0,7/18,16.36%,NFASC;NAV1;EMP1;BOC;ADGRG1;VWA2;PLXNA2
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.48451490865410896,0.9277160292244753,0.5584415584415584,0.8955846152908145,1.0,7/20,25.68%,CCDC88A;CNOT6L;SDCBP;DYNC1H1;RAB3GAP2;ASAP1;FSCN1
prerank,Reactome_2022__mTORC1-mediated Signaling R-HSA-166208,0.6363014600200247,0.9275734881402415,0.6521739130434783,0.8955318130293326,1.0,3/6,26.14%,YWHAB;MTOR;SLC38A9
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.5870505876782344,0.9274506406696221,0.609375,0.8954028333297139,1.0,2/7,13.78%,TRIM5;CD55
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),0.5745981876747301,0.927316897603081,0.5909090909090909,0.8952739578982437,1.0,3/7,33.25%,RPS27;RPS15;PRKDC
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.5442383366084149,0.9271050683751346,0.6231884057971014,0.8953333430239726,1.0,3/11,16.52%,ANK3;PREPL;GOLPH3
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5169017286321159,0.9269723928219467,0.5833333333333334,0.8951956435471207,1.0,5/14,27.76%,KLF4;YWHAE;CSNK2A1;RPS6KA3;XIAP
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.5965980174992863,0.9267472225276793,0.589041095890411,0.895295299017218,1.0,2/7,16.02%,NFE2L2;PSMA7
prerank,CellMarker_Augmented_2021__Bulge Stem cell:Scalp,0.4526696392688373,0.9267223663539169,0.5394736842105263,0.8949653229164716,1.0,8/31,12.83%,DOK5;PPP2R2B;S1PR1;GPM6B;CACNA1C;LRRC4C;NRXN1;TMEM132C
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.6251708633199782,0.9266568989499878,0.6060606060606061,0.8947697936149203,1.0,2/5,23.77%,EIF3A;EIF5
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.5533442799627801,0.9265667506911334,0.609375,0.8945923055285585,1.0,3/8,25.31%,NAA16;NAA50;CREBBP
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Kidney,0.4567983069192881,0.9263867747063,0.6052631578947368,0.8945624401771733,1.0,9/33,15.86%,PPP2R2B;DPP10;MGAT4A;GPM6B;GAS7;NRXN1;TMEM132C;SH2D3C;NCALD
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5571241954045149,0.9262299810556067,0.6065573770491803,0.8945594025708739,1.0,1/9,13.01%,GIGYF2
prerank,Reactome_2022__Chaperonin-mediated Protein Folding R-HSA-390466,0.5003547627085334,0.9260812690982638,0.5972222222222222,0.8944045410649137,1.0,6/23,18.62%,TUBB4B;RGS7;TUBA1B;TUBB6;STAT3;ARFGEF2
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.5929817537609783,0.9257618440570211,0.5967741935483871,0.8946024352093511,1.0,1/5,17.37%,HDAC7
prerank,Reactome_2022__Pyroptosis R-HSA-5620971,-0.6007423500294033,-0.9255816472250679,0.5588235294117647,1.0,1.0,3/5,18.83%,IRF1;IRF2;CASP4
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.4827039393966645,0.9253639759114337,0.6,0.8951214259344399,1.0,6/20,23.03%,ROBO2;ARID5A;ATP1A1;STAT3;TFPI;MEF2C
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.4929506464374998,0.9252215172459206,0.6301369863013698,0.895046806889846,1.0,7/26,13.94%,CD9;CTNND2;SMAD7;CTNNA1;GJA1;CLDN5;PAK2
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.4758585063763409,0.9252166074679118,0.6144578313253012,0.8946913750369617,1.0,5/33,18.78%,GPM6B;DLC1;RAC1;LIMS1;DUSP22
prerank,Reactome_2022__G Alpha (I) Signaling Events R-HSA-418594,0.43563574285887513,0.9247764613705384,0.5925925925925926,0.8952052477151174,1.0,12/42,23.16%,ITPR1;GRM7;ANXA1;RGS7;ADCY2;PRKX;PDE4B;AHCYL1;PPP3CB;ADCY9;PLCB1;PPP3CC
prerank,Reactome_2022__Cytochrome C-Mediated Apoptotic Response R-HSA-111461,0.595848677732468,0.9238119636344594,0.639344262295082,0.8960900727263593,1.0,3/5,37.66%,AVEN;XIAP;MAPK1
prerank,Reactome_2022__Apoptotic Factor-Mediated Response R-HSA-111471,0.595848677732468,0.9238119636344594,0.639344262295082,0.8960900727263593,1.0,3/5,37.66%,AVEN;XIAP;MAPK1
prerank,Reactome_2022__Formation Of Apoptosome R-HSA-111458,0.595848677732468,0.9238119636344594,0.639344262295082,0.8960900727263593,1.0,3/5,37.66%,AVEN;XIAP;MAPK1
prerank,Reactome_2022__Signaling By NOTCH1 R-HSA-1980143,0.4532136808768438,0.9237159972945144,0.5844155844155844,0.8958951120970032,1.0,8/34,17.37%,CNTN1;RPS27A;JAG2;MIB1;HIF1A;CCNC;NCOR2;HDAC7
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.5531235978724746,0.9233585724583538,0.6086956521739131,0.896247358824074,1.0,1/12,5.10%,ROBO2
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),0.4886757311002644,0.9232554426925937,0.5942028985507246,0.8960836119703908,1.0,5/27,12.19%,NES;KDM1A;JUN;CDKN1A;WAPL
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.5879288214581412,-0.9231205710202842,0.627906976744186,1.0,1.0,4/5,23.53%,ACBD6;HADHB;PCCA;DECR1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.431435042861309,-0.9227631873326606,0.5151515151515151,1.0,1.0,3/16,6.11%,DCP1A;RC3H1;PARN
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.6382584357603815,-0.9224504696983048,0.5853658536585366,1.0,1.0,2/5,12.06%,TNFRSF1B;PARD3
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.46997322688700804,-0.9220539834373263,0.4642857142857143,1.0,1.0,2/16,2.18%,PRIMPOL;ISG15
prerank,KEGG_2021_Human__Ferroptosis,0.5410862351260741,0.9218833863633765,0.6666666666666666,0.8984664103900826,1.0,2/16,7.30%,PRNP;ACSL5
prerank,Reactome_2022__Response Of Mtb To Phagocytosis R-HSA-9637690,-0.47434309279356635,-0.9217342708240795,0.6176470588235294,1.0,1.0,1/12,0.37%,RNF213
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.6139723223661159,-0.9212982363275319,0.5945945945945946,1.0,1.0,3/5,16.76%,GSPT1;CLEC16A;IGF1R
prerank,Reactome_2022__PKA-mediated Phosphorylation Of CREB R-HSA-111931,0.5320665316656318,0.9211743906663675,0.6029411764705882,0.8995812659430393,1.0,4/10,28.47%,ADCY2;PRKX;ADCY9;CALM1
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.4604887636073126,0.921140362881236,0.625,0.899274286447348,1.0,9/42,12.96%,NES;ANK2;MAP1B;NFASC;COL4A2;GJA1;BOC;BCAR1;SHC2
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),0.5900276693004158,0.9208597250059829,0.6349206349206349,0.8994779993724614,1.0,2/6,9.91%,ARID5A;ZNF366
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.550873914859894,0.920783398862518,0.6176470588235294,0.8992733553578414,1.0,2/11,12.01%,SMAD7;FOXF1
prerank,Reactome_2022__Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,0.49322388949145646,0.9207370214847536,0.6285714285714286,0.8990245239033662,1.0,7/19,34.98%,RPS27A;LRRFIP1;UBC;CREBBP;PRKDC;EP300;TBK1
prerank,Reactome_2022__Resolution Of Sister Chromatid Cohesion R-HSA-2500257,0.4704094011475921,0.9205309222231901,0.5949367088607594,0.8990507586489904,1.0,14/29,33.07%,RAD21;WAPL;AHCTF1;RPS27;DYNC1H1;PAFAH1B1;TAOK1;SPC25;XPO1;SMC3;DYNC1I2;PPP2R5C;NDEL1;RANBP2
prerank,Reactome_2022__Diseases Of Glycosylation R-HSA-3781865,0.48357435322379133,0.9203629032309314,0.65,0.8990725408533444,1.0,11/25,23.08%,ADAMTS9;GPC5;CHSY1;SLC26A2;DAG1;EGFL7;NOTCH4;PMM2;EXT1;B4GALT1;ADAMTS1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.5981621389869668,0.9203015856602238,0.6507936507936508,0.8988639560659761,1.0,4/5,39.26%,XIAP;DDX3X;PRKN;BIRC2
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.6155643188984671,0.920242915025851,0.6229508196721312,0.8982215466835024,1.0,1/5,6.91%,PRNP
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.6155643188984671,0.920242915025851,0.6229508196721312,0.8982215466835024,1.0,1/5,6.91%,PRNP
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.5915247855197534,0.9201216284075323,0.6666666666666666,0.8980887676254107,1.0,1/7,4.86%,SYTL4
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Undefined,-0.38639962037580755,-0.919672049866884,0.5769230769230769,1.0,1.0,1/34,0.16%,VCAM1
prerank,Reactome_2022__MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,0.4495136186939798,0.919668682795952,0.7014925373134329,0.8987300725690351,1.0,8/40,15.94%,DUSP6;RPS27A;JUN;FOS;PELI1;TAB2;MAPK10;ALPK1
prerank,Reactome_2022__Intra-Golgi Traffic R-HSA-6811438,-0.47645049222253905,-0.9196508045164368,0.5185185185185185,1.0,1.0,5/17,18.54%,VPS45;COG3;CYTH3;TRIP11;MAN1A2
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.43051153019411936,0.9195412717343557,0.5697674418604651,0.8986193014758813,1.0,16/52,23.98%,BCL6;PPFIA2;LRRC4C;LARP4;NEDD4L;PAK2;ADGRB3;PDZD8;DAG1;CFL1;NEDD4;SPARC;ETS1;MEF2C;TANC2;EMP2
prerank,Reactome_2022__Signaling By FGFR1 In Disease R-HSA-5655302,0.49104258611670326,0.9192512741552515,0.6301369863013698,0.8987826094762815,1.0,5/17,18.57%,FGFR1;PIK3R1;GRB2;LRRFIP1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.5090040525694511,0.9182722055031378,0.6052631578947368,0.9005404852570824,1.0,4/17,23.98%,CDK6;RAC1;LIMS1;EMP2
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.42357106703859887,0.9181020420303911,0.6493506493506493,0.9005041921844886,1.0,19/52,31.39%,RPS9;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS27;RPL10;RPL37A;RPL21;RPLP1;RPS15;WDR43;RIOK3;MTREX;XRN2;RPL24;RPS7
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.5829466405820428,0.9177310340384264,0.671875,0.9010064273028553,1.0,3/8,22.28%,RAPGEF3;TPR;YWHAE
prerank,Reactome_2022__HIV Infection R-HSA-162906,0.4367058506150113,0.9176280740698342,0.6493506493506493,0.9009082072908924,1.0,17/68,23.82%,PSMC6;TSG101;SGIP1;PACS1;RPS27A;CCNH;NEDD4L;AP1G1;PSMA7;TPR;CHMP4B;VPS37A;NPM1;UBC;KPNA1;XPO1;FYN
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),-0.5733273041210719,-0.9172760836283027,0.6,1.0,1.0,1/5,7.70%,TAPT1
prerank,"Reactome_2022__Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",0.5502772555551239,0.9170803419820105,0.6417910447761194,0.9017230217716689,1.0,1/7,0.35%,SLCO4A1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.45007241835657785,0.9165484002019598,0.6585365853658537,0.9023652504111467,1.0,11/46,18.78%,SERPINE1;SMAD7;NAV3;SRGAP1;DLC1;ADAM15;MAGI2;CLDN5;CRK;DAG1;DUSP22
prerank,Reactome_2022__Signaling By FGFR In Disease R-HSA-1226099,0.46560868105920783,0.9164393049895465,0.6153846153846154,0.9022093175943187,1.0,5/20,18.57%,FGFR1;PIK3R1;GRB2;LRRFIP1;STAT3
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5522738605568045,0.9162480338847799,0.6865671641791045,0.9021724480124277,1.0,1/10,6.27%,SMAD7
prerank,Reactome_2022__Signaling By PDGF R-HSA-186797,0.5003725066206257,0.9161896907271724,0.5945945945945946,0.9019902951540713,1.0,7/20,18.57%,PIK3R1;GRB2;COL4A2;BCAR1;CRK;PLAT;STAT3
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.44619486631640615,0.9160163117997431,0.6626506024096386,0.9019755501078842,1.0,14/37,21.83%,ERBB4;NEDD9;CD81;ENPP2;PRNP;PECAM1;PAK2;ARHGEF2;STAT3;PTPN1;TEC;SOCS3;GRM5;GPRC5B
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.4911815645172737,0.9158636850230913,0.6301369863013698,0.9018772183567462,1.0,8/17,33.78%,RPL23;OGT;SDCBP;CSNK2A1;EIF3H;TLK2;RPS7;HSP90AB1
prerank,Reactome_2022__Lysosome Vesicle Biogenesis R-HSA-432720,0.5374689591022773,0.9157360702260539,0.6086956521739131,0.90173498290701,1.0,3/9,21.09%,AP1G1;HSPA8;DNM2
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.5361123015898009,-0.9157202371855055,0.5714285714285714,1.0,1.0,1/6,9.54%,ATP6V1H
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5090167766323628,0.915194154149099,0.6212121212121212,0.9025864527436305,1.0,7/13,32.24%,ANXA1;KMT2E;PLCB1;ADAMTS1;EGFR;RGCC;ADAM17
prerank,Reactome_2022__rRNA Modification In Nucleus And Cytosol R-HSA-6790901,0.576771226977615,0.9151007108832941,0.625,0.9023869180400476,1.0,1/7,6.69%,RPS9
prerank,Reactome_2022__Azathioprine ADME R-HSA-9748787,0.6235221461185938,0.9150948648935185,0.6507936507936508,0.9020381813758216,1.0,3/5,37.40%,GUK1;GMPS;VAV3
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.4604896740229545,0.9143915948952646,0.5802469135802469,0.9031300356774694,1.0,3/46,5.02%,PBRM1;BAZ1A;ZBTB1
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.4284699800221492,-0.9143742131834398,0.52,1.0,1.0,2/17,2.18%,PRIMPOL;ISG15
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.5150476867739455,-0.9142669734443608,0.6285714285714286,1.0,1.0,1/10,1.17%,MLLT3
prerank,Reactome_2022__APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,0.48958982204698365,0.914103341797912,0.5769230769230769,0.9034133639135233,1.0,2/20,8.07%,PSMC6;RPS27A
prerank,Reactome_2022__PKA Activation In Glucagon Signaling R-HSA-164378,0.5567481667620118,0.9138536332608134,0.5625,0.9035736115235613,1.0,2/7,21.89%,ADCY2;ADCY9
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),-0.4933004980955435,-0.9137184735275922,0.5,1.0,1.0,1/11,1.06%,CTNNA2
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.43947440903456947,0.9136417303485342,0.6410256410256411,0.9036065385760612,1.0,14/51,14.87%,PLS3;NEDD9;EPS8;MYO1B;TPM4;PPP1R9A;MYO1E;DSTN;SPIRE1;BCAR1;HIP1R;MPRIP;RAC1;TRIOBP
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.5133633202220796,-0.9136278783835822,0.59375,1.0,1.0,4/9,15.75%,RBMX;TRA2A;CIRBP;NCL
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5390399090414777,0.9131916579963436,0.6212121212121212,0.9042050088855043,1.0,3/9,22.42%,RPS27A;TAB2;UBC
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.48726955592933713,0.9131041541327007,0.640625,0.9039659437818749,1.0,7/27,19.12%,ARF1;MT1M;PRNP;MT2A;NDFIP1;TF;SLC30A1
prerank,Reactome_2022__Processing Of Capped Intronless Pre-mRNA R-HSA-75067,0.5908245234636418,0.9130825963330685,0.6119402985074627,0.9033570081747813,1.0,2/5,26.85%,CSTF3;PAPOLA
prerank,Reactome_2022__Processing Of Intronless Pre-mRNAs R-HSA-77595,0.5908245234636418,0.9130825963330685,0.6119402985074627,0.9033570081747813,1.0,2/5,26.85%,CSTF3;PAPOLA
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.523869819574281,-0.9128361979253994,0.5,1.0,1.0,1/8,3.67%,PATJ
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),0.5260370744356456,0.9127246639892624,0.5714285714285714,0.9036482184903392,1.0,3/11,31.18%,NPM1;RPL10;RPL24
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),-0.5026635301556649,-0.9126398572620326,0.6071428571428571,1.0,1.0,1/11,0.64%,THSD1
prerank,CellMarker_Augmented_2021__Liver Bud Hepatic cell:Liver,0.4566936549400373,0.9126193739417818,0.6626506024096386,0.9034972626314395,1.0,16/47,19.34%,SERPINE1;KHDRBS3;MGLL;MT1M;MT2A;SLC38A2;FKBP5;CFH;S100A6;ECT2;TUBA1B;TGM2;RSU1;CARHSP1;DIAPH2;NFIC
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,0.4911697082643758,0.9125621671180777,0.6666666666666666,0.901450322552521,1.0,2/19,8.07%,PSMC6;RPS27A
prerank,Reactome_2022__APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,0.4911697082643758,0.9125621671180777,0.6666666666666666,0.901450322552521,1.0,2/19,8.07%,PSMC6;RPS27A
prerank,Reactome_2022__Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,0.4911697082643758,0.9125621671180777,0.6666666666666666,0.901450322552521,1.0,2/19,8.07%,PSMC6;RPS27A
prerank,Reactome_2022__Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,0.4911697082643758,0.9125621671180777,0.6666666666666666,0.901450322552521,1.0,2/19,8.07%,PSMC6;RPS27A
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,0.4911697082643758,0.9125621671180777,0.6666666666666666,0.901450322552521,1.0,2/19,8.07%,PSMC6;RPS27A
prerank,Reactome_2022__CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,0.4911697082643758,0.9125621671180777,0.6666666666666666,0.901450322552521,1.0,2/19,8.07%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.5497661792203683,0.9125466942186242,0.6428571428571429,0.901121741840222,1.0,4/10,25.66%,NAV3;ARHGEF2;TAOK1;HDGFL3
prerank,Reactome_2022__AKT Phosphorylates Targets In Nucleus R-HSA-198693,-0.5285664469041036,-0.912531892233933,0.5714285714285714,1.0,1.0,2/5,22.31%,FOXO1;CREB1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.4574655145962019,0.9123178055338584,0.5555555555555556,0.9012557743343363,1.0,9/42,26.29%,PSMC6;AGO2;RAC1;PSMA7;FZD4;PPP3CB;PLCB1;PSMB9;CDC42
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.4664620634927509,0.9123006669246658,0.6142857142857143,0.9009231684237975,1.0,5/22,15.35%,CDK6;CDKN1B;CCNH;CDKN1A;CRLF3
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.4962360028964656,0.9122597943930584,0.5945945945945946,0.9006387664787678,1.0,5/26,14.48%,PCK1;SLC8A1;CPEB4;MAP7;LARP1B
prerank,Reactome_2022__Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,-0.4942223656985535,-0.9121925120288576,0.5454545454545454,1.0,1.0,1/8,8.63%,PPP2R5A
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.463113866626664,0.9120207128181609,0.6351351351351351,0.9007205504120483,1.0,8/28,20.64%,SMAD7;SMAD5;ACVR2A;PTPN1;SULF2;SMAD6;NEDD4;ATP2B4
prerank,Reactome_2022__Signal Amplification R-HSA-392518,-0.4982583903516248,-0.9119003537978254,0.6764705882352942,1.0,1.0,2/11,9.88%,PLA2G4A;GNA14
prerank,CellMarker_Augmented_2021__Endothelial cell:Muscle,0.6212427955091645,0.9117273836494842,0.639344262295082,0.9009416295820415,1.0,4/5,35.59%,PECAM1;CDH5;NCAM1;CD34
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.3893175602294933,0.9116256239631385,0.6923076923076923,0.9008316863316912,1.0,34/168,20.58%,BCL6;TBX3;BHLHE40;PHF10;CALR;GAPDH;ZFPM2;ATP8B1;KDM1A;ARID5A;KLF4;CDKN1B;JUN;SPEN;REST;CDKN1A;WAPL;GIGYF2;ZBTB38;RPL13A;NCOR2;ATOH8;LIMS1;BTG2;CRY1;MBD2;NACC2;NR1D2;BCLAF1;CREBZF;SLFN11;RCOR3;ELK3;HSPA8
prerank,Reactome_2022__Glycogen Synthesis R-HSA-3322077,0.592365068533857,0.9114587076071234,0.6363636363636364,0.900813212253477,1.0,3/5,24.09%,RPS27A;UBC;GBE1
prerank,Reactome_2022__Switching Of Origins To A Post-Replicative State R-HSA-69052,0.4805884140745696,0.9114122190530786,0.6,0.9005337611733599,1.0,2/22,8.07%,PSMC6;RPS27A
prerank,Reactome_2022__Beta-catenin Phosphorylation Cascade R-HSA-196299,-0.541680601304986,-0.9110761396261564,0.7096774193548387,1.0,1.0,1/7,8.63%,PPP2R5A
prerank,Reactome_2022__CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,-0.541680601304986,-0.9110761396261564,0.7096774193548387,1.0,1.0,1/7,8.63%,PPP2R5A
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.610104527981204,0.9104739519363372,0.6515151515151515,0.9020242273207875,1.0,1/7,7.38%,KDM1A
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.5259113840094644,0.9103326858648276,0.5769230769230769,0.9019053391851879,1.0,7/11,30.39%,SAMD8;NSMAF;PLPP1;ST6GALNAC3;ACER3;SPTLC2;CERK
prerank,Reactome_2022__Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.4742709503418215,-0.9101860824764294,0.6176470588235294,1.0,1.0,1/13,0.37%,RNF213
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.5635223557249098,0.910046359443753,0.696969696969697,0.9020211604420948,1.0,4/8,36.07%,TF;ACTB;POC1B;ACTG1
prerank,KEGG_2021_Human__GABAergic synapse,0.4803023519223772,0.9099391906594207,0.704225352112676,0.901902366643804,1.0,4/21,9.35%,GLUL;CACNA1C;PLCL1;SLC38A2
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.4733145906231123,0.9098031759997561,0.6341463414634146,0.9017663005011631,1.0,4/27,13.47%,SEC22B;VSIR;CDKN1B;NEDD4L
prerank,Reactome_2022__Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,0.4177993945654965,0.9096141770283841,0.6153846153846154,0.9014814737833913,1.0,13/55,18.88%,RPS11;RPS9;DNAJC5;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12;RPS27;CSNK1D
prerank,Reactome_2022__rRNA Processing In Nucleus And Cytosol R-HSA-8868773,0.4177993945654965,0.9096141770283841,0.6153846153846154,0.9014814737833913,1.0,13/55,18.88%,RPS11;RPS9;DNAJC5;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12;RPS27;CSNK1D
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),0.4820134583497059,0.9092278500505949,0.5789473684210527,0.9018964355111723,1.0,2/21,8.07%,PSMC6;RPS27A
prerank,Reactome_2022__Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,0.5382941164923095,0.9091033401281984,0.6805555555555556,0.9018776174109108,1.0,2/12,14.10%,PACS1;AP1G1
prerank,KEGG_2021_Human__Protein digestion and absorption,-0.427773982172951,-0.9090553398024013,0.5,1.0,1.0,1/13,0.21%,COL8A1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5378009001254324,0.9089792553424876,0.6617647058823529,0.9018024868378989,1.0,6/9,36.63%,UGGT2;VCP;UGGT1;CUL3;NGLY1;ATXN3
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.5103265086397265,0.9088992258550073,0.6086956521739131,0.9015628305961405,1.0,7/18,31.29%,PBRM1;SMARCC1;MBD2;ACTB;SMARCA5;ARID1A;SMARCA1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.46295291185748644,0.9088160451468735,0.5903614457831325,0.9013666562755657,1.0,6/29,18.22%,BCR;TBC1D15;TBC1D9;ECT2;RALGAPB;RALGAPA1
prerank,Reactome_2022__Extracellular Matrix Organization R-HSA-1474244,0.4333020410799599,0.9087730439992366,0.6216216216216216,0.9010624404364396,1.0,11/56,11.58%,LAMC1;SERPINE1;ADAMTS9;LAMA5;PLOD2;P4HA1;COL4A2;ITGA1;PECAM1;ADAM15;NRXN1
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.5614383311671738,-0.9087711157694768,0.5714285714285714,1.0,1.0,2/8,12.40%,RHBDD1;SPPL2A
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.5248882032022394,0.9087491732556986,0.6197183098591549,0.9007671141834281,1.0,1/10,1.49%,TSG101
prerank,CellMarker_Augmented_2021__Migration Phase Fetal Germ cell:Fetal Gonad,0.4763376860071381,0.9085823012083624,0.6029411764705882,0.9007747270357912,1.0,7/26,18.65%,LDHA;SERPINB6;TPM4;MYL6;SDCBP;CARHSP1;ST6GALNAC3
prerank,Reactome_2022__Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,0.47616889263904516,0.908373728831479,0.631578947368421,0.9008601429961844,1.0,7/26,22.28%,HSPA5;HSPH1;HSPA9;TPR;HSPA8;SERPINH1;YWHAE
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.5722796864776777,0.9083044617325,0.6349206349206349,0.9006473406179852,1.0,3/9,17.88%,PINK1;SPIRE1;DDHD1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.40376184149887095,0.9081931199280425,0.6024096385542169,0.9004994943894775,1.0,16/72,19.31%,RTN4;SERPINE1;GAPDH;KDM1A;OGT;GJA1;REST;AGO2;GRB10;WWTR1;FOXC1;SDCBP;RIF1;CFL1;ALMS1;DYNC1H1
prerank,Reactome_2022__Protein Folding R-HSA-391251,0.4902241404309198,0.9079485407989899,0.5972222222222222,0.9006626358882536,1.0,7/25,21.20%,TUBB4B;RGS7;TUBA1B;TUBB6;STAT3;ARFGEF2;TBCD
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.6204039997729862,0.9079260252821468,0.6964285714285714,0.9003465750374346,1.0,2/5,23.67%,NPM1;XPO1
prerank,CellMarker_Augmented_2021__Pericyte:Brain,0.4849191594991922,0.9078609233903592,0.6056338028169014,0.9000954748687958,1.0,2/17,8.39%,TIMP3;COL4A2
prerank,Reactome_2022__ERK/MAPK Targets R-HSA-198753,0.5722080078397944,0.90777578259464,0.6935483870967742,0.8998963216723619,1.0,8/9,39.07%,DUSP6;MEF2C;RPS6KA3;RPS6KA2;RPS6KA5;PPP2CB;MAPK1;MEF2A
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.5705692631462898,0.9076540964121774,0.6119402985074627,0.8998137192547367,1.0,2/5,8.29%,FES;CDK6
prerank,"Reactome_2022__Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",0.45450813005901664,0.9074861096206653,0.6455696202531646,0.899791511025829,1.0,10/33,24.78%,RPS27A;ARHGEF4;GNA13;ECT2;ARHGEF2;KALRN;YWHAE;UBC;PREX1;FGD4
prerank,Reactome_2022__RUNX3 Regulates YAP1-mediated Transcription R-HSA-8951671,0.6173766238431444,0.9063260012103795,0.6376811594202898,0.9018757414618056,1.0,3/5,37.53%,WWTR1;CCN2;TEAD1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5333303419089872,0.9061774797417617,0.6086956521739131,0.9018828912583805,1.0,2/13,4.36%,ERBB4;INPP5F
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),0.4201193066478136,0.9057703190648275,0.65,0.9022774194281764,1.0,18/49,31.39%,RPS9;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS27;RPL10;RPL37A;RPL21;RPLP1;RPS15;WDR43;MTREX;XRN2;RPL24;RPS7
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.5464246119736398,0.9055321891318929,0.6571428571428571,0.9024436038412867,1.0,4/9,26.93%,HSP90AA1;TPR;YWHAE;VCP
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.5270749437642199,-0.905492998902647,0.6285714285714286,1.0,1.0,3/7,20.88%,MOB3B;WWC3;MAPK14
prerank,Reactome_2022__WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,0.5895523665658394,0.9054270059419579,0.6029411764705882,0.9023085944675464,1.0,1/6,18.25%,FZD4
prerank,Reactome_2022__Viral Messenger RNA Synthesis R-HSA-168325,0.5232969008671795,0.9051230004574592,0.6619718309859155,0.9026208127209843,1.0,1/14,3.24%,PBRM1
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.6113776405069786,0.9048105351679196,0.6557377049180327,0.9028984082044061,1.0,3/5,30.23%,SCARB1;ABCG1;ABCA5
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.5461417391665467,0.9045517177906636,0.6666666666666666,0.9030082474100788,1.0,1/12,7.38%,KDM1A
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.4642191786670371,-0.9041896572359533,0.6129032258064516,1.0,1.0,3/12,11.90%,ATP10D;ATP9A;ATP9B
prerank,Reactome_2022__Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,0.5715818379086527,0.9041085176628417,0.6911764705882353,0.9034744254187068,1.0,6/8,41.78%,AHCTF1;KPNB1;NUP54;TNPO1;POM121;NUP160
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.40127797353213096,0.9038705565534524,0.6511627906976745,0.9035324453596378,1.0,20/63,31.39%,RPS9;RPL23;RPL8;RPL34;RPL37;RPLP2;AGO2;RPL13A;TUT7;RPS27;RPL10;RPL37A;RPL21;RPLP1;RPS15;WDR43;MTREX;XRN2;RPL24;RPS7
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.6072020108338156,0.9037610266089454,0.6166666666666667,0.9033887462170085,1.0,1/6,9.14%,YTHDC1
prerank,KEGG_2021_Human__Bladder cancer,0.5278948615805676,0.9036946021515084,0.6865671641791045,0.9031936868937539,1.0,3/11,13.89%,RASSF1;CDKN1A;KRAS
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.5028301873607737,0.903547498218674,0.6493506493506493,0.9030888184764347,1.0,7/15,16.52%,S1PR1;CCDC88A;ARHGEF4;ITGB1;RAC1;PARVB;GOLPH3
prerank,Reactome_2022__RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,0.5311687849835943,0.9034202837879177,0.578125,0.9029197416730828,1.0,2/9,14.40%,CBFB;WWTR1
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.5883113703460696,0.9033233136683302,0.5967741935483871,0.9027465112239965,1.0,5/6,26.93%,HSP90B1;NPLOC4;HERPUD1;SEL1L;VCP
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.5430485246765903,0.9032864588542561,0.6666666666666666,0.9024791962279922,1.0,4/13,28.98%,RPS27A;DYNC1H1;UBC;DYNC1I2
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.5637945340521466,0.9031080691728404,0.6,0.9024475426266461,1.0,2/7,6.27%,S1PR1;SMAD7
prerank,Reactome_2022__Signaling By PDGFR In Disease R-HSA-9671555,0.5577295929137792,0.9028649554448751,0.6285714285714286,0.9025357351822557,1.0,3/12,8.31%,WDR48;PIK3R1;GRB2
prerank,Reactome_2022__Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,0.420761968339207,0.9027727242521214,0.6301369863013698,0.902320143251927,1.0,7/42,15.94%,DUSP6;RPS27A;JUN;FOS;TAB2;MAPK10;ALPK1
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.5175076554454666,-0.9026169860907397,0.5909090909090909,1.0,1.0,2/11,2.55%,CARMIL1;EVL
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.4686075847226298,0.902535746616673,0.6419753086419753,0.9023869366831361,1.0,6/29,14.71%,NFE2L2;ERO1A;PINK1;SERPINB6;MSRA;TXNRD1
prerank,Reactome_2022__Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,0.5860115792404487,0.9023597963591337,0.7068965517241379,0.9023724650513418,1.0,1/6,11.05%,CCNH
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.48046895603813095,0.9021801824233514,0.6052631578947368,0.9023238225652622,1.0,3/21,8.23%,UFL1;RPS27A;RB1CC1
prerank,Reactome_2022__DNA Replication R-HSA-69306,0.46635937133627364,0.9021588619244996,0.6447368421052632,0.9020061379346003,1.0,4/29,10.23%,PSMC6;POLA1;RPS27A;RFC3
prerank,Reactome_2022__HATs Acetylate Histones R-HSA-3214847,-0.40402721562914695,-0.9021344722797211,0.6071428571428571,1.0,1.0,3/26,4.52%,MSL2;H2AC6;YEATS2
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.5932195067839681,0.9019428519168822,0.640625,0.9020430631756767,1.0,3/6,19.10%,FGFR1;FLT1;ABL2
prerank,Reactome_2022__Regulation Of Innate Immune Responses To Cytosolic DNA R-HSA-3134975,0.5952344903455548,0.9011370645734799,0.6451612903225806,0.903270680955417,1.0,2/5,22.42%,RPS27A;UBC
prerank,Reactome_2022__Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,0.4296895388600116,0.900919508649843,0.684931506849315,0.9032473647820117,1.0,14/41,27.54%,DUSP6;RPS27A;JUN;FOS;PELI1;TAB2;MAPK10;ALPK1;UBC;MEF2C;RPS6KA3;MAP2K1;MAP3K8;PIK3C3
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Gonad,0.400865817528416,0.9007668194998666,0.620253164556962,0.9031643630661494,1.0,6/72,11.37%,AKAP12;LDHA;TIMP3;FGFR1;MYH10;ANXA2
prerank,CellMarker_Augmented_2021__pro-Natural Killer Cell (pro-NK cell):Peripheral Blood,0.5116500252668227,0.9007349495677848,0.6533333333333333,0.9028810691286006,1.0,6/11,27.46%,BTG2;BTG1;PNRC1;FGR;N4BP2L1;MAP3K8
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.5872464899140735,-0.9007206496588649,0.6388888888888888,1.0,1.0,2/6,3.85%,ATM;TENT2
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.5872464899140735,-0.9007206496588649,0.6388888888888888,1.0,1.0,2/6,3.85%,ATM;TENT2
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.5999689369695006,0.9005577841907567,0.6865671641791045,0.9028877583670765,1.0,2/7,25.13%,UBE2B;USP22
prerank,Reactome_2022__RHOQ GTPase Cycle R-HSA-9013406,0.45572959035289956,0.9003333441347208,0.631578947368421,0.903043529137769,1.0,4/30,9.85%,ARHGAP21;DLC1;SLC4A7;GJA1
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.551696173868458,-0.9001098662910414,0.6666666666666666,1.0,1.0,1/8,1.06%,CTNNA2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.5578024101920752,0.8998865256985817,0.7424242424242424,0.9036249786085906,1.0,1/10,5.79%,NDUFA12
prerank,CellMarker_Augmented_2021__MKI67+ Progenitor cell:Large Intestine,0.4261195267147832,0.8994539798959265,0.6710526315789473,0.9041293673896835,1.0,14/55,19.28%,APOLD1;HYAL2;DIPK2B;JAG2;VWF;PECAM1;LRRC32;FLT1;CLDN5;FOXC1;FZD4;PODXL;EGFL7;ESAM
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,0.5474725563526641,0.8994319806918648,0.6086956521739131,0.903820718399473,1.0,6/9,43.32%,GATAD2A;KAT6A;EP300;GATAD2B;RBBP4;PDZD2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.6005883928228053,-0.8992786651758884,0.5625,1.0,1.0,2/6,11.42%,SHLD1;SHLD2
prerank,Reactome_2022__Transport Of Organic Anions R-HSA-879518,0.5516495032579706,0.8992782366023762,0.6176470588235294,0.9033954458747444,1.0,1/6,0.35%,SLCO4A1
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.5516495032579706,0.8992782366023762,0.6176470588235294,0.9033954458747444,1.0,1/6,0.35%,SLCO4A1
prerank,Reactome_2022__Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,0.48137242419698284,0.8992041650731836,0.6578947368421053,0.9031979284968076,1.0,2/21,8.07%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.5252863701931585,-0.8991926212487388,0.6341463414634146,1.0,1.0,1/6,4.36%,EZH1
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.60554720540931,0.8991244606965273,0.7076923076923077,0.9030387962275513,1.0,2/6,21.38%,CHST11;EXT1
prerank,Reactome_2022__Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,0.4912976028182898,0.898694573155203,0.6710526315789473,0.9033978671348886,1.0,2/18,8.07%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.5301156778746039,-0.8985966191672242,0.65625,1.0,1.0,1/5,6.00%,IMMP2L
prerank,Reactome_2022__Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,0.5080218485019588,0.8984490739562319,0.6428571428571429,0.9035104564609518,1.0,2/13,11.05%,RPS27A;CCNH
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.5194787882162999,0.898222289628031,0.746031746031746,0.9035126333543367,1.0,5/16,17.88%,PINK1;ZDHHC6;SPIRE1;HIP1R;DDHD1
prerank,CellMarker_Augmented_2021__Oral Keratinocyte Stem cell:Oral Mucosa,0.45804666897804264,0.8980335805168954,0.6493506493506493,0.9035105668879078,1.0,5/27,17.10%,LAMA5;TINAGL1;MYO1B;SEMA3F;DAG1
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.5624563314387165,0.8975670666612702,0.6935483870967742,0.904161473118617,1.0,2/10,10.07%,RAPGEF3;RAP1A
prerank,Reactome_2022__rRNA Processing R-HSA-72312,0.4086701210880702,0.8974442784276522,0.6493506493506493,0.9040531989205365,1.0,13/56,18.88%,RPS11;RPS9;DNAJC5;RPS27A;RPL23;RPL8;RPL34;RPL37;RPLP2;RPL13A;RPS12;RPS27;CSNK1D
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.5380604196777791,0.8973422008653864,0.6461538461538462,0.9038729813290132,1.0,1/9,1.49%,TSG101
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.4870033049242758,-0.8971910089291151,0.5588235294117647,1.0,1.0,2/8,4.25%,IFIH1;PARP9
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),-0.5115237505608695,-0.8970326813310132,0.5945945945945946,1.0,1.0,1/5,7.70%,TAPT1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.4879546659701114,0.8969615146774392,0.6666666666666666,0.9042138326654873,1.0,6/26,17.10%,SMAD7;WWTR1;FOXC1;SPRED1;SDCBP;DAG1
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.5597669112053029,0.8968098747074376,0.6714285714285714,0.9041395312712177,1.0,5/10,26.45%,CPEB4;TMBIM6;MTOR;SLC38A9;CAPN2
prerank,Reactome_2022__MET Activates PTPN11 R-HSA-8865999,0.6151312434599046,0.8967187392591787,0.6896551724137931,0.9040102708497806,1.0,1/5,8.31%,GRB2
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4322790562532361,0.8965379441965661,0.620253164556962,0.9039614860130102,1.0,5/31,14.74%,EPS8;PIK3R1;CCDC88A;ARPC2;RAC1
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.5388407713721767,0.8964437316224048,0.6,0.9037985620736348,1.0,3/7,26.29%,ARHGAP21;UVRAG;CDC42
prerank,CellMarker_Augmented_2021__T cell:Ascites,-0.5445666981627899,-0.8964343221721255,0.6176470588235294,1.0,1.0,2/5,14.42%,GIMAP8;GIMAP4
prerank,CellMarker_Augmented_2021__Suppressor T cell:Peripheral Blood,-0.5445666981627899,-0.8964343221721255,0.6176470588235294,1.0,1.0,2/5,14.42%,GIMAP8;GIMAP4
prerank,Reactome_2022__Heme Signaling R-HSA-9707616,0.4853300330391267,0.895956538161921,0.6231884057971014,0.9045403703660437,1.0,3/20,6.32%,MAFK;CRTC3;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.6075133961355437,0.89594544735471,0.6557377049180327,0.9042210054126271,1.0,1/5,15.99%,BRD4
prerank,Reactome_2022__HDACs Deacetylate Histones R-HSA-3214815,-0.4278608792625707,-0.89573073026997,0.6206896551724138,1.0,1.0,3/15,6.77%,TBL1X;H2AC6;TBL1XR1
prerank,Reactome_2022__Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.5656790333275459,0.8952796760360698,0.7,0.9050845812533455,1.0,3/10,12.91%,CBFB;CDK6;AGO2
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),0.4490601028245872,0.8952685130951713,0.6626506024096386,0.9047610299824317,1.0,5/42,6.32%,ST18;PSMC6;YBX3;HYAL2;NFE2L2
prerank,CellMarker_Augmented_2021__Sertoli cell:Fetal Gonad,0.38977436554880585,0.895233964394691,0.7349397590361446,0.9044799320766529,1.0,30/150,17.77%,B3GNT2;ERBB4;NEDD9;SLC52A3;PPA1;MAP1B;MYO9B;CRTC3;TINAGL1;REL;PRNP;TUBB4B;SRGAP1;SLC4A7;PPP1R9A;RAD21;GAS7;PEBP1;ATP1A1;ADGRG1;CD55;AP1G1;NAV2;DMD;TMEM181;RELL1;DAG1;TPST2;BTG2;DNAJC15
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.5031426954998239,0.8948802181667044,0.6376811594202898,0.904764407188591,1.0,4/15,8.42%,SLCO4A1;SLC52A3;SLC4A10;SLC4A7
prerank,CellMarker_Augmented_2021__Clara cell:Undefined,0.39962608709235353,0.8945564909579135,0.6375,0.905090840816103,1.0,17/60,25.26%,TRIM9;SIK2;SPEN;PIKFYVE;SUGP2;DOCK4;MGAT5;RALGAPB;FAM219A;ZMIZ1;TF;DYNC1H1;PAFAH1B1;MAPK8IP3;CD99L2;WNK1;ADD1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Embryo,0.46847196621552123,0.8944396568120518,0.6438356164383562,0.9050333802820061,1.0,9/22,22.52%,GGT5;VWF;ZNF366;LRRC32;FLT1;NOTCH4;GSN;CDH5;SCARF1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.43173201351142776,0.8942041781641656,0.5915492957746479,0.9051108206075079,1.0,8/42,10.46%,SERPINE1;CD9;TIMP3;SYTL4;SRGN;LAMP2;VWF;PECAM1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.5179690868674132,0.8941400371873904,0.6712328767123288,0.9049270155742747,1.0,5/12,13.52%,SLC8A1;GPM6B;ATP2B1;ANO6;ACVR2A
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),-0.4385518842854038,-0.8935648887300702,0.5,1.0,1.0,1/10,1.06%,CTNNA2
prerank,Reactome_2022__DARPP-32 Events R-HSA-180024,0.4937421395642487,0.8935025333406666,0.6933333333333334,0.9059013987373689,1.0,4/11,28.47%,PDE4B;PPP3CB;PPP3CC;CALM1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.41528037491020214,0.8933623604807795,0.627906976744186,0.9057805754290553,1.0,10/56,17.05%,ERBB4;FES;FGFR1;PINK1;SIK2;PIKFYVE;FLT1;PAK2;GRK5;PRKX
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.42009748737677344,-0.8932733968232238,0.52,1.0,1.0,2/20,2.55%,CARMIL1;EVL
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.5353804757551882,0.8931576342847978,0.6470588235294118,0.9058996935273158,1.0,3/12,14.18%,GRB2;CDKN1A;ECT2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5729493928511047,0.8931195776825208,0.6714285714285714,0.9056107108112463,1.0,2/6,20.40%,NACC2;BCL2L1
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.4364011156756744,-0.8929544099984129,0.6129032258064516,1.0,1.0,1/14,1.46%,CPQ
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.5871472936516402,0.8927080099197341,0.6935483870967742,0.9060073130532417,1.0,3/6,30.23%,ABCG1;PPARG;ABCA5
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.5584391850940219,0.8926359265710516,0.6428571428571429,0.9057941645084033,1.0,2/6,29.93%,MORC3;DAB2IP
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.6010984609698283,0.8925430660654813,0.6617647058823529,0.9056189911041451,1.0,1/6,6.99%,BACH2
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.5789024805629296,0.8923543035084633,0.6964285714285714,0.9053194222227878,1.0,1/6,10.07%,RAP1A
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.5789024805629296,0.8923543035084633,0.6964285714285714,0.9053194222227878,1.0,1/6,10.07%,RAP1A
prerank,Reactome_2022__MyD88-independent TLR4 Cascade R-HSA-166166,0.4183433803840088,0.8923059217241714,0.6388888888888888,0.9050481023843369,1.0,7/43,15.94%,DUSP6;RPS27A;JUN;FOS;TAB2;MAPK10;ALPK1
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,0.4907154315108743,0.8922518931408837,0.6351351351351351,0.904802158774519,1.0,5/13,20.16%,CDKN1B;CDKN1A;CNOT6L;BTG2;NPM1
prerank,Reactome_2022__DNA Double Strand Break Response R-HSA-5693606,-0.4497520596517081,-0.891964632906483,0.5833333333333334,1.0,1.0,3/15,8.13%,BABAM2;ATM;HERC2
prerank,Reactome_2022__Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.4497520596517081,-0.891964632906483,0.5833333333333334,1.0,1.0,3/15,8.13%,BABAM2;ATM;HERC2
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.5547486348269379,0.8918868681942117,0.7058823529411765,0.9051770489864496,1.0,1/7,17.00%,TPR
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.5965756616630827,0.8918051675026215,0.6774193548387096,0.9050025062649694,1.0,2/6,18.57%,HIF1A;STAT3
prerank,Reactome_2022__Fatty Acid Metabolism R-HSA-8978868,-0.4165130903887369,-0.8912169952342165,0.5806451612903226,1.0,1.0,2/25,1.81%,SLC22A5;PLA2G4A
prerank,Reactome_2022__Separation Of Sister Chromatids R-HSA-2467813,0.43820994213356385,0.891149795933347,0.6962025316455697,0.9057793154465508,1.0,15/48,25.63%,PSMC6;RPS27A;RAD21;WAPL;AHCTF1;PSMA7;RPS27;DYNC1H1;PAFAH1B1;TAOK1;UBC;SPC25;XPO1;PSMB9;SMC3
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.5591984185448879,0.8910301207313616,0.6923076923076923,0.9056842645292079,1.0,3/7,21.73%,OGT;CRY1;ARPP19
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.5577439384799627,0.8908582281039261,0.6666666666666666,0.9056227832538472,1.0,3/9,11.24%,SLC12A6;ATP1A1;ATP1B3
prerank,Reactome_2022__Josephin Domain DUBs R-HSA-5689877,0.5434318630002939,0.890729803753343,0.6307692307692307,0.9054818210332174,1.0,3/7,26.93%,RPS27A;UBC;VCP
prerank,Reactome_2022__Myogenesis R-HSA-525793,-0.4733661829022272,-0.8905647506694487,0.5714285714285714,1.0,1.0,2/14,7.14%,CTNNA2;TCF7L1
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.49034281237751226,0.8900570019034031,0.6323529411764706,0.9063451422950283,1.0,6/18,16.49%,NEDD9;CALR;RAC1;TRIOBP;CRK;LIMS1
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.5075608449809581,-0.889808721222057,0.5263157894736842,1.0,1.0,1/7,1.12%,SLC4A4
prerank,Reactome_2022__Notch-HLH Transcription Pathway R-HSA-350054,-0.4337539558335007,-0.8897428935095333,0.5833333333333334,1.0,1.0,4/14,13.86%,TBL1X;TBL1XR1;MAML3;MAML2
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.3802792360622399,-0.8896183465492319,0.6857142857142857,1.0,1.0,6/25,15.54%,EZH1;TCF7L1;MSH3;XPC;HMGN3;UBB
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.5359486814933835,0.8895954004289807,0.6865671641791045,0.9067602854955154,1.0,3/8,9.83%,ARF1;HSP90AA1;HIF1A
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.37614966565336266,0.8895006208229211,0.6989247311827957,0.9066441393069448,1.0,15/146,11.02%,DDIT4;AKAP12;PRKAG2;ARHGAP23;MYO9B;UFL1;BCR;ARHGAP21;SRGAP1;DLC1;ARHGEF4;VWF;RFC3;GNA13;PHLPP1
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.5867453412660658,-0.8894669175183678,0.6666666666666666,1.0,1.0,2/5,14.71%,MFF;PNPT1
prerank,Reactome_2022__RHO GTPase Effectors R-HSA-195258,0.41062691537407936,0.8891756648621091,0.6818181818181818,0.9067203303123615,1.0,26/89,23.67%,PKN3;KDM1A;GRB2;CDKN1B;CTNNA1;MYL6;MYH10;AHCTF1;ARPC2;ITGB1;PPP1CB;MYL12B;RPS27;DIAPH2;ABI1;DYNC1H1;LIMK2;WIPF1;PAFAH1B1;TAOK1;YWHAB;YWHAE;SPC25;NCK1;H3-3B;XPO1
prerank,CellMarker_Augmented_2021__Hepatoblast:Liver,0.42838313361088287,0.8889893263744542,0.6714285714285714,0.9067922861366262,1.0,6/32,6.75%,ZEB2;CLIC2;PLIN2;CACNA1C;CCDC88A;ENPP2
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.47342187326595225,0.8888114287405376,0.6710526315789473,0.9067848401159881,1.0,4/24,16.02%,PSMC6;CDKN1B;CDKN1A;PSMA7
prerank,CellMarker_Augmented_2021__Immature neuron:Undefined,0.548748744139616,0.8887606116188096,0.6285714285714286,0.9065352717849464,1.0,6/10,19.65%,GRIA2;SNAP25;STXBP5L;SYT1;RIMS2;EFR3B
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.6304432396753039,0.8886144577003187,0.7213114754098361,0.9064987167635651,1.0,3/5,27.33%,NEDD4L;YWHAE;AKAP6
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),0.5580756400087706,0.8885944803262072,0.647887323943662,0.905202741473529,1.0,1/7,11.05%,CCNH
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),0.5580756400087706,0.8885944803262072,0.647887323943662,0.905202741473529,1.0,1/7,11.05%,CCNH
prerank,Reactome_2022__mRNA Capping R-HSA-72086,0.5580756400087706,0.8885944803262072,0.647887323943662,0.905202741473529,1.0,1/7,11.05%,CCNH
prerank,Reactome_2022__RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,0.5580756400087706,0.8885944803262072,0.647887323943662,0.905202741473529,1.0,1/7,11.05%,CCNH
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.47244258694379737,-0.8884474852056421,0.6388888888888888,1.0,1.0,1/11,1.12%,SLC4A4
prerank,CellMarker_Augmented_2021__Ciliated cell:Lung,0.4681872594579606,0.8880918133906658,0.704225352112676,0.9057082329754759,1.0,4/32,7.36%,ATF3;CCDC60;TUBB4B;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.5093280176919491,-0.8879476164592459,0.5833333333333334,1.0,1.0,2/11,2.15%,VCAM1;IL15
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.37734444718467053,-0.8879244704126925,0.6896551724137931,1.0,1.0,6/35,8.15%,SLC38A3;ARNT2;ZNRF3;ABCG2;SHROOM2;PTPN21
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.471616962343119,-0.8878109180305276,0.56,1.0,1.0,2/11,6.72%,ANAPC16;CDC14A
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.5271477904191101,0.8877228804310369,0.6811594202898551,0.9059635260887593,1.0,3/13,6.27%,DDIT4;PRKAG2;SMAD7
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.5536859250707558,0.8876953291187483,0.6666666666666666,0.9056900430160038,1.0,3/5,41.65%,ABCG1;ADAM17;ADAM10
prerank,CellMarker_Augmented_2021__Intermediate Progenitor cell:Undefined,0.5349282181965205,0.8876939132492598,0.7049180327868853,0.9053501968460166,1.0,4/12,10.31%,PPP2R2B;SLC4A10;CTNND2;PITPNC1
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.48175847633974994,-0.8875871880189573,0.5806451612903226,1.0,1.0,1/7,4.38%,ATR
prerank,Reactome_2022__Nuclear Receptor Transcription Pathway R-HSA-383280,0.4865468650905359,0.8875820113054738,0.6323529411764706,0.9052351894928883,1.0,8/15,32.56%,ESR2;NCOR2;NR2C1;NR1D2;PPARG;THRB;NR2C2;NR4A1
prerank,Reactome_2022__TICAM1-dependent Activation Of IRF3/IRF7 R-HSA-9013973,0.5809387022224194,0.8872715959174685,0.6615384615384615,0.9053655550501261,1.0,2/6,22.42%,RPS27A;UBC
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5603486191734771,0.887113950417645,0.6774193548387096,0.9053420566960125,1.0,3/7,30.62%,RAB3GAP2;RYR2;SPCS3
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.600283900857102,0.887070304085781,0.6896551724137931,0.904759410639175,1.0,2/5,10.49%,ZDHHC6;ZDHHC14
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.600283900857102,0.887070304085781,0.6896551724137931,0.904759410639175,1.0,2/5,10.49%,ZDHHC6;ZDHHC14
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.5115514251005551,0.8869523956672042,0.6621621621621622,0.9046572932857744,1.0,3/12,14.74%,FES;NAV3;RAC1
prerank,CellMarker_Augmented_2021__Blast cell:Bone Marrow,0.43225078196053235,0.8869196827422144,0.6341463414634146,0.9043560705333848,1.0,9/38,14.42%,FES;GGT5;VWF;ZNF366;PECAM1;LRRC32;CFH;DYSF;TNS1
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4233142920691888,0.8868979662351006,0.6823529411764706,0.9040675173701481,1.0,16/54,23.48%,SMAD7;SMAD5;RPS27A;JUN;LRRC32;FOS;CLDN5;ACVR2A;ITGB1;PXN;ZMIZ1;DUSP22;SMAD6;CDH5;UBC;ADAM9
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.5218000031212431,-0.886833297964046,0.7037037037037037,1.0,1.0,4/11,7.30%,HOMER2;STIM2;HOMER1;PKD2
prerank,Reactome_2022__Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,0.46088415964889595,0.8866618182668674,0.6375,0.9041523666359824,1.0,2/30,8.07%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.5730135783653335,0.8860553253153628,0.6379310344827587,0.9049417969828712,1.0,4/6,29.51%,MEF2C;AKAP6;EFNB2;ATP11A
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.3189224375386283,-0.88594283916573,0.7,1.0,1.0,22/174,11.39%,RNF213;MSL2;UBE3D;ANAPC16;ISG15;MARCHF8;HERC5;ZNRF3;HERC6;NFX1;RC3H1;RTF1;TRIM25;HECW2;HERC2;MDM2;PSMF1;UBE2E2;WSB1;PSMB1;FBXW4;FBXO9
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.5745317224387316,0.8857346061110212,0.6857142857142857,0.905270717832822,1.0,4/7,39.81%,NOTCH4;DLL4;TGFBR2;NRP1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.4985585737381808,0.885332657198097,0.6883116883116883,0.9057567840437881,1.0,1/16,4.06%,GPM6B
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.5504573035649151,0.8852901422031898,0.6153846153846154,0.9054889482054728,1.0,1/6,4.99%,SEC24D
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.4467230834668979,0.8852429711456697,0.7162162162162162,0.9052461449928674,1.0,6/28,14.10%,CANX;ARF1;SEC24D;PIKFYVE;MARCHF1;AP1G1
prerank,Reactome_2022__Signaling By CSF3 (G-CSF) R-HSA-9674555,0.49439281570360416,0.8849708543751925,0.6533333333333333,0.905388285795835,1.0,6/15,22.42%,JAK1;RPS27A;GRB2;STAT3;SOCS3;UBC
prerank,Reactome_2022__Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,0.5805958920646186,0.8847936948552937,0.6666666666666666,0.905286314767827,1.0,5/6,39.28%,CCNH;XPO1;PPP2R2A;PPP2CB;PPME1
prerank,CellMarker_Augmented_2021__Astroglial Progenitor cell:Embryo,-0.3886837303712776,-0.8846823602992695,0.6060606060606061,1.0,1.0,4/30,7.01%,TRANK1;GBP2;APOL3;GIMAP8
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3889785141714372,0.8846403368396877,0.7045454545454546,0.9052216271257089,1.0,10/108,9.93%,PSMC6;SPOPL;FEM1C;HSPA5;TRIM9;NFE2L2;RPS27A;UBE2J1;HSP90B1;NPLOC4
prerank,Reactome_2022__PRC2 Methylates Histones And DNA R-HSA-212300,-0.5248185475579582,-0.8845435312256298,0.7241379310344828,1.0,1.0,2/8,9.83%,H2AC6;DNMT3A
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Bone Marrow,0.44457359672810404,0.8845164355707,0.6891891891891891,0.905094998575571,1.0,4/27,9.19%,NFKBIZ;TCP11L2;NFE2L2;LAMP2
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.5741242114289613,0.8845010098660152,0.6956521739130435,0.9047866973545545,1.0,4/8,22.28%,ENSA;ARPP19;YWHAB;YWHAE
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.4066171056525549,-0.8835641893174859,0.7096774193548387,1.0,1.0,1/24,0.13%,GBP1
prerank,CellMarker_Augmented_2021__Lymphocyte:Undefined,-0.49914065877800573,-0.8834526668068883,0.6060606060606061,1.0,1.0,5/12,14.42%,IRF1;APOL3;GIMAP8;TNFRSF1B;GIMAP4
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.42863398178540835,-0.8832900088420448,0.56,1.0,1.0,5/19,10.07%,GEMIN5;PARP9;GCNT2;RC3H1;LARP1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.36359198102567386,-0.8832271116666912,0.7307692307692307,1.0,1.0,3/36,6.40%,VCAM1;NOD1;PODN
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.48166120506529403,-0.8832268880092544,0.5769230769230769,1.0,1.0,2/10,1.41%,FAXDC2;STARD3
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.5242325977903021,0.8830918853939187,0.6567164179104478,0.9069935097132065,1.0,3/16,17.82%,ATG12;RB1CC1;VMP1
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.5290116139571114,0.8830281769386236,0.6349206349206349,0.9068168270073953,1.0,5/12,20.37%,IL1RAPL1;PTPRD;NEDD4L;ADGRB3;NEDD4
prerank,Reactome_2022__HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,0.4835695183671851,0.88290929031573,0.6307692307692307,0.9067021726591997,1.0,7/17,28.98%,HSP90AA1;FKBP5;DYNC1H1;HSPA8;CAPZA2;DNAJA1;DYNC1I2
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.452605180185783,-0.8827126347665757,0.6206896551724138,1.0,1.0,2/15,2.18%,PRIMPOL;ISG15
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.5922059329843777,-0.8821652130589414,0.7,1.0,1.0,2/5,5.34%,CHKA;PLAAT3
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.5447915751168192,0.8817563307000025,0.65,0.9083613198282702,1.0,1/6,9.83%,HIF1A
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.45456134264987547,0.8816893612126018,0.6666666666666666,0.9081760787961177,1.0,6/33,14.45%,NEDD9;LAMA5;ADAM15;BCAR1;ITGB1;ERBIN
prerank,Reactome_2022__Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,0.4349887534325031,0.8814770773618644,0.6707317073170732,0.9081929463630869,1.0,10/33,23.67%,PSMC6;ENPP2;RPS27A;DCP2;PSMA7;HSPA8;ZFP36;YWHAB;UBC;XPO1
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.5136352977780202,-0.881443505952025,0.59375,1.0,1.0,4/7,15.75%,RBMX;TRA2A;CIRBP;NCL
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.5271598267463681,0.88134712297344,0.6666666666666666,0.9080944323542091,1.0,5/10,29.40%,DUSP1;TOM1L2;CAV2;CDK5RAP2;RGCC
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.5083606607861025,-0.8812998367747865,0.6666666666666666,1.0,1.0,4/7,24.81%,SMYD3;NSD1;SMYD2;PRMT2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5929454908426812,0.8809723612920805,0.7611940298507462,0.9083502076699824,1.0,3/6,20.37%,PRKCE;NEDD4L;NEDD4
prerank,Reactome_2022__Stabilization Of P53 R-HSA-69541,0.48226340950656565,0.8803827285570628,0.6,0.9089639948951795,1.0,2/18,8.07%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.5696953127746229,0.8802364215595707,0.7619047619047619,0.9089105774601433,1.0,2/8,20.40%,PINK1;BCL2L1
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.5791467180760604,0.8802136596669131,0.6727272727272727,0.9085897761902387,1.0,4/5,42.12%,SULF2;PCSK5;KIAA1217;DYNC2I1
prerank,CellMarker_Augmented_2021__Urine-derived Stem cell:Urine,0.6055533127998116,0.8800283777000002,0.71875,0.9082161125000623,1.0,2/5,13.68%,PECAM1;ITGB1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord,0.6055533127998116,0.8800283777000002,0.71875,0.9082161125000623,1.0,2/5,13.68%,PECAM1;ITGB1
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.4836715042867752,-0.8799480595518338,0.5517241379310345,1.0,1.0,2/10,4.20%,RHOBTB1;ARHGAP12
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.5117787911894977,-0.8798795527624579,0.6153846153846154,1.0,1.0,4/7,27.22%,SRPK1;SAFB2;DHX9;SLTM
prerank,Reactome_2022__SARS-CoV Infections R-HSA-9679506,0.3808613932347427,0.8797502553863972,0.7586206896551724,0.9084425064765442,1.0,36/137,23.37%,CANX;S1PR1;RPS11;MGAT4A;GPC5;SEC24D;NFE2L2;RPS9;JAK1;HSP90AA1;KDM1A;RPS27A;GRB2;GJA1;CNBP;ATP1B3;REST;IFNGR1;TAB2;ITGB1;RPS12;MGAT5;BRD4;TPR;FUT8;ST6GALNAC3;RPS27;CHMP4B;IFNGR2;SH3KBP1;YWHAB;YWHAE;UBC;UVRAG;ATP1B1;NCK1
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.47290051632496455,0.8796785630728723,0.6933333333333334,0.9082168405966726,1.0,3/14,20.85%,SSH1;HIP1R;ARFGEF1
prerank,Reactome_2022__Toll-like Receptor Cascades R-HSA-168898,0.41167146658912657,0.8795615852049223,0.7323943661971831,0.908135072471837,1.0,16/54,27.54%,DUSP6;RPS27A;HSP90B1;JUN;FOS;PELI1;TAB2;MAPK10;ALPK1;DNM2;UBC;MEF2C;RPS6KA3;MAP2K1;MAP3K8;PIK3C3
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.4674210646372552,-0.8794640412252905,0.5161290322580645,1.0,1.0,2/9,10.25%,TNRC6C;CPEB3
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.4674210646372552,-0.8794640412252905,0.5161290322580645,1.0,1.0,2/9,10.25%,TNRC6C;CPEB3
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.5727899355648383,0.8793828425142343,0.6666666666666666,0.9077460226124602,1.0,3/5,37.66%,TGM2;PRKN;MAPK1
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.5727899355648383,0.8793828425142343,0.6666666666666666,0.9077460226124602,1.0,3/5,37.66%,TGM2;PRKN;MAPK1
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Fetal Pancreas,0.5948305103255845,0.8791574516730907,0.7586206896551724,0.9077916823729847,1.0,2/5,6.67%,TRIM9;SNAP25
prerank,CellMarker_Augmented_2021__Bone Marrow Stromal cell:Bone Marrow,0.5009585831320753,0.8789894986316343,0.671875,0.907747097062359,1.0,4/11,27.52%,TINAGL1;CAV2;EGFR;ITGA2
prerank,Reactome_2022__Platelet Sensitization By LDL R-HSA-432142,-0.507061020364393,-0.8788873877390553,0.6296296296296297,1.0,1.0,2/10,8.63%,PLA2G4A;PPP2R5A
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.5731218223802304,0.8788010754415474,0.7,0.9074244687737603,1.0,2/5,21.89%,ADCY2;ADCY9
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.5731218223802304,0.8788010754415474,0.7,0.9074244687737603,1.0,2/5,21.89%,ADCY2;ADCY9
prerank,Reactome_2022__Apoptosis R-HSA-109581,0.4112864042666612,0.8787077220875033,0.7261904761904762,0.9072489975115254,1.0,17/59,25.37%,PSMC6;BCAP31;RPS27A;PSMA7;STAT3;GSN;BCL2L1;TNFRSF10B;YWHAB;AVEN;YWHAE;UBC;PPP3CC;KPNA1;PLEC;ADD1;PSMB9
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),-0.47019671887410064,-0.8785545748333394,0.5714285714285714,1.0,1.0,1/13,1.06%,CTNNA2
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.4305567257499468,0.8785494462210206,0.64,0.9072497174824872,1.0,6/39,17.82%,NRCAM;CTNND2;NRXN1;CLDN5;LIMS1;VMP1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.5360612169769934,-0.8784988100141546,0.6571428571428571,1.0,1.0,1/5,5.74%,RC3H1
prerank,CellMarker_Augmented_2021__Neuron:Embryo,0.5579194847817844,0.8784929495542472,0.671875,0.9070253249314426,1.0,1/6,0.80%,GRIA2
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5379117519557371,0.878436151270706,0.6901408450704225,0.906788823678849,1.0,1/7,2.39%,FES
prerank,Reactome_2022__Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.5184295049581715,-0.8781104664221185,0.6097560975609756,1.0,1.0,2/6,7.92%,ATM;RAD51B
prerank,Reactome_2022__Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.5184295049581715,-0.8781104664221185,0.6097560975609756,1.0,1.0,2/6,7.92%,ATM;RAD51B
prerank,Reactome_2022__Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.5184295049581715,-0.8781104664221185,0.6097560975609756,1.0,1.0,2/6,7.92%,ATM;RAD51B
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.5491431378274031,0.8780344211368005,0.6231884057971014,0.9071864353961395,1.0,2/6,15.19%,HSP90AA1;PLPP1
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.49360766565890624,0.8774690281392004,0.7142857142857143,0.9077595558499847,1.0,2/17,7.04%,FES;PINK1
prerank,Reactome_2022__Death Receptor Signaling R-HSA-73887,0.41314947645887434,0.8773889732292505,0.6829268292682927,0.9075557407687783,1.0,16/60,24.78%,RTN4;RPS27A;ARHGEF4;OTUD7B;GNA13;NSMAF;TAB2;ECT2;ARHGEF2;KALRN;TNFRSF10B;YWHAE;UBC;PREX1;RACK1;FGD4
prerank,Reactome_2022__NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,0.52574886996089,0.8773029013843991,0.7285714285714285,0.9073643320974697,1.0,1/12,3.24%,PBRM1
prerank,Reactome_2022__NOTCH4 Activation And Transmission Of Signal To Nucleus R-HSA-9013700,0.5701273768309045,0.8771240057439497,0.71875,0.9073200848305614,1.0,4/5,41.65%,NOTCH4;YWHAZ;DLL4;ADAM10
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.47133636777083965,-0.8771156313760765,0.5588235294117647,1.0,1.0,2/6,13.81%,ABCG2;SLC23A2
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,0.46327279164962865,0.8768441364897184,0.7313432835820896,0.907467742779622,1.0,3/19,10.23%,PRKAG2;RPS27A;RFC3
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.5237706835691216,-0.8768007048281782,0.6578947368421053,1.0,1.0,2/7,7.62%,NKD1;SHROOM2
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.5453094032737064,0.8765135089426976,0.6527777777777778,0.9077213952785681,1.0,3/8,28.42%,HSPA9;SPG7;ATP5F1E
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.4064599065176948,0.8763797926749751,0.7317073170731707,0.9076689066949145,1.0,15/54,17.13%,TRIM5;GAPDH;REL;PINK1;GJA1;PPM1A;PELI1;TAB2;SLC20A1;ECT2;NDFIP1;MTDH;ALPK1;BRD4;MALT1
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,0.44555414277658284,0.8763047952983409,0.6235294117647059,0.9074574189259952,1.0,6/28,17.45%,PSMC6;CBFB;RPS27A;CCNH;PSMA7;GATA2
prerank,Reactome_2022__DNA Replication Pre-Initiation R-HSA-69002,0.46218920794520585,0.8759359553987912,0.6578947368421053,0.9076578023486135,1.0,3/26,8.07%,PSMC6;POLA1;RPS27A
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.507125487647855,0.8758972824095562,0.671875,0.9074016502663718,1.0,2/9,9.38%,ANXA1;JAG2
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Adipose Tissue,-0.4475803419449801,-0.8756327985136151,0.5789473684210527,1.0,1.0,1/13,0.16%,VCAM1
prerank,KEGG_2021_Human__Cortisol synthesis and secretion,0.4845662068831042,0.875535442409703,0.6891891891891891,0.9077281822759056,1.0,9/20,24.25%,ITPR1;CACNA1C;ADCY2;ATF2;ADCY9;PLCB1;SCARB1;CREB3L2;LDLR
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.6139948094081356,0.875501394794035,0.6949152542372882,0.9074396172719241,1.0,2/5,28.02%,TMTC1;TMTC2
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.4840860245641615,-0.8753608883196161,0.7027027027027027,1.0,1.0,1/9,6.93%,PDE9A
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.571069212368435,0.87507769062899,0.7142857142857143,0.9078880078100848,1.0,1/6,12.01%,FOXF1
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.5544261960404921,0.8748218779941421,0.6666666666666666,0.9079902116230151,1.0,2/7,10.07%,RAPGEF3;RAP1A
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.460064958743341,0.8742813972904048,0.684931506849315,0.9086536445049804,1.0,3/23,6.64%,MAP2;SPOCK1;ANO2
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),-0.47736904778363143,-0.8740447597285375,0.59375,1.0,1.0,1/15,1.09%,MSL2
prerank,Reactome_2022__Activation Of RAC1 R-HSA-428540,0.5628930572755875,0.8738500082253768,0.696969696969697,0.9090238439227096,1.0,1/6,23.37%,NCK1
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.5374467965953631,0.8735192582863635,0.65625,0.9091620989274836,1.0,3/6,26.85%,CSTF3;SETX;PAPOLA
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.5410048325216344,0.8734790633978469,0.7076923076923077,0.9089020835734618,1.0,2/8,24.73%,DYSF;RACK1
prerank,Reactome_2022__DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.45549025796867626,-0.8734528490861435,0.6060606060606061,1.0,1.0,2/10,4.14%,ATM;H2AC6
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.36709904522946063,0.8731197541483235,0.7380952380952381,0.9091986788757611,1.0,37/152,24.52%,PDK4;PRKAG2;PKN3;MAP3K5;PGK1;PRKCE;BCR;FGFR1;PINK1;JAK1;CDK6;SIK2;TRIB2;STK38L;STK38;PRAG1;MAPK10;ACVR2A;PAK2;DGKI;GRK5;STAT3;CSNK1D;LIMK2;TEC;CDK8;MORC3;PPP3CB;TAOK1;OXSR1;PRKCH;FYN;HK1;CSNK2A1;WNK1;FGR;HIPK3
prerank,CellMarker_Augmented_2021__Flk1+ Mesodermal cell:Pluripotent Stem Cell,0.4192911689128489,0.8730731216178125,0.6901408450704225,0.9089307205972524,1.0,6/36,18.06%,PLS3;PPP1R9A;NEDD4L;NOS1AP;CADPS2;STOX2
prerank,Reactome_2022__MAPK6/MAPK4 Signaling R-HSA-5687128,0.4421581066508185,0.8730313121396678,0.6923076923076923,0.9086507830179592,1.0,6/37,18.35%,PSMC6;RPS27A;JUN;AGO2;PSMA7;KALRN
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.5151300736120095,-0.8728882482422171,0.7073170731707317,1.0,1.0,1/8,1.94%,PLPPR4
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.5066682501533636,0.872235988689555,0.6716417910447762,0.9098194003105643,1.0,1/11,6.14%,PIK3R1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.5516723907475597,0.8718464381798827,0.6119402985074627,0.9101436147874872,1.0,4/7,27.49%,TPR;DYNC1H1;CHMP4B;HNRNPU
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.42021226308222337,-0.8717073102081252,0.6,1.0,1.0,2/19,2.55%,CARMIL1;EVL
prerank,CellMarker_Augmented_2021__Responder T cell:Blood,-0.4434342783550914,-0.8716254897040784,0.5526315789473685,1.0,1.0,3/10,9.72%,CD74;GIMAP8;TNFRSF1B
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.36528037224774523,0.871329604643798,0.7647058823529411,0.9107594827789456,1.0,40/152,23.03%,ERBB4;KLF6;KLF2;MAP3K5;NPAS3;ESR2;SMAD5;PICALM;KLF4;JUN;HIF1A;CNBP;SETD3;REST;FOS;PPM1A;FOXF1;SMARCC1;NAA16;FOXC1;CRLF3;BRD4;ATOH8;NPAS2;FZD4;ZMIZ1;STAT3;NFIB;NR1D2;RLF;NOTCH4;KMT2E;NPM1;CEP290;DNM2;PPP3CB;MED4;PLCB1;ETS1;MEF2C
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.5061592761332928,0.870902607962316,0.6521739130434783,0.9112330611714199,1.0,5/10,28.98%,CCDC88A;TUBA1B;TUBB;KIF1B;DYNC1I2
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.464373774128675,-0.8708463400243169,0.5909090909090909,1.0,1.0,2/15,4.65%,BMP6;ABCG2
prerank,Reactome_2022__Activation Of BAD And Translocation To Mitochondria R-HSA-111447,0.5705517978384614,0.8700141390996823,0.6617647058823529,0.9124800485875221,1.0,5/7,32.72%,YWHAB;YWHAE;PPP3CC;YWHAQ;YWHAZ
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.4183459069547233,-0.8699824265707791,0.5483870967741935,1.0,1.0,1/14,2.15%,IL15
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.46543543787820496,0.8698925545987353,0.6811594202898551,0.9123573623082253,1.0,4/16,21.12%,ANXA1;FLT1;FOXC1;VEGFC
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.33937693580548983,-0.8693558133112189,0.7692307692307693,1.0,1.0,5/23,8.79%,ATM;PLK2;SP100;MDM2;HIPK2
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.6094766477647433,0.8692425426617536,0.7611940298507462,0.9131860727915245,1.0,1/5,20.16%,NPM1
prerank,Reactome_2022__Frs2-mediated Activation R-HSA-170968,0.5506554403760903,0.8691715588259405,0.7258064516129032,0.9129499125205797,1.0,3/7,25.95%,RAP1A;YWHAB;MAP2K1
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone,0.44139057592070474,0.8689566631094416,0.6714285714285714,0.9123111824668727,1.0,7/28,16.04%,SERPINE1;MGLL;ANXA1;EMP1;CFH;S100A6;PLAT
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Synovial Fluid,0.44139057592070474,0.8689566631094416,0.6714285714285714,0.9123111824668727,1.0,7/28,16.04%,SERPINE1;MGLL;ANXA1;EMP1;CFH;S100A6;PLAT
prerank,CellMarker_Augmented_2021__Amniotic Fluid Stem cell:Amniotic Fluid,0.44139057592070474,0.8689566631094416,0.6714285714285714,0.9123111824668727,1.0,7/28,16.04%,SERPINE1;MGLL;ANXA1;EMP1;CFH;S100A6;PLAT
prerank,Reactome_2022__Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,-0.4844065959954423,-0.8687650069170004,0.6052631578947368,1.0,1.0,1/7,4.14%,H2AC6
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.4712868722087883,0.8686651225481474,0.7313432835820896,0.9124191481349163,1.0,4/23,10.31%,SCP2;SCARB2;ATP8B1;PITPNC1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.5231572989551022,0.8684575452825801,0.6493506493506493,0.9123937393182097,1.0,1/9,7.20%,NAV1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Corneal Endothelium,0.42689007374346566,0.8684088361063024,0.7162162162162162,0.9121503080048633,1.0,11/40,16.04%,SERPINE1;ANXA1;TPM4;MSRB3;COL4A2;EMP1;ANXA2;ANO6;ITGB1;TUBB6;PLAT
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.523979212684843,0.8682537990414855,0.704225352112676,0.911696255748627,1.0,5/10,13.52%,SLC8A1;GPM6B;ATP2B1;ANO6;ACVR2A
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.523979212684843,0.8682537990414855,0.704225352112676,0.911696255748627,1.0,5/10,13.52%,SLC8A1;GPM6B;ATP2B1;ANO6;ACVR2A
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.5633035816666165,0.8681560837204488,0.703125,0.9115945124615982,1.0,2/7,7.76%,CHSY1;SRGN
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.4124331262712809,0.8678924565174386,0.7108433734939759,0.911650088174016,1.0,7/49,9.48%,ADAMTS9;TINAGL1;SRGN;BACE2;OGT;GGT5;ATG4C
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.5898661923292507,0.8676430081315374,0.7076923076923077,0.9117539889732301,1.0,2/7,7.01%,CHSY1;CHST11
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.5206584421433536,0.8667361997317249,0.7142857142857143,0.9129134104320726,1.0,3/12,20.64%,CDKN1B;CDKN1A;ATP2B4
prerank,CellMarker_Augmented_2021__Keratinocyte Progenitor cell:Skin,0.419667769367988,0.866506477175892,0.7,0.9129684465058752,1.0,6/39,11.71%,TIMP3;TINAGL1;PLSCR4;EMP1;VWF;CFH
prerank,CellMarker_Augmented_2021__Epithelial cell:Placenta,0.4757255441619854,0.8658941231107069,0.6363636363636364,0.9136233266080374,1.0,2/13,11.37%,TINAGL1;ANXA2
prerank,CellMarker_Augmented_2021__Stromal cell:Embryoid Body,-0.4242374913877015,-0.8653422585395972,0.6551724137931034,1.0,1.0,1/19,0.16%,VCAM1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.5314958886764556,0.8651373802124857,0.7368421052631579,0.9146157981788765,1.0,6/8,36.52%,KPNA4;KPNA3;KPNA1;KPNB1;RANBP2;NUP54
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.5426710319343245,0.8651087257365632,0.6875,0.9143201429904593,1.0,3/8,17.13%,SMAD7;CD55;MALT1
prerank,Reactome_2022__Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,0.5935688695480822,0.8650973603628085,0.7301587301587301,0.9140045938472154,1.0,1/5,11.18%,PIKFYVE
prerank,Reactome_2022__Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,0.5073700201112665,0.8648847264519935,0.6933333333333334,0.9140752154145941,1.0,1/13,3.24%,PBRM1
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Fetal Kidney,0.343186569186379,0.8647958279227651,0.97,0.9139448472460274,1.0,261/1465,19.92%,MAFF;CEP57;PKM;PCDH9;B3GNT2;DDIT4;PSMC6;RFTN1;NEDD9;LDHA;SCP2;TSG101;SUN2;ELL2;KLF6;HSPA5;NFKBIZ;TCP11L2;BCAP31;CANX;OXR1;TAMALIN;BHLHE40;PPA1;RRBP1;KCNIP4;PPM1D;PBRM1;GLUD1;CALR;JUNB;TSC22D3;TTC7A;S1PR1;CD81;RPS11;SLC4A10;MGAT4A;UPP1;LBR;PDE7A;ARF1;BAZ1A;GAPDH;PLIN2;PGK1;PACS1;ACOX1;ZBTB1;PPHLN1;MBP;UFL1;CRTC3;NDUFA12;ATG12;PIK3R1;CLEC2B;SMAD7;NFE2L2;RPS18;TMEM184B;ZNF586;RPS9;REL;ZNF800;ZFR;TUBB4B;CHST11;CBFB;JAK1;INSIG1;HSP90AA1;KDM1A;RAB21;ZDHHC6;JUND;SRGN;ARID5A;KDSR;TPM4;TMED10;MT2A;RPS27A;RASSF1;RSRC2;RB1CC1;RPL23;DUSP1;ATP2B1;TACC1;CDKN1B;PPP1R9A;TOR1AIP2;UBE2J1;OGT;FOSL2;YTHDC1;NOC3L;SLC38A2;AHNAK;HSP90B1;SMC6;U2SURP;JUN;GPATCH2L;RAD21;RAP1A;CREM;PITPNC1;MYL6;OTUD7B;HSPA9;RBM17;TRIB2;CCNH;CNBP;MICU2;PREPL;SETD3;ATP1B3;SLC2A3;CCNC;ANXA2;REST;COMMD1;ACAP2;CFH;SUGP2;IFNGR1;FOS;PPM1A;STRAP;DDX18;DDX3Y;RPL8;WAPL;BTBD10;RPL34;STK38;RPL37;ZFYVE28;CNOT6L;DCP2;TMEM165;RPLP2;AGO2;GIGYF2;ARPC2;SBNO1;TAF1D;TMF1;ADGRG1;ZBTB10;DUSP16;ITGB1;HIP1R;SMARCC1;CD55;TMEM59;SLC20A1;S100A6;PAK2;SERINC1;ACBD3;LRRFIP1;AP1G1;TUBA1B;ZC3H7A;MPRIP;RPL13A;TXNRD1;GGNBP2;AGTPBP1;NDFIP1;RALY;LPIN2;ANKRD11;SRSF7;ERO1B;SHOC2;UHRF2;CRLF3;CCNL1;RPS12;ADD3;SLC30A7;MTDH;ENSA;AGPAT4;NCALD;UBE2B;ATF2;BRD4;PSMA7;PLAT;HNRNPH3;ADSS2;PSAP;TMEM181;TRAM1;KPNA4;ATOH8;GOLPH3;SND1;TNKS;NAA50;MCPH1;SDCBP;TPR;PRKX;DIP2A;MALT1;PPP1CB;RAB2A;HDAC7;SERINC3;PXN;RIF1;TPST2;BTG2;MYL12B;RSU1;DNAJC15;DDHD1;FUT8;MIDN;ARHGEF2;NAMPT;CRY1;HERPUD1;TRA2B;PPP1R10;TMBIM6;SERF2;RALGAPA1;CFL1;PDE4B;CARHSP1;STAT3;CSNK1G3;RPS27;CSNK1D;MBD2;MTMR6;RNF11;MGAT1;NR1D2;ABI1;HBP1;DYNC1H1;PTPN1;USP34;EIF3A;RLF;BCLAF1;CHMP4B;WIPF1;SOCS3;KMT2E;FBXO34;MORF4L1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.5275724640824767,0.8647022566033705,0.6712328767123288,0.9137101233631132,1.0,1/6,1.43%,SCP2
prerank,Reactome_2022__Glycogen Metabolism R-HSA-8982491,0.5421204811969674,0.8644621440931155,0.696969696969697,0.9137566796907893,1.0,5/7,32.08%,RPS27A;UBC;GBE1;CALM1;UGP2
prerank,Reactome_2022__Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,0.5612386258447477,0.8642963354313772,0.7301587301587301,0.9136867845387798,1.0,2/7,22.42%,RPS27A;UBC
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.5143782877331924,-0.8641788559659412,0.6923076923076923,1.0,1.0,1/7,0.19%,DDX60
prerank,Reactome_2022__MECP2 Regulates Transcription Factors R-HSA-9022707,0.553603758588563,0.864002087049974,0.6229508196721312,0.9137814710479147,1.0,4/5,35.48%,MEF2C;PPARG;MECP2;RBFOX1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.4238852473109831,0.8638862477005917,0.7297297297297297,0.9136474334858755,1.0,3/40,9.30%,LAMC1;PICALM;SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.558849206683743,0.8637554485194606,0.6557377049180327,0.9135776536798556,1.0,3/6,38.54%,ETS1;ADAM17;ACTN4
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Undefined,0.4752225983382567,0.8626756733738287,0.6666666666666666,0.9149710634831941,1.0,6/17,9.06%,NFKBIZ;BHLHE40;JUNB;ANXA1;NFE2L2;FOSL2
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.47201936570145575,-0.8625542160974959,0.6571428571428571,1.0,1.0,3/12,8.50%,CD74;THOC1;MDM2
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.5629038304663246,0.8624233367459849,0.7230769230769231,0.9150611418196698,1.0,1/7,1.86%,PCK1
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood Vessel,-0.36980117786216404,-0.8618312283855587,0.6818181818181818,1.0,1.0,7/45,10.70%,VCAM1;MMRN1;ITIH5;APCDD1;PROM1;GNA14;LDB2
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Blood,-0.36980117786216404,-0.8618312283855587,0.6818181818181818,1.0,1.0,7/45,10.70%,VCAM1;MMRN1;ITIH5;APCDD1;PROM1;GNA14;LDB2
prerank,Reactome_2022__Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,0.4015109315317699,0.8618164442060997,0.7323943661971831,0.9157199650435045,1.0,14/51,27.46%,DUSP6;RPS27A;JUN;FOS;PELI1;TAB2;MAPK10;ALPK1;DNM2;UBC;MEF2C;RPS6KA3;MAP2K1;MAP3K8
prerank,Reactome_2022__Signaling By WNT R-HSA-195721,0.3996893604801403,0.8616600815683718,0.7586206896551724,0.9156975886513046,1.0,3/87,1.62%,PSMC6;ITPR1;WNT2B
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.5331803043058221,-0.8616309881371197,0.6341463414634146,1.0,1.0,1/6,12.43%,MTERF4
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.503504593608716,0.8616186965977333,0.7230769230769231,0.9154190484582782,1.0,1/12,6.27%,SMAD7
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.4425575230074939,0.8614974644175858,0.6753246753246753,0.9153007639964165,1.0,1/27,0.88%,PSMC6
prerank,CellMarker_Augmented_2021__Pit Progenitor cell:Stomach,-0.4501200987066859,-0.8611524539014617,0.6578947368421053,1.0,1.0,4/11,6.37%,GBP2;MVB12B;LIMS2;RASSF3
prerank,Reactome_2022__Vesicle-mediated Transport R-HSA-5653656,0.35070888826984975,0.8611097367740805,0.8202247191011236,0.915678555427774,1.0,51/226,22.52%,SEC22B;TSG101;PRKAG2;ANK2;CALR;HSPH1;SGIP1;SEC24D;SCARB2;HSP90AA1;MCFD2;RAB21;DLC1;RPS27A;GRB2;COL4A2;PICALM;ANK3;HSP90B1;GJA1;MYO1E;TBC1D15;DENND3;ARPC2;TMF1;KIF16B;HIP1R;CD55;ACBD3;AP1G1;RAB30;SYT1;RALGAPB;FZD4;TF;CSNK1D;DYNC1H1;CHMP4B;VPS37A;SH3KBP1;PAFAH1B1;HSPA8;DENND4A;DNM2;SYNJ2;YWHAB;RAB8B;YWHAE;SPARC;UBC;SCARF1
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.5349777445630506,-0.8609413188591551,0.6428571428571429,1.0,1.0,2/10,2.15%,VCAM1;IL15
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.5759283182748988,0.8608925809311943,0.7014925373134329,0.9156962110596824,1.0,1/5,11.47%,REST
prerank,KEGG_2021_Human__Alcoholism,0.42605275991976793,0.8607838304946386,0.618421052631579,0.9155259930854975,1.0,12/31,28.47%,GRIN2B;GRB2;SHC2;KRAS;ATF2;PPP1CB;HDAC7;H3-3B;CREB3L2;MAP2K1;GNAI3;CALM1
prerank,Reactome_2022__Metal Ion SLC Transporters R-HSA-425410,0.5598049784922681,0.860726581128072,0.7142857142857143,0.9152879725984887,1.0,2/6,19.12%,SLC30A7;SLC30A1
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.520921728684239,0.860306657940138,0.671875,0.915701171711609,1.0,1/7,7.14%,ARHGAP21
prerank,KEGG_2021_Human__Fanconi anemia pathway,0.5526320171844222,0.8602972055870434,0.7538461538461538,0.9153794124050991,1.0,1/8,5.26%,WDR48
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.5152497123223522,-0.8599579586059884,0.6511627906976745,1.0,1.0,1/5,2.20%,TTN
prerank,Reactome_2022__Cell-extracellular Matrix Interactions R-HSA-446353,0.5292686243699974,0.8599305172683059,0.7297297297297297,0.9157204379992006,1.0,5/9,17.74%,ITGB1;PARVB;LIMS1;ACTN1;RSU1
prerank,CellMarker_Augmented_2021__Neuron:Undefined,-0.458680804742494,-0.8597635979108129,0.5882352941176471,1.0,1.0,1/12,0.16%,VCAM1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.4605266112751997,0.8594702992317759,0.6956521739130435,0.9161450049797409,1.0,7/24,18.57%,IPO7;HSP90AA1;LAMP2;PTTG1IP;TPR;PPP1R10;STAT3
prerank,CellMarker_Augmented_2021__Limbal Stem cell:Corneal Epithelium,0.503258122218052,0.85926275157169,0.7361111111111112,0.9161624483674136,1.0,2/11,15.94%,NFE2L2;ALPK1
prerank,Reactome_2022__Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,0.4994917512852097,0.8592037133514369,0.6470588235294118,0.9159047776552361,1.0,4/11,19.60%,MYL6;MYH10;MYL12B;LIMK2
prerank,Reactome_2022__Signaling By EGFR R-HSA-177929,0.4450908450914464,0.859161648604745,0.7205882352941176,0.9156313500006997,1.0,3/22,8.31%,PIK3R1;RPS27A;GRB2
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.5709823360526254,0.8591164895584764,0.703125,0.9153740552999455,1.0,4/6,35.62%,JUN;CHD1;EP300;SMARCA4
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.566221339600284,0.8587623650456719,0.7288135593220338,0.9156386768771546,1.0,2/6,8.45%,ANK2;ATP2B1
prerank,Reactome_2022__Prevention Of Phagosomal-Lysosomal Fusion R-HSA-9636383,0.5729994586318246,0.858273779675393,0.7258064516129032,0.916074302286973,1.0,3/5,30.81%,RPS27A;UBC;RAB7A
prerank,Reactome_2022__Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,0.43554825452741475,0.8577811859380123,0.6956521739130435,0.9165613526799745,1.0,2/33,1.86%,ANGPTL4;PCK1
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.4579034262820031,0.8577789018480504,0.6455696202531646,0.9162364608378815,1.0,12/25,30.65%,RAB11FIP3;PRKCE;AHCTF1;ECT2;CSPP1;BCL2L1;UVRAG;CDC42;PIK3C3;CALM1;PRPF40A;CDC14B
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.49062461002122637,-0.8577282770683544,0.5789473684210527,1.0,1.0,1/7,8.79%,HIPK2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.4390321593288796,0.8576314660142199,0.7205882352941176,0.9161464432141976,1.0,6/29,23.37%,BNIP3L;CDKN1B;NPAS2;CHMP4B;SLFN11;NCK1
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.46084951850190625,-0.8574999198990352,0.6774193548387096,1.0,1.0,2/13,2.95%,BABAM2;ATM
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5271322805395534,0.8573255936156879,0.6825396825396826,0.9164301911621607,1.0,2/7,6.06%,INPP5F;HYAL2
prerank,Reactome_2022__DNA Damage Bypass R-HSA-73893,0.46908244491076967,0.8569950667709699,0.6764705882352942,0.9165587451109124,1.0,5/15,15.88%,WDR48;RPS27A;NPLOC4;RFC3;UBE2B
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.4071347993816854,-0.8569078589156262,0.5357142857142857,1.0,1.0,2/10,5.42%,IFIH1;NOD1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.43897400817558657,0.8568384653730079,0.64,0.9164488453033388,1.0,4/34,11.87%,ITPR1;MAP3K5;ERO1A;CDKN1A
prerank,Reactome_2022__Immune System R-HSA-168256,0.34449599736782704,0.8568367277606271,0.88,0.9161285468549971,1.0,69/508,14.32%,PIK3R3;PKM;PSMC6;BCL6;SEC22B;ITPR1;LRRC7;HSPA5;CANX;TRIM5;CALR;S1PR1;IL1RAPL1;CD81;ANXA1;LAMA5;MYO9B;SGIP1;PRKCE;SEC24D;DUSP6;RAPGEF3;UFL1;TRIM9;ATG12;NFASC;PIK3R1;TINAGL1;SMAD7;SNAP25;REL;TUBB4B;JAK1;DNAJC5;HSP90AA1;SERPINB6;DLC1;MT2A;RPS27A;GRB2;CDKN1B;UBE2J1;LAMP2;HSP90B1;JUN;HIF1A;RAP1A;MYO1E;PECAM1;HSPA9;PIKFYVE;SLC2A3;ANXA2;CFH;IFNGR1;CDKN1A;FOS;PELI1;ANO6;EEF1A1;ARPC2;TAB2;MAPK10;NEDD4L;ITGB1;CD55;LRRFIP1;AP1G1;GRB10
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.4465178893153039,0.8565611576634599,0.6842105263157895,0.9163047089124715,1.0,4/22,7.01%,B3GNT2;GPC5;CHSY1;CHST11
prerank,Reactome_2022__Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,0.5203903962666964,0.8565339705531255,0.7049180327868853,0.9156887047871917,1.0,3/9,8.07%,TSG101;SGIP1;RPS27A
prerank,Reactome_2022__Assembly Of HIV Virion R-HSA-175474,0.5203903962666964,0.8565339705531255,0.7049180327868853,0.9156887047871917,1.0,3/9,8.07%,TSG101;SGIP1;RPS27A
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.3912360208681167,0.856481804537976,0.7160493827160493,0.9154484482235586,1.0,15/88,16.87%,EHD4;RAB11FIP3;S1PR1;NUDCD3;CCDC88A;ARHGEF4;EMP1;RAP1A;ANO6;ITGB1;RAC1;BBS9;PARVB;GOLPH3;SDCBP
prerank,Reactome_2022__Late Endosomal Microautophagy R-HSA-9615710,0.4932913295681614,0.8563239955383536,0.6617647058823529,0.9153629661594005,1.0,3/12,8.07%,TSG101;PLIN2;RPS27A
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Brain,0.4119506349125232,0.8563224478961072,0.6666666666666666,0.9150358171364701,1.0,11/38,22.52%,GGT5;VWF;ZNF366;PECAM1;LRRC32;FLT1;CLDN5;ESAM;NOTCH4;CDH5;SCARF1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.4102926249023984,0.8561925971343937,0.7532467532467533,0.9149465822343158,1.0,9/44,17.10%,TRIM5;FGFR1;DUSP1;PEBP1;PHLPP1;FLT1;PAK2;SPRED1;DAG1
prerank,Reactome_2022__Ca2+ Pathway R-HSA-4086398,0.4386519169735853,0.8561668948579211,0.6794871794871795,0.9146594148433992,1.0,5/27,22.39%,ITPR1;AGO2;FZD4;PPP3CB;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.4548325803674311,0.8561420268060655,0.6875,0.914380369520428,1.0,5/21,7.36%,FES;PRKCE;PINK1;NAV3;HSP90AA1
prerank,Reactome_2022__HCMV Late Events R-HSA-9610379,-0.38868117425310167,-0.8560780152855705,0.6666666666666666,1.0,1.0,3/21,6.61%,MVB12B;H2AC6;NUP214
prerank,Reactome_2022__APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.4892144156991801,-0.8555943328716762,0.5517241379310345,1.0,1.0,1/8,1.99%,ANAPC16
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.4892144156991801,-0.8555943328716762,0.5517241379310345,1.0,1.0,1/8,1.99%,ANAPC16
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.42519900655294585,0.8554844167720178,0.7,0.9151541114574886,1.0,1/28,0.72%,ERBB4
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.39837772802199095,0.8554837553388271,0.6794871794871795,0.9148276205151206,1.0,5/42,9.59%,MAP2;GPM6B;PPP1R9A;MICALL2;CNTNAP2
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.558143093479248,0.8552915758238926,0.6666666666666666,0.9148216587710386,1.0,1/6,3.27%,GLUD1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.4878613112414961,-0.8551921395459137,0.6285714285714286,1.0,1.0,1/8,1.83%,CD74
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.5241510572748113,0.8550297174653037,0.6865671641791045,0.9148868528634236,1.0,4/6,35.59%,PRKX;ACVRL1;DLG1;CD34
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.417130983652339,0.8548845920007926,0.6710526315789473,0.9148492626022373,1.0,9/28,26.93%,RAPGEF3;NRXN1;NEDD4L;LGALS3;CDH5;RACK1;ADD1;ASAP1;VCP
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.45279051206387233,0.8546409809418937,0.7368421052631579,0.9149697011017184,1.0,6/29,8.45%,BCL6;ANXA1;GAPDH;POLA1;SRGN;ATP2B1
prerank,CellMarker_Augmented_2021__Epithelial cell:Endometrium,0.569141904973371,0.8544382144002028,0.7313432835820896,0.914967645894373,1.0,1/6,2.39%,FES
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.3285967894389101,-0.8543687248135003,0.8421052631578947,1.0,1.0,8/79,9.24%,RNF213;ANAPC16;ISG15;ZNRF3;RC3H1;TRIM25;MDM2;PSMF1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.5248095497048064,0.854340205390634,0.6911764705882353,0.9148274388549084,1.0,4/8,16.36%,SEMA6B;RAC1;SEMA3F;PLXNA2
prerank,Reactome_2022__Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,0.49541594754219115,0.8539019589359257,0.6944444444444444,0.9151016439985722,1.0,1/13,3.24%,PBRM1
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.38629731635766085,0.853428846185581,0.7647058823529411,0.9156004864774971,1.0,17/74,17.13%,TRIM5;GAPDH;UFL1;REL;PINK1;GJA1;OTUD7B;PPM1A;PELI1;TAB2;SLC20A1;ECT2;NDFIP1;MTDH;ALPK1;BRD4;MALT1
prerank,Reactome_2022__Metalloprotease DUBs R-HSA-5689901,-0.4868520552877643,-0.8528472104611887,0.6785714285714286,1.0,1.0,2/10,4.14%,BABAM2;H2AC6
prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,-0.4934295279063261,-0.8524257090670341,0.6176470588235294,1.0,1.0,4/10,20.82%,TNFSF10;TNFRSF1B;CXCL12;IL6R
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5018578570397214,0.8523341049220132,0.7323943661971831,0.9169506677504,1.0,8/14,29.14%,PRKCE;ANK3;NEDD4L;DMD;NEDD4;WNK1;CAMK2D;FGF12
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.45310855238405584,0.8515876421768943,0.71875,0.9177520033065849,1.0,6/23,13.71%,TSG101;CCDC88A;GRB2;ITGA1;ZFYVE28;HIP1R
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.5186999433355839,-0.8511809189071186,0.6363636363636364,1.0,1.0,1/5,3.90%,DISP1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.5925585794229853,0.8511185836285415,0.7101449275362319,0.9181902687712077,1.0,2/5,39.95%,MTM1;DNAJB6
prerank,CellMarker_Augmented_2021__Mesodermal Embryonic Stem cell:Germ,0.38415549754737716,0.8509827287824072,0.7215189873417721,0.9181161757738018,1.0,12/55,14.42%,ZEB2;S1PR1;SGIP1;ENPP2;GGT5;VWF;ZNF366;PECAM1;LRRC32;FLT1;CLDN5;TNS1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.4471257868409142,-0.850952719711574,0.6388888888888888,1.0,1.0,1/12,6.93%,PDE9A
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.48089723697766096,-0.8505763215043909,0.6857142857142857,1.0,1.0,1/8,2.95%,ATM
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.35536388557441706,-0.8504664573367787,0.7037037037037037,1.0,1.0,8/29,19.97%,SNX2;TBC1D5;ANKFY1;EVI5;TRAPPC10;VPS50;TMEM87A;GBF1
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.5452713145743517,0.8503444134924942,0.676056338028169,0.9188296203969039,1.0,3/6,30.23%,SREBF2;PPARG;ABCA5
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.3916279329885074,-0.8503234872728406,0.5833333333333334,1.0,1.0,4/24,10.25%,TNRC6C;RC3H1;ZC3HAV1;CPEB3
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.412180934324253,-0.8498865135415751,0.6571428571428571,1.0,1.0,3/13,11.55%,ATM;PDGFB;DACH1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.5078447559539525,0.8491887524133412,0.6756756756756757,0.9203455080513074,1.0,1/11,0.72%,ERBB4
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.49422992572957614,-0.8490088782781349,0.5,1.0,1.0,1/10,3.69%,TNRC6C
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.4423589757144999,-0.8478830750501851,0.6551724137931034,1.0,1.0,1/12,3.93%,ZIC1
prerank,Reactome_2022__Signaling By RAF1 Mutants R-HSA-9656223,0.4918098191495851,0.8474078866536027,0.7638888888888888,0.9228361082106267,1.0,11/14,37.66%,VWF;RAP1A;YWHAB;MAP2K1;MARK3;CAMK2D;CALM1;IQGAP1;RAP1B;VCL;MAPK1
prerank,CellMarker_Augmented_2021__Purkinje cell:Brain,0.4126880777874282,0.8473983742475354,0.7272727272727273,0.9225323446861109,1.0,10/44,25.26%,RAB11FIP3;ARHGAP23;TOM1L2;MPRIP;DYNC1H1;PAFAH1B1;CTIF;USP22;PLEC;ADD1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.5642476942464428,0.8472469343016343,0.75,0.9224332522761063,1.0,3/7,27.49%,DCP2;TNKS;HNRNPU
prerank,CellMarker_Augmented_2021__Endothelial cell:Peripheral Blood,0.5934005364937658,0.8471188615623887,0.746031746031746,0.9222831343187256,1.0,2/5,10.46%,VWF;PECAM1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.5557158380639231,0.8467071584675243,0.676056338028169,0.9226949773923738,1.0,3/5,40.42%,KPNA1;KPNB1;DICER1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.43148923729720917,0.8466566090672936,0.6266666666666667,0.9225055964605441,1.0,6/30,25.74%,DCP2;SRSF7;CSTF3;ZFP36;HIPK3;SRSF11
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.5448261361261624,0.8465770800407384,0.71875,0.922288865755519,1.0,3/6,29.99%,CFL1;CAV2;VAPA
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.5077733697332081,0.8465005911842569,0.7,0.9220605138452233,1.0,6/14,26.45%,CPEB4;UBR1;FYN;MTOR;SLC38A9;CAPN2
prerank,Reactome_2022__Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,0.45072671693175576,0.846340498967772,0.7066666666666667,0.9219696457674318,1.0,12/36,13.68%,BCL6;S1PR1;ANXA1;LAMA5;PIK3R1;JAK1;HSP90AA1;HSP90B1;HIF1A;CDKN1A;FOS;ITGB1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),-0.3895574451893533,-0.846276773175235,0.6470588235294118,1.0,1.0,3/25,2.76%,CARMIL1;EVL;OCLN
prerank,Reactome_2022__ARMS-mediated Activation R-HSA-170984,0.5979053137537339,0.846097460325765,0.7580645161290323,0.9221220124401517,1.0,3/5,21.99%,RAP1A;CRK;YWHAB
prerank,CellMarker_Augmented_2021__FOXN4+ cell:Lung,-0.41782978921894987,-0.8457289629759247,0.7096774193548387,1.0,1.0,1/18,0.61%,RTTN
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.46541957273504053,0.845643205546155,0.7162162162162162,0.9225251972697771,1.0,3/20,4.78%,FES;NES;PRKCE
prerank,KEGG_2021_Human__Hepatitis C,0.3949810558080142,0.8454213209311359,0.7349397590361446,0.9225479219085093,1.0,7/53,8.31%,PIK3R3;PPP2R2B;CD81;PIK3R1;JAK1;CDK6;GRB2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.4729764761788028,-0.8452358916965818,0.6153846153846154,1.0,1.0,1/9,3.98%,BMP6
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.4934229604138781,-0.8447086253551309,0.6176470588235294,1.0,1.0,1/8,2.05%,ZC4H2
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4531134972878002,0.8442230264278592,0.68,0.924224003936041,1.0,9/22,28.47%,MGLL;RIC8B;GRK5;CRY1;YWHAB;PLCB1;CAMKMT;GIT2;CALM1
prerank,CellMarker_Augmented_2021__Epithelial cell:Thymus,0.4623081945248536,0.8441715298868352,0.6984126984126984,0.9240032855654182,1.0,6/18,26.40%,LAMA5;BCAR1;SEMA3F;FZD4;EMP2;EGFR
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.4413611702338949,0.8441187357153025,0.6842105263157895,0.9237670623507539,1.0,5/23,19.55%,ROBO2;JAG2;ZMIZ1;STAT3;NOTCH4
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),0.56953495987657,0.8440109202666014,0.6833333333333333,0.9236092818546793,1.0,1/5,32.99%,ACVRL1
prerank,Reactome_2022__Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,0.4977034691245408,0.8430803630323098,0.6567164179104478,0.9248757323649911,1.0,3/10,13.25%,SIN3B;CCNH;TAF1D
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),0.5034753421794824,0.8427891454425454,0.7121212121212122,0.9250344660774129,1.0,5/12,31.39%,RPS27;NPM1;RPS15;RIOK3;RPS7
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.35025293961687504,-0.8425602189046054,0.7727272727272727,1.0,1.0,4/24,4.54%,TLN2;OCLN;LIMS2;SDK1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.4930327044731694,0.8424392730207577,0.6716417910447762,0.9252712809985478,1.0,7/13,33.04%,NEDD4L;ADGRB3;CSMD3;NEDD4;CDKL5;DAB2IP;CAMSAP2
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.5404819389239977,0.8424011109890486,0.75,0.9249959443658263,1.0,2/7,18.88%,BBS9;CSNK1D
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.44631607105427645,0.8423078359587853,0.7183098591549296,0.9248067536196922,1.0,8/29,17.74%,NEDD9;CALR;CDK6;RAC1;TRIOBP;CRK;LIMS1;RSU1
prerank,Reactome_2022__Downstream Signal Transduction R-HSA-186763,0.47203301337811915,0.8418366671023803,0.6956521739130435,0.9252230527081277,1.0,5/15,18.57%,PIK3R1;GRB2;BCAR1;CRK;STAT3
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.4029548450185434,-0.8418258530309926,0.5714285714285714,1.0,1.0,2/20,2.76%,CARMIL1;OCLN
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.4554112603265433,-0.8416767203303106,0.6296296296296297,1.0,1.0,1/10,1.83%,CD74
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.4643177861407907,0.8415574215501127,0.6612903225806451,0.9252564518327177,1.0,8/13,24.38%,SLC4A10;ACOX1;SLC4A7;NEDD4L;NR1D2;PNPLA8;WNK1;PPARG
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.5111714049958587,-0.8412677042975047,0.7272727272727273,1.0,1.0,1/6,0.13%,GBP1
prerank,KEGG_2021_Human__Melanogenesis,0.43034483540481083,0.8408512048013624,0.7435897435897436,0.9260625772429719,1.0,12/29,28.47%,WNT2B;KRAS;ADCY2;FZD4;ADCY9;PLCB1;CREB3L2;CREBBP;MAP2K1;GNAI3;CAMK2D;CALM1
prerank,Reactome_2022__Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.4807471651870476,0.840819692479529,0.7083333333333334,0.9257718409733232,1.0,1/14,2.34%,BCAP31
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.4889602104288659,0.840118094212909,0.7575757575757576,0.9265850180675637,1.0,5/12,20.58%,HSPA5;HSPA9;TMBIM6;PTPN1;HSPA8
prerank,Reactome_2022__Disorders Of Transmembrane Transporters R-HSA-5619115,-0.3280535733320726,-0.8400517128634212,0.8571428571428571,1.0,1.0,2/43,1.12%,SLC22A5;SLC4A4
prerank,KEGG_2021_Human__Pancreatic secretion,0.44150225231464507,0.8398974323295474,0.6986301369863014,0.9266100940067136,1.0,11/26,22.87%,ITPR1;ATP2B1;RAP1A;ATP1A1;ATP1B3;RAC1;ADCY2;ATP2B4;ADCY9;PLCB1;ATP1B1
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.46064100396698304,0.8398280964335775,0.7058823529411765,0.9264130068134964,1.0,4/16,23.53%,CDK6;KLF4;PTPN1;KLF7
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.4782296596784398,-0.839704086323906,0.6285714285714286,1.0,1.0,1/7,2.26%,ARNT2
prerank,Reactome_2022__Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,0.43807892718873753,0.8395893867618103,0.7,0.9264303337301031,1.0,6/22,11.90%,RPS27A;CDK6;CDKN1B;JUN;CDKN1A;FOS
prerank,Reactome_2022__NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,-0.4206838393273084,-0.8391598343232738,0.6896551724137931,1.0,1.0,3/17,6.77%,TBL1X;TNRC6C;TBL1XR1
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.40943630164086664,-0.838914434679913,0.6666666666666666,1.0,1.0,4/18,8.13%,BABAM2;ATM;RAD51B;HERC2
prerank,Reactome_2022__Homology Directed Repair R-HSA-5693538,-0.40943630164086664,-0.838914434679913,0.6666666666666666,1.0,1.0,4/18,8.13%,BABAM2;ATM;RAD51B;HERC2
prerank,CellMarker_Augmented_2021__Germline Stem cell:Ovarian Cortex,-0.3380185594893859,-0.8384377406403348,0.6666666666666666,1.0,1.0,2/38,3.05%,GBP1;IFI27
prerank,CellMarker_Augmented_2021__Germinal Stem cell:Ovary,-0.3380185594893859,-0.8384377406403348,0.6666666666666666,1.0,1.0,2/38,3.05%,GBP1;IFI27
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.5435160082882736,0.8380398153145643,0.7457627118644068,0.9286013355796903,1.0,1/8,10.73%,RBM17
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.5662820745930196,0.8376835221087585,0.7719298245614035,0.9288553661943919,1.0,3/6,31.10%,DGKI;PGS1;DGKG
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.39739423929445944,-0.8375083332108504,0.76,1.0,1.0,7/23,17.34%,GMDS;STAT1;PLXND1;MAML3;MAML2;ZNF423;PBX1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5411359437997255,0.8372616415076394,0.6865671641791045,0.9293310520911139,1.0,3/7,20.40%,HERPUD1;TMBIM6;BCL2L1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.35952000061592726,0.8372463192385304,0.7764705882352941,0.9290477659943924,1.0,20/104,14.42%,SPNS2;APOLD1;CD9;MGLL;TIMP3;HYAL2;PLSCR4;SRGN;EMP1;SLC2A1;GGT5;VWF;PECAM1;LRRC32;CFH;FOXF1;FLT1;CLDN5;CD55;TNS1
prerank,CellMarker_Augmented_2021__Leydig cell:Fetal Gonad,0.37918812911143557,0.8368570001877607,0.8292682926829268,0.929301372714931,1.0,10/87,9.30%,PLS3;ATRNL1;KCNMB4;CD9;PGK1;IPO7;AAMDC;RPS18;CDK6;SLC2A1
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.39731039161627724,-0.8366739546024801,0.6944444444444444,1.0,1.0,3/19,8.13%,BABAM2;ATM;HERC2
prerank,Reactome_2022__Inhibition Of DNA Recombination At Telomere R-HSA-9670095,-0.49551263062272743,-0.8363890402476131,0.71875,1.0,1.0,1/7,4.14%,H2AC6
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.480067069946334,0.8361953759190259,0.7297297297297297,0.9299241353679389,1.0,4/14,20.66%,ANK3;PREPL;GOLPH3;AFDN
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.5104313063488172,-0.8359499435571445,0.7352941176470589,1.0,1.0,2/8,14.82%,LARP1;CIRBP
prerank,KEGG_2021_Human__Viral myocarditis,0.45228349752933183,0.8358735702687092,0.64,0.9301345071570899,1.0,7/17,23.82%,CD55;RAC1;DMD;DAG1;ABL2;ACTB;FYN
prerank,Reactome_2022__Synthesis Of PA R-HSA-1483166,-0.4718828239628263,-0.8354922706147772,0.6470588235294118,1.0,1.0,3/9,13.15%,PLA2G4A;GPD1L;AGPAT3
prerank,Reactome_2022__Regulated Necrosis R-HSA-5218859,0.42380880566352724,0.8354645653837444,0.8051948051948052,0.9304573965112926,1.0,9/24,22.42%,HSP90AA1;RPS27A;OGT;PELI1;SDCBP;CHMP4B;TNFRSF10B;CDC37;UBC
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.4817786270126121,0.8354402497406141,0.7272727272727273,0.9301858629372903,1.0,8/18,33.84%,CCDC88A;DYNC1H1;LIMK2;KPNB1;DST;CAMSAP2;DLG1;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.44872501290781314,0.8354163712303098,0.6933333333333334,0.9298756967230501,1.0,6/24,19.58%,PRKCE;RAD21;ECT2;TPR;DYNC1H1;CSPP1
prerank,Reactome_2022__Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,0.41012542352908815,0.8351022626921838,0.7105263157894737,0.9300547435704277,1.0,4/41,6.35%,ANGPTL4;PLIN2;ACOX1;SIN3B
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4204743490836104,0.8350816056966993,0.7123287671232876,0.9297797563452346,1.0,11/23,33.84%,ANXA1;BRD4;KMT2E;PLCB1;ADAMTS1;EGFR;MECP2;RGCC;ADAM17;CUL3;RAB11A
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.36996882141757415,0.8350388821841933,0.8372093023255814,0.9294933268703561,1.0,14/85,15.67%,RPS11;RPS18;RPS9;RPS27A;RPL23;RPL8;RPL34;RPL37;CNOT6L;DCP2;RPLP2;RPL13A;RPS12;TUT7
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Tooth,0.593413583622554,0.8350334672561359,0.746031746031746,0.9292070976958098,1.0,3/5,36.63%,PODXL;PCDH11X;ATXN3
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Peripheral Blood,0.40204553533852205,0.8343958236598972,0.782051282051282,0.9299364480791958,1.0,12/43,22.52%,GGT5;VWF;ZNF366;PECAM1;LRRC32;FLT1;CLDN5;DYSF;ESAM;NOTCH4;CDH5;SCARF1
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.4189084840926424,-0.8341953668597158,0.5853658536585366,1.0,1.0,3/21,7.52%,ALS2;SNX2;SRGAP2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.5439576385917475,0.8341712696817324,0.7301587301587301,0.9300105591186434,1.0,3/5,27.49%,TPR;CHMP4B;HNRNPU
prerank,Reactome_2022__Advanced Glycosylation Endproduct Receptor Signaling R-HSA-879415,0.5373993741201707,0.8341520482905825,0.7301587301587301,0.9297089580615293,1.0,2/6,24.22%,LGALS3;CAPZA2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Liver,-0.44469706431541667,-0.8340995178004222,0.696969696969697,1.0,1.0,1/5,8.92%,PROM1
prerank,Reactome_2022__PKA Activation R-HSA-163615,0.5171889503164927,0.8336776447787507,0.7230769230769231,0.9300308685943471,1.0,3/8,28.47%,ADCY2;ADCY9;CALM1
prerank,Reactome_2022__APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,0.4466102859860435,0.8336572929380198,0.7662337662337663,0.9297372111568392,1.0,2/23,8.07%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.4399085963682336,-0.8334213208706805,0.6875,1.0,1.0,2/13,1.86%,CD74;IFIH1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.5050503907279805,0.8331269738074768,0.7297297297297297,0.9302987486364048,1.0,4/10,18.57%,ANXA1;PRNP;ERBIN;STAT3
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.47241218750553704,0.8329952341863395,0.7647058823529411,0.930136693658926,1.0,2/20,3.80%,PCK1;GLUL
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.3810586496102647,0.8323028982373837,0.7808219178082192,0.9308871359823241,1.0,18/62,27.62%,DDIT4;CALR;GRB10;GATA2;CRY1;TMBIM6;EGFL7;PTPN1;SULF2;NEDD4;YWHAB;NCK1;PHACTR4;CSNK2A1;RACK1;EGFR;VCP;PIK3CB
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Small Intestine,-0.5008898752028238,-0.8322843257733084,0.6896551724137931,1.0,1.0,3/8,9.32%,MX1;EZH1;ZNF385B
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,0.48635963630051327,0.8318216401757093,0.7619047619047619,0.9313162860950948,1.0,3/13,9.83%,CD9;ANXA1;HIF1A
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5618350009500072,0.8304849651715157,0.75,0.9329698162562428,1.0,4/5,43.80%,GATA2;DLL4;PDCD10;PPP1R16B
prerank,CellMarker_Augmented_2021__Colonic Stem cell:Colon,0.41109802105272375,0.8300768647324842,0.6973684210526315,0.933332288072415,1.0,5/28,17.10%,ASAP2;MYO1B;MYH10;SEMA3F;DAG1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.42284004759043914,0.8297901526793621,0.7638888888888888,0.9334744503818535,1.0,7/25,24.04%,PINK1;LGALS3;HERPUD1;TMBIM6;BCL2L1;MCL1;CSNK2A1
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.4468921246785643,0.8295168519874967,0.7428571428571429,0.9336010764992678,1.0,7/23,18.57%,IPO7;PINK1;LAMP2;PTTG1IP;TPR;PPP1R10;STAT3
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.5281879108345889,0.8292793130256101,0.7796610169491526,0.93361959150405,1.0,2/10,13.28%,PINK1;TMF1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.4144253952174991,0.8291300567784575,0.7682926829268293,0.9335262515856161,1.0,5/37,14.24%,SEC22B;HSP90AA1;CDKN1B;NEDD4L;PTTG1IP
prerank,Reactome_2022__Post-transcriptional Silencing By Small RNAs R-HSA-426496,-0.5263657946207466,-0.8290629534526514,0.7586206896551724,1.0,1.0,1/6,3.69%,TNRC6C
prerank,CellMarker_Augmented_2021__Myofibroblast:Lung,0.4564827930888251,0.8284804747850426,0.7941176470588235,0.9341269271949488,1.0,2/17,8.39%,TIMP3;COL4A2
prerank,Reactome_2022__Growth Hormone Receptor Signaling R-HSA-982772,-0.436716508096338,-0.8276460097997758,0.6923076923076923,1.0,1.0,1/8,3.27%,STAT1
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.5295993804958301,0.8265957860641171,0.765625,0.9366811334103079,1.0,2/5,23.98%,RAP1A;EMP2
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.4906798005317112,-0.8262088753372295,0.6842105263157895,1.0,1.0,2/8,16.87%,TRIP11;DYNC2H1
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.42991276899406183,-0.8261567000637622,0.6521739130434783,1.0,1.0,1/11,2.97%,ZNRF3
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.4756709863074048,0.8257161741504339,0.704225352112676,0.9377580180446708,1.0,1/11,7.04%,PINK1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.4327071423950096,0.8251861869841132,0.704225352112676,0.9381794397198048,1.0,7/16,32.24%,ANXA1;KMT2E;PLCB1;ADAMTS1;EGFR;RGCC;ADAM17
prerank,Reactome_2022__O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.5298814025338222,0.8248197550162842,0.7638888888888888,0.9381131380929775,1.0,1/7,0.77%,ADAMTS9
prerank,Reactome_2022__Defective B3GALTL Causes PpS R-HSA-5083635,0.5298814025338222,0.8248197550162842,0.7638888888888888,0.9381131380929775,1.0,1/7,0.77%,ADAMTS9
prerank,Reactome_2022__NoRC Negatively Regulates rRNA Expression R-HSA-427413,0.49993978128834143,0.8244235646052755,0.7704918032786885,0.9383454823792682,1.0,3/9,13.25%,SIN3B;CCNH;TAF1D
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.4896687592684379,-0.8241482338788648,0.6666666666666666,1.0,1.0,3/11,6.69%,IFI27;TNFSF10;SAT1
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.458251244618335,0.823970737742886,0.72,0.9388545717583912,1.0,8/24,25.50%,ATF3;AGO2;TPR;NPM1;CTIF;NCK1;EIF5;EIF3H
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.37941511129675415,-0.8237410232228137,0.7272727272727273,1.0,1.0,3/32,6.83%,VCAM1;SDK1;ACVR1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4627144580779856,0.8236169822343058,0.7808219178082192,0.9391018761808916,1.0,7/12,38.49%,OGT;SDCBP;EIF3H;TLK2;HSP90AB1;USP7;RYBP
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.4481805288512998,0.8233987349466275,0.7974683544303798,0.9390261757974113,1.0,10/21,22.15%,MICALL2;CTNNA1;PECAM1;CLDN5;PAK2;ECT2;ESAM;AFDN;TBCD;CDH5
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.5015871350850123,0.8233939126295309,0.7424242424242424,0.9383756554123768,1.0,2/6,22.42%,RPS27A;UBC
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.5015871350850123,0.8233939126295309,0.7424242424242424,0.9383756554123768,1.0,2/6,22.42%,RPS27A;UBC
prerank,Reactome_2022__DNA Double-Strand Break Repair R-HSA-5693532,-0.3698350911075914,-0.823132798887333,0.7241379310344828,1.0,1.0,4/26,8.13%,BABAM2;ATM;RAD51B;HERC2
prerank,Reactome_2022__RHO GTPases Activate KTN1 R-HSA-5625970,0.5126494681277178,0.8231135647859323,0.7538461538461538,0.9384884089663935,1.0,3/6,43.03%,CDC42;KLC1;KTN1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.5695107818392324,0.8228197827016558,0.8301886792452831,0.9383108384474942,1.0,3/5,33.86%,AKAP6;SPPL3;PTBP1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.5695107818392324,0.8228197827016558,0.8301886792452831,0.9383108384474942,1.0,3/5,33.86%,AKAP6;SPPL3;PTBP1
prerank,KEGG_2021_Human__Basal transcription factors,0.4928475518552524,0.8222291378051898,0.6865671641791045,0.9389144130040878,1.0,1/8,11.05%,CCNH
prerank,"Reactome_2022__PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",0.5693132821614537,0.8218238445823671,0.8,0.9391495107727412,1.0,2/7,15.72%,BCAR1;CRK
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.36293438022301605,0.8217721653659128,0.8313253012048193,0.938897702433922,1.0,25/104,22.55%,BCL6;ZBTB1;WDR48;UFL1;POLA1;GRB2;MACROD2;SMC6;RFC3;USP45;CDKN1A;ZBTB38;UBE2B;ATF2;SUSD6;RIF1;BTG2;CRY1;NPM1;SLFN11;BCL2L1;MCL1;TAOK1;SETX;UVRAG
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.5007022648273998,0.8215945988416311,0.7681159420289855,0.9388261393227172,1.0,2/9,12.72%,CDKN1A;DCP2
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.3048313998887496,-0.8214968763927449,0.75,1.0,1.0,15/119,11.39%,RNF213;UBE3D;MARCHF8;HERC5;IFI27;HERC6;RC3H1;HECW2;MDM2;PSMF1;UBE2E2;WSB1;PSMB1;FBXW4;FBXO9
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.4695288784110463,-0.821461097751668,0.7096774193548387,1.0,1.0,2/7,16.33%,BICD1;CLASP1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.4790801168002653,0.8214345993798383,0.6986301369863014,0.9387507956717734,1.0,3/13,22.28%,WWTR1;YWHAB;YWHAE
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.4815680871470757,0.8212870328893215,0.7142857142857143,0.9386295601776323,1.0,5/13,20.58%,HSPA5;HSPA9;TMBIM6;PTPN1;HSPA8
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.5190838587259565,0.8208088599329075,0.8088235294117647,0.9390136165675792,1.0,3/6,29.40%,ANO6;GSN;RGCC
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.506300489291886,0.8207912366059061,0.75,0.9387163774042943,1.0,6/9,31.10%,MGLL;DGKI;PGS1;SEL1L;ABHD2;DGKG
prerank,Reactome_2022__Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,0.4760874315132757,0.8207859821170358,0.7647058823529411,0.9384155186099501,1.0,2/12,11.87%,CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.3920886330061262,0.8207479334609924,0.7619047619047619,0.9381454543079242,1.0,7/44,13.31%,ST18;PSMC6;HYAL2;RPS27A;HIF1A;PELI1;TAB2
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.500108705983623,0.8201635340341111,0.7205882352941176,0.9386246994601875,1.0,3/5,13.36%,MGLL;GGT5;PON2
prerank,Reactome_2022__RMTs Methylate Histone Arginines R-HSA-3214858,0.49496927402520274,0.8200080737842061,0.7323943661971831,0.9385954558473624,1.0,2/10,13.73%,PBRM1;SMARCC1
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.43697098463293566,0.8199637215985539,0.7236842105263158,0.938325608650286,1.0,8/23,24.38%,CDK6;REST;ACVR2A;WWTR1;HDAC7;SMAD6;MEF2C;PPARG
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.4436966130603863,0.8199436919910938,0.7424242424242424,0.938025402425751,1.0,6/24,8.84%,BCAP31;SLC8A1;ANK2;CACNA1C;PRNP;PPP1R9A
prerank,Reactome_2022__TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,0.466687519584888,0.8194183155254763,0.7272727272727273,0.938530746577202,1.0,3/13,11.90%,JUN;CCNH;FOS
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.3039249203773671,-0.8192092468958502,1.0,1.0,1.0,17/101,11.95%,SCFD2;CD74;OCLN;VPS45;BICD1;WLS;TBC1D5;HERC2;STX17;ITSN1;PACS2;PIGU;COG3;CNTLN;CEP68;SEPTIN9;EVI5
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.5039975558569225,0.8189435285431661,0.7741935483870968,0.938883123681518,1.0,3/7,39.81%,CDKL5;MAP3K13;NRP1
prerank,CellMarker_Augmented_2021__Abnormal Plasma cell:Peripheral Blood,-0.3779871273172533,-0.8186256174640822,0.85,1.0,1.0,2/32,1.12%,VCAM1;SLC4A4
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),-0.43973662787659157,-0.8178999349223267,0.6551724137931034,1.0,1.0,1/14,2.58%,PLCB4
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),-0.43973662787659157,-0.8178999349223267,0.6551724137931034,1.0,1.0,1/14,2.58%,PLCB4
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.4183552621022899,0.8178928755408215,0.6962025316455697,0.9402574555967346,1.0,11/27,24.73%,SYTL4;TMED10;CNST;MYH10;FRMD4A;GOLPH3;TPR;CEP290;ABCG1;ADAM9;RACK1
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.5104289674428198,0.8175240980448661,0.8,0.9405289265706069,1.0,3/10,22.79%,HSPA9;BCL2L1;SPG7
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.44763648148812335,0.8172306502647392,0.7916666666666666,0.9405829527518857,1.0,7/20,31.63%,DYSF;CTTNBP2NL;NDFIP1;LGALS3;RACK1;RAB7A;PXK
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.45781080863117524,0.8171364375557523,0.7746478873239436,0.9404388094939087,1.0,4/20,11.87%,ZBTB1;HYAL2;KDM1A;CDKN1A
prerank,Reactome_2022__GPER1 Signaling R-HSA-9634597,0.4595625332128165,0.8170600253076433,0.7538461538461538,0.940249058136074,1.0,4/15,27.97%,ITGB1;ADCY2;ADCY9;GNAI3
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.49178758130253775,-0.8169017892404327,0.717948717948718,1.0,1.0,1/6,2.20%,TTN
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.4582034039995939,-0.8166229748832136,0.7142857142857143,1.0,1.0,1/6,6.11%,PARN
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.5356946442318913,0.8165794377716632,0.75,0.9405963114893765,1.0,2/8,21.30%,REST;EPAS1
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.41230460325315665,-0.8165430126936858,0.8076923076923077,1.0,1.0,5/14,12.35%,PARP14;STAT1;PARP9;NLRC5;PTPN2
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.48926286583391065,0.8164707025659879,0.7424242424242424,0.9404561184064092,1.0,3/13,10.04%,TMED10;PICALM;SAMD8
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.4582039379764105,0.8163021535630454,0.7837837837837838,0.9403312415695753,1.0,7/17,16.52%,S1PR1;CCDC88A;ARHGEF4;ITGB1;RAC1;PARVB;GOLPH3
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.47412556768874126,-0.8160737886624957,0.65625,1.0,1.0,2/11,8.53%,PKD2;SAMHD1
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.3907716518319373,-0.8158908064793133,0.75,1.0,1.0,1/15,2.79%,BABAM2
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.3899967704324805,0.8157913999829792,0.7638888888888888,0.9407275574650645,1.0,8/45,23.77%,HSP90AA1;YTHDC1;STRAP;RPS27;EIF3A;RPL10;SETX;EIF5
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.40935820438995557,0.8156429271428376,0.7721518987341772,0.9406064755882382,1.0,8/34,17.61%,CALR;GAPDH;CPEB4;AGO2;GIGYF2;RPL13A;TPR;BTG2
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.5193366212537571,0.8154411627262305,0.8064516129032258,0.9402961645739475,1.0,4/5,27.62%,HIF1A;NOS1AP;SCARB1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.5193366212537571,0.8154411627262305,0.8064516129032258,0.9402961645739475,1.0,4/5,27.62%,HIF1A;NOS1AP;SCARB1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.48028540889293053,0.8149786574351815,0.7391304347826086,0.9406957478905332,1.0,5/15,20.40%,BCAP31;HYAL2;PAK2;BCLAF1;BCL2L1
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.45847417392885725,0.8145372914261594,0.8166666666666667,0.9409621559422319,1.0,2/11,6.75%,CHPT1;ENPP2
prerank,CellMarker_Augmented_2021__4-Cell Stage Cell (Blastomere):Embryo,-0.4401261996002511,-0.8142288455057132,0.7727272727272727,1.0,1.0,1/12,2.90%,GEMIN5
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.3743249142593131,0.8142278502026193,0.788235294117647,0.941129688497854,1.0,14/68,18.22%,RAPGEF3;BCR;PICALM;RAP1A;TBC1D15;RGS7;TBC1D9;ITGB1;ECT2;LIMS1;RALGAPB;TGM2;RSU1;RALGAPA1
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.49052993733154315,-0.8139830839355346,0.7058823529411765,1.0,1.0,1/6,2.95%,ATM
prerank,Reactome_2022__Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,0.4721701908733944,0.8138094247447697,0.6901408450704225,0.9414982195954089,1.0,4/12,18.57%,PIK3R1;GRB2;LRRFIP1;STAT3
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.49622588655466854,0.8135164143161961,0.8208955223880597,0.9415592419853676,1.0,1/14,3.19%,LRRC8B
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.42574140377874237,0.8132874761374568,0.6623376623376623,0.941536798781055,1.0,6/25,15.72%,GPM6B;CCDC88A;DLC1;HIP1R;RAC1;CRK
prerank,Reactome_2022__IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,0.5275232901102598,0.8132842219998252,0.7931034482758621,0.9408932329582381,1.0,2/8,22.42%,RPS27A;UBC
prerank,"Reactome_2022__TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",0.5275232901102598,0.8132842219998252,0.7931034482758621,0.9408932329582381,1.0,2/8,22.42%,RPS27A;UBC
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Esophagus,0.49495911488492583,0.8127253765053322,0.7272727272727273,0.9413634941879268,1.0,2/12,1.12%,ADM;SPNS2
prerank,CellMarker_Augmented_2021__Periosteum-derived Progenitor cell:Periosteum,-0.3590754892196664,-0.8127017601032392,0.84,1.0,1.0,2/28,3.75%,VCAM1;DSE
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.45839390082601933,-0.8126090402912386,0.6170212765957447,1.0,1.0,2/8,8.50%,CD74;MDM2
prerank,Reactome_2022__Intraflagellar Transport R-HSA-5620924,-0.49088152596954415,-0.812357506370217,0.6578947368421053,1.0,1.0,2/7,16.87%,TRIP11;DYNC2H1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Anterior Cruciate Ligament,0.42881907669103,0.8120701918855734,0.7741935483870968,0.9420568561740292,1.0,7/24,16.04%,SERPINE1;ANXA1;EMP1;ANXA2;ITGB1;S100A6;PLAT
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.45698469803044184,-0.8120420711823515,0.75,1.0,1.0,3/10,13.15%,PLA2G4A;GPD1L;AGPAT3
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.45698469803044184,-0.8120420711823515,0.75,1.0,1.0,3/10,13.15%,PLA2G4A;GPD1L;AGPAT3
prerank,Reactome_2022__Prolonged ERK Activation Events R-HSA-169893,0.5088254907126223,0.8117792163411914,0.819672131147541,0.9421554180371015,1.0,4/9,25.95%,RAP1A;CRK;YWHAB;MAP2K1
prerank,Reactome_2022__STING Mediated Induction Of Host Immune Responses R-HSA-1834941,0.5314432076762354,0.8117761654936942,0.8,0.9415238767645754,1.0,4/5,46.88%,PRKDC;TBK1;IFI16;XRCC6
prerank,Reactome_2022__IRF3-mediated Induction Of Type I IFN R-HSA-3270619,0.5314432076762354,0.8117761654936942,0.8,0.9415238767645754,1.0,4/5,46.88%,PRKDC;TBK1;IFI16;XRCC6
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.45977969260144474,0.811436738877121,0.7123287671232876,0.941641427794651,1.0,5/12,22.28%,ANK2;NEDD4L;NEDD4;AHCYL1;YWHAE
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),-0.39669461907141285,-0.8102731143869364,0.7,1.0,1.0,2/13,6.83%,BMP6;ACVR1
prerank,Reactome_2022__SARS-CoV-2-host Interactions R-HSA-9705683,-0.2917673394039765,-0.8098265924324867,0.8947368421052632,1.0,1.0,15/73,12.91%,IFIH1;ISG15;GEMIN5;STAT1;PATJ;VPS45;NOD1;NUP214;TRIM25;STAT2;LARP1;RPS8;HLA-F;HLA-C;HLA-A
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.5066374146172491,0.8095677883558514,0.75,0.9441027203635406,1.0,3/5,20.48%,NRXN1;AGTPBP1;PAFAH1B1
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.4907311296290644,0.8091895730248398,0.7014925373134329,0.9444573936658206,1.0,3/7,18.65%,PSAP;ESYT2;ST6GALNAC3
prerank,Reactome_2022__SARS-CoV-2 Targets Host Intracellular Signaling And Regulatory Pathways R-HSA-9755779,0.5427672130184118,0.80883391795672,0.7971014492753623,0.9447287140892341,1.0,4/6,32.72%,YWHAB;YWHAE;YWHAQ;YWHAZ
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.43340356968390525,-0.8086903095191275,0.6551724137931034,1.0,1.0,2/18,5.07%,STAT1;PLXND1
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.3711702000885393,-0.8085323315998275,0.8,1.0,1.0,1/14,3.05%,IFI27
prerank,Reactome_2022__Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,0.4663866872575287,0.8084139855310783,0.7432432432432432,0.9450036261842822,1.0,5/12,22.42%,JAK1;RPS27A;STAT3;SOCS3;UBC
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.4486664205243779,0.8080836659799733,0.796875,0.9451462187590625,1.0,4/16,5.02%,PNP;CD81;ANXA1;ZBTB1
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.4993135628057143,-0.8077786834893731,0.7727272727272727,1.0,1.0,1/5,7.28%,GCH1
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Brain,0.3895365605093486,0.8073264821990428,0.8076923076923077,0.9458585767928739,1.0,8/42,14.16%,FES;GGT5;VWF;ZNF366;PECAM1;LRRC32;FLT1;DYSF
prerank,Reactome_2022__Sema4D In Semaphorin Signaling R-HSA-400685,0.4411772986399499,0.8071670141816687,0.6891891891891891,0.9457744230383703,1.0,4/14,19.60%,MYL6;MYH10;MYL12B;LIMK2
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.34571863736967295,0.8071159361452895,0.8452380952380952,0.9455470149758299,1.0,20/105,21.09%,BHLHE40;CALR;ZNF280D;ESR2;HIF1A;CREM;CNBP;REST;SBNO1;ZBTB38;WWTR1;RALY;FOXC1;ATF2;ZMIZ1;STAT3;NR1D2;BTG1;DENND4A;DNM2
prerank,KEGG_2021_Human__Mismatch repair,0.5437372878267134,0.8068695954971262,0.746268656716418,0.945594976990168,1.0,1/5,10.23%,RFC3
prerank,Reactome_2022__Diseases Of Mitotic Cell Cycle R-HSA-9675126,0.48700946957978064,0.8062209670598606,0.7222222222222222,0.9461856125797568,1.0,3/11,11.87%,CDK6;CDKN1B;CDKN1A
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Pluripotent Stem Cell,-0.48752872606384656,-0.8062028752472081,0.6756756756756757,1.0,1.0,1/6,1.83%,CD74
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Embryonic Stem Cell,-0.48752872606384656,-0.8062028752472081,0.6756756756756757,1.0,1.0,1/6,1.83%,CD74
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.46462810822307565,0.8061974065995733,0.7164179104477612,0.9459093189516975,1.0,2/12,16.87%,PINK1;SDCBP
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.46439544623662155,0.8061866828221675,0.8227848101265823,0.9456106156275293,1.0,6/17,19.60%,HYAL2;PIK3R1;ECT2;WWTR1;TPR;LIMK2
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.4231291824590423,0.805035228852695,0.8421052631578947,0.9468105667467656,1.0,4/27,10.31%,SPNS2;SCP2;ATP8B1;PITPNC1
prerank,Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,-0.28700468117873146,-0.8044276729473366,1.0,1.0,1.0,12/105,11.39%,RNF213;UBE3D;HERC5;HERC6;HECW2;HERC2;PSMF1;UBE2E2;WSB1;PSMB1;FBXW4;FBXO9
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.4942579717130137,0.804057759805868,0.7368421052631579,0.9478027010688492,1.0,5/9,22.52%,ANXA1;PRKCE;ITGB1;ARFGEF1;SCARF1
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.5169374142433365,0.8035453609680557,0.734375,0.9482373270753146,1.0,2/6,19.31%,CFL1;DYNC1H1
prerank,Reactome_2022__G2/M DNA Damage Checkpoint R-HSA-69473,-0.44388291177711525,-0.8035095717829076,0.78125,1.0,1.0,3/14,8.13%,BABAM2;ATM;HERC2
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.4933031803634825,0.8031421586322999,0.7384615384615385,0.9484234241433064,1.0,2/10,13.49%,BCAR1;DOCK4
prerank,Reactome_2022__Vpr-mediated Nuclear Import Of PICs R-HSA-180910,0.4622055976063093,0.8026825111136466,0.7945205479452054,0.9484682439724703,1.0,3/13,23.64%,SGIP1;TPR;KPNA1
prerank,Reactome_2022__Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,0.4622055976063093,0.8026825111136466,0.7945205479452054,0.9484682439724703,1.0,3/13,23.64%,SGIP1;TPR;KPNA1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.30928330954849403,-0.8025203940121316,0.85,1.0,1.0,7/58,9.75%,RTTN;EXOC5;CDC14A;PKD2;OFD1;TTC17;RFX3
prerank,Reactome_2022__Meiosis R-HSA-1500620,0.4594123980850311,0.8018939605834547,0.7638888888888888,0.9493040862958166,1.0,2/15,9.99%,SUN2;RAD21
prerank,KEGG_2021_Human__Glycerophospholipid metabolism,-0.3838017565428109,-0.8017882946380489,0.8695652173913043,1.0,1.0,5/23,5.34%,PLA1A;PLA2G4A;GPCPD1;CHKA;PLAAT3
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.46364858735928527,0.8016676853484965,0.7384615384615385,0.9492905004531946,1.0,4/12,25.98%,RAB21;TRAK1;MAPK8IP3;KIF1B
prerank,Reactome_2022__TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,0.4661056112934736,0.8012764381671215,0.7246376811594203,0.9495923231537812,1.0,1/7,8.07%,RPS27A
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.49665548520808006,0.8010428211151839,0.7611940298507462,0.9495748954513287,1.0,4/7,27.52%,SDCBP;VEGFC;ANKS1A;ITGA2
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),-0.304046465110509,-0.800728514329373,0.8666666666666667,1.0,1.0,9/54,16.15%,TENT2;THOC1;PARN;BICD1;RBMX;DDX17;FASTKD1;PNPT1;POLR2A
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.4649670031282719,0.8002224566784617,0.7384615384615385,0.9505555681439245,1.0,4/15,25.31%,PRNP;SERF2;GSN;CREBBP
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.47655539048138884,0.8001170179457505,0.734375,0.9501038826825844,1.0,1/11,8.07%,RPS27A
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.47655539048138884,0.8001170179457505,0.734375,0.9501038826825844,1.0,1/11,8.07%,RPS27A
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Breast,0.38958825262844676,0.8000602249916033,0.8354430379746836,0.94952915217648,1.0,7/42,12.83%,PTPRD;CACNA1C;ENPP2;VWF;SULT1C4;FLT1;TMEM132C
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Corneal Endothelium,0.38958825262844676,0.8000602249916033,0.8354430379746836,0.94952915217648,1.0,7/42,12.83%,PTPRD;CACNA1C;ENPP2;VWF;SULT1C4;FLT1;TMEM132C
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.4159132488263637,0.7997800804584603,0.7205882352941176,0.9496204115049154,1.0,5/33,16.57%,SLC4A10;SCARB2;BCAR1;SHC2;CADPS2
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.4810127045347303,0.7996516903443107,0.75,0.9494794434026866,1.0,1/9,4.54%,ARF1
prerank,Reactome_2022__Apoptotic Execution Phase R-HSA-75153,0.4407020976495738,0.798972432629479,0.8205128205128205,0.9500610361269914,1.0,1/19,2.34%,BCAP31
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.4985950616208638,0.798926044653575,0.7702702702702703,0.9498077520101081,1.0,5/8,40.11%,TNFRSF10B;SORT1;DAB2IP;DDX3X;BAG3
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.4772324027985747,-0.7984540494142975,0.7567567567567568,1.0,1.0,3/7,13.09%,SRGAP2C;SEMA6A;RAPGEF2
prerank,Reactome_2022__Regulation Of IFNG Signaling R-HSA-877312,0.4631041987371769,0.7982139484648488,0.7317073170731707,0.9505347334887477,1.0,5/10,19.84%,JAK1;IFNGR1;PTPN1;IFNGR2;SOCS3
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.46920435192627225,0.7980091181961375,0.7761194029850746,0.9505207921549828,1.0,2/12,8.07%,WDR48;RPS27A
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.44809696480365824,0.7973763443786832,0.6571428571428571,0.9511573238920495,1.0,2/19,8.23%,ATG12;RB1CC1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.41666394660746964,-0.7972102483537614,0.6206896551724138,1.0,1.0,2/9,9.35%,USP25;OTUD4
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.36684766174032274,-0.7967463615806497,0.7666666666666667,1.0,1.0,5/17,13.55%,CD74;PDGFC;PDGFB;FN1;GAS6
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.5010392357425145,0.7963025253268704,0.75,0.952469830251062,1.0,1/6,16.60%,TNKS
prerank,Reactome_2022__LDL Clearance R-HSA-8964038,0.5348038440528567,0.7959210492522886,0.7916666666666666,0.9527765279203908,1.0,3/6,44.62%,LDLR;CLTC;CLTA
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.44849186887018094,0.7958299432993307,0.8289473684210527,0.9526684873113594,1.0,7/18,17.29%,SLC8A1;SLC20A2;SLC12A6;ANO6;SLC26A2;SLC20A1;SLC1A2
prerank,CellMarker_Augmented_2021__Pericyte:Subcutaneous Adipose Tissue,0.36248271286401823,0.7957268708274937,0.8125,0.9524970539993592,1.0,9/49,14.42%,GGT5;VWF;ZNF366;PECAM1;LRRC32;CFH;FLT1;CLDN5;TNS1
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.3728127688831424,0.7955300640270279,0.7777777777777778,0.9524078402159668,1.0,15/46,22.39%,PPA1;PTPRD;PGK1;ALPL;PPM1A;DUSP16;SLC20A1;PAK2;PLPP1;STAT3;INPP5A;LIMK2;PPP3CB;TAOK1;PLCB1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4224314066282176,0.7951736801050913,0.7671232876712328,0.9526619154615482,1.0,10/21,32.91%,PINK1;MICALL2;YWHAB;YWHAE;SREBF2;PPP3CC;NPEPPS;YWHAQ;YWHAZ;MAPK8
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.4599267409699883,0.7947678382770731,0.7878787878787878,0.9529829506961341,1.0,2/13,2.18%,PCK1;AFF3
prerank,Reactome_2022__Late SARS-CoV-2 Infection Events R-HSA-9772573,0.4336034546677468,0.7946765585033686,0.7301587301587301,0.9528004574996563,1.0,6/21,18.65%,CANX;MGAT4A;RPS27A;MGAT5;FUT8;ST6GALNAC3
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.5269568048081504,0.7945501495275006,0.8115942028985508,0.9526292679511422,1.0,2/5,27.49%,DCP2;HNRNPU
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.4002948624385609,0.7942992162951847,0.8125,0.9526854633132033,1.0,8/34,18.38%,RAPGEF5;ANK3;PPP1R9A;SLC12A6;SHC2;HIP1R;KALRN;PODXL
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.5355642253587641,0.7942466269567698,0.8461538461538461,0.9524399377210039,1.0,3/6,21.99%,ENSA;ARPP19;YWHAB
prerank,Reactome_2022__PPARA Activates Gene Expression R-HSA-1989781,0.39069156679259714,0.7940279712863956,0.8133333333333334,0.9524589265860326,1.0,3/40,4.94%,ANGPTL4;PLIN2;ACOX1
prerank,CellMarker_Augmented_2021__Ureteric Bud cell:Fetal Kidney,0.4539581115861583,0.7939957308762798,0.8166666666666667,0.9522248078263985,1.0,2/13,11.21%,KDM1A;MYH10
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.4986245272054944,-0.793816839583782,0.7631578947368421,1.0,1.0,3/5,26.00%,CYLD;TRPM7;RIPK1
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.4986245272054944,-0.793816839583782,0.7631578947368421,1.0,1.0,3/5,26.00%,CYLD;TRPM7;RIPK1
prerank,Reactome_2022__MHC Class II Antigen Presentation R-HSA-2132295,0.40385734708415516,0.7935994765939859,0.821917808219178,0.952541514897302,1.0,2/26,4.99%,CANX;SEC24D
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.49847287912118793,-0.7934352499843916,0.7777777777777778,1.0,1.0,2/6,3.40%,CD74;OAS3
prerank,Reactome_2022__Inositol Phosphate Metabolism R-HSA-1483249,-0.41843167565208783,-0.7932471251750944,0.75,1.0,1.0,1/15,2.58%,PLCB4
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.42928812393981525,0.7931475212856369,0.8181818181818182,0.9528914848614493,1.0,3/23,9.83%,PRKAG2;OGT;HIF1A
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Blood,0.34986493533545326,0.793135995626245,0.8352941176470589,0.9525756553188286,1.0,14/91,10.17%,ITPR1;RRBP1;MGAT4A;GPM6B;SCARB2;ARHGEF4;TACC1;UBE2J1;OGT;SLC2A1;SLC38A2;HSP90B1;SMC6;MYO1E
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),-0.338901994670592,-0.7929095612817046,0.782608695652174,1.0,1.0,3/26,4.54%,OCLN;LIMS2;SDK1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.3914164023208923,0.7925507080498283,0.759493670886076,0.9531112288223619,1.0,12/42,27.49%,PSMC6;CDKN1B;FOXC1;PSMA7;SDCBP;BTG2;BTG1;CAV2;USP22;PSMB9;HECA;HNRNPU
prerank,Reactome_2022__Ovarian Tumor Domain Proteases R-HSA-5689896,-0.4349940505984683,-0.7924264372830577,0.7352941176470589,1.0,1.0,3/15,7.22%,IFIH1;NOD1;TRIM25
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.43387412195694375,0.7919143260722064,0.7857142857142857,0.9537356212881593,1.0,6/17,23.37%,OGT;SIK2;GRB10;VWA2;PTPN1;NCK1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.45220019499648106,0.791893233368375,0.7727272727272727,0.9534309698756899,1.0,2/12,18.75%,PPP1R9A;INPP5A
prerank,Reactome_2022__Signaling By BRAF And RAF1 Fusions R-HSA-6802952,0.4148760914469617,0.7917972332928984,0.7721518987341772,0.9532490600345965,1.0,12/28,28.47%,VWF;RAP1A;PEBP1;TRAK1;TENT4A;MPRIP;SND1;YWHAB;MAP2K1;MARK3;CAMK2D;CALM1
prerank,Reactome_2022__Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.4635988285946889,0.7914849566731677,0.7631578947368421,0.9533679452084984,1.0,1/12,0.77%,ADAMTS9
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.4041306869750019,-0.7904210575871898,0.7419354838709677,1.0,1.0,2/15,9.59%,MX1;DNM3
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.3651701922254953,-0.7903151963567198,0.7692307692307693,1.0,1.0,1/23,0.82%,EIF2AK2
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.40465587538371944,0.7902384839791659,0.8181818181818182,0.9549376629250584,1.0,9/29,23.67%,SUN2;AHCTF1;TNKS;RPS27;DYNC1H1;PAFAH1B1;TAOK1;SPC25;XPO1
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.37038467589662494,-0.7898586858523745,0.75,1.0,1.0,2/21,2.55%,CARMIL1;EVL
prerank,Reactome_2022__NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,0.4283035959492319,0.7898081866700669,0.8169014084507042,0.9552525087652036,1.0,4/19,15.64%,PCK1;KDM1A;AGO2;NCOR2
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.4152010077246241,0.7895386494237555,0.8157894736842105,0.9552890222143158,1.0,6/24,19.55%,RAPGEF3;PINK1;CDK6;FOXC1;NFIB;NOTCH4
prerank,Reactome_2022__Chk1/Chk2(Cds1) Mediated Inactivation Of Cyclin B:Cdk1 Complex R-HSA-75035,0.5466373257260959,0.7893895765336829,0.8181818181818182,0.9551586939645302,1.0,4/5,32.72%,YWHAB;YWHAE;YWHAQ;YWHAZ
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.46206149744465963,0.7893017755342545,0.6811594202898551,0.9549765714680083,1.0,5/8,20.61%,HYAL2;FOXF1;FOXC1;SULF2;CEP290
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.43519731567711384,0.7890436334066002,0.7567567567567568,0.9550316633804629,1.0,2/15,5.68%,MAP2;CTNND2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.5552511068051487,-0.7889712547510438,0.7608695652173914,1.0,1.0,1/5,3.43%,DCP1A
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,0.4872714729382356,0.7889436632912489,0.7777777777777778,0.9548460016343785,1.0,3/10,11.87%,CDK6;CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.38733316624836583,0.788729703848197,0.7671232876712328,0.954804845759879,1.0,10/32,26.40%,JAG2;PRAG1;GATA2;ZMIZ1;STAT3;EGFL7;NOTCH4;SREBF2;CREBBP;EGFR
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.36822384676658154,-0.7883692121423475,0.7027027027027027,1.0,1.0,2/19,4.41%,MLLT3;PLK2
prerank,Reactome_2022__Budding And Maturation Of HIV Virion R-HSA-162588,0.46012274406520876,0.7881514216087097,0.828125,0.9553669582033814,1.0,4/12,13.47%,TSG101;SGIP1;RPS27A;NEDD4L
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.35011535659292714,0.7881284150841404,0.8,0.9550703815515286,1.0,15/72,15.48%,ADAMTS9;PDK4;GRIK2;LSAMP;ENPP2;PLSCR4;DUSP1;VWF;LRRC32;CFH;CD55;TNS1;DGKI;PCDH7;KCTD12
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.3892638558663661,0.7878822541204886,0.7875,0.9550772711545724,1.0,8/42,15.72%,GPM6B;CCDC88A;DLC1;KATNBL1;HIP1R;PAK2;RAC1;CRK
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),0.48583317793780956,0.7878471206490892,0.828125,0.9548253548246781,1.0,3/9,11.31%,GLUD1;SLC2A1;SLC2A3
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.4878393540623973,0.7877047059864258,0.8166666666666667,0.9546881802562606,1.0,5/8,33.84%,CHMP4B;KPNB1;CUL3;EML4;RAB11A
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.521351422106358,0.7873459324985238,0.7727272727272727,0.9548097259686866,1.0,2/6,28.15%,CEP290;DNAJA1
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.45864908705571794,0.7871877628437979,0.7272727272727273,0.9543658183975694,1.0,3/12,19.58%,PRKCE;ECT2;CSPP1
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.45864908705571794,0.7871877628437979,0.7272727272727273,0.9543658183975694,1.0,3/12,19.58%,PRKCE;ECT2;CSPP1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.4375956916620378,-0.7870465318589567,0.7,1.0,1.0,2/8,6.83%,BMP6;ACVR1
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.4212640102136772,0.7864142361366495,0.726027397260274,0.955159113537517,1.0,7/23,19.10%,PLOD2;ERO1A;MSRA;STK38;PLAT;CSNK1G3;ABL2
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.4059859371798431,0.7864070910986607,0.7792207792207793,0.9548523262672217,1.0,6/30,20.29%,TSG101;TBC1D15;PIKFYVE;ALMS1;NPM1;GSN
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.3428902419650883,-0.7863391802667214,0.8260869565217391,1.0,1.0,6/25,9.19%,CD74;IL15;BMP6;ACVR1;EFNA5;PDGFB
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.45286129709181216,-0.786025499179931,0.6756756756756757,1.0,1.0,1/8,7.28%,GCH1
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.4972581462820487,-0.786024674644218,0.7692307692307693,1.0,1.0,1/5,6.83%,ACVR1
prerank,Reactome_2022__Regulation Of MECP2 Expression And Activity R-HSA-9022692,-0.39012656672263196,-0.7848591511665765,0.7307692307692307,1.0,1.0,4/17,8.79%,TBL1X;TNRC6C;TBL1XR1;HIPK2
prerank,CellMarker_Augmented_2021__Stem cell:Stomach,0.39134869434179786,0.7847210975180438,0.7894736842105263,0.9565218185607706,1.0,11/37,11.37%,SERPINE1;ANXA1;EPS8;NDRG1;NFE2L2;PLSCR4;ITGA1;FOSL2;EMP1;AHNAK;ANXA2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Ovarian Cortex,0.39134869434179786,0.7847210975180438,0.7894736842105263,0.9565218185607706,1.0,11/37,11.37%,SERPINE1;ANXA1;EPS8;NDRG1;NFE2L2;PLSCR4;ITGA1;FOSL2;EMP1;AHNAK;ANXA2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colon,0.5126588043018931,0.7845249658477038,0.8,0.9565392610339143,1.0,2/5,14.98%,NES;ALCAM
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),0.4883327838289705,0.784145415906022,0.746031746031746,0.9568035785361133,1.0,2/7,31.18%,RPL10;RPL24
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.3570377996169514,0.7840304465863005,0.8333333333333334,0.9566477842262137,1.0,5/52,12.32%,ERBB4;TRIM5;FGFR1;RAP1A;FLT1
prerank,KEGG_2021_Human__Necroptosis,-0.3355028794517331,-0.7837194971894974,0.8260869565217391,1.0,1.0,5/38,5.52%,EIF2AK2;PLA2G4A;STAT1;H2AC6;TNFSF10
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.3993427459729894,-0.7836378410984053,0.6451612903225806,1.0,1.0,3/11,16.71%,TENT2;PNPT1;SCAF8
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.3993427459729894,-0.7836378410984053,0.6451612903225806,1.0,1.0,3/11,16.71%,TENT2;PNPT1;SCAF8
prerank,Reactome_2022__TP53 Regulates Transcription Of Death Receptors And Ligands R-HSA-6803211,-0.46946716280309847,-0.7833302424893449,0.7741935483870968,1.0,1.0,2/6,15.43%,PPP1R13B;IGFBP3
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.4515357891244566,0.7833014771148262,0.7611940298507462,0.9574789839309658,1.0,5/12,30.70%,DCP2;SND1;ZFP36;MTREX;XRN2
prerank,Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509,-0.3144980015035778,-0.782874450304253,1.0,1.0,1.0,8/80,8.10%,MSL2;ARID5B;TBL1X;H2AC6;YEATS2;TBL1XR1;SMYD3;KDM7A
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.5194192094946353,0.7824110833975113,0.8208955223880597,0.9583133129150528,1.0,5/6,26.93%,HSP90B1;NPLOC4;HERPUD1;SEL1L;VCP
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreatic Islet,-0.4292313168260208,-0.7820937640964495,0.6666666666666666,1.0,1.0,2/11,4.73%,IL32;TPD52L1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.5182025906149852,0.7815521020032807,0.7777777777777778,0.959172847960673,1.0,4/5,36.39%,FOXF1;PCSK5;GLI3;NIPBL
prerank,Reactome_2022__Tight Junction Interactions R-HSA-420029,-0.5338573471703016,-0.7814720719183508,0.6956521739130435,1.0,1.0,2/5,12.06%,PATJ;PARD3
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.45187320921414087,0.7813155910309022,0.8115942028985508,0.9591709823289486,1.0,3/13,16.89%,DUSP1;PHLPP1;RELL1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.4652757179453473,0.7812584303885814,0.8153846153846154,0.9589447878801394,1.0,3/12,17.88%,PINK1;SPIRE1;DDHD1
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.507176717596329,0.780605157415083,0.8405797101449275,0.9594503316121944,1.0,2/7,7.09%,CANX;JAK1
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.5218914234608675,0.7805503164430311,0.7536231884057971,0.9591947936862492,1.0,2/5,17.21%,SPEN;TGM2
prerank,Reactome_2022__Cell-Cell Communication R-HSA-1500931,0.37566751671048965,0.778948198764709,0.85,0.9611400829793733,1.0,17/49,26.16%,CADM2;PIK3R1;GRB2;CTNNA1;MAGI2;CLDN5;ITGB1;PARVB;LIMS1;ACTN1;RSU1;AFDN;CDH5;NCK1;FYN;PLEC;WASL
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.33291125257418125,-0.7789017869469999,0.7586206896551724,1.0,1.0,3/16,8.50%,ATM;PLK2;MDM2
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.4629827776518068,0.7785857223463803,0.765625,0.9613028389401114,1.0,6/10,33.86%,DLC1;CDH5;SPPL3;CALM1;MTMR9;PTBP1
prerank,Reactome_2022__EGFR Downregulation R-HSA-182971,0.433421951926664,0.777768446203569,0.8333333333333334,0.9620749483522943,1.0,7/14,28.71%,RPS27A;GRB2;SH3KBP1;UBC;CDC42;EGFR;SH3GL1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.3812845625883006,0.7776024924857704,0.7733333333333333,0.962013402594374,1.0,11/31,31.29%,LAMA5;TINAGL1;WWTR1;SEMA3F;EPAS1;EMP2;EGFR;TM4SF1;DAB2IP;DOCK1;SMARCA1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.5068924832377342,0.7774113606930448,0.7323943661971831,0.9619812497555964,1.0,1/6,10.68%,LRRC32
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Venous Blood,0.5021390915053614,0.7772979282787427,0.7903225806451613,0.9618060736100948,1.0,2/7,7.46%,BCR;ALPL
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.4814194117722883,0.7772526561327919,0.8235294117647058,0.9615320152078431,1.0,2/11,16.36%,ROBO2;PLXNA2
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.3666099946215934,-0.7766348607107948,0.8846153846153846,1.0,1.0,2/20,2.55%,PSTPIP2;EVL
prerank,CellMarker_Augmented_2021__FGFR1HighNME5- Epithelial cell:Esophagus,-0.3400246174693287,-0.7762542887198745,0.8148148148148148,1.0,1.0,5/26,9.08%,VCAM1;NOD1;TGFBR3;STARD9;SLC16A2
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.4255571866969738,0.7762062924122487,0.7846153846153846,0.9626986341947315,1.0,3/15,22.47%,PINK1;GOLPH3;SREBF2
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.4081177971280611,0.775823395552271,0.7702702702702703,0.9628604986012923,1.0,9/25,23.64%,IPO7;RPL23;PTTG1IP;KPNA4;TPR;PPP1R10;STAT3;KPNA3;KPNA1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.3855636564914825,-0.7756182368565201,0.71875,1.0,1.0,3/17,8.21%,MLLT3;RTF1;MLLT1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.3855636564914825,-0.7756182368565201,0.71875,1.0,1.0,3/17,8.21%,MLLT3;RTF1;MLLT1
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.3464955260240019,0.7754509570086203,0.8809523809523809,0.9630295819866178,1.0,8/88,10.62%,PSMC6;WDR48;SMAD7;RPS27A;OGT;HIF1A;USP45;OTUD7B
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Germ,0.5212207827558202,0.7749554706439432,0.8448275862068966,0.9632900975226694,1.0,3/6,18.38%,CD9;ITGB1;PODXL
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.4564944780041664,-0.7749247045867466,0.7419354838709677,1.0,1.0,2/7,11.69%,EEA1;MFF
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.469534557163385,-0.7748812607017999,0.6829268292682927,1.0,1.0,2/7,8.50%,CD74;MDM2
prerank,Reactome_2022__NRAGE Signals Death Thru JNK R-HSA-193648,0.396839336818575,0.7742514568507163,0.8441558441558441,0.9638103396917249,1.0,7/27,24.78%,ARHGEF4;GNA13;ECT2;ARHGEF2;KALRN;PREX1;FGD4
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.38693147766304614,0.774091844672036,0.8421052631578947,0.9637227886529842,1.0,7/29,31.45%,SMAD7;TRIB2;CSNK1D;RACK1;VCP;RNF19A;PTK2
prerank,Reactome_2022__HIV Life Cycle R-HSA-162587,0.3734760048426449,0.7740825382901353,0.8666666666666667,0.9634267820360088,1.0,11/41,23.67%,TSG101;SGIP1;RPS27A;CCNH;NEDD4L;TPR;CHMP4B;VPS37A;UBC;KPNA1;XPO1
prerank,KEGG_2021_Human__Synaptic vesicle cycle,0.4178997947734845,0.7738196379837732,0.8194444444444444,0.9635259182950381,1.0,4/20,21.09%,SNAP25;SYT1;SLC1A2;DNM2
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.45651766313756525,-0.7736796733953744,0.75,1.0,1.0,4/7,27.86%,INO80;TOP2B;LATS1;NSL1
prerank,Reactome_2022__Activation Of GABAB Receptors R-HSA-991365,0.4751820411300655,0.7734812586239675,0.782608695652174,0.9636688577827792,1.0,3/8,27.97%,ADCY2;ADCY9;GNAI3
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.4164486244129,-0.7731643498168609,0.7142857142857143,1.0,1.0,5/10,13.55%,CD74;PDGFC;PDGFB;FN1;GAS6
prerank,Reactome_2022__Assembly Of Pre-Replicative Complex R-HSA-68867,0.4045221866847556,0.7731156283528012,0.8441558441558441,0.9638372846279337,1.0,2/24,8.07%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.45906954856490334,-0.7728917396083675,0.78,1.0,1.0,2/7,8.50%,CD74;MDM2
prerank,Reactome_2022__Cell Junction Organization R-HSA-446728,0.399971274951842,0.771979390285916,0.8082191780821918,0.9650139133992629,1.0,10/31,22.15%,CADM2;CTNNA1;CLDN5;ITGB1;PARVB;LIMS1;ACTN1;RSU1;AFDN;CDH5
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.32763740295835697,-0.7718866292892467,0.8888888888888888,1.0,1.0,6/23,13.20%,EXOC5;STXBP6;OPTN;VPS35L;EXOC1;EXOC6
prerank,KEGG_2021_Human__Endocytosis,0.3427686595631589,0.7717649911324342,0.8823529411764706,0.9649590078912949,1.0,28/103,26.40%,TSG101;EHD4;RAB11FIP3;ARF1;ASAP2;ACAP2;WASHC4;ARPC2;NEDD4L;GRK5;ARFGEF2;CHMP4B;WIPF1;VPS37A;SH3KBP1;NEDD4;HSPA8;ARFGEF1;DNM2;CAV2;RUFY2;CAPZA2;LDLR;PSD3;ASAP1;WASL;CDC42;EGFR
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Placenta,0.35619779039184607,0.7713832484559948,0.8717948717948718,0.9651816070778577,1.0,9/40,14.42%,ZEB2;ENPP2;GGT5;VWF;PECAM1;LRRC32;CFH;FLT1;TNS1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.4439528237072851,0.7709098812135297,0.76,0.9654770537222754,1.0,2/12,2.92%,CLIC2;ANK2
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.4231888612921709,0.7708697973022178,0.7647058823529411,0.9651921945729429,1.0,6/11,34.16%,GSN;ARFGEF1;CDH5;RACK1;CYRIB;RAP1B
prerank,Reactome_2022__Glycosphingolipid Metabolism R-HSA-1660662,0.4600885112359354,0.770737238389199,0.746268656716418,0.9650971823756405,1.0,3/7,18.96%,ESYT2;ARSG;EGFL7
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.38946712314049065,0.7702052899432636,0.863013698630137,0.9655527936996067,1.0,11/44,19.10%,FES;DUSP1;ADGRG1;RASA1;PLXNA2;PRKX;TGM2;PPP1CB;RSU1;PODXL;ABL2
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.46235251822028417,0.7685899966133005,0.7777777777777778,0.9672838208176966,1.0,3/12,11.42%,BCAP31;HSP90AA1;SLC25A16
prerank,Reactome_2022__VxPx Cargo-Targeting To Cilium R-HSA-5620916,0.45292956957428976,0.7683446598307583,0.7571428571428571,0.9673849749049005,1.0,1/10,3.48%,RAB11FIP3
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.479207267737803,-0.768251851332373,0.7333333333333333,1.0,1.0,2/5,23.82%,POLR2A;DHX9
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.34048660925624086,-0.7678578752772373,0.7878787878787878,1.0,1.0,4/20,9.19%,ATM;ATR;PARN;PDGFB
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.48286241707062943,0.767793958854867,0.7619047619047619,0.9678211730980076,1.0,1/7,16.52%,GOLPH3
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.4230079913595002,0.767645437700563,0.8533333333333334,0.9676890404392253,1.0,5/16,21.65%,CANX;PICALM;SYT1;DNM2;SYNJ2
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.389292355448546,-0.767549941769607,0.7096774193548387,1.0,1.0,1/10,5.23%,SLC25A29
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.44378981050039457,0.767389349423774,0.7794117647058824,0.9677098793475875,1.0,9/15,37.16%,ACTN1;ACTB;CLIC1;STXBP3;PIK3CB;MYL12A;MYH9;ACTG1;VCL
prerank,CellMarker_Augmented_2021__Muller cell:Retina,0.41396171327156706,0.7672651408827479,0.8289473684210527,0.9675778699441605,1.0,4/21,10.09%,TM6SF1;GLUL;VWF;GAS7
prerank,Reactome_2022__TNFR1-induced Proapoptotic Signaling R-HSA-5357786,-0.4868505541345382,-0.7667830472597458,0.78125,1.0,1.0,1/5,3.24%,USP25
prerank,Reactome_2022__Telomere Maintenance R-HSA-157579,0.43390263043112853,0.7667392745482633,0.8,0.9680607228505735,1.0,2/15,10.23%,POLA1;RFC3
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.4646284022339481,0.7667378987056603,0.8059701492537313,0.9677432217935547,1.0,1/12,5.55%,YBX3
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4844949409014515,0.7665856221352843,0.7164179104477612,0.9676440493687065,1.0,1/5,6.27%,SMAD7
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.3529341353739058,0.7663177769284827,0.8117647058823529,0.9676576005743466,1.0,14/78,19.44%,ZEB2;PSMC6;GPC5;CTNND2;PPM1A;WWTR1;UBE2B;PSMA7;TNKS;AMFR;FZD4;CSNK1G3;CSNK1D;USP34
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,-0.3984617104930537,-0.7660768355450042,0.6451612903225806,1.0,1.0,4/10,16.79%,ATM;MDM2;UBB;MDM4
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.452603302590013,-0.7660567386261168,0.6875,1.0,1.0,1/7,2.18%,ISG15
prerank,Reactome_2022__Glucagon-type Ligand Receptors R-HSA-420092,-0.4580769975350074,-0.7651347811984365,0.6451612903225806,1.0,1.0,1/5,16.68%,GNB4
prerank,Reactome_2022__Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,-0.4580769975350074,-0.7651347811984365,0.6451612903225806,1.0,1.0,1/5,16.68%,GNB4
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.4992162552528177,0.7650252809392892,0.796875,0.969077097766334,1.0,4/6,36.39%,FOXF1;PCSK5;GLI3;NIPBL
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.3753747382151701,0.764774979563223,0.7922077922077922,0.9691337519246084,1.0,6/36,8.79%,CD81;DPP10;PRKCE;PIK3R1;PRNP;ANK3
prerank,Reactome_2022__Gene Silencing By RNA R-HSA-211000,-0.3467789399150145,-0.7643178725734284,0.8333333333333334,1.0,1.0,3/24,6.61%,TNRC6C;H2AC6;NUP214
prerank,Reactome_2022__Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.4876685041505119,-0.7642345607743064,0.8292682926829268,1.0,1.0,1/5,2.95%,ATM
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.4669127604741475,0.763594445714311,0.7887323943661971,0.9701488418805622,1.0,3/7,16.73%,CD9;CRK;ACTN1
prerank,Reactome_2022__Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,0.4089787501496058,0.7635876933061778,0.8414634146341463,0.96986757479244,1.0,8/25,13.84%,SLC8A1;SLC4A10;SLC20A2;SLC4A7;SLC38A2;SLC12A6;SLC26A2;SLC20A1
prerank,Reactome_2022__RND3 GTPase Cycle R-HSA-9696264,0.43094238255634,0.7632560575096935,0.8225806451612904,0.9699565684989474,1.0,4/17,8.61%,PIK3R1;CCDC88A;ARHGAP21;PICALM
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.3487303356973575,-0.7632381947333255,0.84,1.0,1.0,1/24,0.82%,EIF2AK2
prerank,Reactome_2022__Signaling By NOTCH R-HSA-157118,0.3523820998611592,0.762835156482956,0.8433734939759037,0.9701289253569835,1.0,20/68,25.37%,PSMC6;CNTN1;RPS27A;JAG2;MIB1;JUN;HIF1A;CCNC;AGO2;NCOR2;PSMA7;HDAC7;NOTCH4;CDK8;B4GALT1;UBC;H3-3B;SEL1L;CREBBP;PSMB9
prerank,CellMarker_Augmented_2021__Stem cell:Gastrointestinal Tract,0.3719331222011726,0.7626891719208122,0.8783783783783784,0.9700111030734045,1.0,6/52,9.61%,CANX;SCARB2;EPS8;SMAD5;MYO1B;MIB1
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.3867470550911777,-0.7625038920858747,0.8235294117647058,1.0,1.0,1/15,1.22%,ALS2
prerank,Reactome_2022__Cell-cell Junction Organization R-HSA-421270,0.4009170766817857,0.7624654036346874,0.7567567567567568,0.969983973945673,1.0,3/18,13.12%,CADM2;CTNNA1;CLDN5
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.28528506887093336,-0.7624378795455578,0.9047619047619048,1.0,1.0,5/60,7.36%,TENT2;THOC1;IVNS1ABP;BICD1;WBP4
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.45083108870373756,-0.7622578988939437,0.6363636363636364,1.0,1.0,1/5,2.95%,ATM
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.4437916082545744,0.7619597826302289,0.7714285714285715,0.9703047147460019,1.0,4/10,20.82%,LAMA5;PRKX;DAG1;ACTB
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.47616843676908716,0.7618437120054099,0.7777777777777778,0.9701507277416763,1.0,3/7,7.25%,PRKAG2;LBR;INSIG1
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.35897187824577215,0.7610549541410382,0.8571428571428571,0.9708984936364153,1.0,8/52,9.16%,CD81;RAPGEF3;HYAL2;PIK3R1;PRNP;PINK1;ANK3;MICALL2
prerank,Reactome_2022__Ub-specific Processing Proteases R-HSA-5689880,0.35942979242653383,0.7607397848722863,0.8292682926829268,0.9710050469475732,1.0,5/57,9.83%,PSMC6;WDR48;SMAD7;RPS27A;HIF1A
prerank,CellMarker_Augmented_2021__PROM1High Progenitor cell:Large Intestine,0.3966238208216917,0.7606804407440116,0.8051948051948052,0.9707460389754194,1.0,6/33,7.78%,PPP2R3A;MAP1B;NAV1;NAV3;MCFD2;SRGAP1
prerank,Reactome_2022__Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,0.4298797855344557,0.7605063606858469,0.7972972972972973,0.9706174317900678,1.0,7/13,30.25%,CBFB;CDKN1A;GATA2;STAT3;H3-3B;KMT2A;DEK
prerank,Reactome_2022__Signaling By PDGFRA Extracellular Domain Mutants R-HSA-9673770,0.49455687920580244,0.7602410583176403,0.7681159420289855,0.9706335632756364,1.0,2/7,8.31%,PIK3R1;GRB2
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.3100794525614653,-0.7600331644647189,0.9285714285714286,1.0,1.0,5/28,8.50%,GBP2;RANBP17;NUP214;TAF3;MDM2
prerank,CellMarker_Augmented_2021__Hemangioblast:Germ,0.4986557136630446,0.7598235001983261,0.7647058823529411,0.9708340589490545,1.0,3/6,22.15%,PECAM1;PODXL;CDH5
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.4717943987804093,0.759778435754321,0.7575757575757576,0.9705718303873051,1.0,4/8,29.24%,OGT;RIF1;MTF2;KMT2A
prerank,CellMarker_Augmented_2021__Natural Killer cell:Liver,-0.47084526422302553,-0.7596677056199783,0.7741935483870968,1.0,1.0,2/6,14.42%,GIMAP8;GIMAP4
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.44718264569868,0.7593023135389082,0.7910447761194029,0.9708336337018365,1.0,9/14,37.16%,ACTN1;ACTB;CLIC1;STXBP3;PIK3CB;MYL12A;MYH9;ACTG1;VCL
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.48980840319761254,0.7590365657563424,0.8169014084507042,0.9708532854026862,1.0,2/7,13.94%,HYAL2;PAK2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gall Bladder,0.4485658068666952,0.7589024977825621,0.8059701492537313,0.9707176735996697,1.0,3/13,18.38%,NES;ADCY2;PODXL
prerank,Reactome_2022__Late Phase Of HIV Life Cycle R-HSA-162599,0.3701499302404673,0.7584027708193628,0.8472222222222222,0.9709900016906153,1.0,8/37,20.00%,TSG101;SGIP1;RPS27A;CCNH;NEDD4L;TPR;CHMP4B;VPS37A
prerank,Reactome_2022__MicroRNA (miRNA) Biogenesis R-HSA-203927,0.49323270249381324,0.7583007420469837,0.8,0.9708472173948506,1.0,1/7,12.91%,AGO2
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.42256407892136955,0.7577916261210769,0.765625,0.9712347488171429,1.0,6/11,33.33%,NAA50;MORF4L1;CREBBP;PHF20L1;KAT6A;EP300
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.4065330068084061,0.7575939897575314,0.8082191780821918,0.9711568819260177,1.0,5/18,24.49%,UFL1;HSPA9;PRKX;KMT2E;TET2
prerank,Reactome_2022__Epigenetic Regulation Of Gene Expression R-HSA-212165,0.38582242804928274,0.7574724337794162,0.8518518518518519,0.9709961595707008,1.0,11/28,31.69%,SIN3B;MYO1E;CCNH;TAF1D;H3-3B;TET2;SMARCA5;MTF2;GATAD2A;DEK;AEBP2
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryoid Body,0.34736468136629917,0.7571582471944193,0.8987341772151899,0.97105895504062,1.0,8/46,13.12%,ADAMTS9;PLSCR4;COL4A2;VWF;GJA1;LRRC32;FLT1;CLDN5
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.4825965637319023,-0.7569977994732235,0.7804878048780488,1.0,1.0,1/5,9.19%,PDGFB
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.34477681093855894,-0.756576192701084,0.8095238095238095,1.0,1.0,2/27,3.40%,IFIH1;OAS3
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.4753465095383926,0.7552920593305202,0.8208955223880597,0.9731966175471616,1.0,3/7,23.08%,DOCK4;MEF2C;ADAMTS1
prerank,Reactome_2022__COPI-mediated Anterograde Transport R-HSA-6807878,0.37892452288875866,0.7547592941424538,0.8289473684210527,0.9735035324023436,1.0,3/26,13.78%,ANK2;ANK3;CD55
prerank,Reactome_2022__HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.48313171065050375,-0.7542914347210408,0.7222222222222222,1.0,1.0,1/5,2.95%,ATM
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),0.5315589291924481,0.7537907765991807,0.8714285714285714,0.9744978348629619,1.0,4/5,40.74%,SPG7;ATP5F1E;CHCHD3;IMMT
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.4553225866176193,0.7534236221333971,0.7704918032786885,0.9746853689728243,1.0,5/9,35.59%,CRY1;ATP2B4;FYN;EP300;CD34
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.35957118121535364,-0.7533760504376311,0.8095238095238095,1.0,1.0,7/18,14.42%,CD74;GIMAP8;TNFRSF1B;HLA-C;SERPINB9;HLA-A;GIMAP4
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.3792683421014621,0.753231457069951,0.7837837837837838,0.9745310098312059,1.0,3/30,6.06%,SERPINE1;NFKBIZ;HYAL2
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.4274358967324882,0.7531888094247561,0.7681159420289855,0.9742832436867809,1.0,6/17,26.40%,CCDC88A;WAPL;ZBTB38;SLFN11;SMC3;EGFR
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.40466739774444294,-0.7530916448253642,0.7222222222222222,1.0,1.0,2/11,14.21%,EZH1;KAT6B
prerank,Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407,0.36453784049098203,0.753001018753453,0.8292682926829268,0.9742333776443214,1.0,12/46,13.84%,SLCO4A1;SLC8A1;SLC4A10;SLC2A13;SLC20A2;SLC4A7;SLC2A1;SLC38A2;SLC12A6;SLC2A3;SLC26A2;SLC20A1
prerank,Reactome_2022__Regulation Of TP53 Activity R-HSA-5633007,0.36424072122026857,0.7522898504352329,0.8533333333333334,0.9747442230377458,1.0,3/39,10.23%,PRKAG2;RPS27A;RFC3
prerank,Reactome_2022__Metabolism Of RNA R-HSA-8953854,0.32283365337574166,0.7518727035934857,0.9325842696629213,0.9749601169179938,1.0,27/187,18.88%,PSMC6;TRMT9B;RPS11;RPS9;ENPP2;DNAJC5;RPS27A;RPL23;U2SURP;RBM17;CCNH;RPL8;RPL34;RPL37;CNOT6L;DCP2;RPLP2;RPL13A;SRSF7;RPS12;TUT7;PSMA7;TPR;TRA2B;CSTF3;RPS27;CSNK1D
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.3639004523753523,0.7518637875583509,0.9,0.9746442892157203,1.0,7/35,14.42%,PCK1;TIMP3;PLSCR4;MT2A;PIKFYVE;CFH;TNS1
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.336001469275016,0.7516491252180018,0.9146341463414634,0.9746159144787148,1.0,8/88,10.62%,PSMC6;WDR48;SMAD7;RPS27A;OGT;HIF1A;USP45;OTUD7B
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.43364503433378077,0.7513435411020638,0.8059701492537313,0.9747383147102033,1.0,2/16,7.84%,TBX3;DLC1
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.35193632349486853,-0.7511451041628225,0.88,1.0,1.0,3/24,5.23%,SLC4A4;ATP10D;SLC25A29
prerank,Reactome_2022__EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,0.3933262366659848,0.7511220565797686,0.8354430379746836,0.9746740450982175,1.0,12/24,33.12%,AHCTF1;RPS27;DYNC1H1;PAFAH1B1;TAOK1;SPC25;XPO1;DYNC1I2;PPP2R5C;NDEL1;RANBP2;EML4
prerank,Reactome_2022__Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,0.4338352946693048,0.7503245021620606,0.8059701492537313,0.9753272411260183,1.0,4/11,22.42%,RPS27A;GRB2;SH3KBP1;UBC
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.48654986564615144,0.7502359775103318,0.8484848484848485,0.9751229701721515,1.0,1/5,12.40%,ANO6
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.44285064576263744,0.7501902653440389,0.8428571428571429,0.9748793984958384,1.0,1/12,3.96%,SLC4A10
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),0.4631498224876819,0.7497196734026438,0.8225806451612904,0.9751842815139886,1.0,2/7,41.97%,IRAK3;IFI16
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.40237183003263427,-0.7493533273475191,0.813953488372093,1.0,1.0,3/10,17.53%,THOC1;SCAF8;CDK12
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.4685572242816693,0.7491628570415946,0.84,0.9755534522322246,1.0,2/9,8.63%,CD9;KLF4
prerank,CellMarker_Augmented_2021__Epithelial cell:Amniotic Membrane,0.47060893876216797,0.748926972870221,0.8,0.9755212758305266,1.0,1/7,1.89%,SLC52A3
prerank,Reactome_2022__Drug ADME R-HSA-9748784,0.4096567788886908,0.7488075003303805,0.7846153846153846,0.9753745547443813,1.0,3/16,12.24%,PCK1;GGT5;SULT1C4
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.4114822770560563,0.7483434832132356,0.7323943661971831,0.9755715138273074,1.0,4/18,25.15%,SYTL4;DYSF;SCARB1;PLEC
prerank,CellMarker_Augmented_2021__Endothelial cell:Intervertebral Disc,0.3615932150477887,0.7480795060424544,0.9166666666666666,0.9755930306489434,1.0,8/41,14.42%,GGT5;VWF;ZNF366;PECAM1;LRRC32;FLT1;CLDN5;TNS1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.32508083592456505,-0.7478729687607708,0.8214285714285714,1.0,1.0,3/18,8.50%,ATM;PLK2;MDM2
prerank,Reactome_2022__Gastrulation R-HSA-9758941,-0.4345744680851064,-0.7476558070378029,0.6666666666666666,1.0,1.0,5/5,56.63%,TRIM33;LEF1;CTNNB1;SMAD2;SMAD3
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5073970290429761,0.7476326236398386,0.84375,0.9759221303093857,1.0,2/6,33.39%,DIP2A;RPS6KA5
prerank,Reactome_2022__Sialic Acid Metabolism R-HSA-4085001,-0.430410087518739,-0.7470436653612209,0.7894736842105263,1.0,1.0,2/7,8.58%,ST3GAL6;ST3GAL1
prerank,KEGG_2021_Human__Systemic lupus erythematosus,0.46159570866669625,0.7467489638467739,0.8363636363636363,0.9766872351392011,1.0,3/7,23.51%,GRIN2B;ACTN1;H3-3B
prerank,Reactome_2022__Pre-NOTCH Expression And Processing R-HSA-1912422,-0.33951756568456903,-0.746698783095092,0.8518518518518519,1.0,1.0,3/23,5.63%,TNRC6C;H2AC6;ST3GAL6
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.36553656581411076,0.7459946729812953,0.8625,0.9774125282713715,1.0,6/28,24.38%,SMAD7;SMAD5;ACVR2A;SMAD6;CDH5;PPARG
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.4222397805890798,0.7458778165372001,0.8472222222222222,0.9772226024185083,1.0,7/17,24.73%,CALR;DYSF;TGM2;GATA2;SCARB1;FGR;RACK1
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.3996000161210097,-0.745714482495397,0.7878787878787878,1.0,1.0,1/18,2.15%,IL15
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.4737460605030751,0.7455051175840265,0.782608695652174,0.9773292829829611,1.0,2/7,26.29%,MSN;CDC42
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.4090924790912879,0.7454851155723337,0.8428571428571429,0.9770502326140994,1.0,8/24,23.48%,SMAD7;ADGRG1;RAC1;LIMS1;TGM2;RSU1;AFDN;ADAM9
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.3685238808404607,0.7447705452013599,0.8809523809523809,0.9775531474225277,1.0,4/35,13.47%,SEC22B;CDKN1B;EEF1A1;NEDD4L
prerank,Reactome_2022__SUMOylation Of Intracellular Receptors R-HSA-4090294,0.4361598703853083,0.7447219309221728,0.75,0.9773063224592662,1.0,4/10,29.46%,PIAS2;NR2C1;PPARG;THRB
prerank,Reactome_2022__RAF Activation R-HSA-5673000,0.4467489669651726,0.7446524163874438,0.8533333333333334,0.9770846288252497,1.0,8/13,31.85%,SHOC2;PPP1CB;YWHAB;MAP2K1;MARK3;CAMK2D;CALM1;PPP2R5C
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Embryo,-0.3310792527185441,-0.7446310185893613,0.8695652173913043,1.0,1.0,3/25,6.29%,CARMIL1;BMP6;ITIH5
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.45109163831928484,0.744407579387344,0.859375,0.9771091561021936,1.0,3/9,16.55%,AGO2;TUT7;SND1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.39590192731224694,-0.7432928944490745,0.7435897435897436,1.0,1.0,1/10,6.93%,PDE9A
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.5158231247432787,0.7432380227185081,0.8333333333333334,0.9782780985365593,1.0,3/5,29.93%,PTPN1;NEDD4;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.41874022193342797,-0.7431343790350208,0.7692307692307693,1.0,1.0,2/13,2.82%,CD74;SHLD1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.4173670766549703,0.7418976718642158,0.8421052631578947,0.9795817237379674,1.0,9/17,22.15%,MICALL2;PECAM1;CLDN5;PAK2;ECT2;ESAM;AFDN;TBCD;CDH5
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.4207504483114135,0.741791472642193,0.7746478873239436,0.9793667097153876,1.0,2/12,19.12%,TF;SLC30A1
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.34579995706420086,-0.7417232147656756,0.84375,1.0,1.0,1/19,2.20%,TTN
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.48226233128813784,0.7416411882660289,0.8387096774193549,0.9792052603762472,1.0,1/5,5.92%,DHRS7B
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),0.46431835944984023,0.7416030747390685,0.8307692307692308,0.9789264140780108,1.0,5/7,47.62%,ABHD2;ACACA;ELOVL7;CBR4;ABCD3
prerank,Reactome_2022__Thromboxane Signaling Thru TP Receptor R-HSA-428930,0.462532836341655,0.7412756074015369,0.8507462686567164,0.9791033606063373,1.0,1/7,10.86%,GNA13
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.4860869653121468,0.7412275349232345,0.8524590163934426,0.9788531927107005,1.0,1/7,9.59%,CNTNAP2
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.43159830324557663,0.7403591849367798,0.8676470588235294,0.9794711418490338,1.0,5/15,21.65%,INPP5F;MTMR12;PLPP1;MTMR6;SYNJ2
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.4541695892501302,0.7398877315505397,0.765625,0.9797081964086879,1.0,1/8,3.90%,ANXA1
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.42037065662789086,-0.7396749228769806,0.6785714285714286,1.0,1.0,2/7,12.14%,SPRY3;NTNG1
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.4378485343722839,0.739657038070909,0.8307692307692308,0.9796926997943887,1.0,3/9,23.16%,INPP5A;PPP3CB;PPP3CC
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.45313156872678495,0.7393484453746331,0.8088235294117647,0.9797447349043835,1.0,5/11,21.67%,CDKN1B;CCNH;CDKN1A;ACTB;CDC37
prerank,Reactome_2022__Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.37852416854901405,-0.7387561923929495,0.8,1.0,1.0,3/13,8.13%,BABAM2;ATM;HERC2
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.4662888503252103,-0.7387475711325516,0.775,1.0,1.0,1/5,10.31%,ATP9A
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.4541330022240051,-0.7386084508838617,0.7674418604651163,1.0,1.0,1/5,11.31%,MFHAS1
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.36441527858440076,0.7380125256433632,0.8767123287671232,0.981047265873297,1.0,11/50,17.74%,RAPGEF3;PINK1;PICALM;RAP1A;RGS7;ITGB1;ECT2;PSAP;LIMS1;TGM2;RSU1
prerank,Reactome_2022__Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,0.3954241108980229,0.7379532361243731,0.8181818181818182,0.9808182651252284,1.0,11/22,33.07%,AHCTF1;RPS27;DYNC1H1;PAFAH1B1;TAOK1;SPC25;XPO1;DYNC1I2;PPP2R5C;NDEL1;RANBP2
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Peripheral Blood,0.4235421167985013,0.7373593013724178,0.796875,0.9812071744786376,1.0,2/12,16.73%,CD55;ACTN1
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.40726895142332475,0.7373138545749879,0.7971014492753623,0.9809214815002942,1.0,8/17,36.39%,DAG1;CFL1;PLCB1;RAB14;TRIP12;NR2C2;INSR;NIPBL
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.41659098050396126,0.7371566611672522,0.8676470588235294,0.9808169240781308,1.0,3/11,36.39%,GRM5;FAM107A;NIPBL
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,0.36853889907474935,0.736276488665549,0.8428571428571429,0.981556609407515,1.0,8/27,22.42%,RPS27A;JAG2;MIB1;CCNC;NCOR2;HDAC7;CDK8;UBC
prerank,Reactome_2022__Golgi-to-ER Retrograde Transport R-HSA-8856688,0.3655836068003237,0.7361177103664325,0.9210526315789473,0.9814519157483632,1.0,1/33,1.04%,SEC22B
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.374318699010891,0.7358674111737784,0.8648648648648649,0.9814394509559807,1.0,12/29,31.85%,FGFR1;PIK3R1;FLT1;NEDD4;DIPK2A;FGR;EGFR;PIK3CB;PIP5K1C;DAB2IP;PTK2;PPP2R5C
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.34325285786427473,-0.7357618226421454,0.7931034482758621,1.0,1.0,1/9,2.76%,OCLN
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.36239939762140005,0.7357485757471537,0.8780487804878049,0.9812498162982247,1.0,9/35,16.68%,PRKAG2;RAP1A;TRIB2;CDKN1A;TAB2;PAK2;ECT2;WWTR1;SPRED1
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.4239656397739356,0.7355546209743155,0.8095238095238095,0.9811913725202407,1.0,3/13,18.88%,TMED10;GOLPH3;CSNK1D
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.4805203832465305,0.7352317885697062,0.8070175438596491,0.9811896267645576,1.0,1/5,7.04%,PINK1
prerank,CellMarker_Augmented_2021__Exhausted CD4+ T cell:Liver,0.3477242795867334,0.7351854673923753,0.868421052631579,0.9809294502654314,1.0,4/44,10.25%,PKM;GAPDH;SRGN;CREM
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4257031060259898,0.7347815360074107,0.8289473684210527,0.9811365921417323,1.0,2/9,13.31%,RPS27A;TAB2
prerank,"Reactome_2022__WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",-0.4531590480445238,-0.7346952411457666,0.7857142857142857,1.0,1.0,1/5,16.65%,RORA
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.4000095065957396,0.7344176568058444,0.9090909090909091,0.9811950098916908,1.0,4/21,11.87%,IPO7;CDKN1B;CCNH;CDKN1A
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.35255691415200363,0.7341873685902097,0.926829268292683,0.9811826548790225,1.0,8/44,20.42%,NEDD9;LARP4;RAC1;BRWD3;PDZD8;CFL1;SH3KBP1;DPYSL2
prerank,CellMarker_Augmented_2021__Erythroid cell:Umbilical Cord Blood,0.38998285660340776,0.73369980003073,0.890625,0.9814284099715835,1.0,3/24,17.53%,DPY19L1P1;LARP4;RIF1
prerank,Reactome_2022__Membrane Trafficking R-HSA-199991,0.2998036580084814,0.7335711854553506,0.9438202247191011,0.9812286588815502,1.0,43/216,22.42%,SEC22B;TSG101;PRKAG2;ANK2;SGIP1;SEC24D;SCARB2;MCFD2;RAB21;RPS27A;GRB2;PICALM;ANK3;GJA1;MYO1E;TBC1D15;DENND3;ARPC2;TMF1;KIF16B;HIP1R;CD55;ACBD3;AP1G1;RAB30;SYT1;RALGAPB;FZD4;TF;CSNK1D;DYNC1H1;CHMP4B;VPS37A;SH3KBP1;PAFAH1B1;HSPA8;DENND4A;DNM2;SYNJ2;YWHAB;RAB8B;YWHAE;UBC
prerank,Reactome_2022__InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,0.43438478426273064,0.7331280314901482,0.8095238095238095,0.9814707092886575,1.0,4/10,22.42%,RPS27A;GRB2;SH3KBP1;UBC
prerank,Reactome_2022__Diseases Of Programmed Cell Death R-HSA-9645723,0.3993852028324778,0.7330879261994613,0.7710843373493976,0.9811968943689844,1.0,2/15,9.77%,POLA1;JUN
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.42887192863166157,0.732771428672376,0.8055555555555556,0.9813046172890091,1.0,4/12,12.40%,SLC8A1;ATP1A1;ATP1B3;ANO6
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.4757172742789334,0.7327615733925212,0.7592592592592593,0.9810027894472425,1.0,2/5,26.40%,TEC;EGFR
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.31892081289511237,0.7326379428387033,0.9634146341463414,0.9808317228531062,1.0,27/118,26.03%,BHLHE40;CALR;ZNF280D;CCDC88A;ESR2;HIF1A;CREM;CNBP;REST;SBNO1;ZBTB38;WWTR1;FOXC1;ATF2;STAT3;NR1D2;BTG1;DENND4A;GRM5;DNM2;RPL10;MEF2C;NSD2;TERF2IP;CREBBP;SMC3;ZNF718
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Embryonic Stem Cell,0.3456369932522311,0.7323604519890393,0.9014084507042254,0.9805745557367063,1.0,11/42,15.48%,MGLL;SCARB2;ENPP2;PLSCR4;EMP1;TBC1D9;CCDC149;DOCK4;TNS1;ALCAM;KCTD12
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Embryonic Stem Cell,0.3456369932522311,0.7323604519890393,0.9014084507042254,0.9805745557367063,1.0,11/42,15.48%,MGLL;SCARB2;ENPP2;PLSCR4;EMP1;TBC1D9;CCDC149;DOCK4;TNS1;ALCAM;KCTD12
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.40518362133627855,0.7323192404602558,0.8461538461538461,0.980305073672943,1.0,5/16,29.43%,SMARCC1;NPM1;NAP1L4;SMARCA5;ARID1A
prerank,KEGG_2021_Human__Wnt signaling pathway,-0.3024083403321605,-0.7320610506489829,0.875,1.0,1.0,8/53,10.41%,PLCB4;TBL1X;ZNRF3;NKD1;TBL1XR1;TCF7L1;CTBP2;TLE4
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.36694032552962674,-0.7319315486348309,0.8620689655172413,1.0,1.0,4/15,12.48%,MGMT;SLF2;SHLD2;RNF169
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.4281762553274184,0.7318306513080953,0.8732394366197183,0.9805503265500816,1.0,2/8,13.31%,RPS27A;TAB2
prerank,Reactome_2022__RHOV GTPase Cycle R-HSA-9013424,0.4195552592765733,0.7318209604301886,0.8717948717948718,0.980256360429104,1.0,2/18,7.94%,PIK3R1;TPM4
prerank,Reactome_2022__Protein Ubiquitination R-HSA-8852135,0.38393737306305414,0.7311686850715305,0.8108108108108109,0.9807022366122133,1.0,7/27,26.93%,RPS27A;UBE2B;UBC;UBE2Q2;UBE2R2;UBE2H;VCP
prerank,Reactome_2022__Signal Regulatory Protein Family Interactions R-HSA-391160,-0.4411925901632996,-0.7304602363618572,0.7222222222222222,1.0,1.0,1/5,3.00%,SKAP2
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.3975375562665555,0.7299072934027129,0.855072463768116,0.9817816187418624,1.0,3/19,12.32%,FGFR1;PIK3R1;FLT1
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.44724489606332474,-0.7296720898535874,0.868421052631579,1.0,1.0,2/6,8.92%,NKD1;PROM1
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.47201883056112237,-0.7292907833360889,0.78125,1.0,1.0,2/5,15.22%,OPTN;TRIP11
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.4108284122448541,-0.7290093310396455,0.8181818181818182,1.0,1.0,2/8,10.36%,DISP1;CFLAR
prerank,Reactome_2022__Miscellaneous Transport And Binding Events R-HSA-5223345,0.5154671208904238,0.7286248007614619,0.8382352941176471,0.9829201544095355,1.0,2/5,15.59%,LRRC8B;ADD3
prerank,Reactome_2022__Diseases Of Carbohydrate Metabolism R-HSA-5663084,0.44428195731454956,0.7286187448603008,0.819672131147541,0.9826082152935693,1.0,3/6,24.09%,RPS27A;UBC;GBE1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.43243448555564873,-0.7281812212483374,0.7567567567567568,1.0,1.0,2/7,9.19%,PKD2;PDGFB
prerank,Reactome_2022__G Alpha (12/13) Signaling Events R-HSA-416482,0.362495856373396,0.7280733659014088,0.8441558441558441,0.9829050361188736,1.0,7/33,24.78%,ARHGEF4;GNA13;ECT2;ARHGEF2;KALRN;PREX1;FGD4
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.3716671063305856,-0.7278753664757125,0.8387096774193549,1.0,1.0,2/9,10.25%,TNRC6C;CPEB3
prerank,Reactome_2022__Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,0.37100146585133703,0.7278575237646755,0.8533333333333334,0.9828183610300549,1.0,2/20,7.25%,SEC24D;INSIG1
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.4196369860112199,0.727729003726324,0.8208955223880597,0.982671977932721,1.0,5/12,22.02%,SMAD7;ACVR2A;SDCBP;SMAD6;RBPMS
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.31867312437156586,0.7274501589574085,0.898876404494382,0.9826522043953865,1.0,18/93,22.18%,ELL2;ZBTB1;AFF4;ESR2;CBFB;ELP4;CCNH;WWTR1;NCOR2;NR2C1;HDAC7;CSTF3;NR1D2;NFIC;NOTCH4;TFCP2;MED4;SETX
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.4223573527197635,-0.7271707519616918,0.8,1.0,1.0,2/7,16.79%,ACVR1;MDM4
prerank,KEGG_2021_Human__Pertussis,0.38327820076421093,0.7269744106491358,0.8472222222222222,0.9827870259951917,1.0,5/16,18.30%,JUN;FOS;MAPK10;ITGB1;CFL1
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.347002519655681,0.7267693822072941,0.85,0.9826513283114235,1.0,12/57,23.67%,PSMC6;RPS27A;DCP2;GIGYF2;PSMA7;CARHSP1;NPM1;HSPA8;ZFP36;YWHAB;UBC;XPO1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Peripheral Blood,0.3759755897774584,0.7261639138803597,0.8148148148148148,0.9831512104763426,1.0,11/28,13.92%,NFKBIZ;ANXA1;NFE2L2;ERO1A;KLF4;FOSL2;EMP1;AHNAK;ANXA2;CD55;S100A6
prerank,Reactome_2022__NOD1/2 Signaling Pathway R-HSA-168638,-0.39816520631302904,-0.7260890366212182,0.78125,1.0,1.0,4/9,20.88%,NOD1;CYLD;CASP4;MAPK14
prerank,KEGG_2021_Human__Tuberculosis,-0.28994363764156306,-0.7256389730971284,1.0,1.0,1.0,3/34,3.72%,CD74;STAT1;CASP10
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.40911692631356844,0.7251357007468272,0.8133333333333334,0.9840579250985634,1.0,4/14,23.45%,WAPL;TOM1L2;PPP1R10;MAX
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,0.478206280648745,0.7249578025848621,0.8484848484848485,0.9838973925010547,1.0,1/7,2.50%,BNIP3L
prerank,Reactome_2022__RHOBTB GTPase Cycle R-HSA-9706574,0.37990564255186726,0.7246762831395057,0.8441558441558441,0.9838141305198271,1.0,6/21,21.67%,PDE5A;HSP90AA1;STK38;ACTN1;TRA2B;CDC37
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.43867244283962475,-0.724528569498827,0.8205128205128205,1.0,1.0,2/5,3.37%,PLA2G4A;GPCPD1
prerank,Reactome_2022__JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,0.4529536313015784,0.7244868856844506,0.8387096774193549,0.9837028686062238,1.0,2/6,13.39%,TAB2;MAPK10
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.4675826686633343,0.7239508340182984,0.8636363636363636,0.9839877946959318,1.0,2/6,29.00%,ATP2B4;RIOK3
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.40947229800982327,0.7236698527266338,0.8933333333333333,0.9840272356194406,1.0,9/19,22.15%,MICALL2;PECAM1;CLDN5;PAK2;ECT2;ESAM;AFDN;TBCD;CDH5
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.3908771603779564,0.7234464998189202,0.8714285714285714,0.9839895801022807,1.0,3/20,10.23%,BAZ1A;POLA1;RFC3
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.42108266171940784,-0.7232391294585296,0.7222222222222222,1.0,1.0,1/5,4.94%,BCOR
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.37265096730692254,0.7229318141328005,0.8375,0.9843161713769021,1.0,8/33,18.73%,RAPGEF3;PIK3R1;CCDC88A;DLC1;PAK2;RAC1;PXN;ALMS1
prerank,Reactome_2022__Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,-0.39589276734966344,-0.7228913325870341,0.8,1.0,1.0,2/7,13.86%,MAML3;MAML2
prerank,Reactome_2022__RUNX3 Regulates NOTCH Signaling R-HSA-8941856,-0.39589276734966344,-0.7228913325870341,0.8,1.0,1.0,2/7,13.86%,MAML3;MAML2
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.39807276860995094,0.7227725909441088,0.8636363636363636,0.9842364359450203,1.0,10/20,31.55%,TIMP3;TAB2;STAT3;RASIP1;MCL1;MTOR;TLK2;DAB2IP;MTMR9;FOXK2
prerank,Reactome_2022__RHOBTB1 GTPase Cycle R-HSA-9013422,-0.3604190179758601,-0.7227291541421821,0.8846153846153846,1.0,1.0,1/13,1.51%,RHOBTB1
prerank,Reactome_2022__Suppression Of Phagosomal Maturation R-HSA-9637687,0.44295348001373774,0.722289814746429,0.8356164383561644,0.984401746183763,1.0,5/8,32.19%,RPS27A;UBC;KPNA1;RAB7A;KPNB1
prerank,Reactome_2022__Transcriptional Regulation By E2F6 R-HSA-8953750,-0.39755123331874476,-0.7222894057587266,0.76,1.0,1.0,1/10,6.80%,MGA
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.48040520986561785,0.7221132793570589,0.8461538461538461,0.9842730504657726,1.0,2/6,26.29%,MSN;CDC42
prerank,Reactome_2022__Phase II - Conjugation Of Compounds R-HSA-156580,0.3906308074007591,0.7220942377980977,0.8307692307692308,0.983994033761809,1.0,5/15,17.58%,PRNP;GGT5;SULT1C4;SLC26A2;TPST2
prerank,Reactome_2022__Deadenylation-dependent mRNA Decay R-HSA-429914,-0.3638127861780138,-0.7219909069075557,0.9,1.0,1.0,2/16,6.11%,DCP1A;PARN
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.34586690203821935,-0.7219478461755289,0.875,1.0,1.0,4/24,10.36%,CASP10;NOD1;TNFSF10;CFLAR
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.4434777961539955,-0.7217928358294601,0.7,1.0,1.0,1/5,5.82%,MIA3
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.3923812867152478,0.7214104190581005,0.8787878787878788,0.984428503952147,1.0,7/22,23.48%,NDRG1;MT2A;HIF1A;NEDD4L;NEDD4;AHCYL1;ADAM9
prerank,KEGG_2021_Human__Thyroid cancer,0.4152123055912736,0.720882493319341,0.8285714285714286,0.9847823032465152,1.0,5/15,25.95%,CDKN1A;KRAS;TPR;PPARG;MAP2K1
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.4076266161765413,-0.7200413786045159,0.8108108108108109,1.0,1.0,1/9,1.43%,ARID5B
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.373963304811851,0.7198810848742305,0.85,0.9855726818025469,1.0,5/25,17.45%,PSMC6;CBFB;FOXC1;PSMA7;GATA2
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.3230551845642025,0.7195507026484143,0.9101123595505618,0.9856394456667589,1.0,16/109,20.61%,TSG101;EHD4;RAB11FIP3;NUDCD3;ATG12;RB1CC1;BBS9;TNKS;VMP1;CSNK1D;DYNC1H1;CHMP4B;VPS37A;NPM1;GSN;CEP290
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.34835250420154085,0.7187992940828064,0.8970588235294118,0.9861531712425992,1.0,4/39,12.51%,PRKAG2;RPL23;RFC3;RPL37
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.39467716672601005,0.7185581857103553,0.8309859154929577,0.9861463968255548,1.0,10/19,31.55%,PINK1;TAB2;STAT3;RASIP1;MCL1;MTOR;TLK2;SMG1;MTMR9;FOXK2
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.3720003498444495,0.7174057039953827,0.8313253012048193,0.987130791926483,1.0,6/22,18.35%,ANK3;PPP1R9A;TMEM132C;SHC2;VWA2;KALRN
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.48844339539988857,0.7172262929173545,0.8035714285714286,0.9870330022231624,1.0,4/5,34.63%,SETX;UVRAG;CALCOCO2;INSR
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.45543402041895514,-0.716535161427756,0.8529411764705882,1.0,1.0,4/6,12.67%,FGD6;SRGAP2;DNM3;FGD5
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Liver,0.30791019233325373,0.716037318953975,0.9651162790697675,0.9881560120315683,1.0,25/134,18.09%,PKM;DDIT4;NEDD9;INPP5F;GAPDH;PGK1;PRNP;SSH1;CTNNA1;RAP1A;MYO1E;CREM;SLC12A6;CDKN1A;PELI1;DUSP16;PAK2;ZC3H7A;CTTNBP2NL;PPP1CB;HDAC7;VMP1;LGALS3;NAMPT;HERPUD1
prerank,Reactome_2022__RUNX2 Regulates Bone Development R-HSA-8941326,0.41030521508605794,0.7159332107548124,0.7647058823529411,0.9879498729281003,1.0,3/12,20.19%,CBFB;WWTR1;SMAD6
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.3996690896725148,0.7158313612584045,0.8333333333333334,0.9877717484704485,1.0,4/16,22.34%,LARP4;PDZD8;CFL1;SPARC
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),0.3394075635667647,0.7157489277163827,0.8831168831168831,0.9875797978323592,1.0,3/33,7.36%,HSPA5;PINK1;HSP90AA1
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.39463639233197806,-0.7157169141373355,0.8,1.0,1.0,2/8,21.73%,RPS8;RPS16
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4343917457456079,0.7154664982345876,0.7702702702702703,0.9875969741899605,1.0,4/10,23.37%,HERPUD1;TMBIM6;BCL2L1;NCK1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.3088252267623842,0.7153637330697026,0.9204545454545454,0.9873668932123995,1.0,15/131,16.02%,PSMC6;SPOPL;TSG101;FEM1C;TRIM9;NFE2L2;PINK1;MIB1;NPLOC4;OTUD7B;PELI1;NEDD4L;NDFIP1;UBE2B;PSMA7
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.4753179897590437,-0.7148940057098288,0.7567567567567568,1.0,1.0,1/5,1.35%,EYS
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),0.4620467644526298,0.7148878776529985,0.8181818181818182,0.9876034445289369,1.0,2/7,16.18%,SAMD8;DMD
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In6:Brain,0.35974643087785196,0.7145187438385217,0.7746478873239436,0.9876658393668264,1.0,11/31,20.29%,PDK4;PINK1;VWF;CCDC149;TOM1L2;CLDN5;TNS1;PLXNA2;EGFL7;NFIC;GSN
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.4662255292836386,0.7140644656353529,0.8656716417910447,0.9879021484339796,1.0,1/6,6.24%,CCDC88A
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.4058310583492103,0.7139194664894075,0.8461538461538461,0.9876931282726881,1.0,3/15,13.12%,CBFB;RAP1A;CLDN5
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.3924232318349116,0.7138805061711132,0.8571428571428571,0.9874390396844145,1.0,6/14,28.90%,TOR1AIP2;ATP1B3;VMP1;ATP1B1;HNRNPU;RYR2
prerank,Reactome_2022__Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,0.4312174723976959,0.7138181685217249,0.9130434782608695,0.9871851103993311,1.0,4/13,26.29%,HSPA9;ANXA2;MSN;CDC42
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.45611243893024794,0.7137640864964166,0.8253968253968254,0.9869348149742719,1.0,1/7,9.43%,GGT5
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.4376631398963863,0.7136044557096674,0.8181818181818182,0.9867576223546488,1.0,6/9,33.23%,COMMD1;NEDD4L;ATP2B4;CAMK2D;FGF12;DLG1
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.42558793772503445,0.713395177430418,0.85,0.9867020792784259,1.0,1/8,11.16%,SETD3
prerank,Reactome_2022__Cellular Senescence R-HSA-2559583,0.3463324443714533,0.713276890139441,0.8933333333333333,0.9865077132640317,1.0,8/51,13.39%,MAP3K5;RPS27A;CDK6;CDKN1B;JUN;CDKN1A;FOS;MAPK10
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.42998927118218927,0.7129434081879841,0.8484848484848485,0.9862164857038156,1.0,4/6,22.39%,JAK1;GRB2;STAT3;PLCB1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.42998927118218927,0.7129434081879841,0.8484848484848485,0.9862164857038156,1.0,4/6,22.39%,JAK1;GRB2;STAT3;PLCB1
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.4099338313113244,0.7125117339576525,0.8260869565217391,0.9863762088811103,1.0,4/14,22.07%,SSH1;KLF4;GRM5;RPL10
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.38139472594566265,-0.7124558321139342,0.8235294117647058,1.0,1.0,1/7,11.37%,NLRC5
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.3631409955063934,0.7123167662069655,0.891566265060241,0.9862862009021941,1.0,2/27,7.07%,PSMC6;CBFB
prerank,CellMarker_Augmented_2021__Lymphoid cell:Blood,0.36181401774144095,0.7122494423315514,0.8428571428571429,0.9860818706308909,1.0,2/31,6.99%,ZEB2;BACH2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3600192637254326,0.7120793177778392,0.8205128205128205,0.9859331070098413,1.0,7/25,26.67%,ATP8B1;TBC1D15;RAC1;PODXL;FSCN1;CDC42;CDKL5
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.3863665223128508,0.7119687486811329,0.8387096774193549,0.98572208700936,1.0,3/16,20.48%,ARHGAP21;TRAK1;PAFAH1B1
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.3693577426664677,-0.7118522087457827,0.8,1.0,1.0,2/19,9.72%,IFI27;TNFRSF1B
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.4015419649638628,-0.7115262981953974,0.7906976744186046,1.0,1.0,3/9,12.35%,GRB14;KANK1;PTPN2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.36743253041668467,0.710869044440938,0.922077922077922,0.9866885405318975,1.0,3/36,10.28%,HSPH1;KLF4;LARP4
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.4641306555149599,0.7105011702838189,0.9,0.9867612749133566,1.0,3/6,12.78%,SLC4A10;SLC4A7;TMEM165
prerank,CellMarker_Augmented_2021__Trophectoderm cell:Embryo,0.36633879690815097,0.7104729516959689,0.8904109589041096,0.9864844424614178,1.0,8/32,17.45%,ARHGAP23;ATP8B1;ADAM15;S100A6;LRRFIP1;ACTN1;ADK;GATA2
prerank,KEGG_2021_Human__Inflammatory bowel disease,0.4208849875309023,0.7100491501312566,0.8636363636363636,0.9867336310882476,1.0,4/11,19.81%,JUN;IFNGR1;STAT3;IFNGR2
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.4221244518115719,0.7095444106320339,0.8793103448275862,0.9870137903082301,1.0,1/10,2.52%,TRIM5
prerank,Reactome_2022__CD209 (DC-SIGN) Signaling R-HSA-5621575,0.428762399035111,0.7091743711505428,0.8405797101449275,0.987124363632356,1.0,4/10,33.39%,FYN;CREBBP;EP300;RPS6KA5
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.37423171833376734,-0.7090774691252572,0.8571428571428571,1.0,1.0,3/8,17.13%,PTPN2;OSBPL8;PPARD
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.42119005362969586,0.7086534552010543,0.8688524590163934,0.9872901687125979,1.0,3/9,19.42%,BCAR1;PLAT;PTPN1
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.40395917517833974,0.7084695033269678,0.8382352941176471,0.9871863635921639,1.0,4/14,13.47%,SLC8A1;ATP1B3;ANO6;NEDD4L
prerank,CellMarker_Augmented_2021__Neural Stem cell:Undefined,0.40681679777844704,0.708255510639588,0.8888888888888888,0.9871447976642667,1.0,2/15,9.30%,NES;SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.38437720975936907,0.7081738233183451,0.8208955223880597,0.9869202452297411,1.0,6/20,16.52%,GLUD1;SYTL4;TMED10;MYH10;FRMD4A;GOLPH3
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.4616727341660536,0.7079747584907891,0.8923076923076924,0.986830460188358,1.0,3/7,33.65%,RACK1;VCP;GLI3
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.3855428623170613,0.7079466583833325,0.8918918918918919,0.9865612834738376,1.0,11/21,42.52%,EIF3A;XPO1;UGGT1;KPNB1;PRPF8;PTBP1;POLR2B;UBAP2L;IMMT;NUP160;DHX15
prerank,CellMarker_Augmented_2021__Retinoid Acid Signaling-Responsive Fetal Germ cell:Fetal Gonad,0.34806620149081635,0.7078951396724974,0.9333333333333333,0.9862853745800689,1.0,4/44,7.09%,AFF3;LBR;AAMDC;JAK1
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.4412573419225043,-0.7074453827559871,0.84375,1.0,1.0,1/6,16.68%,GNB4
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.3720189110191461,0.7073873599974858,0.9487179487179487,0.9865235037404331,1.0,5/25,17.45%,PSMC6;CBFB;FOXC1;PSMA7;GATA2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.40867842005546934,0.7072646405161306,0.9130434782608695,0.986323627480492,1.0,2/16,7.38%,WDR48;KDM1A
prerank,Reactome_2022__Other Semaphorin Interactions R-HSA-416700,0.4930856851960149,0.7069566714796622,0.8852459016393442,0.9863065465445047,1.0,3/5,16.36%,ITGA1;ITGB1;PLXNA2
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.40565214503321945,-0.705940265639512,0.8611111111111112,1.0,1.0,4/8,17.85%,AGPAT3;PPIP5K2;TPK1;ITPKB
prerank,Reactome_2022__Metabolism Of Cofactors R-HSA-8978934,0.451184106579429,0.7052965484020907,0.8870967741935484,0.9877607272509308,1.0,1/5,7.36%,HSP90AA1
prerank,CellMarker_Augmented_2021__Endothelial cell:Plasma,-0.4026403135273333,-0.704864733826285,0.8333333333333334,1.0,1.0,4/8,14.42%,GIMAP8;TNFRSF1B;RCSD1;GIMAP4
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.40706957117868914,0.7041819617998905,0.8840579710144928,0.9887007765849856,1.0,4/17,10.49%,GLUL;ATG12;ZDHHC6;ZDHHC14
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.46449503808423803,0.7032645132955553,0.8428571428571429,0.9893268914853618,1.0,1/6,20.29%,GSN
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.4343414391768421,0.7031087734346384,0.8970588235294118,0.9891849749902734,1.0,4/9,17.21%,ANXA1;XKR6;RAC1;TGM2
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.41727972069906605,0.7029076718812889,0.8285714285714286,0.9890224989360258,1.0,6/11,34.79%,BACE2;DAG1;ADAM9;SPPL3;ADAM17;MYH9
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.27304309104194324,-0.7028822139299435,0.9375,1.0,1.0,7/59,11.02%,EIF2AK2;GEMIN5;CAPRIN1;LARP4B;LARP1;CPEB3;GSPT1
prerank,Reactome_2022__Calcineurin Activates NFAT R-HSA-2025928,0.47164721556426475,0.7014622951597769,0.8208955223880597,0.9901570819314784,1.0,2/5,28.47%,PPP3CB;CALM1
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.4445748346452479,0.7012304966762988,0.8769230769230769,0.990066627095987,1.0,2/7,28.53%,DLGAP2;DLGAP1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.35828495025220775,0.7011338677123032,0.935064935064935,0.9898455815431416,1.0,19/42,33.84%,SUN2;AHCTF1;TNKS;RPS27;DYNC1H1;PAFAH1B1;TAOK1;SPC25;XPO1;SMC3;VCP;MECP2;DYNC1I2;ZNF207;NDEL1;KPNB1;RANBP2;EML4;RAB11A
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.46915655945362544,0.7011100628747508,0.8125,0.9895696808975613,1.0,4/5,33.84%,LIMK2;KPNB1;DLG1;RAB11A
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.44302531132469125,0.7008723254105271,0.7894736842105263,0.9894966718970168,1.0,1/8,13.04%,TRAK1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.3114564060804424,-0.7008382139610688,0.9032258064516129,1.0,1.0,1/17,1.04%,PSTPIP2
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.4353084028636745,-0.7003630186985138,0.75,1.0,1.0,2/5,13.68%,PARN;MCM9
prerank,Reactome_2022__Chromosome Maintenance R-HSA-73886,0.3895967416615494,0.7002330479182564,0.8783783783783784,0.9899423748301107,1.0,6/21,26.06%,POLA1;RFC3;NPM1;H3-3B;TERF2IP;SMARCA5
prerank,Reactome_2022__RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,0.38037044177947166,0.7001949294424107,0.8481012658227848,0.9896632667270769,1.0,2/14,7.07%,SIN3B;CBFB
prerank,Reactome_2022__RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.31484897196588746,-0.6999789976704457,0.96,1.0,1.0,1/35,1.22%,ALS2
prerank,CellMarker_Augmented_2021__Goblet cell:Large Intestine,-0.4270078363486546,-0.6998995869230811,0.7222222222222222,1.0,1.0,2/5,11.10%,IFI27;HLA-F
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colorectum,0.4543649017358563,0.6997880788485383,0.8412698412698413,0.9897276066404159,1.0,2/6,14.98%,ITGB1;ALCAM
prerank,Reactome_2022__Glucagon Signaling In Metabolic Regulation R-HSA-163359,0.4049956107468838,0.6997045245278917,0.890625,0.9894864863618422,1.0,2/11,21.89%,ADCY2;ADCY9
prerank,Reactome_2022__Negative Regulation Of MET Activity R-HSA-6807004,0.40507894242886694,0.6996511482301379,0.8153846153846154,0.9892386540359367,1.0,5/14,22.42%,RPS27A;GRB2;PTPN1;SH3KBP1;UBC
prerank,CellMarker_Augmented_2021__Stem cell:Adipose Tissue,0.4738672872138101,0.699393748122654,0.864406779661017,0.9891693124865621,1.0,2/5,13.68%,PECAM1;ITGB1
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.42813590135566554,0.6993537487007324,0.8714285714285714,0.9889114459838559,1.0,1/9,2.90%,SLC8A1
prerank,Reactome_2022__G2/M Checkpoints R-HSA-69481,0.36527552516519546,0.6992902414017972,0.9130434782608695,0.9886777310280966,1.0,3/30,10.23%,PSMC6;RPS27A;RFC3
prerank,Reactome_2022__TNF Signaling R-HSA-75893,0.38386677191830526,0.6986679398462906,0.8933333333333333,0.9890814685261482,1.0,4/20,13.31%,RPS27A;OTUD7B;NSMAF;TAB2
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.3988533330651563,0.6983804073738166,0.828125,0.9890944691090287,1.0,2/12,13.52%,KLF4;ACVR2A
prerank,Reactome_2022__GABA Receptor Activation R-HSA-977443,0.42032896698374494,0.6983359746841032,0.8450704225352113,0.9888335199999673,1.0,5/10,36.28%,ADCY2;ADCY9;GNAI3;GABRB1;GNG11
prerank,Reactome_2022__Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,0.3580942416031387,0.6982789414203697,0.92,0.988572732020334,1.0,9/28,29.19%,PRKAG2;MYO1E;RALGAPB;YWHAB;YWHAE;STXBP3;RAB14;CALM1;YWHAQ
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.39311282485379845,-0.6975498505042299,0.8888888888888888,1.0,1.0,1/11,1.67%,IL32
prerank,CellMarker_Augmented_2021__Endothelial cell:Adipose Tissue,0.46874239893132486,0.6975359936459703,0.8135593220338984,0.9890649795668275,1.0,2/6,10.46%,VWF;PECAM1
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.40817428157306135,0.6974259528001084,0.803030303030303,0.9888658609220274,1.0,3/8,30.81%,PIKFYVE;RAB14;RAB7A
prerank,CellMarker_Augmented_2021__Monocyte:Peripheral Blood,0.47648369336865015,0.6973577129772832,0.8688524590163934,0.9886224045176105,1.0,1/5,8.71%,ITGA1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.4008782574994547,-0.6966087650797981,0.8108108108108109,1.0,1.0,2/8,9.19%,PKD2;PDGFB
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.47386601768780817,0.6965647536705986,0.8181818181818182,0.9890697344973125,1.0,1/5,25.44%,MTOR
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.39006073175751266,-0.6959229695028738,0.8928571428571429,1.0,1.0,1/12,1.41%,STARD3
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.3740387609314585,0.6958862264416424,0.8307692307692308,0.9894689375649631,1.0,6/19,15.27%,GRB2;PRAG1;ADGRG1;ERBIN;RAC1;SHOC2
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.46591174881017644,0.6957923182924716,0.9076923076923077,0.9892767736487039,1.0,1/6,11.16%,SETD3
prerank,CellMarker_Augmented_2021__Ectoderm cell:Germ,-0.33280756365783515,-0.6956816392158134,0.8181818181818182,1.0,1.0,2/24,3.69%,MVB12B;TNRC6C
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.4476962705752755,0.6954530561912428,0.8461538461538461,0.9894092321171263,1.0,4/8,23.82%,PRNP;LGALS3;SLC30A1;FYN
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.3490241730826874,-0.6952191818231652,0.8260869565217391,1.0,1.0,2/17,4.65%,BMP6;ABCG2
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.3485330830286258,-0.6951962599581777,0.8461538461538461,1.0,1.0,1/12,1.04%,PSTPIP2
prerank,Reactome_2022__Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,0.40205175239189894,0.6951958227815401,0.8472222222222222,0.989323063114649,1.0,2/16,5.66%,GLUD1;CRTC3
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.3493661943683186,0.6951262606205945,0.9178082191780822,0.9891140529614332,1.0,2/26,5.50%,HSPA5;RAPGEF3
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.29325529261877514,-0.6949518197267923,0.9629629629629629,1.0,1.0,6/42,8.53%,BABAM2;ATM;PARP9;RAD51B;HERC2;SAMHD1
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.40891176457802414,0.6945031257481094,0.85,0.9894887392992687,1.0,3/12,26.06%,NPM1;NAP1L4;SMARCA5
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.33554450176231165,0.6944735750276635,0.8947368421052632,0.9892081626168281,1.0,9/36,25.84%,UFL1;SIN3B;UBE2B;NAA50;MORF4L1;RCOR3;USP22;CREBBP;PHF20L1
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.4212475869689316,0.6944262519965013,0.8103448275862069,0.9889345796996593,1.0,1/7,7.76%,SRGN
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.3887407669126214,0.6944076724981655,0.88,0.9886441173919618,1.0,2/14,6.91%,VSIR;PRNP
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.46852119088322564,0.6941422488816892,0.8656716417910447,0.9886060612611338,1.0,2/6,11.18%,PINK1;PIKFYVE
prerank,Reactome_2022__Inflammasomes R-HSA-622312,0.4130067187030085,0.6941317258555776,0.84375,0.9883158784380871,1.0,2/7,33.78%,BCL2L1;HSP90AB1
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),-0.4009873021819741,-0.6939705583225153,0.7105263157894737,1.0,1.0,2/6,10.49%,EVL;KANK1
prerank,KEGG_2021_Human__Proximal tubule bicarbonate reclamation,0.4552913506928578,0.6938057778033577,0.8387096774193549,0.9883494806529789,1.0,4/8,11.24%,PCK1;GLUD1;ATP1A1;ATP1B3
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.35980896872640555,0.6931526670795627,0.9090909090909091,0.9886725161727683,1.0,4/25,10.09%,SLC8A1;MGLL;CPEB4;GAS7
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.35895188055907357,-0.6929402595002636,0.8333333333333334,1.0,1.0,2/12,4.38%,ATM;ATR
prerank,Reactome_2022__Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,0.4111009235018856,0.6919618351590721,0.8307692307692308,0.9893902515469962,1.0,1/9,10.86%,GNA13
prerank,Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516,0.3065603472692694,0.6915397903779852,0.975609756097561,0.9894983645578106,1.0,23/101,22.55%,CANX;RPS11;MGAT4A;GPC5;SEC24D;RPS9;JAK1;HSP90AA1;RPS27A;GJA1;CNBP;TAB2;RPS12;MGAT5;TPR;FUT8;ST6GALNAC3;RPS27;CHMP4B;YWHAB;YWHAE;UBC;UVRAG
prerank,CellMarker_Augmented_2021__Thymic Emigrant cell:Blood,-0.37664829414570933,-0.6912841603717004,0.8529411764705882,1.0,1.0,4/9,14.42%,GIMAP8;TNFRSF1B;RCSD1;GIMAP4
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.4280477514029719,0.6910700063434407,0.8387096774193549,0.989725488424966,1.0,3/10,17.45%,CALR;ANO6;GATA2
prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,0.33888897361970227,0.6909173587699783,0.8970588235294118,0.9895647404617083,1.0,3/24,14.74%,JUN;MAPK10;RAC1
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.44475733107738974,0.6907765451217985,0.828125,0.9894040910865911,1.0,1/7,2.90%,SLC8A1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.401731408630659,0.6907451004320168,0.9,0.9891177743645639,1.0,2/12,6.24%,IL1RAPL1;CCDC88A
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.4043509713400977,0.6900923568712675,0.9054054054054054,0.9893957069740504,1.0,3/11,21.59%,CNOT6L;TUT7;ZFP36
prerank,CellMarker_Augmented_2021__Goblet cell:Small Intestine,-0.45837638461312097,-0.690051635358951,0.8571428571428571,1.0,1.0,1/5,2.31%,FAM193B
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Undefined,0.44319591442121864,0.6897411335897609,0.8870967741935484,0.9894322827000624,1.0,2/8,10.46%,ITGA1;PECAM1
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.4596637157741546,0.689410381108892,0.9166666666666666,0.9894382724382178,1.0,4/6,28.47%,PDZD8;VMP1;AHCYL1;CALM1
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.42307076176473946,0.6893264258973142,0.796875,0.9892541433305628,1.0,2/7,21.89%,ADCY2;ADCY9
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),0.41788904670304516,0.6889082693969102,0.8852459016393442,0.989409514417243,1.0,2/12,10.70%,UFL1;HSPA9
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.4718395424848591,0.6888442581696678,0.9076923076923077,0.9891678285798455,1.0,1/5,23.24%,RAB3GAP2
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.3260493790709041,0.6887064254109446,0.9066666666666666,0.9890076937678616,1.0,9/44,21.09%,ARF1;MYO1B;COMMD1;KIF16B;ACBD3;AP1G1;ARFGEF2;HSPA8;DNM2
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.43875677079502384,0.6884834184267137,0.8461538461538461,0.9888917367918387,1.0,3/5,47.52%,EGFR;LCOR;NRIP1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.4298228958444785,0.6882432318810802,0.8461538461538461,0.988826696582998,1.0,3/7,26.40%,GATA2;EGFL7;EGFR
prerank,KEGG_2021_Human__Rheumatoid arthritis,0.38802177828704165,0.6879805336438705,0.8235294117647058,0.9887989717032688,1.0,3/11,12.32%,JUN;FOS;FLT1
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4253003602646337,0.6879665870603313,0.863013698630137,0.9885104144723992,1.0,1/9,8.37%,DUSP1
prerank,Reactome_2022__Deadenylation Of mRNA R-HSA-429947,0.39569996475034147,0.6879047534460438,0.8873239436619719,0.98825928631633,1.0,2/11,15.67%,CNOT6L;TUT7
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.4763584434808634,0.6872012441325515,0.8307692307692308,0.9885872464458885,1.0,2/7,15.80%,SAMD8;AGPAT4
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.4485139056799412,0.6871112203764184,0.864406779661017,0.9884174773724632,1.0,2/7,14.10%,PIKFYVE;AP1G1
prerank,Reactome_2022__SUMOylation Of Transcription Cofactors R-HSA-3899300,0.3883566495542568,0.6867567680712959,0.8533333333333334,0.9885320274307302,1.0,9/19,34.93%,PIAS2;UHRF2;NCOR2;NPM1;CREBBP;MRTFA;PHC2;EP300;NCOA1
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.348808332718694,0.6864709910909813,0.9012345679012346,0.9884672358463019,1.0,8/29,23.69%,PTBP2;AHNAK;PRX;RASA1;HNRNPH3;TRA2B;ZNF326;PTBP3
prerank,Reactome_2022__Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,0.39922928191725354,0.6862546978623562,0.9104477611940298,0.9883078030595859,1.0,3/12,10.23%,RPS27A;NPLOC4;RFC3
prerank,Reactome_2022__Interleukin-15 Signaling R-HSA-8983432,0.42851502223838606,0.6858213805337645,0.9375,0.9883749558560856,1.0,2/8,8.31%,JAK1;GRB2
prerank,KEGG_2021_Human__Sphingolipid metabolism,0.4142786179699707,0.6856442686144769,0.8305084745762712,0.9882494423114395,1.0,3/12,16.25%,KDSR;PLPP1;PSAP
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.40902126457217725,-0.6843682348751123,0.868421052631579,1.0,1.0,1/8,5.39%,RHBDD1
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.33622907899336063,-0.6841084499754433,0.8709677419354839,1.0,1.0,2/11,4.25%,STAT1;PARP9
prerank,Reactome_2022__TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,0.3555652570470899,0.6825063068426541,0.8666666666666667,0.9908773714456519,1.0,3/16,15.94%,RPS27A;TAB2;ALPK1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.3926081365056697,-0.6824435688871167,0.7948717948717948,1.0,1.0,3/10,12.35%,GRB14;KANK1;PTPN2
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.43429063051587347,0.6821582791068385,0.8823529411764706,0.9909605668608109,1.0,1/5,18.27%,ZMIZ1
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.43392613222338416,0.6819645065886496,0.9076923076923077,0.990817499109647,1.0,4/7,27.49%,TPR;DYNC1H1;CHMP4B;HNRNPU
prerank,Reactome_2022__Kinesins R-HSA-983189,-0.3744095777615747,-0.6816865001273124,0.7777777777777778,1.0,1.0,1/7,5.44%,KIF26B
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.3991113861762917,0.6814447501133106,0.8947368421052632,0.9909749182186796,1.0,4/13,19.55%,MBP;KLF4;PODXL;NOTCH4
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.4137581066018116,0.6814382768805204,0.8235294117647058,0.990673343380512,1.0,6/9,28.90%,SLC8A1;DMD;GSN;ATP1B1;CAMK2D;RYR2
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.42895653374066234,0.681239401059831,0.8840579710144928,0.9905912116270773,1.0,2/5,23.08%,DOCK4;ADAMTS1
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.35453363116622777,0.68120026904608,0.9178082191780822,0.9903236589129777,1.0,6/24,16.57%,SYTL4;TMED10;MYH10;FRMD4A;GOLPH3;CADPS2
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.4225722883797153,-0.6802364220968056,0.7435897435897436,1.0,1.0,2/6,12.06%,TNFRSF1B;PARD3
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.38391347259404385,0.6795968234251688,0.8676470588235294,0.9914654193061878,1.0,2/17,7.38%,ZBTB1;KDM1A
prerank,"Reactome_2022__Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.40167775187643034,-0.6795780156148853,0.8421052631578947,1.0,1.0,3/7,18.86%,NMT1;NMT2;METAP2
prerank,Reactome_2022__Phototransduction Cascade R-HSA-2514856,-0.40167775187643034,-0.6795780156148853,0.8421052631578947,1.0,1.0,3/7,18.86%,NMT1;NMT2;METAP2
prerank,Reactome_2022__Translation Of Structural Proteins R-HSA-9683701,0.4129603560417937,0.679224703663397,0.8666666666666667,0.9915078171891376,1.0,2/12,8.07%,CANX;RPS27A
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.37575495396029146,-0.6786403287957214,0.8064516129032258,1.0,1.0,1/6,6.11%,PARN
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.42317186907491616,-0.6786086543728667,0.8,1.0,1.0,2/5,11.61%,PARP12;PARP11
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),0.33688617216742245,0.6785633073489448,0.9066666666666666,0.9918702561347063,1.0,2/29,7.36%,PSMC6;HSP90AA1
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.30215052352911853,0.6781985082782611,0.9634146341463414,0.9919259776879091,1.0,18/69,25.02%,TRIM5;CRTC3;ESR2;KDM1A;RPS27A;TAB2;MTDH;ATF2;MALT1;ARHGEF2;FZD4;STAT3;NPM1;ANXA3;UBC;PRKCH;PPARG;TERF2IP
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.3216370793252146,-0.6776693224795812,1.0,1.0,1.0,8/17,21.54%,RAD51B;SAMHD1;INO80;MCM9;WRN;NSMCE2;NUCKS1;PSMD14
prerank,Reactome_2022__Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.2604431548778527,-0.6776017208439709,0.9411764705882353,1.0,1.0,6/71,10.33%,CWC27;THOC1;NUP214;WBP4;DDX42;RBMX
prerank,Reactome_2022__Cargo Trafficking To Periciliary Membrane R-HSA-5620920,0.400174468639801,0.6760900920695502,0.8615384615384616,0.9935641921889645,1.0,1/12,3.48%,RAB11FIP3
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.42670798574160934,-0.675998921864243,0.8787878787878788,1.0,1.0,1/5,4.41%,PLK2
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.41064625377206176,0.6757688006786005,0.9242424242424242,0.9935554105953157,1.0,1/14,6.29%,NDRG1
prerank,CellMarker_Augmented_2021__Macrophage:Brain,-0.37239019614372293,-0.6753236889647578,0.8333333333333334,1.0,1.0,3/13,3.80%,CD74;DSE;SH3BGRL
prerank,Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733,0.33309416922749696,0.675280509638854,0.9701492537313433,0.993724981161857,1.0,11/41,23.82%,PIK3R1;GRB2;PECAM1;ATP1B3;ITGB1;ESAM;TNFRSF10B;GLG1;ATP1B1;CD99L2;FYN
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.333100018889558,-0.6749464013783306,0.8846153846153846,1.0,1.0,5/22,8.34%,BMP6;ACVR1;HIVEP1;SMAD1;TGFBR3
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),-0.333100018889558,-0.6749464013783306,0.8846153846153846,1.0,1.0,5/22,8.34%,BMP6;ACVR1;HIVEP1;SMAD1;TGFBR3
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.43036147179182804,-0.6748606950540389,0.8918918918918919,1.0,1.0,2/5,15.14%,TNFRSF1B;SH3D19
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.4500549417332826,0.6745631505328838,0.8648648648648649,0.9940424654312519,1.0,1/5,2.90%,SLC8A1
prerank,Reactome_2022__Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.3523621511470426,-0.674213289455688,0.875,1.0,1.0,2/11,3.88%,MVB12B;STAM2
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.3896204442647665,0.6739565985314862,0.8701298701298701,0.9942319633671082,1.0,5/15,29.40%,WWTR1;FOXC1;SDCBP;MTOR;RGCC
prerank,Reactome_2022__Free Fatty Acids Regulate Insulin Secretion R-HSA-400451,-0.44457663362648314,-0.6737995402045748,0.813953488372093,1.0,1.0,1/5,9.88%,GNA14
prerank,Reactome_2022__Pre-NOTCH Transcription And Translation R-HSA-1912408,-0.3264478005838146,-0.6728343261136533,0.8333333333333334,1.0,1.0,4/18,13.86%,TNRC6C;H2AC6;MAML3;MAML2
prerank,Reactome_2022__EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,-0.33074966041980497,-0.6726201975982979,0.9130434782608695,1.0,1.0,1/16,7.09%,EFNA5
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.43951240003950737,0.6725195958425118,0.8983050847457628,0.9951609805670091,1.0,1/7,1.49%,TSG101
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.3798339934023362,0.6724943167229754,0.8904109589041096,0.9948727690406376,1.0,5/12,26.85%,CCNH;TAF1D;CSTF3;SETX;PAPOLA
prerank,Reactome_2022__Cell Cycle Checkpoints R-HSA-69620,0.3151223773197521,0.6718296724474385,0.9534883720930233,0.995246639577935,1.0,18/62,25.37%,PSMC6;RPS27A;CDKN1B;RFC3;CDKN1A;AHCTF1;PSMA7;RPS27;DYNC1H1;PAFAH1B1;TAOK1;YWHAB;YWHAE;UBC;SPC25;XPO1;NSD2;PSMB9
prerank,Reactome_2022__Telomere Extension By Telomerase R-HSA-171319,0.4473031317781551,0.6711035092998767,0.9354838709677419,0.99563707818635,1.0,4/6,48.37%,TERF2IP;POT1;ANKRD28;SHQ1
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,-0.3275726546930975,-0.6706246836131229,0.92,1.0,1.0,2/20,6.61%,THOC1;NUP214
prerank,Reactome_2022__Opioid Signaling R-HSA-111885,0.3253095507396828,0.6706002587771982,0.922077922077922,0.9957888693448385,1.0,9/33,23.16%,ITPR1;ADCY2;PRKX;PDE4B;AHCYL1;PPP3CB;ADCY9;PLCB1;PPP3CC
prerank,Reactome_2022__Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,0.33536162159434824,0.6703815349959595,0.9315068493150684,0.9957123004614081,1.0,4/35,8.31%,RRBP1;PIK3R1;TPM4;GRB2
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts R-HSA-192105,-0.3897826884201512,-0.6703353000408135,0.8181818181818182,1.0,1.0,1/6,12.51%,OSBPL9
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.44742641619389617,0.6698243282740316,0.8888888888888888,0.9959076032571168,1.0,2/5,27.78%,LIMK2;TCHP
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.3917048760596767,0.6695968431677753,0.9104477611940298,0.9957303991969395,1.0,3/11,17.00%,CALR;DUSP16;TPR
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.40730374423674603,-0.6687684478609255,0.8888888888888888,1.0,1.0,1/6,3.82%,LIMS2
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.30379235745270194,-0.6685458110027227,0.9259259259259259,1.0,1.0,4/21,11.31%,ANKRD6;TPD52L1;HIPK2;MFHAS1
prerank,Reactome_2022__Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.46924522099071697,-0.6684474493703713,0.8,1.0,1.0,1/5,3.43%,DCP1A
prerank,CellMarker_Augmented_2021__Progenitor-like Angiogenesis-Promoting cell:Blood,0.32159648532426327,0.6683200140077331,0.9358974358974359,0.9923403961495346,1.0,8/40,19.55%,GGT5;VWF;PECAM1;LRRC32;FLT1;CLDN5;ESAM;NOTCH4
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Adipose Tissue,0.32159648532426327,0.6683200140077331,0.9358974358974359,0.9923403961495346,1.0,8/40,19.55%,GGT5;VWF;PECAM1;LRRC32;FLT1;CLDN5;ESAM;NOTCH4
prerank,CellMarker_Augmented_2021__Keratinocyte:Epithelium,0.32159648532426327,0.6683200140077331,0.9358974358974359,0.9923403961495346,1.0,8/40,19.55%,GGT5;VWF;PECAM1;LRRC32;FLT1;CLDN5;ESAM;NOTCH4
prerank,CellMarker_Augmented_2021__Cardiomyocyte Progenitor cell:Myocardium,0.32159648532426327,0.6683200140077331,0.9358974358974359,0.9923403961495346,1.0,8/40,19.55%,GGT5;VWF;PECAM1;LRRC32;FLT1;CLDN5;ESAM;NOTCH4
prerank,CellMarker_Augmented_2021__Endothelial cell:Bladder,0.32159648532426327,0.6683200140077331,0.9358974358974359,0.9923403961495346,1.0,8/40,19.55%,GGT5;VWF;PECAM1;LRRC32;FLT1;CLDN5;ESAM;NOTCH4
prerank,CellMarker_Augmented_2021__Submandibular Gland Stem cell:Submandibular Gland,0.32159648532426327,0.6683200140077331,0.9358974358974359,0.9923403961495346,1.0,8/40,19.55%,GGT5;VWF;PECAM1;LRRC32;FLT1;CLDN5;ESAM;NOTCH4
prerank,CellMarker_Augmented_2021__Stromal Vascular Fraction cell:Adipose Tissue,0.32159648532426327,0.6683200140077331,0.9358974358974359,0.9923403961495346,1.0,8/40,19.55%,GGT5;VWF;PECAM1;LRRC32;FLT1;CLDN5;ESAM;NOTCH4
prerank,CellMarker_Augmented_2021__Endothelial cell:Corpus Luteum,0.32159648532426327,0.6683200140077331,0.9358974358974359,0.9923403961495346,1.0,8/40,19.55%,GGT5;VWF;PECAM1;LRRC32;FLT1;CLDN5;ESAM;NOTCH4
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Umbilical Cord Blood,0.32159648532426327,0.6683200140077331,0.9358974358974359,0.9923403961495346,1.0,8/40,19.55%,GGT5;VWF;PECAM1;LRRC32;FLT1;CLDN5;ESAM;NOTCH4
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Periodontal Ligament,0.32159648532426327,0.6683200140077331,0.9358974358974359,0.9923403961495346,1.0,8/40,19.55%,GGT5;VWF;PECAM1;LRRC32;FLT1;CLDN5;ESAM;NOTCH4
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Peripheral Blood,0.32159648532426327,0.6683200140077331,0.9358974358974359,0.9923403961495346,1.0,8/40,19.55%,GGT5;VWF;PECAM1;LRRC32;FLT1;CLDN5;ESAM;NOTCH4
prerank,CellMarker_Augmented_2021__Dendritic cell:Umbilical Cord Blood,0.32159648532426327,0.6683200140077331,0.9358974358974359,0.9923403961495346,1.0,8/40,19.55%,GGT5;VWF;PECAM1;LRRC32;FLT1;CLDN5;ESAM;NOTCH4
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Blood,0.32159648532426327,0.6683200140077331,0.9358974358974359,0.9923403961495346,1.0,8/40,19.55%,GGT5;VWF;PECAM1;LRRC32;FLT1;CLDN5;ESAM;NOTCH4
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Bone Marrow,0.32159648532426327,0.6683200140077331,0.9358974358974359,0.9923403961495346,1.0,8/40,19.55%,GGT5;VWF;PECAM1;LRRC32;FLT1;CLDN5;ESAM;NOTCH4
prerank,CellMarker_Augmented_2021__Monocyte:Umbilical Cord Blood,0.32159648532426327,0.6683200140077331,0.9358974358974359,0.9923403961495346,1.0,8/40,19.55%,GGT5;VWF;PECAM1;LRRC32;FLT1;CLDN5;ESAM;NOTCH4
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.3083963696615441,0.6682119454949709,0.974025974025974,0.992108362237817,1.0,7/49,15.70%,TRIM5;UFL1;HSP90AA1;HIF1A;TMEM59;PTTG1IP;MTDH
prerank,CellMarker_Augmented_2021__Cytokine Induced Killer cell:Blood,-0.3734469830483558,-0.6681904543260354,0.8529411764705882,1.0,1.0,2/5,22.52%,GIMAP4;GIMAP7
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Liver,-0.3734469830483558,-0.6681904543260354,0.8529411764705882,1.0,1.0,2/5,22.52%,GIMAP4;GIMAP7
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.4032467852990182,-0.6678152573538959,0.8648648648648649,1.0,1.0,1/7,4.41%,PLK2
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.44392701556138436,0.6676030571519334,0.8688524590163934,0.9920651350969231,1.0,1/5,4.36%,INPP5F
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.44392701556138436,0.6676030571519334,0.8688524590163934,0.9920651350969231,1.0,1/5,4.36%,INPP5F
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.3850975578377733,-0.6674859480815353,0.8444444444444444,1.0,1.0,2/5,20.88%,WWC3;MAPK14
prerank,Reactome_2022__Deubiquitination R-HSA-5688426,0.307889129868579,0.6669515761758174,0.9753086419753086,0.9922636956839126,1.0,7/84,10.62%,PSMC6;WDR48;SMAD7;RPS27A;OGT;HIF1A;OTUD7B
prerank,CellMarker_Augmented_2021__Type I pneumocyte:Undefined,-0.319077543041001,-0.6668397996471274,0.9705882352941176,1.0,1.0,3/20,8.15%,SHROOM2;LAMA3;PTPN21
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),0.38242544205747725,0.6667523827280464,0.9,0.9921453428711974,1.0,3/11,18.57%,VSIR;TRIB2;STAT3
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.40569740694746864,0.6661748480780549,0.875,0.992038824765689,1.0,4/9,34.66%,ITGB1;FAM171A1;CUL3;PHACTR1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.40569740694746864,0.6661748480780549,0.875,0.992038824765689,1.0,4/9,34.66%,ITGB1;FAM171A1;CUL3;PHACTR1
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.4215127323897232,-0.6656191127920356,0.7894736842105263,1.0,1.0,2/5,16.07%,LARP1;CLEC16A
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.32780570657889263,0.6656053784110916,0.9615384615384616,0.9922471496057684,1.0,10/49,23.67%,PSMC6;RPS27A;DCP2;PSMA7;CARHSP1;HSPA8;ZFP36;YWHAB;UBC;XPO1
prerank,Reactome_2022__HIV Transcription Initiation R-HSA-167161,0.39779763018832226,0.6654908763577455,0.835820895522388,0.9920423466426758,1.0,1/9,11.05%,CCNH
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.2885153498976441,0.6647418834186654,0.9875,0.992377072624371,1.0,11/109,11.13%,CANX;ARF1;LRP1B;RAB21;TMED10;ANK3;LAMP2;HSP90B1;TBC1D15;TBC1D9;PREPL
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryo,0.3482728621048836,0.6643138441130516,0.9583333333333334,0.9924153462937856,1.0,9/27,24.30%,VWF;ZNF366;PECAM1;CLDN5;ESAM;NOTCH4;CDH5;SCARF1;FGR
prerank,Reactome_2022__Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.3747387971702174,-0.6640199468199777,0.8918918918918919,1.0,1.0,2/9,7.22%,ISG15;TRIM25
prerank,Reactome_2022__Netrin-1 Signaling R-HSA-373752,0.3577939096294598,0.6632282853517802,0.9104477611940298,0.9929860238213473,1.0,8/19,32.91%,UNC5C;NCK1;FYN;WASL;CDC42;DOCK1;PTK2;MAPK8
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.36618699262412874,0.6631545577628513,0.8840579710144928,0.9927446515996892,1.0,3/16,16.60%,HSP90AA1;KLF4;TNKS
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.35726933290264706,0.6631040420556003,0.9466666666666667,0.9925233782013797,1.0,6/19,18.57%,IPO7;BACH2;PTTG1IP;TPR;PPP1R10;STAT3
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.4031336474142468,0.6626124682242707,0.8904109589041096,0.9926613023243921,1.0,3/8,23.85%,PPFIA2;MEF2C;TANC2
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.38815365916014677,0.6613114389847595,0.8923076923076924,0.9933010190899517,1.0,2/13,10.23%,RPS27A;RFC3
prerank,Reactome_2022__Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,0.39522378565751554,0.6611084835912572,0.9365079365079365,0.993146231525637,1.0,8/10,39.15%,STAT3;NPM1;MECP2;CUL1;EML4;RPS6;MAPK1;CLTC
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.4108524159591355,0.6607285665369458,0.8939393939393939,0.9932207330565996,1.0,5/9,36.87%,CSNK1D;HDGFL3;ZNF207;NDEL1;RANBP9
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.3356625871342112,0.6602508144343338,0.8933333333333333,0.9933250761855973,1.0,6/29,17.61%,CALR;GAPDH;GIGYF2;RPL13A;PLAT;BTG2
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.3792648037071792,-0.6600637362537424,0.8529411764705882,1.0,1.0,4/13,12.72%,FAM120B;CTBP2;FOXO1;OSBPL8
prerank,Reactome_2022__Neurexins And Neuroligins R-HSA-6794361,0.34368594202576563,0.659816361048708,0.9367088607594937,0.9934227174392084,1.0,6/21,16.63%,GRIN2B;LRRTM4;NRXN3;NRXN1;DLGAP2;SYT1
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.3146126515684761,-0.6595897150979352,0.84,1.0,1.0,4/25,12.01%,IFIH1;NUP214;SENP6;SENP7
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.43319185412391303,0.6595497012661705,0.828125,0.9933709585799754,1.0,5/7,20.82%,SLC2A1;NEDD4L;CTTNBP2NL;NEDD4;ACTB
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.4315605735541195,0.6582523226418516,0.9076923076923077,0.9941552937623181,1.0,1/7,3.75%,CD81
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.39976062761580267,-0.658239911122475,0.8055555555555556,1.0,1.0,2/8,9.88%,HOMER1;GNA14
prerank,Reactome_2022__Glycerophospholipid Biosynthesis R-HSA-1483206,0.32136439987182414,0.6571018675077025,0.9382716049382716,0.9947865906695678,1.0,8/30,17.88%,CHPT1;MGLL;SH2D3C;LPIN2;AGPAT4;DDHD2;LPGAT1;DDHD1
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.4520376845484778,0.657042869756258,0.9444444444444444,0.9945322110832336,1.0,2/5,8.42%,SLC4A10;SLC4A7
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.43242087721237255,0.6569550336817213,0.8615384615384616,0.9943177604130052,1.0,2/7,18.65%,SAMD8;ST6GALNAC3
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Large Intestine,0.3176371200261375,0.6559317888426062,0.963855421686747,0.9948556579051795,1.0,3/42,8.87%,LRRTM4;SRGAP1;TOR1AIP2
prerank,Reactome_2022__SARS-CoV-1 Infection R-HSA-9678108,0.35870827071294153,0.6554572173064341,0.9076923076923077,0.9949294483694681,1.0,6/19,22.55%,CANX;RPS27A;ST6GALNAC3;CHMP4B;UBC;UVRAG
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.3788972789840003,-0.6554117376674402,0.8809523809523809,1.0,1.0,2/5,17.13%,TNFRSF1B;PPARD
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.3962954070024683,0.6537433892490034,0.8529411764705882,0.995874188912829,1.0,1/11,3.90%,ANXA1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.38092790855241876,-0.6537160278552654,0.9722222222222222,1.0,1.0,1/9,5.58%,THOC1
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.3532406102328391,0.6530149230750822,0.9078947368421053,0.9961595208429692,1.0,3/17,14.74%,PIK3R1;ARPC2;RAC1
prerank,Reactome_2022__RAC3 GTPase Cycle R-HSA-9013423,0.3194163122760353,0.6528740763804015,0.9883720930232558,0.995981312148868,1.0,9/42,23.11%,LBR;PIK3R1;ARHGAP21;ITGB1;ERBIN;ABL2;ABI1;TMPO;PREX1
prerank,Reactome_2022__Processing Of SMDT1 R-HSA-8949664,0.40603403692988016,0.6526617393582833,0.90625,0.9952389937945759,1.0,2/7,22.79%,MICU2;SPG7
prerank,Reactome_2022__Mitochondrial Calcium Ion Transport R-HSA-8949215,0.40603403692988016,0.6526617393582833,0.90625,0.9952389937945759,1.0,2/7,22.79%,MICU2;SPG7
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.40603403692988016,0.6526617393582833,0.90625,0.9952389937945759,1.0,2/7,22.79%,MICU2;SPG7
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.42860543255330635,0.652570424153729,0.8923076923076924,0.9949819319196226,1.0,4/5,55.06%,LRP6;CSNK1A1;CTNNB1;GSK3B
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.27639668537824114,-0.6524787160036137,1.0,1.0,1.0,24/24,72.56%,RBMX;POLR2A;WRN;TOPBP1;RBFOX2;HNRNPC;ATXN2;PCBP2;GTF2F2;HNRNPR;DDX24;WTAP;HNRNPM;HNRNPD;HNRNPA2B1;MMS19;HNRNPA3;POLR2B;PTBP1;HNRNPK;HNRNPF;HNRNPH1;XRN2;HNRNPU
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.4357489509340913,0.6524039448736255,0.9242424242424242,0.9945145219402716,1.0,3/7,16.18%,TPM4;MYL6;DMD
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.4357489509340913,0.6524039448736255,0.9242424242424242,0.9945145219402716,1.0,3/7,16.18%,TPM4;MYL6;DMD
prerank,Reactome_2022__RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,-0.4050531914893617,-0.6520769406629455,0.7878787878787878,1.0,1.0,5/5,59.58%,DHX9;RIPK1;IKBKB;NFKB1;NFKBIA
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),-0.37350296711443515,-0.651138983796626,0.8823529411764706,1.0,1.0,2/7,8.55%,RAD51B;MSH3
prerank,Reactome_2022__Retrograde Neurotrophin Signaling R-HSA-177504,-0.38357931233237574,-0.6509241624015067,0.84375,1.0,1.0,1/6,9.59%,DNM3
prerank,Reactome_2022__TCF Dependent Signaling In Response To WNT R-HSA-201681,0.32408254722860735,0.6506321869819046,0.9876543209876543,0.9955823629407896,1.0,11/50,25.37%,PSMC6;RPS27A;PSMA7;TNKS;FZD4;USP34;UBC;H3-3B;XPO1;CREBBP;PSMB9
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.39482924393682034,0.6502023267209139,0.9014084507042254,0.995602864834378,1.0,3/11,16.60%,KDM1A;JUN;TNKS
prerank,Reactome_2022__Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.4050531914893617,-0.6501530623640747,0.75,1.0,1.0,5/5,59.58%,IKBKB;NFKB1;TRAF3;HMGB1;NFKBIA
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.4168007238020716,0.6501085156499976,0.8727272727272727,0.995365882795964,1.0,2/6,20.48%,DYNC1H1;PAFAH1B1
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.3661392311991029,-0.6498705821818633,0.8518518518518519,1.0,1.0,3/13,12.08%,EYS;ZIC2;PITPNA
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.3576999018361115,0.6497147439802584,0.8974358974358975,0.995383136977526,1.0,3/15,14.74%,PIK3R1;ARPC2;RAC1
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.4129619328422077,0.649496419851675,0.8852459016393442,0.9952486289479499,1.0,2/8,19.28%,RASA1;ESAM
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.40361206307610975,0.6494543107084116,0.9411764705882353,0.9949690900767083,1.0,2/8,13.12%,CBFB;CLDN5
prerank,CellMarker_Augmented_2021__Natural Killer cell:Undefined,0.40307073264879695,0.64936006695504,0.8524590163934426,0.9947325783632753,1.0,1/7,3.75%,CD81
prerank,CellMarker_Augmented_2021__Platelet:Bone Marrow,-0.3337462887413605,-0.6489318112206759,0.96875,1.0,1.0,4/11,14.42%,GIMAP8;TNFRSF1B;RCSD1;GIMAP4
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Stem Cell,-0.3337462887413605,-0.6489318112206759,0.96875,1.0,1.0,4/11,14.42%,GIMAP8;TNFRSF1B;RCSD1;GIMAP4
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Umbilical Cord Blood,-0.3337462887413605,-0.6489318112206759,0.96875,1.0,1.0,4/11,14.42%,GIMAP8;TNFRSF1B;RCSD1;GIMAP4
prerank,CellMarker_Augmented_2021__Endothelial cell:Eye,-0.3337462887413605,-0.6489318112206759,0.96875,1.0,1.0,4/11,14.42%,GIMAP8;TNFRSF1B;RCSD1;GIMAP4
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.3296592848702954,-0.6488642435616035,1.0,1.0,1.0,1/11,2.76%,OCLN
prerank,Reactome_2022__Insulin Processing R-HSA-264876,-0.34231373057898246,-0.6488311946687736,1.0,1.0,1.0,4/12,13.20%,EXOC5;MYRIP;EXOC1;EXOC6
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.37149189753592887,0.647964511620359,0.8904109589041096,0.9956366278676583,1.0,6/18,28.18%,ECT2;SYT1;RYR3;MEF2C;ADD1;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.43443329366551664,0.6478459228471665,0.8793103448275862,0.995423123585727,1.0,3/6,24.38%,REST;NFIB;PPARG
prerank,KEGG_2021_Human__RNA degradation,0.3453828692977598,0.6473824112530143,0.92,0.9954897408289713,1.0,6/22,20.69%,HSPA9;CNOT6L;DCP2;TENT4A;BTG2;BTG1
prerank,Reactome_2022__Pexophagy R-HSA-9664873,-0.36651895223799374,-0.6473272252784819,0.8095238095238095,1.0,1.0,1/6,2.95%,ATM
prerank,Reactome_2022__Regulation Of NF-kappa B Signaling R-HSA-9758274,0.3943100901741935,0.6468569343474194,0.8709677419354839,0.9956419384920104,1.0,1/8,8.07%,RPS27A
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.391144924245146,0.646691020937669,0.8974358974358975,0.9954681279949436,1.0,3/12,14.21%,LBR;INSIG1;LSS
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.415568985978648,-0.6465803020142727,0.825,1.0,1.0,3/5,18.86%,NMT1;NMT2;METAP2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),0.4060907307335868,0.6449574915871138,0.9375,0.9965516291422528,1.0,2/9,17.13%,CD55;MALT1
prerank,Reactome_2022__PLC Beta Mediated Events R-HSA-112043,0.338452331297063,0.6449208988737151,0.9452054794520548,0.9962888179430022,1.0,1/21,1.35%,ITPR1
prerank,CellMarker_Augmented_2021__1-Cell Stage Cell (Blastomere):Embryo,0.4124456072978759,0.6447939801373436,0.9117647058823529,0.9960985243869637,1.0,1/6,12.43%,STK38
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.367475100191679,-0.6443314057646613,0.8292682926829268,1.0,1.0,3/6,18.27%,TNFRSF1B;HSPD1;CD47
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.38665091171965293,0.6443088915570108,0.8985507246376812,0.9961450936358835,1.0,2/12,10.07%,RAPGEF3;RAP1A
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3394926208570868,0.6441688367381438,0.9315068493150684,0.9959483810860369,1.0,6/22,22.10%,HYAL2;FGFR1;PAK2;LGALS3;TNFRSF10B;BCL2L14
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.3739026058778637,0.6439188803341943,0.9354838709677419,0.9958668036968118,1.0,3/8,32.24%,OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.3289215907632371,-0.6437754451034962,0.9565217391304348,1.0,1.0,2/23,5.58%,TENT2;THOC1
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.29793407461768356,0.6437022046675525,0.9746835443037974,0.9957688482960148,1.0,13/68,17.61%,ZBTB1;PURA;POLA1;RPS27A;NOC3L;RAD21;RFC3;USP45;CNBP;UHRF2;UBE2B;RIF1;BTG2
prerank,KEGG_2021_Human__Adherens junction,0.32132382904110923,0.6433951950264919,0.9577464788732394,0.9957234996875962,1.0,14/42,26.40%,FGFR1;CTNNA3;CTNNA1;RAC1;ACTN1;PTPN1;AFDN;ACTB;FYN;CSNK2A1;CREBBP;WASL;CDC42;EGFR
prerank,KEGG_2021_Human__Lysine degradation,-0.3079593200797638,-0.6428512886027029,0.9411764705882353,1.0,1.0,4/22,10.15%,EZH1;SMYD3;ACAT1;AASS
prerank,Reactome_2022__SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,-0.3218455576288519,-0.6428330399224684,0.9393939393939394,1.0,1.0,2/13,8.50%,NUP214;MDM2
prerank,Reactome_2022__DNA Damage Recognition In GG-NER R-HSA-5696394,0.37426544996679195,0.6427415896068972,0.9402985074626866,0.995934277292096,1.0,1/9,8.07%,RPS27A
prerank,Reactome_2022__Regulation Of TP53 Degradation R-HSA-6804757,-0.34234333406880596,-0.642466321395181,0.90625,1.0,1.0,4/14,16.79%,ATM;MDM2;UBB;MDM4
prerank,Reactome_2022__Regulation Of TP53 Expression And Degradation R-HSA-6806003,-0.34234333406880596,-0.642466321395181,0.90625,1.0,1.0,4/14,16.79%,ATM;MDM2;UBB;MDM4
prerank,Reactome_2022__Oncogene Induced Senescence R-HSA-2559585,0.3506892527082256,0.6423331748796866,0.9041095890410958,0.9959545536225635,1.0,2/16,8.29%,RPS27A;CDK6
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.2867767965053783,-0.6422807257360448,0.9523809523809523,1.0,1.0,6/29,13.55%,CD74;STAT1;CFLAR;PTPN2;SPPL2A;GAS6
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.34078623930289803,0.6422128251430761,0.9358974358974359,0.9957287143240964,1.0,5/26,17.13%,CALR;WASHC4;SRSF7;TPR;MALT1
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.32847748083486983,0.6417136664421921,0.8888888888888888,0.9957818435829585,1.0,4/26,14.40%,PRNP;CDKN1B;CDKN1A;WWTR1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.3673505457124173,-0.6416619684144863,0.8947368421052632,1.0,1.0,1/8,2.18%,ISG15
prerank,Reactome_2022__G-protein Beta:Gamma Signaling R-HSA-397795,0.4004164157193141,0.6412122847350459,0.9354838709677419,0.9958218236511717,1.0,3/8,36.28%,PLCB1;CDC42;GNG11
prerank,"Reactome_2022__Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",-0.40000188312461743,-0.6410550237499553,0.8285714285714286,1.0,1.0,1/6,3.43%,DCP1A
prerank,CellMarker_Augmented_2021__Bipolar cell:Retina,-0.39880686977194746,-0.6409855847591205,0.84,1.0,1.0,1/5,11.53%,KIAA1549
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.3541301687923484,-0.6406423041105385,0.9166666666666666,1.0,1.0,2/7,17.42%,TMCC1;SPAST
prerank,Reactome_2022__G-protein Mediated Events R-HSA-112040,0.3294038898976075,0.6405932154342738,0.9452054794520548,0.9959470203213362,1.0,1/23,1.35%,ITPR1
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),-0.32449126023236163,-0.640222250733181,1.0,1.0,1.0,2/14,6.77%,TBL1X;TBL1XR1
prerank,Reactome_2022__Peptide Hormone Metabolism R-HSA-2980736,0.36195608459012035,0.6401162659751972,0.935064935064935,0.9959639854151945,1.0,4/18,15.62%,ERO1A;KLF4;ERO1B;SLC30A7
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.3501574545761209,-0.6399723710199592,0.8387096774193549,1.0,1.0,2/12,4.62%,ATR;SLF2
prerank,Reactome_2022__RNA Polymerase I Promoter Escape R-HSA-73772,0.41127669371102066,0.6396410034711606,0.9180327868852459,0.9960038762156661,1.0,2/5,13.25%,CCNH;TAF1D
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.4203110846046043,0.6392564506933204,0.9245283018867925,0.9959749565742757,1.0,3/6,13.47%,SLC4A10;SLC4A7;NEDD4L
prerank,Reactome_2022__E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,0.3515405141105966,0.6387681150171546,0.9104477611940298,0.9960082713764327,1.0,4/16,26.93%,RPS27A;UBE2B;UBC;VCP
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.3256857987223721,0.6383660430011456,0.974025974025974,0.9959760938830655,1.0,12/34,28.90%,KCNMB4;ECT2;SYT1;RYR3;NEDD4;AHCYL1;MEF2C;ADAM9;ADD1;CAMK2D;CALM1;RYR2
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.39928446643541177,-0.6370179066251289,0.8571428571428571,1.0,1.0,2/5,18.83%,HSPA1A;CASP4
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.3882755633858669,-0.6369382481243967,0.9285714285714286,1.0,1.0,1/7,3.69%,TNRC6C
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.3882755633858669,-0.6369382481243967,0.9285714285714286,1.0,1.0,1/7,3.69%,TNRC6C
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.2834972232584268,-0.6367861176615482,0.9655172413793104,1.0,1.0,1/18,3.69%,TNRC6C
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),-0.4125247699898186,-0.6364532728397141,0.7142857142857143,1.0,1.0,1/5,5.63%,ST3GAL6
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.4027787089692445,0.6354378270546833,0.9295774647887324,0.9977471737584946,1.0,1/5,12.62%,CNOT6L
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.32813033129194935,0.6352237989712141,0.9625,0.9976425247690329,1.0,6/34,12.78%,SLC8A1;CACNA1C;ATP1A1;ATP1B3;ANO6;TMEM165
prerank,Reactome_2022__Transport Of Mature Transcript To Cytoplasm R-HSA-72202,-0.32145569273432306,-0.634928440440205,1.0,1.0,1.0,2/21,6.61%,THOC1;NUP214
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.34946636902884415,0.6348946003359563,0.8831168831168831,0.9975510204559862,1.0,1/15,2.52%,TRIM5
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.39476375794386886,0.6348142265522876,0.9242424242424242,0.9973418584057002,1.0,1/8,5.87%,POLA1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.36144878317807105,0.6346867707240426,0.9565217391304348,0.9971589701272995,1.0,3/17,15.25%,KDM1A;JUN;FOXC1
prerank,KEGG_2021_Human__Taste transduction,0.40315641411178743,0.6334977384800836,0.921875,0.9977114541592677,1.0,1/7,5.15%,CACNA1C
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.3612460712561013,-0.6327339861785622,0.918918918918919,1.0,1.0,1/10,3.24%,USP25
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.4401374246240324,0.6313163731186621,0.8985507246376812,0.9986129589514126,1.0,2/5,21.14%,BCL2L1;MCL1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.4401374246240324,0.6313163731186621,0.8985507246376812,0.9986129589514126,1.0,2/5,21.14%,BCL2L1;MCL1
prerank,CellMarker_Augmented_2021__Adventitial cell:Skeletal Muscle,0.3652050030711156,0.6301739437719736,0.9577464788732394,0.9991906464195451,1.0,1/17,0.61%,ZEB2
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.3427361331282299,-0.6300482445205176,0.9032258064516129,1.0,1.0,2/11,5.55%,IFI27;SP100
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.3525117056184437,0.6298090078207103,0.9242424242424242,0.9991413068584879,1.0,2/15,8.31%,NDRG1;GRB2
prerank,KEGG_2021_Human__Cell cycle,0.3234243045074679,0.6297720877206486,0.9873417721518988,0.9988896882437467,1.0,5/37,11.87%,CDK6;CDKN1B;RAD21;CCNH;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.41794675155179545,0.6294364466017396,0.9420289855072463,0.9988306800363222,1.0,2/5,28.15%,NDFIP1;DNAJA1
prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,-0.300936604890507,-0.6292528484200463,0.9,1.0,1.0,4/13,17.95%,CREB5;DCTN4;DYNC2H1;PRKACB
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.4027302747656097,0.6292352515004667,0.9285714285714286,0.9983443701544338,1.0,4/7,39.97%,UBR1;MTOR;SESN3;LARS1
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.4027302747656097,0.6292352515004667,0.9285714285714286,0.9983443701544338,1.0,4/7,39.97%,UBR1;MTOR;SESN3;LARS1
prerank,Reactome_2022__CREB1 Phosphorylation Thru Activation Of Adenylate Cyclase R-HSA-442720,0.3818841825347667,0.6289654838766318,0.9032258064516129,0.9982203903324814,1.0,2/7,28.47%,PRKX;CALM1
prerank,Reactome_2022__NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,0.31025687143625075,0.6288114687406268,0.9102564102564102,0.9980573845024311,1.0,7/25,22.42%,RPS27A;HIF1A;CCNC;NCOR2;HDAC7;CDK8;UBC
prerank,Reactome_2022__RHOU GTPase Cycle R-HSA-9013420,0.3545952263161257,0.6283897081732098,0.96,0.9980996832270127,1.0,2/20,8.31%,PIK3R1;GRB2
prerank,Reactome_2022__RNA Polymerase II Transcription Termination R-HSA-73856,0.363516846247632,0.6272394390329962,0.9324324324324325,0.9983469746415286,1.0,5/15,26.85%,SRSF7;CSTF3;THOC2;SRSF11;PAPOLA
prerank,Reactome_2022__mRNA 3-End Processing R-HSA-72187,0.363516846247632,0.6272394390329962,0.9324324324324325,0.9983469746415286,1.0,5/15,26.85%,SRSF7;CSTF3;THOC2;SRSF11;PAPOLA
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.36063836349928996,0.6271794349175783,0.92,0.9980767273702419,1.0,4/16,21.59%,AGO2;ZC3H7A;NOTCH4;ZFP36
prerank,Reactome_2022__Mitotic Prophase R-HSA-68875,0.32985796054690847,0.6271230495561841,0.96,0.9978066386947715,1.0,8/28,23.51%,LPIN2;ENSA;MCPH1;TPR;RAB2A;ARPP19;TMPO;H3-3B
prerank,CellMarker_Augmented_2021__Lymphoid cell:Peripheral Blood,-0.34760295404953245,-0.6268292196946176,0.9285714285714286,1.0,1.0,1/11,2.55%,EVL
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.3986888926671323,-0.6266415456317066,0.8636363636363636,1.0,1.0,1/5,5.98%,ZNHIT6
prerank,Reactome_2022__Interleukin-6 Signaling R-HSA-1059683,0.40071354371325085,0.626626650007058,0.9285714285714286,0.9978587064479494,1.0,3/9,19.84%,JAK1;STAT3;SOCS3
prerank,Reactome_2022__Defective Pyroptosis R-HSA-9710421,0.39343246827472383,0.6262007603757344,0.9295774647887324,0.9978392095417797,1.0,1/7,5.87%,POLA1
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.4049148897133461,0.6261439525284359,0.8636363636363636,0.9975596762511099,1.0,2/5,32.06%,ATP11A;HDAC9
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.3577449339495229,0.6258107837443175,0.9041095890410958,0.9974622869339222,1.0,3/15,23.85%,PPFIA2;CFL1;TANC2
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.4001535292106262,0.6252804666278482,0.9682539682539683,0.9972059723737514,1.0,2/6,23.16%,PPP3CB;PPP3CC
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.4001535292106262,0.6252804666278482,0.9682539682539683,0.9972059723737514,1.0,2/6,23.16%,PPP3CB;PPP3CC
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.30291088628975305,-0.624676102957388,0.9615384615384616,1.0,1.0,2/15,9.24%,USP25;PSMF1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.3204920079543235,0.6246138879451897,0.9518072289156626,0.9974594255334717,1.0,5/33,14.24%,HSP90AA1;KLF4;OGT;LARP4;PTTG1IP
prerank,Reactome_2022__Transcriptional Regulation By Small RNAs R-HSA-5578749,-0.33326331785149765,-0.6245178706536564,0.8888888888888888,1.0,1.0,2/17,6.61%,H2AC6;NUP214
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.3331366361142988,0.6244930358153462,0.9473684210526315,0.997235591850383,1.0,4/25,14.18%,ANXA1;GRB2;CDKN1A;ECT2
prerank,CellMarker_Augmented_2021__Osteoblast:Bone Marrow,0.36898936638451785,0.6243413236954047,0.9333333333333333,0.9967688537614138,1.0,4/11,22.44%,ALPL;DYSF;SULF2;COL18A1
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryoid Body,0.36898936638451785,0.6243413236954047,0.9333333333333333,0.9967688537614138,1.0,4/11,22.44%,ALPL;DYSF;SULF2;COL18A1
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.24397212741446064,-0.6242537945953726,1.0,1.0,1.0,23/104,17.24%,SCFD2;CD74;RANBP17;VPS45;NUP214;WLS;TBC1D5;HERC2;TECPR2;STX17;TNPO3;EVI5;VPS36;USP6NL;STX3;SNX13;XPO4;STX8;TBC1D4;SYNRG;GGA2;SEC31A;IPO8
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.279266285121284,-0.6242159270845445,0.9666666666666667,1.0,1.0,3/26,8.50%,ISG15;RHBDD1;MDM2
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.43193000924090313,0.6240223032462183,0.9047619047619048,0.9967140540323156,1.0,1/5,7.04%,PINK1
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.41093630656837904,0.6239058911439246,0.9230769230769231,0.9965004262183889,1.0,4/7,36.02%,SND1;MTREX;XRN2;ENTPD4
prerank,Reactome_2022__TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,-0.3147748811250781,-0.6234167711241966,0.84375,1.0,1.0,1/11,3.24%,USP25
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.37640348561497705,0.623350790080273,0.9166666666666666,0.9965786219194103,1.0,3/10,26.72%,KIF16B;SORT1;RAB14
prerank,PanglaoDB_Augmented_2021__Microglia,0.3655980178184258,0.6232701585704412,0.8852459016393442,0.9963359971998258,1.0,2/14,11.90%,PECAM1;FOS
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.3533335936006786,0.6232189254899948,0.9154929577464789,0.9960935142416902,1.0,4/11,22.66%,HIF1A;ACVR2A;STAT3;ETS1
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Placenta,0.3156243008128893,0.622964778059881,0.927536231884058,0.9959483206027484,1.0,4/23,14.42%,CACNA1C;GGT5;LRRC32;TNS1
prerank,KEGG_2021_Human__Arginine and proline metabolism,0.387117507242837,0.622564033934563,0.8888888888888888,0.9959132803084338,1.0,1/8,7.92%,P4HA1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.3099957277613292,-0.6214770802709139,0.9259259259259259,1.0,1.0,4/15,20.48%,THOC1;WDR70;SMARCAD1;NUCKS1
prerank,Reactome_2022__Regulation Of Gene Expression By Hypoxia-inducible Factor R-HSA-1234158,0.3914899487224397,0.6204799060261204,0.8636363636363636,0.997085424862513,1.0,3/6,25.31%,HIF1A;EPAS1;CREBBP
prerank,CellMarker_Augmented_2021__Epidermal Transit Amplifying cell:Foreskin,-0.3003183949436035,-0.6204391500910209,0.9333333333333333,1.0,1.0,8/19,24.52%,PALD1;PSMB1;NDUFS4;POMP;METAP2;PSMD14;RALA;SLIRP
prerank,Reactome_2022__B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,0.3421569127794331,0.6196753228346807,0.9264705882352942,0.9973542028116785,1.0,6/12,33.33%,MYO1E;TAF1D;H3-3B;SMARCA5;DEK;EP300
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.2840505443772098,-0.6196045855328843,1.0,1.0,1.0,8/21,18.19%,PODN;ZNF521;LDB2;LAMA2;IGFBP7;CNRIP1;CXCL12;FAT4
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.2823890796372723,0.6193111660852318,1.0,0.9973026106780524,1.0,21/71,24.78%,RAPGEF3;PICALM;RAP1A;TBC1D15;RGS7;ITGB1;ECT2;CRK;PLXNA2;LIMS1;TGM2;RSU1;RASIP1;AFDN;ARFGEF1;CAV2;LRCH1;RAB3GAP2;WNK1;RACK1;FGD4
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.3339399819400575,0.6192298165749736,0.958904109589041,0.9970538030499655,1.0,1/22,5.37%,EPS8
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.2837655057445535,0.6185916097472564,0.9871794871794872,0.997205981842385,1.0,9/47,19.55%,ESR2;CCNH;TAF1D;WWTR1;NCOR2;NR2C1;HDAC7;NR1D2;NOTCH4
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.3745141717033912,0.6185690416592932,0.9701492537313433,0.9969250309197554,1.0,4/9,23.67%,BACH2;MALT1;NPM1;XPO1
prerank,Reactome_2022__SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,0.3170389442351568,0.6184609345941617,0.9746835443037974,0.996728242121188,1.0,5/28,17.37%,SMC6;RAD21;PIAS2;TPR;HDAC7
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.3140157418511418,0.6171943428773655,0.8974358974358975,0.997154912923432,1.0,4/24,14.18%,KDM1A;GRB2;CDKN1A;ECT2
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.32527280707732886,-0.616606825679744,0.9310344827586207,1.0,1.0,2/15,16.33%,OFD1;CLASP1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.3431327904748336,0.6165383360548962,0.9420289855072463,0.9972261643587714,1.0,3/17,22.42%,RPS27A;GSN;UBC
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.38351063829787235,-0.6153569678418781,0.8292682926829268,1.0,1.0,5/5,61.73%,UBN1;CABIN1;ATRX;NASP;RBBP4
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.33262373602980305,-0.6153546623742501,0.7804878048780488,1.0,1.0,7/7,66.83%,ROCK1;IKBKB;FMNL3;ROCK2;FMNL2;NCKAP1;DLG1
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.3842905344947676,0.6152913922621026,0.921875,0.9977363668186847,1.0,2/7,15.67%,AGO2;TUT7
prerank,KEGG_2021_Human__TGF-beta signaling pathway,0.3318791798435825,0.6151437383074726,0.9420289855072463,0.997536344035987,1.0,3/26,13.52%,SMAD7;SMAD5;ACVR2A
prerank,Reactome_2022__Interleukin-6 Family Signaling R-HSA-6783589,0.3641584804482166,0.61499541001923,0.9154929577464789,0.9973493416782626,1.0,3/12,19.84%,JAK1;STAT3;SOCS3
prerank,Reactome_2022__Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,0.3768017657139068,0.6145516296054236,0.9295774647887324,0.9973366018563501,1.0,2/11,18.62%,STAT3;ARFGEF2
prerank,Reactome_2022__Base Excision Repair R-HSA-73884,-0.39525742401843383,-0.6142719990266529,0.8709677419354839,1.0,1.0,1/5,4.14%,H2AC6
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.34445891671045636,0.6142554304536074,0.9583333333333334,0.9972464902837079,1.0,1/18,6.14%,PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.3182192945376224,0.6142024115353836,0.9166666666666666,0.9969791554090229,1.0,6/28,27.94%,CLDN5;HIP1R;AMFR;ADD1;MARK3;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.27409311718756024,0.6140880795413337,1.0,0.9967570875243073,1.0,14/82,19.55%,KLF2;PIK3R1;JAG2;VWF;HIF1A;NRXN1;GRB10;MGAT5;LIMS1;ZMIZ1;STAT3;RIMS2;SULF2;NOTCH4
prerank,KEGG_2021_Human__Inositol phosphate metabolism,0.33326395064871817,0.6135753845716244,0.9726027397260274,0.9967767477898756,1.0,9/28,27.73%,INPP5F;PIKFYVE;INPP5A;MTMR6;SYNJ2;PLCB1;PIK3C3;PIK3CB;PIP5K1C
prerank,Reactome_2022__RHO GTPases Activate Formins R-HSA-5663220,-0.2506022261788137,-0.6133946545053367,1.0,1.0,1.0,4/37,8.63%,EVL;SCAI;SRGAP2;PPP2R5A
prerank,Reactome_2022__Intrinsic Pathway For Apoptosis R-HSA-109606,0.3364556147904022,0.613154525048834,0.9701492537313433,0.9967319889163598,1.0,10/19,32.91%,STAT3;BCL2L1;YWHAB;AVEN;YWHAE;PPP3CC;XIAP;YWHAQ;YWHAZ;MAPK8
prerank,Reactome_2022__Transcription Of HIV Genome R-HSA-167172,0.35507210550964863,0.61308440399084,0.9850746268656716,0.9964812111800895,1.0,1/12,11.05%,CCNH
prerank,PanglaoDB_Augmented_2021__Basophils,0.3350240183179069,0.6114747056529652,0.9090909090909091,0.9969965859204419,1.0,4/18,24.30%,LAMA5;GATA2;TEC;FGR
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.38052916343058074,0.6114555164647232,0.9384615384615385,0.9967169187063908,1.0,2/6,24.73%,DAG1;RACK1
prerank,Reactome_2022__Regulation Of PTEN mRNA Translation R-HSA-8943723,0.36912109844511226,0.6103816752815481,0.935064935064935,0.997096826784367,1.0,2/9,12.91%,CNOT6L;AGO2
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.3414360946938009,-0.6098545921586289,0.8648648648648649,1.0,1.0,1/6,9.08%,SLC16A2
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,0.359521313060007,0.6098284293563488,0.9565217391304348,0.997135648602066,1.0,5/9,29.40%,CNOT6L;BTG2;NPM1;CNOT2;RGCC
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.3349341138801888,0.6057875926843768,0.9857142857142858,0.9991001033068817,1.0,3/16,12.40%,ATP8B1;PLSCR4;ANO6
prerank,Reactome_2022__Pre-NOTCH Processing In Golgi R-HSA-1912420,-0.3528077266558644,-0.6053088090726743,0.8611111111111112,1.0,1.0,1/7,5.63%,ST3GAL6
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.34027644886216224,-0.6048598954433093,0.8666666666666667,1.0,1.0,1/10,6.61%,NUP214
prerank,Reactome_2022__Transport Of SLBP Independent Mature mRNA R-HSA-159227,-0.34027644886216224,-0.6048598954433093,0.8666666666666667,1.0,1.0,1/10,6.61%,NUP214
prerank,Reactome_2022__SUMOylation Of SUMOylation Proteins R-HSA-4085377,-0.34027644886216224,-0.6048598954433093,0.8666666666666667,1.0,1.0,1/10,6.61%,NUP214
prerank,Reactome_2022__Transport Of SLBP Dependant Mature mRNA R-HSA-159230,-0.34027644886216224,-0.6048598954433093,0.8666666666666667,1.0,1.0,1/10,6.61%,NUP214
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.34027644886216224,-0.6048598954433093,0.8666666666666667,1.0,1.0,1/10,6.61%,NUP214
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.34027644886216224,-0.6048598954433093,0.8666666666666667,1.0,1.0,1/10,6.61%,NUP214
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Liver,0.29512450738297824,0.6045692158505979,0.9861111111111112,0.9988196180908909,1.0,9/36,23.48%,DNAJC5;PICALM;KPNA4;MIDN;CHMP4B;FNDC3B;ATP13A3;OXSR1;ADAM9
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Kidney,0.29512450738297824,0.6045692158505979,0.9861111111111112,0.9988196180908909,1.0,9/36,23.48%,DNAJC5;PICALM;KPNA4;MIDN;CHMP4B;FNDC3B;ATP13A3;OXSR1;ADAM9
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Lymph,0.29512450738297824,0.6045692158505979,0.9861111111111112,0.9988196180908909,1.0,9/36,23.48%,DNAJC5;PICALM;KPNA4;MIDN;CHMP4B;FNDC3B;ATP13A3;OXSR1;ADAM9
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.3403819629041472,0.6033864415405265,0.948051948051948,0.9991789907270907,1.0,9/19,30.94%,CDK6;ATOH8;NFIB;CAV2;SPARC;MTSS1;RGCC;DAB2IP;CASK
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.3535698180920167,-0.6033854070838118,0.9230769230769231,1.0,1.0,2/6,12.06%,ADGRG6;PARD3
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.3568391113283369,0.6030570672959424,0.9285714285714286,0.999079106693076,1.0,6/12,24.38%,FLT1;ATOH8;CAV2;SPARC;MEF2C;PPARG
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.3531293268146701,0.602895318380845,0.9701492537313433,0.9988765860534261,1.0,1/14,4.91%,GRIN2B
prerank,Reactome_2022__Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,0.4100198541523661,0.6028658543027688,0.9264705882352942,0.9985907675356928,1.0,1/5,7.38%,KDM1A
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryo,-0.31149533085751024,-0.6026297914299961,0.9459459459459459,1.0,1.0,4/12,10.92%,TCF7L1;CTBP2;PROM1;SEMA6A
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.3719385058244826,0.6023042673584453,0.9402985074626866,0.9987124470828758,1.0,2/9,9.85%,JUN;GJA1
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.33532392360892693,0.6022559858925013,0.948051948051948,0.9984556990899854,1.0,2/18,9.35%,PIK3R1;SLC38A2
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.2942066581998712,-0.6006704632963717,1.0,1.0,1.0,3/12,11.42%,THOC1;MSH3;SHLD2
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.40656784383678357,0.5998241896407589,0.9230769230769231,0.9994171856236521,1.0,4/5,35.62%,MTOR;WDR43;EIF2AK3;SMARCA4
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.3445685824227279,-0.5995327799942253,0.9565217391304348,1.0,1.0,1/11,6.80%,MGA
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.3445685824227279,-0.5995327799942253,0.9565217391304348,1.0,1.0,1/11,6.80%,MGA
prerank,Reactome_2022__Regulation Of IFNA/IFNB Signaling R-HSA-912694,-0.32681923970718535,-0.5993124744395325,1.0,1.0,1.0,2/7,9.30%,STAT1;STAT2
prerank,Reactome_2022__Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,-0.32632799436407156,-0.5990055907311145,0.9310344827586207,1.0,1.0,1/11,6.61%,NUP214
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,-0.32632799436407156,-0.5990055907311145,0.9310344827586207,1.0,1.0,1/11,6.61%,NUP214
prerank,Reactome_2022__Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,0.32686394928805473,0.5986789511207,0.9444444444444444,0.9997083626702311,1.0,7/16,33.33%,MYO1E;TAF1D;H3-3B;SMARCA5;GATAD2A;DEK;EP300
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.3496544733735783,0.5977990256887146,0.9516129032258065,0.9998552077755797,1.0,4/15,20.58%,STXBP5L;NDFIP1;PTPN1;HSPA8
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.3694573491360442,-0.5975888910573127,0.8717948717948718,1.0,1.0,1/5,9.43%,PIK3C2B
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),-0.282829835207152,-0.5966757840864503,1.0,1.0,1.0,4/17,14.71%,RC3H1;NBDY;HSPA1A;PNPT1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.36264345814969134,-0.5964070205758336,0.975,1.0,1.0,1/5,5.07%,PLXND1
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.33813178442707204,0.5961757868605938,0.9565217391304348,1.0,1.0,5/11,33.33%,NAA16;NAA50;CREBBP;KAT6A;EP300
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.3124000884868578,0.5960623130351146,0.8904109589041096,1.0,1.0,3/18,21.59%,GIGYF2;TUT7;ZFP36
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.3537976002892402,0.5957937837567462,0.9354838709677419,1.0,1.0,4/9,30.81%,KIF16B;EMP2;PIK3C3;RAB7A
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.3734909514097349,0.5954162023138154,0.9571428571428572,0.9999297503600935,1.0,1/7,9.27%,EMP1
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.3089056091627073,-0.5948726151089536,0.8823529411764706,1.0,1.0,3/10,12.83%,MRPS31;EEFSEC;PTCD3
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.3702127659574468,-0.5948397666855828,0.9024390243902439,1.0,1.0,5/5,63.05%,ROCK1;IKBKB;PPP1R12A;ROCK2;NUAK1
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.33334692310269654,0.5946752742905395,0.9850746268656716,1.0,1.0,4/13,19.50%,FGFR1;FOXF1;FUT8;SULF2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Embryo,0.3834880237970738,0.5940206812527179,0.9552238805970149,1.0,1.0,3/7,22.87%,MAP7;VWA2;ATP1B1
prerank,Reactome_2022__Mitotic Spindle Checkpoint R-HSA-69618,-0.2635584089739621,-0.5938327840698325,1.0,1.0,1.0,2/27,8.63%,ANAPC16;PPP2R5A
prerank,Reactome_2022__Regulation Of FZD By Ubiquitination R-HSA-4641263,-0.3257873923318522,-0.5916286926953395,0.8285714285714286,1.0,1.0,1/8,2.97%,ZNRF3
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.3703278761879405,0.5913356686929327,0.9298245614035088,1.0,1.0,1/6,11.29%,MAGI2
prerank,CellMarker_Augmented_2021__Macrophage:Intervertebral Disc,-0.3389815487036993,-0.5910112300327883,0.868421052631579,1.0,1.0,3/7,14.42%,GIMAP8;TNFRSF1B;GIMAP4
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:White Adipose Tissue,0.3390829841137305,0.5910018880325433,0.9655172413793104,1.0,1.0,2/8,19.55%,PECAM1;NOTCH4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.37360920434270956,-0.5905894258506613,0.9032258064516129,1.0,1.0,3/6,18.27%,HSPD1;NFAT5;CD47
prerank,CellMarker_Augmented_2021__Leydig cell:Testis,-0.33798865932177635,-0.5903398931232505,0.90625,1.0,1.0,1/5,6.96%,SCAI
prerank,Reactome_2022__Competing Endogenous RNAs (ceRNAs) Regulate PTEN Translation R-HSA-8948700,0.36934709917630515,0.5901680990313188,0.96,1.0,1.0,2/8,12.91%,CNOT6L;AGO2
prerank,CellMarker_Augmented_2021__Oocyte:Embryo,-0.2452304235707592,-0.5895357653197493,1.0,1.0,1.0,6/30,13.04%,EPB41L5;DHX32;TAPT1;TMCC1;ZNF407;CHIC1
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-0.38111702127659575,-0.5892823759843144,0.8888888888888888,1.0,1.0,5/5,61.97%,FCHSD2;WASF2;CYFIP1;ABI2;NCKAP1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.32032828950728154,-0.5892678729033959,0.9090909090909091,1.0,1.0,2/8,9.00%,ST3GAL6;UGCG
prerank,Reactome_2022__Signaling By NOTCH3 R-HSA-9012852,0.31783504150130826,0.5891076251563663,0.92,1.0,1.0,3/20,9.61%,RPS27A;JAG2;MIB1
prerank,Reactome_2022__Transferrin Endocytosis And Recycling R-HSA-917977,-0.3443947000740209,-0.588665406893255,0.8064516129032258,1.0,1.0,1/7,9.54%,ATP6V1H
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.3038635252546479,0.587296971656493,1.0,1.0,1.0,11/23,33.84%,RAD21;TENT4A;NAA50;MCPH1;CHMP4B;CSNK2A1;ZNF207;KPNB1;CUL3;EML4;RAB11A
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.36068617565966826,0.5872614988549985,0.9491525423728814,1.0,1.0,2/7,17.85%,CD55;LGALS3
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.3750805527313549,0.5871026518744074,0.9032258064516129,1.0,1.0,1/6,15.17%,SRSF7
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.3750805527313549,0.5871026518744074,0.9032258064516129,1.0,1.0,1/6,15.17%,SRSF7
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.3205639797818569,-0.5869565203484076,0.9,1.0,1.0,6/6,68.02%,ACBD6;OGDH;SUCLG2;ACACB;ACOT9;ACACA
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.28720861155100696,0.5867848311228361,0.9855072463768116,1.0,1.0,8/36,22.39%,MAP3K5;PINK1;PHLPP1;SDCBP;DUSP22;TAOK1;MAPK8IP3;PLCB1
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),-0.32366222850180365,-0.586566311821144,0.9666666666666667,1.0,1.0,2/10,11.00%,ARHGAP12;GULP1
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.32408170954092186,0.5860588821879237,0.9538461538461539,1.0,1.0,5/11,34.16%,ARFGEF1;CDH5;RACK1;CYRIB;RAP1B
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.36194891019578346,0.5857894184707939,0.8852459016393442,1.0,1.0,2/7,29.85%,UBE2B;PEX5L
prerank,Reactome_2022__Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,0.2691475726873911,0.5846660208261888,0.9879518072289156,1.0,1.0,1/58,1.04%,SEC22B
prerank,Reactome_2022__Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,-0.32532725415385577,-0.5844924266110316,0.896551724137931,1.0,1.0,1/11,6.61%,NUP214
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.31419754753744067,-0.5841364823489614,0.9629629629629629,1.0,1.0,2/15,14.82%,BICD1;CIRBP
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.3873175909148403,0.5837586008017741,0.9074074074074074,1.0,1.0,2/6,13.68%,NEDD4L;ITGB1
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.3491040462076712,0.583357815360149,1.0,1.0,1.0,2/10,21.09%,TF;DNM2
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.2280868167243092,-0.5829983932150404,1.0,1.0,1.0,11/46,20.21%,SNX2;TBC1D5;ANKFY1;EEA1;EVI5;KLHL20;STX8;VPS50;TMEM87A;GBF1;VPS13A
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.31816741557079264,0.5823005816584702,0.9014084507042254,1.0,1.0,3/16,24.38%,KLF4;CDH5;PPARG
prerank,Reactome_2022__Signaling By WNT In Cancer R-HSA-4791275,-0.2969278559521151,-0.5822378297128373,0.9629629629629629,1.0,1.0,2/14,8.74%,PPP2R5A;CTBP2
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.3774219219778067,0.5817013492423584,0.9649122807017544,1.0,1.0,2/6,37.16%,ZDHHC21;VCL
prerank,KEGG_2021_Human__Other types of O-glycan biosynthesis,-0.2918705403396755,-0.5816684281494583,0.9285714285714286,1.0,1.0,3/16,9.80%,XXYLT1;GXYLT1;C1GALT1
prerank,CellMarker_Augmented_2021__HES1High Progenitor cell:Stomach,0.2848957210300062,0.581631301163638,1.0,1.0,1.0,3/32,9.67%,TINAGL1;BACE2;VWF
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.3636539497816167,0.5815952395426016,0.8955223880597015,1.0,1.0,3/8,20.56%,DLC1;ABL2;RASIP1
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.3916459047780043,0.5813320992773303,0.9193548387096774,1.0,1.0,1/5,19.92%,MORF4L1
prerank,Reactome_2022__RND2 GTPase Cycle R-HSA-9696270,-0.30304909008851455,-0.5812190117386169,0.9411764705882353,1.0,1.0,5/16,13.12%,PLXND1;LRRC1;RBMX;ARHGAP35;KIDINS220
prerank,Reactome_2022__FGFR2 Alternative Splicing R-HSA-6803529,-0.321618743343983,-0.5801217659877664,0.9714285714285714,1.0,1.0,9/9,67.94%,POLR2A;RBFOX2;TIAL1;GTF2F2;HNRNPM;POLR2B;PTBP1;HNRNPF;HNRNPH1
prerank,Reactome_2022__SUMOylation Of DNA Replication Proteins R-HSA-4615885,-0.3031294807757894,-0.5799930017677536,0.967741935483871,1.0,1.0,1/12,6.61%,NUP214
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.3027887396695349,0.5797223704150195,1.0,1.0,1.0,7/30,28.95%,YTHDC1;SRSF7;TPR;ZFP36;THOC2;SRSF11;SMG1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex6:Brain,0.3645176215640291,0.579424636824525,0.9545454545454546,1.0,1.0,2/10,19.04%,DLC1;RYR3
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Stomach,0.36851383200043275,0.5785638742766173,0.9863013698630136,1.0,1.0,5/9,33.31%,TBC1D15;MTOR;PITPNM2;ANKRD37;C2CD2
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.38771660181203815,0.5764295503104617,0.9285714285714286,1.0,1.0,2/5,18.49%,HIF1A;TF
prerank,Reactome_2022__Rab Regulation Of Trafficking R-HSA-9007101,-0.25997156682833433,-0.5762640647714923,1.0,1.0,1.0,2/41,6.16%,ALS2;OPTN
prerank,CellMarker_Augmented_2021__Naive CD8+ T cell:Peripheral Blood,0.2915686518469674,0.5757765734726666,0.9736842105263158,1.0,1.0,6/28,20.16%,BACH2;FKBP5;CD55;NDFIP1;ACTN1;NPM1
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.32172956975439604,-0.5753469759278476,0.9473684210526315,1.0,1.0,1/9,5.95%,TMEM106B
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.26720006823568937,0.574821289732229,0.9873417721518988,1.0,1.0,8/42,19.55%,ESR2;CCNH;WWTR1;NCOR2;NR2C1;HDAC7;NR1D2;NOTCH4
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.3877089481875001,0.5744949120555504,0.9661016949152542,1.0,1.0,1/6,7.38%,KDM1A
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.2805911508780843,-0.574139185024025,1.0,1.0,1.0,4/22,16.33%,OFD1;STARD9;INO80;CLASP1
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.31152902483493494,0.5738787577209612,1.0,1.0,1.0,5/22,24.38%,AGO2;TPR;STAT3;ZFP36;PPARG
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.3075831020638764,0.5734435753953244,1.0,1.0,1.0,2/19,9.99%,SMC6;RAD21
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Undefined,0.2559630003494171,0.5718495015343611,1.0,1.0,1.0,14/89,21.33%,PIKFYVE;GIGYF2;SBNO1;TNKS;TPR;RIF1;RALGAPA1;ALMS1;USP34;CSPP1;BCLAF1;CEP290;ARFGEF1;TAOK1
prerank,Reactome_2022__RNA Polymerase I Transcription R-HSA-73864,0.3320903624650189,0.5717700486353362,0.9253731343283582,1.0,1.0,2/12,13.25%,CCNH;TAF1D
prerank,Reactome_2022__ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.3500931098696462,-0.5708362449297786,0.9142857142857143,1.0,1.0,6/6,65.07%,DHX9;RIPK1;IKBKB;NFKB1;NFKBIA;TBK1
prerank,CellMarker_Augmented_2021__Neural Crest Stem cell:Hair Follicle,0.3330154914709905,0.5708282607201555,0.9,1.0,1.0,2/10,22.34%,TRIB2;SPARC
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.32073911987817505,0.5705163098615906,0.9295774647887324,1.0,1.0,2/15,11.95%,OTUD7B;PPM1A
prerank,Reactome_2022__Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,0.35295438027813897,0.5704390026074772,0.9420289855072463,1.0,1.0,1/8,10.65%,RGS7
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.34358651243227517,0.5703911379876916,0.9861111111111112,1.0,1.0,4/10,21.59%,AGO2;TENT4A;BTG2;ZFP36
prerank,Reactome_2022__RNA Polymerase I Promoter Clearance R-HSA-73854,0.3322031064127927,0.5696240418208105,0.9295774647887324,1.0,1.0,2/11,13.25%,CCNH;TAF1D
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.37606973161405965,0.566921175255737,0.9833333333333333,1.0,1.0,2/7,29.32%,CDH5;CDH18
prerank,Reactome_2022__Recycling Pathway Of L1 R-HSA-437239,0.32033258834543493,0.5667498307166876,0.927536231884058,1.0,1.0,8/14,39.15%,DPYSL2;DNM2;MSN;RPS6KA3;RPS6KA2;RPS6KA5;MAPK1;CLTC
prerank,CellMarker_Augmented_2021__T Helper cell:Undefined,-0.3561170212765957,-0.5664119602198573,0.85,1.0,1.0,5/5,64.46%,IL6R;ENTPD1;IL13RA1;IL18R1;CD34
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.2836549077941916,0.5661481237928371,0.9710144927536232,1.0,1.0,7/36,24.73%,CTNND2;CBFB;GRB10;SULF2;CCNY;CSNK2A1;RACK1
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.37730713258465065,0.5648215053700282,0.9393939393939394,1.0,1.0,2/5,24.81%,AP1G1;SORT1
prerank,Reactome_2022__Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,-0.31414210267272014,-0.5633635581123174,0.96,1.0,1.0,1/12,6.61%,NUP214
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) R-HSA-5685942,0.3435453313050418,0.5632620782615276,0.9375,1.0,1.0,2/11,10.23%,RPS27A;RFC3
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.3760037790376608,0.5631719172951047,0.9310344827586207,1.0,1.0,2/6,25.44%,PPARG;MTOR
prerank,Reactome_2022__Prolactin Receptor Signaling R-HSA-1170546,0.36737757265499993,0.5614142009833665,0.9558823529411765,1.0,1.0,1/5,31.37%,CUL1
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.33549182151779205,0.5613672195334602,0.971830985915493,1.0,1.0,5/9,37.18%,LIMK2;DNM2;RAB11A;CCDC186;SYNJ1
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.28356325272619176,0.5612265960960323,0.974025974025974,1.0,1.0,2/32,7.36%,HSPH1;HSP90AA1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.32475334822825785,0.5610280501671915,0.953125,1.0,1.0,1/13,8.26%,RPL23
prerank,Reactome_2022__Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,0.3078631375770704,0.5586801661224223,0.9848484848484849,1.0,1.0,2/13,21.89%,ADCY2;ADCY9
prerank,Reactome_2022__Aquaporin-mediated Transport R-HSA-445717,0.3078631375770704,0.5586801661224223,0.9848484848484849,1.0,1.0,2/13,21.89%,ADCY2;ADCY9
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.32300800318819667,0.5579273735968385,0.9264705882352942,1.0,1.0,3/11,20.66%,SMAD7;PODXL;AFDN
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.2642498115686377,0.5576140822079282,1.0,1.0,1.0,11/45,25.02%,TRIM5;RPS27A;TAB2;MTDH;MALT1;ARHGEF2;STAT3;NPM1;UBC;PRKCH;TERF2IP
prerank,KEGG_2021_Human__Mucin type O-glycan biosynthesis,-0.27225620029333786,-0.5566040778495338,1.0,1.0,1.0,2/13,9.80%,ST3GAL1;C1GALT1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3671222799344809,0.5563983931431313,1.0,1.0,1.0,4/5,33.84%,BRD4;NPM1;MECP2;RAB11A
prerank,Reactome_2022__Ion Transport By P-type ATPases R-HSA-936837,0.31219642348461446,0.5556104917809039,0.9863013698630136,1.0,1.0,10/18,29.51%,ATP8B1;ATP2B1;ATP1B3;ATP2B4;ATP11C;ATP1B1;ATP8A1;CAMK2D;CALM1;ATP11A
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.2510118680014451,0.5550880315283052,1.0,1.0,1.0,10/77,18.33%,YTHDC1;U2SURP;SPEN;RBM17;STRAP;RALY;SRSF7;HNRNPH3;TRA2B;CSTF3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.3692188466531284,-0.5545485048356641,0.96875,1.0,1.0,1/5,9.06%,STXBP4
prerank,Reactome_2022__PKMTs Methylate Histone Lysines R-HSA-3214841,0.2900596063798674,0.5536336133342327,0.9857142857142858,1.0,1.0,5/20,31.69%,SETD3;KMT2E;NSD2;KMT2A;AEBP2
prerank,"Reactome_2022__Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.2762337441931895,-0.5536282907009521,1.0,1.0,1.0,5/16,21.70%,NOD1;CYLD;CASP4;MAPK14;APP
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),0.3906225299138979,0.5532140852208309,0.953125,1.0,1.0,2/5,17.98%,ERBIN;ARHGEF2
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.31327899593844144,0.5531401545090856,0.9558823529411765,1.0,1.0,4/12,26.35%,GOLPH3;MSN;CDC42;SIPA1L3
prerank,CellMarker_Augmented_2021__Preadipocyte:Adipose Tissue,-0.3221092686040964,-0.5520100910117994,0.9375,1.0,1.0,3/8,14.42%,GIMAP8;TNFRSF1B;GIMAP4
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.3481413451159474,0.5493238712822673,0.95,1.0,1.0,3/6,21.70%,FUT8;ST6GALNAC3;B4GALT1
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.345207836537866,-0.5480497658282296,0.8857142857142857,1.0,1.0,1/5,9.67%,PIGU
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.36113955552523946,0.545723332204218,0.9142857142857143,1.0,1.0,3/6,29.24%,SETD3;WDR82;KMT2A
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.3008050543786572,-0.5455496716027354,0.9428571428571428,1.0,1.0,2/11,19.89%,PDGFB;NSMCE2
prerank,CellMarker_Augmented_2021__Kupffer cell:Fetal Liver,0.35447556288741544,0.5446242809512994,0.9393939393939394,1.0,1.0,1/5,10.46%,PECAM1
prerank,CellMarker_Augmented_2021__M2 macrophage:Serum,0.35447556288741544,0.5446242809512994,0.9393939393939394,1.0,1.0,1/5,10.46%,PECAM1
prerank,CellMarker_Augmented_2021__M2 macrophage:Brain,0.35447556288741544,0.5446242809512994,0.9393939393939394,1.0,1.0,1/5,10.46%,PECAM1
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.27260694886816966,0.5437402145942895,0.9859154929577465,1.0,1.0,8/28,24.78%,SCARB2;TBC1D15;CRK;PLXNA2;PAFAH1B1;RASIP1;RAB3GAP2;FGD4
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.3027439012884806,-0.5433776627738279,1.0,1.0,1.0,1/7,9.06%,STXBP4
prerank,Reactome_2022__Role Of ABL In ROBO-SLIT Signaling R-HSA-428890,0.37084098910625496,0.5426493617040314,0.9452054794520548,1.0,1.0,1/5,19.10%,ABL2
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.3250864591646715,-0.5424948681629658,0.9142857142857143,1.0,1.0,6/6,67.57%,NSMCE2;CDC16;ANAPC5;CDC27;RB1;CUL3
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.3250864591646715,-0.5424948681629658,0.9142857142857143,1.0,1.0,6/6,67.57%,NSMCE2;CDC16;ANAPC5;CDC27;RB1;CUL3
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.3250864591646715,-0.5424948681629658,0.9142857142857143,1.0,1.0,6/6,67.57%,NSMCE2;CDC16;ANAPC5;CDC27;RB1;CUL3
prerank,Reactome_2022__Interleukin-20 Family Signaling R-HSA-8854691,0.3517917342224472,0.5416981105393553,0.9863013698630136,1.0,1.0,3/8,19.84%,JAK1;STAT3;SOCS3
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.3540353682267527,-0.5408674295183877,0.8918918918918919,1.0,1.0,1/5,8.58%,ST3GAL1
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.32500034589588367,-0.5398990441528786,0.9210526315789473,1.0,1.0,1/6,13.57%,MTMR3
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.330316742081448,-0.5397873657734987,0.9666666666666667,1.0,1.0,8/8,67.07%,CCM2;RBPJ;STARD13;PRKD2;CTNNB1;RHOA;RHOB;ACVRL1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),0.3665912948842901,0.5397461251517356,0.9814814814814815,1.0,1.0,1/6,7.38%,KDM1A
prerank,KEGG_2021_Human__Spliceosome,0.27390706623932587,0.5388895829477917,1.0,1.0,1.0,5/36,20.58%,U2SURP;RBM17;SRSF7;TRA2B;HSPA8
prerank,CellMarker_Augmented_2021__Epithelial cell:Epithelium,0.2670885973647384,0.5386865866174295,1.0,1.0,1.0,9/37,22.52%,GGT5;VWF;ZNF366;PECAM1;CLDN5;ESAM;NOTCH4;CDH5;SCARF1
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),-0.32481158192241233,-0.537854106595161,0.9393939393939394,1.0,1.0,1/5,11.69%,MFF
prerank,Reactome_2022__Amino Acids Regulate mTORC1 R-HSA-9639288,-0.27762096423280025,-0.5375432363481151,1.0,1.0,1.0,1/13,9.54%,ATP6V1H
prerank,Reactome_2022__SUMOylation Of RNA Binding Proteins R-HSA-4570464,-0.25283111316968176,-0.5363291354978145,0.9583333333333334,1.0,1.0,1/15,6.61%,NUP214
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.33044558841862426,0.5359049836997377,1.0,1.0,1.0,1/11,5.26%,WDR48
prerank,Reactome_2022__CTLA4 Inhibitory Signaling R-HSA-389513,-0.338899618020538,-0.5357688943072859,0.9655172413793104,1.0,1.0,1/8,8.63%,PPP2R5A
prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,-0.3500931098696462,-0.5351902814285038,0.9696969696969697,1.0,1.0,6/6,65.07%,RIPK1;IKBKB;NFKB1;ADAR;NFKBIA;TBK1
prerank,GO_Biological_Process_2021__morphogenesis of an endothelium (GO:0003159),-0.3300531914893617,-0.5341727762927998,1.0,1.0,1.0,5/5,67.07%,CCM2;PRKD2;CTNNB1;RHOB;ACVRL1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.3551367112791354,0.5340038301310477,0.95,1.0,1.0,1/5,17.10%,DAG1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.3551367112791354,0.5340038301310477,0.95,1.0,1.0,1/5,17.10%,DAG1
prerank,Reactome_2022__Amyloid Fiber Formation R-HSA-977225,0.2941526020293631,0.5339444230369219,0.9863013698630136,1.0,1.0,4/17,23.51%,RPS27A;GSN;UBC;H3-3B
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.2562311887220189,0.5337771101720541,0.9705882352941176,1.0,1.0,13/29,38.62%,TNKS;OXSR1;CSNK2A1;WNK1;HIPK3;MAP2K1;CAMK2D;MAPK8;PRKDC;NLK;TBK1;MAPK1;TGFBR2
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Bone Marrow,0.31892604272084235,0.5336338060605547,0.9253731343283582,1.0,1.0,1/8,10.46%,PECAM1
prerank,Reactome_2022__RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,0.36365004563066516,0.5335033450282645,0.9855072463768116,1.0,1.0,1/5,18.91%,NFIB
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.3614632979889184,0.5324821314753962,0.9402985074626866,1.0,1.0,3/5,25.23%,LPIN2;LPGAT1;SEL1L
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.2864462460611747,-0.5321518774149901,0.9428571428571428,1.0,1.0,3/10,20.88%,HSPD1;CD47;MAPK14
prerank,Reactome_2022__TBC/RABGAPs R-HSA-8854214,0.33964745574238553,0.5317775067177877,0.9830508474576272,1.0,1.0,6/10,33.84%,TBC1D15;RAB8B;RABGAP1;RAB7A;RABEP1;RAB11A
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.3397424524381198,0.5309658142069256,0.9838709677419355,1.0,1.0,1/9,7.04%,PINK1
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.32342597677135776,0.5306850629402864,0.9841269841269841,1.0,1.0,1/8,12.01%,FOXF1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.24075257495736643,0.5300985561569657,1.0,1.0,1.0,23/71,33.86%,YTHDC1;U2SURP;SPEN;RBM17;RALY;SRSF7;HNRNPH3;TRA2B;CSTF3;HSPA8;CWC22;SRSF11;PAPOLA;HNRNPU;MTREX;PRPF40A;CWF19L2;HNRNPH1;HNRNPF;HNRNPK;PRPF8;RNPC3;PTBP1
prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,0.23307058605661962,0.5298255970060407,1.0,1.0,1.0,17/60,32.48%,RPS27A;UBE2J1;NEDD4L;PIAS2;UBE2B;SOCS3;NEDD4;UBC;UBE2Q2;UBE2R2;UBE2H;XIAP;TRIP12;UBR5;UBE3A;CUL1;CUL3
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.28565351583638104,-0.5296818808218563,0.9642857142857143,1.0,1.0,4/11,19.23%,PPP1R13B;NMT1;PMAIP1;YWHAG
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.28565351583638104,-0.5296818808218563,0.9642857142857143,1.0,1.0,4/11,19.23%,PPP1R13B;NMT1;PMAIP1;YWHAG
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.2898046049166431,0.5272107285764844,0.9552238805970149,1.0,1.0,4/17,20.45%,SIN3B;REST;MORF4L1;RCOR3
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.27596987616666346,-0.5270559822412697,1.0,1.0,1.0,2/21,5.58%,TENT2;THOC1
prerank,CellMarker_Augmented_2021__Monocyte:Bone Marrow,0.3368258806785519,0.5266962453773076,0.9538461538461539,1.0,1.0,1/6,10.46%,PECAM1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.31061153554434673,0.5266135081272798,0.9871794871794872,1.0,1.0,2/16,9.35%,PIK3R1;SLC38A2
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.3139043771000323,-0.5265486455530477,0.875,1.0,1.0,2/7,21.01%,CLASP1;PHLDB2
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.3554427606589946,0.5259042768171007,0.9821428571428571,1.0,1.0,1/6,12.88%,BCAR1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.29718192956035755,0.52585488572529,0.9710144927536232,1.0,1.0,2/21,10.20%,CCDC88A;TBC1D15
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.2949946751863685,-0.5253729654828662,0.9375,1.0,1.0,9/9,70.60%,POLR2A;BAZ2A;FUBP3;EPC1;PTMA;MMS19;MEF2A;POLR2B;THRB
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.343508326068072,0.5243040140454204,0.9696969696969697,1.0,1.0,2/5,21.12%,FOXC1;VEGFC
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.2840858943390029,0.5237524656498872,0.9861111111111112,1.0,1.0,6/26,22.34%,HIF1A;ATOH8;EGFL7;VEGFC;CAV2;SPARC
prerank,Reactome_2022__Regulation Of FOXO Transcriptional Activity By Acetylation R-HSA-9617629,-0.322609100494687,-0.5223856203835429,0.9487179487179487,1.0,1.0,1/7,11.26%,FOXO1
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.3289628366616769,0.5213699792012219,1.0,1.0,1.0,3/6,40.42%,KPNA1;KPNB1;DICER1
prerank,Reactome_2022__NLRP3 Inflammasome R-HSA-844456,-0.338031914893617,-0.5201351704130421,0.9791666666666666,1.0,1.0,5/5,66.27%,APP;SUGT1;NFKB1;TXNIP;HSP90AB1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.3296659863704655,0.5189025595834846,0.9682539682539683,1.0,1.0,4/7,44.54%,ACACA;FAR1;HSD17B4;CBR4
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2777417556225168,0.5185939337707093,0.9868421052631579,1.0,1.0,6/28,28.95%,YTHDC1;SRSF7;TPR;THOC2;SRSF11;SMG1
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.2777417556225168,0.5185939337707093,0.9868421052631579,1.0,1.0,6/28,28.95%,YTHDC1;SRSF7;TPR;THOC2;SRSF11;SMG1
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.27690074367532364,0.5177729876243043,0.9868421052631579,1.0,1.0,6/29,28.95%,YTHDC1;SRSF7;TPR;THOC2;SRSF11;SMG1
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),-0.3024439119065785,-0.5168916450806885,0.9230769230769231,1.0,1.0,2/5,18.03%,SPG11;RAB27A
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.2905043198336851,0.5167208040539981,0.9859154929577465,1.0,1.0,1/12,7.04%,PINK1
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.3217811903492185,0.515551789109513,0.9375,1.0,1.0,3/7,36.87%,CSNK1D;NDEL1;RANBP9
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.2736388679484183,0.5128398348609347,0.9852941176470589,1.0,1.0,7/28,21.99%,PRNP;WWTR1;ENSA;DMD;ATP2B4;ARPP19;YWHAB
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.2634193452250962,0.5127289425779993,1.0,1.0,1.0,10/29,32.48%,PELI1;NEDD4L;UBE2B;AMFR;UBE2Q2;UBE2R2;UBE2H;UBR5;UBE3A;CUL3
prerank,Reactome_2022__Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.338031914893617,-0.5120525792167451,1.0,1.0,1.0,5/5,66.27%,SUGT1;ENTPD1;NFKB1;TXNIP;HSP90AB1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.2819637424405899,-0.5105354064112679,0.9705882352941176,1.0,1.0,2/8,12.91%,HLA-F;HLA-A
prerank,Reactome_2022__Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,0.29436705597893714,0.509932450640809,0.987012987012987,1.0,1.0,4/14,27.76%,RPS27A;UBC;XPO1;XIAP
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.31191148528354407,0.5093918023111752,0.9710144927536232,1.0,1.0,2/7,35.33%,TMEM65;DLL4
prerank,Reactome_2022__Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,0.3254647553068358,0.507129248847819,0.9375,1.0,1.0,2/6,32.03%,LMBRD1;ACACA
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.24411970706587857,0.5068170030387208,1.0,1.0,1.0,13/32,38.62%,TNKS;OXSR1;CSNK2A1;WNK1;HIPK3;MAP2K1;CAMK2D;MAPK8;PRKDC;NLK;TBK1;MAPK1;TGFBR2
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.22929394993535102,0.5063512046196318,1.0,1.0,1.0,26/85,33.86%,YTHDC1;U2SURP;SPEN;RBM17;CCNH;RALY;SRSF7;HNRNPH3;TRA2B;CSTF3;HSPA8;THOC2;CWC22;SRSF11;PAPOLA;HNRNPU;MTREX;PRPF40A;CWF19L2;HNRNPH1;HNRNPF;HNRNPK;PRPF8;RPRD1B;RNPC3;PTBP1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.3284928697275586,0.5060803049504309,1.0,1.0,1.0,1/6,12.01%,FOXF1
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.28264148698285274,0.5059992349513373,0.9863013698630136,1.0,1.0,8/15,33.52%,PRKX;PODXL;RASIP1;MTSS1;MEF2C;RYR2;ACVRL1;RHOB
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.3295756372237534,0.5053544830347252,0.984375,1.0,1.0,3/5,34.77%,ADCY9;ZDHHC21;AKAP13
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.2944131550689568,-0.5044119906467776,0.8888888888888888,1.0,1.0,2/6,21.51%,MFF;OPA1
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.22551080587029587,-0.5043292642187848,1.0,1.0,1.0,2/29,7.36%,IVNS1ABP;WBP4
prerank,Reactome_2022__Presynaptic Function Of Kainate Receptors R-HSA-500657,0.3242743067518377,0.5040826219362406,0.9846153846153847,1.0,1.0,2/5,36.28%,PLCB1;GNG11
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,0.3242743067518377,0.5040826219362406,0.9846153846153847,1.0,1.0,2/5,36.28%,PLCB1;GNG11
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.2657524891583351,-0.5015182555245289,0.9696969696969697,1.0,1.0,1/11,7.30%,PKD2
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.2945807233537521,-0.5009380519094726,0.972972972972973,1.0,1.0,1/5,12.27%,ARHGAP35
prerank,Reactome_2022__Regulation Of TNFR1 Signaling R-HSA-5357905,0.2853896419210441,0.5001340410360005,1.0,1.0,1.0,2/16,10.62%,RPS27A;OTUD7B
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),-0.33014099494546423,-0.5000899946124655,0.9782608695652174,1.0,1.0,6/6,67.07%,MBOAT2;PTPN11;TRPS1;ZBTB16;SOX5;ACVRL1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.2898041742558409,0.4970886485549117,0.9855072463768116,1.0,1.0,7/13,32.91%,HIP1R;YWHAB;YWHAE;PPP3CC;YWHAQ;YWHAZ;MAPK8
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.2728586115094479,-0.49685376493029265,0.9375,1.0,1.0,5/11,28.47%,GIMAP4;RORA;GIMAP7;NFATC2;NR3C1
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.2603082247517972,0.49645185770045536,0.9838709677419355,1.0,1.0,3/15,17.58%,SULT1C4;ADSS2;TPST2
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.2965576504840809,0.495807345233669,0.9710144927536232,1.0,1.0,4/9,37.37%,UBE2B;UBE2H;PRKN;UBE2D3
prerank,Reactome_2022__Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,0.2780032953222752,0.4955648119829409,1.0,1.0,1.0,1/16,13.28%,TMF1
prerank,"Reactome_2022__Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",0.28941084742570566,0.4947131360251718,0.9830508474576272,1.0,1.0,2/8,18.59%,TPST2;ARSG
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.3045137027620987,-0.494408411542068,0.9347826086956522,1.0,1.0,1/7,5.79%,BMP2K
prerank,Reactome_2022__SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,0.23291310852906216,0.494299911002273,1.0,1.0,1.0,13/60,26.56%,SMC6;RAD21;PIAS2;UHRF2;NCOR2;NR2C1;TPR;HDAC7;NPM1;PPARG;CREBBP;SMC3;RNF168
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.3057902661029184,0.4941789918783783,0.9846153846153847,1.0,1.0,3/7,31.82%,RELL1;SASH1;GADD45B
prerank,Reactome_2022__Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,-0.2793953673463534,-0.49391704376532647,1.0,1.0,1.0,1/11,6.61%,NUP214
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Pancreas,-0.3103723404255319,-0.49390005899298645,0.9487179487179487,1.0,1.0,5/5,69.03%,CHN1;SYT11;CDH2;ABI2;OPCML
prerank,Reactome_2022__Nuclear Envelope Breakdown R-HSA-2980766,0.2810137147688948,0.49116243013671207,1.0,1.0,1.0,3/16,22.63%,LPIN2;TPR;TMPO
prerank,Reactome_2022__YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,0.3197174843640254,0.4909926027667144,1.0,1.0,1.0,1/7,14.40%,WWTR1
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.31353839371579206,0.4899202048738279,0.9393939393939394,1.0,1.0,3/6,26.93%,CHMP4B;SORT1;VCP
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.27719317263887683,0.4888800828828551,1.0,1.0,1.0,5/11,39.97%,GOLPH3;SLC38A9;SIK3;WDR59;LARS1
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.29121202590932815,0.4888576223177907,0.9846153846153847,1.0,1.0,3/11,20.56%,DLC1;ABL2;RASIP1
prerank,Reactome_2022__mRNA Splicing R-HSA-72172,0.22757952723898375,0.4885522196773201,1.0,1.0,1.0,18/57,33.86%,U2SURP;RBM17;SRSF7;TRA2B;CSTF3;HSPA8;CWC22;SRSF11;PAPOLA;HNRNPU;MTREX;PRPF40A;HNRNPH1;HNRNPF;HNRNPK;PRPF8;RNPC3;PTBP1
prerank,Reactome_2022__SUMOylation R-HSA-2990846,0.22532361616470403,0.4879646868732179,1.0,1.0,1.0,13/62,26.56%,SMC6;RAD21;PIAS2;UHRF2;NCOR2;NR2C1;TPR;HDAC7;NPM1;PPARG;CREBBP;SMC3;RNF168
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.3119680172253084,0.4873636654045764,0.9726027397260274,1.0,1.0,4/7,34.45%,SLC1A2;SLC6A6;SLC7A5;SLC1A1
prerank,Reactome_2022__Biotin Transport And Metabolism R-HSA-196780,-0.3204787234042553,-0.4869504062212212,0.9318181818181818,1.0,1.0,5/5,68.02%,PCCA;SLC5A6;ACACB;HLCS;ACACA
prerank,CellMarker_Augmented_2021__Effector CD4+ Memory T (Tem) cell:Blood,-0.2686265490919951,-0.48667137478278916,1.0,1.0,1.0,1/5,13.36%,RCSD1
prerank,Reactome_2022__mRNA Splicing - Minor Pathway R-HSA-72165,-0.2554006753811137,-0.4863961023310224,1.0,0.9999492722048373,1.0,2/9,16.15%,DDX42;POLR2A
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.2631045467647211,-0.485126249855582,0.9615384615384616,0.9994191368116799,1.0,1/11,6.61%,NUP214
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.3038454478556859,0.48465870783331905,0.967741935483871,1.0,1.0,4/8,32.99%,TMEFF2;ADAM17;MRTFA;ACVRL1
prerank,Reactome_2022__Nuclear Import Of Rev Protein R-HSA-180746,-0.2407261087192054,-0.4840124283099621,0.9642857142857143,0.9988253789413737,1.0,1/12,6.61%,NUP214
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.3115396075529654,0.4829976892089669,0.971830985915493,1.0,1.0,2/6,29.40%,FSCN1;RGCC
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.2719384710838788,0.482571368173453,1.0,1.0,1.0,3/12,25.44%,RAC1;MSN;MTOR
prerank,Reactome_2022__Interactions Of Rev With Host Cellular Proteins R-HSA-177243,0.2742061749979392,0.47669717531723926,1.0,1.0,1.0,6/13,36.52%,TPR;NPM1;XPO1;KPNB1;RANBP2;NUP54
prerank,Reactome_2022__mRNA Splicing - Major Pathway R-HSA-72163,0.2221615048584664,0.4762449021074611,1.0,1.0,1.0,17/56,33.86%,U2SURP;RBM17;SRSF7;TRA2B;CSTF3;HSPA8;CWC22;SRSF11;PAPOLA;HNRNPU;MTREX;PRPF40A;HNRNPH1;HNRNPF;HNRNPK;PRPF8;PTBP1
prerank,Reactome_2022__NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,-0.24516729234154616,-0.4727069928727759,1.0,1.0,1.0,2/9,13.86%,MAML3;MAML2
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.2480026909219187,0.4727019501666443,0.9857142857142858,1.0,1.0,7/19,33.33%,ATF2;NAA50;MORF4L1;CREBBP;PHF20L1;KAT6A;EP300
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),-0.28854127617772785,-0.47254736665783403,1.0,1.0,1.0,2/6,18.03%,SPG11;RAB27A
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.31451199758768683,0.4709241423394981,1.0,1.0,1.0,3/5,29.93%,PIK3CB;CD63;DAB2IP
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.2798616653365257,-0.4707003078572187,0.96875,0.9996219779996586,1.0,6/6,72.08%,GNB4;GNAI2;GNG4;GNB1;GNG11;GNAI3
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.2941529619257711,0.46904696989787487,0.96875,1.0,1.0,3/6,33.25%,SH3KBP1;CYRIB;PRKDC
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),-0.2597817407505989,-0.46528450269479193,1.0,1.0,1.0,8/8,74.10%,USP6NL;AKAP9;STX18;ARMH3;PDCD10;MAPK1;CAMSAP2;MAP2K1
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.26848235253621877,0.46514000621437773,1.0,1.0,1.0,4/14,27.94%,BACE2;DAG1;ADAM9;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.25377577764685033,-0.4644795310779436,0.9714285714285714,0.9992331788493628,1.0,1/10,6.43%,ELAPOR2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.2806977130591789,0.46205121248698006,0.9850746268656716,1.0,1.0,4/6,37.66%,DNAJC13;MAP2K1;USP7;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.27528831135426046,0.46025742991722146,0.9726027397260274,1.0,1.0,3/10,34.58%,MTOR;RGCC;MTPN
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.26437699680511184,-0.4594231684375874,1.0,0.9994071066824378,1.0,9/9,73.65%,MDM4;PRKAA1;PDE3B;NCOR1;HDAC4;SNX3;IRAK3;CST3;EGFR
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.29563662706361743,0.4576311088940157,0.9705882352941176,1.0,1.0,3/7,31.45%,FLT1;FGR;PTK2
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.2958784040494449,0.45622372572762737,1.0,1.0,1.0,3/6,40.35%,ELK4;HDAC9;SFPQ
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.24664490053450752,-0.4514978351469902,1.0,0.9999659579518897,1.0,2/9,14.98%,BST2;MAP3K2
prerank,Reactome_2022__Activation Of HOX Genes During Differentiation R-HSA-5619507,0.2433291077440223,0.4511026211619729,0.9848484848484849,1.0,1.0,5/18,28.23%,JUN;PIAS2;H3-3B;CREBBP;YY1
prerank,Reactome_2022__RHO GTPases Activate NADPH Oxidases R-HSA-5668599,0.28506410198814663,0.45077045483801015,1.0,1.0,1.0,4/6,47.84%,PIK3C3;MAPK1;PDZD2;PRKCA
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreatic Acinar Tissue,0.28660616233187375,0.45014390484205913,0.9857142857142858,1.0,1.0,3/8,32.59%,SH2D3C;FGR;ST8SIA4
prerank,CellMarker_Augmented_2021__Definitive Endoderm cell:Germ,0.28660616233187375,0.45014390484205913,0.9857142857142858,1.0,1.0,3/8,32.59%,SH2D3C;FGR;ST8SIA4
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreatic Acinar Tissue,0.28660616233187375,0.45014390484205913,0.9857142857142858,1.0,1.0,3/8,32.59%,SH2D3C;FGR;ST8SIA4
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.25673593604313383,0.44959269891293596,1.0,1.0,1.0,2/17,17.00%,AGO2;TPR
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.25673593604313383,0.44959269891293596,1.0,1.0,1.0,2/17,17.00%,AGO2;TPR
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.2551999537527757,0.44650563690194417,1.0,1.0,1.0,3/14,23.43%,ABL2;YWHAB;PHACTR4
prerank,Reactome_2022__SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,0.25511328293108193,0.44462762188367977,1.0,1.0,1.0,2/18,17.00%,PIAS2;TPR
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.2878150991146759,0.4437424883102697,1.0,1.0,1.0,2/7,29.40%,DAG1;RGCC
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.27573438663667205,0.4436988400978872,1.0,1.0,1.0,2/9,26.06%,NPM1;SMARCA5
prerank,Reactome_2022__Interleukin-37 Signaling R-HSA-9008059,0.2797835800522414,0.4420579961966563,0.9841269841269841,1.0,1.0,6/9,43.43%,STAT3;PTPN14;TBK1;IL18R1;PTPN12;SMAD3
prerank,Reactome_2022__Iron Uptake And Transport R-HSA-917937,-0.2228027052217874,-0.4370261931860147,1.0,1.0,1.0,4/20,17.00%,ABCG2;ATP6V1H;UBB;IREB2
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.27836735367287935,0.43621229365137903,1.0,0.9996084533016861,1.0,2/8,26.06%,NPM1;SMARCA5
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.27836735367287935,0.43621229365137903,1.0,0.9996084533016861,1.0,2/8,26.06%,NPM1;SMARCA5
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.27836735367287935,0.43621229365137903,1.0,0.9996084533016861,1.0,2/8,26.06%,NPM1;SMARCA5
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.27836735367287935,0.43621229365137903,1.0,0.9996084533016861,1.0,2/8,26.06%,NPM1;SMARCA5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),-0.27993053302918347,-0.43426918021741123,1.0,1.0,1.0,2/5,20.88%,HSPD1;MAPK14
prerank,KEGG_2021_Human__Notch signaling pathway,0.24635062632763205,0.43355073537306354,1.0,0.9996018521292636,1.0,3/19,19.55%,JAG2;NCOR2;NOTCH4
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.2798616653365257,-0.43294972399947956,1.0,0.99880058897191,1.0,6/6,72.08%,OPA1;GIMAP7;LRRK2;MFN1;AK3;GNAI3
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.2798616653365257,-0.43294972399947956,1.0,0.99880058897191,1.0,6/6,72.08%,OPA1;GIMAP7;LRRK2;MFN1;AK3;GNAI3
prerank,Reactome_2022__ALK Mutants Bind TKIs R-HSA-9700645,-0.23938434005810946,-0.43184293156177767,1.0,0.9979727685942295,1.0,1/9,9.93%,FN1
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),0.23669184771326898,0.42884371961531104,1.0,0.9997545707187135,1.0,4/12,32.99%,CDKN1A;TERF2IP;KMT2A;ACVRL1
prerank,Reactome_2022__G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,0.27451378328771225,0.42872379314060804,1.0,0.9994906471232298,1.0,2/5,36.28%,CDC42;GNG11
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.25153047644397125,-0.4236519279218434,1.0,0.998040330962023,1.0,8/8,74.93%,ATXN7;UIMC1;TRRAP;SUPT3H;USP3;USP15;USP7;USP22
prerank,Reactome_2022__Activation Of BH3-only Proteins R-HSA-114452,0.25049337805128435,0.4152230994208855,1.0,1.0,1.0,6/11,32.91%,YWHAB;YWHAE;PPP3CC;YWHAQ;YWHAZ;MAPK8
prerank,Reactome_2022__XBP1(S) Activates Chaperone Genes R-HSA-381038,0.2623302013346772,0.41053709389654064,1.0,1.0,1.0,2/6,28.21%,ADD1;DNAJC3
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.2857972470900836,-0.4034266229533688,1.0,0.9986392918648079,1.0,2/5,15.54%,MDM2;UBB
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.2381484269881223,0.4006001813553472,1.0,1.0,1.0,2/13,21.09%,TF;DNM2
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.2630143404078286,0.39983920722394845,1.0,1.0,1.0,2/10,23.03%,DMD;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.24416573701479535,0.3862561167055631,1.0,1.0,1.0,3/8,32.48%,PPP1R10;USP22;CUL3
prerank,Reactome_2022__Regulation Of Localization Of FOXO Transcription Factors R-HSA-9614399,0.2387346337351378,0.3811853266462457,1.0,1.0,1.0,3/7,32.72%,YWHAB;YWHAQ;YWHAZ
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.2376515838796144,0.380717800507237,1.0,0.999949188203183,1.0,2/11,26.06%,NPM1;SMARCA5
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),0.25328385777221774,0.3791236188800775,1.0,0.9994347641438815,1.0,3/5,41.59%,TERF2IP;POLR2B;POT1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),0.25328385777221774,0.3791236188800775,1.0,0.9994347641438815,1.0,3/5,41.59%,TERF2IP;POLR2B;POT1
